{"drug_targets_metabolic_all": {"N-(3-phenylamino-4-pyridinyl)methanesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06DRL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "PMID27539678-Compound-13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0HM6Q", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "1-(4-Methylpent-3-en-2-ylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07EFI", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID27539678-Compound-11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QT5B", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "PMID27539678-Compound-10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0DG7E", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "PMID27539678-Compound-17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0TR9T", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "PMID27539678-Compound-16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G2TX", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "PMID27539678-Compound-14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H1BQ", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "Ranirestat": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0K8TI", "drug_id_DB": "DB05327", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "N-(naphthalen-1-yl)benzo[d]isoxazol-3-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00HAZ", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Se-Ethyl-Isoselenourea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02RNH", "drug_id_DB": "DB02589", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "ASP-3258": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N7HS", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "BMS-191095": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D04JGA", "drug_id_DB": "", "metabolic_annotation_str": "ABCC9(ATP-binding cassette transporter C9 (ABCC9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["10060"]}, "PMID27539678-Compound-12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07QBL", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "2,4'-Dimethoxy-5,3'-dipropyl-biphenyl": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NB0I", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Meloxicam(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0G7FJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Venlafaxine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00285", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "1-(4-methoxyphenyl)-3-(1,3,4-thiadiazol-2-yl)urea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09XWS", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "CP-83101": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D07QSA", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Gliclazide": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0M2MR", "drug_id_DB": "DB01120", "metabolic_annotation_str": "ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC8"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6833"]}, "5-butyl-6-chloropyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RE9X", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "AMG 747": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04NIZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "ABT-761": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D08PXR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "BUDDLEDIN A": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O7SM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID1656041C4rr": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X0GG", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Duloxetine(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D01AXB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "4-adamantyl resorcinol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02VKX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "LY178002": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TN4X", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "N-Cyclohexyl-2-phenyl-acetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07QNN", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Furosemide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GPR35(G-protein coupled receptor 35); ", "drug_id_TTD": "", "drug_id_DB": "DB00695", "metabolic_annotation_str": "CA2(Carbonic anhydrase 2); SLC12A1(Solute carrier family 12 member 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["CA2", "SLC12A1"], "metabolic_genes_id": ["760", "6557"]}, "SQ-33600": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0Y3OR", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "7-Methoxy-9H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05FQN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Enoximone": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0E0SW", "drug_id_DB": "DB04880", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "IC-041": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01BZR", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "B-Octylglucoside": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "APOA2(Apolipoprotein A-II (APOA2) ,MOA:Inhibitor); NR3C1(Glucocorticoid receptor (NR3C1) ,MOA:Inhibitor); RHO(Rhodopsin (RHO) ,MOA:Inhibitor); NR3C2(Mineralocorticoid receptor  (MR) ,MOA:Inhibitor); PTPN1(PTPN1 messenger RNA (PTPN1 mRNA) ,MOA:Inhibitor); MAPK14(Stress-activated protein kinase 2a (p38 alpha) ,MOA:Inhibitor); ", "drug_id_TTD": "D02UVH", "drug_id_DB": "", "metabolic_annotation_str": "LIPF(Gastric triacylglycerol lipase (LIPF) ,MOA:Inhibitor); STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPF", "STS", "PLA2G2A", "PNLIP", "PTGS1", "NOS2", "PTGS2", "LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8513", "412", "5320", "5406", "5742", "4843", "5743", "4047", "4047"]}, "5-(isopropylamino)quinolin-8-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01CSZ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "aminooxyacetic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01BTV", "drug_id_DB": "", "metabolic_annotation_str": "GOT1(Cytoplasmic aspartate aminotransferase (GOT1) ,MOA:Inhibitor); CBS(Cystathionine beta-synthase (CBS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GOT1", "CBS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2805", "875"]}, "Butanoic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4JQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "2-methoxyestradiol-17-O-sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04GDW", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "4,3'',5''-trimethoxy-[1,1':2',1'']-terphenyl": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AW4W", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5243"]}, "SM-10888": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05UHJ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "4-(4-Cyanophenoxy)-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05EBZ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8RD", "drug_id_DB": "DB03596", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "2-Furan-2-yl-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZDQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "PMID26099857-Compound-WO2011037610Formula(I)": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07XPI", "drug_id_DB": "", "metabolic_annotation_str": "SLCO2A1(Prostaglandin transporter (SLC21A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLCO2A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6578"]}, "[3,4''']biflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02GTZ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "RP-66364": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated", "Terminated"], "non_metabolic": "LTB4R(Leukotriene B4 receptor 1 (LTB4R) ,MOA:Modulator); LTB4R(Leukotriene B4 receptor 1 (LTB4R) ,MOA:Modulator); ", "drug_id_TTD": "D05BBQ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "1-(3-Phenylallylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B9IX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "1-(2-(2-chlorophenoxy)pyridin-3-yl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Z5GR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "4-Hydrazinocarbonyl-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q0EK", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Azelaic Acid": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0E4WR", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "79644"]}, "3-(6-hydroxy-2-naphthyl)benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F0EI", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "P'-geranyl 3,5,8-trihydroxy-3-methyloctanate 8-diphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZWA", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "Monofluorine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01NST", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["3620"]}, "Benzimidazole and imadazopyridine carboximidamide compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Q3SU", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Benzimidazole and imadazopyridine carboximidamide compound 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0B5FA", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2-biphenyl-4-yl-1-phenothiazin-10-yl-ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04CTO", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "WF-2421": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D09BHF", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["231"]}, "[3H]GlySar": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3VU", "drug_id_DB": "", "metabolic_annotation_str": "SLC15A1(Solute carrier family 15 member 1 (SLC15A1) ,MOA:Modulator); SLC15A2(Solute carrier family 15 member 2 (SLC15A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC15A1", "SLC15A2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6564", "6565"]}, "Buparlisib": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D01QSO", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Inhibitor); PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD", "PIK3CA", "PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5293", "5290", "5291", "5294"]}, "N-1,3,4-thiadiazol-2-ylsulfamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00BMI", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "Chlorpromazine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HTR1A(5-hydroxytryptamine receptor 1A); ADRA2A(Alpha-2A adrenergic receptor); CALM1(Calmodulin); CHRM1(Muscarinic acetylcholine receptor M1); DRD2(D(2) dopamine receptor); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); ORM2(Alpha-1-acid glycoprotein 2); CHRM3(Muscarinic acetylcholine receptor M3); DRD1(D(1A) dopamine receptor); DRD1(D(1A) dopamine receptor); DRD4(D(4) dopamine receptor); DRD4(D(4) dopamine receptor); DRD5(D(1B) dopamine receptor); DRD5(D(1B) dopamine receptor); ADRA1D(Alpha-1D adrenergic receptor); HTR2A(5-hydroxytryptamine receptor 2A); HTR2A(5-hydroxytryptamine receptor 2A); HTR7(5-hydroxytryptamine receptor 7); ADRA1A(Alpha-1A adrenergic receptor); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); ADRA1B(Alpha-1B adrenergic receptor); HTR2B(5-hydroxytryptamine receptor 2B); HTR6(5-hydroxytryptamine receptor 6); KCNH2(Potassium voltage-gated channel subfamily H member 2); HRH4(Histamine H4 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00477", "metabolic_annotation_str": "SMPD1(Sphingomyelin phosphodiesterase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SMPD1"], "metabolic_genes_id": ["6609"]}, "2-(3-Methyl-indole-1-sulfonyl)-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y8JN", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E4SM", "drug_id_DB": "DB04044", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0G6BJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "P-Anisic Acid(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07IRQ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "4-Methyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DI7W", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "ONO-3805": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D08JCL", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6715", "79644"]}, "1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04SNH", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "6,6-dimethyl-1-phenyl-3-aza-bicyclo[3.1.0]hexane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZAL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "AKOS003197197": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06BHM", "drug_id_DB": "", "metabolic_annotation_str": "CTH(Cystathionine gamma-lyase (CTH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1491"]}, "[14C]acetylCoA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K0FZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC33A1(Acetyl-CoA transporter (SLC33A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC33A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["9197"]}, "(+/-)-threo-N-(4-Phenylbutyl)ritalinol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H2RD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JY9B", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID2153213C2d": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05GWF", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID2153213C2f": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G4ZG", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID2153213C2c": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02MEX", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "12-Phenylheme": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S8UN", "drug_id_DB": "DB02468", "metabolic_annotation_str": "HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMOX1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3162"]}, "Fluoratec": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D00JSG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6531", "6531"]}, "PYROGALLOL": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06TPF", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4'-(Pyridin-4-ylmethyl)biphenyl-3-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WN9P", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "2-(adamantan-1-ylamino)-5,5-diethyl-oxazol-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZG3Q", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "AG-270": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0C2BP", "drug_id_DB": "", "metabolic_annotation_str": "MAT2A(S-adenosylmethionine synthase type-2 (MAT2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAT2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4144"]}, "2-(4-Phenyl-butyl)-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08MCE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "5-(4-Chloro-phenyl)-1-methyl-piperidine-2-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H7NB", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "PMID27967267-Compound-43": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YF7A", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1-(thiophen-2-yl)-3-aza-bicyclo[3.1.0]hexane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TO4N", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "PMID28627961-Compound-31": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LY6S", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "PMID28627961-Compound-30": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S2UD", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "PMID28627961-Compound-33": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0JH7Q", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "PMID28627961-Compound-32": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I1GO", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "(R)-N-benzyl-4-(pyrrolidin-2-ylmethoxy)aniline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01RVF", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "4-(1H-IMIDAZOL-1-YL)PHENOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W6VA", "drug_id_DB": "DB08214", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "4,5-Bis(4-chlorophenyl)-1,2-selenazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E5MK", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "N-Hydroxy-N-methyl-3-naphthalen-2-yl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E4JU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "5-Methyl-2-p-tolyl-thiazol-4-ol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04IFV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "SCH-54470": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Inhibitor); ECE1(Endothelin-converting enzyme 1 (ECE1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0K9YR", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Indomethacin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PPARG(Peroxisome proliferator-activated receptor gamma); PPARA(Peroxisome proliferator-activated receptor alpha); PTGR2(Prostaglandin reductase 2); PTGDR2(Prostaglandin D2 receptor 2); ", "drug_id_TTD": "", "drug_id_DB": "DB00328", "metabolic_annotation_str": "PLA2G2A(Phospholipase A2, membrane associated); PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); AKR1C3(Aldo-keto reductase family 1 member C3); GLO1(Lactoylglutathione lyase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PLA2G2A", "PTGS1", "PTGS2", "AKR1C3", "GLO1"], "metabolic_genes_id": ["5320", "5742", "5743", "8644", "2739"]}, "CL-277082": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D06FCR", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "AG-SPT201": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0V3ZN", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["495"]}, "Bervastatin": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0L1LJ", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID25514969-Compound-9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09RTV", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "NSC-122427": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R2YN", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "TPN-729": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XQ8A", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "PF-04957325": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04TZA", "drug_id_DB": "", "metabolic_annotation_str": "PDE8A(Phosphodiesterase 8 (PDE8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE8A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5151"]}, "prunetin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A9RM", "drug_id_DB": "", "metabolic_annotation_str": "ALDH2(Mitochondrial aldehyde dehydrogenase (ALDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["217"]}, "6-Methyl-4-(4-phenylpiperazin-1-yl)coumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03XXV", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1-Cycloheptyl-3-(1-propionylpiperidin-4-yl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3VZ", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Bis-(5-pyridin-3-yl-thiophen-2-ylmethyl)-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0M0IQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "(6-Butoxy-2-naphthyl)-2-aminopropane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V7RM", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Oxindole derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AK5Y", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "PMID27109571-Compound-7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Q9LM", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "PMID27109571-Compound-8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L4EU", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "PMID27109571-Compound-9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08SLP", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "13-n-Heptanamidotridec-5-ynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BJC", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "WA-8242-A1": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03IDX", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5319"]}, "Sodium sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H7JJ", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "N-[O-Phosphono-Pyridoxyl]-Isoleucine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QCG", "drug_id_DB": "DB02635", "metabolic_annotation_str": "BCAT2(Branched-chain-amino-acid transaminase 2 (BCAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCAT2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["587"]}, "ASP-9521": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0H7XJ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8644"]}, "6-Chloropurine Riboside, 5'-Monophosphate(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VD5N", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); PPAT(Amidophosphoribosyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2", "PPAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3615", "5471"]}, "[(1e)-4-Phenylbut-1-Enyl]Benzene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G2LF", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Bip-tyr-thr-pro-lys-thr(obzl)-gly": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y5WA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Ioflupane i-123": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D02GJZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6531", "6531"]}, "3-(3-Adamantan-1-yl-ureido)-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RK4K", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Acetic acid 2-hept-3-ynylsulfanyl-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8XG", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Flavin-Adenine Dinucleotide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "NQO2(Quinone reductase 2 (NQO2) ,MOA:Inhibitor); ", "drug_id_TTD": "D00IMW", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); DPYD(Dihydrothymine dehydrogenase (DPYD) ,MOA:Inhibitor); TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR", "NQO1", "MAOA", "MAOB", "NOS1", "XDH", "DPYD", "TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2936", "1728", "4128", "4129", "4842", "7498", "1806", "7296"]}, "(2S)-abyssinone II": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NH6T", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "US8846654, 251": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0A5JS", "drug_id_DB": "", "metabolic_annotation_str": "PDE8A(Phosphodiesterase 8 (PDE8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE8A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5151"]}, "8-Benzyloxycaffeine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JN9R", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "diclofenac sodium patch": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0V1JS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Autoantibody LKM-3": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HP6W", "drug_id_DB": "", "metabolic_annotation_str": "UGT2B7(UDP-glucuronosyltransferase 2B7 (UGT2B7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UGT2B7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7364"]}, "ISIS 32003": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FJE", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "ISIS 32002": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8DY", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "ISIS 32000": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04PYV", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "Naproxen": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0DJ1B", "drug_id_DB": "DB00788", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "ISIS 32005": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SMF", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "ISIS 32004": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0QH9X", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "ISIS 32008": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09WIW", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "3-(2-naphthyl)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F6ZH", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "2-Chloro-N-(3-morpholinopropyl)nicotinamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NS9X", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "[3H]thiamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07TYL", "drug_id_DB": "", "metabolic_annotation_str": "SLC19A2(Solute carrier family 19 member 2 (SLC19A2) ,MOA:Modulator); SLC19A3(Solute carrier family 19 member 3 (SLC19A3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC19A2", "SLC19A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["10560", "80704"]}, "EPIANDROSTERONE": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0O8FW", "drug_id_DB": "", "metabolic_annotation_str": "G6PD(Glucose-6-phosphate dehydrogenase (G6PD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["G6PD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2539"]}, "5-{8(Z),-pentadecenyl}resorcinol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OE5N", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Nepafenac": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D02IHW", "drug_id_DB": "DB06802", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "2-(4-Piperidin-1-ylmethylphenoxy)benzothiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PF9Q", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "US9434727, 93": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02TPQ", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "PMID8246237C18t": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FD8Q", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "L-748780": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q4FH", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "4'-cyano-3-(imidazolylmethyl)flavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CR6B", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Mazindol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00579", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC18A2(Synaptic vesicular amine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3", "SLC18A2"], "metabolic_genes_id": ["6530", "6532", "6531", "6531", "6571"]}, "1-(1-Biphenyl-4-yl-3-methyl-butyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RD3C", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "1-(pyridin-4-yl)piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3HK", "drug_id_DB": "", "metabolic_annotation_str": "PLD1(Phospholipase D1 (PLD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5337"]}, "4'-(1-(pyridin-4-yl)propyl)biphenyl-3-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U6JI", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "ANTHRONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C6BU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "APA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01IGU", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "Sulfinpyrazone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01138", "metabolic_annotation_str": "ABCC1(Multidrug resistance-associated protein 1); ABCC1(Multidrug resistance-associated protein 1); ABCC2(Canalicular multispecific organic anion transporter 1); SLC22A12(Solute carrier family 22 member 12); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC1", "ABCC1", "ABCC2", "SLC22A12"], "metabolic_genes_id": ["4363", "4363", "1244", "116085"]}, "ABX-1431": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0CW8S", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "1,2-Bis-(3-nitro-phenyl)-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UT1X", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Levamisole(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRNA3(Neuronal acetylcholine receptor subunit alpha-3); ", "drug_id_TTD": "", "drug_id_DB": "DB00848", "metabolic_annotation_str": "ALPG(Alkaline phosphatase, placental-like); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALPG"], "metabolic_genes_id": ["251"]}, "DOV 21947": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06AXY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "HOE-694": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0K2CV", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1", "SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6548", "6550", "6550"]}, "Tacrine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00382", "metabolic_annotation_str": "BCHE(Cholinesterase); ACHE(Acetylcholinesterase); CES1(Liver carboxylesterase 1); CES1(Liver carboxylesterase 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["BCHE", "ACHE", "CES1", "CES1"], "metabolic_genes_id": ["590", "43", "1066", "1066"]}, "9-Deazahypoxanthine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N5BA", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "IC87114": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZIK", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "(R)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01GSG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "N-hydroxyglycine derivative": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ZYX", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Entacapone": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0J1VY", "drug_id_DB": "DB00494", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "3-[6-(benzylmethylamino)hexyloxy]xanthen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8DZ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Aminobenzolamide derivative": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QEK", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "ESUPRONE": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0ZM5W", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "2-nonylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07PNA", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Thenoyltrifluoroacetone(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4QX", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "PF-489791": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0M9FQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "3-{3-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04HNO", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "Etidronic acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PTPRS(Receptor-type tyrosine-protein phosphatase S); ", "drug_id_TTD": "", "drug_id_DB": "DB01077", "metabolic_annotation_str": "SLC25A5(ADP/ATP translocase 2); SLC25A4(ADP/ATP translocase 1); SLC25A6(ADP/ATP translocase 3); ATP6V1A(V-type proton ATPase catalytic subunit A); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC25A5", "SLC25A4", "SLC25A6", "ATP6V1A"], "metabolic_genes_id": ["292", "291", "293", "523"]}, "Tarnylcypromine derivative 3": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); KDM1B(Lysine-specific histone demethylase 1B (KDM1B) ,MOA:Inhibitor); ", "drug_id_TTD": "D0O7IH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "TDI-0079": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05SCQ", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "ARI-809": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0M9RE", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "SQ-34919": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0RU3M", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Levonorgestrel(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ESR1(Estrogen receptor); NR3C1(Glucocorticoid receptor); SHBG(Sex hormone-binding globulin); PGR(Progesterone receptor); AR(Androgen receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00367", "metabolic_annotation_str": "SRD5A1(3-oxo-5-alpha-steroid 4-dehydrogenase 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SRD5A1"], "metabolic_genes_id": ["6715"]}, "2-Benzyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7YU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "10-Hydroxy-infractopicrin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FI9G", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09LUD", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "1-(naphthalen-2-yl)-3-aza-bicyclo[3.1.0]hexane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ANE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Bip-tyr-thr-ala-pro-phe": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06QDX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Fotemustine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0S1ZB", "drug_id_DB": "DB04106", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiole-3-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02PLG", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "GNF-PF-2094": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0ZY7X", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "COUMATE": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Y6OA", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "STS", "CYP19A1", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "412", "1588", "762", "765", "768", "23632"]}, "Benzene sulfonamide derivative 16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06LEZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "1-(3-chlorophenyl)-2-(piperidin-1-yl)propan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ZIQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "7-(benzyloxy)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RNZ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA4", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "762", "768", "23632"]}, "3,6,8-Tribromo-dibenzo[1,4]dioxin-1-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NU1W", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "Piperidine carboxamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V4FE", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Dalbavancin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07QAR", "drug_id_DB": "", "metabolic_annotation_str": "PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNLIP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5406"]}, "4-Pentadeca-1,3,6-trienylsulfanyl-butyric acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R2XE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "2-Aminomethyl-5-(p-methoxyphenyl)tetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IB6Y", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "1,1,1-trifluoro-3-(octylsulfinyl)propan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04UEN", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "HP-228": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09ZKS", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4843"]}, "5-phenyl-1H-1,2,3-triazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O3IE", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "8-acetyl-7-propoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03LHJ", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "2-(4-Butoxy-phenoxy)-N-hydroxy-propionamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N6CN", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Vigabatrin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0R3QY", "drug_id_DB": "DB01080", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "3r-Hydroxydecanoyl-Coa": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04TMV", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B4(Estradiol 17 beta-dehydrogenase 4 (HSD17B4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3295"]}, "4-(4-butoxyphenoxy)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01QWO", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "N-Hydroxy-4-naphthalen-2-yl-benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K7XU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-pentafluorophenylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O4KL", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Cis-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H1VT", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Brutieridin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q2EH", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "1-(3-Chlorobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4WQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "GSK2126458": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03EZE", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "L-768277": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0B0TO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "PMID16242323C15b": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W5HL", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "4-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HGK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "5-(2-Imidazol-1-yl-ethyl)-7,8-dihydro-quinoline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZGF", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "TBXAS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "6916", "5743"]}, "Omeprazole(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D01XNB", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J6KJ", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "3-chloro-1-(4-hydroxyphenyl)propan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UT2X", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "PMID16242323C15a": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6SD", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "2-Amino-1-(4-methylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00EUD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Di(2,6-di-t-butylphenol)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C3SL", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "BIS(9)-HUPERZINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UF9K", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N-(1H-indazol-5-yl)acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7YE", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Omigapil": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06KSV", "drug_id_DB": "", "metabolic_annotation_str": "GAPDH(Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GAPDH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2597"]}, "N-hydroxy-nor-L-arginine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZIC", "drug_id_DB": "", "metabolic_annotation_str": "ARG2(Kidney-type arginase (ARG2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ARG2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["384"]}, "PMID28870136-Compound-39": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SK3R", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-38": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02DLG", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-37": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X1MK", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-36": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03VLV", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "4-(2-Propynylthio)pyridine-3-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02BMV", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "ICI-211965": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4HT", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Cyclopropane 1-carboxylic acid derivative 9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0DB7W", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Metazamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FF3D", "drug_id_DB": "", "metabolic_annotation_str": "G6PD(Glucose-6-phosphate dehydrogenase (G6PD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["G6PD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2539"]}, "1-(1-Biphenyl-4-yl-propyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GEH", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "1-dodecyl-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "CDC25A(M-phase inducer phosphatase 1 (MPIP1) ,MOA:Inhibitor); ", "drug_id_TTD": "D00ANJ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Procyanidin B-2 3,3'-di-O-gallate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YCQ", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "[3H]histidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "SLC15A3(Solute carrier family 15 member 3 (SLC15A3) ,MOA:Modulator); SLC15A4(Solute carrier family 15 member 4 (SLC15A4) ,MOA:Modulator); ", "drug_id_TTD": "D07UTZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC38A5(Solute carrier family 38 member 5 (SLC38A5) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC38A5"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["92745"]}, "N-(4-Cyano-3-methanesulfonyl-benzoyl)-guanidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04UMY", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1", "SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6548", "6550", "6550"]}, "JNJ-17305600": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0F4NP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "Lenalidomide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TNFSF11(Tumor necrosis factor ligand superfamily member 11); CDH5(Cadherin-5); CRBN(Protein cereblon); ", "drug_id_TTD": "", "drug_id_DB": "DB00480", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS2"], "metabolic_genes_id": ["5743"]}, "Zileuton": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D09JUG", "drug_id_DB": "DB00744", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "(3-Bromo-propyl)-trimethyl-ammonium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RLO", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1-(Propan-2-ylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X3SO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "CHF-2819": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04GTP", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "N-(1,3,4-thiadiazol-2-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03WDY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "BMS-480404": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WF7I", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "N5-(1-iminopent-3-enyl)-L-ornithine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04EIE", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "WIN-35065-2": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G9ID", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "(S)-NORDULOXETINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I4TO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "Cyclopropane 1-carboxylic acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0PI7V", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Cyclopropane 1-carboxylic acid derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G6DW", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "6-Methyl-4-(4-o-tolylpiperazin-1-yl)coumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JAX", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "4-azidobenzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6TM", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Epocarbazolin-A": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D09JYF", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "AR-C70484XX": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W4VM", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "7-fluoro-2-(4-fluorophenyl)-4H-chromene-4-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y5OB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Imisopasem manganese": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00OYQ", "drug_id_DB": "", "metabolic_annotation_str": "SOD2(Superoxide dismutase Mn (SOD Mn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6648"]}, "4-amino-N-(4-iodophenyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06BHC", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Indolizine derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D00CKV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "PLA2G7"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "7941"]}, "AGS-16M8F": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D00MCN", "drug_id_DB": "", "metabolic_annotation_str": "ENPP3(Phosphodiesterase I beta (ENPP3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5169"]}, "Protriptyline(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00MYQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "3,4,5,6-Tetrachloro-[1,2]benzoquinone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N0HK", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43", "1066", "1066"]}, "Empagli ozin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07UEJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "MPL-S": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0T4GZ", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4843"]}, "Glycinamide Ribonucleotide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07DGI", "drug_id_DB": "DB02236", "metabolic_annotation_str": "GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2618", "2618"]}, "EV-077": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08PKI", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6916"]}, "MR-20814": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00AVS", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Adamantan-2-yl-piperidin-1-yl-methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05NSB", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "(E)-3-(4-(methylsulfonyl)styryl)thiophene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03XZJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "BPL-001": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02SRB", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Phenelzine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0P9AC", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "3-hydroxybenzylhydrazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9BM", "drug_id_DB": "", "metabolic_annotation_str": "DDC(Aromatic-L-amino-acid decarboxylase (DDC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DDC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1644"]}, "MORIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "MCL1(Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1) ,MOA:Inhibitor); ESR2(Estrogen receptor beta (ESR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0NJ4H", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN", "SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2194", "116085"]}, "7-((1H-imidazol-1-yl)methyl)-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DJ3R", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "5,7-dichloro-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NJ4G", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "ORE-1001(TTD)": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D08EYQ", "drug_id_DB": "", "metabolic_annotation_str": "ACE2(Angiotensin-converting enzyme 2 (ACE2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["59272"]}, "Tilarginine acetate": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06OQI", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4846"]}, "QUERCITRIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07DJS", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Dimethyl 2,2,2-trifluoro-1-phenylethyl phosphate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XP0J", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "677T": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L0AI", "drug_id_DB": "", "metabolic_annotation_str": "MTHFR(MTHFR messenger RNA (MTHFR mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["MTHFR"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["4524"]}, "OBIDOXIME": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3OZ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-(1,1'-Biphenyl-4-Yl)Propanoic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FTI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "US10065972, Example 396": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QE9Q", "drug_id_DB": "", "metabolic_annotation_str": "AADAT(Kynurenine oxoglutarate transaminase II (AADAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AADAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["51166"]}, "N-Omega-Hydroxy-L-Arginine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GL9I", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7QA", "drug_id_DB": "DB08155", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Zenarestat": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0C7KK", "drug_id_DB": "DB02132", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Ethyl 2-(2-oxohexadecanamido)acetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K0HD", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "4-oxo-4H-chromene-3-carboxylic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04TGN", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CHRNB2(Neuronal acetylcholine receptor beta-2 (CHRNB2) ,MOA:Inhibitor); CHRNB4(Neuronal acetylcholine receptor beta-4 (CHRNB4) ,MOA:Inhibitor); CHRNA4(Neuronal acetylcholine receptor alpha-4 (CHRNA4) ,MOA:Inhibitor); ", "drug_id_TTD": "D03YQY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "3-hydroxy-2-methoxybenzaldehyde": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C9ZY", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "3-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U7RR", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "7-fluoro-2-p-tolyl-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C9GI", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "3-(3-aminocyclopentyl)-1H-indole-5-carbonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05REQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Pyrophosphate 2-": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ANG(Angiogenin (ANG) ,MOA:Inhibitor); ", "drug_id_TTD": "D0A1DU", "drug_id_DB": "", "metabolic_annotation_str": "GMPS(Glutamine amidotransferase (GMPS) ,MOA:Inhibitor); PGD(Phosphogluconate dehydrogenase (PGD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GMPS", "PGD"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8833", "5226"]}, "SDZ-CPI-975": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0I3PG", "drug_id_DB": "", "metabolic_annotation_str": "CPT1B(Carnitine O-palmitoyltransferase I (CPT1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CPT1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1375"]}, "N-cyclohexyl-2-oxo-2H-chromene-3-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01UFM", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "ABT-702": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D08LUT", "drug_id_DB": "", "metabolic_annotation_str": "ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["132"]}, "NARINGENIN": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "ESR2(Estrogen receptor beta (ESR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D02ABO", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "HSD17B1", "GLO1", "CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "3292", "2739", "1545"]}, "Alkylene Linked Bis-Galanthamine derivative": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E6YH", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1-(2-(3-methoxyphenyl)-1-phenylethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08LAY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "BCH": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05BOD", "drug_id_DB": "", "metabolic_annotation_str": "SLC7A5(Large neutral amino acids transporter 1 (SLC7A5) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC7A5"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["8140"]}, "1,3-DIPHENYLUREA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X7IM", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "TJN-598": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D01OUA", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "NSC-339583": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L3VV", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "NSC-339580": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VB8K", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "Fentanyl(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "OPRM1(Mu-type opioid receptor); OPRD1(Delta-type opioid receptor); OPRK1(Kappa-type opioid receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00813", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCB1"], "metabolic_genes_id": ["5243"]}, "Valdecoxib(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0L6DA", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "7-Hydroxy-3-(3-hydroxyphenyl)-1-naphthonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04EPO", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Calyculin-A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O7ZE", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "4-(4-(thiophen-3-yl)benzyl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z3GX", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "3,5-bis(2-methylpyridin-4-yl)-1H-1,2,4-triazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C9ZN", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "2alpha-Hydroxyurs-12-en-28-oic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KS6A", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Isorhamnetin 3,7-disulfate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08NKL", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Triazolo-pyridine derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05VBJ", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "O7-Nitrooxyethyl chrysin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01KAM", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Triazolo-pyridine derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0A8EV", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Indomethacin analog 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0GY2Z", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor. Antagonist. Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor; Antagonist; Blocker"], "metabolic_genes_id": ["8644"]}, "Triazolo-pyridine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0U3KV", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Triazolo-pyridine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z8VY", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "3-(Aminooxy)propan-1-amine hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6WI", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "Soraphen A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WD1E", "drug_id_DB": "DB02859", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "1-methoxy-3-(3-(pyridin-4-yl)-1H-indol-6-yl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3WC", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "E-6087": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07RUC", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "3-Methoxyl-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07UVN", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "E-6080": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00HFD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "3-(6-Bromo-naphthalen-2-yl)-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RJ6S", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "1-(4-Chloro-phenyl)-2-phenyl-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3RN", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "ABYSSINONE V": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L3IQ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "HMG-CoA reductase inhibitor": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D04CIL", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Phenanthrene-2-carboxylic acid hydroxyamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DP9F", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "DADMe-ImmG": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07VEW", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "Probucol(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0H2DQ", "drug_id_DB": "", "metabolic_annotation_str": "ABCA1(ATP-binding cassette transporter A1 (ABCA1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCA1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["19"]}, "Aramchol": {"drug_status_TTD": ["Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D09PVO", "drug_id_DB": "", "metabolic_annotation_str": "SCD(Acyl-CoA desaturase (SCD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SCD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6319"]}, "4-Benzenesulfonylamino-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YD9F", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "(-)-7-N-methyldibromophakellin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M6KL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["239"]}, "[3H](R)-NPTS": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07IYZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "Alseroxylon": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0I3IG", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6571"]}, "XR-9504": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HIM", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1", "ABCC1", "ABCC1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5243", "4363", "4363"]}, "7-(piperidin-4-ylmethoxy)-2-naphthonitrile": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR3A(5-HT 3A receptor (HTR3A) ,MOA:Inhibitor); KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D06QIQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "11-keto-ursolic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09VPP", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "(+/-)-2-Phenylthiomorpholin-5-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04FLL", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Guanylhydrazone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GTV", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "1-(6-Amino-4-methylpyridin-2-yl)propan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ZGN", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "(6-Benzyloxy-2-naphthyl)-2-aminopropane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03HXD", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Fluvastatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D08GHB", "drug_id_DB": "DB01095", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "4-Ethyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FHX", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "Sodium 2,3,5,6-tetrafluorobenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G6OW", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "BMS-182657": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Modulator); ", "drug_id_TTD": "D04MBS", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "DECYL(DIMETHYL)PHOSPHINE OXIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B0JK", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "N-(2-benzyloxy-4-nitrophenyl)methanesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C5ZP", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-acetylserotonin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04275", "metabolic_annotation_str": "SPR(Sepiapterin reductase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["SPR"], "metabolic_genes_id": ["6697"]}, "GSK2696273": {"drug_status_TTD": ["Preregistration"], "non_metabolic": "", "drug_id_TTD": "D0F4QV", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["100"]}, "2-Methyl-[1,4]thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SB5H", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "Seviteronel": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Q9KR", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "PMID30273516-Compound-40": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0P0ES", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "PMID30273516-Compound-41": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0KP4J", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "Sulfonamide derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00JLX", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Sulfonamide derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0R8OW", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3,4,5-trimethoxy-N-(thiazol-2-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8MX", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-(4-iodobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U6QM", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "Sulfonamide derivative 8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06FHJ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Kazinol F": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UN0R", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Kazinol C": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D5OG", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E8DX", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "4-hydroxybenzylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZBH", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "3,3-(1,3-Thiazole-2,5-diyl)diphenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00YNA", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "3292"]}, "2-Benzhydryl-7-hydroxy-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04GYD", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "4-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09VPA", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "6-Nitroindazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0FS", "drug_id_DB": "DB03100", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4843"]}, "(+)-(5S,8S,10S)-20-methoxy-9,15-ene-puupehenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02LUF", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "2-Phenethyl-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z7NC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "1-Amino-3-(aminoxy)-2-propanol Dihydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XR2J", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "3-methoxy-5-(6-methoxynaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08IDC", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1584"]}, "(7-Benzyloxy-2-oxo-2H-chromen-4-yl)acetonitrile": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TFD", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "2-(phenylsulfonyl)-1-p-tolylethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02WUU", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "1-[(prop-1-ylamino)ethyl]-1,1-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L1RM", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "1-(4-butoxyphenyl)propan-2-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KQB", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Etoricoxib": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09MGR", "drug_id_DB": "DB01628", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Beta-D-Glucopyranose Spirohydantoin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05WSU", "drug_id_DB": "DB01823", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Carbamoyl phosphate disodium": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y6EL", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "762"]}, "PHENIDONE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P1LP", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "Selegiline Hydrochloride": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0J2MJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "AVI-4557(TTD)": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0J6FE", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(CYP3A4 messenger RNA (CYP3A4 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["1576"]}, "3-[4-Fluoro-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QPK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "Lixivaptan": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "AVPR2(Vasopressin V2 receptor (V2R) ,MOA:Antagonist); ", "drug_id_TTD": "D07EEN", "drug_id_DB": "", "metabolic_annotation_str": "HDC(Histidine decarboxylase (HDC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HDC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3067"]}, "Amineptine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04836", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": ".", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "5'-S-ethyl-5'-thioadenosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LM6A", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "Adamantan-1-yl-piperidin-1-yl-methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D3NV", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "IPI-145": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0RU0O", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Modulator); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD", "PIK3CG"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5293", "5294"]}, "Acetic acid 2-pentylsulfanyl-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7EI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "5-Carbazol-9-yl-pentanoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ORM", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "Sulfamic acid 3-benzoyl-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G8HD", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "PALBINONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03DEO", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "RPR 200765A": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D01QRG", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "2,5-dideoxy-2,5-imino-dl-glycero-D-manno-heptitol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R5RE", "drug_id_DB": "", "metabolic_annotation_str": "LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LCT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3938"]}, "4-Allyl-6-nitro-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GLO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "L-745337": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D05EYG", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "(+/-)-threo-N-Propargylmethylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N6OH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-Amino-3-Oxo-4-Sulfo-Butyric Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GRM", "drug_id_DB": "DB02735", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "Imidapril hci": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0S0ES", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "Lazabemide analog 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0C7LB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Almitrine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0D9NA", "drug_id_DB": "DB01430", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["476"]}, "Complex heterocyclic compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0F1FD", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "3-(imidazolylmethyl)-4'-nitroflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08EZA", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "VULM-1457": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OH1O", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "(-)-yatein": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01FBL", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6PH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Statin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W7VX", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3156"]}, "3-(1H-indol-3-yl)-N,N-dimethylpropan-1-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RTM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "DODECANESULFONATE ION": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7WJ", "drug_id_DB": "DB07681", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Sulfasalazine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "IKBKB(Inhibitor of nuclear factor kappa-B kinase subunit beta); CHUK(Inhibitor of nuclear factor kappa-B kinase subunit alpha); PPARG(Peroxisome proliferator-activated receptor gamma); ", "drug_id_TTD": "", "drug_id_DB": "DB00795", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2); ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); PTGS1(Prostaglandin G/H synthase 1); TBXAS1(Thromboxane-A synthase); ACAT1(Acetyl-CoA acetyltransferase, mitochondrial); PTGS2(Prostaglandin G/H synthase 2); SLC7A11(Cystine/glutamate transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PLA2G1B", "ALOX5", "ALOX5", "PTGS1", "TBXAS1", "ACAT1", "PTGS2", "SLC7A11"], "metabolic_genes_id": ["5319", "240", "240", "5742", "6916", "38", "5743", "23657"]}, "PF-04937319": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0M5PH", "drug_id_DB": "", "metabolic_annotation_str": "GCK(Glucokinase (GCK) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GCK"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2645"]}, "Alpha-ketoisovalerate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03NOU", "drug_id_DB": "", "metabolic_annotation_str": "BCAT2(Branched-chain-amino-acid transaminase 2 (BCAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCAT2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["587"]}, "1,1,1,3-Tetrafluoro-6-phenylhexan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05TGU", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "ZL-N-91": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JNC", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Modulator); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Modulator", "Modulator"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "(3R)-9-amino-3-methyl-1,2,3,4-tetrahydroacridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R1FR", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Penciclovir": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07BYK", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "S-(2-Chlorobenzyl)isothiourea hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02DRL", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(6-Methoxy-2-naphthyl)-2-aminopropane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02IDM", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-(5-Methanesulfonyl-2-methyl-benzoyl)-guanidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T1OG", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1", "SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6548", "6550", "6550"]}, "Dalvastatin": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0Y9XD", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "7-chloro-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A6RU", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "N1-[4-(Phenylmethoxy)phenyl]-L-aspartamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LZ3O", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Orlistat(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "CNR1(Cannabinoid receptor 1 (CB1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0T9TJ", "drug_id_DB": "", "metabolic_annotation_str": "PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PNLIP"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5406"]}, "HARMINE": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "DYRK3(Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3) ,MOA:Inhibitor); DYRK1A(Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) ,MOA:Inhibitor); DYRK2(Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2) ,MOA:Inhibitor); ", "drug_id_TTD": "D00OWF", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "5S-HETE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CJR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Ketoprofen(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0W9WF", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "447C88": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D04ODQ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "4-Benzyl-6-nitro-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09NVT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Hydrochlorothiazide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0U4UQ", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "6-(4-Methoxy-benzenesulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P3AU", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "2-Phenyl-3-pyridin-4-ylmethylene-chroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07FGX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "PMID30074415-Compound-12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UK9U", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "Tiaprofenic acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01600", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "ALTU-236": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GET", "drug_id_DB": "", "metabolic_annotation_str": "PAH(Phenylalanine hydroxylase (PAH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PAH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5053"]}, "2-(N-tert-Butylamino)-3'-chloropentanophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XY9E", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "3-(4-Chlorophenyl)-2-nortropene": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0BB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "N-(3-Phenyl-propyl)-nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D0KT", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Acid blue 25": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "P2RY2(P2Y purinoceptor 2 (P2RY2) ,MOA:Inhibitor); ", "drug_id_TTD": "D08DXA", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "BCT-100": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D06XAT", "drug_id_DB": "", "metabolic_annotation_str": "ARG1(Arginase (ARG) ,MOA:Modulator); ARG2(Arginase (ARG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ARG1", "ARG2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["383", "384"]}, "N-(1'-Phenyl-ethyl) estradiol-16-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04CQM", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "HINOKITIOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4YW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Imidazoleisoindoles derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03PQB", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Imidazoleisoindoles derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09TSM", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "1-(4-Bromobenzyl)-5-phenyl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07DQJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "N,N-dimethyl(2-phenoxyphenyl)methanamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VC1K", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "PMID27967267-Compound-42": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07HNU", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "5-(pyridin-4-yl)-1,3,4-thiadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02UKE", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "N-benzylnorlitebamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07YQY", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Eniluracil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03516", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase); AOX1(Aldehyde oxidase); DPYD(Dihydropyrimidine dehydrogenase [NADP(+)]); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["XDH", "AOX1", "DPYD"], "metabolic_genes_id": ["7498", "316", "1806"]}, "NIS-62949": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y3PP", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "SQ-32709": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0N5HO", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2222"]}, "Praziquantel": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0L9ZR", "drug_id_DB": "", "metabolic_annotation_str": "HPGDS(Glutathione-dependent PGD synthase (HPGDS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HPGDS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["27306"]}, "1-(3,4-dichlorobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AL3G", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "2-(2-chlorophenoxy)-3-(piperidin-4-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0F6GB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "GARVEATIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J9JH", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3-[1'-{4'-(Benzyloxy)-phenyl}]-quinuclidine-2-ene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01UKV", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "4,4'-thiodipyridine-3-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03KRB", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "PMID25470667-Compound-BAY744113": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D08UCB", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "1-(1-(4-thiophen-3-ylphenyl)ethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00IUN", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "3-[(1s)-1-(Dimethylamino)Ethyl]Phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J9FT", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "NE58027": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4MO", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Rivastigmine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0WY5Q", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["43"]}, "N5-[4-(N-Phenylamino)phenyl]-L-glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6DL", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Green tea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L1XR", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "L-Tryptophan": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05EJG", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["3620"]}, "3-(5-Bromo-6-methoxy-naphthalen-2-yl)-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04IBH", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "1,2-bis(2,3-fluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LTW", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "1066", "1066"]}, "Cardiolipin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V6RT", "drug_id_DB": "", "metabolic_annotation_str": "SLC25A4(Adenine nucleotide translocator 1 (SLC25A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC25A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["291"]}, "Syringic Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q7DJ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "CS-722": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0H9DE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "4,6-dinitrobenzo[c][1,2,5]thiadiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AA8E", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "A1-adenosine receptor": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E5ZK", "drug_id_DB": "", "metabolic_annotation_str": "ADCY2(Adenylate cyclase type 2 (ADCY2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADCY2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["108"]}, "NSC-23180": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F5VY", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43", "1066", "1066"]}, "CI-1002": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0M2GI", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["43"]}, "1-(cyclopropyl)methyl-5'-O-tritylinosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04OWX", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "1-Acetoxy-2-tert-butyldimethylsilyl-oxylycorine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TSE", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "(S)-3-(naphthalen-2-ylmethoxy)pyrrolidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0E3DM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Para-Mercury-Benzenesulfonic Acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ESR2(Estrogen receptor beta); ", "drug_id_TTD": "", "drug_id_DB": "DB02983", "metabolic_annotation_str": "CLC(Galectin-10); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["CLC"], "metabolic_genes_id": ["1178"]}, "BZYX": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ACI", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "YM-26734": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D07OGR", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5319"]}, "BREQUINAR": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0N3XT", "drug_id_DB": "", "metabolic_annotation_str": "DHODH(Dihydroorotate dehydrogenase (DHODH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHODH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1723"]}, "Sanguiin H-6": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1QQ", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "PQR309": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ", "drug_id_TTD": "D0TU7B", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5291", "5294"]}, "O-tolyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U7BQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "PMID27967267-Compound-neotuberostemonine": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V2JR", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-isoursolic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LDI", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Trimethyl-(4-oxo-pentyl)-ammonium iodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O6AH", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Sulfonamide-thiadiazole derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0W9VU", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "Sulfonamide-thiadiazole derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06LLY", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "Piroxicam(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00554", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "Indapamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00808", "metabolic_annotation_str": "SLC12A3(Solute carrier family 12 member 3); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC12A3"], "metabolic_genes_id": ["6559"]}, "(+/-)-threo-3-Fluororitalinol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FYY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "N-butylgalactonojirimycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KJV", "drug_id_DB": "", "metabolic_annotation_str": "UGCG(Ceramide glucosyltransferase (UGCG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UGCG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7357"]}, "Loxoprofen gel": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0LR4B", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Flurbiprofen(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0A1PX", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "SF1126(TTD)": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ", "drug_id_TTD": "D03NJY", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "BENZOQUINONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M2EM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "BMS-770767": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0L4US", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3290"]}, "Esomeprazole(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0C6DT", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "NE10790": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06III", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "PMI-008": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T8QY", "drug_id_DB": "", "metabolic_annotation_str": "LIPE(Hormone sensitive lipase (LIPE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3991"]}, "3-(6-Amino-purin-9-yl)-4-butoxy-butan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05RDO", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "PMI-001": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "IL2(Interleukin-2 (IL2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0I9LH", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "1-[(tert-butylamino)ethyl]-1,1-bisphosphonicacid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DL1F", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "3-[1-(4-Cyanobenzyl)-1H-imidazol-5-yl]-1-propanol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PH1G", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "FR-194738": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D04DMO", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6713"]}, "CFTR inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N4FJ", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1080"]}, "PSN357": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0P7WJ", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Myophosphorylase (PYGM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5837"]}, "DIOA": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K9KZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A5(Solute carrier family 12 member 5 (SLC12A5) ,MOA:Inhibitor); SLC12A6(Solute carrier family 12 member 6 (SLC12A6) ,MOA:Inhibitor); SLC12A4(Solute carrier family 12 member 4 (SLC12A4) ,MOA:Inhibitor); SLC12A7(Solute carrier family 12 member 7 (SLC12A7) ,MOA:Inhibitor); SLC12A7(Solute carrier family 12 member 7 (SLC12A7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A5", "SLC12A6", "SLC12A4", "SLC12A7", "SLC12A7"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["57468", "9990", "6560", "10723", "10723"]}, "Indomethacin(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0R1RS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "AG-881": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0K9PC", "drug_id_DB": "", "metabolic_annotation_str": "IDH3B(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH1(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH2(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH3A(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH3G(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDH3B", "IDH1", "IDH2", "IDH3A", "IDH3G"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3420", "3417", "3418", "3419", "3421"]}, "3-(4-Amino-phenyl)-3-butyl-piperidine-2,6-dione": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B5MZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11A1(Cholesterol desmolase (CYP11A1) ,MOA:Inhibitor); CYP11A1(Cholesterol desmolase (CYP11A1) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11A1", "CYP11A1", "CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1583", "1583", "1588"]}, "JTT-654": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01THN", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "JTT-651": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D09HAL", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Revamilast": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X0PW", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "ISOTETRANDRINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AN2Q", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Isopropyl-methyl-prop-2-ynyl-amine hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X3SE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Darapladib(TTD)": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0L5UO", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5319"]}, "GFPDGG": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03CYY", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "8-[(3-Trifluoromethyl)benzyloxy]caffeine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FJX", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Tetra-hydro-carboline derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RB6K", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "Tetra-hydro-carboline derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00PJE", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "US10034861, Example 165": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00LVD", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "US10034861, Example 164": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06WJK", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "N5-[4-(Phenylmethoxy)phenyl]-L-glutamamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04CZF", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "L-731128": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06RCI", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "3,4-Dichloro-N-(2-methyl-1H-indol-5-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09NNZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Alpha-Homonojirimycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03TYC", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2548"]}, "ZIMELIDINE": {"drug_status_TTD": ["Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D0C1XS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "3-benzyl-1-cyclohexylpyrrolidin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00QOL", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "CL-283796": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0E1UZ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "ISIS 140157": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1US", "drug_id_DB": "", "metabolic_annotation_str": "SOAT2(SOAT2 messenger RNA (SOAT2 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOAT2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["8435"]}, "M-16209": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0V4UO", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "ISIS 140158": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02YNE", "drug_id_DB": "", "metabolic_annotation_str": "SOAT2(SOAT2 messenger RNA (SOAT2 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOAT2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["8435"]}, "1-(3-(4-chlorobenzyl)quinoxalin-2-yl)hydrazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B5CR", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "(4-Iodo-butyl)-trimethyl-ammonium iodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P8KQ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "(4-((1H-imidazol-1-yl)methyl)phenyl)methanol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8QD", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0U7BJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "PMID25514969-Compound-8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05TMN", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "Diflunisal(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D08LFZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "(11H-Dibenzo[b,e][1,4]dioxepin-8-yl)-acetic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GF9J", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "4-Flourobenzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00SJT", "drug_id_DB": "DB01784", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "3-Imidazol-1-ylmethyl-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RRV", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "S 1743": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01NIJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC37A4", "SLC37A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2542", "2542"]}, "5-[5-Methoxy-indan-(1Z)-ylidenemethyl]-thiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U6IT", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Methimazole": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0S4BR", "drug_id_DB": "DB00763", "metabolic_annotation_str": "TPO(Thyroid peroxidase (TPO) ,MOA:Inhibitor); TPO(Thyroid peroxidase (TPO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPO", "TPO"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7173", "7173"]}, "LIK-066": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X2UI", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "NCX-4016": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05OQX", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "NCX-1067": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04XQG", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3156"]}, "7-tert-butyl-2, 3-dihydro-3, 3-dimethyl substituted dihydrofuran 30 (DHDMBF30)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02COM", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP", "ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4860", "240", "240"]}, "3-(4-Fluorophenyl)-2-nortropene": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0US2X", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "N-(4-cyanophenyl)sulfamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4EV", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "2-N-Cyclopropylamino-1-(4-methylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H7PI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "3,7,3',4'-TETRAHYDROXYFLAVONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "CDK6(Cyclin-dependent kinase 6 (CDK6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0MF5Y", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "4-(4-methoxy-benzylideneamino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07QIU", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "5-(4-Chlorophenyl)-4-p-tolyl-1,2-selenazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08RYB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Tricarballylic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ZAO", "drug_id_DB": "", "metabolic_annotation_str": "ACO2(Citrate hydro-lyase (ACO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACO2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["50"]}, "5,3'-Dipropyl-biphenyl-2,4'-diol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R6ZC", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "VAP-1": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05SPX", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8639"]}, "3-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02NAG", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "Bupropion(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRNA3(Neuronal acetylcholine receptor subunit alpha-3); HTR3A(5-hydroxytryptamine receptor 3A); ", "drug_id_TTD": "", "drug_id_DB": "DB01156", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "4-Furan-2-yl-6-nitro-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1VS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Nimesulide(TTD)": {"drug_status_TTD": ["Withdrawn from market", "Withdrawn from market", "Withdrawn from market"], "non_metabolic": "LTF(Lactotransferrin (LTF) ,MOA:Inhibitor); TNFSF10(TNF related apoptosis inducing ligand (TNFSF10) ,MOA:Modulator); ", "drug_id_TTD": "D0C0JT", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Metyrapone": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Q9JT", "drug_id_DB": "DB01011", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "FR230513": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06QTC", "drug_id_DB": "DB03572", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Thiamylal(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GABRA1(Gamma-aminobutyric acid receptor subunit alpha-1); ", "drug_id_TTD": "", "drug_id_DB": "DB01154", "metabolic_annotation_str": "KCNJ8(ATP-sensitive inward rectifier potassium channel 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["KCNJ8"], "metabolic_genes_id": ["3764"]}, "3-(2,4-dihydroxyphenyl)propionic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02LHQ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Microxine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "CDK1(Cyclin-dependent kinase 1 (CDK1) ,MOA:Inhibitor); ", "drug_id_TTD": "D08JML", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "(+/-)-threo-N-(4-Phenylbutyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08YJE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "1,1':4',1''-terphenyl-3,4''-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C9KZ", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "D-254C": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ZFX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "PMID12014956C12 ": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02PVD", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "6-(Benzofuran-2-sulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R3MB", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Polybrominated diphenyl ether derivative": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A3QB", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "Dorzolamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00869", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); CA4(Carbonic anhydrase 4); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA1", "CA2", "CA3", "CA4"], "metabolic_genes_id": ["759", "760", "761", "762"]}, "Palmarumycin derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02ODA", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "GBR-12289": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0G8KT", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Palmarumycin derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0HH1K", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Palmarumycin derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SC3B", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Palmarumycin derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ZZ6N", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "S-(4-Methylbenzyl)isothiourea hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LFV", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2-Cinnamamido-N4-hexyl-N1-hydroxysuccinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UI1P", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Protoporphyrin IX": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AF3A", "drug_id_DB": "", "metabolic_annotation_str": "HPGDS(Glutathione-dependent PGD synthase (HPGDS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HPGDS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["27306"]}, "US8586571, 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J9YV", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "N-(3-(phenylthio)pyridin-4-yl)methanesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01WLL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "MK-8109": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02TJT", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2348"]}, "4-Ethyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y8DZ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "GDC-0084": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07BGC", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "ProSavin": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2", "Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D05ICS", "drug_id_DB": "", "metabolic_annotation_str": "TH(Tyrosine 3-monooxygenase (TH) ,MOA:Modulator); DDC(Aromatic-L-amino-acid decarboxylase (DDC) ,MOA:Modulator); GCH1(GTP cyclohydrolase-I (GCH1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TH", "DDC", "GCH1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["7054", "1644", "2643"]}, "S-(N-4bromophenyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I2AG", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "L-Homoarginine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F8VS", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "5'-Deoxy-5'-dimethylsulfonioadenosine chloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I7IA", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "4-phenylthiazole-2-thiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02SRL", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2-(Aminomethyl)-5-phenethyltetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L0AY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "3-[4-Chloro-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V3YH", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "4-(hydroxymethyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05XZM", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "765", "768", "23632"]}, "AZD1722": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04TQO", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Modulator); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6550", "6550"]}, "PMID1875346C18": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06HNA", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "16-beta-hydroxymethyl-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z1AT", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Aconitate Ion": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00UFR", "drug_id_DB": "DB04351", "metabolic_annotation_str": "ACO2(Citrate hydro-lyase (ACO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACO2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["50"]}, "Acetic acid 2-hexylsulfanyl-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04KAM", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "5-Naphthalen-2-yl-oxazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L8KL", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "PMID26560362-Compound-90": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0GL1X", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "5-[4-(Pyridin-4-ylmethyl)phenyl]-1H-indole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04CFP", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "KadcoccitoneA": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G3TH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "ACETYLSULFANILAMIDE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04POB", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "768"]}, "3-epicorosolic acid methyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01EBV", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "PMID26815044-Compound-127": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0A2RI", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-126": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00LSQ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-125": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0U5GU", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-124": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02WJB", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-123": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02CXZ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-122": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KR9E", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-121": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03FQY", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(S)-Ethyl 6-(2-oxohexadecanamido)decanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B2RW", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "US9388139, 12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SG9Q", "drug_id_DB": "", "metabolic_annotation_str": "PDE3B(Phosphodiesterase 3B (PDE3B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5140"]}, "1-adamantan-1-yl-3-(4-pentyloxybutyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07TOI", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Garveatin C": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3XP", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Garveatin E": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P2ET", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "LIPOCRINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F5EJ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Sulfamic acid 3-(3-methoxy-benzoyl)-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02RJA", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "Selegiline(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "TACR1(Substance-P receptor (TACR1) ,MOA:Antagonist); ", "drug_id_TTD": "D0S2UG", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "4-MA": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ZPJ", "drug_id_DB": "", "metabolic_annotation_str": "HSD3B1(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); HSD3B2(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD3B1", "HSD3B2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3283", "3284"]}, "(E)-(thiophen-2-ylmethylidene)amino benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7AS", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7941"]}, "N-Phenylbenzo[d]oxazol-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00JPV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-(1,3-diphenylpropyl)piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W6WL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Lovastatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06WTZ", "drug_id_DB": "DB00227", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "THIOCTIC ACID": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P6PQ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["43", "5743"]}, "OX-914": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0RJ1W", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "BPH-652": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PP5M", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "2-N-Hydroxyamino-1-(4-ethylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3EJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "5-Hydroxymethyl-Chonduritol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03092", "metabolic_annotation_str": "AMY1B(Alpha-amylase 1); AMY1A(Alpha-amylase 1); AMY1C(Alpha-amylase 1); AMY2A(Pancreatic alpha-amylase); AMY2B(Alpha-amylase 2B); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["AMY1B", "AMY1A", "AMY1C", "AMY2A", "AMY2B"], "metabolic_genes_id": ["277", "276", "278", "279", "280"]}, "Isosorbide-2-benzylcarbamate-5-cyclopropanoate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T5MD", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Cordil": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated", "Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0P6EL", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1B1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1A3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1B2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1A2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1B3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1", "ATP1B1", "ATP1A3", "ATP1B2", "ATP1A2", "ATP1B3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["476", "481", "478", "482", "477", "483"]}, "N,N'-(1',8'-octylene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0VQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "D-22888": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0R1QJ", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Modulator); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Modulator", "Modulator"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Thiazole derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YX1C", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "RTI-219": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z4UF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "S-(N-ethyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I8PQ", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "OPC-22575": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6LA", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["495"]}, "6-amino-9-methoxy-7H-furo[3,2-g]chromen-7-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S0JH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "(-)-huperzine B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZJO", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Benzodiazepine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0TK5G", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "KC-11404": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "PTAFR(Platelet-activating factor receptor (PTAFR) ,MOA:Modulator); ", "drug_id_TTD": "D04APY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "L-869298": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W7WV", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "PF-06427878": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0UL2I", "drug_id_DB": "", "metabolic_annotation_str": "DGAT2(Diacylglycerol O-acyltransferase 2 (DGAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["84649"]}, "Lactoferrin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0O5WD", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "BIS(8)-HUPERZINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8EC", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "NADH(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "NQO2(Ribosyldihydronicotinamide dehydrogenase [quinone]); NDUFA4L2(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2); ", "drug_id_TTD": "", "drug_id_DB": "DB00157", "metabolic_annotation_str": "NDUFS8(NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial); NDUFA4(Cytochrome c oxidase subunit NDUFA4); GAPDHS(Glyceraldehyde-3-phosphate dehydrogenase, testis-specific); NDUFAB1(Acyl carrier protein, mitochondrial); NDUFA1(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1); PHGDH(D-3-phosphoglycerate dehydrogenase); NDUFS4(NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial); NDUFB5(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial); NDUFB3(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3); NDUFC1(NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial); NDUFA2(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2); IDH3B(Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial); NDUFS5(NADH dehydrogenase [ubiquinone] iron-sulfur protein 5); UGDH(UDP-glucose 6-dehydrogenase); NDUFS7(NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial); NDUFS2(NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial); NDUFS6(NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial); NDUFB1(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1); NDUFS3(NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial); NDUFS3(NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial); ALDH1A2(Retinal dehydrogenase 2); NDUFB6(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6); NDUFA3(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3); NDUFA3(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3); NDUFB4(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4); NDUFB8(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial); NDUFB2(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial); NDUFA7(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7); NDUFC2(NADH dehydrogenase [ubiquinone] 1 subunit C2); NDUFA10(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial); H6PD(GDH/6PGL endoplasmic bifunctional protein); NDUFB10(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10); ADH1C(Alcohol dehydrogenase 1C); LDHA(L-lactate dehydrogenase A chain); LDHA(L-lactate dehydrogenase A chain); ALDH1A1(Retinal dehydrogenase 1); GLUD1(Glutamate dehydrogenase 1, mitochondrial); DHFR(Dihydrofolate reductase); CYB5R3(NADH-cytochrome b5 reductase 3); GSR(Glutathione reductase, mitochondrial); MT-ND1(NADH-ubiquinone oxidoreductase chain 1); MT-ND2(NADH-ubiquinone oxidoreductase chain 2); MT-ND3(NADH-ubiquinone oxidoreductase chain 3); MT-ND4L(NADH-ubiquinone oxidoreductase chain 4L); MT-ND4(NADH-ubiquinone oxidoreductase chain 4); MT-ND5(NADH-ubiquinone oxidoreductase chain 5); MT-ND6(NADH-ubiquinone oxidoreductase chain 6); HMGCR(3-hydroxy-3-methylglutaryl-coenzyme A reductase); GAPDH(Glyceraldehyde-3-phosphate dehydrogenase); ALDH2(Aldehyde dehydrogenase, mitochondrial); CYP17A1(Steroid 17-alpha-hydroxylase/17,20 lyase); LDHB(L-lactate dehydrogenase B chain); ADH1A(Alcohol dehydrogenase 1A); LDHC(L-lactate dehydrogenase C chain); ADH4(Alcohol dehydrogenase 4); PDHA1(Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial); QDPR(Dihydropteridine reductase); HMOX1(Heme oxygenase 1); DLD(Dihydrolipoyl dehydrogenase, mitochondrial); DLAT(Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial); PDHB(Pyruvate dehydrogenase E1 component subunit beta, mitochondrial); ADH5(Alcohol dehydrogenase class-3); IMPDH2(Inosine-5'-monophosphate dehydrogenase 2); MTHFD2(Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial); HSD3B1(3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1); HSD17B1(Estradiol 17-beta-dehydrogenase 1); TYR(Tyrosinase); AKR1B1(Aldose reductase); HPGD(15-hydroxyprostaglandin dehydrogenase [NAD(+)]); ACADS(Short-chain specific acyl-CoA dehydrogenase, mitochondrial); AKR1C4(Aldo-keto reductase family 1 member C4); NDUFB7(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7); NDUFV2(NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial); GPD1(Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic); ME2(NAD-dependent malic enzyme, mitochondrial); HSD3B2(3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2); NDUFS1(NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial); NDUFS1(NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial); HSD11B1(Corticosteroid 11-beta-dehydrogenase isozyme 1); PDHA2(Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial); ALDH4A1(Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial); BLVRB(Flavin reductase (NADPH)); HMOX2(Heme oxygenase 2); HMOX2(Heme oxygenase 2); ALDH3A1(Aldehyde dehydrogenase, dimeric NADP-preferring); HIBADH(3-hydroxyisobutyrate dehydrogenase, mitochondrial); PYCR1(Pyrroline-5-carboxylate reductase 1, mitochondrial); HSD17B3(Testosterone 17-beta-dehydrogenase 3); HSD17B2(Estradiol 17-beta-dehydrogenase 2); ADH7(Alcohol dehydrogenase class 4 mu/sigma chain); MDH1(Malate dehydrogenase, cytoplasmic); MDH2(Malate dehydrogenase, mitochondrial); HADHA(Trifunctional enzyme subunit alpha, mitochondrial); AKR1C3(Aldo-keto reductase family 1 member C3); ALDH3B1(Aldehyde dehydrogenase family 3 member B1); ALDH1A3(Aldehyde dehydrogenase family 1 member A3); ME1(NADP-dependent malic enzyme); ALDH3B2(Aldehyde dehydrogenase family 3 member B2); AMT(Aminomethyltransferase, mitochondrial); ALDH7A1(Alpha-aminoadipic semialdehyde dehydrogenase); GLUD2(Glutamate dehydrogenase 2, mitochondrial); GLUD2(Glutamate dehydrogenase 2, mitochondrial); NDUFV1(NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial); IDH3A(Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial); IDH3G(Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial); ALDH3A2(Fatty aldehyde dehydrogenase); ALDH5A1(Succinate-semialdehyde dehydrogenase, mitochondrial); HSD17B4(Peroxisomal multifunctional enzyme type 2); NDUFA8(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8); AKR1C2(Aldo-keto reductase family 1 member C2); BLVRA(Biliverdin reductase A); NDUFV3(NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial); NDUFA6(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6); NDUFA6(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6); NDUFA6(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6); NDUFA6(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6); NDUFA6(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6); HSD17B7(3-keto-steroid reductase); HSD11B2(Corticosteroid 11-beta-dehydrogenase isozyme 2); SORD(Sorbitol dehydrogenase); OGDH(2-oxoglutarate dehydrogenase, mitochondrial); ALDH6A1(Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial); BDH1(D-beta-hydroxybutyrate dehydrogenase, mitochondrial); BDH1(D-beta-hydroxybutyrate dehydrogenase, mitochondrial); CYP4A11(Cytochrome P450 4A11); AKR1C1(Aldo-keto reductase family 1 member C1); EHHADH(Peroxisomal bifunctional enzyme); NNT(NAD(P) transhydrogenase, mitochondrial); TSTA3(GDP-L-fucose synthase); TSTA3(GDP-L-fucose synthase); NSDHL(Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating); MSMO1(Methylsterol monooxygenase 1); NDUFA5(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5); NDUFA9(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial); ME3(NADP-dependent malic enzyme, mitochondrial); HADH(Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial); CDO1(Cysteine dioxygenase type 1); LDHAL6A(L-lactate dehydrogenase A-like 6A); NDUFA11(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11); HSD17B8(Estradiol 17-beta-dehydrogenase 8); HSD17B8(Estradiol 17-beta-dehydrogenase 8); HSD17B8(Estradiol 17-beta-dehydrogenase 8); HSD17B8(Estradiol 17-beta-dehydrogenase 8); HSD17B8(Estradiol 17-beta-dehydrogenase 8); HSD17B8(Estradiol 17-beta-dehydrogenase 8); RDH5(11-cis retinol dehydrogenase); PYCR2(Pyrroline-5-carboxylate reductase 2); HSD17B10(3-hydroxyacyl-CoA dehydrogenase type-2); LDHAL6B(L-lactate dehydrogenase A-like 6B); NDUFA13(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13); DHCR7(7-dehydrocholesterol reductase); AASS(Alpha-aminoadipic semialdehyde synthase, mitochondrial); NDUFA12(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12); NDUFB9(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["NDUFS8", "NDUFA4", "GAPDHS", "NDUFAB1", "NDUFA1", "PHGDH", "NDUFS4", "NDUFB5", "NDUFB3", "NDUFC1", "NDUFA2", "IDH3B", "NDUFS5", "UGDH", "NDUFS7", "NDUFS2", "NDUFS6", "NDUFB1", "NDUFS3", "NDUFS3", "ALDH1A2", "NDUFB6", "NDUFA3", "NDUFA3", "NDUFB4", "NDUFB8", "NDUFB2", "NDUFA7", "NDUFC2", "NDUFA10", "H6PD", "NDUFB10", "ADH1C", "LDHA", "LDHA", "ALDH1A1", "GLUD1", "DHFR", "CYB5R3", "GSR", "MT-ND1", "MT-ND2", "MT-ND3", "MT-ND4L", "MT-ND4", "MT-ND5", "MT-ND6", "HMGCR", "GAPDH", "ALDH2", "CYP17A1", "LDHB", "ADH1A", "LDHC", "ADH4", "PDHA1", "QDPR", "HMOX1", "DLD", "DLAT", "PDHB", "ADH5", "IMPDH2", "MTHFD2", "HSD3B1", "HSD17B1", "TYR", "AKR1B1", "HPGD", "ACADS", "AKR1C4", "NDUFB7", "NDUFV2", "GPD1", "ME2", "HSD3B2", "NDUFS1", "NDUFS1", "HSD11B1", "PDHA2", "ALDH4A1", "BLVRB", "HMOX2", "HMOX2", "ALDH3A1", "HIBADH", "PYCR1", "HSD17B3", "HSD17B2", "ADH7", "MDH1", "MDH2", "HADHA", "AKR1C3", "ALDH3B1", "ALDH1A3", "ME1", "ALDH3B2", "AMT", "ALDH7A1", "GLUD2", "GLUD2", "NDUFV1", "IDH3A", "IDH3G", "ALDH3A2", "ALDH5A1", "HSD17B4", "NDUFA8", "AKR1C2", "BLVRA", "NDUFV3", "NDUFA6", "NDUFA6", "NDUFA6", "NDUFA6", "NDUFA6", "HSD17B7", "HSD11B2", "SORD", "OGDH", "ALDH6A1", "BDH1", "BDH1", "CYP4A11", "AKR1C1", "EHHADH", "NNT", "TSTA3", "TSTA3", "NSDHL", "MSMO1", "NDUFA5", "NDUFA9", "ME3", "HADH", "CDO1", "LDHAL6A", "NDUFA11", "HSD17B8", "HSD17B8", "HSD17B8", "HSD17B8", "HSD17B8", "HSD17B8", "RDH5", "PYCR2", "HSD17B10", "LDHAL6B", "NDUFA13", "DHCR7", "AASS", "NDUFA12", "NDUFB9"], "metabolic_genes_id": ["4728", "4697", "26330", "4706", "4694", "26227", "4724", "4711", "4709", "4717", "4695", "3420", "4725", "7358", "374291", "4720", "4726", "4707", "4722", "4722", "8854", "4712", "4696", "4696", "4710", "4714", "4708", "4701", "4718", "4705", "9563", "4716", "126", "3939", "3939", "216", "2746", "1719", "1727", "2936", "4535", "4536", "4537", "4539", "4538", "4540", "4541", "3156", "2597", "217", "1586", "3945", "124", "3948", "127", "5160", "5860", "3162", "1738", "1737", "5162", "128", "3615", "10797", "3283", "3292", "7299", "231", "3248", "35", "1109", "4713", "4729", "2819", "4200", "3284", "4719", "4719", "3290", "5161", "8659", "645", "3163", "3163", "218", "11112", "5831", "3293", "3294", "131", "4190", "4191", "3030", "8644", "221", "220", "4199", "222", "275", "501", "2747", "2747", "4723", "3419", "3421", "224", "7915", "3295", "4702", "1646", "644", "4731", "4700", "4700", "4700", "4700", "4700", "51478", "3291", "6652", "4967", "4329", "622", "622", "1579", "1645", "1962", "23530", "7264", "7264", "50814", "6307", "4698", "4704", "10873", "3033", "1036", "160287", "126328", "7923", "7923", "7923", "7923", "7923", "7923", "5959", "29920", "3028", "92483", "51079", "1717", "10157", "55967", "4715"]}, "2,8-Diamino-9-benzyl-1,9-dihydro-purin-6-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4HR", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "2,3,5-Trimethoxy-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G2JV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Flosulide": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D05REH", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "Tacrine heterodimer derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0CB1C", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "1-(2-adamantyl)-3-benzylpyrrolidin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3FW", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "(1-Amino-3-methyl-butyl)-phosphinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N3UO", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Filaminast": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0H9KW", "drug_id_DB": "DB02660", "metabolic_annotation_str": "PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5142"]}, "Estradiol 17-O-sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00LFX", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "BEMORADAN": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08HKT", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "6-methoxy-2-methyl-9H-beta-carbolin-2-ium": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XI4U", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Dorzolamide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05UYW", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Mesuagenin D": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00FEH", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-N-Ethylamino-1-(4-methylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07SZF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Coumaricacid": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0BT3Y", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "US8846654, 294": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05SRL", "drug_id_DB": "", "metabolic_annotation_str": "PDE8A(Phosphodiesterase 8 (PDE8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE8A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5151"]}, "KAEMPFERIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04DYO", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "2-Biphenyl-4-yl-N-hydroxy-N-methyl-acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HQK", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Bromfenac(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0U1OM", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "TRIMEDOXIME": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G5QX", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "TAK-329": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0L5FB", "drug_id_DB": "", "metabolic_annotation_str": "GCK(Glucokinase (GCK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2645"]}, "GSK1059615": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0L0ZC", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "Morniflumate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TBXA2R(Thromboxane A2 receptor); LTB4R(Leukotriene B4 receptor 1); LTB4R(Leukotriene B4 receptor 1); ", "drug_id_TTD": "", "drug_id_DB": "DB09285", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS2"], "metabolic_genes_id": ["240", "240", "5743"]}, "4-[(2-Methyl-1H-imidazol-1-yl)methyl]pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01DFX", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "5-benzyl-1,3,4-oxadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z8MX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(RS/SR)-2-[1-(4-chlorophenyl)pentyl]piperidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07PAT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-p-tolyl-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03BQJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(1S)-MENTHYL HEXYL PHOSPHONATE GROUP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09DQV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "9-(5,5-Difluoro-5-Phosphonopentyl)Guanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BNM", "drug_id_DB": "DB04260", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "4'-(2-methyl-1-(pyridin-4-yl)propyl)biphenyl-3-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00YHD", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "BTS-67582": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0P2MH", "drug_id_DB": "", "metabolic_annotation_str": "ABCC9(ATP-binding cassette transporter C9 (ABCC9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["10060"]}, "2-(benzyloxyamino)-N-hydroxyhexanamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y1XM", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "768"]}, "Dimethylallyl Diphosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01785", "metabolic_annotation_str": "FDPS(Farnesyl pyrophosphate synthase); IDI1(Isopentenyl-diphosphate Delta-isomerase 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["FDPS", "IDI1"], "metabolic_genes_id": ["2224", "3422"]}, "5-methoxy-2-(4-(methylsulfonyl)phenyl)-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P4QS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03IMZ", "drug_id_DB": "", "metabolic_annotation_str": "LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHB(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHC(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LDHA", "LDHA", "LDHB", "LDHC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3939", "3939", "3945", "3948"]}, "4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ISX", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "1-Imidazol-1-ylmethylxanthen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SZX", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588"]}, "(+/-)-threo-N-(5-Phenylpentyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S6CT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "PMID2909732C7": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J8BD", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Icatibant(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "BDKRB2(B2 bradykinin receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB06196", "metabolic_annotation_str": "ANPEP(Aminopeptidase N); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ANPEP"], "metabolic_genes_id": ["290"]}, "Hexahydro-cyclopenta[b]pyrrol-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QFO", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "6-Benzylthioinosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K1YY", "drug_id_DB": "", "metabolic_annotation_str": "ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["132"]}, "[6,4''']biflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LWK", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "APC-2059": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08RMH", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "Isoquinolone derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Y7XJ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor. Antagonist. Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor; Antagonist; Blocker"], "metabolic_genes_id": ["8644"]}, "aminobenzovesamicol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8WR", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A3(Vesicular acetylcholine transporter (SLC18A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6572"]}, "1-(2-bromoethyl)-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JI0H", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1-(1-Propionylpiperidin-4-yl)-3-o-tolylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P8MM", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "4-(4-cyclohexylthiosemicarbazono)methyl-phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BUM", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "5-hydroxyvaleric acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y4TF", "drug_id_DB": "DB04781", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["210"]}, "7-Butyl-azepan-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03QMU", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "Vapill": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00LPZ", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8639"]}, "AG2034": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0A8LP", "drug_id_DB": "", "metabolic_annotation_str": "GART(GAR transformylase (GART) ,MOA:Modulator); GART(GAR transformylase (GART) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2618", "2618"]}, "Pentoxifylline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ADORA2A(Adenosine receptor A2a); ADORA1(Adenosine receptor A1); ", "drug_id_TTD": "", "drug_id_DB": "DB00806", "metabolic_annotation_str": "NT5E(5'-nucleotidase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["NT5E"], "metabolic_genes_id": ["4907"]}, "(+/-)-5'-deoxy-4'-fluoro-5'-methylthio-DADMe-ImmH": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BGQ", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "(+)-5-deoxyadeenophorine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0WB", "drug_id_DB": "", "metabolic_annotation_str": "GLA(Alpha-galactosidase A (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2717"]}, "PF-915275": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07FHW", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Di-Stearoyl-3-Sn-Phosphatidylcholine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06LYY", "drug_id_DB": "DB04178", "metabolic_annotation_str": "SLC25A4(Adenine nucleotide translocator 1 (SLC25A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC25A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["291"]}, "PMID8246234C3h": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07VEB", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Casopitant(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TACR1(Substance-P receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB06634", "metabolic_annotation_str": "CYP3A4(Cytochrome P450 3A4); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CYP3A4"], "metabolic_genes_id": ["1576"]}, "Daio-Orengedokuto (DOT)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CGL", "drug_id_DB": "", "metabolic_annotation_str": "PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNLIP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5406"]}, "Sodium trithiocarbonate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D5XC", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "Chlorthalidone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00310", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); SLC12A1(Solute carrier family 12 member 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA1", "SLC12A1"], "metabolic_genes_id": ["759", "6557"]}, "2-(3-Phenyl-propyl)-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4TM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "4-phospho-D-erythronate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C4VG", "drug_id_DB": "", "metabolic_annotation_str": "PGD(Phosphogluconate dehydrogenase (PGD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PGD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5226"]}, "4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "NR3C1(Glucocorticoid receptor messenger RNA (GCR mRNA) ,MOA:Inhibitor); CHRM2(Muscarinic acetylcholine receptor M2 (CHRM2) ,MOA:Inhibitor); CHRM4(Muscarinic acetylcholine receptor M4 (CHRM4) ,MOA:Inhibitor); HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); CHRM5(Muscarinic acetylcholine receptor M5 (CHRM5) ,MOA:Inhibitor); ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); ADORA3(Adenosine A3 receptor (ADORA3) ,MOA:Inhibitor); CHRM1(Muscarinic acetylcholine receptor M1 (CHRM1) ,MOA:Inhibitor); DRD2(Dopamine D2 receptor (D2R) ,MOA:Inhibitor); CHRNB2(Neuronal acetylcholine receptor beta-2 (CHRNB2) ,MOA:Inhibitor); CHRM3(Muscarinic acetylcholine receptor M3 (CHRM3) ,MOA:Inhibitor); TACR2(Substance-K receptor (TACR2) ,MOA:Inhibitor); CNR1(Cannabinoid receptor 1 (CB1) ,MOA:Inhibitor); DRD1(Dopamine D1 receptor (D1R) ,MOA:Inhibitor); HRH2(Histamine H2 receptor (H2R) ,MOA:Inhibitor); ADRA1D(Adrenergic receptor alpha-1D (ADRA1D) ,MOA:Inhibitor); EDNRA(Endothelin A receptor (EDNRA) ,MOA:Inhibitor); TACR1(Substance-P receptor (TACR1) ,MOA:Inhibitor); NPY1R(Neuropeptide Y receptor type 1 (NPY1R) ,MOA:Inhibitor); HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ADORA2A(Adenosine A2a receptor (ADORA2A) ,MOA:Inhibitor); ADORA1(Adenosine A1 receptor (ADORA1) ,MOA:Inhibitor); NTSR1(Neurotensin receptor type 1 (NTSR1) ,MOA:Inhibitor); CCKBR(Gastrin/cholecystokinin type B receptor (CCKBR) ,MOA:Inhibitor); MC4R(Melanocortin receptor 4 (MC4R) ,MOA:Inhibitor); HTR7(5-HT 7 receptor (HTR7) ,MOA:Inhibitor); ADRA1A(Adrenergic receptor alpha-1A (ADRA1A) ,MOA:Inhibitor); HRH1(Histamine H1 receptor (H1R) ,MOA:Inhibitor); ADRA1B(Adrenergic receptor alpha-1B (ADRA1B) ,MOA:Inhibitor); OPRM1(Opioid receptor mu (MOP) ,MOA:Inhibitor); HTR2B(5-HT 2B receptor (HTR2B) ,MOA:Inhibitor); CHRNA4(Neuronal acetylcholine receptor alpha-4 (CHRNA4) ,MOA:Inhibitor); HTR3A(5-HT 3A receptor (HTR3A) ,MOA:Inhibitor); MTNR1A(Melatonin receptor type 1A (MTNR1A) ,MOA:Inhibitor); HTR4(5-HT 4 receptor (HTR4) ,MOA:Inhibitor); HRH3(Histamine H3 receptor (H3R) ,MOA:Inhibitor); ", "drug_id_TTD": "D0T2RY", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE", "SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["43", "6530", "6532", "6531", "6531"]}, "Pyrimethamine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0C0SK", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2348"]}, "NE58043": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y3XR", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "(+)-(5S,8S,9R,10S)-20-methoxypuupehenone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H8FG", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "BLY719": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D01LMM", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5290"]}, "ONT-093": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0SR4G", "drug_id_DB": "DB14069", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5243"]}, "ISIS 32006": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A5LZ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "5-isopropyl-2-(phenylamino)thiazol-4(5H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BN7E", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "7-Nitroindazole-2-Carboxamidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N5LD", "drug_id_DB": "DB03065", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "2-Adamantan-2-ylidenemethyl-benzooxazol-6-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03XJE", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ILO", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "1-(4-chlorobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01JZO", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "Alpha-Hydroxy-Midazolam": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q7QU", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "3-(Benzyloxy)Pyridin-2-Amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MAPK14(Stress-activated protein kinase 2a (p38 alpha) ,MOA:Inhibitor); ", "drug_id_TTD": "D09DRF", "drug_id_DB": "DB02352", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "ASP8232": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01VLT", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8639"]}, "BPH-675": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1XZ", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "1-(3-Bromomethyl-phenyl)-2,2,2-trifluoro-ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D5QT", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "((3R,4R)-4-(o-tolyloxy)chroman-3-yl)methanamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SHR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "NLG802": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0N4VB", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Verapamil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CACNA1A(Voltage-dependent P/Q-type calcium channel subunit alpha-1A); CACNA1G(Voltage-dependent T-type calcium channel subunit alpha-1G); CACNA1H(Voltage-dependent T-type calcium channel subunit alpha-1H); ADRA1D(Alpha-1D adrenergic receptor); ADRA1A(Alpha-1A adrenergic receptor); ADRA1B(Alpha-1B adrenergic receptor); CACNA1B(Voltage-dependent N-type calcium channel subunit alpha-1B); KCNH2(Potassium voltage-gated channel subfamily H member 2); ", "drug_id_TTD": "", "drug_id_DB": "DB00661", "metabolic_annotation_str": "SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A4"], "metabolic_genes_id": ["6532"]}, "Acetic acid 2-heptylselanyl-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01EWD", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "(R)-2-amino-3-(4-octylphenylamino)propan-1-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3LA", "drug_id_DB": "", "metabolic_annotation_str": "SPHK2(Sphingosine kinase 2 (SPHK2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["56848"]}, "N,N-Diethyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K7EC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1-[4-(4-Iodophenoxy)phenyl]piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P7DF", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "RG-7234": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04ZNL", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B2(Corticosteroid 11-beta-dehydrogenase 2 (HSD11B2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3291"]}, "LIDORESTAT": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04BFU", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "4'-(6-Methoxypyridin-3-yl)biphenyl-3-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G5CP", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "NS-11757": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4BF", "drug_id_DB": "", "metabolic_annotation_str": "ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC8"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6833"]}, "1-(3-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZOP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "1,8,9-Trimethoxy-9,10-dihydro-anthracene": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07OKS", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-(2-Phenylacetamidoethyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09LWR", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Trisnorsqualene cyclopropylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1DW", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "FUROSIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G3SL", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "PSB-0952": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "P2RY6(P2Y purinoceptor 6 (P2RY6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0DZ1K", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z3JI", "drug_id_DB": "DB02979", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "IZONSTERIDE": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D07BXC", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6715", "79644"]}, "4-Bromo-N-hydroxy-benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7AM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "TK-DLI": {"drug_status_TTD": ["Preregistration"], "non_metabolic": "", "drug_id_TTD": "D08AMJ", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7083"]}, "4-Hydrazino-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NN3Q", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "3-[7'-(Methoxy)-napht-2'-yl]-quinuclidine-2-ene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NL2L", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "5,6-dihydroxy-7-nitro-2,3-dihydroinden-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HW3Y", "drug_id_DB": "", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "Rilopirox": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00RJB", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "7-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05HFD", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "GSK-356278": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0K9DI", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "3-(3,4-dichlorophenyl)-2-nortropene": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1FM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "LX-2932": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D01FLN", "drug_id_DB": "", "metabolic_annotation_str": "SGPL1(Sphingosine-1-phosphate lyase 1 (SGPL1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SGPL1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8879"]}, "Amitifadine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "DRD2(D(2) dopamine receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB05964", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "Enalapril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00SEB", "drug_id_DB": "DB00584", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "2-Amino-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OI1H", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "765", "768", "23632"]}, "Azonan-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02MFQ", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "1-(pentyloxy)-4-phenoxybenzene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07LTR", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "NEOLIGNAN 9-NOR-7,8-DEHYDRO-ISOLICARIN B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M6UZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "5'-phenylthio-ImmH": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R5RF", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "4-Methyl-3,6-dihydro-1H-pyridin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PFL", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "3-(decylthio)-1,1,1-trifluoropropan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E5CF", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07YSQ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "ONO-1581": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01QOU", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "[3H]estrone-3-sulphate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04AXP", "drug_id_DB": "", "metabolic_annotation_str": "SLCO1A2(Sodium-independent organic anion transporter (SLCO1A2) ,MOA:Modulator); SLCO4A1(Organic anion transporter E (SLCO4A1) ,MOA:Modulator); SLCO1C1(Organic anion transporter F (SLCO1C1) ,MOA:Modulator); SLCO3A1(Organic anion transporter D (SLCO3A1) ,MOA:Modulator); SLCO1B1(Liver organic anion transporter 1 (SLCO1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLCO1A2", "SLCO4A1", "SLCO1C1", "SLCO3A1", "SLCO1B1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["6579", "28231", "53919", "28232", "10599"]}, "ASB17061": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0B1OH", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1215"]}, "EXISULIND": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0M9VE", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8654"]}, "PGL-2001": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04ZND", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "KY-382": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V9MG", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "A-87049": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D04KDA", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "1-(4-bromophenyl)-2-(tert-butylamino)propan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4AD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "BI-44847": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D00SFY", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "Trequinsin": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D01FRF", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "O2-Sulfo-Glucuronic Acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "FGF1(Fibroblast growth factor 1); HGF(Hepatocyte growth factor); ", "drug_id_TTD": "", "drug_id_DB": "DB02264", "metabolic_annotation_str": "HS3ST3A1(Heparan sulfate glucosamine 3-O-sulfotransferase 3A1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["HS3ST3A1"], "metabolic_genes_id": ["9955"]}, "N-(14-methylallyl)norgalanthamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00YHI", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "6-(1H-Indole-2-sulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2FM", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "P'-geranyl 2-fluoromevalonate 5-diphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P6GH", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "Canaline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08KEZ", "drug_id_DB": "DB02821", "metabolic_annotation_str": "OAT(Ornithine delta-aminotransferase (OAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["OAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4942"]}, "Chlorthalidone(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09NIA", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "N-(3-phenoxypyridin-4-yl)methanesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VF6F", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "DYSIDINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "PTPN1(PTPN1 messenger RNA (PTPN1 mRNA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0U9HN", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5320"]}, "10S-hydroxylobelane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4KN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Idursulfase(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06CZJ", "drug_id_DB": "", "metabolic_annotation_str": "IDS(Iduronate 2-sulfatase (IDS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["IDS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3423"]}, "V-11294A": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08SNX", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "3-(4-Amino-phenyl)-3-heptyl-piperidine-2,6-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E2RV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Nitroarginine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GC1Y", "drug_id_DB": "DB04223", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842"]}, "Isosorbide-2-benzylcarbamate-5-propionate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04PKD", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03FGM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "ANNULIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DB2N", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09JLP", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J0BB", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3-Methyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6MB", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09EFW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "US8933095, 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07JBL", "drug_id_DB": "", "metabolic_annotation_str": "AADAT(Kynurenine oxoglutarate transaminase II (AADAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AADAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["51166"]}, "9-(4-Hydroxybutyl)-N2-Phenylguanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G5VO", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "11BETA,13-DIHYDRO-10-EPI-8-DEOXYCUMAM-BRIN B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04TBB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-(6-Methoxynaphthalen-2-yl)-5-phenylpyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q6BJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "N-Isopropyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K3YM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "ZARAGOZIC ACID B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OI4E", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "N-butylnorlitebamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08LBC", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "S-8921": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02FEV", "drug_id_DB": "", "metabolic_annotation_str": "SLC10A2(Ileal sodium/bile acid cotransporter (SLC10A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC10A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6555"]}, "S-14080": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0M6JP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Pseudocolumbamine trifluoroacetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RA5T", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Benzene sulfonamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ZL9P", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Benzene sulfonamide derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0P1BE", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Benzene sulfonamide derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S0DL", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "SK&F-96321": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R0VG", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "GBR 12530": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0X4DE", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Benzene sulfonamide derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0R3JM", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "2-methoxyestrrone-3-O-sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09PUF", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "12-(3-n-Hexylureido)dodec-8(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TWI", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "ABS-301": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D02UQU", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["43"]}, "16-(pyridin-3-yl)methyl-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1LT", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "3,4,6-Tribromo-2-(2,4-dibromo-phenoxy)-phenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03YMX", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "5-[5-Methoxy-indan-(1E)-ylidenemethyl]-thiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C8EO", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Sulfamic acid ester derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06SKI", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(S)-N-(1-phenylethyl)acetimidamide hydrobromide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7MJ", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "Guanosine-5'-Triphosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HRAS(GTPase HRas); HRAS(GTPase HRas); RAP2A(Ras-related protein Rap-2a); RAB5A(Ras-related protein Rab-5A); RND3(Rho-related GTP-binding protein RhoE); ARF1(ADP-ribosylation factor 1); RHEB(GTP-binding protein Rheb); ", "drug_id_TTD": "", "drug_id_DB": "DB04137", "metabolic_annotation_str": "GLUD1(Glutamate dehydrogenase 1, mitochondrial); PFKFB1(6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1); ADSS1(Adenylosuccinate synthetase isozyme 1); UCKL1(Uridine-cytidine kinase-like 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["GLUD1", "PFKFB1", "ADSS1", "UCKL1"], "metabolic_genes_id": ["2746", "5207", "122622", "54963"]}, "AMIFLAMINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X5AA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "TRYPTOLINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA2C(Adrenergic receptor alpha-2C (ADRA2C) ,MOA:Inhibitor); HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D03LPH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "TERRITREM B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P5YS", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Cruentaren": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D09IFW", "drug_id_DB": "", "metabolic_annotation_str": "ATP6V1A(Vacuolar-type proton ATPase catalytic A (v-ATPase-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP6V1A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["523"]}, "N-Cyclopentyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04AWS", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "4-Sulfamoyloxy-benzoic acid cycloheptyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05TRN", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "4-Methyl-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09IQS", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "1-(2-(benzo[b]thiophen-4-yl)ethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01IJX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,4-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N7CQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "BMS-986205": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0DP5I", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Benzylsulfinic Acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "HPN(Serine protease hepsin (HPN) ,MOA:Inhibitor); ", "drug_id_TTD": "D0PA1G", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "Cycloalkyl acid derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03UNB", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "Cycloalkyl acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02USA", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "5-Bromothienyldeoxyuridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ST5A", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "4-phenoxyphenylboronic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2JA", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "3-[4-(4-Hydroxyphenyl)-1,3-oxazol-2-yl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IZ4Z", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Pyridostigmine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0O2WB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-(ethylthiomethyl)-5-hydroxy-4H-pyran-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H5XP", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Selenazole-4-Carboxyamide-Adenine Dinucleotide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07HZQ", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "APN-201": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0HE9J", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "VU0240551": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M2PP", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A5(Solute carrier family 12 member 5 (SLC12A5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A5"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["57468"]}, "N-(3,3-diphenyl-propyl)-nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08HUX", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Amide derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0M8KB", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "ISIS 1827": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W1XD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["240", "240"]}, "Amfepramone": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0B7OD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "2-(N-Cyclopropylamino)-3-chloropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07SAA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "bromsulphthalein": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8GY", "drug_id_DB": "", "metabolic_annotation_str": "SLCO2A1(Prostaglandin transporter (SLC21A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLCO2A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6578"]}, "4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02NQK", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "(2S)-euchrenone a7": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09OPA", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "UDP-glucose": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MIE", "drug_id_DB": "", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GALE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2582"]}, "LY335979": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06DCL", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Modulator); ABCB4(Multidrug resistance protein 3 (ABCB4) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1", "ABCB4"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5243", "5244"]}, "(4S,5S)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03HCR", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "(S)-2-Amino-3-phenyl-propane-1-thiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04KOZ", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "GSK2586881": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0ET2T", "drug_id_DB": "", "metabolic_annotation_str": "ACE2(Angiotensin-converting enzyme 2 (ACE2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["59272"]}, "9-[9-(beta-Carboline-9-yl)nonyl]-beta-carboline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y4SO", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Resorcinol compound 29": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ZT3U", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 28": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Q1HU", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "4-(Allylamino)-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09TKG", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "Resorcinol compound 25": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K6TN", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 24": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07PSJ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 27": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QR0E", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 26": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0IH6G", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 21": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04ZZM", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "AD-5467": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0O2ET", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Resorcinol compound 23": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00QVY", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 22": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06YKN", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(E)-4-(2-(thiophen-3-yl)vinyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N0GX", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Hexyl-trimethyl-ammonium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1SE", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-N-Allylamino-1-(4-methylthiophenyl)propan": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8QM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Chlorphentermine Hydrochloride": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06CDO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "4-(4-phenoxybenzoyl)benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W6HB", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "1H-indole-4,7-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TM0Z", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "AZD1772//RDX5791": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04AIB", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Modulator); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6550", "6550"]}, "PD-132301-2": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0YO6E", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "LU32-176B": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02SDM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); SLC6A12(Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1", "SLC6A12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6529", "6539"]}, "Reboxetine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0N8FQ", "drug_id_DB": "DB00234", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "3-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08PNF", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "[3H]nitrobenzylmercaptopurine ribonucleoside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07EVI", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2030"]}, "OPC-14523(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB05422", "metabolic_annotation_str": "SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A4"], "metabolic_genes_id": ["6532"]}, "Pyrido[3,2-e][1,2,4]triazolo[4,3-a]pyrazine derivative 2": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0T8WU", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "2-(N-tert-Butylamino)-3'-chloroheptanophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01RWY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "NEODYSIDENIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q0LD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["239"]}, "NLX-P101": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0VT0T", "drug_id_DB": "", "metabolic_annotation_str": "GLUL(Glutamate decarboxylase (GLUL) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GLUL"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2752"]}, "7-methoxy-2-p-tolyl-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZI0S", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Budipine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0RM9Q", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "5-Hex-5-enyl-2-nonyl-3,4-dihydro-2H-pyrrole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D3TG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-Carbazol-9-yl-propionic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07OKT", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "(+/-)-threo-N-(2-Methylthiopene)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M3YA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "4',4-Dihydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PG8M", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Sapropterin hydrochloride": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0S2IQ", "drug_id_DB": "", "metabolic_annotation_str": "PAH(Phenylalanine hydroxylase (PAH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PAH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5053"]}, "Eusynstyelamide C": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05BGM", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "5-iodo-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07OVY", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "6-Imidazol-1-ylmethyl-8-phenyl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L0NY", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "5(E)-(5'-Deoxyadenosin-5'-ylidene)pentanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B0QY", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "S-Benzyl-brassinin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ETX", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "NBI-59159": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F5SO", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A1(Excitatory amino acid transporter 3 (SLC1A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6505"]}, "9-O-[2-(Phenylol-1-yloxy)hexyl]berberine bromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02WKB", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "METHYLENEDIOXYMETHAMPHETAMINE": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0F5NJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3", "SLC18A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Antagonist"], "metabolic_genes_id": ["6530", "6532", "6531", "6531", "6571"]}, "L-136662": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F7KG", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "10-trifluoroacetyl-DDACTHF": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F2WA", "drug_id_DB": "", "metabolic_annotation_str": "GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2618", "2618"]}, "1,2-Bis-(4-methoxy-phenyl)-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UZ8R", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1,1,1-Trifluoro-6-(4-hexyloxy-phenyl)-hexan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06XFP", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Butyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8PE", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "(+/-)-threo-N-Benzyl-3'-chloromethylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P7NW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Radicicol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HSP90AB1(Heat shock protein HSP 90-beta); HSP90B1(Endoplasmin); PDK3([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial); ", "drug_id_TTD": "", "drug_id_DB": "DB03758", "metabolic_annotation_str": "DLAT(Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["DLAT"], "metabolic_genes_id": ["1737"]}, "10-Benzoyl-1,8-dihydroxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06XYZ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "ARISTEROMYCIN": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "ADORA2A(Adenosine A2a receptor (ADORA2A) ,MOA:Inhibitor); ADORA1(Adenosine A1 receptor (ADORA1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0I7BL", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "10R-hydroxylobel-7-ene": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I1ME", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Methyl 2-(2-oxo-8-phenyloctanamido)acetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PP8T", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "(+/-)-7-fluoro-2-(4-fluorophenyl)chroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2JH", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(2R,3S)-2-[(3-Iodophenoxy)phenylmethyl]morpholine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09RCL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Vortioxetine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03WEX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Tepoxalin": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "IL4(Interleukin-4 (IL4) ,MOA:Inhibitor); ", "drug_id_TTD": "D04WMR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "2-Hydroxy-N,6-bis(3-hydroxyphenyl)-1-naphthamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02QLY", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "2-(benzyloxyamino)-N-hydroxyacetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00TRF", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "5-N-Allyl-Arginine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WHV", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "8-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Q3VI", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Torasemide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00214", "metabolic_annotation_str": "SLC12A2(Solute carrier family 12 member 2); SLC12A1(Solute carrier family 12 member 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC12A2", "SLC12A1"], "metabolic_genes_id": ["6558", "6557"]}, "Quercetin 3-O-neohesperidoside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G1OW", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "(-)-3-O-acetylspectaline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08BPE", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "6-Hydroxypropylthymine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00CEO", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "PMID26815044-Compound-93": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0DW3Z", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "KHK2455": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08XDL", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "NSC-527035": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04DKX", "drug_id_DB": "", "metabolic_annotation_str": "ALDH3A2(Fatty aldehyde dehydrogenase (ALDH3A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH3A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["224"]}, "5-benzhydryl-1,3,4-thiadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G9WX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0GG2J", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "1,2-bis(2-fluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02GJG", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Isosorbide-di-(ethylcarbamate)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8AQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Menadione(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "F2(Prothrombin); F9(Coagulation factor IX); BGLAP(Osteocalcin); PROC(Vitamin K-dependent protein C); PROS1(Vitamin K-dependent protein S); NQO2(Ribosyldihydronicotinamide dehydrogenase [quinone]); GGCX(Vitamin K-dependent gamma-carboxylase); VKORC1L1(Vitamin K epoxide reductase complex subunit 1-like protein 1); VKORC1(Vitamin K epoxide reductase complex subunit 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00170", "metabolic_annotation_str": "NQO1(NAD(P)H dehydrogenase [quinone] 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["NQO1"], "metabolic_genes_id": ["1728"]}, "VS-5584": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Modulator); MAPKAP1(Target of rapamycin complex 2 MAPKAP1 (MTORC2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0U3DP", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "3-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L8EN", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203"]}, "3-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8CR", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "1-(4-Bromobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03VRC", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "3-Hydroxyisoxazole-4-Carboxylic Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09EDP", "drug_id_DB": "", "metabolic_annotation_str": "LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHB(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHC(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LDHA", "LDHA", "LDHB", "LDHC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3939", "3939", "3945", "3948"]}, "S-(4-Nitrobenzyl)isothiourea hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3OY", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2-Aminomethyl-pyrrolidine-3,4-diol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z2RR", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "Ambenonium": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06IAQ", "drug_id_DB": "DB01122", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02QBV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "US10077269, Example 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05TQB", "drug_id_DB": "", "metabolic_annotation_str": "PDE4C(Phosphodiesterase 4C (PDE4C) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4C"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5143"]}, "Prop-2-ynyl 4-sulfamoylbenzoate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00IAE", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "GW-3600": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D01QUF", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "4-(4-tert-butylbenzylideneamino)benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02DCD", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "7-(2-Hydroxyethyl)-3-O-rhamnosylicariin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03BWH", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "NE58062": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7YD", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "10-Propargyl-5,8-Dideazafolic Acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "NQO2(Ribosyldihydronicotinamide dehydrogenase [quinone]); ", "drug_id_TTD": "", "drug_id_DB": "DB03541", "metabolic_annotation_str": "TYMS(Thymidylate synthase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["TYMS"], "metabolic_genes_id": ["7298"]}, "4-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7LC", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "4-methyl-2-oxo-2H-chromen-7-yl sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00OBI", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "UK-369003": {"drug_status_TTD": ["Discontinued in Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0N5SC", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "WAY-213613": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02JJX", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A2(Excitatory amino acid transporter 2 (SLC1A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6506"]}, "L-702-539": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q9TL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "HERNIARIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U4BB", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "762", "765", "768", "23632"]}, "1-(4-methoxyphenyl)-3-(5-methylthiazol-2-yl)urea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X5AY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "NE-10575": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4MM", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "NERIDRONIC ACID": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0V8PA", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "J-104123": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I3TX", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID25399762-Compound-Figure1-Neonectrolide A": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V6TF", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "EM1396": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K9YS", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "4-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F5YU", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "KW-5092": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08ZRR", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "M-Phenoxybenzoic Acid For Cis-Isomer": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DF1Z", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "A-134974": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0S9XV", "drug_id_DB": "", "metabolic_annotation_str": "ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["132"]}, "1,2-Dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H6JC", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "ThermoProfen": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0C4DZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "7-(3-Hydroxy-phenyl)-naphthalen-2-ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ESR1(Estrogen receptor (ESR) ,MOA:Inhibitor); ESR2(Estrogen receptor beta (ESR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D01IAT", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "N-(3-phenoxy-4-pyridinyl)ethanesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BO9W", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Multi-epitope peptide melanoma vaccine": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "PMEL(Melanocytes lineage-specific antigen GP100 (PMEL) ,MOA:.); MLANA(MART-1 melanoma antigen (MLANA) ,MOA:.); ", "drug_id_TTD": "D0P5TG", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["7299"]}, "PMID1895299C4p": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02OET", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "3,4'-(thiophene-2,4-diyl)diphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I5YT", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "1-(6-Methoxy-naphthalen-2-yl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M9VK", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "YM-992": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D01ESB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "SUN-C8257": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1HT", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "N-(5-methylthiazol-2-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QVX", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "NSC-666292": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3ED", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Celgosivir": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D08CDE", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8972", "8972"]}, "Benzyl-(2-thiophen-2-yl-quinazolin-4-yl)-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02NWF", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142"]}, "Fucose": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "LTF(Lactotransferrin (LTF) ,MOA:Inhibitor); IGF1R(Insulin-like growth factor I receptor (IGF1R) ,MOA:Inhibitor); ELANE(Neutrophil elastase (NE) ,MOA:Inhibitor); ELANE(Neutrophil elastase (NE) ,MOA:Inhibitor); F7(Coagulation factor VII (F7) ,MOA:Inhibitor); C1S(Complement C1s component (C1S) ,MOA:Inhibitor); CTLA4(Cytotoxic T-lymphocyte protein 4 (CTLA-4) ,MOA:Inhibitor); SELE(E-selectin (SELE) ,MOA:Inhibitor); CTSS(Cathepsin S (CTSS) ,MOA:Inhibitor); DPP4(Dipeptidyl peptidase 4 (DPP-4) ,MOA:Inhibitor); FCER1G(Immunoglobulin epsilon Fc receptor gamma (FCERG) ,MOA:Inhibitor); CD209(Membrane-associated lectin type-C (CD209) ,MOA:Inhibitor); ", "drug_id_TTD": "D0G6XS", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); GLA(Alpha-galactosidase A (GLA) ,MOA:Inhibitor); LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "GLA", "LCT", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "2717", "3938", "43"]}, "ECOPLADIB": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P5UW", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Avanafil": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y5JC", "drug_id_DB": "DB06237", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8654"]}, "2,3-diamino-benzo[b]thiophene derivative 5": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0HV0Y", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); IDO2(Indoleamine 2,3-dioxygenase 2 (IDO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2", "IDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999", "169355"]}, "2,3-diamino-benzo[b]thiophene derivative 4": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D04BZI", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); IDO2(Indoleamine 2,3-dioxygenase 2 (IDO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2", "IDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999", "169355"]}, "2,3-diamino-benzo[b]thiophene derivative 7": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0F4VD", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); IDO2(Indoleamine 2,3-dioxygenase 2 (IDO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2", "IDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999", "169355"]}, "2,3-diamino-benzo[b]thiophene derivative 6": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0FF6H", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); IDO2(Indoleamine 2,3-dioxygenase 2 (IDO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2", "IDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999", "169355"]}, "2,3-diamino-benzo[b]thiophene derivative 1": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0RA7I", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); IDO2(Indoleamine 2,3-dioxygenase 2 (IDO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2", "IDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999", "169355"]}, "2,3-diamino-benzo[b]thiophene derivative 3": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0E8XV", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999"]}, "2,3-diamino-benzo[b]thiophene derivative 2": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D05TIP", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); IDO2(Indoleamine 2,3-dioxygenase 2 (IDO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2", "IDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999", "169355"]}, "2-HYDROXYGARVIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4MG", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2,3-diamino-benzo[b]thiophene derivative 8": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D05ZGX", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); IDO2(Indoleamine 2,3-dioxygenase 2 (IDO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2", "IDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999", "169355"]}, "2,3,4-Trimethoxy-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K5GG", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "ANDROSTENEDONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W9PF", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "AMT-030": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0M9WX", "drug_id_DB": "", "metabolic_annotation_str": "AGXT(Alanine glyoxylate aminotransferase (AGXT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AGXT"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["189"]}, "Atomoxetine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D04CRN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ISG", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "4-(4-methyl-benzylideneamino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3UR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Desvenlafaxine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB06700", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Coumarin/resveratrol hybrid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L9FL", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Coumarin/resveratrol hybrid derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z5VD", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "4'-(Pyridin-4-ylmethyl)biphenyl-4-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y5KX", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "3-(imidazolylmethyl)flavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07SOM", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Sulfamic acid 12-sulfamoyloxy-dodecyl ester": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZXR", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "ISIS 31996": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z4LP", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "dolichol phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9IA", "drug_id_DB": "", "metabolic_annotation_str": "MVK(Mevalonate kinase (MVK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4598"]}, "Rescinnamine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0G8NJ", "drug_id_DB": "DB01180", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "P'-geranyl 3,5,9-trihydroxy-3-methylnonanate 9-diphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ENO", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "CHLOROPUUPEHENONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W5DZ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "Acurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q7SP", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "PMID28870136-Compound-59": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09XUJ", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-58": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V7OE", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "1-(3-Bromobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JMO", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "PMID28870136-Compound-55": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07DGB", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-54": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V5NK", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-57": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00BQR", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-56": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0U2YE", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-51": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06YAB", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-50": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09QNH", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-53": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01NBW", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-52": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H9IX", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "[11C]GlySar": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08QDL", "drug_id_DB": "", "metabolic_annotation_str": "SLC15A1(Solute carrier family 15 member 1 (SLC15A1) ,MOA:Modulator); SLC15A2(Solute carrier family 15 member 2 (SLC15A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC15A1", "SLC15A2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6564", "6565"]}, "1-(1-phenyl-2-o-tolylethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A1HH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "1-(10H-phenothiazin-10-yl)-4-phenylbutan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YZ3E", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "PMID1992149C13": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VMO", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "8-Iodo-Guanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01NTY", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "Pentostatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0T3AD", "drug_id_DB": "DB00552", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Go-Y022": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0IO0I", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Go-Y026": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4LS", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "GK1-399": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D7VO", "drug_id_DB": "", "metabolic_annotation_str": "GCK(Glucokinase (GCK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2645"]}, "PA-824": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02AYL", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "Azathioprine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07QCE", "drug_id_DB": "", "metabolic_annotation_str": "PPAT(Amidophosphoribosyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PPAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5471"]}, "ND1251": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D00ACC", "drug_id_DB": "", "metabolic_annotation_str": "SMPD4(Sphingomyelin phosphodiesterase 4 (SMPD4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SMPD4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["55627"]}, "10-methoxy-N(1)-methylburnamine-17-O-veratrate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00HFT", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LKO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "(3-((1H-imidazol-1-yl)methyl)phenyl)methanol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WHC", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "AL5927": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M8HC", "drug_id_DB": "DB03526", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "4-Fluoren-9-ylidenemethyl-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04IJE", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "L-NAME": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D3AI", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "Hydroxy amidine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05BYE", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "SKF-97574": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0R2EY", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "2-(4-(methylsulfonyl)phenyl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4BT", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "N-(2-hexyloxy-4-nitrophenyl)methanesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F9MQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "4-(2-amino-1,3-thiazol-4-yl)phenol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB07292", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["LTA4H"], "metabolic_genes_id": ["4048"]}, "3-Phenylcyclopentanecarboxylic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z0IR", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "Diphenhydramine(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "HRH1(Histamine H1 receptor (H1R) ,MOA:Antagonist); ", "drug_id_TTD": "D01FGR", "drug_id_DB": "", "metabolic_annotation_str": "HNMT(Histamine N-methyltransferase (HNMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HNMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3176"]}, "Altropane": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0A8XY", "drug_id_DB": "DB04947", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "PSB-6426": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R2UZ", "drug_id_DB": "", "metabolic_annotation_str": "ENTPD1(Ectonucleoside triphosphate diphosphohydrolase 1 (CD39) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENTPD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["953"]}, "HEPTANOATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L7UB", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A8(Solute carrier family 22 member 8 (SLC22A8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A8"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9376"]}, "4-Imidazol-1-ylmethyl-1-nitrothioxanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W9ZC", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-(5-[1,3]dithiolan-2-yl-furan-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02EAP", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "2,4,6 trinitrobenzene sulfonate 1,3-bis (2-chlorethyl)-1-nitrosourea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YQ0G", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "Bumetanide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00887", "metabolic_annotation_str": "CFTR(Cystic fibrosis transmembrane conductance regulator); SLC12A2(Solute carrier family 12 member 2); SLC12A1(Solute carrier family 12 member 1); SLC12A5(Solute carrier family 12 member 5); SLC12A4(Solute carrier family 12 member 4); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CFTR", "SLC12A2", "SLC12A1", "SLC12A5", "SLC12A4"], "metabolic_genes_id": ["1080", "6558", "6557", "57468", "6560"]}, "Triazolo-phthalazine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MA2R", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "1-(4-Cyanobenzyl)-5-phenyl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q8KM", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "1,2-bis(3,4-difluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U0BV", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Cis-2-fluoro-2-phenylcyclopropanamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04TZI", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "N-(pentafluorophenyl)sulfamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PA5L", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "BIFENOX": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KH3M", "drug_id_DB": "", "metabolic_annotation_str": "LIPE(Hormone sensitive lipase (LIPE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3991"]}, "2-(N-Cyclopentylamino)-3'-chloropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O2LC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "2-(2-methoxyphenyl)-1H-indene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N7OP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C7WG", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "768"]}, "DIMETHYLGRISABINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02XSH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Balsalazide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PPARG(Peroxisome proliferator-activated receptor gamma); ", "drug_id_TTD": "", "drug_id_DB": "DB01014", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "(+/-)-threo-N-(2-Phenylethyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XHX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "PMID25399762-Compound-Table1-C2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K2LB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00YBT", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z6ZH", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0DM9L", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0C2EW", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Q1MN", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06BFA", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Paroxetine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HTR3E(5-hydroxytryptamine receptor 3E); HTR3B(5-hydroxytryptamine receptor 3B); ADRB2(Beta-2 adrenergic receptor); CHRM2(Muscarinic acetylcholine receptor M2); CHRM4(Muscarinic acetylcholine receptor M4); HTR1A(5-hydroxytryptamine receptor 1A); CHRM5(Muscarinic acetylcholine receptor M5); ADRA2A(Alpha-2A adrenergic receptor); CHRM1(Muscarinic acetylcholine receptor M1); ADRB3(Beta-3 adrenergic receptor); DRD2(D(2) dopamine receptor); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); CHRM3(Muscarinic acetylcholine receptor M3); DRD1(D(1A) dopamine receptor); DRD5(D(1B) dopamine receptor); ADRA1D(Alpha-1D adrenergic receptor); HTR1D(5-hydroxytryptamine receptor 1D); HTR1B(5-hydroxytryptamine receptor 1B); HTR2A(5-hydroxytryptamine receptor 2A); HTR2A(5-hydroxytryptamine receptor 2A); HTR1E(5-hydroxytryptamine receptor 1E); HTR1F(5-hydroxytryptamine receptor 1F); HTR7(5-hydroxytryptamine receptor 7); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); HTR2B(5-hydroxytryptamine receptor 2B); HTR2B(5-hydroxytryptamine receptor 2B); HTR3A(5-hydroxytryptamine receptor 3A); HTR6(5-hydroxytryptamine receptor 6); HTR4(5-hydroxytryptamine receptor 4); HTR3D(5-hydroxytryptamine receptor 3D); HTR3C(5-hydroxytryptamine receptor 3C); ", "drug_id_TTD": "", "drug_id_DB": "DB00715", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "Inosinic Acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04566", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase, muscle form); IMPDH2(Inosine-5'-monophosphate dehydrogenase 2); ADSS1(Adenylosuccinate synthetase isozyme 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PYGM", "IMPDH2", "ADSS1"], "metabolic_genes_id": ["5837", "3615", "122622"]}, "PMID25399762-Compound-Table1-C9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06EIP", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Phendimetrazine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ADRA1A(Alpha-1A adrenergic receptor); ADRA1B(Alpha-1B adrenergic receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01579", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2"], "metabolic_genes_id": ["6530"]}, "SRT501": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "SIRT1(NAD-dependent deacetylase sirtuin-1 (SIRT1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0U3EP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5742"]}, "C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03DUN", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "4-Nitro-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06LVE", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "4-(Quinolinoxy)-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05JAJ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "AZD8329": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0O1ZI", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,5-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04SHY", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "Hyacinthacine B3": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ATW", "drug_id_DB": "", "metabolic_annotation_str": "LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LCT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3938"]}, "6-Pyridin-3-yl-3,4-dihydro-1H-quinolin-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CPC", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1", "PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1584", "5139"]}, "CJ-13610": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01DAD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Pyruvic acid(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0G4JI", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "3-(4-Amino-phenyl)-1-methyl-pyrrolidine-2,5-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01MPK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Aminocarbonyl dihydrogen phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H0PQ", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "AZD-0865": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0S0EQ", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "Metadoxine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0YH0N", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6529"]}, "1,2-bis(2,4-difluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZT5C", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "16-(4-dimethylamino-benzylidene)-estrone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02MQT", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Amiloride(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "SCNN1A(Amiloride-sensitive sodium channel subunit alpha); SCNN1B(Amiloride-sensitive sodium channel subunit beta); SCNN1G(Amiloride-sensitive sodium channel subunit gamma); SCNN1D(Amiloride-sensitive sodium channel subunit delta); ASIC1(Acid-sensing ion channel 1); ASIC2(Acid-sensing ion channel 2); ", "drug_id_TTD": "", "drug_id_DB": "DB00594", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1); AOC1(Amiloride-sensitive amine oxidase [copper-containing]); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC9A1", "AOC1"], "metabolic_genes_id": ["6548", "26"]}, "EPZ-004777": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ENZ", "drug_id_DB": "", "metabolic_annotation_str": "DOT1L(Histone-lysine N-methyltransferase (HLNM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DOT1L"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["84444"]}, "N,N'-(1',12'-dodecydene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F0PY", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Balsalazide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0A6KR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "PHENOL": {"drug_status_TTD": ["Phase 2/3", "Phase 2/3", "Phase 2/3", "Phase 2/3", "Phase 2/3", "Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D0L6HN", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "768", "23632"]}, "L-689065": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05FKT", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "(2R,3S)-2-[(4-Iodophenoxy)phenylmethyl]morpholine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D9FA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "YM-750": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0D9AD", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "PTI-601": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "OPRM1(Opioid receptor mu (MOP) ,MOA:Modulator); ", "drug_id_TTD": "D03PMB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "Bip-tyr-thr-pro-thr(obzl)-gly": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FS4V", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Ibuproxam": {"drug_status_TTD": ["Withdrawn from market", "Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D0U2CB", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-adamantan-1-yl-3-(3-hydroxypropyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05MAT", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "3 beta-O-acetyloleanolic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZI8Y", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "1-(4-Cyanobenzyl)-5-hydroxymethyl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ORG", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "PMID30273516-Compound-22a": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D02IVA", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "PMID30273516-Compound-22b": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D07KON", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "Miltefosine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB09031", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCB1"], "metabolic_genes_id": ["5243"]}, "(+/-)-threo-N-Benzyl-3',4'-dichlororitalinol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y2YH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-Propyl-pentanoic acid 4-sulfamoyl-benzyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EX9Q", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "Chebulinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z9YK", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "1-(4-Benzylsulfanyl-phenyl)-propylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03HFH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "1-[(n-oct-1-ylamino)ethyl]-1,1-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B9ZZ", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "1-(4-(methylsulfonyl)phenyl)-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07AFA", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "TETRAHYDROBENXIMIDAZOLE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00YPO", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "4-Methylimidazole(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KK4F", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "TINGENONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F6AI", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "N,N-Dipropyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B0ZM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "5-(3-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05OML", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Forskolin": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0Y7VM", "drug_id_DB": "", "metabolic_annotation_str": "ADCY2(Adenylate cyclase type 2 (ADCY2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADCY2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["108"]}, "BAY 80-6946": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0S5LD", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD", "PIK3CA", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Modulator"], "metabolic_genes_id": ["5293", "5290", "5294"]}, "N-methyl-N-ethyl estrone-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03XMR", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Daidzin": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D01WGJ", "drug_id_DB": "DB02115", "metabolic_annotation_str": "ALDH2(Mitochondrial aldehyde dehydrogenase (ALDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["217"]}, "KOTALANOL": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F9YZ", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "BYL719": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0W7HE", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Modulator); PI4KA(Phosphatidylinositol-4-kinase alpha (PI4KA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CA", "PI4KA"], "metabolic_mechanism_of_action": ["Modulator", "Inhibitor"], "metabolic_genes_id": ["5290", "5297"]}, "Suprofen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00870", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "5-phenyl-1,3,4-oxadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07KXZ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "2-Benzyl-7-hydroxy-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0QP9D", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "JNJ-28583867": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "HRH3(Histamine H3 receptor (H3R) ,MOA:Inhibitor); ", "drug_id_TTD": "D0A9QT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "4-Sulfamoyloxy-benzoic acid pentyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00OZS", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "1-(4-tert-butylphenylsulfonyl)azepan-4-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q2TF", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "1,2-Di(berberine-9-O-yl)ethane dibromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K2FQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Tormentic acid methyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GVN", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Modafinil": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D07HQC", "drug_id_DB": "DB00745", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6531", "6531"]}, "Benzoic acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KD6U", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "BMY-22089": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0E2CO", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "CO-101": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0V0CJ", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6241"]}, "4-(4-(thiophen-2-yl)benzyl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LJ9D", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "PMID25514969-Compound-10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08HYS", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "2,5-dideoxy-2,5-imino-D-altritol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SQ1T", "drug_id_DB": "", "metabolic_annotation_str": "GLA(Alpha-galactosidase A (GLA) ,MOA:Inhibitor); LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLA", "LCT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2717", "3938"]}, "amidepsines": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0N0WE", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "Vitamin A(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "APOD(Apolipoprotein D); RETSAT(All-trans-retinol 13,14-reductase); ", "drug_id_TTD": "", "drug_id_DB": "DB00162", "metabolic_annotation_str": "DHRS3(Short-chain dehydrogenase/reductase 3); ALDH1A2(Retinal dehydrogenase 2); LRAT(Lecithin retinol acyltransferase); ALDH1A1(Retinal dehydrogenase 1); PTGDS(Prostaglandin-H2 D-isomerase); ALDH1A3(Aldehyde dehydrogenase family 1 member A3); RDH13(Retinol dehydrogenase 13); RDH13(Retinol dehydrogenase 13); RDH13(Retinol dehydrogenase 13); RDH13(Retinol dehydrogenase 13); RDH13(Retinol dehydrogenase 13); RDH13(Retinol dehydrogenase 13); RDH13(Retinol dehydrogenase 13); RDH13(Retinol dehydrogenase 13); RDH13(Retinol dehydrogenase 13); RDH13(Retinol dehydrogenase 13); RDH11(Retinol dehydrogenase 11); RDH5(11-cis retinol dehydrogenase); RDH12(Retinol dehydrogenase 12); DHRS4(Dehydrogenase/reductase SDR family member 4); DHRS4(Dehydrogenase/reductase SDR family member 4); RDH14(Retinol dehydrogenase 14); RDH8(Retinol dehydrogenase 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["DHRS3", "ALDH1A2", "LRAT", "ALDH1A1", "PTGDS", "ALDH1A3", "RDH13", "RDH13", "RDH13", "RDH13", "RDH13", "RDH13", "RDH13", "RDH13", "RDH13", "RDH13", "RDH11", "RDH5", "RDH12", "DHRS4", "DHRS4", "RDH14", "RDH8"], "metabolic_genes_id": ["9249", "8854", "9227", "216", "5730", "220", "112724", "112724", "112724", "112724", "112724", "112724", "112724", "112724", "112724", "112724", "51109", "5959", "145226", "10901", "10901", "57665", "50700"]}, "N5-(1-Imino-3-Butenyl)-L-Ornithine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BPC", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "Niflumic Acid": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00HGB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "5'-iodotubercidin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RDY", "drug_id_DB": "", "metabolic_annotation_str": "ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["132"]}, "(R)-tacrine(10)-hupyridone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A9IM", "drug_id_DB": "DB04614", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Apigenin-7-O-beta-D-glucuronide methyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BH6B", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "2,5-Bis-(3-cyclopentyloxy-4-methoxy-phenyl)-furan": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N2KP", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "GDC-0980/RG7422": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Modulator); ", "drug_id_TTD": "D0O6VZ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "S-(N-4chlorophenyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I6JQ", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "Lazabemide": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06QRW", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "3-(1-ethyl-3,4-dihydronaphthalen-2-yl)-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MA9G", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "LIAROZOLE": {"drug_status_TTD": ["Phase 2/3", "Phase 2/3"], "non_metabolic": "CYP26A1(Cytochrome P450 26 (CYP26A1) ,MOA:Inhibitor); ", "drug_id_TTD": "D08UGX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "4-Methyl-6-(2-methylprop-1-enyl)pyridin-2-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06JZQ", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}serinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T8AD", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "2-(3'-Ethyl-biphenyl-4-yl)-propionic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08QAH", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "DA-8031": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0F8HN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "6-Bromo-4,9-dihydro-3H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04GVX", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-Benzyl-(6-methoxy-2-naphthyl)-2-aminopropane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M0HM", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "PMID1656041C11jj": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4PL", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Decyle nelycorine dibromo salt derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0Y4CG", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Isogemichalcone C": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZIW", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "PF-526014": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0U7OD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-(2-fluorophenoxy)-3-(piperidin-4-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0K6ZT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "GSK2647544": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0E6KN", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7941"]}, "SKF-96231": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0W8OH", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "C-(1H-Indol-3-yl)-methylamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05FMZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "PMID7629799C2d": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MM5G", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID7629799C2e": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KJ7C", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "BERGAPTOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D5YP", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "ORG-25935": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0LT0U", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "(+/-)-threo-N-(4-Nitrobenzyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9MQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "N-(2,4-dihydroxybenzyl)-3,4-dihydroxybenzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T2WM", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Ethinamate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01031", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_genes_id": ["759", "760"]}, "Pyridino tricyclic compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MO3W", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3,4'-(1H-1,2,4-triazole-3,5-diyl)dipyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IW5C", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Vitamin C": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07AHW", "drug_id_DB": "", "metabolic_annotation_str": "SLC23A2(Solute carrier family 23 member 2 (SLC23A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC23A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["9962"]}, "CHRYSIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CDK6(Cyclin-dependent kinase 6 (CDK6) ,MOA:Inhibitor); ", "drug_id_TTD": "D01UYI", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "AKR1B1", "CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "231", "1545"]}, "GI-197111": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0O8SY", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6715", "79644"]}, "1,3,8-Trihydroxy-6-methyl-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00BSX", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Cyclopentylcytosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08XAW", "drug_id_DB": "", "metabolic_annotation_str": "CTPS1(CTP synthase (CTPS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTPS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1503"]}, "3,5-di(pyridin-4-yl)-1H-1,2,4-triazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZC8K", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "3,5-Di-tert-butyl-[1,2]benzoquinone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z1WQ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1-benzyl-5'-O-tritylinosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W6LJ", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "Pentamidine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05EAM", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "2-(5-phenyl-furan-2-yl)-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P1UC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "2,4'-Diacetoxy-5,3'-di-(2-propenyl)-biphenyl": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y1TA", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "2-(3-benzylquinoxalin-2-ylamino)ethanol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H1GQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "TA-270": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0L4SL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-Propylidenethiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DU4B", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "ISIS 150463": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05EJO", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(SOD1 messenger RNA (SOD1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6647"]}, "ISIS 150464": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BP6T", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(SOD1 messenger RNA (SOD1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6647"]}, "MMI270": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADAMTS4(Aggrecanase-1 (ADAMTS4) ,MOA:Inhibitor); MMP1(Matrix metalloproteinase-1 (MMP-1) ,MOA:Inhibitor); MMP2(Matrix metalloproteinase-2 (MMP-2) ,MOA:Inhibitor); MMP3(Matrix metalloproteinase-3 (MMP-3) ,MOA:Inhibitor); MMP7(Matrix metalloproteinase-7 (MMP-7) ,MOA:Inhibitor); MMP9(Matrix metalloproteinase-9 (MMP-9) ,MOA:Inhibitor); MMP8(Matrix metalloproteinase-8 (MMP-8) ,MOA:Inhibitor); MMP13(Matrix metalloproteinase-13 (MMP-13) ,MOA:Inhibitor); MMP14(Matrix metalloproteinase-14 (MMP-14) ,MOA:Inhibitor); ", "drug_id_TTD": "D0A4TC", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "768"]}, "D-211B": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LD1X", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "D-211A": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SB6Y", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "TNP-351": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00CQW", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1719"]}, "1-aminopentylphosphonic acid monophenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RH4S", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Phenyl-Uridine-5'-Diphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05PNI", "drug_id_DB": "", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GALE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2582"]}, "Isoflurophate(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0B2OT", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "ISAINDIGOTONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01GSW", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "bongkrek acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GHW", "drug_id_DB": "", "metabolic_annotation_str": "SLC25A4(Adenine nucleotide translocator 1 (SLC25A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC25A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["291"]}, "Acetaminophen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TRPV1(Transient receptor potential cation channel subfamily V member 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00316", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); PTGES3(Prostaglandin E synthase 3); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PTGS1", "PTGS2", "PTGES3"], "metabolic_genes_id": ["5742", "5743", "10728"]}, "S-(4-Bromobenzyl)isothiourea hydrobromide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03JAE", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "NSC-12999": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZPJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-Biphenyl-3-yl-N-hydroxy-N-methyl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09WYM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "(4S,5S)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06EXH", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "NOX-200": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0OX9Q", "drug_id_DB": "", "metabolic_annotation_str": "SLC36A2(Solute carrier family 36 member 2 (SLC36A2) ,MOA:Inhibitor); SLC6A14(Amino acid transporter ATB0+ (SLC6A14) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC36A2", "SLC6A14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["153201", "11254"]}, "CI-930": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0BK6B", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "3-[(Z)-2-phenylvinyl]pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02UZI", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "CLP-635": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V6KL", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A5(Solute carrier family 12 member 5 (SLC12A5) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A5"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["57468"]}, "4-Carbazol-9-yl-butyric acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05JAH", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "3-Benzyl-4-hydroxy-6,7-dimethyl-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08XJX", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "2-[4-(2-Thienyl)phenyl]-4-methylmorpholin-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K1QV", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Benzyl 2-hydroxyiminoolean-12-en-28-oate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09NIM", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "1-[(prop-2-ylamino)ethyl]-1,1-bisphosphonicacid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7XQ", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Alacepril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0X5SJ", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "PMID1895299C6v": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4YT", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "BIX-01294": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PPL", "drug_id_DB": "", "metabolic_annotation_str": "EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT1(Euchromatic histone-lysine N-methyltransferase 1 (EHMT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["10919", "10919", "10919", "10919", "10919", "10919", "10919", "79813"]}, "Enzastaurin(TTD)": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "PRKCB(Protein kinase C beta (PRKCB) ,MOA:Modulator); AKT1(RAC-alpha serine/threonine-protein kinase (AKT1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0I6VU", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "(S)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L6HE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "5-benzhydryl-1,3,4-oxadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01IFR", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "LUFFARIELLOLIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04TKG", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5320"]}, "2,4,3',5'-tetrahydroxybibenzyl": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07HYL", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "LP-403812": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02KNP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A7(Sodium-dependent proline transporter (SLC6A7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6534"]}, "1-(4-(methylsulfonyl)phenyl)-3-phenylurea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LL9E", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "3-Butyl-[1,4]oxazepan-(5Z)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L9SL", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "Geranyl Diphosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02552", "metabolic_annotation_str": "GGPS1(Geranylgeranyl pyrophosphate synthase); FDPS(Farnesyl pyrophosphate synthase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["GGPS1", "FDPS"], "metabolic_genes_id": ["9453", "2224"]}, "FR-145237": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0O2AC", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "SC-49483": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0O1HL", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "3-alpha-Phenylmethoxy-3-beta-phenyl-nortropane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S0EE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "3-(4-ethyl-3,4-dihydronaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4NG", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Acebilustat": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07VNH", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "(S)-6-Amino-2-(2-imino-ethylamino)-hexanoic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3QN", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "[3H]SB-733993": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H7RV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "Premarin/Pravachol": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "ESR1(Estrogen receptor (ESR) ,MOA:Modulator); ESR2(Estrogen receptor beta (ESR2) ,MOA:Modulator); ", "drug_id_TTD": "D0G7IV", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3156"]}, "1-(3-Fluorobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08HHA", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "SR12813": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0C7RV", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3156"]}, "1-methyl-L-tryptophan": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YFT", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "AMT-011": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D01RNV", "drug_id_DB": "", "metabolic_annotation_str": "LPL(Lipoprotein lipase (LPL) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LPL"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4023"]}, "Enprofylline(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09AMZ", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "Florifenine": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0Y7BV", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Mallotusinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0QN6H", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "(L-)-S-adenosyl-L-homocysteine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "DNMT3B(DNA [cytosine-5]-methyltransferase 3B (DNMT3B) ,MOA:Inhibitor); ", "drug_id_TTD": "D09CLP", "drug_id_DB": "", "metabolic_annotation_str": "HNMT(Histamine N-methyltransferase (HNMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HNMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3176"]}, "UCB-101333-3": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CHRM3(Muscarinic acetylcholine receptor M3 (CHRM3) ,MOA:Inhibitor); ", "drug_id_TTD": "D02ZPV", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "BETULIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KJY", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "A-80426": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated", "Terminated", "Terminated", "Terminated", "Terminated", "Terminated", "Terminated"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); DRD2(Dopamine D2 receptor (D2R) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA2C(Adrenergic receptor alpha-2C (ADRA2C) ,MOA:Inhibitor); DRD4(Dopamine D4 receptor (D4R) ,MOA:Inhibitor); DRD4(Dopamine D4 receptor (D4R) ,MOA:Inhibitor); HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0K9JP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "4-Hydroxy-3-(2-naphthylmethyl)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4YP", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "N-(2-phenylethyl),N-(pyrrol-2-ylmethyl)amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8UE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "4-[4-(benzhydryloxy)piperidino]butyl benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R2QC", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "(4S,5R)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03YRO", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "F-3796": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D09IUG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "(-)-Tolserine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04FHZ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "(1-Phenyl-ethyl)-(2-phenyl-quinazolin-4-yl)-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G8ZD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Staurosporine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PDPK1(3-phosphoinositide-dependent protein kinase 1); LCK(Tyrosine-protein kinase Lck); CHRM1(Muscarinic acetylcholine receptor M1); PIM1(Serine/threonine-protein kinase pim-1); CDK2(Cyclin-dependent kinase 2); CSK(Tyrosine-protein kinase CSK); ZAP70(Tyrosine-protein kinase ZAP-70); SYK(Tyrosine-protein kinase SYK); MAPKAPK2(MAP kinase-activated protein kinase 2); GSK3B(Glycogen synthase kinase-3 beta); PRKCQ(Protein kinase C theta type); ITK(Tyrosine-protein kinase ITK/TSK); ", "drug_id_TTD": "", "drug_id_DB": "DB02010", "metabolic_annotation_str": "PIK3CG(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PIK3CG"], "metabolic_genes_id": ["5294"]}, "A-366": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C5EG", "drug_id_DB": "", "metabolic_annotation_str": "EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT1(Euchromatic histone-lysine N-methyltransferase 1 (EHMT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["10919", "10919", "10919", "10919", "10919", "10919", "10919", "79813"]}, "NMI-150": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0Z5OJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Nitrogen/sulfur-substituted estrene derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0PI1W", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "3-(4-Methanesulfonyl-phenyl)-1-phenyl-propynone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HWQ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "8S-hydroxylobel-9-ene": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z4IH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "N-Benzyl-1H-indole-2-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z5YO", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "SB 239063": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08LYB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Carbamide derivative 26": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02ZUW", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Carbamide derivative 24": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00IPI", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Carbamide derivative 25": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09RGE", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Saframycin A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6UK", "drug_id_DB": "", "metabolic_annotation_str": "GAPDH(Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["GAPDH"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["2597"]}, "4-Imidazol-1-ylmethylxanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F5AC", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-(5-methylthiazol-2-yl)-2-phenylacetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05OFR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "3-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7FS", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "Phenylalanylmethane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3CS", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "Taliglucerase alfa": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0G6HA", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Modulator); GBA(Glucosylceramidase (GBA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2629", "2629"]}, "Digoxin(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved", "Approved", "Approved", "Approved"], "non_metabolic": "SLCO4C1(Organic anion transporter M1 (SLCO4C1) ,MOA:Modulator); ", "drug_id_TTD": "D02OZE", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1A3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1A2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1", "ATP1B1", "ATP1A3", "ATP1B2", "ATP1A2", "ATP1B3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["476", "481", "478", "482", "477", "483"]}, "EC-SOD, PPL Therapeutics": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TFB", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "Oxidized glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4TY", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "L-731120": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02VUM", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "1-Adamantan-1-yl-3-(4-methoxy-phenyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04NJC", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "1-(3-Methoxy-naphthalen-2-yl)-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03KLN", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "GSK2256294": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0A8KQ", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2053"]}, "(4S,5R)-4,5-Dimethyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08UWE", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "Rostafuroxin": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08UUK", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1B1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1A3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1B2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1A2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1B3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1", "ATP1B1", "ATP1A3", "ATP1B2", "ATP1A2", "ATP1B3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["476", "481", "478", "482", "477", "483"]}, "Amtolmetin guacil": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0S5RZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "SACCHARIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A0YX", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "BRL50481": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00MBG", "drug_id_DB": "", "metabolic_annotation_str": "PDE7B(Phosphodiesterase 7B (PDE7B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE7B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["27115"]}, "CCX915(TTD)": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "CCR2(C-C chemokine receptor type 2 (CCR2) ,MOA:Antagonist); ", "drug_id_TTD": "D0MT0A", "drug_id_DB": "", "metabolic_annotation_str": "ABCC9(ATP-binding cassette transporter C9 (ABCC9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["10060"]}, "BIW-8962": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0N6TD", "drug_id_DB": "", "metabolic_annotation_str": "GM2A(Ganglioside GM2 activator (GM2A) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["GM2A"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["2760"]}, "MK-886": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0K2ER", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Amlodipine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CACNA1B(Voltage-dependent N-type calcium channel subunit alpha-1B); CACNA1B(Voltage-dependent N-type calcium channel subunit alpha-1B); CACNB1(Voltage-dependent L-type calcium channel subunit beta-1); CACNA2D3(Voltage-dependent calcium channel subunit alpha-2/delta-3); CACNA1I(Voltage-dependent T-type calcium channel subunit alpha-1I); ", "drug_id_TTD": "", "drug_id_DB": "DB00381", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); SMPD1(Sphingomyelin phosphodiesterase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["CA1", "SMPD1"], "metabolic_genes_id": ["759", "6609"]}, "CX157": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00RWQ", "drug_id_DB": "DB05205", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "1-N-Acetyl-Beta-D-Glucosamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I9PG", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Moclobemide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01ZSO", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "FORMONONETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7BR", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6524"]}, "Tolnaftate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02NTO", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "BS 7581": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0SE3C", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Cyclic Guanosine Monophosphate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "PRKAR1A(cAMP-dependent protein kinase A type I (PRKAR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D09LAQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "3-[5-(4-hydroxyphenyl)-1,3-thiazol-2-yl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00SLE", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Ridogrel(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TBXA2R(Thromboxane A2 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01207", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["TBXAS1"], "metabolic_genes_id": ["6916"]}, "Anthracene-2-carboxylic acid hydroxyamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CT9V", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Methyl 3-(1-Benzyl-1H-imidazol-5-yl)-propanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03CWL", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZUQ", "drug_id_DB": "DB08157", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "3-(1H-inden-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02LWB", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "N5-(1-iminobut-3-enyl)-L-ornithine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L5KY", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "(+/-)-threo-N-(4-Methylpyridine)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07YGR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-(N-tert-Butylamino)-4'-chloropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05PLF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "3-(thiophen-3-yl)-1H-indol-6-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0YP", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "SKL-PD": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00AHV", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "1,8-Dichloro-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04MBD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID25037917C58": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M6UK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A7(Sodium-dependent proline transporter (SLC6A7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3", "SLC6A7"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531", "6534"]}, "Sulindac(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "MAPK3(Mitogen-activated protein kinase 3); PPARD(Peroxisome proliferator-activated receptor delta); PTGDR2(Prostaglandin D2 receptor 2); ", "drug_id_TTD": "", "drug_id_DB": "DB00605", "metabolic_annotation_str": "AKR1B10(Aldo-keto reductase family 1 member B10); AKR1B1(Aldose reductase); PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["AKR1B10", "AKR1B1", "PTGS1", "PTGS2"], "metabolic_genes_id": ["57016", "231", "5742", "5743"]}, "CPI-613": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07NVI", "drug_id_DB": "", "metabolic_annotation_str": "OGDH(Alpha-ketoglutarate dehydrogenase (OGDH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["OGDH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4967"]}, "(R)-nipecotic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2EF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6529"]}, "Decane-1,10-diyl disulfamate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00YEF", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "EPZ-5676": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0C6GK", "drug_id_DB": "", "metabolic_annotation_str": "DOT1L(Histone-lysine N-methyltransferase (HLNM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DOT1L"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["84444"]}, "(-)-pinoresinol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01KTM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "246"]}, "6-(4-Decyloxy-phenyl)-1,1,1-trifluoro-hexan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4WJ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Benzyl-(2-pyridin-4-yl-quinazolin-4-yl)-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8YQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A", "PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5138", "5141", "5142"]}, "Cocaine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "SCN2B(Sodium channel subunit beta-2); CHRM2(Muscarinic acetylcholine receptor M2); CHRM1(Muscarinic acetylcholine receptor M1); SCN1A(Sodium channel protein type 1 subunit alpha); SCN4A(Sodium channel protein type 4 subunit alpha); SCN7A(Sodium channel protein type 7 subunit alpha); SCN1B(Sodium channel subunit beta-1); SCN5A(Sodium channel protein type 5 subunit alpha); SCN9A(Sodium channel protein type 9 subunit alpha); SCN4B(Sodium channel subunit beta-4); SCN2A(Sodium channel protein type 2 subunit alpha); SIGMAR1(Sigma non-opioid intracellular receptor 1); SCN3B(Sodium channel subunit beta-3); SCN11A(Sodium channel protein type 11 subunit alpha); SCN8A(Sodium channel protein type 8 subunit alpha); SCN10A(Sodium channel protein type 10 subunit alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB00907", "metabolic_annotation_str": "CES1(Liver carboxylesterase 1); CES1(Liver carboxylesterase 1); SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CES1", "CES1", "SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["1066", "1066", "6530", "6532", "6531", "6531"]}, "Mivacurium(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRM2(Muscarinic acetylcholine receptor M2); CHRM3(Muscarinic acetylcholine receptor M3); CHRNA2(Neuronal acetylcholine receptor subunit alpha-2); ", "drug_id_TTD": "", "drug_id_DB": "DB01226", "metabolic_annotation_str": "BCHE(Cholinesterase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["BCHE"], "metabolic_genes_id": ["590"]}, "Isosorbide-2-(methylcarbamate)-5-mononitrate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04SYM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "BLV-0801": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06BBF", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "[3H]vesamicol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07EMU", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A3(Vesicular acetylcholine transporter (SLC18A3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6572"]}, "(+/-)-2-(4'-Ethoxyphenyl)thiomorpholine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J0QW", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "4'-bromo-3-(imidazolylmethyl)-7-methoxyflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06WPP", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "5-bromo-6-(cyclopropylamino)uracil hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y5UF", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "AVP-786": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "SIGMAR1(Opioid receptor sigma 1 (OPRS1) ,MOA:Modulator); ", "drug_id_TTD": "D0Z6IB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "4-hydroxy-3-nitrobenzaldehyde": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03VZF", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "[35S]ACPPB": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09FDV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "4-Hydroxy-3-methyl-but-2-enoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06VNT", "drug_id_DB": "", "metabolic_annotation_str": "SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC52A2", "SLC52A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["79581", "79581"]}, "1-(10H-phenothiazin-10-yl)-3-phenylbutan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YEB", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "CDP840": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0UG4T", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Stannsoporfin(TTD)": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02JAY", "drug_id_DB": "", "metabolic_annotation_str": "HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMOX1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3162"]}, "5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04769", "metabolic_annotation_str": "PIK3CG(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PIK3CG"], "metabolic_genes_id": ["5294"]}, "NSC-275420": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E2LU", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "(R)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01UUZ", "drug_id_DB": "", "metabolic_annotation_str": "SPHK2(Sphingosine kinase 2 (SPHK2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["56848"]}, "Inhibitor Idd 384": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VHG", "drug_id_DB": "DB01689", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "NSC-27236": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05JRZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "4-(4-(pentyloxy)phenoxy)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I7MC", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "DFGYVAE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CSQ", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID25399762-Compound-Figure3-Lycojaponicumin A": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0M0EP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "13-(3-n-Pentylureido)tridec-5(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X1EG", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Lys[Z(NO2)]-Pro": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FZM", "drug_id_DB": "", "metabolic_annotation_str": "SLC15A1(Solute carrier family 15 member 1 (SLC15A1) ,MOA:Inhibitor); SLC15A2(Solute carrier family 15 member 2 (SLC15A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC15A1", "SLC15A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6564", "6565"]}, "US8586571, 12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08PYU", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "Uridine-Diphosphate-N-Acetylglucosamine(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KC2Z", "drug_id_DB": "", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GALE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2582"]}, "Ferroportin mab": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07SQT", "drug_id_DB": "", "metabolic_annotation_str": "SLC40A1(Solute carrier family 40 member 1 (SLC40A1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC40A1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["30061"]}, "4-hydroxylonchocarpin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3QP", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "3-phenylprop-1-enylboronic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04RCR", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "YM-543": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0H2NI", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "PMID29324067-Compound-38": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04OXC", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "VESNARINONE": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0L0ZF", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "MDAM (y-methylene-10-deazaaminopterin)": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0DO5J", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1719"]}, "Donepezil(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0NS6H", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["43"]}, "Oxindole 94": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "CDK8(Cyclin-dependent kinase 8 (CDK8) ,MOA:Inhibitor); MAPK14(Stress-activated protein kinase 2a (p38 alpha) ,MOA:Inhibitor); ", "drug_id_TTD": "D0VC0I", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "MOXIFETIN HYDROGEN MALEATE": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0I9UH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6532"]}, "[3H]estradiol-17beta-glucuronide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I3LQ", "drug_id_DB": "", "metabolic_annotation_str": "SLCO1B3(Liver organic anion transporter 2 (SLCO1B3) ,MOA:Modulator); SLCO1B1(Liver organic anion transporter 1 (SLCO1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLCO1B3", "SLCO1B1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["28234", "10599"]}, "3-(6-Amino-purin-9-yl)-5-m-tolyl-pentan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E6ON", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "4-bromophenylboronic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z1CL", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "MLN4760": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0V4ZC", "drug_id_DB": "", "metabolic_annotation_str": "ACE2(Angiotensin-converting enzyme 2 (ACE2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["59272"]}, "9-O-[3-(2-Pyridinoxyl)butyl]-berberine bromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02QMU", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "4-(3-hydroxy-benzylideneamino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1AW", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "AL4623": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HNP", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "PMID26666989-Compound-Figure11Ala up": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0U7WQ", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "TRYPTAMINE": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D08CJK", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "P-tolyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PQ5R", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Pyridoxal Phosphate": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "F2(Coagulation factor IIa (F2) ,MOA:Inhibitor); ", "drug_id_TTD": "D06JGH", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "CVT-1": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0GH1C", "drug_id_DB": "", "metabolic_annotation_str": "CEL(Bile-salt-activated lipase (CEL) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CEL"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1056"]}, "N,N'-dicyclohexyl-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RX9W", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "PMID25470667-Compound-AZD3988": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0MX3Y", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "5-bromo-6-hydrazinouracil hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00PMF", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "2-(2'-Aminoethyl)-5-benzyltetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J5AR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Alpha-glucosidase": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0Y2SE", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8972", "8972"]}, "3-(3-Benzoyl-1H-pyrrol-1-yl)propanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CX4E", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "N-isopropyl estrone-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4SL", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "3-(2,5-Dioxo-pyrrolidin-1-yl)-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09JAB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "LAS-186323": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0F1JY", "drug_id_DB": "", "metabolic_annotation_str": "DHODH(Dihydroorotate dehydrogenase (DHODH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DHODH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1723"]}, "Liprotamase": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0T9LR", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Modulator); PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A", "PNLIP"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["279", "5406"]}, "CORONARIDINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04XXE", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-Hex-5-enyl-5-nonyl-pyrrolidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O1JC", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Laevulinic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A1PW", "drug_id_DB": "DB02239", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["210"]}, "9-Ethyl-beta-carboline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4DW", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Amidox": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D06PWA", "drug_id_DB": "", "metabolic_annotation_str": "RRM1(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2B(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM1", "RRM2", "RRM2B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6240", "6241", "50484"]}, "1-Methyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A9HL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-(3-nitropyridin-2-yl)-4-tosylpiperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V5TC", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "GNF-PF-4292": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0FQ1Z", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "BAG956": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04DBA", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "2-hydrazinylbenzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0FJ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA6", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "765", "768"]}, "Sulfamic acid 16-sulfamoyloxy-hexadecyl ester": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CBA", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "MK-0963": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D06AGD", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "79644"]}, "N-Omega-Propyl-L-Arginine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O2KO", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "Chloroquine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); GSTA2(Glutathione S-transferase A2); HMGB1(High mobility group protein B1); TLR9(Toll-like receptor 9); ", "drug_id_TTD": "", "drug_id_DB": "DB00608", "metabolic_annotation_str": "GSTM1(Glutathione S-transferase Mu 1); ACE2(Angiotensin-converting enzyme 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["GSTM1", "ACE2"], "metabolic_genes_id": ["2944", "59272"]}, "Atomoxetine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GRIN2D(Glutamate receptor ionotropic, NMDA 2D); GRIN3B(Glutamate receptor ionotropic, NMDA 3B); OPRK1(Kappa-type opioid receptor); KCNJ3(G protein-activated inward rectifier potassium channel 1); GRIN1(Glutamate receptor ionotropic, NMDA 1); GRIN2A(Glutamate receptor ionotropic, NMDA 2A); GRIN2B(Glutamate receptor ionotropic, NMDA 2B); GRIN2C(Glutamate receptor ionotropic, NMDA 2C); GRIN3A(Glutamate receptor ionotropic, NMDA 3A); ", "drug_id_TTD": "", "drug_id_DB": "DB00289", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "ETHISTERONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SLA", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "1-(3-cyano-1-methyl-1H-indol-6-yl)-3-phenylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H1II", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N2LE", "drug_id_DB": "DB04757", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "4-Chlorobenzenemethanethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZJW", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "CHF-5480": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K9PS", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "NOSTOCARBOLINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NU3J", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1-adamantan-1-yl-3-(2-heptyloxyethyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YS1G", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "ISIS-SGLT2": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0G8LN", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6524"]}, "4'-(4-Nitrobenzensulfonamide)-4-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09OGW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Zaragozic Acid D2": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SC4X", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "(1-Amino-2-phenyl-ethyl)-phosphinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9YU", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Demecarium bromide": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06IDT", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "EUGENIIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K2XJ", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "O5-Acetyl-O7-nitrooxyethyl chrysin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08OYH", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Gluconolactone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QWD", "drug_id_DB": "DB04564", "metabolic_annotation_str": "LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LCT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3938"]}, "(5S,6S)-[Octahydro-quinolin-(2E)-ylidene]amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R9KX", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "Bupropion+naltrexone": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D01TMQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "FPL-64170": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04QVN", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Prodipine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0P2DU", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "PF-04447943": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JPG", "drug_id_DB": "", "metabolic_annotation_str": "PDE9A(Phosphodiesterase 9 (PDE9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE9A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5152"]}, "6-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08MHU", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "1-(4-Nitro-phenyl)-2-phenyl-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7FN", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Methyl-(1,2,3,4-tetrahydro-naphthalen-1-yl)-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MX1T", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "3-iodotyrosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CI3A", "drug_id_DB": "", "metabolic_annotation_str": "TH(Tyrosine 3-monooxygenase (TH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7054"]}, "4-Methyl-piperidin-(2E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7PK", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "(+/-)-threo-N-Methyl-30-methylmethylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05TWV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "ANTIOQUINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H7RH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "9-O-[3-(4-Nitro-phenoxyl)butyl]-berberine bromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P2VL", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "SK1-I": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05SLY", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "Hexahydro-pyrrolizin-(3E)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VN7G", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "PMX-53": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "TACR2(Substance-K receptor (TACR2) ,MOA:Inhibitor); C5AR1(C5a anaphylatoxin chemotactic receptor (C5AR1) ,MOA:Modulator); MC4R(Melanocortin receptor 4 (MC4R) ,MOA:Inhibitor); AVPR1A(Vasopressin V1a receptor (V1AR) ,MOA:Inhibitor); OPRL1(Nociceptin receptor (OPRL1) ,MOA:Inhibitor); OPRL1(Nociceptin receptor (OPRL1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0G2XE", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Ad-OC-hsvTK/valacyclovir": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D02KBE", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "1-allyl-5'-O-tritylinosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06BMN", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "(+/-)-threo-N-(2-Phenylethyl)ritalinol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09QSO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "1,2-bis(2,3,5-trifluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08UOB", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "AZM-131": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D09VRZ", "drug_id_DB": "", "metabolic_annotation_str": "PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PNLIP"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5406"]}, "Isocarboxazid(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0I2VK", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "ISIS 32024": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01DFK", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "4-(3,4-Dimethoxyphenethyl)aniline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O6ZM", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Adyvia": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02CQL", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "PMID1895299C1": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XMY", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "EPC-K1": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03RNX", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "MS-1819": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0D7AM", "drug_id_DB": "", "metabolic_annotation_str": "PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PNLIP"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5406"]}, "Arsenic trioxide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "IKBKB(Inhibitor of nuclear factor kappa-B kinase subunit beta); JUN(Transcription factor AP-1); CCND1(G1/S-specific cyclin-D1); MAPK3(Mitogen-activated protein kinase 3); MAPK1(Mitogen-activated protein kinase 1); PML(Protein PML); AKT1(RAC-alpha serine/threonine-protein kinase); CDKN1A(Cyclin-dependent kinase inhibitor 1); HDAC1(Histone deacetylase 1); ", "drug_id_TTD": "", "drug_id_DB": "DB01169", "metabolic_annotation_str": "TXNRD1(Thioredoxin reductase 1, cytoplasmic); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["TXNRD1"], "metabolic_genes_id": ["7296"]}, "Clonidine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03SKR", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8639"]}, "2-N-Hydroxyamino-1-(4-methylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04GHK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Dimethylallyl Diphosphate(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XBZ", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "TRIPTOCALLINE A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02DYB", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "6-methoxykaempferol 3-O-beta-D-robinobioside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03NEF", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "BPH-252": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I6YD", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "9-hydrazino-1,2,3,4-tetrahydroacridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08XPP", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Oleclumab": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D02GRR", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "NSC-37173": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B3XP", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "[3H]NFPS": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AYM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "LOR-220": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02WGD", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "(E)-Octadec-9-enoic acid phenylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F0JI", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "EC-145": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09JGH", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2348"]}, "ISOPILINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DX0R", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Neu-120": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2"], "non_metabolic": "GSK3B(Glycogen synthase kinase-3 beta (GSK-3B) ,MOA:Modulator); ", "drug_id_TTD": "D0D1UQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "CV-6504": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0V3HG", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Allylamines": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F9RE", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "NVP 231": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S9JG", "drug_id_DB": "", "metabolic_annotation_str": "CERK(Ceramide kinase (CERK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CERK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["64781"]}, "Phenyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V7EK", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Piperonal": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N3SU", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "90Y-cG250": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D05CVC", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["768"]}, "Hyperforin": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09VTJ", "drug_id_DB": "DB01892", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742"]}, "BUTYLATEDHYDROXYTOLUENE": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0W1SL", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "RS-14491": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O3BL", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142"]}, "PMID28447479-Compound-20": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0F7NL", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "PMID28447479-Compound-21": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0B7KP", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "PMID28447479-Compound-22": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FM6Y", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5168"]}, "PMID28447479-Compound-23": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0U8BD", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5168"]}, "PMID28447479-Compound-24": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00LWY", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5168"]}, "AR-C133057XX": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OW8M", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "E-3040": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0JY4Y", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Nicotinamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PARP1(Poly [ADP-ribose] polymerase 1); BST1(ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2); SIRT5(NAD-dependent protein deacylase sirtuin-5, mitochondrial); ", "drug_id_TTD": "", "drug_id_DB": "DB02701", "metabolic_annotation_str": "LDHA(L-lactate dehydrogenase A chain); LDHA(L-lactate dehydrogenase A chain); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["LDHA", "LDHA"], "metabolic_genes_id": ["3939", "3939"]}, "AMINOHIPPURIC ACID": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04DLM", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A8(Solute carrier family 22 member 8 (SLC22A8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A8"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9376"]}, "Tin protoporphyrin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HX0D", "drug_id_DB": "", "metabolic_annotation_str": "HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMOX1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3162"]}, "2-(7-(benzyloxy)-1H-indol-3-yl)ethanamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "TRPM8(Long transient receptor potential channel 8 (TRPM8) ,MOA:Inhibitor); ", "drug_id_TTD": "D0C8MT", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "1-Phenyl-propane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TLP", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "2,3,5,6-Tetrafluoro-4-pentafluorophenylazo-phenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZNR", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "6715"]}, "3-(pyridin-4-yl)-1H-indol-7-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AL2E", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "CA-50040": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ZAK", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["495"]}, "{2-[3-(Phenylsulfonyl)-1H-indol-4-yl]ethyl}amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4FW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "N,N'-(1',9'-nonylene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QNR", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "N,N-dimethylarginine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02DQQ", "drug_id_DB": "DB01686", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4843"]}, "2-(3-methoxybenzylthio)-2-phenylacetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3WR", "drug_id_DB": "", "metabolic_annotation_str": "LIPE(Hormone sensitive lipase (LIPE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3991"]}, "MINALRESTAT": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0J6JZ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["231"]}, "O-spiroketal glucoside": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M8EH", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "2-Methyl-1,2-di-pyridin-3-yl-propan-1-one oxime": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HV5D", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "3-Benzyl-4-hydroxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09FMZ", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "Phenyl 4-(4,5-dihydro-1H-imidazol-2-yl)benzoate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SRB", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "A-849531": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZEP", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "AZD5904": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0Y3LJ", "drug_id_DB": "", "metabolic_annotation_str": "MPO(Myeloperoxidase (MPO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MPO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4353"]}, "NSC-45592": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03NSJ", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "alpha-methylphenylalanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08URY", "drug_id_DB": "", "metabolic_annotation_str": "PAH(Phenylalanine hydroxylase (PAH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PAH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5053"]}, "(2-hydroxy-3-phenoxypropyl)(propan-2-yl)amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0C7PK", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Phenelzine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00780", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); GPT(Alanine aminotransferase 1); MAOB(Amine oxidase [flavin-containing] B); ABAT(4-aminobutyrate aminotransferase, mitochondrial); AOC3(Membrane primary amine oxidase); GPT2(Alanine aminotransferase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MAOA", "GPT", "MAOB", "ABAT", "AOC3", "GPT2"], "metabolic_genes_id": ["4128", "2875", "4129", "18", "8639", "84706"]}, "1-(4-nitrophenyl)-2-(phenylsulfonyl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06UPR", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "2-(N-(2-fluorophenyl)pyrrol-2-yl) acetic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07STC", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "PA-799": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D05CBJ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "BIIB-513": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NS9C", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "GFPEGG": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C1RY", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Pyroglutamic Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HCRT(Orexin (HCRT) ,MOA:Inhibitor); ANG(Angiogenin (ANG) ,MOA:Inhibitor); ", "drug_id_TTD": "D0U7QA", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["279"]}, "GSK683699": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "GABBR2(Gamma-aminobutyric acid B receptor (GABBR) ,MOA:Inhibitor); ITGA4(Integrin alpha-4 (ITGA4) ,MOA:Binder); GABRA1(GABA(A) receptor alpha-1 (GABRA1) ,MOA:Inhibitor); GABRG2(GABA(A) receptor gamma-2 (GABRG2) ,MOA:Inhibitor); GABRA5(GABA(A) receptor alpha-5 (GABRA5) ,MOA:Inhibitor); GABRA3(GABA(A) receptor alpha-3 (GABRA3) ,MOA:Inhibitor); GABRA2(GABA(A) receptor alpha-2 (GABRA2) ,MOA:Inhibitor); GABRB2(GABA(A) receptor beta-2 (GABRB2) ,MOA:Inhibitor); GABBR1(Gamma-aminobutyric acid B receptor (GABBR) ,MOA:Inhibitor); GABBR1(Gamma-aminobutyric acid B receptor (GABBR) ,MOA:Inhibitor); GABBR1(Gamma-aminobutyric acid B receptor (GABBR) ,MOA:Inhibitor); GABBR1(Gamma-aminobutyric acid B receptor (GABBR) ,MOA:Inhibitor); GABBR1(Gamma-aminobutyric acid B receptor (GABBR) ,MOA:Inhibitor); GABBR1(Gamma-aminobutyric acid B receptor (GABBR) ,MOA:Inhibitor); GABBR1(Gamma-aminobutyric acid B receptor (GABBR) ,MOA:Inhibitor); ", "drug_id_TTD": "D0C9XA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); SLC6A11(GABA transporter-3 (SLC6A11) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1", "SLC6A11"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6529", "6538"]}, "3,6-Dihydroxy-Xanthene-9-Propionic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07FGO", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "5-Bromo-4,9-dihydro-3H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08HAM", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-N-diethyl estradiol-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02MZN", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "(1'H-Phenothiazin-1'-yl)(piperidin-1-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09OPL", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "2-oxo-2H-thiochromene-3-carboxylic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D6UR", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "7-Iodo-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3ID", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "L-Nw-nitroarginine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G2UL", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "Pyrazole derivative 80": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "ABHD6(Monoacylglycerol lipase ABHD6 (ABHD6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0X9GC", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Pyrazole derivative 83": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S2JF", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Pyrazole derivative 82": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "ABHD6(Monoacylglycerol lipase ABHD6 (ABHD6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0LL0X", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Pyrazole derivative 85": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04ZEX", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Pyrazole derivative 84": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YM0G", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Pyrazole derivative 87": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07JTJ", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "4'-Amino-4-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O7CX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Porphobilinogen": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U6QC", "drug_id_DB": "DB02272", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["210"]}, "6-(3-aza-bicyclo[3.1.0]hexan-1-yl)quinoline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N4YP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "1-[5-(triphenylmethoxy)pentyl]thymine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KWL", "drug_id_DB": "", "metabolic_annotation_str": "TK2(Thymidine kinase 2 (Mt-TK2) ,MOA:Inhibitor); TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK2", "TK1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7084", "7083"]}, "1-hexadecyl-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZL6B", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "4-((naphthalen-2-yloxy)methyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR3A(5-HT 3A receptor (HTR3A) ,MOA:Inhibitor); KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D01FFX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "3-Butyl-[1,4]thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01MEA", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "PMID29338548-Compound-41": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06BUG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-40": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0W2YK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-45": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V5KY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-44": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0M6PI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-47": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XS1I", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-46": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0B5NJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-49": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XG8H", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-48": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MT4C", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "BChE inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NN5F", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "CYANATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04FXD", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["759"]}, "2-Benzyl-1-hydroxy-3H-benzo[f]chromen-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ITX", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "Levomilnacipran": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D02XOK", "drug_id_DB": "DB08918", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6530", "6532"]}, "flavone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADORA3(Adenosine A3 receptor (ADORA3) ,MOA:Antagonist); AR(Androgen receptor messenger RNA (AR mRNA) ,MOA:Inhibitor); GABRA1(GABA(A) receptor alpha-1 (GABRA1) ,MOA:Inhibitor); ADORA2B(Adenosine A2b receptor (ADORA2B) ,MOA:Antagonist); ADORA1(Adenosine A1 receptor (ADORA1) ,MOA:Antagonist); ", "drug_id_TTD": "D0S0RK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-(1,2-dihydroacenaphthylen-5-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04PKP", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "6-chloro-5-propylpyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DX8A", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "5-{8(Z),11(Z),14-pentadecatrienyl}resorcinol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ESC", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(R)-2,6-Bis-hydroxymethyl-piperidine-3,4,5-triol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q1KL", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2548"]}, "1,2-bis(3,4,5-trifluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01HZN", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "6-Thiophen-2-yl-imidazo[2,1-b]thiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J3TS", "drug_id_DB": "", "metabolic_annotation_str": "MT-ND3(NADH dehydrogenase (MT-ND3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MT-ND3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4537"]}, "1-(3,4-Dimethyl-phenyl)-2-phenyl-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8YZ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Ebselen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB12610", "metabolic_annotation_str": "EPHX2(Bifunctional epoxide hydrolase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["EPHX2"], "metabolic_genes_id": ["2053"]}, "9-O-[3-(4-Bromo-phenoxyl)butyl]-berberine bromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZL9I", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "C75": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MXA", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "Tetradecane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J0JY", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "1-(4-Cyanobenzyl)-5-(4-pyridyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06RSD", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "(-)-thujaplicatintrimethyl ether": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08BOH", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "1-(4-Cyanobenzyl)-5-(4-methylphenyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V6QN", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "EC0489": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D06CVN", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2348"]}, "NSC-50187": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7VA", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "LT-1951": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D06HBT", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4843"]}, "O-Sialic Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "SELE(E-selectin (SELE) ,MOA:Inhibitor); ", "drug_id_TTD": "D08WQM", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "SOM3355": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0XT8W", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6571"]}, "GENESERINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02DUJ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID18754614C9": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q1XK", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Tempol": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04GZS", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "CTL-102-GDEPT": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0E0FY", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["231"]}, "Protoporphyrin Ix Containing Co": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07SAI", "drug_id_DB": "DB02110", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "US9127005, P0L": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0OX9E", "drug_id_DB": "", "metabolic_annotation_str": "PLD1(Phospholipase D1 (PLD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5337"]}, "CEB-925": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0J8TH", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1,2-dicyclohexylethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LJ2F", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q4VO", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "Zoledronate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0VM2L", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2224"]}, "P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04BBF", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "3,4-difluorobenzaldehyde O-benzoyloxime": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JI8S", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7941"]}, "3-benzyloxy-4-methoxy-2'-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9BG", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "(E)-6-Styrylisatin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GUX", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "ITI-007": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Antagonist); ", "drug_id_TTD": "D0Q0EF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["6532"]}, "COX-2 inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LSB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "NSC-356483": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GIV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "9-Benzyl-6-(4-nitro-benzylsulfanyl)-9H-purine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I7ON", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2030"]}, "BIA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XT0I", "drug_id_DB": "DB03336", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "SKF-104351": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D09SCI", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "1-(3-methoxyphenyl)-2-(phenylsulfonyl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EU9W", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "2-(4-Chlorobenzylidene)cyclopentanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MC5H", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "2-Aminomethyl-5-(phenyl)tetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N0TQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Amoxapine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GABRP(Gamma-aminobutyric acid receptor subunit pi); GABRD(Gamma-aminobutyric acid receptor subunit delta); CHRM2(Muscarinic acetylcholine receptor M2); CHRM4(Muscarinic acetylcholine receptor M4); HTR1A(5-hydroxytryptamine receptor 1A); CHRM5(Muscarinic acetylcholine receptor M5); ADRA2A(Alpha-2A adrenergic receptor); ADRA2A(Alpha-2A adrenergic receptor); CHRM1(Muscarinic acetylcholine receptor M1); CHRM1(Muscarinic acetylcholine receptor M1); DRD2(D(2) dopamine receptor); GABRA1(Gamma-aminobutyric acid receptor subunit alpha-1); GABRA1(Gamma-aminobutyric acid receptor subunit alpha-1); ADRA2B(Alpha-2B adrenergic receptor); GABRB1(Gamma-aminobutyric acid receptor subunit beta-1); GABRG2(Gamma-aminobutyric acid receptor subunit gamma-2); ADRA2C(Alpha-2C adrenergic receptor); CHRM3(Muscarinic acetylcholine receptor M3); DRD1(D(1A) dopamine receptor); DRD4(D(4) dopamine receptor); DRD4(D(4) dopamine receptor); ADRA1D(Alpha-1D adrenergic receptor); HTR1B(5-hydroxytryptamine receptor 1B); HTR2A(5-hydroxytryptamine receptor 2A); GABRB3(Gamma-aminobutyric acid receptor subunit beta-3); GABRA5(Gamma-aminobutyric acid receptor subunit alpha-5); GABRA3(Gamma-aminobutyric acid receptor subunit alpha-3); HTR7(5-hydroxytryptamine receptor 7); ADRA1A(Alpha-1A adrenergic receptor); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); HTR2B(5-hydroxytryptamine receptor 2B); HTR3A(5-hydroxytryptamine receptor 3A); GABRA2(Gamma-aminobutyric acid receptor subunit alpha-2); GABRB2(Gamma-aminobutyric acid receptor subunit beta-2); GABRA4(Gamma-aminobutyric acid receptor subunit alpha-4); HTR6(5-hydroxytryptamine receptor 6); GABRE(Gamma-aminobutyric acid receptor subunit epsilon); GABRA6(Gamma-aminobutyric acid receptor subunit alpha-6); GABRG1(Gamma-aminobutyric acid receptor subunit gamma-1); GABRG3(Gamma-aminobutyric acid receptor subunit gamma-3); HRH4(Histamine H4 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00543", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "3-(decylsulfonyl)-1,1,1-trifluoropropan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0FN", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "7-ethoxy-8-propionyl-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01FOK", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "(+/-)-threo-N-(3-Methylthiopene)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0NO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Hexadecanoic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "RHO(Rhodopsin (RHO) ,MOA:Inhibitor); ", "drug_id_TTD": "D02TVS", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "2-(N-tert-Butylamino)-3'-chlorooctanophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07IOX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "RP-70676": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D03YPL", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "MONODICTYOCHROMONE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F8IB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Diminazene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B8TJ", "drug_id_DB": "DB03608", "metabolic_annotation_str": "AOC1(Diamine oxidase (AOC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["26"]}, "4-(Carbamolymethylthio)pyridine-3-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V5OW", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "Milacemide": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D07OLO", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "BVT.2733": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02ENG", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "N-methyl,N-(benzyl),N-(pyrrol-2-ylmethyl)amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MO1O", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Tert-Butyl 3-(2-oxo-8-phenyloctanamido)propanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05TZP", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "RIG-200": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D00TLD", "drug_id_DB": "", "metabolic_annotation_str": "GUCY1B1(Guanylate cyclase soluble beta-1 (GUCY1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2983"]}, "Trans-2-(4-chlorophenyl)-2-fluorocyclopropanamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03LGV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "4-hydroxy-but-2-enoate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01TPW", "drug_id_DB": "", "metabolic_annotation_str": "SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC52A2", "SLC52A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["79581", "79581"]}, "PMID8709131C15": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OF1X", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID8709131C17": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MA8Q", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "4-Sulfamoyloxy-benzoic acid cyclopentyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U7PV", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "ABIRATERONE": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02STN", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1586"]}, "Gamma-mangostin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05IWY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "7-methyl-2-p-tolyl-4H-chromene-4-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08HKC", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PYRIDINE": {"drug_status_TTD": ["Phase 4"], "non_metabolic": "", "drug_id_TTD": "D0T8LY", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "4-Fluorobenzenemethanethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PR7L", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "ISOPENTENYL PYROPHOSPHATE(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04714", "metabolic_annotation_str": "GGPS1(Geranylgeranyl pyrophosphate synthase); FDPS(Farnesyl pyrophosphate synthase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["GGPS1", "FDPS"], "metabolic_genes_id": ["9453", "2224"]}, "N5-[(4-Phenoxy)-3-pyridyl]-L-glutamamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TMR", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "3-[10-(benzylmethylamino)decyloxy]xanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02XHM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1-Naphthalen-2-yl-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G6QL", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "(-)-uniflorine A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KE8R", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2548"]}, "2'-Hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S9YA", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Calcium carbimide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB09116", "metabolic_annotation_str": "ALDH3B2(Aldehyde dehydrogenase family 3 member B2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALDH3B2"], "metabolic_genes_id": ["222"]}, "US8586571, 36": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I1LE", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "ZIFROSILONE": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0F1VQ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "4-(3-Adamantan-1-yl-ureido)-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WHU", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4KE", "drug_id_DB": "DB02986", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "1-[(n-hex-1-ylamino)ethyl]-1,1-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01GAR", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Sulfamic acid 4-(3-methoxy-benzoyl)-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ADL", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "PMID27109571-Compound-27": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D00KCT", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-26": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0CT9O", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-25": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D01NVM", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "EX5": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08VKT", "drug_id_DB": "", "metabolic_annotation_str": "MTHFR(MTHFR messenger RNA (MTHFR mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["MTHFR"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["4524"]}, "PMID27109571-Compound-23": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0R9RK", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-22": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D08IIV", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-21": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0U2SI", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-20": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D06JEA", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "IGERNELLIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03NLE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "BMS-694153": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D05MSG", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "(4-Bromo-butyl)-trimethyl-ammonium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03FZK", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID27109571-Compound-29": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D03CJT", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-28": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D05XAT", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "ISOQUINE": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D03GNI", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "4-nitrobenzo[c][1,2,5]thiadiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8FG", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "6-chloro-5-phenylpyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01IGW", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "4-[4-(benzyloxy)piperidino]butyl-4-chlorobenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H1NU", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "PMID20299227C12": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HKR", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "CALAA-01": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "TF(Transferrin (TF) ,MOA:Modulator); ", "drug_id_TTD": "D0A1GR", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6241"]}, "PMID27539678-Compound-7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RE9W", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "PMID27539678-Compound-6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02DLL", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "7-Bromo-4,9-dihydro-3H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W4TW", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Rac-2q": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C8UF", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "PMID27539678-Compound-9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0VB2X", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "PHENYLSULFAMATE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4FM", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Di(2,6-dimethylphenol)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04LNI", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4NO", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "Istaroxime(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ATP2A2(Sarcoplasmic/endoplasmic reticulum calcium ATPase 2); ", "drug_id_TTD": "", "drug_id_DB": "DB06157", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase subunit alpha-1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ATP1A1"], "metabolic_genes_id": ["476"]}, "Bucelipase alfa": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D04MZR", "drug_id_DB": "", "metabolic_annotation_str": "CEL(Bile-salt-activated lipase (CEL) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CEL"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1056"]}, "STX 64": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D05NJI", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "XL147": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03KAC", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "3-methoxydesaminokynurenine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ASH", "drug_id_DB": "", "metabolic_annotation_str": "KYNU(Kynureninase (KYNU) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KYNU"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8942"]}, "1-Methyl-5-phenyl-piperidin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ZRX", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "4-Sulfamoyloxy-benzoic acid cyclooctyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T5OD", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "SB-210313": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D00XOQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Mumbaistatin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6OT", "drug_id_DB": "", "metabolic_annotation_str": "SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC37A4", "SLC37A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2542", "2542"]}, "7-Methyl-[1,4]thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01EHS", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "4-(dimethylamino)-N-(thiazol-2-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09MTV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "FR-62765": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0RZ0N", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["231"]}, "Chlorpropamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00672", "metabolic_annotation_str": "ABCC8(ATP-binding cassette sub-family C member 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC8"], "metabolic_genes_id": ["6833"]}, "BPN14770": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0IZ8X", "drug_id_DB": "", "metabolic_annotation_str": "PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5144"]}, "BABIM": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D02INZ", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "Estradiol 3,17-O,O-bis-sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S3RZ", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "1-(2-(phenoxymethyl)phenyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0S4JT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Mepacrine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O2DQ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "N,N-diethyl estrone-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A5CD", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "N-(4-phenylbutyl)-1H-pyrrole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P3DV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Sulfaphenazole": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0A4YE", "drug_id_DB": "", "metabolic_annotation_str": "CYP2C9(S-mephenytoin 4-hydroxylase (CYP2C9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2C9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1559"]}, "6-Acetyl-7-hydroxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02MAK", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "5-propyl-2'-deoxyuridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C7YS", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "1-(1-(Biphenyl-4-yl)allyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RI7T", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "NCI-58425": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B4KG", "drug_id_DB": "", "metabolic_annotation_str": "LIPE(Hormone sensitive lipase (LIPE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3991"]}, "Phenmetrazine": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0M2MC", "drug_id_DB": "DB00830", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "Tihoacetate derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03QGH", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "Erythro-3,4-dichloromethylphenidate hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04EXA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "PMID1656041C11nn": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M9BZ", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "1-acetamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XIB", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Heteroaryl-cyclopropylamine derivative 3": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D06VMN", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "SODIUM ZINC DIHYDROLIPOYLHISTIDINATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7DV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Heteroaryl-cyclopropylamine derivative 1": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D07NTA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "1-(4-fluorophenyl)-3-(phenylsulfonyl)propan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ADD", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "NS398": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D09BKE", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "SC-41661A": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XKA", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Hypoxanthine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03HVE", "drug_id_DB": "DB04076", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "ER-119884": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U0NT", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Bisphosphonates": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4ZA", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "4-(4-methyl-phenyliminomethyl)-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T2SD", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "BW755C": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0DP8P", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "BAY2402234": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08DMH", "drug_id_DB": "", "metabolic_annotation_str": "DHODH(Dihydroorotate dehydrogenase (DHODH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DHODH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1723"]}, "Nicotinyl hydroxamic acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FQ3D", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "ISOPENTENYL PYROPHOSPHATE(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J8KR", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "(RS/SR)-2-[1-(3,4-dichlorophenyl)butyl]piperidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SLZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "M-100240": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Modulator); ", "drug_id_TTD": "D0N5HN", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "NNC052090": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P3KI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A12(Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6539"]}, "2-oxo-N-m-tolyl-2H-chromene-3-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00WSM", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "MAACKIAIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ODW", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6524"]}, "1-(4-(benzyloxy)phenyl)propan-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SBZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "C2-MAD": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4AL", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "NIPECOTIC ACID": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADORA3(Adenosine A3 receptor (ADORA3) ,MOA:Inhibitor); ", "drug_id_TTD": "D0RF2M", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); SLC6A11(GABA transporter-3 (SLC6A11) ,MOA:Inhibitor); ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1", "SLC6A11", "ABAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6529", "6538", "18"]}, "1-adamantan-1-yl-3-(5-butoxypentyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M0KA", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "(+/-)-2-(4'-Propoxyphenyl)thiomorpholin-5-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z5BU", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "IODIDE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08RKK", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "4-Hydroxy-2,5-dimethyl-3(2H)-furanone": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03ZOH", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "4-amino-N-(2-chlorophenyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7ND", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "PMID25399762-Compound-Figure1-Chukrasone A": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K3UV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "PMID25399762-Compound-Figure1-Chukrasone B": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Y9VB", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "KELATORPHAN": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "ENPEP(Glutamyl aminopeptidase (ENPEP) ,MOA:Inhibitor); ", "drug_id_TTD": "D04QJY", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "[3H]ETB-TBOA": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CIW", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A7(Excitatory amino acid transporter 5 (SLC1A7) ,MOA:Modulator); SLC1A3(Excitatory amino acid transporter 1 (SLC1A3) ,MOA:Modulator); SLC1A2(Excitatory amino acid transporter 2 (SLC1A2) ,MOA:Modulator); SLC1A1(Excitatory amino acid transporter 3 (SLC1A1) ,MOA:Modulator); SLC1A6(Excitatory amino acid transporter 4 (SLC1A6) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A7", "SLC1A3", "SLC1A2", "SLC1A1", "SLC1A6"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["6512", "6507", "6506", "6505", "6511"]}, "IMIRESTAT": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0Q7AW", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Lecimibide": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D03EHR", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "OXYRESVERATROL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ZRX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Piperazine carbamic compound 4": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "ABHD6(Monoacylglycerol lipase ABHD6 (ABHD6) ,MOA:Inhibitor); ", "drug_id_TTD": "D00TVG", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Piperazine carbamic compound 5": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "ABHD6(Monoacylglycerol lipase ABHD6 (ABHD6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Z7FL", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Nectamazin C": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ETD", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Piperazine carbamic compound 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "ABHD6(Monoacylglycerol lipase ABHD6 (ABHD6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0J6TA", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Piperazine carbamic compound 2": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "ABHD6(Monoacylglycerol lipase ABHD6 (ABHD6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0LC5Y", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Piperazine carbamic compound 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09LAD", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "N-Isopropyl-N'-Hydroxyguanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q8EX", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "6-(3-Fluoropropyl)-4-methylpyridin-2-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FXW", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "PMID27967267-Compound-stenine": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02GCZ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-[2-(3,5-Dimethoxy-phenyl)-vinyl]-furan": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06VXW", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "Furosemide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0PQ3G", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "Aluminium": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0V8TQ", "drug_id_DB": "DB01370", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["476"]}, "3,4-Dimethoxy-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T0CK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "CI-972": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D05UPB", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "4'-hydroxy-6,3',5'-triprenylisoflavonone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05SQA", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "CI-976": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D1XG", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "BI-L-357": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0U6AL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-(2-phenoxyphenyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D00HCC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Maltose(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03323", "metabolic_annotation_str": "AMY2B(Alpha-amylase 2B); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["AMY2B"], "metabolic_genes_id": ["280"]}, "ZM-230487": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0D8MD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-benzyl-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O0LU", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "2,4-Dimethoxy-3'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A7PA", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "6,11-dihydro-5H-benzo[a]carbazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E5VT", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P4GF", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "2-Propanol, Isopropanol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); NR1H2(Oxysterols receptor LXR-beta (NR1H2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0W7LK", "drug_id_DB": "", "metabolic_annotation_str": "HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); GCH1(GTP cyclohydrolase-I (GCH1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMOX1", "PLA2G2A", "AHCY", "NOS3", "GCH1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3162", "5320", "191", "4846", "2643"]}, "12-(3-n-Pentylureidooxy)dodec-8(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B0MU", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "YM-976": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0C7JT", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Hydroflumethiazide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00WAM", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "RDEA-684": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06UTH", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "5-(4-Chlorophenyl)-4-(4-methoxyphenyl)isothiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J6TU", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "4-(1H-indol-3-yl)-1-morpholinobutan-1-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08NDV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Trilostane(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ESR1(Estrogen receptor); ESR2(Estrogen receptor beta); ", "drug_id_TTD": "", "drug_id_DB": "DB01108", "metabolic_annotation_str": "HSD3B1(3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1); HSD3B2(3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["HSD3B1", "HSD3B2"], "metabolic_genes_id": ["3283", "3284"]}, "Metaiodobenzylguanidine I-131": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05FQD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6530"]}, "7-(3,5-dihydroxyphenyl)naphthalene-1,3-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A7WB", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "S-hexylglutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08IXW", "drug_id_DB": "", "metabolic_annotation_str": "HPGDS(Glutathione-dependent PGD synthase (HPGDS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HPGDS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["27306"]}, "2,3,4,5-Tetrafluoro-6-pentafluorophenylazo-phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05VLU", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "4-Butyl-thiazolidin-(2E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07OQX", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "1-Phenyl-2-p-tolyl-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B8YX", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "3-(4-Amino-phenyl)-3-hexyl-piperidine-2,6-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O1ZM", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "MKC-1106-MT": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "MLANA(MART-1 melanoma antigen (MLANA) ,MOA:Modulator); ", "drug_id_TTD": "D0J7MQ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7299"]}, "Gemcitabine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03UVS", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6241"]}, "Sulfasalazine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02ZTJ", "drug_id_DB": "", "metabolic_annotation_str": "ABCG2(ATP-binding cassette transporter G2 (ABCG2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCG2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9429"]}, "2-(4-Methoxy-phenyl)-5-phenyl-thiazol-4-ol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05PHI", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "SPH-1285": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0V7FG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N-(5-m-Tolyl-furan-2-carbonyl)-guanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06AKW", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RO8V", "drug_id_DB": "DB07940", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "PMID7473541C19": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K7GL", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Disulfide compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XV4L", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "NKS-01": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U9LL", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "5-Methoxymethyl-3-pyrrol-1-yl-oxazolidin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FXI", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Ouabain(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01092", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase subunit alpha-1); ATP1A3(Sodium/potassium-transporting ATPase subunit alpha-3); ATP1A2(Sodium/potassium-transporting ATPase subunit alpha-2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ATP1A1", "ATP1A3", "ATP1A2"], "metabolic_genes_id": ["476", "478", "477"]}, "OCHNAFLAVONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0OA", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5320"]}, "1-Benzyl-2-methyl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07LMI", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "GARCINONE D": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05YJR", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "RP6530": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0LG7X", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "6-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05GQQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "AX-048": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05GUD", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "CAPROCTAMINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NJ5W", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "N-(2-phenylcyclopropyl) amino acid derivative 3": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D08IOP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-(2-phenylcyclopropyl) amino acid derivative 1": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); KDM4A(Lysine-specific demethylase 4A (KDM4A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0UL9U", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "AC1M1SP5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z7YQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE8A(Phosphodiesterase 8 (PDE8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE8A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5151"]}, "FR117016": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04GWR", "drug_id_DB": "DB02616", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Zabiciprilat": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00FHI", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Subersic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A8OW", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "PMID19191557C8": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WG7H", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID19191557C3": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AP5M", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID29338548-Compound-27": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H5VO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-26": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FG2H", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-25": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01IJO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-24": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00JEC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-23": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EF0P", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-22": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0T2QP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-21": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0W7FS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-20": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S6BG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "Reserpine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0J4JM", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6571"]}, "Captopril(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0I0EG", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "PMID29338548-Compound-29": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08UQK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-28": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X1ZA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "Five-membered heteroaromatic compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05CNJ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4-((4-methoxyphenyl)diazenyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z1WF", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Five-membered heteroaromatic compound 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UZ6C", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Five-membered heteroaromatic compound 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0T9XC", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Hydroflumethiazide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KCNMA1(Calcium-activated potassium channel subunit alpha-1); ", "drug_id_TTD": "", "drug_id_DB": "DB00774", "metabolic_annotation_str": "CA12(Carbonic anhydrase 12); CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); ATP1A1(Sodium/potassium-transporting ATPase subunit alpha-1); CA4(Carbonic anhydrase 4); CA7(Carbonic anhydrase 7); SLC12A1(Solute carrier family 12 member 1); CA9(Carbonic anhydrase 9); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA12", "CA1", "CA2", "ATP1A1", "CA4", "CA7", "SLC12A1", "CA9"], "metabolic_genes_id": ["771", "759", "760", "476", "762", "766", "6557", "768"]}, "PF-04620110": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0M0NT", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "Carboxylic acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00PHK", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "1-(2-((3-fluorophenoxy)methyl)phenyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Y5CG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "1(beta)-O-galloylpedunculagin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F9KV", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "SCH51866": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02VHD", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); PDE9A(Phosphodiesterase 9 (PDE9) ,MOA:Inhibitor); PDE1A(Phosphodiesterase 1A (PDE1A) ,MOA:Inhibitor); PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); PDE1C(Phosphodiesterase 1C (PDE1C) ,MOA:Inhibitor); PDE7B(Phosphodiesterase 7B (PDE7B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A", "PDE9A", "PDE1A", "PDE1B", "PDE1C", "PDE7B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8654", "5152", "5136", "5153", "5137", "27115"]}, "3,5-Dinitrocatechol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09AYR", "drug_id_DB": "DB02105", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "Isovanillin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0E9CD", "drug_id_DB": "", "metabolic_annotation_str": "AOX1(Aldehyde oxidase (AOX1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOX1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["316"]}, "2-Aminothiazoline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02335", "metabolic_annotation_str": "NOS3(Nitric oxide synthase, endothelial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["NOS3"], "metabolic_genes_id": ["4846"]}, "2'3'-Dideoxyinosine": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04XYL", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "WAY-196025": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F9PM", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "RPAF-AH": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0AK5G", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7941"]}, "Artemether": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0M9BW", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["476"]}, "1-propionyl-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CFJ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Pyrazole derivative 81": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "ABHD6(Monoacylglycerol lipase ABHD6 (ABHD6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0O9DS", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "A-3309": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D04BLE", "drug_id_DB": "", "metabolic_annotation_str": "SLC10A2(Ileal sodium/bile acid cotransporter (SLC10A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC10A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6555"]}, "(Z)-2,6-diisopropyl-N-phenyloctadec-9-enamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9RD", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "2,5-Bis-(3,4-dimethoxy-phenyl)-furan": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01CAY", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "4-(2-Phenylacetamido)-3-bromobenzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z5GE", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "(R)-3-(naphthalen-2-ylmethoxy)pyrrolidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0XF5P", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-Imidazol-1-ylmethylxanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AW7Q", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Indomethacin analog 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0F0PK", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor. Antagonist. Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor; Antagonist; Blocker"], "metabolic_genes_id": ["8644"]}, "IC980033": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O2HL", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "Triazolo-pyridine derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01ITP", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "8-methyl-2-morpholino-7-phenoxy-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WIJ", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "2-Hex-5-enyl-5-non-8-enyl-3,4-dihydro-2H-pyrrole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZGN", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "7-fluoro-2-p-tolyl-4H-chromene-4-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I9AA", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "GALLOCATECHIN GALLATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07KXK", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "SC-58451": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0O9JX", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "GSK-8062": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G9YL", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Quinones": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06BCY", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "alpha-propyldopacetamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IT5D", "drug_id_DB": "", "metabolic_annotation_str": "TH(Tyrosine 3-monooxygenase (TH) ,MOA:Inhibitor); TPH1(Tryptophan 5-hydroxylase 1 (TPH1) ,MOA:Inhibitor); TPH2(L-Tryptophan hydroxylase 2 (TPH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TH", "TPH1", "TPH2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7054", "7166", "121278"]}, "US9127005, P2B": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09BSA", "drug_id_DB": "", "metabolic_annotation_str": "PLD1(Phospholipase D1 (PLD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5337"]}, "US9127005, P2C": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06OKT", "drug_id_DB": "", "metabolic_annotation_str": "PLD1(Phospholipase D1 (PLD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5337"]}, "TASPINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L0ZH", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Heptane-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05AVX", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Trecadrine": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0S8RD", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "1-(3,4-dihydronaphthalen-2-yl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N4VI", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Irindalone": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0V9HI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Chlorothiazide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0M9WM", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Allyl-trimethyl-ammonium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M1CG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Minaprine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRM1(Muscarinic acetylcholine receptor M1); DRD2(D(2) dopamine receptor); DRD1(D(1A) dopamine receptor); HTR2A(5-hydroxytryptamine receptor 2A); HTR2B(5-hydroxytryptamine receptor 2B); ", "drug_id_TTD": "", "drug_id_DB": "DB00805", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); ACHE(Acetylcholinesterase); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MAOA", "ACHE", "SLC6A4"], "metabolic_genes_id": ["4128", "43", "6532"]}, "1S,2R-milnacipran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03BQV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "VU0364739": {"drug_status_TTD": ["Clinical trial"], "non_metabolic": "", "drug_id_TTD": "D03JRG", "drug_id_DB": "", "metabolic_annotation_str": "PLD2(Phospholipase D2 (PLD2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5338"]}, "Fenoprofen": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D03XYW", "drug_id_DB": "DB00573", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "3,5-Dimethoxy-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "NQO2(Quinone reductase 2 (NQO2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Q8UZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Allyl 4-(2-oxohexadecanamido)butanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ND4N", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "1,2-Bis-(4-bromo-phenyl)-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FFD", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "AS-1397": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I4LX", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Homoserine Lactone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07WXS", "drug_id_DB": "DB02624", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "Seridopidine": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0U5PR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6531", "6531"]}, "NSC-37031": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I2DB", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "GSK256066": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U7PS", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "3-(2-Diethylamino-propionamino)-rutaecarpine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03DIP", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "LP-661438": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CYQ", "drug_id_DB": "", "metabolic_annotation_str": "DCK(Deoxycytidine kinase (DCK) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DCK"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1633"]}, "3-[11-(benzylmethylamino)undecyloxy]xanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05GPI", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Buproprion+zonisamide": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04LTQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A8(Solute carrier family 22 member 8 (SLC22A8) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A8"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["9376"]}, "4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6IE", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA6", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "765", "768"]}, "Indazole derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UC2S", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["3620"]}, "1-(4-propoxyphenyl)propan-2-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H6UA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Indazole derivative 3": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0JB1V", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:.); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:.); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2"], "metabolic_mechanism_of_action": [".", ".", "."], "metabolic_genes_id": ["3620", "6999", "6999"]}, "2-N-Hydroxyamino-1-(4-ethylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LLP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "YH-1238": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C7SC", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "2-(N-(2-Ffuorophenyl)pyrrol-3-yl) acetic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FGY", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "PMID27977313-Compound-5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CV1Q", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G9QO", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S2AY", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "DEMETHOXYCURCUMIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EDF", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "N-(3-phenoxy-4-pyridinyl)propanesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L6TP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "PMID27977313-Compound-8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09ACU", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "4-(2-(2-fluorobenzyloxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D04NDO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "iOWH032": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0N4PW", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1080"]}, "8-Bromo-4,9-dihydro-3H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0G2EF", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "4,7-Dioxosebacic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06UYC", "drug_id_DB": "DB04560", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["210"]}, "S-(N-heptyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01UKL", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "N-(Propylamide-acetophenone)-1-deoxynojirimycin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09IWI", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2629", "2629"]}, "W-198": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0GS2W", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5243"]}, "8R-hydroxylobel-9-ene": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B6UU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "N-(2-Phenylethyl)-1H-indole-2-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YO7C", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "(S)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KD9M", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "1-valproylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KZ2D", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Vardenafil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00862", "metabolic_annotation_str": "PDE5A(cGMP-specific 3',5'-cyclic phosphodiesterase); PDE6G(Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma); PDE6H(Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PDE5A", "PDE6G", "PDE6H"], "metabolic_genes_id": ["8654", "5148", "5149"]}, "(Z)-5-octadecen-7,9-diynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NU6K", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "MOFEGILINE": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D01LAC", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "2,2-difluoromevalonate 5-diphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G7HQ", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "N-(benzimidazolylcarbonyl)-piperidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N3XY", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "AVE-8112": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D01WZL", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "AphanamgrandiolA": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XY6I", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "GSK-644784": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05HVY", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Duloxetine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00476", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "BENZYL BENZOATE": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0G1VX", "drug_id_DB": "", "metabolic_annotation_str": "LIPE(Hormone sensitive lipase (LIPE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3991"]}, "2-[(2,2-diphenylacetyl)amino]benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03POE", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "CVT-10216": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W4WP", "drug_id_DB": "", "metabolic_annotation_str": "ALDH2(Mitochondrial aldehyde dehydrogenase (ALDH2) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH2"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["217"]}, "MF-8623": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7SD", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Reserpine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00206", "metabolic_annotation_str": "SLC18A1(Chromaffin granule amine transporter); SLC18A2(Synaptic vesicular amine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC18A1", "SLC18A2"], "metabolic_genes_id": ["6570", "6571"]}, "1-adamantan-1-yl-3-(5-hydroxypentyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UJ9V", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "norzotepine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05WFQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "BMY-30129": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08VGT", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "RO-09-4889": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03GGN", "drug_id_DB": "", "metabolic_annotation_str": "DPYD(Dihydrothymine dehydrogenase (DPYD) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DPYD"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1806"]}, "5-Hydrazino-1H-tetrazole": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EC1A", "drug_id_DB": "", "metabolic_annotation_str": "CTH(Cystathionine gamma-lyase (CTH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1491"]}, "2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06NDR", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "1-(4-ethylphenylsulfonyl)-4-phenylazepan-4-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04LGV", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "GSK2194069": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03VGO", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "Azaindole derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02VYR", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Corosolic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F9RO", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "OCTYL_GALLATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ZSX", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "1,4-Butanediol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "MAN1B1(Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase); ", "drug_id_TTD": "", "drug_id_DB": "DB01955", "metabolic_annotation_str": "PLA2G2A(Phospholipase A2, membrane associated); PLA2G2E(Group IIE secretory phospholipase A2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PLA2G2A", "PLA2G2E"], "metabolic_genes_id": ["5320", "30814"]}, "Heptyl-methyl-prop-2-ynyl-amine hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z2NN", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Isosorbide-2-benzylcarbamate-5-nicotinate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03NTO", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Tacrine-dihydropyridine hybrid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0C1UA", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["43"]}, "3-Deoxyguanosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J0HK", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "KC-764": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0S6GJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Isosorbide-2-(benzylcarbamate)-5-mononitrate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IC5U", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "P-coumaric acid derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J4YH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Darapladib(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB06311", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PLA2G4A"], "metabolic_genes_id": ["5321"]}, "EMR-62203": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X1LO", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "4-methylphenyl-difluoromethanesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GPL", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "PSD-508": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X4IV", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ABT", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "4-Sulfonamide-[1-(4-Aminobutane)]Benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O0HT", "drug_id_DB": "DB03697", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "XR-9456": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04GYT", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1", "ABCC1", "ABCC1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5243", "4363", "4363"]}, "1,1,1,3-Tetrafluoro-7-phenylheptan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03FQJ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "PD-169316": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3ZN", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "INCB13739": {"drug_status_TTD": ["Phase 2a"], "non_metabolic": "", "drug_id_TTD": "D05XLO", "drug_id_DB": "DB05064", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "ZPL521": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D02XBN", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "PKI-402": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07PMP", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "1-(3-methylpyridin-2-yl)-4-tosylpiperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9NX", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Pirazolac": {"drug_status_TTD": ["Discontinued in Preregistration", "Discontinued in Preregistration"], "non_metabolic": "", "drug_id_TTD": "D0E0JF", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "DAEDALIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02IJM", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X7IZ", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "17 beta-N,N-diethylcarbamoyl-4-aza-5 alpha-androstan-3-one (4MA)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06LVG", "drug_id_DB": "", "metabolic_annotation_str": "HSD3B1(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); HSD3B2(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD3B1", "HSD3B2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3283", "3284"]}, "2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08UWI", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "F-12509A": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0O0JH", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "BW B70C": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0HJ1Y", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "FV-100": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D04QPD", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "4-(3-Pent-1-ynyl-benzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D01DAU", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Thieno[2,3-c]pyridine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0IT3V", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(10H-phenothiazin-10-yl)(p-tolyl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01LVY", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "BAY-60-7550": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V9MI", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Kodaistatin C": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I3IR", "drug_id_DB": "", "metabolic_annotation_str": "SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC37A4", "SLC37A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2542", "2542"]}, "Tiagabine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0ED7U", "drug_id_DB": "DB00906", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6529"]}, "3-(2-N-Piperidyl-propionamino)-rutaecarpine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C3IS", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "N-Benzyl-(6-butoxy-2-naphthyl)-2-aminopropane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02AQG", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "KAR5585": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0VS3W", "drug_id_DB": "", "metabolic_annotation_str": "TPH1(Tryptophan 5-hydroxylase 1 (TPH1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["TPH1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["7166"]}, "4-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U6NJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "GlyH-101": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1FV", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Blocker (channel blocker)); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Blocker (channel blocker)"], "metabolic_genes_id": ["1080"]}, "Monoisopropyl Ester Phosphonic Acid Group": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NL4Z", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1'-(4-Methyl-benzyl)-[1,4']bipiperidinyl": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00LMT", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "LAS-31180": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D01OFY", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5139"]}, "VALIOLAMINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TQA", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2548"]}, "P-coumaric acid derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06LMS", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "[Cyclopentyl-(2-nitro-benzoyl)-amino]-acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U7TM", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "HGT-1410": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Q5BK", "drug_id_DB": "", "metabolic_annotation_str": "SGSH(N-sulphoglucosamine sulphohydrolase (SGSH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SGSH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6448"]}, "NSC-93358": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09MYQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Bis-7-tacrine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4IE", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "1-(3,4-dihydroxy-5-nitrophenyl)-2-phenoxyethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01AFH", "drug_id_DB": "", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "2-Deoxy-Glucose-6-Phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8RR", "drug_id_DB": "DB02604", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "VPC-94075": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00YNY", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "1-(3,5-dichlorobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ORY", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OE1R", "drug_id_DB": "DB07462", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "2-Propyl-pentanoic acid 4-sulfamoyl-benzylamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1OY", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "N-(furan-2-ylmethyl)-estrone-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K8VL", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "PHENYLMETHANESULFONAMIDE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07SIA", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "GFPTGG": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1LA", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Fomepizole(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02NJA", "drug_id_DB": "", "metabolic_annotation_str": "ADH1A(Alcohol dehydrogenase 1A (ADH1A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ADH1A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["124"]}, "Sulfamylon": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0K1QD", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA4", "CA6", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "762", "765", "23632"]}, "1-(1,4-diacetylphenyl)dithiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08UHS", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Mevastatin": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0J9GD", "drug_id_DB": "DB06693", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["3156"]}, "Beta-Alanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8SX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A11(GABA transporter-3 (SLC6A11) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A11"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6538"]}, "N-propynyl amidebenzenesulphonide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XFH", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01GAX", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "crotylaldehyde": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CSB", "drug_id_DB": "", "metabolic_annotation_str": "ALDH2(Mitochondrial aldehyde dehydrogenase (ALDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["217"]}, "LY-2334737": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0F2JY", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6241"]}, "N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BQN", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Ezetimibe(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09LWS", "drug_id_DB": "", "metabolic_annotation_str": "NPC1L1(Niemann-Pick C1-like protein 1 (NPC1L1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NPC1L1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["29881"]}, "MEDIORESINOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RGP", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Mycophenolic hydroxamic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01LDQ", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); PPAT(Amidophosphoribosyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2", "PPAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3615", "5471"]}, "Tetrazole acetic acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FX9D", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "4-((benzylideneamino)methyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I1XT", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "PMID1527791C29": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W5FM", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "L-Myo-Inositol-1-Phosphate(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08MFC", "drug_id_DB": "", "metabolic_annotation_str": "IMPA2(Inositol-1(or4)-monophosphatase (IMPA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3613"]}, "2-[2-(3,5-Dimethoxy-phenyl)-vinyl]-thiophene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z1AL", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "2-Cyclohexyl-N-phenethyl-acetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04PNC", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "16-(pyridin-3-yl)methylene-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08EHR", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "3-Propyl-[1,4]thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BKV", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "L-Thiocitrulline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01EBY", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "4-(2-Oxo-2-phenyl-acetyl)-benzoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BB2U", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "2-Methyl-1,2-di-pyridin-3-yl-propylchloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QWX", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "1-(7-Methoxy-2-phenyl-chroman-4-yl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S0OV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "(S)-3-hydroxy-3-methylglutaryl-CoA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06XQX", "drug_id_DB": "", "metabolic_annotation_str": "HMGCS1(Hydroxymethylglutaryl-CoA synthase 1 (HMGCS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3157"]}, "SB-203347": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PLG", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5319"]}, "Talotrexin": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0GL7H", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["2348"]}, "o-hydroxyatorvastatin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03TKT", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2,3,4-tribromo-6-(2,4-dibromophenoxy)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C3AG", "drug_id_DB": "", "metabolic_annotation_str": "GMPS(Glutamine amidotransferase (GMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8833"]}, "2-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03XHF", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Aom-0763": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z2NY", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "L-761000": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03KSL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Methyl arachidonyl fluorophosphonate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V6QA", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Benzoic acid linked peptide analog 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X4EC", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzoic acid linked peptide analog 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08OJB", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01EEM", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Benzoic acid linked peptide analog 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AG7M", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzoic acid linked peptide analog 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QC9I", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzoic acid linked peptide analog 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CI2U", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzoic acid linked peptide analog 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0F0VF", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Aryl sulphoxide imine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YW4T", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Benzyl-biphenyl-4-ylmethyl-imidazol-1-yl-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0QL1V", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "2-amino-N1-benzyl-N3-hydroxymalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z4AC", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "N-Butyl-N'-Hydroxyguanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q7VU", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "6-(pyridin-3-yl)-2-naphthonitrile": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1GH", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "MK-8245": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0S0RS", "drug_id_DB": "", "metabolic_annotation_str": "SCD(Acyl-CoA desaturase (SCD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SCD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6319"]}, "PMID8576905C4": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04DZS", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Dextromethorphan+quinidine": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0J8RR", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-(pyridinepyrroylylcarbonyl)-piperidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SM2O", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "Delta-Amino Valeric Acid(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06KOT", "drug_id_DB": "", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["210"]}, "Dapagliflozin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01TNW", "drug_id_DB": "DB06292", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "MT-Immucillin-H": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JOV", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "1-(2-amino-benzothiazol-5-yl)-2-ethyl-isothiourea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00TDJ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842"]}, "4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9VU", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "MR-20492": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DO1T", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Bifemelane": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D02CGY", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4128"]}, "MR-20496": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R4WW", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "MR-20494": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02LTV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "APC-366": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0N9WB", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "Torasemide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0J9XZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "[3H]BSP": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ADY", "drug_id_DB": "", "metabolic_annotation_str": "SLCO1A2(Sodium-independent organic anion transporter (SLCO1A2) ,MOA:Modulator); SLCO1B3(Liver organic anion transporter 2 (SLCO1B3) ,MOA:Modulator); SLCO1C1(Organic anion transporter F (SLCO1C1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLCO1A2", "SLCO1B3", "SLCO1C1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["6579", "28234", "53919"]}, "1-(9-Phenyl-9H-fluoren-9-yl)1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02SIT", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Trans-(1S(R),2S(R))-2-Hydroxycyclooctyl nitrate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L1AV", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "Pyridine and pyrimidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07UNH", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "7-Acetonyloxy-3,4-cyclohexene-8-methylcoumarin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FFH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "BF-389": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0L6VH", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "FA-70": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01UPT", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GYH", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "(5S,6R)-[Octahydro-quinolin-(2E)-ylidene]amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4YY", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "6-(4-Hydroxy-phenyl)-naphthalen-1-ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ESR1(Estrogen receptor (ESR) ,MOA:Inhibitor); ESR2(Estrogen receptor beta (ESR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0H8PI", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D06BAC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "PMID1992138C8b": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G2QW", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID7473541C20": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R8NC", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID7473541C21": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZD1B", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID7966163C6d": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZT0F", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID7966163C6g": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09IQG", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID7966163C6c": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03CUH", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID18412317C13b": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TIT", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "4-methoxyphenylsulfamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T8SN", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "4-(Cyclohexylamino)-1-naphthol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A7NH", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Orlistat(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01083", "metabolic_annotation_str": "LIPF(Gastric triacylglycerol lipase); PNLIP(Pancreatic triacylglycerol lipase); FASN(Fatty acid synthase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["LIPF", "PNLIP", "FASN"], "metabolic_genes_id": ["8513", "5406", "2194"]}, "(S)-tacrine(10)-hupyridone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4UO", "drug_id_DB": "DB04615", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "5-fluoro-6-iodo-UMP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DW2F", "drug_id_DB": "", "metabolic_annotation_str": "UMPS(Orotidine 5'-monophosphate decarboxylase (UMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7372"]}, "N-Benzyl-N-(1H-indol-2-ylmethyl)-N-methylamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ANK", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Phenethylboronic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ORV", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "1-(1-Biphenyl-4-yl-ethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08YCD", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "FR-152558": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0J4GQ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-[3-Methyl-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TM4K", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Rutin(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ALJ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07OMY", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Benzthiazide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00562", "metabolic_annotation_str": "CA12(Carbonic anhydrase 12); CA1(Carbonic anhydrase 1); CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); CA4(Carbonic anhydrase 4); CA4(Carbonic anhydrase 4); CA6(Carbonic anhydrase 6); CA5A(Carbonic anhydrase 5A, mitochondrial); CA7(Carbonic anhydrase 7); SLC12A3(Solute carrier family 12 member 3); CA9(Carbonic anhydrase 9); CA9(Carbonic anhydrase 9); CA13(Carbonic anhydrase 13); CA14(Carbonic anhydrase 14); CA5B(Carbonic anhydrase 5B, mitochondrial); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA12", "CA1", "CA1", "CA2", "CA2", "CA3", "CA4", "CA4", "CA6", "CA5A", "CA7", "SLC12A3", "CA9", "CA9", "CA13", "CA14", "CA5B"], "metabolic_genes_id": ["771", "759", "759", "760", "760", "761", "762", "762", "765", "763", "766", "6559", "768", "768", "377677", "23632", "11238"]}, "Nortriptyline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PGRMC1(Membrane-associated progesterone receptor component 1); ADRB2(Beta-2 adrenergic receptor); CHRM2(Muscarinic acetylcholine receptor M2); CHRM4(Muscarinic acetylcholine receptor M4); HTR1A(5-hydroxytryptamine receptor 1A); CHRM5(Muscarinic acetylcholine receptor M5); ADRA2A(Alpha-2A adrenergic receptor); CHRM1(Muscarinic acetylcholine receptor M1); ADRB3(Beta-3 adrenergic receptor); DRD2(D(2) dopamine receptor); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); CHRM3(Muscarinic acetylcholine receptor M3); ADRA1D(Alpha-1D adrenergic receptor); HTR2A(5-hydroxytryptamine receptor 2A); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); SIGMAR1(Sigma non-opioid intracellular receptor 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00540", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "Mefenamic acid(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05FTJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "1,1':4',1''-terphenyl-3,3''-diol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JOZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "3292"]}, "PAC-10649": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YK4L", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "N-methyl,N-(propargyl),N-(pyrrol-2-ylmethyl)amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03KDD", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Pegorgotein": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0N4SU", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "(N-(3-phenoxycinnamyl)-acetohydroxamic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UH6R", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-(methylamino)naphthalen-1-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G8IH", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "US9434727, 153": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04BAA", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "4-Methyl-1,1':4',1''-terphenyl-3,4''-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J8LU", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Istaroxime(TTD)": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06HIO", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1A3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1A2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1", "ATP1B1", "ATP1A3", "ATP1B2", "ATP1A2", "ATP1B3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["476", "481", "478", "482", "477", "483"]}, "US9493447, 1001": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EN2M", "drug_id_DB": "", "metabolic_annotation_str": "PDE8A(Phosphodiesterase 8 (PDE8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE8A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5151"]}, "DU-1777": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D05COG", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Amoxapine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09IOI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "Axokine": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D01OKS", "drug_id_DB": "", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "2-(1H-Imidazol-4-yl)benzene-1,3-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00BGN", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "QR-333": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0B4XX", "drug_id_DB": "DB05533", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Hexahydro naphthalene derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L3BE", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Hexahydro naphthalene derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05SOY", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "5-((1H-imidazol-1-yl)methyl)-7,8-dihydroquinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0QI", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-(pyridin-3-yl)prop-2-yn-1-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O1HH", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "2-(3,4-Dihydroxy-benzyl)-7-hydroxy-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A9NE", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "[14C]methylamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JS4B", "drug_id_DB": "", "metabolic_annotation_str": "RHAG(Ammonium transporter Rh type A (RHAG) ,MOA:Modulator); RHCG(Ammonium transporter Rh type C (RHCG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["RHAG", "RHCG"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6005", "51458"]}, "(R)-2-(4-Isobutyl-phenyl)-N-phenyl-propionamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4LW", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B4CV", "drug_id_DB": "DB08256", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "(S)-Methyl 4-(2-oxohexadecanamido)octanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K2PI", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "CACOSPONGIONOLIDE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02IVU", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "5320"]}, "(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HVL", "drug_id_DB": "DB02773", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Crocusatin-K": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04XED", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Protriptyline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00344", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "Avastin+/-Tarceva": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "VEGFA(Vascular endothelial growth factor A (VEGFA) ,MOA:Inhibitor); DUSP1(Dual specificity protein phosphatase 1 (DUSP1) ,MOA:Inhibitor); CDC25B(M-phase inducer phosphatase 2 (MPIP2) ,MOA:Inhibitor); PIN1(Rotamase Pin1 (PIN1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0C0NH", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "IDO1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "3620"]}, "N-(5-o-Tolyl-furan-2-carbonyl)-guanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08BDI", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "BENZOYLENUREA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06XVV", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "Flufenamic Acid": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved"], "non_metabolic": "AR(Androgen receptor (AR) ,MOA:Inhibitor); ", "drug_id_TTD": "D0B2WJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2", "AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743", "8644"]}, "N-(4-Sulfamoyl-phenyl)-benzamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KB6T", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "N-Formylmethionine(TTD)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "SERPINC1(Antithrombin-III (ATIII) ,MOA:Inhibitor); ", "drug_id_TTD": "D0GV9Q", "drug_id_DB": "", "metabolic_annotation_str": "MT-ND3(NADH dehydrogenase (MT-ND3) ,MOA:Inhibitor); GCLM(Glutamate--cysteine ligase modifier (GCLM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MT-ND3", "GCLM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4537", "2730"]}, "ICI-198583": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q0EB", "drug_id_DB": "", "metabolic_annotation_str": "TYMS(Thymidylate synthase (TYMS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7298"]}, "6-Chloro-N-(2-morpholinoethyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05GGH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Spermidine": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D08BXT", "drug_id_DB": "DB03566", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "S-tenatoprazole": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0N1PZ", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "1-Adamantan-1-yl-3-(3-hydroxy-phenyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01JJV", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "5-fluoro-6-amino-UMP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C7PT", "drug_id_DB": "", "metabolic_annotation_str": "UMPS(Orotidine 5'-monophosphate decarboxylase (UMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7372"]}, "(1-Amino-ethyl)-phosphinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06RLF", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "SKF-105809": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0Y4OI", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Modulator", "Modulator"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "2-oxo-N-p-tolyl-2H-chromene-3-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H0GZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "6,7-dichloro-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z8HX", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "FL-386": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05YLL", "drug_id_DB": "", "metabolic_annotation_str": "DPYD(Dihydrothymine dehydrogenase (DPYD) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DPYD"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1806"]}, "ABBV-3067": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0A1YF", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1080"]}, "Difluoromethylornithine": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Y1MW", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ARG2(Kidney-type arginase (ARG2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1", "ARG2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4953", "384"]}, "1,2-bis(3,5-difluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4MF", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "PMID2296036C2t": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05UQC", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Ad5CMV-NIS": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0G8DV", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A5(Sodium/iodide cotransporter (SLC5A5) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A5"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6528"]}, "4'-(p-Toluenesulfonamide)-4-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SE1R", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Zanapezil": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0AM8W", "drug_id_DB": "DB04859", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1-(4-(methylsulfonyl)phenyl)-1H-pyrrole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00TKO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "PGL-2": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0I3RN", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "3-acetyl-11-keto-beta-boswellic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02XEX", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); HSD11B2(Corticosteroid 11-beta-dehydrogenase 2 (HSD11B2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1", "HSD11B2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3290", "3291"]}, "(+/-)-2-(4-fluorophenyl)-7-methoxychroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1XZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "TEBUFELONE": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0P3KA", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "240", "240", "5742", "5743"]}, "MDL 101,731": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05HZI", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6241"]}, "13-(3-n-Pentylureido)tridec-8-ynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02CKF", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "1-(2-(2-fluorobenzyloxy)phenyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D07DWS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "1,2-Bis-(2-chloro-phenyl)-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03HZT", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "5-[5-Bromo-indan-(1E)-ylidenemethyl]-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E9WX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "6-((1H-imidazol-1-yl)methyl)-2H-chromene-2-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T2IX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "NSC-683634": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HR9S", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "ENIPORIDE": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0V9RU", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1", "SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6548", "6550", "6550"]}, "N-methyl estrone-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SGP", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Suprofen(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07BPS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "IncarviatoneA": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LZ2M", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Hexafluronium bromide": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Q2MH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "4-Phenylimidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J9DD", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Organon": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D07PNC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6536"]}, "2-Methyl-beta-carboline-2-ium iodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05XPL", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "ATLIPROFEN METHYL ESTER": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D03AKL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Butyrylthiocholine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08LNT", "drug_id_DB": "DB04250", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "(+/-)-2-(4'-Butoxyphenyl)thiomorpholine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3XC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "SULFAMIDE": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0V0UK", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762", "768"]}, "8-(3-Nitro-phenyl)-6-phenyl-[1,7]naphthyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02NKD", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142"]}, "2-(4-Butoxy-phenoxy)-N-hydroxy-N-methyl-acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T0CY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID29473428-Compound-48": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04VUH", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "7-hydroxycoumarin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "CCND1(G1/S-specific cyclin-D1 (CCND1) ,MOA:Inhibitor); ", "drug_id_TTD": "D02JEZ", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "PMID27841045-Compound-143": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z2IO", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "1,1,1,2,2,4-hexafluoro-7-phenylheptan-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZUX", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "PMID27841045-Compound-144": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AJ5T", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PMID27841045-Compound-145": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EZ5O", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "6-Fluoro-N-(2-morpholinoethyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04EDK", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "DG051": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06XEL", "drug_id_DB": "DB05177", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Ganoderic acid A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03NPA", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B2(Corticosteroid 11-beta-dehydrogenase 2 (HSD11B2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3291"]}, "Actoferrin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NZ3Q", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "9-(3-n-Pentylureido)non-4(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08XYV", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Nitroprusside(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00325", "metabolic_annotation_str": "NPR1(Atrial natriuretic peptide receptor 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["NPR1"], "metabolic_genes_id": ["4881"]}, "[1,3]Thiazinan-(2E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9II", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "2-N,N-Dimethylamino-1-(4-methylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00DDT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "6-[4-(Pyridin-4-ylmethyl)phenyl]naphthalen-2-ol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07VGT", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "2,5-Dimethoxy-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W7GU", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Imitrodast": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0K4UW", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "2-Thiazol-5-ylmethyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XQ8P", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "(R)-2-((4-phenoxyphenoxy)methyl)piperidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00FDS", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "(S)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01KZF", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C24": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04FJY", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "6-(3-Hydroxy-phenyl)-naphthalen-2-ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ESR1(Estrogen receptor (ESR) ,MOA:Inhibitor); ESR2(Estrogen receptor beta (ESR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0P8PK", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "HSD17B1", "TYR"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "3292", "7299"]}, "PMID25399762-Compound-Table1-C21": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S2LV", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C20": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UL2R", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C23": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0HR6P", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C22": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07GZU", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table 6-12": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D0E7SF", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table 6-13": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D06KBT", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table 6-10": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D0AI6J", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table 6-11": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D02WXS", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table 6-14": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D0PM2S", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table 6-15": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Q1EG", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "BIIB067": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0I1CQ", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6647"]}, "ETHOXYCLUSIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A1SJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "NORARISTEROMYCIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F5AJ", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "DIOSMETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RFY", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "NK3201": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H3SL", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "8alpha,19-dihydroxylabd-13 E-en-15-oic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8ZU", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "AEZS-126": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03FIE", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "C4-MAD": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03HDS", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "BCX-3408": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02ZKR", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "Deoxythymidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01GLG", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "[123I]iodobenzovesamicol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09AWB", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A3(Vesicular acetylcholine transporter (SLC18A3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6572"]}, "TAS-114": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Z6KF", "drug_id_DB": "", "metabolic_annotation_str": "DUT(dUTP pyrophosphatase (DUT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DUT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1854"]}, "Minodronate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00NPT", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "3-methoxyphenyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I5LV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Egonol compound 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D03DIQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Sertraline(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0K0TC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Deslanoside": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07TGN", "drug_id_DB": "DB01078", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["476"]}, "4-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D8GU", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "CL-5343": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VD7H", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "ISIS-SOD1": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D05BYO", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(SOD1 messenger RNA (SOD1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6647"]}, "2-Amino-1-(4-ethylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02VHZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "[3H]WIN35428": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N3DD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "4-amino-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B4GV", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "Naphthalene-2-carboxylic acid hydroxyamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04UJI", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-Benzyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04RQG", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Thieno[3,2-e][1]benzothiophene-4,5-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ZCX", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Recombinant human butyrylcholinesterase": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06HUH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["590"]}, "Trimethyl-(3-nitro-phenyl)-ammonium iodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M8SQ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3,5-dichlorosalicylic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06SPO", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "PMID18800762C11": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04TIS", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Sitimagene ceradenovec": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0W8RX", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7083"]}, "PMID18800762C14": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U9LD", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "PMID18800762C16": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08CSK", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "PMID18800762C19": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C9LF", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "3,3'-(3-Methylthiene-2,5-diyl]diphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P6JE", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Kaempferol-3-O-methyl ether": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0S6NP", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "TG100-115(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB05552", "metabolic_annotation_str": "PIK3CD(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform); PIK3CG(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PIK3CD", "PIK3CG"], "metabolic_genes_id": ["5293", "5294"]}, "TG100-115(TTD)": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0C3ZR", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "Brinzolamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01194", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); CA4(Carbonic anhydrase 4); CA5A(Carbonic anhydrase 5A, mitochondrial); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA1", "CA2", "CA3", "CA4", "CA5A"], "metabolic_genes_id": ["759", "760", "761", "762", "763"]}, "1-(1,2-diphenylethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01EIS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "[3-(3,4-Dichloro-phenyl)-indan-1-yl]-methyl-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06KNV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "4-((1H-imidazol-1-yl)methyl)benzonitrile": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HEA", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "1-Benzo[b]thiophen-2-yl-cyclopentylamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02EHL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ES6Z", "drug_id_DB": "DB08492", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "CFTRinh-172": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P3ZK", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Blocker (channel blocker)); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Blocker (channel blocker)"], "metabolic_genes_id": ["1080"]}, "(+/-)-7-methyl-2-p-tolylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z2XR", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "N-6060": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P5LX", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "SAR245409": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ", "drug_id_TTD": "D01PGR", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "Zwitterionic sulfobetaine derivative": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09KZQ", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "OXAMATE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LP2H", "drug_id_DB": "", "metabolic_annotation_str": "LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHB(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHC(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LDHA", "LDHA", "LDHB", "LDHC", "ABAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3939", "3939", "3945", "3948", "18"]}, "Seroxat": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06VML", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "PMID27841045-Compound-130": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04IGE", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Hydralazine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HIF1A(Hypoxia-inducible factor 1-alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB01275", "metabolic_annotation_str": "P4HA1(Prolyl 4-hydroxylase subunit alpha-1); AOC3(Membrane primary amine oxidase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["P4HA1", "AOC3"], "metabolic_genes_id": ["5033", "8639"]}, "Azetidinyl-piperidine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0VY7R", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "1-(4-bromophenyl)-3-hydroxyurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G6IO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "4-(2-(3-chlorophenoxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D00DEH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Azetidinyl-piperidine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05SWA", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "3-hydroxy-3-methyl-6-phosphohexanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08QCI", "drug_id_DB": "", "metabolic_annotation_str": "PMVK(Phosphomevalonate kinase (PMVK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PMVK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10654"]}, "Flavopiridol": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "CDK9(Cyclin-dependent kinase 9 (CDK9) ,MOA:Inhibitor); ", "drug_id_TTD": "D0LF1U", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Myophosphorylase (PYGM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Azetidinyl-piperidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00PFS", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Ibrolipim": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0SA3J", "drug_id_DB": "", "metabolic_annotation_str": "LPL(Lipoprotein lipase (LPL) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LPL"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4023"]}, "Pantoprazole(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0T6XX", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "2-phenylamino-9-(4-hydroxy-butyl)-6-oxopurine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4SQ", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "SERGLIFLOZIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03AJS", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6524"]}, "BS 9106": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0ZZ2L", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "1-aminobutylphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05EPO", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Threo-ritalinol hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O1WV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "BCEAB": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J3SW", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "WOGONIN": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00MXS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2", "XDH"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5743", "7498"]}, "8-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08XKO", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "PMID26815044-Compound-30": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0W6ZO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "N-Cyclohexyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GKY", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "B-Nonylglucoside": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "RHO(Rhodopsin (RHO) ,MOA:Inhibitor); ", "drug_id_TTD": "D0K1UI", "drug_id_DB": "", "metabolic_annotation_str": "PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNLIP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5406"]}, "(-)-DEBROMOFLUSTRAMINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00QLR", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "SECOCULARIDINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0RS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Metolazone": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01WLC", "drug_id_DB": "DB00524", "metabolic_annotation_str": "SLC12A3(Solute carrier family 12 member 3 (SLC12A3) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A3"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6559"]}, "Methylbenzenesulfonamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04VDD", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "16-(pyridin-2-yl)methyl-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WM4K", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Metal complex derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0VK1L", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Metal complex derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07CDS", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Metal complex derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08VQU", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "N,N'-(1',2'-ethylene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X9TF", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "CD-160130": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U4SS", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "P-tolylboronic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L8ZG", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "3-(2-propyn-1-yl)thymidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01CUJ", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "PMID12238936C3a": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ICD", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Propylhexedrine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TAAR1(Trace amine-associated receptor 1); ", "drug_id_TTD": "", "drug_id_DB": "DB06714", "metabolic_annotation_str": "SLC18A2(Synaptic vesicular amine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC18A2"], "metabolic_genes_id": ["6571"]}, "PMID12238936C3f": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3DY", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "SPN-812": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01BAU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "6-oxo-estrone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03BZT", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Immucillin-G": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A9WP", "drug_id_DB": "DB02230", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "Motexafin gadolinium(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB05428", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase subunit M2); TXNRD1(Thioredoxin reductase 1, cytoplasmic); TXNRD2(Thioredoxin reductase 2, mitochondrial); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["RRM2", "TXNRD1", "TXNRD2"], "metabolic_genes_id": ["6241", "7296", "10587"]}, "EXIGUAMINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08GZK", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4,7-dichloro-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EK7H", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "ISOLONGIFOLOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7YB", "drug_id_DB": "", "metabolic_annotation_str": "UGT2B7(UDP-glucuronosyltransferase 2B7 (UGT2B7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UGT2B7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7364"]}, "DIFLUOROBENZTROPINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CHRM1(Muscarinic acetylcholine receptor M1 (CHRM1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Y8UC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "3-[12-(benzylmethylamino)dodecyloxy]xanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8LK", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "NSC-94258": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01KKU", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "HSD17B1", "AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "3292", "231"]}, "N-Pyridoxyl-Glycine-5-Monophosphate(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09AHL", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05CCT", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-(1H-Imidazol-4-yl)benzenethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0EE", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2,4-Disulfamyltrifluoromethylaniline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M3PO", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "BGT226": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Modulator); ", "drug_id_TTD": "D0X7IN", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "indole-3-propionic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZYK", "drug_id_DB": "", "metabolic_annotation_str": "SLC36A1(Solute carrier family 36 member 1 (SLC36A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC36A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["206358"]}, "Iodotubercidin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S2FW", "drug_id_DB": "", "metabolic_annotation_str": "ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["132"]}, "Gliquidone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01251", "metabolic_annotation_str": "ABCC8(ATP-binding cassette sub-family C member 8); KCNJ8(ATP-sensitive inward rectifier potassium channel 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC8", "KCNJ8"], "metabolic_genes_id": ["6833", "3764"]}, "Beta-D-Glucose(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "NCAN(Neurocan core protein); SMARCA5(SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5); IFNB1(Interferon beta); MB(Myoglobin); LGALS2(Galectin-2); SFTPD(Pulmonary surfactant-associated protein D); LGALS7B(Galectin-7); LGALS7B(Galectin-7); LGALS7(Galectin-7); LGALS7B(Galectin-7); LGALS7(Galectin-7); LGALS7(Galectin-7); LGALS7B(Galectin-7); LGALS7(Galectin-7); KRTAP5-3(Keratin-associated protein 5-3); KRTAP5-3(Keratin-associated protein 5-3); KRTAP5-3(Keratin-associated protein 5-3); LCTL(Lactase-like protein); KRTAP5-2(Keratin-associated protein 5-2); KRTAP5-2(Keratin-associated protein 5-2); KRTAP5-2(Keratin-associated protein 5-2); NUDT9(ADP-ribose pyrophosphatase, mitochondrial); SIGLEC1(Sialoadhesin); ", "drug_id_TTD": "", "drug_id_DB": "DB02379", "metabolic_annotation_str": "AMY1B(Alpha-amylase 1); AMY1A(Alpha-amylase 1); AMY1C(Alpha-amylase 1); AMY2A(Pancreatic alpha-amylase); PYGM(Glycogen phosphorylase, muscle form); HK1(Hexokinase-1); AMY2B(Alpha-amylase 2B); PTGS1(Prostaglandin G/H synthase 1); GCK(Glucokinase); GNPDA1(Glucosamine-6-phosphate isomerase 1); GLT6D1(Glycosyltransferase 6 domain-containing protein 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["AMY1B", "AMY1A", "AMY1C", "AMY2A", "PYGM", "HK1", "AMY2B", "PTGS1", "GCK", "GNPDA1", "GLT6D1"], "metabolic_genes_id": ["277", "276", "278", "279", "5837", "3098", "280", "5742", "2645", "10007", "360203"]}, "KURAIDIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GUJ", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A", "SLC5A1", "PDE4A", "SLC5A2", "PDE4B", "PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8654", "6523", "5141", "6524", "5142", "5139"]}, "(+/-)-threo-N-(4-Chlorobenzyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U5DH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Pseudopalmatine trifluoroacetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L8UL", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Benzylcinnamate": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XV2A", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID26666989-Compound-Figure9toprightR02": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0W5DU", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "(8-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GTX", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "1-(2,3-Dihydro-1H-indol-5-ylmethyl)-propylamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GFV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "ISOSAKUTANETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01FJE", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "Ethyl Bis(4-hydroxy-2-oxo-2H-chromen-3-yl)acetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ONP", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "1-(2-(3-fluorophenoxy)phenyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0N2RJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "6-fluoromevalonate 5-diphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U7OO", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "Oxypurinol": {"drug_status_TTD": ["Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D08FWK", "drug_id_DB": "DB05262", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Double Oxidized Cysteine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PTPN1(PTPN1 messenger RNA (PTPN1 mRNA) ,MOA:Inhibitor); CDK2(Cyclin-dependent kinase 2 (CDK2) ,MOA:Inhibitor); CDC25B(M-phase inducer phosphatase 2 (MPIP2) ,MOA:Inhibitor); PREP(Prolyl endopeptidase (PREP) ,MOA:Inhibitor); CRYBB1(Beta-crystallin B1 (CRYBB1) ,MOA:Inhibitor); GANAB(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0H1GU", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); GAA(Alpha-glucosidase (GLA) ,MOA:Inhibitor); GANC(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM", "GAA", "GANC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972", "2548", "2595"]}, "7,3',4'-trihydroxyisoflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J5DN", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "2-Adamantan-1-yl-N-decyl-acetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U6TM", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "PMID18078750C1b": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Inhibitor); ", "drug_id_TTD": "D0N4RO", "drug_id_DB": "", "metabolic_annotation_str": "CPA1(Carboxypeptidase A1 (CPA1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CPA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1357"]}, "1-[(cyclohexylamino)ethyl]-1,1-bisphosphonicacid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B2YN", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "(+/-)-threo-N-(4-Methoxybenzyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09OOO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-Hydroxycinnamic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05WQF", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "4-[4-(6-methoxynaphthalen-2-yl)benzyl]pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05PKT", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "2,2',4,4'-tetrahydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BH2T", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "CS-W011402": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0W5OE", "drug_id_DB": "", "metabolic_annotation_str": "PDE4C(Phosphodiesterase 4C (PDE4C) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4C"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5143"]}, "(2-Chloro-ethyl)-trimethyl-ammonium chloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J3EU", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "METYRAPOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WW4F", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "1-(3,4-dihydroxy-2-nitrophenyl)-2-phenylethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C0OT", "drug_id_DB": "", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "PMID7966163C4e": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06MMN", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Benoxaprofen": {"drug_status_TTD": ["Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D00CCI", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "N,N'-(1',6-hexylene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7UG", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Aryl 1,2-diamine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03CYB", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(E)-2-(4-(methylsulfonyl)styryl)thiophene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08HRA", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Acetic acid 2-phenyl-5-propyl-thiazol-4-yl ester": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C1XI", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Biphenyl derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L4GL", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "6-Thiophen-3-yl-imidazo[2,1-b]thiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07FRX", "drug_id_DB": "", "metabolic_annotation_str": "MT-ND3(NADH dehydrogenase (MT-ND3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MT-ND3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4537"]}, "RDX-5791": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05GBV", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Modulator); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6550", "6550"]}, "Epacadostat": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0PM5U", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "1,3-Di(berberine-9-O-yl)ethane dibromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P5BT", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "2-amino-2,3-dihydro-1H-indene-5-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CYN", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "23632"]}, "[Au(CN)2]-": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CM3O", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["759"]}, "LANIQUIDAR": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0A5MI", "drug_id_DB": "", "metabolic_annotation_str": "ABCB4(Multidrug resistance protein 3 (ABCB4) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5244"]}, "3-Amino-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q6XB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1-Cyclopentylidenethiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TS8S", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "RTI-336": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D04KWY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6531", "6531"]}, "2-(N-Cyclopentylamino)-3'-fluoropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09XWL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "1-adamantan-1-yl-3-(1-butyl-piperidin-4-yl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D3GF", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "N-benzyl,N-methyl-1H-pyrrole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C8RD", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "2-HYDROXY-3,5-DIIODOBENZOIC ACID(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "EDNRA(Endothelin-1 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB04674", "metabolic_annotation_str": "AKR1C1(Aldo-keto reductase family 1 member C1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["AKR1C1"], "metabolic_genes_id": ["1645"]}, "Rofecoxib": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05VLS", "drug_id_DB": "DB00533", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "R-sibutramine metabolite": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0B2OC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6530", "6532"]}, "2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07YZD", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "4-(2-(4-fluorophenoxy)-4-methylphenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06UDU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "GSK1614235": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D09GLS", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6523"]}, "Azole benzene derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J3ZM", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Azole benzene derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06XJG", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "6-Hydroxy-N-(2-morpholinoethyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D0SC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "MLN-977": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0P1TZ", "drug_id_DB": "DB05431", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Azole benzene derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XY7C", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "TOLSERINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PF7F", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Ethanol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HTR3E(5-hydroxytryptamine receptor 3E); GABRP(Gamma-aminobutyric acid receptor subunit pi); GABRD(Gamma-aminobutyric acid receptor subunit delta); HTR3B(5-hydroxytryptamine receptor 3B); GABRA1(Gamma-aminobutyric acid receptor subunit alpha-1); CHRNB2(Neuronal acetylcholine receptor subunit beta-2); GABRB1(Gamma-aminobutyric acid receptor subunit beta-1); VCAM1(Vascular cell adhesion protein 1); GLRA1(Glycine receptor subunit alpha-1); GLRA2(Glycine receptor subunit alpha-2); GABRB3(Gamma-aminobutyric acid receptor subunit beta-3); CHRNA5(Neuronal acetylcholine receptor subunit alpha-5); CHRNB4(Neuronal acetylcholine receptor subunit beta-4); GABRA5(Gamma-aminobutyric acid receptor subunit alpha-5); L1CAM(Neural cell adhesion molecule L1); CHRNA3(Neuronal acetylcholine receptor subunit alpha-3); GABRA3(Gamma-aminobutyric acid receptor subunit alpha-3); CHRNA7(Neuronal acetylcholine receptor subunit alpha-7); GRIA1(Glutamate receptor 1); GRIA2(Glutamate receptor 2); GRIA3(Glutamate receptor 3); CHRNA4(Neuronal acetylcholine receptor subunit alpha-4); HTR3A(5-hydroxytryptamine receptor 3A); GABRA2(Gamma-aminobutyric acid receptor subunit alpha-2); GABRB2(Gamma-aminobutyric acid receptor subunit beta-2); KCNJ6(G protein-activated inward rectifier potassium channel 2); GRIA4(Glutamate receptor 4); GABRA4(Gamma-aminobutyric acid receptor subunit alpha-4); KCNJ5(G protein-activated inward rectifier potassium channel 4); KCNJ3(G protein-activated inward rectifier potassium channel 1); GABRE(Gamma-aminobutyric acid receptor subunit epsilon); CACNA1D(Voltage-dependent L-type calcium channel subunit alpha-1D); CACNB1(Voltage-dependent L-type calcium channel subunit beta-1); CHRNB3(Neuronal acetylcholine receptor subunit beta-3); CACNG1(Voltage-dependent calcium channel gamma-1 subunit); CACNA1S(Voltage-dependent L-type calcium channel subunit alpha-1S); CHRNA2(Neuronal acetylcholine receptor subunit alpha-2); CHRNA6(Neuronal acetylcholine receptor subunit alpha-6); GABRA6(Gamma-aminobutyric acid receptor subunit alpha-6); HTR3D(5-hydroxytryptamine receptor 3D); GABRG1(Gamma-aminobutyric acid receptor subunit gamma-1); GRIN3A(Glutamate receptor ionotropic, NMDA 3A); HTR3C(5-hydroxytryptamine receptor 3C); KCNJ9(G protein-activated inward rectifier potassium channel 3); GABRG3(Gamma-aminobutyric acid receptor subunit gamma-3); CHRNA10(Neuronal acetylcholine receptor subunit alpha-10); CHRNA9(Neuronal acetylcholine receptor subunit alpha-9); CACNG2(Voltage-dependent calcium channel gamma-2 subunit); ", "drug_id_TTD": "", "drug_id_DB": "DB00898", "metabolic_annotation_str": "SLC29A2(Equilibrative nucleoside transporter 2); SLC29A1(Equilibrative nucleoside transporter 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["SLC29A2", "SLC29A1"], "metabolic_genes_id": ["3177", "2030"]}, "3-Bromo-5-phenylsalicylc acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00DDO", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "M-tolyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FQW", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "3-Benzyl-4-hydroxy-2H-benzo[h]chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03CDH", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "MR-16089": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08IIW", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Miltefosine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00FGR", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "Methoxyestradiol": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D9NZ", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6647"]}, "2-(hexylthiomethyl)-5-hydroxy-4H-pyran-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09SIW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID27172114-Compound-49": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X5OC", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "3-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AZK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "PMID27172114-Compound-47": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06EDH", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Cis-3-phenoxy-2,3-dihydro-1H-inden-1-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B5AG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "MF268": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D06ZAM", "drug_id_DB": "DB04021", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PUUPEHEDIONE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05FJM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "246", "239"]}, "1,4-Dithiothreitol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "AXIN1(Axin-1); LGALS1(Galectin-1); PPIB(Peptidyl-prolyl cis-trans isomerase B); TRPM7(Transient receptor potential cation channel subfamily M member 7); MSRA(Mitochondrial peptide methionine sulfoxide reductase); MSRA(Mitochondrial peptide methionine sulfoxide reductase); CAMK2A(Calcium/calmodulin-dependent protein kinase type II subunit alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB04447", "metabolic_annotation_str": "ALDH1A1(Retinal dehydrogenase 1); HMGCR(3-hydroxy-3-methylglutaryl-coenzyme A reductase); TPI1(Triosephosphate isomerase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ALDH1A1", "HMGCR", "TPI1"], "metabolic_genes_id": ["216", "3156", "7167"]}, "LXR-015-2": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0LR2Q", "drug_id_DB": "", "metabolic_annotation_str": "CRAT(Carnitine acyltransferase (CRAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CRAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1384"]}, "Sulfamic acid 3-(4-hydroxy-benzoyl)-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S5BA", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "Pyridostigmine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ALB(Serum albumin); ", "drug_id_TTD": "", "drug_id_DB": "DB00545", "metabolic_annotation_str": "BCHE(Cholinesterase); ACHE(Acetylcholinesterase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_genes_id": ["590", "43"]}, "Ranitidine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HRH2(Histamine H2 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00863", "metabolic_annotation_str": "ACHE(Acetylcholinesterase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ACHE"], "metabolic_genes_id": ["43"]}, "2-Phenyl-4-[1,2,4]triazol-1-yl-chroman-7-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O0BL", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "ISIS 140148": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I2SY", "drug_id_DB": "", "metabolic_annotation_str": "SOAT2(SOAT2 messenger RNA (SOAT2 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOAT2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["8435"]}, "Azelastine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HRH2(Histamine H2 receptor); HRH1(Histamine H1 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00972", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2); LTC4S(Leukotriene C4 synthase); LTC4S(Leukotriene C4 synthase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PLA2G1B", "LTC4S", "LTC4S"], "metabolic_genes_id": ["5319", "4056", "4056"]}, "9-O-[3-(Phenylamino)propyl]-berberine bromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00NIX", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05RSP", "drug_id_DB": "DB04779", "metabolic_annotation_str": "LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LCT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3938"]}, "Alpha-acarviosinyl-(1-->9)-3-alpha-D-glucopyranosylpropen": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09WFG", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["279"]}, "BSO": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K8LM", "drug_id_DB": "", "metabolic_annotation_str": "GCLM(Glutamate--cysteine ligase modifier (GCLM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCLM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2730"]}, "Pralatrexate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB06813", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase); TYMS(Thymidylate synthase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["DHFR", "TYMS"], "metabolic_genes_id": ["1719", "7298"]}, "[3H]L-aspartic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BKX", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A7(Excitatory amino acid transporter 5 (SLC1A7) ,MOA:Modulator); SLC1A3(Excitatory amino acid transporter 1 (SLC1A3) ,MOA:Modulator); SLC1A2(Excitatory amino acid transporter 2 (SLC1A2) ,MOA:Modulator); SLC1A1(Excitatory amino acid transporter 3 (SLC1A1) ,MOA:Modulator); SLC1A6(Excitatory amino acid transporter 4 (SLC1A6) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A7", "SLC1A3", "SLC1A2", "SLC1A1", "SLC1A6"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["6512", "6507", "6506", "6505", "6511"]}, "Cerulenin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03ZFG", "drug_id_DB": "DB01034", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "1-(2-(2-ethylphenyl)-1-phenylethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EO5P", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "NSC-26699": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2JV", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "Alpha-D-Mannose": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "SERPINC1(Antithrombin-III (ATIII) ,MOA:Inhibitor); LDLR(Low-density lipoprotein receptor (LDL-R) ,MOA:Inhibitor); CGA(Glycoprotein hormones alpha (CGA) ,MOA:Inhibitor); APOH(Beta-2-glycoprotein 1 (APOH) ,MOA:Inhibitor); LTF(Lactotransferrin (LTF) ,MOA:Inhibitor); SERPIND1(Heparin cofactor II (SERPIND1) ,MOA:Inhibitor); CD2(T-cell surface antigen CD2 (CD2) ,MOA:Inhibitor); CTSD(Cathepsin D (CTSD) ,MOA:Inhibitor); IGF1R(Insulin-like growth factor I receptor (IGF1R) ,MOA:Inhibitor); RHO(Rhodopsin (RHO) ,MOA:Inhibitor); IL6R(Interleukin 6 receptor (IL6R) ,MOA:Inhibitor); CTLA4(Cytotoxic T-lymphocyte protein 4 (CTLA-4) ,MOA:Inhibitor); DNASE1(Deoxyribonuclease I (DNASE1) ,MOA:Inhibitor); DPP4(Dipeptidyl peptidase 4 (DPP-4) ,MOA:Inhibitor); FCER1G(Immunoglobulin epsilon Fc receptor gamma (FCERG) ,MOA:Inhibitor); IL6ST(Interleukin 6 receptor (IL6R) ,MOA:Inhibitor); ADAM33(ADAM metallopeptidase 33 (ADAM33) ,MOA:Inhibitor); RTN4R(Reticulon-4 receptor (RTN4R) ,MOA:Inhibitor); CD209(Membrane-associated lectin type-C (CD209) ,MOA:Inhibitor); ", "drug_id_TTD": "D07LUR", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); GLA(Alpha-galactosidase A (GLA) ,MOA:Inhibitor); LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "BCHE", "GLA", "LCT", "CES1", "CES1", "PTGS1", "NOS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "590", "2717", "3938", "1066", "1066", "5742", "4842"]}, "Isosorbide-2-(butylcarbamate)-5-benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y5KN", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "2-(butylthiomethyl)-5-hydroxy-4H-pyran-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZAV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(S)-2-amino-1-(4-butylthiophenyl)-propane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z0ZU", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-6547": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ZXT", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "HBR-985": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1XJ", "drug_id_DB": "", "metabolic_annotation_str": "ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC8"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6833"]}, "2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06IEN", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA", "ACE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2629", "2629", "1636", "43"]}, "O-methyldauricine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UV1S", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Bip-tyr-thr-pro-lys-thr": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00NEE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "3-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AY4E", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Chimeric natriuretic peptide": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D036P7", "drug_id_DB": "", "metabolic_annotation_str": "NPR2(Atrial natriuretic peptide receptor B (NPR2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NPR2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4882"]}, "OLEIC ACID": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4EA", "drug_id_DB": "", "metabolic_annotation_str": "FABP1(Fatty acid-binding protein 1 (FABP1) ,MOA:Inhibitor); FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP1", "FABP4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2168", "2167"]}, "SODIUM PERFLUOROHEXANESULFONAMIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4ZW", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "DFMO": {"drug_status_TTD": ["Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D05UOW", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "5-(4-Chloro-phenyl)-1-methyl-piperidin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JH9F", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "7-[1,2,4]Triazol-4-ylmethyl-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L9BT", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Nicotinamide-Adenine-Dinucleotide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "DHPS(Deoxyhypusine synthase (DHPS) ,MOA:Inhibitor); GANAB(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0R6JE", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); GSR(Glutathione reductase (GR) ,MOA:Inhibitor); HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ALDH2(Mitochondrial aldehyde dehydrogenase (ALDH2) ,MOA:Inhibitor); LDHB(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHC(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); GAA(Alpha-glucosidase (GLA) ,MOA:Inhibitor); IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); HSD17B4(Estradiol 17 beta-dehydrogenase 4 (HSD17B4) ,MOA:Inhibitor); BLVRA(Biliverdin reductase A (BLVRA) ,MOA:Inhibitor); SORD(Sorbitoldehydrogenase (SORD) ,MOA:Inhibitor); GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); GANC(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM", "LDHA", "LDHA", "GSR", "HMGCR", "ALDH2", "LDHB", "LDHC", "GAA", "IMPDH2", "HSD17B1", "AHCY", "HSD17B4", "BLVRA", "SORD", "GALE", "GANC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972", "3939", "3939", "2936", "3156", "217", "3945", "3948", "2548", "3615", "3292", "191", "3295", "644", "6652", "2582", "2595"]}, "6-Chloro-N-(3-morpholinopropyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04SJC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Escitalopram(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HTR1A(5-hydroxytryptamine receptor 1A); ADRA2A(Alpha-2A adrenergic receptor); CHRM1(Muscarinic acetylcholine receptor M1); DRD2(D(2) dopamine receptor); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); ADRA1D(Alpha-1D adrenergic receptor); HTR2A(5-hydroxytryptamine receptor 2A); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01175", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-Methoxyestradiol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HIF1A(Hypoxia-inducible factor 1-alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB02342", "metabolic_annotation_str": "CYP1A1(Cytochrome P450 1A1); CYP19A1(Aromatase); COMT(Catechol O-methyltransferase); CYP1B1(Cytochrome P450 1B1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CYP1A1", "CYP19A1", "COMT", "CYP1B1"], "metabolic_genes_id": ["1543", "1588", "1312", "1545"]}, "ADV-1002401": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D05LOV", "drug_id_DB": "", "metabolic_annotation_str": "GCK(Glucokinase (GCK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2645"]}, "TINGENIN B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BU5K", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "(+/-)-2-Phenylthiomorpholine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HU4J", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "6-bromo-1-methyl-3-(pyridin-4-yl)-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05AJZ", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "ML-3403": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "MAPK12(MAP kinase p38 (MAPK12) ,MOA:Inhibitor); MAPK11(Stress-activated protein kinase 2b (p38 beta) ,MOA:Inhibitor); MAPK14(Stress-activated protein kinase 2a (p38 alpha) ,MOA:Inhibitor); ", "drug_id_TTD": "D0W4FF", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "PMID25470667-Compound-roselipins": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z4RS", "drug_id_DB": "", "metabolic_annotation_str": "DGAT2(Diacylglycerol O-acyltransferase 2 (DGAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["84649"]}, "alphabeta-methyleneADP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9GJ", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "Bicyclic pyrimidine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N8BA", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7941"]}, "Urea and carbamate bioisostere derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09HTY", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "9-amino-7H-dibenzo[de,h]quinolin-7-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N9DB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Sanguinarine": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0T3NB", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1B1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1A3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1B2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1A2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ATP1B3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1", "ATP1B1", "ATP1A3", "ATP1B2", "ATP1A2", "ATP1B3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["476", "481", "478", "482", "477", "483"]}, "Probenecid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PANX1(Pannexin-1); TAS2R16(Taste receptor type 2 member 16); ", "drug_id_TTD": "", "drug_id_DB": "DB01032", "metabolic_annotation_str": "SLC22A6(Solute carrier family 22 member 6); SLC22A8(Solute carrier family 22 member 8); SLC22A11(Solute carrier family 22 member 11); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC22A6", "SLC22A8", "SLC22A11"], "metabolic_genes_id": ["9356", "9376", "55867"]}, "SORAPRAZAN": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Q0YN", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "Amitriptyline": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y5UG", "drug_id_DB": "DB00321", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "4-bromo-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D4US", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "AC1MOZOL": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0A0ZU", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "Repaglinide(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0N5YA", "drug_id_DB": "", "metabolic_annotation_str": "ABCC9(ATP-binding cassette transporter C9 (ABCC9) ,MOA:Blocker); ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC9", "ABCC8"], "metabolic_mechanism_of_action": ["Blocker", "Blocker"], "metabolic_genes_id": ["10060", "6833"]}, "2-(5-Bromo-indole-1-sulfonyl)-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H2UM", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "NSC-106080": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "NQO2(Quinone reductase 2 (NQO2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0J3RB", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "1954U89": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D05HCO", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1719"]}, "9-O-[3-(Phenylol-1-yloxy)propyl]berberine bromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W7XL", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "IMRECOXIB": {"drug_status_TTD": ["Phase 4", "Phase 4"], "non_metabolic": "", "drug_id_TTD": "D0AL8M", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "N-(pyridin-3-ylmethyl) estradiol-16-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06AYL", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Isosorbide-2-(methylcarbamate)-5-benzoate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K8BT", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Cynooxide anion": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T6VB", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["759"]}, "2-(N-Pyrrolidinyl)-3'-methylpropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GY8R", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "5-Hydroxymethyl-Chonduritol(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P8YV", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["279"]}, "methylglyoxal": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G4CI", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "S,S-(2-Hydroxyethyl)Thiocysteine(TTD)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "SERPINB5(Maspin (SERPINB5) ,MOA:Inhibitor); ", "drug_id_TTD": "D0P7JE", "drug_id_DB": "", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["210", "5142"]}, "Vanoxerine": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0N2HF", "drug_id_DB": "DB03701", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Blocker); SLC6A3(Dopamine transporter (DAT) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Blocker", "Blocker"], "metabolic_genes_id": ["6531", "6531"]}, "1,2,3,4-Tetrahydro-naphthalen-1-ylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UF1R", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "N-(4-Ethylphenyl)-2-oxo-2H-chromene-3-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1WD", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Eicosapentaenoic acid/docosa-hexaenoic acid": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0Q5XX", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "N-Hydroxy-N-methyl-3-phenanthren-3-yl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E1NK", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-Hydroxybenzylalcohol": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X7BT", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "2-chloro-6(methylamino)purine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D9OC", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "3-(4-Amino-phenyl)-3-pentyl-piperidine-2,6-dione": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2GB", "drug_id_DB": "", "metabolic_annotation_str": "CYP11A1(Cholesterol desmolase (CYP11A1) ,MOA:Inhibitor); CYP11A1(Cholesterol desmolase (CYP11A1) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11A1", "CYP11A1", "CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1583", "1583", "1588"]}, "PFK-158": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0W0VR", "drug_id_DB": "", "metabolic_annotation_str": "PFKFB3(Renal carcinoma antigen NY-REN-56 (PFKFB3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PFKFB3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5209"]}, "4-aminobenzoic acid hydrazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05OZR", "drug_id_DB": "", "metabolic_annotation_str": "MPO(Myeloperoxidase (MPO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MPO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4353"]}, "Dyphylline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ADORA2A(Adenosine receptor A2a); ADORA1(Adenosine receptor A1); ", "drug_id_TTD": "", "drug_id_DB": "DB00651", "metabolic_annotation_str": "PDE4A(cAMP-specific 3',5'-cyclic phosphodiesterase 4A); PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); PDE4C(cAMP-specific 3',5'-cyclic phosphodiesterase 4C); PDE4D(cAMP-specific 3',5'-cyclic phosphodiesterase 4D); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4C", "PDE4D"], "metabolic_genes_id": ["5141", "5142", "5143", "5144"]}, "1-adamantan-1-yl-3-piperidin-4-yl-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J5KK", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "7-hydroxy-2-phenylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ZPO", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "4r-Fluoro-N6-Ethanimidoyl-L-Lysine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JZ3S", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "PMID24809814C31": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S5OU", "drug_id_DB": "", "metabolic_annotation_str": "SGPL1(Sphingosine-1-phosphate lyase 1 (SGPL1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SGPL1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8879"]}, "Imidazole derivative 10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00NVU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "PF-3557156": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0PZ4Y", "drug_id_DB": "", "metabolic_annotation_str": "PDE7A(Phosphodiesterase 7A (PDE7A) ,MOA:Modulator); PDE7B(Phosphodiesterase 7B (PDE7B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE7A", "PDE7B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5150", "27115"]}, "PMID27109571-Compound-24": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0SK0L", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "N-n-pentyl-7-methoxytacrine hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05UJV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "PMID29757691-Compound-2a": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0H3YG", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "PMID1656041C11dd": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FRE", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "HALOPEMIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07RPV", "drug_id_DB": "", "metabolic_annotation_str": "PLD1(Phospholipase D1 (PLD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5337"]}, "Taurocholic Acid": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D09NTG", "drug_id_DB": "", "metabolic_annotation_str": "CEL(Bile-salt-activated lipase (CEL) ,MOA:Inhibitor); SLC10A2(Ileal sodium/bile acid cotransporter (SLC10A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CEL", "SLC10A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Modulator"], "metabolic_genes_id": ["1056", "6555"]}, "Decoyinine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L9WG", "drug_id_DB": "", "metabolic_annotation_str": "GMPS(Glutamine amidotransferase (GMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8833"]}, "4-fluoro-N-(4-(methylsulfonyl)phenyl)aniline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JQ3X", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Paroxetine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06GDY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "Acetate Ion": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CALM1(Calmodulin (CALM) ,MOA:Inhibitor); CALM2(Calmodulin (CALM) ,MOA:Inhibitor); CALM3(Calmodulin (CALM) ,MOA:Inhibitor); TXN(Thioredoxin (TXN) ,MOA:Inhibitor); PTPN1(PTPN1 messenger RNA (PTPN1 mRNA) ,MOA:Inhibitor); MMP12(Matrix metalloproteinase-12 (MMP-12) ,MOA:Inhibitor); ESR2(Estrogen receptor beta (ESR2) ,MOA:Inhibitor); CELA1(Pancreatic elastase 1 (CELA1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0F2ME", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1", "CA2", "PLA2G1B", "LTA4H", "ACE", "NOS3", "NOS1", "AKR1C3", "ABAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6647", "760", "5319", "4048", "1636", "4846", "4842", "8644", "18"]}, "GSK568859": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0CA3J", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7941"]}, "HL-004": {"drug_status_TTD": ["Preclinical", "Preclinical"], "non_metabolic": "", "drug_id_TTD": "D09MJO", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "RG1577": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02PSS", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "Dichlorphenamide": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0J4GO", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Modulator); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Modulator", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "2-benzyl-N1-hydroxy-N3-(3-phenylpropyl)malonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YA8C", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "VOROZOLE": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D3PF", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "7-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NI4Z", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "6-Phosphogluconic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E4AN", "drug_id_DB": "", "metabolic_annotation_str": "PGD(Phosphogluconate dehydrogenase (PGD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PGD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5226"]}, "4-amino-6-chlorobenzene-1,3-disulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z1HY", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA6", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "765", "768"]}, "MEMOQUIN": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01KVT", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "1-(3,4-dichlorophenyl)-3-aza-bicyclo[3.1.0]hexane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D06IIF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "4-(3-Methoxy-phenyl)-isoxazolidine-3,5-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ZZX", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "KD-7332": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4DU", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "4-Hydroxy-4-phenyl-butyric acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XKM", "drug_id_DB": "", "metabolic_annotation_str": "SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC52A2", "SLC52A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["79581", "79581"]}, "3-[7-Methoxy-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YS2F", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "Telotristat ethyl": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0RE6T", "drug_id_DB": "DB12095", "metabolic_annotation_str": "TPH1(Tryptophan hydroxylase (TPH) ,MOA:Modulator); TPH2(Tryptophan hydroxylase (TPH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TPH1", "TPH2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["7166", "121278"]}, "7-fluoro-2-(4-methoxyphenyl)-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W7XK", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "LEMINOPRAZOLE": {"drug_status_TTD": ["Discontinued in Preregistration", "Discontinued in Preregistration", "Discontinued in Preregistration"], "non_metabolic": "", "drug_id_TTD": "D0QZ4S", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "4-[2-(2-Thienyl)acetamido]benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W9VC", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "GP515": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D07OAC", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "ADK"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "132"]}, "CLEBOPRIDE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "DRD2(Dopamine D2 receptor (D2R) ,MOA:Inhibitor); ", "drug_id_TTD": "D0A2BE", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Bis-cyclosal-d4TMP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EI5V", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "(R)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08PZX", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "3-(4-Amino-phenyl)-3-propyl-piperidine-2,6-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AM2Z", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "ALBANOL A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01OQW", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "4-methoxyphenyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01FNH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "IODOINDOMETHACIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HSZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "4-(4'-N-Methylphenyl)diazenylbenzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RDE", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "768"]}, "Cyclopropane 1-carboxylic acid derivative 8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0O9IS", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Managlinat dialanetil(TTD)": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0G2ZL", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Modulator); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8789", "2203"]}, "Selegiline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01037", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); MAOB(Amine oxidase [flavin-containing] B); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_genes_id": ["4128", "4129"]}, "Cyclopropane 1-carboxylic acid derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0BU9N", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "GTP-004": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D01KDM", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Cyclopropane 1-carboxylic acid derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0JZ9L", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Cyclopropane 1-carboxylic acid derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UJ8Z", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Cyclopropane 1-carboxylic acid derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04BYB", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Cyclopropane 1-carboxylic acid derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0O8MJ", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Spironolactone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CACNB4(Voltage-dependent L-type calcium channel subunit beta-4); CACNA1A(Voltage-dependent P/Q-type calcium channel subunit alpha-1A); CACNA1G(Voltage-dependent T-type calcium channel subunit alpha-1G); CACNG3(Voltage-dependent calcium channel gamma-3 subunit); CACNA1F(Voltage-dependent L-type calcium channel subunit alpha-1F); CACNA1H(Voltage-dependent T-type calcium channel subunit alpha-1H); NR3C1(Glucocorticoid receptor); SHBG(Sex hormone-binding globulin); PGR(Progesterone receptor); NR3C2(Mineralocorticoid receptor); AR(Androgen receptor); CACNB3(Voltage-dependent L-type calcium channel subunit beta-3); CACNA2D1(Voltage-dependent calcium channel subunit alpha-2/delta-1); CACNG7(Voltage-dependent calcium channel gamma-7 subunit); CACNA1B(Voltage-dependent N-type calcium channel subunit alpha-1B); CACNA1D(Voltage-dependent L-type calcium channel subunit alpha-1D); CACNB1(Voltage-dependent L-type calcium channel subunit beta-1); CACNG1(Voltage-dependent calcium channel gamma-1 subunit); CACNB2(Voltage-dependent L-type calcium channel subunit beta-2); CACNA1S(Voltage-dependent L-type calcium channel subunit alpha-1S); CACNA1E(Voltage-dependent R-type calcium channel subunit alpha-1E); CACNA2D4(Voltage-dependent calcium channel subunit alpha-2/delta-4); CACNA2D4(Voltage-dependent calcium channel subunit alpha-2/delta-4); CACNA2D3(Voltage-dependent calcium channel subunit alpha-2/delta-3); CACNG6(Voltage-dependent calcium channel gamma-6 subunit); CACNA2D2(Voltage-dependent calcium channel subunit alpha-2/delta-2); CACNA1I(Voltage-dependent T-type calcium channel subunit alpha-1I); CACNG4(Voltage-dependent calcium channel gamma-4 subunit); CACNG5(Voltage-dependent calcium channel gamma-5 subunit); CACNG2(Voltage-dependent calcium channel gamma-2 subunit); ", "drug_id_TTD": "", "drug_id_DB": "DB00421", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-hydroxylase/17,20 lyase); SRD5A1(3-oxo-5-alpha-steroid 4-dehydrogenase 1); CYP11B2(Cytochrome P450 11B2, mitochondrial); SRD5A3(Polyprenol reductase); ", "drug_status_DB": ".", "metabolic_genes_name": ["CYP17A1", "SRD5A1", "CYP11B2", "SRD5A3"], "metabolic_genes_id": ["1586", "6715", "1585", "79644"]}, "BMY-21950": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04NCJ", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2,4,5-Triarylimidazole analogue": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08IRN", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PWT-33597": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Modulator); ", "drug_id_TTD": "D0Y0FE", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5290"]}, "2-Amino-1-(4-ethylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02JVG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Lufironil": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01NCH", "drug_id_DB": "", "metabolic_annotation_str": "P4HA1(Prolyl 4-hydroxylasesubunit alpha-1 (P4HA1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["P4HA1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5033"]}, "7-hydroxy-6-propionyl-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EY2F", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "Quinoline derivative 17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04MFJ", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Quinoline derivative 16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QW7F", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Azepan-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ALG", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "NSC-368272": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ARY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "4-(4-fluoro-phenyliminomethyl)-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y9ZO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "1,2,3,4,6-penta-O-galloyl-beta-D-glucose": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "F2(Coagulation factor IIa (F2) ,MOA:Inhibitor); F10(Coagulation factor Xa (F10) ,MOA:Inhibitor); ", "drug_id_TTD": "D00QDR", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH", "SQLE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7498", "6713"]}, "BENZOLAMIDE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E8CC", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "NAV5001": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0X8HB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6531", "6531"]}, "1,1,1-Trifluoro-6-(naphthalen-2-yl)hexan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03DIV", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "N-Hydroxy-4-isobutyl-benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L3BQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-(1-(thiophen-2-yl)ethylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q5RG", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-50": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06KKO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-51": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0A0RM", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-52": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0PN6U", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "US9073936, 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0HO1Q", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "Desvenalfaxine succinate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03CEF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "Aryl pyrimidine derivative 9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UF8Z", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Aryl pyrimidine derivative 8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ZY4T", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Aryl pyrimidine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ZB9T", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Aryl pyrimidine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03ROY", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Aryl pyrimidine derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01TDT", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Aryl pyrimidine derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XR0Z", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Aryl pyrimidine derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z2JJ", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Aryl pyrimidine derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MV3E", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "HuMax-CD38b": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1QH", "drug_id_DB": "", "metabolic_annotation_str": "CD38(Cyclic ADP-ribose hydrolase 1 (CD38) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CD38"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["952"]}, "ketoprofen patch": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0E6BP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "1-(3,4-dichlorobenzyl)-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07EDG", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "1066", "1066"]}, "3-[4-(benzylmethylamino)butoxy]xanthen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01EZC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Sulfamic acid benzo[1,3]dioxol-2-ylmethyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A5XB", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Chlormerodrin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00534", "metabolic_annotation_str": "ALDH5A1(Succinate-semialdehyde dehydrogenase, mitochondrial); SLC12A1(Solute carrier family 12 member 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALDH5A1", "SLC12A1"], "metabolic_genes_id": ["7915", "6557"]}, "2,2',4,4',6'-pentahydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01VOU", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Piclamilast(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01791", "metabolic_annotation_str": "PDE4A(cAMP-specific 3',5'-cyclic phosphodiesterase 4A); PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); PDE4C(cAMP-specific 3',5'-cyclic phosphodiesterase 4C); PDE4D(cAMP-specific 3',5'-cyclic phosphodiesterase 4D); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4C", "PDE4D"], "metabolic_genes_id": ["5141", "5142", "5143", "5144"]}, "Isosorbide-2-benzylcarbamate-5-isonicotinate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09YLY", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Carprofen(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0IT2X", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Clomipramine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GSTP1(Glutathione S-transferase P); HTR2A(5-hydroxytryptamine receptor 2A); HTR2B(5-hydroxytryptamine receptor 2B); ", "drug_id_TTD": "", "drug_id_DB": "DB01242", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "4-(6-Methoxy-3-methylnaphthalen-2-yl)isoquinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4KP", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "N-Acetyl-N'-Beta-D-Glucopyranosyl Urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EDR", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "PMID19191557C21": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G9LW", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "4-(propylamino)naphthalen-1-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08MRL", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "CT-2584": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0V0DI", "drug_id_DB": "", "metabolic_annotation_str": "PCYT1B(Cholinephosphate cytidylyltransferase (PCYT1B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PCYT1B"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["9468"]}, "1,2,5,6-tetrahydro pyrido[1,2-a]quinolin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00IFJ", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "1-(4-Cyanobenzyl)-5-bromo-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L2QD", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "3-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04YVS", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "Ronomilast": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0O8JW", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "(S)(+)-7-methyl-2-p-tolylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TB1E", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "BVT-3498": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0E0GW", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "PSAMMAPLIN A": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HDAC4(Histone deacetylase 4 (HDAC4) ,MOA:Inhibitor); HDAC1(Histone deacetylase 1 (HDAC1) ,MOA:Inhibitor); HDAC2(Histone deacetylase 2 (HDAC2) ,MOA:Inhibitor); HDAC10(Histone deacetylase 10 (HDAC10) ,MOA:Inhibitor); HDAC8(Histone deacetylase 8 (HDAC8) ,MOA:Inhibitor); HDAC6(Histone deacetylase 6 (HDAC6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0N0TS", "drug_id_DB": "", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GALE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2582"]}, "6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09WQW", "drug_id_DB": "DB08258", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "QUIPAZINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR3B(5-HT 3B receptor (HTR3B) ,MOA:Inhibitor); HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); HTR1D(5-HT 1D receptor (HTR1D) ,MOA:Inhibitor); HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); HTR3A(5-HT 3A receptor (HTR3A) ,MOA:Inhibitor); HTR6(5-HT 6 receptor (HTR6) ,MOA:Inhibitor); ", "drug_id_TTD": "D08BCF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Phenoxodiol": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2"], "non_metabolic": "XIAP(X-linked inhibitor of apoptosis protein (XIAP) ,MOA:Modulator); ", "drug_id_TTD": "D03YOS", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8877"]}, "1-(1-Benzyl-2-biphenyl-4-yl-ethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7GG", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1-(3,4-Dichloro-phenyl)-3-diethylamino-indan-5-ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J0ES", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Tilmacoxib": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Z5LZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "daidzein": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ESR1(Estrogen receptor (ESR) ,MOA:Inhibitor); ESR2(Estrogen receptor beta (ESR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0SY2M", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "PF-543": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SND", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "9-[5-(beta-Carboline-9-yl)pentyl]-beta-carboline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07YXP", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "4-Sulfamoyloxy-benzoic acid nonyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06SMY", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "BIS(12)-HUPERZINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06EJS", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-(6-Amino-purin-9-yl)-7-phenyl-heptan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09JNN", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "PC-SOD": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U6PJ", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "S-methyl 4-methyl-4-morpholinopent-2-ynethioate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M0YO", "drug_id_DB": "", "metabolic_annotation_str": "ALDH3A2(Fatty aldehyde dehydrogenase (ALDH3A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH3A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["224"]}, "(Z)-7-octedecan-9-ynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CU3I", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "N6022": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09LPV", "drug_id_DB": "", "metabolic_annotation_str": "CBR1(S-nitrosoglutathione reductase (CBR1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CBR1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["873"]}, "NCX 1022": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0E8YH", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "fenclonine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F2GG", "drug_id_DB": "", "metabolic_annotation_str": "PAH(Phenylalanine hydroxylase (PAH) ,MOA:Inhibitor); TPH1(Tryptophan 5-hydroxylase 1 (TPH1) ,MOA:Inhibitor); TPH2(L-Tryptophan hydroxylase 2 (TPH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PAH", "TPH1", "TPH2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5053", "7166", "121278"]}, "CARIPORIDE": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0N8QQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1", "SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6548", "6550", "6550"]}, "3-(6-Methoxynaphthalen-2-yl)-4-methylpyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B2UM", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "2-methoxy-1,4-naphthoquinone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04OXY", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Sulfamic acid 2-nonyl-4-oxo-4H-chromen-6-yl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00AON", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "4-Methyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08DQZ", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "S-Isopropyl-Isothiourea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1LO", "drug_id_DB": "DB04018", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "2-fluoro-5-(3-methylthiophen-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VD5O", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "3-(4-Amino-phenyl)-3-methyl-pyrrolidine-2,5-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05HRP", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-[4-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L1JF", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588"]}, "2-phenylpiperidine hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DH9G", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "5-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03WOS", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "XZK-monascus": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06BBV", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3156"]}, "Rogletimide": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D06JUR", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1-(4-bromophenethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P8PG", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "5-Bromovinyldeoxyuridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D3WJ", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "1-(4-Cyanobenzyl)-5-(2-methylphenyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I2UH", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "7-nitro-1H-indazole": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03WOZ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "2-phenyl-N-(thiazol-2-yl)acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09DBH", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Decyl sulfamate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09WSJ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "Hesperetin(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D07MGA", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "NISOXETINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02YOO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "ANNULIN B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07RGV", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "ANNULIN C": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B9IA", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "DDATHF": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "PDF(Polypeptide deformylase (PDF) ,MOA:Inhibitor); ", "drug_id_TTD": "D06YIB", "drug_id_DB": "", "metabolic_annotation_str": "GART(GAR transformylase (GART) ,MOA:Modulator); GART(GAR transformylase (GART) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2618", "2618"]}, "N5-[4-Benzylphenyl]-L-glutamamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U2AM", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "4-[4-benzyloxy)benzoyl]benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01AUS", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "BGC-20-1259": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03PRV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "1-[2-(2-triphenylmethoxyethoxy)ethyl]thymine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GKK", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "Azocan-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K1CM", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y8RM", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1", "PLA2G7"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066", "7941"]}, "ISIS 1820": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4NE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["240", "240"]}, "ISIS 1821": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y8VJ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["240", "240"]}, "ISIS 1822": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PP1I", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["240", "240"]}, "N-(benzyl),N-(pyrrol-2-ylmethyl)amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O2UK", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "5,8-Dihydroxy-1,4-naphthoquinone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AS0V", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "7296"]}, "2-(Phenylsulfonamido)acetic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04YIV", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Pitavastatin derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G8JX", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2-((2-iodophenoxy)(phenyl)methyl)morpholine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4AQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "Golden phosphorous acetyletic compound 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0W1DK", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR", "TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2936", "7296"]}, "Golden phosphorous acetyletic compound 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RR2D", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Golden phosphorous acetyletic compound 2": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D02NYT", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR", "TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2936", "7296"]}, "Tacrine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0E6YQ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "4-[4-(benzyloxy)piperidino]butyl-4-fluorobenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WB1D", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Proguanil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01131", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["DHFR"], "metabolic_genes_id": ["1719"]}, "2-(phenylsulfonyl)-1-(thiophen-3-yl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UJ2C", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "1-benzene sulfonyl-cis-2,6-dimethyl piperidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03KMG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-[5-(4-Hydroxyphenyl)-2-thienyl]-5-methylphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GQE", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Alendronate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09KLR", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2224"]}, "Digoxin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00390", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase subunit alpha-1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ATP1A1"], "metabolic_genes_id": ["476"]}, "5-chloro-6-hydrazinouracil hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G1DS", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "Dyphylline(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02PWM", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "AL5300": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08CNG", "drug_id_DB": "DB04089", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "NADH(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0B8SV", "drug_id_DB": "", "metabolic_annotation_str": "MT-ND3(NADH dehydrogenase (MT-ND3) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["MT-ND3"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["4537"]}, "CH-3697": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05YEL", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Modulator); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Modulator", "Modulator"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "2-Pyridin-3-ylmethyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HZ9X", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "6-(2-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YQS", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TY8X", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA6", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "765", "768"]}, "(10H-phenothiazin-10-yl)(o-tolyl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09DWA", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1,2-bis(3-fluorophenyl)-2-hydroxyethanon": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AW4P", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1,1,1-trifluoro-3-(hexylthio)propan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z7WK", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "isobutylmethylxanthine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADORA3(Adenosine A3 receptor (ADORA3) ,MOA:Inhibitor); ADORA2A(Adenosine A2a receptor (ADORA2A) ,MOA:Inhibitor); ADORA2B(Adenosine A2b receptor (ADORA2B) ,MOA:Inhibitor); ADORA1(Adenosine A1 receptor (ADORA1) ,MOA:Antagonist); ", "drug_id_TTD": "D0R6MT", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A", "PDE5A", "PDE4A", "PDE4B", "PDE4D", "PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5138", "8654", "5141", "5142", "5144", "5139"]}, "SAR164653": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D01CIB", "drug_id_DB": "", "metabolic_annotation_str": "CTSA(Cathepsin A (CTSA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CTSA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5476"]}, "4-Amino-3-fluoro-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04CVC", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "3-(2-Bromophenyl)-2-thioxo-(1H )-quinazolin-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PUS", "drug_id_DB": "", "metabolic_annotation_str": "PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5142"]}, "N-cyclobutyl-N-(piperidin-4-yl)-2-naphthamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X8GC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "folipastatin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4NV", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5319"]}, "[1,4]Thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N3HU", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "10-Acetyl-1,8-dihydroxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FPY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "GALLICACID": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y3TZ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "Trisnorsqualene difluoromethylidene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03RKP", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "FK778": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X4IA", "drug_id_DB": "", "metabolic_annotation_str": "DHODH(Dihydroorotate dehydrogenase (DHODH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHODH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1723"]}, "3-hydroxyphenethyl 3,4,5-trihydroxybenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZQC", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzthiazide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0L2MX", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "(2R,3S,4S,5R)-2-nonylpiperidine-3,4,5-triol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1WB", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2629", "2629"]}, "O-2442": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00QGB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "MB-03966": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00WHC", "drug_id_DB": "", "metabolic_annotation_str": "ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["132"]}, "RO-4840700": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00CFU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "Carbamate derivative 14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FK7E", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "N-Cyclohexyl-N'-Decylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7ID", "drug_id_DB": "DB03677", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Carbamate derivative 10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Y7LM", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "ATR-01": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0LM4U", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "MVI-816": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09PGG", "drug_id_DB": "", "metabolic_annotation_str": "ACP3(Prostatic acid phosphatase (ACPP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACP3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["55"]}, "NP-7557": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D03DFY", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Rabeprazole": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0KL4J", "drug_id_DB": "DB01129", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["495"]}, "Apilimod dimesylate": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03SUQ", "drug_id_DB": "", "metabolic_annotation_str": "PIKFYVE(Phosphatidylinositol-3-phosphate 5-kinase (PIP5K3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIKFYVE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["200576"]}, "Crofelemer": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "ANO1(Calcium-dependent chloride channel anoctamin (ANO) ,MOA:Modulator); ", "drug_id_TTD": "D09VXM", "drug_id_DB": "DB04941", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1080"]}, "[11C]DTBZ": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07QQY", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6571"]}, "Managlinat dialanetil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB05518", "metabolic_annotation_str": "FBP1(Fructose-1,6-bisphosphatase 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["FBP1"], "metabolic_genes_id": ["2203"]}, "(Hydroxyethyloxy)Tri(Ethyloxy)Octane(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "RHO(Rhodopsin (RHO) ,MOA:Inhibitor); ", "drug_id_TTD": "D06PVF", "drug_id_DB": "", "metabolic_annotation_str": "PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNLIP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5406"]}, "BRD9539": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RO9T", "drug_id_DB": "", "metabolic_annotation_str": "EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["10919", "10919", "10919", "10919", "10919", "10919", "10919"]}, "Nortropinyl-arylsulfonylurea 3": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ROV", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "1-Bromo-6-(3-hydroxyphenyl)-2-naphthol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08PDK", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "FLUORO-NEPLANOCIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O2CM", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "AR-H047108": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03EZB", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "VE-822": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ATM(ATM serine/threonine kinase (ATM) ,MOA:Inhibitor); ATR(Serine/threonine-protein kinase ATR (FRP1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0H6GI", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "US10092575, Example 158": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J1LK", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "N,N'-(1',11'-undecydene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02JXK", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "CB-839": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01PBW", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Modulator); GLS2(Glutaminase (GLS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2744", "27165"]}, "MDL-28618": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P6SY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "4-[4-(benzhydryloxy)benzoyl]benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04AED", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "8-Methyl-3-p-tolyl-8-aza-bicyclo[3.2.1]octane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07RQT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-(benzylamino)-5,5-diethyloxazol-4(5H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L5KQ", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "ISOSCOPOLETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E0RW", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "4-(tert-butylamino)naphthalen-1-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1ZJ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2,5-bis(4-hydroxybenzylidene)cyclopentanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S0QN", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Trisnorsqualene alcohol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z9PB", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "(2E, 6E)-farnesylbisphosphonate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01WWK", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "CMI-392": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "PTAFR(Platelet-activating factor receptor (PTAFR) ,MOA:Modulator); ", "drug_id_TTD": "D0D5ZV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Salsalate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01399", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "Pyrazolo[1,5-a]pyrimidine derivative 28": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0WR6N", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "Pyrazolo[1,5-a]pyrimidine derivative 29": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0XT7O", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "2-N-(n-Propyl)amino-1-(4-methylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02MMS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "N-Hydroxy-2-(naphthalen-2-ylsulfanyl)-acetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06AFP", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "3,4,5,6-Tetrahydrobenzo[c]quinolizin-3-(4aH)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SPJ", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "3-(furan-3-yl)-1-methyl-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J9OS", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "QNEQCPQVSac": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V7CD", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6523"]}, "Trandolapril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0M5OC", "drug_id_DB": "DB00519", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "3-Benzoyl-N-hydroxy-benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05RIE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "GLPTGG": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B2FM", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "LUM001": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09JXH", "drug_id_DB": "", "metabolic_annotation_str": "SLC10A2(Ileal sodium/bile acid cotransporter (SLC10A2) ,MOA:Inhibitor); SLC10A1(Sodium/bile acid cotransporter (SLC10A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC10A2", "SLC10A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6555", "6554"]}, "AS602868": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "NFKB1(Nuclear factor NF-kappa-B (NFKB) ,MOA:Inhibitor); NFKB2(Nuclear factor NF-kappa-B (NFKB) ,MOA:Inhibitor); RELB(Nuclear factor NF-kappa-B (NFKB) ,MOA:Inhibitor); RELA(Nuclear factor NF-kappa-B (NFKB) ,MOA:Inhibitor); REL(Nuclear factor NF-kappa-B (NFKB) ,MOA:Inhibitor); ", "drug_id_TTD": "D01OLO", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "5-Fluoro-6-ethyluridine-5'-O-monophosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P7AS", "drug_id_DB": "", "metabolic_annotation_str": "UMPS(Orotidine 5'-monophosphate decarboxylase (UMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7372"]}, "Acyl oxymethyl acrylamide ester derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J4PE", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Acyl oxymethyl acrylamide ester derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z2MX", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR", "TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2936", "7296"]}, "PMID26815044-Compound-64": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I3KT", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Isopentyl Pyrophosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05DDS", "drug_id_DB": "DB02508", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "8-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4EV", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-(Aminomethyl)-5-(1'-naphthethyl)tetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T5VG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "Malathion(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00772", "metabolic_annotation_str": "BCHE(Cholinesterase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["BCHE"], "metabolic_genes_id": ["590"]}, "6-(2-Fluoropropyl)-4-methylpyridin-2-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07VFC", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "Finasteride(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01216", "metabolic_annotation_str": "SRD5A1(3-oxo-5-alpha-steroid 4-dehydrogenase 1); AKR1D1(3-oxo-5-beta-steroid 4-dehydrogenase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SRD5A1", "AKR1D1"], "metabolic_genes_id": ["6715", "6718"]}, "Isosorbide-2-(ethylcarbamate)-5-mononitrate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J5AU", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "(3-Hydroxy-2-methyl-phenyl)-trimethyl-ammonium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08JOR", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "GDC0941": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08QGT", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "MK 8719": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03HDL", "drug_id_DB": "", "metabolic_annotation_str": "OGA(Beta-N-acetylhexosaminidase (OGA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["OGA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10724"]}, "3-aminoacetamido-4'-methylfuro[3,2-g]coumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O0QN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "LAROPIPRANT": {"drug_status_TTD": ["Phase 4", "Phase 4", "Phase 4", "Phase 4", "Phase 4", "Phase 4", "Phase 4"], "non_metabolic": "TBXA2R(Thromboxane A2 receptor (TBXA2R) ,MOA:Inhibitor); PTGFR(Prostaglandin F2-alpha receptor (PTGFR) ,MOA:Inhibitor); PTGER2(Prostaglandin E2 receptor EP2 (PTGER2) ,MOA:Inhibitor); PTGIR(Prostacyclin receptor (PTGIR) ,MOA:Inhibitor); PTGDR(Prostaglandin D2 receptor (PTGDR) ,MOA:Inhibitor); PTGDR2(Prostaglandin D2 receptor 2 (PTGDR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0WL5V", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "N-tert-Butyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DB9T", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N-Tridecanoic Acid(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YGT", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "5320"]}, "5-bromo-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02OAB", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "((E)-7-But-2-enyl)-azepan-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01YNT", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "PF-05212384": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Modulator); ", "drug_id_TTD": "D0D8JB", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "4-chlorophenyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04IXN", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N-Hydroxy-3-naphthalen-2-yl-N-phenyl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T1HY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "FINROZOLE": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04PSL", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "2-Phenoxymethyl-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N9FH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "BC11-28": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SH7F", "drug_id_DB": "", "metabolic_annotation_str": "PDE8A(Phosphodiesterase 8 (PDE8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE8A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5151"]}, "Cis-1-adamantan-1-yl-3-(4-hydroxycyclohexyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6ZY", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Ibandronate(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D08SJZ", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2224"]}, "Gallium maltolate(TTD)": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05ACQ", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["6241"]}, "PUMAPRAZOLE": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0M8HH", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "2-(N-Isopropylamino)-3'-chloropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02EKR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Lpc-Ether(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03633", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2); GM2A(Ganglioside GM2 activator); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PLA2G1B", "GM2A"], "metabolic_genes_id": ["5319", "2760"]}, "Cis-2-Fluoro-2-(4-methoxyphenyl)cyclopropylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B2TV", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Dofequidar fumarate": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0H0EM", "drug_id_DB": "", "metabolic_annotation_str": "ABCB4(Multidrug resistance protein 3 (ABCB4) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5244"]}, "1-(4-fluorophenyl)-2-(phenylsulfonyl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P7RN", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "G-619": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "TBXA2R(Thromboxane A2 receptor (TBXA2R) ,MOA:Modulator); ", "drug_id_TTD": "D0RU7T", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6916"]}, "4-Cyclohexyl-4-hydroxy-but-2-enoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0FG", "drug_id_DB": "", "metabolic_annotation_str": "SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC52A2", "SLC52A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["79581", "79581"]}, "PMID1656041C11ff": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O2FD", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "7-methoxytacrine": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0S1VV", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "AN-2898": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00JED", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "CGS 8515": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0QI8I", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "2-(4,5-dihydro-1H-imidazol-2-yl)quinoline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4AB", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "6-Hydroxy-benzothiazole-2-sulfonic acid amide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q2LL", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "765", "768", "23632"]}, "4-(4-Chlorophenyl)-5-p-tolyl-1,2-selenazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09MDB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Tacrine-phenothiazine hybrid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I2FM", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "GNF-PF-5411": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D05ROV", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Dodecanoic acid adamantan-1-ylamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06DZO", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "4-(2-Pyridin-2-ylacetamido)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N7WP", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "2-[4-(2-Piperidin-1-ylethyl)phenoxy]benzothiazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Q8LS", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "1,4-Butanediol(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O6SI", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5320"]}, "Epristeride": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02KRI", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "79644"]}, "2,3-dihydrobenzo[d]thiazole-2-thiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09DSZ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Nesiritide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "NPR3(Atrial natriuretic peptide receptor 3); ", "drug_id_TTD": "", "drug_id_DB": "DB04899", "metabolic_annotation_str": "NPR1(Atrial natriuretic peptide receptor 1); NPR2(Atrial natriuretic peptide receptor 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["NPR1", "NPR2"], "metabolic_genes_id": ["4881", "4882"]}, "2,4-Dichlorobenzenemethanethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SZ9F", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03DAM", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "768"]}, "6-chlorotacrine hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M0BM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "5-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2WC", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842"]}, "PTC299": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "VEGFA(Vascular endothelial growth factor A (VEGFA) ,MOA:Modulator); ", "drug_id_TTD": "D05VVX", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "3,4,5-tribromo-2-(2', 4'-dibromo-phenoxy)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V1DW", "drug_id_DB": "", "metabolic_annotation_str": "GMPS(Glutamine amidotransferase (GMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8833"]}, "2,5-imino-2,5,6-trideoxy-D-manno-heptitol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6BK", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2548"]}, "CI-999": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0PG0S", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "16-isobutylidene-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G4KT", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Meta-Tyrosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05XGI", "drug_id_DB": "", "metabolic_annotation_str": "TH(Tyrosine 3-monooxygenase (TH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7054"]}, "4-CYANOPHENOL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00IUB", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "765"]}, "Pyrazine carboxamide derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0H2WY", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "1-(2-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03JOX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "PMID18800762C51": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09KGN", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "PI-103": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8XH", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "2,2-dimethyl-3-methyleneheptadecane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01NDE", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Ferritarg P": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0D8KU", "drug_id_DB": "", "metabolic_annotation_str": "FTH1(Ferritin (FTH1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["FTH1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["2495"]}, "3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NX0M", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "NS 2028": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U3YQ", "drug_id_DB": "", "metabolic_annotation_str": "GUCY2D(Soluble guanylyl cyclase (GUCY2D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY2D"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3000"]}, "3-Phenanthren-9-yl-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00DUJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "BIS(16)-HUPERZINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P5CV", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1,2-bis(3,4-difluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6OM", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Patrome": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D03QFN", "drug_id_DB": "", "metabolic_annotation_str": "DDC(Aromatic-L-amino-acid decarboxylase (DDC) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DDC"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1644"]}, "SSR-504734": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D06SBS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6536"]}, "Hydroxychloroquine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TLR9(Toll-like receptor 9); TLR7(Toll-like receptor 7); ", "drug_id_TTD": "", "drug_id_DB": "DB01611", "metabolic_annotation_str": "ACE2(Angiotensin-converting enzyme 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ACE2"], "metabolic_genes_id": ["59272"]}, "BENZOIN": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z5KQ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "KAEMPFEROL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "AR(Androgen receptor messenger RNA (AR mRNA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0G3TK", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "HSD17B1", "AKR1B1", "ALOX15", "GLO1", "CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "3292", "231", "246", "2739", "1545"]}, "T-1095": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X1YF", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6523"]}, "N-Hydroxy-4-iodo-benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06MUA", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Azaindole derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0D6UT", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Azaindole derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J5GS", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "LY-2523199": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01MYN", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Azaindole derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RK1R", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Azaindole derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00GMJ", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "NSC-73410": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JNQ", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "(R)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07WIJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "N-(biphenyl-3-yl)benzo[d]isoxazol-3-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C1EP", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "FK-143": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0J3CT", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6715", "79644"]}, "3,4-Dibromo-2-(5-bromo-2-hydroxy-phenoxy)-phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F1VR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "Volanesorsen": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0A8TA", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "FR236913": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V6TX", "drug_id_DB": "DB02830", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Isoxazoles and isoxazoline derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Q7NM", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Isoxazoles and isoxazoline derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06KFU", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Isoxazoles and isoxazoline derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WL1Z", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Isoxazoles and isoxazoline derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03EYJ", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Isoxazoles and isoxazoline derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0TK3W", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Isoxazoles and isoxazoline derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00XMF", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "PMID25399762-Compound-Figure1-Aphanamixoid A": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0TX9E", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "2-(N-Pyrrolidinyl)-3'-methoxypropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01YED", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "CHLORPYRIFOS": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M5ES", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Tacrine-caffeic acid hybrid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05WPG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Tacrine-caffeic acid hybrid derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SW0V", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "ISIS-SOD1Rx": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D02VBX", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(SOD1 messenger RNA (SOD1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6647"]}, "3-(4-Phenylpiperazin-1-carbonyl)coumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7HC", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-(6-Amino-purin-9-yl)-non-5-en-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FWE", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Glycine type-1 transporter inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TZ5E", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "Biliverdine Ix Alpha": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06SCF", "drug_id_DB": "", "metabolic_annotation_str": "HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMOX1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3162"]}, "3,5-Diacetoxy-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7VY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Tolmetin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00500", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "Quinoline derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0U2CK", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "4-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D9FR", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "CDRI-85/92": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N0KG", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["495"]}, "4-(2-fluoro-6-(2-fluorophenoxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0W8YO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "1-adamantan-1-yl-3-(6-propyloxyhexyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RST", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Tiazofurin adenine dinucleotide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4BK", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); PPAT(Amidophosphoribosyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2", "PPAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3615", "5471"]}, "6-(2-Imidazol-1-yl-vinyl)-1H-quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TZ8C", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "Bermoprofen": {"drug_status_TTD": ["Discontinued in Preregistration", "Discontinued in Preregistration"], "non_metabolic": "", "drug_id_TTD": "D01IRW", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "6-Hydroxy-1,6-Dihydro Purine Nucleoside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06EHE", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "PMID2296036C2g": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O1OC", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Trisodium phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01DOW", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JZV", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "1-Cyclohexylidenethiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EB9U", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "S-(3-Chlorobenzyl)isothiourea hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07NSZ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "1-(1-Adamantyl)-3-(1-propionylpiperidin-4-yl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U4KM", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "ERIODICTYOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AIJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "BMN-110": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0OQ9V", "drug_id_DB": "", "metabolic_annotation_str": "GALNS(N-acetylgalactosamine 6 sulfatase (GALNS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GALNS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2588"]}, "De-O-sulfonated kotalanol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8GU", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "MILACAINIDE TARTRATE": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05DON", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["6916"]}, "BEZ235": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Modulator); ", "drug_id_TTD": "D0VG0D", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "1-Methyl-3-propyl-3,7-dihydro-purine-2,6-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00TQR", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5144"]}, "Nojirimycine Tetrazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E2BH", "drug_id_DB": "DB02471", "metabolic_annotation_str": "LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LCT", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3938", "5837"]}, "3-[1-(4-Bromobenzyl)-1H-imidazol-5-yl]-1-propanol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AK9S", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "ROMe": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H2LN", "drug_id_DB": "", "metabolic_annotation_str": "SPHK2(Sphingosine kinase 2 (SPHK2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["56848"]}, "5-Phenyl-pentanoic acid benzyl-hydroxy-amide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ARK", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Burnamine-17-O-3',4',5'-trimethoxybenzoate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I2FC", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "Tacrine-indole hybrid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G9HY", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Tacrine-indole hybrid derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05QVX", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Tacrine-indole hybrid derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I7KU", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1-(4-Cyanobenzyl)-5-(3-methylphenyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02PSL", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "(+/-)-3-((naphthalen-2-yloxy)methyl)pyrrolidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SN6R", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "4-(2-(benzyloxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D01YNZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "DYSIDENIN": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WDW", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "alpha-linolenic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C5SV", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "1-D-glucopyranosyl uracil": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P1XH", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "GR-253035": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0C2HF", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "16-beta-ethoxymethyl-estrone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B9HX", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Nabumetone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00461", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "T-82": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0PC1V", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C1OB", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "9-O-[4-(Phenylol-1-yloxy)butyl]berberine bromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01TLN", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "2-(tert-Butylamino)-3',4'-dichloropentanophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G1XP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "ACEROGENIN B": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1MI", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "Roclatan": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0BN7W", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6530"]}, "4'-Methoxy-5,3'-dipropyl-biphenyl-2ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7ZQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742"]}, "14-(n-Hexylamino)-14-oxotetradec-8(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05IKY", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "5-Methoxy-N-phenylbenzo[d]oxazol-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XL5D", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1,1,1,2,2,3,3,5-octafluoro-8-phenyloctan-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9CN", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "N-ethyl estrone-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4BE", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "4-hydroxy-8-nitro-3-phenylquinolin-2(1H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BY6E", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GNAS(Guanine nucleotide-binding protein G(s) subunit alpha isoforms short); ", "drug_id_TTD": "", "drug_id_DB": "DB06843", "metabolic_annotation_str": "ADCY5(Adenylate cyclase type 5); ADCY2(Adenylate cyclase type 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ADCY5", "ADCY2"], "metabolic_genes_id": ["111", "108"]}, "Benzothiazoline derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01CFL", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "4-aminonaphthalen-1-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08XXD", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Biphenyl-4-carboxylic acid hydroxyamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04XPJ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-aryl quinol derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L2NG", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID26815044-Compound-114": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06FUM", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(6-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F6TM", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "MERCK-544": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00PSW", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "N-n-propyl-7-methoxytacrine hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08PWL", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID26815044-Compound-115": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07PNX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "1-adamantan-1-yl-3-piperidin-4-ylmethyl-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09VSL", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Amitifadine(TTD)": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D04PXS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "ETHYLGALLATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CPD", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "BioE-743": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0RI4I", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1728"]}, "P-coumaric acid derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SF6C", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "ASIATIC ACID": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LC7K", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "P-coumaric acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0O3JR", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "P-coumaric acid derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01VTT", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-118": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01ZCC", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "LOR-2501": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0K4OL", "drug_id_DB": "", "metabolic_annotation_str": "RRM1(RRM1 messenger RNA (RRM1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6240"]}, "P-coumaric acid derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SJ4S", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Bestatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0RA5Q", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "1-Hydroxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P8IX", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "2-Naphthalen-1-ylmethyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F1ZE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-(2-(benzyloxy)-6-fluorophenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D08JLB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "3-(2-N-Pyrrolyl-propionamino)-rutaecarpine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F6VM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "CX-1001": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GZ5F", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["6532"]}, "N'-(phenylsulfonyl)quinoline-6-carbohydrazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W0FI", "drug_id_DB": "", "metabolic_annotation_str": "BCAT2(Branched-chain-amino-acid transaminase 2 (BCAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCAT2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["587"]}, "PMID29473428-Compound-4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09FPV", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03JQL", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["3620"]}, "4,6-Dichloro-1H-indole-2-carboxylic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "GRIN1(Glutamate receptor ionotropic NMDA 1 (NMDAR1) ,MOA:Inhibitor); GRIN2A(Glutamate receptor ionotropic NMDA 2A (NMDAR2A) ,MOA:Inhibitor); GRIN2B(Glutamate receptor ionotropic NMDA 2B (NMDAR2B) ,MOA:Inhibitor); ", "drug_id_TTD": "D03GBO", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203"]}, "US9073936, 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z1CK", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "1-(2-(2-chlorophenyl)-1-phenylethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z9OX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "US9073936, 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0E9JC", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "2-(2,3-Dihydro-1H-indol-5-yl)-1-methyl-ethylamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0NB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "Hydroxyurea(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01005", "metabolic_annotation_str": "RRM1(Ribonucleoside-diphosphate reductase large subunit); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["RRM1"], "metabolic_genes_id": ["6240"]}, "(+/-)-7-fluoro-2-p-tolylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0KU", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Tendamistat": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "GANAB(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0P6IA", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Alpha-glucosidase (GLA) ,MOA:Inhibitor); GANC(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA", "GANC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2548", "2595"]}, "P-9808": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0C9IS", "drug_id_DB": "", "metabolic_annotation_str": "HMBS(Porphobilinogen deaminase (HMBS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMBS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3145"]}, "3,3'-pyrazine-2,5-diyldiphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DC3E", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "2,3-Dimethoxy-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4MF", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-p-Tolyl-8-aza-bicyclo[3.2.1]octane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02UUC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "5-Iododeoxyuridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02IED", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "PMID25399762-Compound-Figure2-Artoxanthochromane": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03QMA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Finasteride(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D08IWD", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "79644"]}, "3-(3-hydroxyphenyl)quinolin-7-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06NDT", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "8-(3-Azido-phenyl)-6-iodo-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8DB", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "N-Butyl 2beta-hydroxyolean-12-en-28-oate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ASL", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "SULFAMATE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03VDJ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762", "768"]}, "7-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OY1J", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Gallopamil": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Inhibitor); ATP2A2(Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (ATP2A2) ,MOA:Inhibitor); ", "drug_id_TTD": "D00ERV", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "[4',4''']-biflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L6GV", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Acetohexamide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07WFK", "drug_id_DB": "", "metabolic_annotation_str": "ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC8"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6833"]}, "S-(Dimethylarsenic)Cysteine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "TLR2(Toll-like receptor 2 (TLR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D08TGY", "drug_id_DB": "DB03963", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "2-(benzyloxy)naphthalene": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07TWV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07FVL", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "LONCHOCARPUSONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZDD", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "BMS-262084": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09YQM", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); TPSD1(Delta-tryptase (TPSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1", "TPSD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7177", "23430"]}, "1-(2-(naphthalen-2-yl)-1-phenylethyl)piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A3YK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Delta-Amino Valeric Acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02068", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase); GATM(Glycine amidinotransferase, mitochondrial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ALAD", "GATM"], "metabolic_genes_id": ["210", "2628"]}, "XANTHOSTIGMINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4HG", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Phenoxyarsonous acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01GNQ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "5-(2-1H-indenyl)-1,3-benzodioxole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07OAV", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "N-Methylmesoporphyrin Containing Copper": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GJZ", "drug_id_DB": "", "metabolic_annotation_str": "FECH(Ferrochelatase (FECH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FECH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2235"]}, "BYK-191023": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D3CJ", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "Dexibuprofen(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D06YPU", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Quinapril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0I7SZ", "drug_id_DB": "DB00881", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "(2-Mercapto-ethyl)-trimethyl-ammonium iodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GT6I", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-(3-Methyl-piperazin-1-yl)-6-nitro-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05MJO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "HOMOERIODICTYOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CR8V", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "1,2,3-benzenetricarboxylic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05UYC", "drug_id_DB": "", "metabolic_annotation_str": "SLC25A1(Mitochondrial citrate transporter (SLC25A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC25A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6576"]}, "CP-470,711": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05DAN", "drug_id_DB": "", "metabolic_annotation_str": "SORD(Sorbitoldehydrogenase (SORD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SORD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6652"]}, "6-(3,5-dimethoxy-phenyl)-naphthalen-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05XGZ", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5243"]}, "4-(1H-1,2,3-triazol-5-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UV8T", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2-amino-4-methylpyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O3XZ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "4-methylaminomethyl-7-methoxycoumarin": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0QH6F", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "2-(1-Imidazol-1-yl-ethyl)-9H-carbazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U5GF", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "NSC-289311": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07PHT", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "EQ-1280": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8RL", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "S-(N-hexyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YI5C", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "HINOKININ": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X3CF", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "NSC-625409": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y9HD", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Cerivastatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03KIA", "drug_id_DB": "DB00439", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "4,6-Dinitro salicylic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BR1D", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "FR-129169": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D00KQT", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "Org-24461": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0U1HP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6536"]}, "2-Phenethyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06HUQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "3-(4-Amino-phenyl)-3-ethyl-pyrrolidine-2,5-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z1OI", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "US20160326143, 50": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D08NHT", "drug_id_DB": "", "metabolic_annotation_str": "LTC4S(Leukotriene C4 synthase (LTC4S) ,MOA:Inhibitor); LTC4S(Leukotriene C4 synthase (LTC4S) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTC4S", "LTC4S"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4056", "4056"]}, "Stiripentol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GABRP(Gamma-aminobutyric acid receptor subunit pi); GABRD(Gamma-aminobutyric acid receptor subunit delta); GABRA1(Gamma-aminobutyric acid receptor subunit alpha-1); GABRB1(Gamma-aminobutyric acid receptor subunit beta-1); GABRG2(Gamma-aminobutyric acid receptor subunit gamma-2); GABRB3(Gamma-aminobutyric acid receptor subunit beta-3); GABRA5(Gamma-aminobutyric acid receptor subunit alpha-5); GABRA3(Gamma-aminobutyric acid receptor subunit alpha-3); GABRA2(Gamma-aminobutyric acid receptor subunit alpha-2); GABRB2(Gamma-aminobutyric acid receptor subunit beta-2); GABRA4(Gamma-aminobutyric acid receptor subunit alpha-4); GABRE(Gamma-aminobutyric acid receptor subunit epsilon); GABRA6(Gamma-aminobutyric acid receptor subunit alpha-6); GABRG1(Gamma-aminobutyric acid receptor subunit gamma-1); GABRG3(Gamma-aminobutyric acid receptor subunit gamma-3); ", "drug_id_TTD": "", "drug_id_DB": "DB09118", "metabolic_annotation_str": "LDHA(L-lactate dehydrogenase A chain); LDHA(L-lactate dehydrogenase A chain); LDHB(L-lactate dehydrogenase B chain); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["LDHA", "LDHA", "LDHB"], "metabolic_genes_id": ["3939", "3939", "3945"]}, "Trimipramine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00HZV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "(+/-)-7-methoxy-2-phenylchroman-4-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2FO", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "4129"]}, "N-(3-Bromophenyl)-5-methoxybenzo[d]oxazol-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C4KD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-(4-Cyanobenzyl)-5-(3-fluorophenyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00PXF", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "3-azageranylgeranyl diphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R9ZY", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Methyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07AYF", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "3-(2,3-Dihydro-1,4-benzodioxin-6-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I9PA", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Metformin(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0D7LA", "drug_id_DB": "", "metabolic_annotation_str": "SLC47A1(Solute carrier family 47 member 1 (SLC47A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC47A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["55244"]}, "PHENYLSULFAMIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06IYU", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "lisinopril-tryptophan": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B8WQ", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "D-aspartic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08CAB", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A7(Excitatory amino acid transporter 5 (SLC1A7) ,MOA:Modulator); SLC1A3(Excitatory amino acid transporter 1 (SLC1A3) ,MOA:Modulator); SLC1A2(Excitatory amino acid transporter 2 (SLC1A2) ,MOA:Modulator); SLC1A1(Excitatory amino acid transporter 3 (SLC1A1) ,MOA:Modulator); SLC1A6(Excitatory amino acid transporter 4 (SLC1A6) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A7", "SLC1A3", "SLC1A2", "SLC1A1", "SLC1A6"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["6512", "6507", "6506", "6505", "6511"]}, "DS-1150b": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03UZC", "drug_id_DB": "", "metabolic_annotation_str": "SLC2A4(Glucose transporter type 4 (SLC2A4) ,MOA:Modulator); SLC2A4(Glucose transporter type 4 (SLC2A4) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC2A4", "SLC2A4"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6517", "6517"]}, "N1-(2-aminoethyl)ethane-1,2-diamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09WVV", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "765", "768", "23632"]}, "4-(2-oxohexadecanamido)butanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03NYE", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SJ3W", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "1-(1-(4-fluorophenyl)ethylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OG4X", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Succinamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04ULX", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "N-Hydroxy-3-naphthalen-2-yl-N-p-tolyl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06AFD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "N-Propargyl-1(S)-Aminoindan": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K5LJ", "drug_id_DB": "DB03894", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Topical etoricoxib": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00EDB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "PMID27841045-Compound-129": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RN2X", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "4-Methoxybenzenemethanethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08PIF", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "GPD-1116": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01XFZ", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Mycophenolate mofetil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00688", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2); PTS(6-pyruvoyl tetrahydrobiopterin synthase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["IMPDH2", "PTS"], "metabolic_genes_id": ["3615", "5805"]}, "4-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZYL", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "LY256548": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XNF", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["5319"]}, "Recombinant human iduronate-2-sulfatase": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0L1DR", "drug_id_DB": "", "metabolic_annotation_str": "IDS(Iduronate 2-sulfatase (IDS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["IDS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3423"]}, "N,O6-Disulfo-Glucosamine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "FGF1(Fibroblast growth factor 1); ANXA5(Annexin A5); HGF(Hepatocyte growth factor); ", "drug_id_TTD": "", "drug_id_DB": "DB03959", "metabolic_annotation_str": "HS3ST3A1(Heparan sulfate glucosamine 3-O-sulfotransferase 3A1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["HS3ST3A1"], "metabolic_genes_id": ["9955"]}, "3-Bromo-2'-hydroxy-4-methoxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00LWQ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "1,2-Bis-(3-methoxy-phenyl)-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01VAU", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Inosinic Acid(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H2YT", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM", "IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5837", "3615"]}, "(R)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}alaninamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05HVV", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "CKD-533": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06URK", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "FENBUFEN": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D06LHG", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Sulfamic acid 4-benzoyl-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B2XN", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "ABC294640": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X6BX", "drug_id_DB": "", "metabolic_annotation_str": "SPHK2(Sphingosine kinase 2 (SPHK2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["56848"]}, "Sulfamic acid 4-(2-hydroxy-benzoyl)-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M2WG", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "(2R,3R)-iodoreboxetine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01JVP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "[2-(Purin-9-yl)ethyl]-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E4DR", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Alkavervir": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y2MC", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6571"]}, "Cis-2-(4-chlorophenyl)-2-fluorocyclopropanamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06AAA", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "6-hydroxybenzo[d][1,3]oxathiol-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M8UY", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "2,2',4,4'-tetrahydroxy-6'-methoxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L3KR", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Miglustat": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0HR8Z", "drug_id_DB": "DB00419", "metabolic_annotation_str": "UGCG(Ceramide glucosyltransferase (UGCG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UGCG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7357"]}, "ISOCONAZOLE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GJ7J", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "N-Methyl,N-phenyl-1H-indole-2-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F7JK", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-(1-Methyl-1H-indol-2-ylmethyl)-N-phenylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KB2R", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "7-(1-(1H-imidazol-1-yl)ethyl)-9H-fluoren-2-ol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GJI", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "Hypericum": {"drug_status_TTD": ["Phase 4"], "non_metabolic": "", "drug_id_TTD": "D08BYK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "2-(Aminomethyl)-5-(1'-naphthyl)tetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y3BI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Cladribine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "POLA1(DNA polymerase alpha catalytic subunit); POLE2(DNA polymerase epsilon subunit 2); POLE(DNA polymerase epsilon catalytic subunit A); POLE4(DNA polymerase epsilon subunit 4); POLE3(DNA polymerase epsilon subunit 3); ", "drug_id_TTD": "", "drug_id_DB": "DB00242", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase); RRM1(Ribonucleoside-diphosphate reductase large subunit); RRM2(Ribonucleoside-diphosphate reductase subunit M2); RRM2B(Ribonucleoside-diphosphate reductase subunit M2 B); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PNP", "RRM1", "RRM2", "RRM2B"], "metabolic_genes_id": ["4860", "6240", "6241", "50484"]}, "Lapaquistat acetate": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02FXU", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "2,6-di-tert-butyl-4-methoxyphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZUN", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "SBC-102": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0CH4A", "drug_id_DB": "", "metabolic_annotation_str": "LIPA(Lysosomal acid lipase (LIPA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3988"]}, "Isosorbide-2-benzylcarbamate-5-(o-toluate)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EQ1Z", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "PHENYLDIFLUOROMETHANESULFONAMIDE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UN0E", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Lactol derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AY4N", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2,4-Dimethoxy-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I1SI", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "PMID29473428-Compound-72": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YV6X", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-71": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H3ZZ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-70": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0U3KX", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-76": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0F4MN", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999"]}, "Tetramethylammonium Ion": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9SK", "drug_id_DB": "", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GALE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2582"]}, "Aloe-emodin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BUG", "drug_id_DB": "", "metabolic_annotation_str": "ALDH3A2(Fatty aldehyde dehydrogenase (ALDH3A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH3A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["224"]}, "TGR-1202": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0O8SJ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5293", "5294"]}, "ASP1941": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D07FBM", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "NSC-47729": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05YCQ", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "16-(4-cyano-benzylidene)-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U7DJ", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "PMID15686906C17": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07QAX", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Piperazine derivative 8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WD8Z", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5168"]}, "3-[9-(benzylmethylamino)nonyloxy]xanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AQ3K", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "DOV-216303": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0H9GQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Binuclear gold(I) compound 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WK9J", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Binuclear gold(I) compound 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0F3BO", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Binuclear gold(I) compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02UTG", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Cacospongionolide E": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03BAB", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "5320"]}, "CGS-18320B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V1UY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "P-7435": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0M4HL", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "6-chloro-5-heptylpyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03IMY", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "4-benzyloxy-2'-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05UPM", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "2,2'-bi(1,3,4-thiadiazole)-5,5'(4H,4'H)-dithione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7TM", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(RS/SR)-2-[1-(4-chlorophenyl)hexyl]piperidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EMO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "4-[5-(3-Hydroxyphenyl)-2-thienyl)-2-methyl]phenol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Y2RL", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565", "3292"]}, "3-(4-methoxyphenyl)-6-methyl-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R9TX", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "6-(2-Chloro-benzenesulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00EPD", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "But-3-enyl-trimethyl-ammonium bromide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZQL", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Nitrobenzylthioinosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S0PI", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2030"]}, "N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A7ZH", "drug_id_DB": "DB07742", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "SPERMINE": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated", "Terminated", "Terminated", "Terminated"], "non_metabolic": "GRIN1(Glutamate receptor ionotropic NMDA 1 (NMDAR1) ,MOA:Inhibitor); GRIN2A(Glutamate receptor ionotropic NMDA 2A (NMDAR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0LD9S", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["762", "765", "768", "23632"]}, "Wortmannin(TTD)": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0P1JI", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5293", "5294"]}, "GSC-1": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z7LK", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "MT-061 lead": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06SYA", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "2,2-dimethyl-2H-benzo[g]chromene-5,10-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08YHA", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "RO-4998452": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U7SR", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "Aldosterone(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0I1LH", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "5-Methoxy-4,9-dihydro-3H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0V6XA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-((1H-indol-2-yl)methyl)(phenyl)methanamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08QZP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "BW A4C": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D05WPQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "240", "240"]}, "BAY-17-1998": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0L7ZX", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7177"]}, "PMID27321640-Compound-76": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KN9S", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "PMID27321640-Compound-75": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09PMC", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "PMID27321640-Compound-74": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0A5YE", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Miglitol(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0D0ZD", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "FR221647": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L5XY", "drug_id_DB": "DB02096", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "PMID25514969-Compound-Figure3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01EEY", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "N'-Pyridoxyl-Lysine-5'-Monophosphate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I5PZ", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM", "ODC1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5837", "4953"]}, "Anastrozole": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0W0BF", "drug_id_DB": "DB01217", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "INCB40093": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D07CWH", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "6,7'-oxybis(2-phenyl-4H-chromen-4-one)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1IJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "3-bromophenyl-difluoromethanesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01JTI", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "P-TOLUENESULFONAMIDE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZC3W", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA6", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "765", "768"]}, "Hydroxyurea(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07CWD", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6241"]}, "N-ethyl estradiol-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V5JV", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "ADMVA": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0P7SO", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["231"]}, "1,4-diphenyl-(1E,3E)-1,3-butadiene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J0MX", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "6-amino-N-(3,3-diphenylpropyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P3WB", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Rasagiline": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06OMW", "drug_id_DB": "DB01367", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(+/-)-threo-3',5'-Dichloromethylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZQW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "1-Methyl-4-p-tolyl-piperidine-4-carbonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1AZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "PMID8246233C28": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1ER", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Desvenlafaxine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0O3FG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "9-Hydroxy-7,8-benzoflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0DB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "SAFIRONIL": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0P2BD", "drug_id_DB": "", "metabolic_annotation_str": "P4HA1(Prolyl 4-hydroxylasesubunit alpha-1 (P4HA1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["P4HA1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5033"]}, "CH-5132799": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03XAQ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Inhibitor); PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD", "PIK3CA", "PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5293", "5290", "5291", "5294"]}, "3-Nitro-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZHE", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Cilastatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02GIU", "drug_id_DB": "DB01597", "metabolic_annotation_str": "DPEP1(Dehydropeptidase I (DPEP1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DPEP1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1800"]}, "[3H]alanine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X1RG", "drug_id_DB": "", "metabolic_annotation_str": "SLC38A4(Solute carrier family 38 member 4 (SLC38A4) ,MOA:Modulator); SLC38A2(Solute carrier family 38 member 2 (SLC38A2) ,MOA:Modulator); SLC38A1(Solute carrier family 38 member 1 (SLC38A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC38A4", "SLC38A2", "SLC38A1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["55089", "54407", "81539"]}, "Metyrosine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0B3QM", "drug_id_DB": "DB00765", "metabolic_annotation_str": "TH(Tyrosine 3-monooxygenase (TH) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["TH"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["7054"]}, "MGBG": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D05FFR", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "Gallium nitrate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "IL1B(Interleukin-1 beta); BGLAP(Osteocalcin); ", "drug_id_TTD": "", "drug_id_DB": "DB05260", "metabolic_annotation_str": "ATP6V1B2(V-type proton ATPase subunit B, brain isoform); RRM2(Ribonucleoside-diphosphate reductase subunit M2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ATP6V1B2", "RRM2"], "metabolic_genes_id": ["526", "6241"]}, "Beta-D-Mannose": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "RHO(Rhodopsin (RHO) ,MOA:Inhibitor); ", "drug_id_TTD": "D0SD9H", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "PTGS1", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "5742", "23632"]}, "1-adamantan-1-yl-3-(4-pentyloxycylclohexyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05MTA", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Biricodar(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ABCB5(ATP-binding cassette sub-family B member 5); ", "drug_id_TTD": "", "drug_id_DB": "DB04851", "metabolic_annotation_str": "ABCC1(Multidrug resistance-associated protein 1); ABCC1(Multidrug resistance-associated protein 1); ABCG2(ATP-binding cassette sub-family G member 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC1", "ABCC1", "ABCG2"], "metabolic_genes_id": ["4363", "4363", "9429"]}, "NIK-616": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D07UHY", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "8-Propionyl-7-propoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0FY", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "2-p-tolyl-4H-chromene-4-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01VPZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "N-(Adamant-1-yl)-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VXE", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Deserpidine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01089", "metabolic_annotation_str": "SLC18A2(Synaptic vesicular amine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC18A2"], "metabolic_genes_id": ["6571"]}, "Caracemide": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0R5UZ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "(-)-CATECHINGALLATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RB1V", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "(2R)-2-Methyl-4,5-dideoxy": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9DD", "drug_id_DB": "", "metabolic_annotation_str": "PGD(Phosphogluconate dehydrogenase (PGD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PGD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5226"]}, "Huprine X": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09RJH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Nimesulide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "LTF(Lactotransferrin); ", "drug_id_TTD": "", "drug_id_DB": "DB04743", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2); PLA2G2E(Group IIE secretory phospholipase A2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS2", "PLA2G2E"], "metabolic_genes_id": ["5743", "30814"]}, "HPP-851": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0U1BU", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "5,5'-methylenebis(1,3,4-thiadiazole-2(3H)-thione)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03TYV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "2-(heptylthiomethyl)-5-hydroxy-4H-pyran-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F6RH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Cis-1-adamantan-1-yl-3-(4-methoxycyclohexyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08RFH", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "3-benzyl-N-(2-morpholinoethyl)quinoxalin-2-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KW6V", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Glimepiride(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KCNJ1(ATP-sensitive inward rectifier potassium channel 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00222", "metabolic_annotation_str": "ABCC8(ATP-binding cassette sub-family C member 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC8"], "metabolic_genes_id": ["6833"]}, "XR-9577": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S8CE", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1", "ABCC1", "ABCC1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5243", "4363", "4363"]}, "Cacodylate Ion": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CALM1(Calmodulin (CALM) ,MOA:Inhibitor); CALM2(Calmodulin (CALM) ,MOA:Inhibitor); CALM3(Calmodulin (CALM) ,MOA:Inhibitor); TXN(Thioredoxin (TXN) ,MOA:Inhibitor); THRB(Thyroid hormone receptor beta (THRB) ,MOA:Inhibitor); ", "drug_id_TTD": "D09TVP", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "1,2-bis(2,3,5-trifluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2HH", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "8-acetyl-7-(benzyloxy)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O6ZD", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "Acetic acid 2-heptylsulfanyl-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X9VY", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "3'-Oxo-Adenosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7QT", "drug_id_DB": "DB03273", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "Trazodone": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Modulator); ", "drug_id_TTD": "D00USF", "drug_id_DB": "DB00656", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "PINOCEMBRIN": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0G5CS", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "PMID27967267-Compound-12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QJ5H", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID27967267-Compound-13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02SQQ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID27967267-Compound-14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UX5I", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID27967267-Compound-15": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01FRI", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "7-acetonyloxy-3-acetylamino-8-methoxycoumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R4PR", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Triapine": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0DT1R", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6241"]}, "4-Methyl-5,6-dihydro-pyrido[1,2-a]quinolin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07KDB", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "S-(N-methyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FX3J", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "N-(4-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07XMM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "NE97220": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02SNU", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "6-bromo-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04KUP", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "ALPHA-FMH": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0U5BF", "drug_id_DB": "", "metabolic_annotation_str": "HDC(Histidine decarboxylase (HDC) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HDC"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3067"]}, "2-(N''-Acetyl-hydrazino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02KDH", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "768"]}, "7,4'-Dihydroxyflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SY6C", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1-Cyclohexyl-3-phenyl-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C5GW", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "MK-866": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0S2PY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "N5-[4-(2-Oxo-3-phenylpropoxy)phenyl]-L-glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DI4I", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Heptanoic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H2RZ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "6-Benzenesulfonyl-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OZ4C", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "TOCOTRIENOL": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03VFL", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Neostigmine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D08USJ", "drug_id_DB": "DB01400", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "LX-4211": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0U7IL", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Modulator); SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6523", "6524"]}, "5-Pyridin-3-yl-1,3-dihydro-2H-indol-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K2DR", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "BAY 1082439": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0KJ2J", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5291"]}, "N1-(3-phenoxybenzyl)-N3-hydroxymalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UT7Y", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "5-Ethyl-4-propyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03QSQ", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "Tert-Butyl 3-(2-oxohexadecanamido)propanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06OXA", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "UNC0321": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CX4W", "drug_id_DB": "", "metabolic_annotation_str": "EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["10919", "10919", "10919", "10919", "10919", "10919", "10919"]}, "FLUORESCEIN": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "SMAD3(Mothers against decapentaplegic homolog 3 (SMAD3) ,MOA:Inhibitor); ", "drug_id_TTD": "D06TJJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A8(Solute carrier family 22 member 8 (SLC22A8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A8"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9376"]}, "ASKENDOSIDE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07RGP", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "4-hydroxyphenethyl 3,4,5-trihydroxybenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZR4M", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "N-Neopentyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R2GR", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "ONO-1714": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0R5XK", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4843"]}, "ADIPATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KFG", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A8(Solute carrier family 22 member 8 (SLC22A8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A8"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9376"]}, "SODIUM CITRATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KTE", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "Pyridine-amide derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0UY7A", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "6,8-Dinitro-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09PEZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Pyrazofurin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GOC", "drug_id_DB": "", "metabolic_annotation_str": "UMPS(Orotidine 5'-monophosphate decarboxylase (UMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7372"]}, "3-(4-morpholinothieno[3,2-d]pyrimidin-2-yl)phenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05BPX", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5291", "5294"]}, "AMA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05BKG", "drug_id_DB": "", "metabolic_annotation_str": "HDC(Histidine decarboxylase (HDC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HDC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3067"]}, "1-anilinonaphthalene-8-sulfonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C7RS", "drug_id_DB": "", "metabolic_annotation_str": "FABP1(Fatty acid-binding protein 1 (FABP1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2168"]}, "4-(2-(2-fluoro-5-methylphenoxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D04ZPF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "N-methyl-N-(prop-2-ynyl)-1H-pyrrole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ULQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "2,2-Dibenzylcyclopentanol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V5AQ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "2-(tert-Butylamino)-3',4'-dichlorobutyrophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04KZX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "TAK-700": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0X3OI", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1586"]}, "FAICAR": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z5WG", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "US10034861, Example 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V8ZY", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "AP-2243": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1MC", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "S-(N-pentyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3VR", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "1-Hydroxy-8-methoxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CWX", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "10S-hydroxylobel-7-ene": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T6XD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "N-(4-Chloro-3-methanesulfonyl-benzoyl)-guanidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04OTF", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1", "SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6548", "6550", "6550"]}, "ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03UCC", "drug_id_DB": "DB08658", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N-adamantyl-N'-cyclohexylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VZE", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "HM-5016699": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ", "drug_id_TTD": "D02ELN", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "PMID18072721C50": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L6HX", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2-[4-(1H-Indol-5-yl)-phenyl]-propionic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JQ1T", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Lesinurad(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB11560", "metabolic_annotation_str": "SLC22A12(Solute carrier family 22 member 12); SLC22A11(Solute carrier family 22 member 11); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC22A12", "SLC22A11"], "metabolic_genes_id": ["116085", "55867"]}, "Thiazoline derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07UBZ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Thiazoline derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H4LK", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3,4-dihydroxyxanthone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FQ3N", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "AZD8186": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03BHZ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5291", "5294"]}, "Etodolac(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0N1WU", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "4-Chloro-6-nitro-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P0US", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "3-Bromo-1H-indazole-7-carbonitrile": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EHB", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); HRH4(Histamine H4 receptor (H4R) ,MOA:Inhibitor); HRH3(Histamine H3 receptor (H3R) ,MOA:Inhibitor); ", "drug_id_TTD": "D01JXM", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "AV-201": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02ITL", "drug_id_DB": "", "metabolic_annotation_str": "DDC(Aromatic-L-amino-acid decarboxylase (DDC) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DDC"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1644"]}, "1-Ethyl-3-imidazol-1-ylmethyl-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05VAN", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "[2-(Imidazol-2-yl-thio)ethyl]-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B0LU", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "NSC-656158": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MAPK10(Stress-activated protein kinase JNK3 (JNK3) ,MOA:Inhibitor); ", "drug_id_TTD": "D0B4CA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "GR148672X": {"drug_status_TTD": ["Clinical trial", "Clinical trial"], "non_metabolic": "", "drug_id_TTD": "D05EMV", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "23-hydroxybetulinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YDW", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "OCOPHYLLALS A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UH3W", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "OCOPHYLLALS B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y1UG", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00YCG", "drug_id_DB": "DB06828", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Bip-tyr(3bzl)-thr-pro-lys-thr": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01DNN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "1-(4-Methoxy-phenyl)-2-phenyl-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T5XC", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "[3H]N5-methylfolate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C2VP", "drug_id_DB": "", "metabolic_annotation_str": "SLC46A1(Proton-coupled folate transporter (SLC46A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC46A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["113235"]}, "FENOFIBRIC ACID": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0NF1U", "drug_id_DB": "", "metabolic_annotation_str": "FABP1(Fatty acid-binding protein 1 (FABP1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2168"]}, "S-33516": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0DR3I", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "1-(4-tert-butylphenylsulfonyl)-4-methoxyazepane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M3XF", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "EFIPLADIB": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0E1WY", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "5-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7NR", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "PA-10040": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03SSG", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["495"]}, "9-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2YR", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Hydroquinone": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "ITGB3(Glycoprotein IIb/IIIa receptor (GPIIb/IIIa) ,MOA:Antagonist); ITGA2B(Glycoprotein IIb/IIIa receptor (GPIIb/IIIa) ,MOA:Antagonist); ", "drug_id_TTD": "D03UOT", "drug_id_DB": "DB09526", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "BGS-649": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02XMD", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1-(1-phenyl-2-(pyridin-4-yl)ethyl)piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07TEJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Piceatannol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB08399", "metabolic_annotation_str": "ATP5F1B(ATP synthase subunit beta, mitochondrial); ATP5F1A(ATP synthase subunit alpha, mitochondrial); ATP5F1C(ATP synthase subunit gamma, mitochondrial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ATP5F1B", "ATP5F1A", "ATP5F1C"], "metabolic_genes_id": ["506", "498", "509"]}, "BOLINAQUINONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3CM", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "5320"]}, "LCI699": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D03AJU", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B2(Aldosterone synthase (CYP11B2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1585"]}, "7-((1H-imidazol-1-yl)methyl)isoquinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PU5V", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "CPP -15": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0TP1P", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["18"]}, "US20160326143, 38": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0V6RN", "drug_id_DB": "", "metabolic_annotation_str": "LTC4S(Leukotriene C4 synthase (LTC4S) ,MOA:Inhibitor); LTC4S(Leukotriene C4 synthase (LTC4S) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTC4S", "LTC4S"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4056", "4056"]}, "Acarbose(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00284", "metabolic_annotation_str": "MGAM(Maltase-glucoamylase, intestinal); MGAM(Maltase-glucoamylase, intestinal); AMY2A(Pancreatic alpha-amylase); GAA(Lysosomal alpha-glucosidase); SI(Sucrase-isomaltase, intestinal); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MGAM", "MGAM", "AMY2A", "GAA", "SI"], "metabolic_genes_id": ["8972", "8972", "279", "2548", "6476"]}, "FK-409": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0ZM8B", "drug_id_DB": "", "metabolic_annotation_str": "GUCY2D(Soluble guanylyl cyclase (GUCY2D) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY2D"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3000"]}, "4-iodo-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03UTI", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "CP-294838": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G4ZT", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "7-Hydroxy-2-(4-methoxy-benzyl)-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05SLZ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "1400W": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AO5D", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "9-Amino-1,2,3,4-tetrahydro-acridine-1,7-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0PS", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "5-Indan-(1Z)-ylidenemethyl-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09QDY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "[14C]TEA": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNU1(Calcium-activated potassium channel KCa5.1 (KCNU1) ,MOA:Blocker (channel blocker)); KCNQ3(Voltage-gated potassium channel Kv7.3 (KCNQ3) ,MOA:Blocker (channel blocker)); KCNQ2(Voltage-gated potassium channel Kv7.2 (KCNQ2) ,MOA:Blocker (channel blocker)); KCNQ2(Voltage-gated potassium channel Kv7.2 (KCNQ2) ,MOA:Blocker (channel blocker)); KCNA2(Voltage-gated potassium channel Kv1.2 (KCNA2) ,MOA:Blocker (channel blocker)); KCNA6(Voltage-gated potassium channel Kv1.6 (KCNA6) ,MOA:Blocker (channel blocker)); KCNA3(Voltage-gated potassium channel Kv1.3 (KCNA3) ,MOA:Blocker (channel blocker)); KCNA5(Voltage-gated potassium channel Kv1.5 (KCNA5) ,MOA:Blocker (channel blocker)); KCNJ4(Inward rectifier potassium channel Kir2.3 (KCNJ4) ,MOA:Blocker (channel blocker)); KCNC1(Voltage-gated potassium channel Kv3.1 (KCNC1) ,MOA:Blocker (channel blocker)); KCNQ4(Voltage-gated potassium channel Kv7.4 (KCNQ4) ,MOA:Blocker (channel blocker)); KCNC4(Voltage-gated potassium channel Kv3.4 (KCNC4) ,MOA:Blocker (channel blocker)); KCNA1(Voltage-gated potassium channel Kv1.1 (KCNA1) ,MOA:Blocker (channel blocker)); KCNC3(Voltage-gated potassium channel Kv3.3 (KCNC3) ,MOA:Blocker (channel blocker)); KCNB1(Voltage-gated potassium channel Kv2.1 (KCNB1) ,MOA:Blocker (channel blocker)); KCNA10(Voltage-gated potassium channel Kv1.8 (KCNA10) ,MOA:Blocker (channel blocker)); KCNT1(Calcium-activated potassium channel KCa4.1 (KCNT1) ,MOA:Blocker (channel blocker)); KCNT2(Calcium-activated potassium channel KCa4.2 (KCNT2) ,MOA:Blocker (channel blocker)); KCNMB4(Charybdotoxin receptor beta-4 (BKbeta4) ,MOA:Inhibitor); KCNN1(Calcium-activated potassium channel KCa2.1 (KCNN1) ,MOA:Blocker (channel blocker)); KCNB2(Voltage-gated potassium channel Kv2.2 (KCNB2) ,MOA:Blocker (channel blocker)); KCNC2(Voltage-gated potassium channel Kv3.2 (KCNC2) ,MOA:Blocker (channel blocker)); KCNA7(Voltage-gated potassium channel Kv1.7 (KCNA7) ,MOA:Blocker (channel blocker)); KCNN2(Calcium-activated potassium channel KCa2.2 (KCNN2) ,MOA:Blocker (channel blocker)); KCNQ5(Voltage-gated potassium channel Kv7.5 (KCNQ5) ,MOA:Blocker (channel blocker)); KCND1(Voltage-gated potassium channel Kv4.1 (KCND1) ,MOA:Blocker (channel blocker)); KCNN3(Calcium-activated potassium channel KCa2.3 (KCNN3) ,MOA:Blocker (channel blocker)); TRPV2(Transient receptor potential cation channel V2 (TRPV2) ,MOA:Blocker (channel blocker)); ", "drug_id_TTD": "D06PZZ", "drug_id_DB": "", "metabolic_annotation_str": "AQP1(Aquaporin-1 (AQP1) ,MOA:Inhibitor); SLC47A2(Multidrug and toxin extrusion protein 2 (MATE2) ,MOA:Modulator); SLC47A1(Solute carrier family 47 member 1 (SLC47A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AQP1", "SLC47A2", "SLC47A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Modulator", "Modulator"], "metabolic_genes_id": ["358", "146802", "55244"]}, "MF-8615": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0K0XG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "8-(3-Chlorobenzyloxy)caffeine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08YCE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "PMID28870136-Compound-61": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04GYR", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "13-(n-Pentylcarbamoyloxy)tridec-8(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03CSL", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Sterol derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0O0OD", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Sterol derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YZ3U", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Sterol derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08FMC", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2-(N-tert-Butylamino)-3'-chlorohexanophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8IZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "4-(4-Chlorophenyl)-5-(4-methoxyphenyl)isothiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PQ3Q", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "6-Methyl-4-(4-benzoylpiperazin-1-yl)coumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09NEH", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-Amino-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J2AE", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA4", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "762", "768", "23632"]}, "BLI-1005": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0E2EY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "example 166  (WO2014154727)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01QJT", "drug_id_DB": "", "metabolic_annotation_str": "CTSA(Cathepsin A (CTSA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTSA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5476"]}, "SULTHIAME": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06PII", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "N-Hydroxy-3-naphthalen-2-yl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09PDD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "ZAPOTIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04FIN", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "(S)-2-((4-phenoxyphenoxy)methyl)piperidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05NXQ", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "(2S,3S)-iodoreboxetine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KKN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "1-(2-(4-fluorophenoxy)phenyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0M3TK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07TAJ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "762", "765", "768", "23632"]}, "IMGN-853": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07DPC", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2348"]}, "6-Isoquinolin-4-yl-3,4-dihydroquinolin-2(1H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03YHZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "OPC-21268": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "AVPR1A(Vasopressin V1a receptor (V1AR) ,MOA:Antagonist); ", "drug_id_TTD": "D08ORO", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID30074415-Compound-GS3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01YQE", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "1-(4-aminophenyl)-2-pyrrolidin-1-yl-pentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R2BM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "PMID9216829C5m": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4LW", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "(S)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}serinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IN0X", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "5-{8(Z),11(Z)-pentadecadienyl}resorcinol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04WLH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID29757691-Compound-8c": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0VQ2N", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "PMID29757691-Compound-8b": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D04FAS", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "PMID29757691-Compound-8a": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0RS6O", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "PMID9216829C5j": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05OHM", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "4-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M5EW", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-(benzimidazole/indole) benzoic acid derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02JPV", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "N-(benzimidazole/indole) benzoic acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S6TL", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "3-Fluoro-4-hydrazino-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01YHK", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "N-methyl estradiol-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JI0Q", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "(6-Methoxy-2-oxo-2H-quinolin-1-yl)-acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7MD", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Aminoglutethemide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09IBZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Sphingosine(TTD)": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0L0YG", "drug_id_DB": "", "metabolic_annotation_str": "PCYT1B(Cholinephosphate cytidylyltransferase (PCYT1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PCYT1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9468"]}, "(cis)-1,6-diphenyl-3-aza-bicyclo[3.1.0]hexane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ZFG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "INCB50465": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07RHP", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "INDISULAM": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04IIU", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["768"]}, "7-butoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LU4S", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "765", "768", "23632"]}, "Cyclic hydroxamate derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0IE8M", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "JNJ-10392980": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D00UIN", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Udenafil": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01GUS", "drug_id_DB": "DB06267", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "NB-598": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0I3XW", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "8-(3-Azido-phenyl)-6-pyridin-4-ylmethyl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z5SB", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "S-p-bromobenzyl glutatione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R3IN", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "BAY 1021189": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06ZEO", "drug_id_DB": "", "metabolic_annotation_str": "GUCY2D(Soluble guanylyl cyclase (GUCY2D) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY2D"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3000"]}, "2-propylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8WV", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "TCD-717": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0G2XR", "drug_id_DB": "", "metabolic_annotation_str": "CHKA(Choline kinase (CHKA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CHKA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1119"]}, "PMID29473428-Compound-50": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03CTR", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-53": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09LKN", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-52": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FY1Q", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "MyriberineA": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I9CK", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "PMID29473428-Compound-54": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YY4R", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2-N-(Isopropyl)amino-1-(4-methylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7VU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "PMID29473428-Compound-59": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08XQG", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-58": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09HVV", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(+/-)-huprineY hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00DKI", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "AX-006": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GQP", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "4-[5-(3-Hydroxyphenyl)-3-thienyl]-2-methylphenol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D01RZP", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565", "3292"]}, "EDP-322": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D09LSY", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5243"]}, "3,4-Benzo-7-acetonyloxy-8-methylcoumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y1XS", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Trapidil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PDGFRB(Platelet-derived growth factor receptor beta); ", "drug_id_TTD": "", "drug_id_DB": "DB09283", "metabolic_annotation_str": "PDE2A(cGMP-dependent 3',5'-cyclic phosphodiesterase); PDE8A(High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A); PDE5A(cGMP-specific 3',5'-cyclic phosphodiesterase); PDE9A(High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A); PDE8B(High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B); PDE6A(Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha); PDE4A(cAMP-specific 3',5'-cyclic phosphodiesterase 4A); PDE6B(Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta); PDE6C(Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'); PDE1A(Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A); PDE1B(Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B); PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); PDE4C(cAMP-specific 3',5'-cyclic phosphodiesterase 4C); PDE4D(cAMP-specific 3',5'-cyclic phosphodiesterase 4D); PDE3B(cGMP-inhibited 3',5'-cyclic phosphodiesterase B); PDE7A(High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A); PDE1C(Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C); PDE3A(cGMP-inhibited 3',5'-cyclic phosphodiesterase A); PDE11A(Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A); PDE7B(cAMP-specific 3',5'-cyclic phosphodiesterase 7B); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PDE2A", "PDE8A", "PDE5A", "PDE9A", "PDE8B", "PDE6A", "PDE4A", "PDE6B", "PDE6C", "PDE1A", "PDE1B", "PDE4B", "PDE4C", "PDE4D", "PDE3B", "PDE7A", "PDE1C", "PDE3A", "PDE11A", "PDE7B"], "metabolic_genes_id": ["5138", "5151", "8654", "5152", "8622", "5145", "5141", "5158", "5146", "5136", "5153", "5142", "5143", "5144", "5140", "5150", "5137", "5139", "50940", "27115"]}, "US8853215, 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0IV0E", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "METHYLENEDIOXYAMPHETAMINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TMK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "5-Bromo-8-imidazol-1-ylmethyl-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UI8Q", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N1-benzyl-N3-hydroxy-2-isobutylmalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06TVS", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "MOL 6131": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q4PB", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "N-benzyl-9-oxo-9,10-dihydroacridine-3-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z0YB", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "DL-TBOA": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GUB", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A7(Excitatory amino acid transporter 5 (SLC1A7) ,MOA:Inhibitor); SLC1A3(Excitatory amino acid transporter 1 (SLC1A3) ,MOA:Inhibitor); SLC1A2(Excitatory amino acid transporter 2 (SLC1A2) ,MOA:Inhibitor); SLC1A1(Excitatory amino acid transporter 3 (SLC1A1) ,MOA:Inhibitor); SLC1A6(Excitatory amino acid transporter 4 (SLC1A6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A7", "SLC1A3", "SLC1A2", "SLC1A1", "SLC1A6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6512", "6507", "6506", "6505", "6511"]}, "PMID27977313-Compound-28": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QA9N", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-29": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0PT8T", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Naphthalen-2-yl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q0BV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "TOFIMILAST": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09TFB", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "PMID27977313-Compound-27": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08BVX", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "N5-(1-iminopropyl)-L-ornithine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04PBI", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "3-(6-Amino-purin-9-yl)-4-phenethyloxy-butan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D8YG", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Lactam derivative 3": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0H9RP", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "PMID22464687C15a": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E9TE", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Lactam derivative 4": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0A8SI", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "Lactam derivative 5": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D04QGW", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "UNIFLORINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J2JM", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2548"]}, "Bromfenac(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00963", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "1-(cyclohexyl)methyl-5'-O-tritylinosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ITH", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "NKP-46": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0V2RK", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6241"]}, "Isocitric Acid(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R6GQ", "drug_id_DB": "", "metabolic_annotation_str": "ACO2(Citrate hydro-lyase (ACO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACO2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["50"]}, "N5-[4-(2-phenylethoxy)phenyl]-L-glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N6TC", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "1-((9H-Fluoren-2-yl)ethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZME", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "3-(dodecylsulfinyl)-1,1,1-trifluoropropan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B4GJ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1-(2-(naphthalen-2-yl)ethyl)piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7UJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "6-Chloro-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B8BC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "[2-(Benzoimidazol-1-yl)ethyl]-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P2BY", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Eflornithine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0X7JR", "drug_id_DB": "DB06243", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "Phenylarsonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M6RM", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "Piclamilast(TTD)": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Z2FB", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "PMID27321640-Compound-59": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09RWM", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "PMID27321640-Compound-58": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02PFP", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Guanine(TTD)": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D08NKJ", "drug_id_DB": "", "metabolic_annotation_str": "GCH1(GTP cyclohydrolase-I (GCH1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCH1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2643"]}, "Delapril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0G8QW", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "4-(1-Imidazol-1-yl-vinyl)-benzonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N7QV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "NXN-462": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0W9IT", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "(6-methylthio-2-naphthyl)isopropylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R4TI", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "2-Aminomethyl-5-(p-chlorophenyl)tetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RT9B", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "ISIS 191756": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ZCH", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["8694", "8694"]}, "ISIS 191755": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YZW", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["8694", "8694"]}, "S-(N-butyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XKH", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "SOPHORAFLAVANONE B": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ESR1(Estrogen receptor (ESR) ,MOA:Inhibitor); ESR2(Estrogen receptor beta (ESR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0S8AV", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "SUN13834": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0I8FV", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1215"]}, "CLR457": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D07ACZ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "PMID29334795-Compound-61": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "HRH1(Histamine H1 receptor (H1R) ,MOA:.); HRH3(Histamine H3 receptor (H3R) ,MOA:.); ", "drug_id_TTD": "D0FA3G", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6532"]}, "S-(4-Cyanobenzyl)isothiourea hydrobromide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03JMD", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01KOO", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Loxapine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRM2(Muscarinic acetylcholine receptor M2); CHRM4(Muscarinic acetylcholine receptor M4); HTR1A(5-hydroxytryptamine receptor 1A); CHRM5(Muscarinic acetylcholine receptor M5); ADRA2A(Alpha-2A adrenergic receptor); CHRM1(Muscarinic acetylcholine receptor M1); DRD2(D(2) dopamine receptor); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); CHRM3(Muscarinic acetylcholine receptor M3); DRD1(D(1A) dopamine receptor); DRD1(D(1A) dopamine receptor); DRD4(D(4) dopamine receptor); DRD4(D(4) dopamine receptor); DRD5(D(1B) dopamine receptor); DRD5(D(1B) dopamine receptor); HRH2(Histamine H2 receptor); HTR1D(5-hydroxytryptamine receptor 1D); HTR1B(5-hydroxytryptamine receptor 1B); HTR2A(5-hydroxytryptamine receptor 2A); HTR1E(5-hydroxytryptamine receptor 1E); HTR7(5-hydroxytryptamine receptor 7); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); HTR3A(5-hydroxytryptamine receptor 3A); HTR5A(5-hydroxytryptamine receptor 5A); HTR6(5-hydroxytryptamine receptor 6); HRH4(Histamine H4 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00408", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-oxo-N-phenyl-2H-chromene-3-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03PXS", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "2beta,3alpha-dihydroxyurs-12-en-28-oic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BU6J", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "1-cyclohexylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G9NE", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "GSK-1360707": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0K7OW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "N-(1-benzofuran-3-ylmethyl)sulfamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7DE", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "16-(2',2'-Dimethyl)-propylidene-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ZNI", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "6-hydroxy-1,2-dimethyl-9H-beta-carbolin-2-ium": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CGV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "BPH-742": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X8YK", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "KAZINOL S": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02UUK", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Epigallocatechin gallate(TTD)": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "ELANE(Neutrophil elastase (NE) ,MOA:Inhibitor); ELANE(Neutrophil elastase (NE) ,MOA:Inhibitor); MMP2(Matrix metalloproteinase-2 (MMP-2) ,MOA:Inhibitor); MMP14(Matrix metalloproteinase-14 (MMP-14) ,MOA:Inhibitor); ", "drug_id_TTD": "D0U2BH", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN", "SQLE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2194", "6713"]}, "Benzaldehyde O-benzoyloxime": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A1SO", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7941"]}, "MANGIFERIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04UYB", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "DASANTAFIL": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0K2QG", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "Lobeline(TTD)": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01IVE", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6571"]}, "BAY 79-4620": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03PQW", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["768"]}, "ALX-5407": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D05WWJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6536"]}, "Hydroxyalanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BI4H", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "LY-266111": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7OP", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "S-Ethyl-N-Phenyl-Isothiourea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01TDG", "drug_id_DB": "DB03707", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842"]}, "GS-6624": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09NCU", "drug_id_DB": "", "metabolic_annotation_str": "LOXL2(Lysyl oxidase homolog 2 (LOXL2) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["LOXL2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["4017"]}, "1-(2-hydroxyphenyl)-3-p-tolylprop-2-en-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ZDQ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "PMID27841045-Compound-134": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FM8Q", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1PZ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Perindopril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03KYG", "drug_id_DB": "DB00790", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "ABBV-2451": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0VT6X", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1080"]}, "AMENTOFLAVONE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "GABRA1(GABA(A) receptor alpha-1 (GABRA1) ,MOA:Inhibitor); GABRG2(GABA(A) receptor gamma-2 (GABRG2) ,MOA:Inhibitor); GABRA5(GABA(A) receptor alpha-5 (GABRA5) ,MOA:Inhibitor); GABRA3(GABA(A) receptor alpha-3 (GABRA3) ,MOA:Inhibitor); GABRA2(GABA(A) receptor alpha-2 (GABRA2) ,MOA:Inhibitor); GABRB2(GABA(A) receptor beta-2 (GABRB2) ,MOA:Inhibitor); MCL1(Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1) ,MOA:Inhibitor); ", "drug_id_TTD": "D06HRX", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Tetra-hydro-isoquinoline derivative 3": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D02EME", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "MAOA", "ACHE", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "4128", "43", "4129"]}, "Tetra-hydro-isoquinoline derivative 2": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0NB7Z", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "MAOA", "ACHE", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "4128", "43", "4129"]}, "Tetra-hydro-isoquinoline derivative 1": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D04AXC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "MAOA", "ACHE", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "4128", "43", "4129"]}, "Velaglucerase alfa": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0G5ET", "drug_id_DB": "DB06720", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Modulator); GBA(Glucosylceramidase (GBA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2629", "2629"]}, "4'-(Pyridin-4-ylmethyl)biphenyl-4-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P5CT", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "L-Myo-Inositol-1-Phosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03542", "metabolic_annotation_str": "IMPA1(Inositol monophosphatase 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["IMPA1"], "metabolic_genes_id": ["3612"]}, "3-(1H-indol-1-yl)-N-methyl-3-phenylpropan-1-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PJD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "(5-(pyridin-3-yl)furan-2-yl)methanamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D06QFO", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Acetic acid 2-hex-2-ynylsulfanyl-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RCV", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "3-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VUO", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1-D-glucopyranosyl cytosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02AFI", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "G-207 virus construct": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2", "Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0YU1M", "drug_id_DB": "", "metabolic_annotation_str": "RRM1(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2B(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM1", "RRM2", "RRM2B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6240", "6241", "50484"]}, "1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D08EKQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Coenzyme A(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KAT2A(Histone acetyltransferase KAT2A); KAT2B(Histone acetyltransferase KAT2B); KAT5(Histone acetyltransferase KAT5); ", "drug_id_TTD": "", "drug_id_DB": "DB01992", "metabolic_annotation_str": "CS(Citrate synthase, mitochondrial); HMGCR(3-hydroxy-3-methylglutaryl-coenzyme A reductase); DBI(Acyl-CoA-binding protein); CRAT(Carnitine O-acetyltransferase); ACAT2(Acetyl-CoA acetyltransferase, cytosolic); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CS", "HMGCR", "DBI", "CRAT", "ACAT2"], "metabolic_genes_id": ["1431", "3156", "1622", "1384", "39"]}, "8-Bromo-6-methyl-3-(4'-methoxyphenyl)coumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H3RQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "AG-221": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0K7FT", "drug_id_DB": "", "metabolic_annotation_str": "IDH3B(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH1(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH2(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH3A(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH3G(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDH3B", "IDH1", "IDH2", "IDH3A", "IDH3G"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3420", "3417", "3418", "3419", "3421"]}, "N-benzyl-2-oxo-2H-chromene-3-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06QNN", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID27967267-Compound-39": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04XHE", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID27967267-Compound-36": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00AQW", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["43"]}, "Trichlormethiazide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01021", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); ATP1A1(Sodium/potassium-transporting ATPase subunit alpha-1); CA4(Carbonic anhydrase 4); SLC12A3(Solute carrier family 12 member 3); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA1", "CA2", "ATP1A1", "CA4", "SLC12A3"], "metabolic_genes_id": ["759", "760", "476", "762", "6559"]}, "1H-1,2,3-benzotriazol-1-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D07ANY", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "4-(2-amino-1,3-thiazol-4-yl)phenol(TTD)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01KOI", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1", "LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203", "4048"]}, "FR-229934": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0W8QG", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "Teriflunomide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB08880", "metabolic_annotation_str": "DHODH(Dihydroorotate dehydrogenase (quinone), mitochondrial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["DHODH"], "metabolic_genes_id": ["1723"]}, "Rosuvastatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0JE2E", "drug_id_DB": "DB01098", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "1-(2-(3-chlorophenyl)-1-phenylethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EX2M", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "Adamantan-1-yl-piperazin-1-yl-methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00DDJ", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "MEDI6012": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0T5YB", "drug_id_DB": "", "metabolic_annotation_str": "LCAT(Lecithin-cholesterol acyltransferase (LCAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LCAT"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3931"]}, "4-methoxyphenylboronic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4HS", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07NRP", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07ZTT", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0PP8O", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0JJ8K", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0D4YR", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00YOY", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07EUB", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "3,3'-(3-Phenylthiene-2,5-diyl)diphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B6SF", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J8YF", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Phentermine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "NPY(Pro-neuropeptide Y); ", "drug_id_TTD": "", "drug_id_DB": "DB00191", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); SLC6A2(Sodium-dependent noradrenaline transporter); MAOB(Amine oxidase [flavin-containing] B); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MAOA", "SLC6A2", "MAOB", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["4128", "6530", "4129", "6532", "6531", "6531"]}, "Diethylphosphono Group": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06SWV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "PMID25399762-Compound-Table1-C14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V2NC", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Eliglustat tartrate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0J8IJ", "drug_id_DB": "", "metabolic_annotation_str": "UGCG(Ceramide glucosyltransferase (UGCG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["UGCG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7357"]}, "2-Bromo-N-(2-morpholinoethyl)nicotinamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02BBT", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "PMID25399762-Compound-Table1-C15": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08YYW", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Sodium nitroprusside": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D07XVR", "drug_id_DB": "", "metabolic_annotation_str": "GUCY1A1(Soluble guanylate cyclase (GCS) ,MOA:Modulator); GUCY1B1(Soluble guanylate cyclase (GCS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY1A1", "GUCY1B1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2982", "2983"]}, "PMID25399762-Compound-Table1-C17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00KTI", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA2C(Adrenergic receptor alpha-2C (ADRA2C) ,MOA:Inhibitor); HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0C1SE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Trimipramine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ADRB2(Beta-2 adrenergic receptor); CHRM2(Muscarinic acetylcholine receptor M2); CHRM4(Muscarinic acetylcholine receptor M4); HTR1A(5-hydroxytryptamine receptor 1A); CHRM5(Muscarinic acetylcholine receptor M5); ADRA2A(Alpha-2A adrenergic receptor); CHRM1(Muscarinic acetylcholine receptor M1); ADRB3(Beta-3 adrenergic receptor); DRD2(D(2) dopamine receptor); ADRA2B(Alpha-2B adrenergic receptor); CHRM3(Muscarinic acetylcholine receptor M3); DRD1(D(1A) dopamine receptor); DRD5(D(1B) dopamine receptor); HTR1D(5-hydroxytryptamine receptor 1D); HTR2A(5-hydroxytryptamine receptor 2A); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); HTR3A(5-hydroxytryptamine receptor 3A); ", "drug_id_TTD": "", "drug_id_DB": "DB00726", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Acarbose Derived Hexasaccharide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03AHW", "drug_id_DB": "DB03971", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["279"]}, "(4-nitrophenyl)(10H-phenothiazin-10-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4RD", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N-methyl-1-(2-thiophen-2-ylphenyl)methanamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2YG", "drug_id_DB": "DB07196", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "PMID25399762-Compound-Table 7-Veratraldehyde": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0TR7N", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "2-hydroxy-5-isopropyl-2,4,6-cycloheptatrien-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z1XR", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "6,8-Dichloro-1,2,3,4-tetrahydro-acridin-9-ylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D4SK", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "BXT-51072": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07NCV", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4843"]}, "4-(2-(3-fluorophenoxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0IC4J", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "N-Hydroxy-3-phenyl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MYE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID25399762-Compound-Table1-C19": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01PCI", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Abiraterone acetate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06CNP", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1586"]}, "MEPTAZINOL": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0S5YC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Bisquinolinium derivative": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DA0V", "drug_id_DB": "", "metabolic_annotation_str": "CHKA(Choline kinase (CHKA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CHKA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1119"]}, "PMID19456099C13": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00QFL", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID19456099C15": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B9EV", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Dutasteride(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0A9YA", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "79644"]}, "TURBINATINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I0EN", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Pargyline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01626", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); MAOB(Amine oxidase [flavin-containing] B); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_genes_id": ["4128", "4129"]}, "GSK618334": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0HI1K", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "2-Chloro-N-(2-morpholinoethyl)nicotinamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R5EW", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "2-Hydrazino-3-methyl-4(3H)-quinazolinone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02VIV", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "2-(2,4-dichlorophenyl)-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3VS", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "2-Sulfamoyl-benzoic acid methyl ester": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CQI", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "768"]}, "ISIS 32039": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07NAT", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "Isosorbide-di-(propylcarbamate)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FP5F", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "R-226161": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA2C(Adrenergic receptor alpha-2C (ADRA2C) ,MOA:Inhibitor); TACR1(Substance-P receptor (TACR1) ,MOA:Inhibitor); ADRA1A(Adrenergic receptor alpha-1A (ADRA1A) ,MOA:Inhibitor); HRH1(Histamine H1 receptor (H1R) ,MOA:Inhibitor); ", "drug_id_TTD": "D0PN9R", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Peldesine": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08OBT", "drug_id_DB": "DB02568", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "1,2-Di-naphthalen-2-yl-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03WOU", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "ISIS 32035": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02IBE", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "LAS-37779": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0V2CN", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "1-(4-nitrophenyl)-2-pyrrolidin-1-yl-pentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06QGD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "FR239087": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ZMX", "drug_id_DB": "DB03370", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "1-Phenyl-3-(1-propionylpiperidin-4-yl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R6CW", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "PMID25470667-Compound-PF-04620110": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z7VF", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "AS-601811": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0P9EL", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "6-acetyl-7-propoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7KJ", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "LU-53439": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BV8Y", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "7-(2-Nitro-ethyl)-azepan-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03CAJ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "2-N-Ethylamino-1-(4-ethylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05UHO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "MEM-1414": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03CWX", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "BMS-820132": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D02AVC", "drug_id_DB": "", "metabolic_annotation_str": "GCK(Glucokinase (GCK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2645"]}, "L-MDAM": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0S9OH", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1719"]}, "2-N-Methylamino-1-(4-ethylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R8XV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "4-Piperidino-Piperidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07WHV", "drug_id_DB": "DB03056", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "CRILVASTATIN": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0CC8L", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "1-(Bis-biphenyl-4-yl-methyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L6HY", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "1-Cyclohexyl-3-phenethyl-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08RPW", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "L-2-Amino-4-(Guanidinooxy)Butyric Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V9FZ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "ALPHA-NAPHTHOFLAVONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "PRKDC(DNA-dependent protein kinase catalytic (PRKDC) ,MOA:Inhibitor); ", "drug_id_TTD": "D0I7GE", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "EUK-207": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0U1FZ", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "N-(Chlorophenyl)-N'-Hydroxyguanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08DNK", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "1-(3,5-difluorobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HTG", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "GZ402671": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0LR4Q", "drug_id_DB": "", "metabolic_annotation_str": "UGCG(Ceramide glucosyltransferase (UGCG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["UGCG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7357"]}, "2-(tert-butylamino)-1-m-tolylpropan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7CS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "STX-140": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07ZNI", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "STS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "412"]}, "[14C]GlySar": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PWQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC15A1(Solute carrier family 15 member 1 (SLC15A1) ,MOA:Modulator); SLC15A2(Solute carrier family 15 member 2 (SLC15A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC15A1", "SLC15A2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6564", "6565"]}, "SC-558": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C1GO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "(R/S)-2-((4-benzylphenoxy)methyl)piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H9NZ", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "PMID22533316C4": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZEY", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "PMID22533316C3": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z3CK", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "PMID22533316C1": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XPB", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "1,3-bis(nitrooxy)propan-2-yl 2-acetoxybenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4QW", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Dihydropyrido pyrimidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FO4C", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W4IK", "drug_id_DB": "DB02895", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "N-hydroxy-4-(naphthalen-1-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HDAC8(Histone deacetylase 8 (HDAC8) ,MOA:Inhibitor); ", "drug_id_TTD": "D03HNC", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Monoamine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00EGV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Cholic Acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ESRRG(Estrogen-related receptor gamma); GPBAR1(G-protein coupled bile acid receptor 1); NR1H4(Bile acid receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB02659", "metabolic_annotation_str": "ADH1C(Alcohol dehydrogenase 1C); MT-CO1(Cytochrome c oxidase subunit 1); MT-CO2(Cytochrome c oxidase subunit 2); MT-CO3(Cytochrome c oxidase subunit 3); PLA2G1B(Phospholipase A2); COX6C(Cytochrome c oxidase subunit 6C); COX8A(Cytochrome c oxidase subunit 8A, mitochondrial); COX5B(Cytochrome c oxidase subunit 5B, mitochondrial); COX4I1(Cytochrome c oxidase subunit 4 isoform 1, mitochondrial); COX6B1(Cytochrome c oxidase subunit 6B1); COX7C(Cytochrome c oxidase subunit 7C, mitochondrial); COX5A(Cytochrome c oxidase subunit 5A, mitochondrial); FECH(Ferrochelatase, mitochondrial); CES1(Liver carboxylesterase 1); CES1(Liver carboxylesterase 1); COX7A1(Cytochrome c oxidase subunit 7A1, mitochondrial); COX7B(Cytochrome c oxidase subunit 7B, mitochondrial); FABP6(Gastrotropin); COX6A2(Cytochrome c oxidase subunit 6A2, mitochondrial); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ADH1C", "MT-CO1", "MT-CO2", "MT-CO3", "PLA2G1B", "COX6C", "COX8A", "COX5B", "COX4I1", "COX6B1", "COX7C", "COX5A", "FECH", "CES1", "CES1", "COX7A1", "COX7B", "FABP6", "COX6A2"], "metabolic_genes_id": ["126", "4512", "4513", "4514", "5319", "1345", "1351", "1329", "1327", "1340", "1350", "9377", "2235", "1066", "1066", "1346", "1349", "2172", "1339"]}, "PXS-4159": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R0FU", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8639"]}, "Imipramine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KCNH1(Potassium voltage-gated channel subfamily H member 1); CHRM2(Muscarinic acetylcholine receptor M2); CHRM4(Muscarinic acetylcholine receptor M4); HTR1A(5-hydroxytryptamine receptor 1A); CHRM5(Muscarinic acetylcholine receptor M5); CHRM1(Muscarinic acetylcholine receptor M1); DRD2(D(2) dopamine receptor); ORM2(Alpha-1-acid glycoprotein 2); CHRM3(Muscarinic acetylcholine receptor M3); DRD1(D(1A) dopamine receptor); DRD5(D(1B) dopamine receptor); ADRA1D(Alpha-1D adrenergic receptor); HTR2A(5-hydroxytryptamine receptor 2A); HTR7(5-hydroxytryptamine receptor 7); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); HTR6(5-hydroxytryptamine receptor 6); KCNH2(Potassium voltage-gated channel subfamily H member 2); KCND2(Potassium voltage-gated channel subfamily D member 2); KCND3(Potassium voltage-gated channel subfamily D member 3); ", "drug_id_TTD": "", "drug_id_DB": "DB00458", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "ICARIIN": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D05OQG", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "6-oxo-16-formyl-estrone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02JRB", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "KRN-2391": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0S6SU", "drug_id_DB": "", "metabolic_annotation_str": "ABCC9(ATP-binding cassette transporter C9 (ABCC9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["10060"]}, "Plevitrexed (R)-isomer": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04FYZ", "drug_id_DB": "", "metabolic_annotation_str": "TYMS(Thymidylate synthase (TYMS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7298"]}, "FIG 1": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04WVV", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Azetidinyl-piperazine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0B5BT", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "ZD-2138": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07HBI", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Azetidinyl-piperazine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00KFI", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "2-(N-Cyclopentylamino)-3'-methylpropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9EO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "3-[4-(5-Chloro-2-thienyl)pyridin-2-yl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A7PU", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "CHALCONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ERH", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "AA-861": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D06XRQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "(E)-5-(3-Chlorostyryl)isatin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06AJP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "5-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D00NSA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "L-5-(bromovinyl)deoxyuridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7FB", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "(R)-2-(4-Benzylphenoxymethyl)pyrrolidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06SMN", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "2-Cyclohexyl-N-(4-methoxy-phenyl)-acetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6OL", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "1-(3-benzylquinoxalin-2-yl)hydrazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O4XF", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "3-Bromo-6-nitro-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02PKR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "N-n-hexyl-7-methoxytacrine hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9YQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Prifelone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GBX", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "(R)-Norfluoxetine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ENH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-(benzylideneamino)ethanesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U0QW", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Aminolevulinic Acid Hydrochloride": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0O4GY", "drug_id_DB": "", "metabolic_annotation_str": "PPOX(Protoporphyrinogen oxidase (PPOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PPOX"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5498"]}, "PMID26666989-Compound-Figure9middle11": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D01DXB", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9middle10": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D03WPO", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9middle13": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0MT6D", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9middle12": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D08GSN", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "Nomifensine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04821", "metabolic_annotation_str": "MPO(Myeloperoxidase); MAOA(Amine oxidase [flavin-containing] A); SLC6A2(Sodium-dependent noradrenaline transporter); MAOB(Amine oxidase [flavin-containing] B); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC18A2(Synaptic vesicular amine transporter); ", "drug_status_DB": ".", "metabolic_genes_name": ["MPO", "MAOA", "SLC6A2", "MAOB", "SLC6A4", "SLC6A3", "SLC6A3", "SLC18A2"], "metabolic_genes_id": ["4353", "4128", "6530", "4129", "6532", "6531", "6531", "6571"]}, "1,11-bis(pyridinium)-undecane dibromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07YJG", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Calcium carbimide(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0A9KF", "drug_id_DB": "", "metabolic_annotation_str": "ALDH1A1(Acetaldehyde dehydrogenase (ALDH) ,MOA:Inhibitor); ALDH2(Acetaldehyde dehydrogenase (ALDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH1A1", "ALDH2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["216", "217"]}, "3-Nitro-4'-nitro-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J8FS", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "L-Alanine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09PUL", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "5-(4-Methoxyphenyl)-4-p-tolylisothiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08RCQ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "MK-434": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07UOS", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "79644"]}, "2-(4-methoxyphenyl)-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K8SK", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "6,7-Dihydroxy-2-phenyl-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05HBF", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "2-Imidazol-1-yl-7-methoxy-3-phenyl-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W4IB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "NE21650": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ZDC", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "BENZENESULFONAMIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09QHC", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["759"]}, "1,3-Bis-(3-imidazolidin-2-yl-phenyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QXU", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "LAM-002": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0JW6R", "drug_id_DB": "", "metabolic_annotation_str": "PIKFYVE(Phosphatidylinositol-3-phosphate 5-kinase (PIP5K3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIKFYVE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["200576"]}, "EXRD-4605": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X0ZD", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "CONTIGOSIDE B": {"drug_status_TTD": ["Phase 2/3", "Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D04PBH", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE", "AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1636", "231"]}, "R-NORDULOXETINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WB6P", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "FR233623": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7CM", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "S-Benzyl-Glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K2UP", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "2-benzyl-N1-hydroxy-N3-phenethylmalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D8FZ", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Dexniguldipine(TTD)": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0B1MJ", "drug_id_DB": "", "metabolic_annotation_str": "ABCB4(Multidrug resistance protein 3 (ABCB4) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5244"]}, "Acanthus ilicifolius Linn": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CXQ", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A", "ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["279", "240", "240"]}, "PMID29473428-Compound-34": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0IS1M", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-33": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S7BW", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(4-fluorophenyl)(pyridin-4-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J0WO", "drug_id_DB": "DB06917", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Tadalafil(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05MQK", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "PMID29473428-Compound-39": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02XQE", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["3620"]}, "PMID27414413-Compound-Figure8right": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0D5YG", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "PMID28870136-Compound-47": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FK2Q", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "VOACANGINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00AJB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "TAK-802": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03GAX", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "4-(4-hydroxybenzylideneamino)benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R6JK", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Tadalafil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00820", "metabolic_annotation_str": "PDE5A(cGMP-specific 3',5'-cyclic phosphodiesterase); PDE11A(Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PDE5A", "PDE11A"], "metabolic_genes_id": ["8654", "50940"]}, "1-Imidazol-1-yl-3-(4-octylphenoxy)propan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y2BD", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "PMID28447479-Compound-4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0GA6X", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "3-(2-Bromophenyl)-6-methylcoumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8ET", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "JTT-553": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0U5NY", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "N-Benzyl,N-methyl-1H-indole-2-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0TN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Ethylvanillin": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N9JJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "NSC-75308": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AAP", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "MG-28": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09IGF", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "Scopolamine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRM2(Muscarinic acetylcholine receptor M2); CHRM4(Muscarinic acetylcholine receptor M4); CHRM5(Muscarinic acetylcholine receptor M5); CHRM1(Muscarinic acetylcholine receptor M1); CHRNB2(Neuronal acetylcholine receptor subunit beta-2); CHRM3(Muscarinic acetylcholine receptor M3); CHRNA4(Neuronal acetylcholine receptor subunit alpha-4); ", "drug_id_TTD": "", "drug_id_DB": "DB00747", "metabolic_annotation_str": "SI(Sucrase-isomaltase, intestinal); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SI"], "metabolic_genes_id": ["6476"]}, "P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GSY", "drug_id_DB": "DB03752", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "3-(4-(4-hydroxyphenyl)phthalazin-1-ylamino)phenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8XY", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "4-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C6US", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "4-((1H-imidazol-1-yl)methyl)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0QW7W", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "L-betagamma-meATP": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "PDXK(Pyridoxal kinase (PDXK) ,MOA:Inhibitor); INSR(Insulin receptor (INSR) ,MOA:Inhibitor); ", "drug_id_TTD": "D0UG4S", "drug_id_DB": "", "metabolic_annotation_str": "PDXK(Pyridoxal kinase (PDXK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDXK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8566"]}, "BVDU-MP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PC2Y", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "N-[5-(2-Nitro-phenyl)-furan-2-carbonyl]-guanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D3OX", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "Nitroglycerin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00727", "metabolic_annotation_str": "NPR1(Atrial natriuretic peptide receptor 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["NPR1"], "metabolic_genes_id": ["4881"]}, "D-Gluconhydroximo-1,5-Lactam": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R2BA", "drug_id_DB": "", "metabolic_annotation_str": "LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LCT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3938"]}, "N-p-Tolyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DR7A", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "6-(Toluene-4-sulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IB8C", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "2-hydroxyphenethyl 3,4,5-trihydroxybenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09YJS", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "analog 3 (Vlattas et al., 1996)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GAU", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "Bimetopyrole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04IXJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "NSAIDs": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PZH", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "4-(4-propoxyphenoxy)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y6IV", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "PF-3409409": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CHRM4(Muscarinic acetylcholine receptor M4 (CHRM4) ,MOA:Inhibitor); CHRM5(Muscarinic acetylcholine receptor M5 (CHRM5) ,MOA:Inhibitor); ", "drug_id_TTD": "D0N2KU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "NPS 1776": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00DBH", "drug_id_DB": "", "metabolic_annotation_str": "ALDH3A2(Fatty aldehyde dehydrogenase (ALDH3A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH3A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["224"]}, "threo-3-methylglutamate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04MSI", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A2(Excitatory amino acid transporter 2 (SLC1A2) ,MOA:Inhibitor); SLC1A6(Excitatory amino acid transporter 4 (SLC1A6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A2", "SLC1A6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6506", "6511"]}, "N-benzyl-1H-pyrrole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4FA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "DS-7423": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Modulator); ", "drug_id_TTD": "D0X4RT", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "N-biphenyl-3-ylmethyl-N'-hydroxy-malonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J9TD", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "(R/S) EF-1500": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H2HC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); SLC6A12(Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1", "SLC6A12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6529", "6539"]}, "[3H]N-methyl-SSR504734": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GI5V", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "5-hydroxy-2-(pentylthiomethyl)-4H-pyran-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GRN", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "AC1LDDOQ": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0NI7A", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "Flurpiridaz F 18": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0U1VZ", "drug_id_DB": "", "metabolic_annotation_str": "NDUFA13(Mitochondrial complex I (NDUFA13) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NDUFA13"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["51079"]}, "3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09JRN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "2-Sulfhydryl-Ethanol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "SERPINA1(Alpha-1-antitrypsin (SERPINA1) ,MOA:Inhibitor); SERPINA1(Alpha-1-antitrypsin (SERPINA1) ,MOA:Inhibitor); HMGB1(High mobility group protein B1 (HMGB1) ,MOA:Inhibitor); CDC25B(M-phase inducer phosphatase 2 (MPIP2) ,MOA:Inhibitor); PDF(Polypeptide deformylase (PDF) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Q5FV", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); HSD3B1(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); HSD3B2(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "ALAD", "HSD3B1", "HSD3B2", "GLO1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "210", "3283", "3284", "2739"]}, "ISIS 191731": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01PKX", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["8694", "8694"]}, "EUGENOL": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "AR(Androgen receptor messenger RNA (AR mRNA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0O4QB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "AGN-190383": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HZ3Q", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5319"]}, "1-phenyl-2-(1-phenyl-1H-tetrazol-5-yloxy)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y9XK", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "N-(4'-methyl-piperazinyl) estradiol-16-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08NFA", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "MT-001": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ZIK", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3156"]}, "MTR105": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X1RQ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "Guanosine-5'-Monophosphate(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "DLG4(Presynaptic density protein 95 (DLG4) ,MOA:Inhibitor); ", "drug_id_TTD": "D04AWP", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "2-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C0MP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "EPICATECHIN": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05TPI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "16-(2',2'-Dimethyl)-propylidene-estrone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I0KV", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Meclofenamate Sodium": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0MN9K", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Riociguat(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB08931", "metabolic_annotation_str": "GUCY1A2(Guanylate cyclase soluble subunit alpha-2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["GUCY1A2"], "metabolic_genes_id": ["2977"]}, "N-(biphenyl-4-yl)benzo[d]isoxazol-3-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IM1Q", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "PMID2296036C4d": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I9TR", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Acetaminophen(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0U5QK", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "SLC6A2", "SLC6A4", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "6530", "6532", "5743"]}, "PMID2296036C4i": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ZAL", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Decamethonium(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRNB2(Neuronal acetylcholine receptor subunit beta-2); CHRNA4(Neuronal acetylcholine receptor subunit alpha-4); CHRNA2(Neuronal acetylcholine receptor subunit alpha-2); ", "drug_id_TTD": "", "drug_id_DB": "DB01245", "metabolic_annotation_str": "ACHE(Acetylcholinesterase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ACHE"], "metabolic_genes_id": ["43"]}, "N-hydroxycarbamate derivative": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HRH1(Histamine H1 receptor (H1R) ,MOA:Inhibitor); ", "drug_id_TTD": "D0L7FS", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HOE", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "2-phenoxy-3-(piperidin-4-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0CG2Y", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "15-hydroxyeicosatetraenoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01VLQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "2-(p-Methylsulfonylbenzoyl)furan": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VBX", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "2-Pyridin-2-ylmethyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KCN", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "BMS-536924": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ERBB2(ERBB2 messenger RNA (HER2 mRNA) ,MOA:Inhibitor); LCK(LCK tyrosine protein kinase (LCK) ,MOA:Inhibitor); IGF1R(Insulin-like growth factor I receptor (IGF1R) ,MOA:Inhibitor); MET(Proto-oncogene c-Met (MET) ,MOA:Inhibitor); PDGFRB(Platelet-derived growth factor receptor beta (PDGFRB) ,MOA:Inhibitor); PDGFRA(Platelet-derived growth factor receptor alpha (PDGFRA) ,MOA:Inhibitor); CCNE1(G1/S-specific cyclin-E1 (CCNE1) ,MOA:Inhibitor); CDK2(Cyclin-dependent kinase 2 (CDK2) ,MOA:Inhibitor); MAPK1(Extracellular signal-regulated kinase 2 (ERK2) ,MOA:Inhibitor); AKT1(RAC-alpha serine/threonine-protein kinase (AKT1) ,MOA:Inhibitor); KDR(Vascular endothelial growth factor receptor 2 (KDR) ,MOA:Inhibitor); PTK2(Focal adhesion kinase 1 (FAK) ,MOA:Inhibitor); ", "drug_id_TTD": "D0M4SY", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "EVT302": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06PHS", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "A-78773": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0X9KE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "SQ-26332": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Inhibitor); ", "drug_id_TTD": "D0I5QZ", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "FK-070": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "TBXA2R(Thromboxane A2 receptor (TBXA2R) ,MOA:Modulator); ", "drug_id_TTD": "D0WH9U", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6916"]}, "PMID26815044-Compound-H": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00YRS", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-I": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K2XK", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03KYZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Curcumin(TTD)": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "APP(Amyloid beta A4 protein (APP) ,MOA:Inhibitor); MMP9(Matrix metalloproteinase-9 (MMP-9) ,MOA:Inhibitor); MMP13(Matrix metalloproteinase-13 (MMP-13) ,MOA:Inhibitor); DNMT3B(DNA [cytosine-5]-methyltransferase 3B (DNMT3B) ,MOA:Inhibitor); ", "drug_id_TTD": "D07SDQ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CYP3A4", "CA4", "PTGS1", "CA6", "NOS2", "PTGS2", "XDH", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "1576", "762", "5742", "765", "4843", "5743", "7498", "768", "23632"]}, "Sulfamic acid 6-sulfamoyloxy-hexyl ester": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X0PO", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "4-formylphenyl-O-beta-Dglucopyranoside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ELG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "CV-6504.HCL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F0KV", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6916"]}, "Coformycin": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T0OW", "drug_id_DB": "", "metabolic_annotation_str": "AMPD1(Adenosine monophosphate deaminase (AMPD) ,MOA:Inhibitor); AMPD3(Adenosine monophosphate deaminase (AMPD) ,MOA:Inhibitor); AMPD2(Adenosine monophosphate deaminase (AMPD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMPD1", "AMPD3", "AMPD2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["270", "272", "271"]}, "3-Ethoxy-5-(6-methoxynaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y3AV", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "FolateImmune": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0N8JG", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2348"]}, "3-[6-(5-Chloro-2-thienyl)pyridin-2-yl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05AIT", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "PMID25470667-Compound-K-604": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04TSP", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "1-(2,5-Dimethyl-1H-pyrrol-1-yl)thiourea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZVP", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "NE11808": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W0FX", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "PMID30273516-Compound-12": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D05TBZ", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "PMID30273516-Compound-15": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0KN6L", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "PMID30273516-Compound-14": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0YE0P", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "AZD-7806": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FCT", "drug_id_DB": "", "metabolic_annotation_str": "SLC10A2(Ileal sodium/bile acid cotransporter (SLC10A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC10A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6555"]}, "3-[5-(4-Hydroxyphenyl)-3-thienyl]phenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NM0P", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "3292"]}, "2-(4-hydroxyphenyl)-7-methoxychroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3LM", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "ZD-9720": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D04GJX", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Modulator); LSS(Lanosterol synthase (LSS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["4047", "4047"]}, "PD-146176": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0J8RS", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "3-[2-(5-Chloro-2-thienyl)pyridin-4-yl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0QX5D", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "8-Bromo-Adenosine-5'-Monophosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R5ZH", "drug_id_DB": "DB03349", "metabolic_annotation_str": "PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5142"]}, "5-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyrimidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04REX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1-(1-Propionylpiperidin-4-yl)-3-p-tolylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I4KB", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "1-(1-(4'-Ethylbiphenyl-4-yl)propyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X1DV", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "S-2474": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04DUJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "N-(4-Sulfamoyl-phenyl)-isobutyramide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T2YZ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "768"]}, "Clomipramine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0ZS8P", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "PMID28627961-Compound-22": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EB9M", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "1,1,1-Trifluoro-7-phenylheptan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08YHD", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Methyl 2-(Benzylamino)-1H-indole-3-carboxylate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05IQL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-(4-methoxyphenyl)-3-(4-methylthiazol-2-yl)urea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G3SF", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "7-Pyridin-3-yl-2H-1,4-benzothiazin-3(4H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O7TC", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "N-isobutyl-2-oxo-2H-chromene-3-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09FAD", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "2'-aminoimidazolylmethyluracils": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CQ1J", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "6-(4-Fluorobutyl)-4-methylpyridin-2-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GYE", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "3,5-Dihydroxyl-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J4VR", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "A-80263": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0T4EL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Phenyl Boronic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EJ9B", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "ZD-7717": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D06YOD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Hexahydro-cyclopenta[c]pyrrol-(1Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LE6N", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "PMID2153213C1a": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R1FP", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID2153213C1e": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EAN", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID2153213C1f": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RA8F", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID28870136-Compound-60": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MA9U", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "Cyclothiazide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03CNS", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Salsalate(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y0JH", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "1,2,4-Triazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OT2H", "drug_id_DB": "DB03594", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "BW284C51": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O1QB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Suronacrine maleate": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0MZ9A", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE", "SLC6A2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["43", "6530"]}, "BIS(20)-HUPERZINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZJK", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Canagliflozin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D08DFX", "drug_id_DB": "DB08907", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MD4U", "drug_id_DB": "DB02878", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["210"]}, "StarGen": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0F6SY", "drug_id_DB": "", "metabolic_annotation_str": "ABCA4(ATP-binding cassette transporter A4 (ABCA4) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCA4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["24"]}, "5-(2-phenethylpiperazin-1-yl)-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F5AQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A8HW", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "NBI-98854": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0IX1I", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6571"]}, "Aminosalicylic Acid": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D01WJL", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Modulator); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["1719", "5742", "5743"]}, "1-[6-(triphenylmethoxy)hexyl]thymine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02CCD", "drug_id_DB": "", "metabolic_annotation_str": "TK2(Thymidine kinase 2 (Mt-TK2) ,MOA:Inhibitor); TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK2", "TK1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7084", "7083"]}, "2'-epi-guianin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KYE", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Satigrel": {"drug_status_TTD": ["Discontinued in Preregistration"], "non_metabolic": "", "drug_id_TTD": "D0L0MO", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6916"]}, "PMID28870136-Compound-69": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08LPX", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "N-benzyl-6-(3,3,3-trifluoropropoxy)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02YEE", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Diazacholesterol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06IAT", "drug_id_DB": "", "metabolic_annotation_str": "DHCR24(Delta(24)-sterol reductase (DHCR24) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DHCR24"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1718"]}, "Topiramate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CACNB4(Voltage-dependent L-type calcium channel subunit beta-4); CACNA1F(Voltage-dependent L-type calcium channel subunit alpha-1F); GABRA1(Gamma-aminobutyric acid receptor subunit alpha-1); SCN1A(Sodium channel protein type 1 subunit alpha); SCN4A(Sodium channel protein type 4 subunit alpha); GRIK1(Glutamate receptor ionotropic, kainate 1); CACNB3(Voltage-dependent L-type calcium channel subunit beta-3); SCN7A(Sodium channel protein type 7 subunit alpha); CACNA1D(Voltage-dependent L-type calcium channel subunit alpha-1D); CACNB1(Voltage-dependent L-type calcium channel subunit beta-1); CACNB2(Voltage-dependent L-type calcium channel subunit beta-2); GRIK2(Glutamate receptor ionotropic, kainate 2); GRIK3(Glutamate receptor ionotropic, kainate 3); CACNA1S(Voltage-dependent L-type calcium channel subunit alpha-1S); SCN5A(Sodium channel protein type 5 subunit alpha); SCN9A(Sodium channel protein type 9 subunit alpha); CACNA1E(Voltage-dependent R-type calcium channel subunit alpha-1E); GRIK4(Glutamate receptor ionotropic, kainate 4); GRIK5(Glutamate receptor ionotropic, kainate 5); SCN2A(Sodium channel protein type 2 subunit alpha); SCN11A(Sodium channel protein type 11 subunit alpha); SCN8A(Sodium channel protein type 8 subunit alpha); SCN10A(Sodium channel protein type 10 subunit alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB00273", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); CA4(Carbonic anhydrase 4); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA1", "CA2", "CA3", "CA4"], "metabolic_genes_id": ["759", "760", "761", "762"]}, "2-Oxoolean-12-en-28-oic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZJM", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "ISIS 32014": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00TQI", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "ISIS 32015": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V9MH", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "ISIS 32010": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3RP", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "(+/-)-2-(4'-Butoxyphenyl)thiomorpholin-5-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4GR", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Pyridoxamine-5'-Phosphate(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01NBK", "drug_id_DB": "", "metabolic_annotation_str": "BCAT2(Branched-chain-amino-acid transaminase 2 (BCAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCAT2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["587"]}, "5,6-Dichloro-N-(2-morpholinoethyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J3IA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Autologous cell based gene therapy": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0H3GK", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4846"]}, "3-(3-Carboxy-propionylamino)-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H5XD", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "4-isothiocyanatobenzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1AN", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "2-(tert-Butylamino)-3',5'-difluoropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02NUR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "E-4021": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00SPK", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "1-(2-Naphthyl)-2-aminopropane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00YVE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "2-(cyclooctylamino)-5,5-diethyloxazol-4(5H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4ZR", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "4-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YD9J", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "1-(4-chlorophenylsulfonyl)-4-phenylazepan-4-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KG3M", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "TOLOXATONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V3NT", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "5-(4-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04KCX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzothiazole analog 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AE8D", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzothiazole analog 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z0DX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzothiazole analog 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WT1C", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzothiazole analog 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03PLQ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Benzothiazole analog 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00DYI", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID17963374C31": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R0UV", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Sulfinpyrazone(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D03DEI", "drug_id_DB": "", "metabolic_annotation_str": "ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Modulator); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC1", "ABCC1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["4363", "4363"]}, "SA-6541": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03UIF", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Papaverine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01113", "metabolic_annotation_str": "PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PDE4B"], "metabolic_genes_id": ["5142"]}, "8-amino-9-benzylguanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z3OD", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "RPR-101821": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D08ALQ", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2222"]}, "(E)-2-(4-(methylsulfonyl)styryl)furan": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UD5X", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Genistein(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ESR1(Estrogen receptor); SHBG(Sex hormone-binding globulin); TOP2A(DNA topoisomerase 2-alpha); ESRRA(Steroid hormone receptor ERR1); AKT1(RAC-alpha serine/threonine-protein kinase); PTK2B(Protein-tyrosine kinase 2-beta); NCOA2(Nuclear receptor coactivator 2); NCOA1(Nuclear receptor coactivator 1); ESR2(Estrogen receptor beta); GPER1(G-protein coupled estrogen receptor 1); ", "drug_id_TTD": "", "drug_id_DB": "DB01645", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CYP1B1"], "metabolic_genes_id": ["1545"]}, "1,2-Bis-(4-chloro-phenyl)-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05EYA", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "ENASIDENIB MESYLATE": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0WH4P", "drug_id_DB": "", "metabolic_annotation_str": "IDH3B(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH1(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH2(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH3A(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); IDH3G(Isocitrate dehydrogenase (IDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDH3B", "IDH1", "IDH2", "IDH3A", "IDH3G"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3420", "3417", "3418", "3419", "3421"]}, "N-isopropylnorlitebamineN-methoiodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PF3Z", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID25514969-Compound-Figure2-3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L5NZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "US8846654, 11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EF6R", "drug_id_DB": "", "metabolic_annotation_str": "PDE8A(Phosphodiesterase 8 (PDE8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE8A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5151"]}, "3,3'-(1,2,4-Thiadiazol-2,5-diyl)diphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R5WV", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "(+/-)-2-(4'-Methoxyphenyl)thiomorpholine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TFN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Miglitol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GANAB(Neutral alpha-glucosidase AB); ", "drug_id_TTD": "", "drug_id_DB": "DB00491", "metabolic_annotation_str": "MGAM(Maltase-glucoamylase, intestinal); MGAM(Maltase-glucoamylase, intestinal); GAA(Lysosomal alpha-glucosidase); GANC(Neutral alpha-glucosidase C); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MGAM", "MGAM", "GAA", "GANC"], "metabolic_genes_id": ["8972", "8972", "2548", "2595"]}, "ARI-3037MO": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01VMZ", "drug_id_DB": "", "metabolic_annotation_str": "DGAT2(Diacylglycerol O-acyltransferase 2 (DGAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["84649"]}, "Lisinopril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07HGR", "drug_id_DB": "DB00722", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "O-Acetylserine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IB5L", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "5-Chlorosalicylic Acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05FMD", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03WQK", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Oxametacin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9QW", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "TDI-0060": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BT4P", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "chaetocin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04FNI", "drug_id_DB": "", "metabolic_annotation_str": "SUV39H1(Lysine N-methyltransferase 1A (SUV39H1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SUV39H1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6839"]}, "Isosorbide-di-(butylcarbamate)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05XPW", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N-[(5-chloro-1-benzothien-3-yl)methyl]sulfamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GI2R", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "N2-(3-trifluoromethylphenyl)guanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YJ5W", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "3,4-Dihydro-1H-quinolin-(2E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4SV", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "AllerB": {"drug_status_TTD": ["Phase 2b"], "non_metabolic": "", "drug_id_TTD": "D0C0KP", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "1-adamantan-1-yl-3-(6-hydroxyhexyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z8RL", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "N-(phosphonacetyl)-L-aspartate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L6CN", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CAD(Aspartate carbamoyltransferase (CAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA4", "CAD"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "762", "790"]}, "1-methyl-1H-indole-3-carbonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FSR", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "1,4-phenylene disulfamate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C6ED", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "768"]}, "6-Hydroxy-7,8-Dihydro Purine Nucleoside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4UU", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "1-(10H-phenothiazin-10-yl)-2-phenylbutan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N6XS", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08NQM", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4129", "5294"]}, "1-(3-Oxocyclohexylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z9JS", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "7-chloro-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X0ER", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "2-Acetylamino-indan-5-sulfonic acid hydrate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TBP", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "DCCCyB": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0R8HY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "PMID25399762-Compound-Figure1-Sarcaboside A": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05GWJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "4,6-Dideoxy-4-Amino-Alpha-D-Glucose": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y9RY", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["279"]}, "N-(4-Sulfamoyl-phenyl)-butyramide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K3LN", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "PMID25399762-Compound-Figure1-Sarcaboside B": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05MYL", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "3-((1H-imidazol-1-yl)methyl)aniline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C7YL", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "GLPDGG peptide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X0GV", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "(E)-4-(2-(thiophen-2-yl)vinyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02VXW", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "1-(1-Biphenyl-4-yl-2-phenyl-ethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M8JE", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "GlyT1 PET radiotracers": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D02XSL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "Talmapimod(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); IL1B(Interleukin-1 beta); MAPK14(Mitogen-activated protein kinase 14); ", "drug_id_TTD": "", "drug_id_DB": "DB05412", "metabolic_annotation_str": "MT-CO2(Cytochrome c oxidase subunit 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MT-CO2"], "metabolic_genes_id": ["4513"]}, "Benzothiazole-2-sulfonic acid amide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XL5K", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "N,N'-(1',7'-heptylene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EX1R", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "N-dodecylgallate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VS1V", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "Pralidoxime Chloride": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0X7NU", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["43"]}, "Ethyl octylfluorophosphonate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6GY", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "SOTB07": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06VFP", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "5-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0L8ND", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Acetyldigitoxin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0V3GA", "drug_id_DB": "DB00511", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["476"]}, "ZSTK474": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0O1LD", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "4-[(diphenylmethyl)amino]-2-phenylquinazoline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "AGTR1(Angiotensin II receptor type-1 (AGTR1) ,MOA:Antagonist); ", "drug_id_TTD": "D0RE7T", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "LY-2599506": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01CGV", "drug_id_DB": "", "metabolic_annotation_str": "GCK(Glucokinase (GCK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2645"]}, "1-(4-hydroxyphenyl)prop-2-en-1-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L7RB", "drug_id_DB": "", "metabolic_annotation_str": "ALDH5A1(Succinate-semialdehyde dehydrogenase (ALDH5A1) ,MOA:Inhibitor); ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH5A1", "ABAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7915", "18"]}, "Repaglinide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PPARG(Peroxisome proliferator-activated receptor gamma); ", "drug_id_TTD": "", "drug_id_DB": "DB00912", "metabolic_annotation_str": "ABCC8(ATP-binding cassette sub-family C member 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC8"], "metabolic_genes_id": ["6833"]}, "1-(2,2'-bithiophen-5-yl)methanamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R7BT", "drug_id_DB": "DB07094", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "3-Imidazol-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JCO", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "24-ethyl-cholest-7-ene-3,5,6-triol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J4LR", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "(5-pyridin-3-yl-furan-2-yl)methanethiol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0YP4A", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "CGS-13080": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D09QRO", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "LINOLEIC ACID": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03LOG", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "Esomeprazole(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "DDAH1(N(G),N(G)-dimethylarginine dimethylaminohydrolase 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00736", "metabolic_annotation_str": "ATP4A(Potassium-transporting ATPase alpha chain 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ATP4A"], "metabolic_genes_id": ["495"]}, "5-Iodo-2'-Deoxyuridine-5'-Monophosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04GXW", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "URC102": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03BSK", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "NMI-1182": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D04SHO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "7-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00WFB", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3VJ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "Goxalapladib": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0MC3R", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7941"]}, "PGX-200097": {"drug_status_TTD": ["Preclinical", "Preclinical"], "non_metabolic": "DRD2(Dopamine D2 receptor (D2R) ,MOA:Inhibitor); ", "drug_id_TTD": "D0U1CL", "drug_id_DB": "", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "NSC-58046": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D9NQ", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "8-(3-Fluorobenzyloxy)caffeine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04LPY", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "AMG-221": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07EBU", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "1-(4-chlorobenzyl)-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C9AD", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "ABBV-2737": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0U0QC", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1080"]}, "CGS-30440": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Modulator); ", "drug_id_TTD": "D0KR3X", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "HouttuynoidA": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0P1PC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "PMID29473428-Compound-15": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0DW4P", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L8KM", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XT4V", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07NFQ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K8EV", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L9BG", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["3620"]}, "S6-nitrobenzyl mercaptopurine riboside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TOP", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2030"]}, "DS-7250": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0Z2QR", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Modulator); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8694", "8694"]}, "1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D09FIC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-(3'-Allyl-biphenyl-4-yl)-propionic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M9RL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "2-(4-chlorobenzylidene)cyclopentyl ethyl ether": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XMO", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "KU-0060648": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "PRKDC(DNA-dependent protein kinase catalytic (PRKDC) ,MOA:Inhibitor); ", "drug_id_TTD": "D0R0TW", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5291", "5294"]}, "SQ-14603": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CVG", "drug_id_DB": "", "metabolic_annotation_str": "CPA1(Carboxypeptidase A1 (CPA1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CPA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1357"]}, "Pyrrolopyrimidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KX3H", "drug_id_DB": "", "metabolic_annotation_str": "ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC1", "ABCC1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4363", "4363"]}, "IODOSUPROFEN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T5DO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "4-Methylbenzenemethanethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K3SZ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4-chloro-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04AXR", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "S 0957": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00UCE", "drug_id_DB": "", "metabolic_annotation_str": "SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC37A4", "SLC37A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2542", "2542"]}, "1,2-bis(2,3,6-trifluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E2IG", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "8-AMINOGUANINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R6UA", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "BI-135585": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0B5HF", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3290"]}, "1-(3,5-dibromobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GIW", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "(R/R)BEFLOXATONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M0XR", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "4-(2-(4-fluorobenzyloxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0R3TA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Valdecoxib(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00580", "metabolic_annotation_str": "CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA2", "CA3", "PTGS2"], "metabolic_genes_id": ["760", "761", "5743"]}, "PMID25399762-Compound-Table 5-O-methyl-M30": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03VGN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Doxepin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRM2(Muscarinic acetylcholine receptor M2); CHRM4(Muscarinic acetylcholine receptor M4); HTR1A(5-hydroxytryptamine receptor 1A); CHRM5(Muscarinic acetylcholine receptor M5); CHRM1(Muscarinic acetylcholine receptor M1); CHRM3(Muscarinic acetylcholine receptor M3); HRH2(Histamine H2 receptor); ADRA1D(Alpha-1D adrenergic receptor); HTR2A(5-hydroxytryptamine receptor 2A); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); HTR2B(5-hydroxytryptamine receptor 2B); HTR6(5-hydroxytryptamine receptor 6); KCNH2(Potassium voltage-gated channel subfamily H member 2); HRH4(Histamine H4 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01142", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "NC-2500": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KKF", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Methotrexate Sodium": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0D3DU", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1719"]}, "2-phenyl-5H-indeno[1,2-d]pyrimidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3BX", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "MMDA(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HTR2A(5-hydroxytryptamine receptor 2A); ", "drug_id_TTD": "", "drug_id_DB": "DB01442", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); SLC6A2(Sodium-dependent noradrenaline transporter); MAOB(Amine oxidase [flavin-containing] B); SLC6A4(Sodium-dependent serotonin transporter); SLC18A1(Chromaffin granule amine transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC18A2(Synaptic vesicular amine transporter); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["MAOA", "SLC6A2", "MAOB", "SLC6A4", "SLC18A1", "SLC6A3", "SLC6A3", "SLC18A2"], "metabolic_genes_id": ["4128", "6530", "4129", "6532", "6570", "6531", "6531", "6571"]}, "S-Ethylisothiourea(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4NQ", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "RB 2": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "P2RY2(P2Y purinoceptor 2 (P2RY2) ,MOA:Inhibitor); P2RY6(P2Y purinoceptor 6 (P2RY6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0B0ZQ", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "ISIS-GCCRrx": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0J3RP", "drug_id_DB": "", "metabolic_annotation_str": "GUCY2C(Guanylyl cyclase C (GUCY2C) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY2C"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2984"]}, "Voglibose": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D04ZTY", "drug_id_DB": "DB04878", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "1,3-Dihydro-naphtho[2,3-d]imidazol-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3UP", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "6-chloro-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W0OJ", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "PF-4191834": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0L5XG", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-Amino-3-chloro-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YU8J", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "BS 7840": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0J9SO", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "4-aminosalicylate sodium (oral controlled release, ulcerative colitis), AGI Therapeutics": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0Q3QS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "L-454560": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JD4C", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "UCPH-101": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I3EE", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A3(Excitatory amino acid transporter 1 (SLC1A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6507"]}, "1,3,9,9a-Tetrahydro-imidazo[4,5-b]quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07LCE", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "Edrophonium(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0S5LH", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "L-NMMA": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0O3IT", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "Daratumumab": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0RV4P", "drug_id_DB": "DB09331", "metabolic_annotation_str": "CD38(Cyclic ADP-ribose hydrolase 1 (CD38) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["CD38"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["952"]}, "ISIS 140161": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O1CN", "drug_id_DB": "", "metabolic_annotation_str": "SOAT2(SOAT2 messenger RNA (SOAT2 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOAT2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["8435"]}, "LX2931": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09ZWH", "drug_id_DB": "", "metabolic_annotation_str": "SGPL1(Sphingosine-1-phosphate lyase 1 (SGPL1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SGPL1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8879"]}, "L-659,699": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07SEU", "drug_id_DB": "", "metabolic_annotation_str": "HMGCS1(Hydroxymethylglutaryl-CoA synthase 1 (HMGCS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3157"]}, "T2c-003": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D00QKL", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["231"]}, "Pyrimidine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WR0Q", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "[14C]glycine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09LLO", "drug_id_DB": "", "metabolic_annotation_str": "SLC38A4(Solute carrier family 38 member 4 (SLC38A4) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC38A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["55089"]}, "Methyl-piperidine compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XM9M", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "1-propyl-5'-O-tritylinosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05OUP", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "4-(4-fluoro-benzylideneamino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6RO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Pyrrolo[2,3-d]pyrimidine derivative 28": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "BTK(Tyrosine-protein kinase BTK (ATK) ,MOA:Inhibitor); ", "drug_id_TTD": "D00GTY", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "ANOLOBINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "DRD2(Dopamine D2 receptor (D2R) ,MOA:Inhibitor); ", "drug_id_TTD": "D0M1OE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "GSK2330672": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X8CH", "drug_id_DB": "", "metabolic_annotation_str": "SLC10A2(Ileal sodium/bile acid cotransporter (SLC10A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC10A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6555"]}, "N-(2,4-Dimethoxy-phenyl)-3,5-dimethoxy-benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J9OG", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "E2027": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0S0FD", "drug_id_DB": "", "metabolic_annotation_str": "PDE9A(Phosphodiesterase 9 (PDE9) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE9A"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["5152"]}, "NP-61": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D04UKJ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Beta-D-Glucose(TTD)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "GANAB(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_id_TTD": "D07ONX", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); GAA(Alpha-glucosidase (GLA) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); GCK(Glucokinase (GCK) ,MOA:Inhibitor); GANC(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A", "GAA", "PYGM", "PTGS1", "GCK", "GANC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["279", "2548", "5837", "5742", "2645", "2595"]}, "2'-deoxythymidine triphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09WYY", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "Pyrido[3,2-e][1,2,4]triazolo[4,3-a]pyrazine derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D01LSP", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "2,5-Dideoxy-2,5-imino-D-mannitol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R5HV", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "US8592431, 457": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K8EF", "drug_id_DB": "", "metabolic_annotation_str": "SLC33A1(Acetyl-CoA transporter (SLC33A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC33A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9197"]}, "3-methoxy-N-(4-methylthiazol-2-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "GRM5(Metabotropic glutamate receptor 5 (mGluR5) ,MOA:Inhibitor); ", "drug_id_TTD": "D0L3RY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "BOF-4272": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0B8SC", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PF-04691502": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Modulator); ", "drug_id_TTD": "D0N5JZ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "GOSSYPETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z7EL", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "HYDRAZINECARBOXAMIDE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4IY", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Cyclopropane 1-carboxylic acid derivative 10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FW5Q", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Uridine-5'-Diphosphate(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HAL", "drug_id_DB": "", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GALE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2582"]}, "4-(Pent-3-ylamino)-1-naphthol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08MOG", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Curcumin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GSTP1(Glutathione S-transferase P); VDR(Vitamin D3 receptor); PPARG(Peroxisome proliferator-activated receptor gamma); ", "drug_id_TTD": "", "drug_id_DB": "DB11672", "metabolic_annotation_str": "ABCC5(Multidrug resistance-associated protein 5); CBR1(Carbonyl reductase [NADPH] 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC5", "CBR1"], "metabolic_genes_id": ["10057", "873"]}, "RHC80267": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LXG", "drug_id_DB": "", "metabolic_annotation_str": "DAGLB(Diacylglycerol lipase beta (DAGLB) ,MOA:Inhibitor); DAGLA(Diacylglycerol lipase alpha (DAGLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DAGLB", "DAGLA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["221955", "747"]}, "1,1,1,2,2-Pentafluoro-9-phenyl-nonan-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05MUN", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Geranylcoumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03DMA", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Pyridoxine-5'-Phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B8JD", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "Ezetimibe(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00973", "metabolic_annotation_str": "ANPEP(Aminopeptidase N); SOAT1(Sterol O-acyltransferase 1); NPC1L1(Niemann-Pick C1-like protein 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ANPEP", "SOAT1", "NPC1L1"], "metabolic_genes_id": ["290", "6646", "29881"]}, "(+/-)-threo-N-(6-Phenylhexyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07LRZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Sulphadoxine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07PAO", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "RTU-1096": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F8KR", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8639"]}, "Hydroxy amidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05QAL", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3-(1-Benzyl-1H-imidazol-5-yl)-1-propanol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D8KN", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Hydrochlorothiazide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KCNMA1(Calcium-activated potassium channel subunit alpha-1); ", "drug_id_TTD": "", "drug_id_DB": "DB00999", "metabolic_annotation_str": "SLC12A3(Solute carrier family 12 member 3); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC12A3"], "metabolic_genes_id": ["6559"]}, "Diacerein(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); NR1H2(Oxysterols receptor LXR-beta); NR1H3(Oxysterols receptor LXR-alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB11994", "metabolic_annotation_str": "CYP1A2(Cytochrome P450 1A2); CYP2E1(Cytochrome P450 2E1); CYP3A4(Cytochrome P450 3A4); ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2D6(Cytochrome P450 2D6); CYP2C9(Cytochrome P450 2C9); CYP3A5(Cytochrome P450 3A5); CYP3A7(Cytochrome P450 3A7); CYP3A43(Cytochrome P450 3A43); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CYP1A2", "CYP2E1", "CYP3A4", "ALOX5", "ALOX5", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2C9", "CYP3A5", "CYP3A7", "CYP3A43"], "metabolic_genes_id": ["1544", "1571", "1576", "240", "240", "1565", "1565", "1565", "1565", "1565", "1559", "1577", "1551", "64816"]}, "3,4-Dihydroxycinnamic Acid(TTD)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "MIF(Macrophage migration inhibitory factor (MIF) ,MOA:Inhibitor); MIF(Macrophage migration inhibitory factor (MIF) ,MOA:Inhibitor); ", "drug_id_TTD": "D0V9EN", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PARABEN": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0A8JP", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "N-Hydroxy-2-methyl-3-naphthalen-2-yl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I9RY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Donepezil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GRIN2D(Glutamate receptor ionotropic, NMDA 2D); GRIN3B(Glutamate receptor ionotropic, NMDA 3B); IL1B(Interleukin-1 beta); NFKB1(Nuclear factor NF-kappa-B p105 subunit); HTR2A(5-hydroxytryptamine receptor 2A); TNFAIP6(Tumor necrosis factor-inducible gene 6 protein); NFKB2(Nuclear factor NF-kappa-B p100 subunit); GRIN1(Glutamate receptor ionotropic, NMDA 1); GRIN2A(Glutamate receptor ionotropic, NMDA 2A); GRIN2B(Glutamate receptor ionotropic, NMDA 2B); GRIN2C(Glutamate receptor ionotropic, NMDA 2C); GRIN3A(Glutamate receptor ionotropic, NMDA 3A); ", "drug_id_TTD": "", "drug_id_DB": "DB00843", "metabolic_annotation_str": "BCHE(Cholinesterase); ACHE(Acetylcholinesterase); NOS1(Nitric oxide synthase, brain); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["BCHE", "ACHE", "NOS1"], "metabolic_genes_id": ["590", "43", "4842"]}, "5-chloro-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9ZQ", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "1-(1,4-diphenylbutan-2-yl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L7BK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "1,2-bis(3,5-difluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09LSR", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05RAB", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "1-Biphenyl-4-yl-3-aza-bicyclo[3.1.0]hexane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J4EF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "PMID17574412C33": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00UOI", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "1-(1-(pyridin-3-yl)ethylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A3QM", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "{4-[4-(4-bromophenoxy)benzoyl]phenyl}acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BQG", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "3-(3-Benzylnaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05IXU", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Sulindac(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Z5IU", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "3,4,5-Trimethoxy-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "NQO2(Quinone reductase 2 (NQO2) ,MOA:Inhibitor); ", "drug_id_TTD": "D09MQF", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-(6-Amino-purin-9-yl)-6-o-tolyl-hexan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KC9E", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Naphthalene-1,4-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BVH", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "cinnamic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T2QL", "drug_id_DB": "", "metabolic_annotation_str": "PMVK(Phosphomevalonate kinase (PMVK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PMVK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10654"]}, "SLX-2101": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04NPP", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "R1678": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0B6IZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6536"]}, "1,1-diphenyl-3-(phenylsulfonyl)propan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07IRZ", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Acetazolamide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0E1SW", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["759"]}, "4-(2-(3-fluorophenoxy)-4-methylphenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q6SH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "CYANIDIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V3PG", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "2-methylsulfanylestradiol 3,17-O,O-bis-sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FH1V", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "PMID28627961-Compound-44": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WG5P", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "3-[3-(4-hydroxyphenyl)isoxazol-5-yl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02UUR", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "PMID28627961-Compound-41": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0O2DY", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "FAS-031": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6AU", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "PMID30273516-Compound-39": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D00KII", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "PMID30273516-Compound-38": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D07IQM", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "Vidofludimus": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00LSI", "drug_id_DB": "", "metabolic_annotation_str": "DHODH(Dihydroorotate dehydrogenase (DHODH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHODH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1723"]}, "5'-Deoxy-5'-(Methylthio)-Tubercidin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02JUP", "drug_id_DB": "DB02933", "metabolic_annotation_str": "MTAP(S-methyl-5'-thioadenosine phosphorylase (MTAP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MTAP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4507"]}, "PMID30273516-Compound-37": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D05CXZ", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "4-Hydroxybenzoicacid": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0NH9P", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "ACENAPHTHOQUINONE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06VGD", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "1066", "1066"]}, "ETHYLPHENSERINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XL1R", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "KM-01221": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QCE", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZY4C", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "SSR-125047": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "SIGMAR1(Opioid receptor sigma 1 (OPRS1) ,MOA:Binder); ", "drug_id_TTD": "D0Q7QY", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Fosinopril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0X8KY", "drug_id_DB": "DB00492", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "N-Carboxymethyl-N-cyclopentyl-phthalamic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K8ED", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "1-aminohexylphosphonic acid monophenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04XBZ", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Fused heterocyclic compound 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G9OT", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Fused heterocyclic compound 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0NS7W", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Fused heterocyclic compound 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0DQ6C", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Fused heterocyclic compound 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03JDR", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Fused heterocyclic compound 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01FMW", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Fused heterocyclic compound 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AV1B", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Fused heterocyclic compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SY6J", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Probenecid(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0L7FM", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A8(Solute carrier family 22 member 8 (SLC22A8) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A8"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["9376"]}, "Fused heterocyclic compound 9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08KAT", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Fused heterocyclic compound 8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N0MV", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "SR-31747": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D4JI", "drug_id_DB": "", "metabolic_annotation_str": "EBP(Cholestenol delta-isomerase (EBP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["EBP"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["10682"]}, "1-(3-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9BL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-Hexadecynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05HRK", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "Formic Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "FGF1(Heparin-binding growth factor 1 (FGF1) ,MOA:Inhibitor); ", "drug_id_TTD": "D06EWG", "drug_id_DB": "", "metabolic_annotation_str": "HPGDS(Glutathione-dependent PGD synthase (HPGDS) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HPGDS", "CA2", "HMOX1", "ALAD", "NOS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["27306", "760", "3162", "210", "4842"]}, "PMID25399762-Compound-Figure2-Spirooliganone B": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I5DV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Imidazopyrimidinone derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09IKN", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "FR122047": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CMJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "GERANYLGERANYL DIPHOSPHATE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "FNTA(Farnesyl protein transferase (Ftase) ,MOA:Inhibitor); FNTB(CAAX farnesyltransferase beta (FNTB) ,MOA:Inhibitor); FNTB(CAAX farnesyltransferase beta (FNTB) ,MOA:Inhibitor); FNTB(Farnesyl protein transferase (Ftase) ,MOA:Inhibitor); FNTB(Farnesyl protein transferase (Ftase) ,MOA:Inhibitor); ", "drug_id_TTD": "D0QX6B", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Imidazo[5,1-c][1,2,4]benzotriazine derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L6AM", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "RS-8359": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06QOJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Imidazo[5,1-c][1,2,4]benzotriazine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QI8G", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo[5,1-c][1,2,4]benzotriazine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I5UY", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo[5,1-c][1,2,4]benzotriazine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MK7X", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Lys[Z(NO2)]-Lys[Z(NO2)]": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E1YE", "drug_id_DB": "", "metabolic_annotation_str": "SLC15A2(Solute carrier family 15 member 2 (SLC15A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC15A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6565"]}, "PMID25399762-Compound-Figure3-Lycojaponicumin C": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H7HH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "PMID25399762-Compound-Figure3-Lycojaponicumin B": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0E7OQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "1H-Indole-2,3-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SP2O", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "BAY1436032": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0C6RM", "drug_id_DB": "", "metabolic_annotation_str": "IDH1(Mutated oxalosuccinate decarboxylase (mIDH1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDH1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3417"]}, "6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07WLT", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1584"]}, "1,1,1-trifluoro-3-(octylthio)propan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3GH", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "SB-201076": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09AXB", "drug_id_DB": "", "metabolic_annotation_str": "ACLY(ATP-citrate synthase (ACLY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACLY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["47"]}, "4-(4-nitro-benzylideneamino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03FXI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E2LR", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F7DM", "drug_id_DB": "DB04753", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "Cerliponase Alfa": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06CAS", "drug_id_DB": "", "metabolic_annotation_str": "TPP1(Tripeptidyl-peptidase I (TPP1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TPP1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1200"]}, "Vilazodone": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Modulator); ", "drug_id_TTD": "D0X6BV", "drug_id_DB": "DB06684", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "1,3-Dihydro-imidazo[4,5-b]quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N6MR", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I9KV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "FR-122788": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00MIM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Dasatinib(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ABL1(Tyrosine-protein kinase ABL1); LCK(Tyrosine-protein kinase Lck); FYN(Tyrosine-protein kinase Fyn); YES1(Tyrosine-protein kinase Yes); LYN(Tyrosine-protein kinase Lyn); PDGFRB(Platelet-derived growth factor receptor beta); FGR(Tyrosine-protein kinase Fgr); KIT(Mast/stem cell growth factor receptor Kit); HSPA8(Heat shock cognate 71 kDa protein); BCR(Breakpoint cluster region protein); SRC(Proto-oncogene tyrosine-protein kinase Src); EPHA2(Ephrin type-A receptor 2); CSK(Tyrosine-protein kinase CSK); ABL2(Abelson tyrosine-protein kinase 2); FRK(Tyrosine-protein kinase FRK); STAT5B(Signal transducer and activator of transcription 5B); EPHA5(Ephrin type-A receptor 5); EPHB4(Ephrin type-B receptor 4); BTK(Tyrosine-protein kinase BTK); MAPK14(Mitogen-activated protein kinase 14); NR4A3(Nuclear receptor subfamily 4 group A member 3); MAP3K20(Mitogen-activated protein kinase kinase kinase MLT); ", "drug_id_TTD": "", "drug_id_DB": "DB01254", "metabolic_annotation_str": "PPAT(Amidophosphoribosyltransferase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PPAT"], "metabolic_genes_id": ["5471"]}, "Broussonin C": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00MPM", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Arachidonic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HD9P", "drug_id_DB": "DB04557", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "LY134046": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ZKW", "drug_id_DB": "", "metabolic_annotation_str": "PNMT(Phenylethanolamine N-methyltransferase (PNMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5409"]}, "Propylthiouracil(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D00MIN", "drug_id_DB": "", "metabolic_annotation_str": "TPO(Thyroid peroxidase (TPO) ,MOA:Inhibitor); TPO(Thyroid peroxidase (TPO) ,MOA:Inhibitor); DIO1(Iodothyronine deiodinase type I (DIO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPO", "TPO", "DIO1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7173", "7173", "1733"]}, "F-1394": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03QZB", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "2',4'-dicyanobiphenyl-4-yl sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I4LL", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "Temocapril hydrochloride": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02DSZ", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "2-phenyl-2,3-dihydrobenzo[h]chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FOJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "2-methyl-3-(pyridin-4-yl)-1H-indol-6-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06RQV", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "Polyhydroxy benzamide derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0D2JW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Polyhydroxy benzamide derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MM1Y", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Polyhydroxy benzamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09YKI", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Polyhydroxy benzamide derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0GW5H", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Polyhydroxy benzamide derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01RTO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "naringin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09VQM", "drug_id_DB": "", "metabolic_annotation_str": "SLCO1A2(Sodium-independent organic anion transporter (SLCO1A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLCO1A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6579"]}, "N,N'-(1',10'-decylene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MC3U", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Cyclohexyl carbamate derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J2HH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Cyclohexyl carbamate derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0F3HA", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Cyclohexyl carbamate derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03PYA", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Cyclohexyl carbamate derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L1SV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Cyclohexyl carbamate derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UT9H", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Cyclohexyl carbamate derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09VRO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Cyclohexyl carbamate derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LC2G", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Cyclohexyl carbamate derivative 8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06LIQ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3-[5-(3-Fluorophenyl)-2-thienyl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2GN", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "5-(4-Chlorophenyl)-4-p-tolyl-3H-1,2-dithiol-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XIX", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "PMID25470667-Compound-Figure4-1A": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0L5DV", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT2(Diacylglycerol O-acyltransferase 2 (DGAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1", "DGAT2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694", "84649"]}, "PMID17574411C41": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RHH", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID17574411C42": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G6PS", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Crestor/TriLipix": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D04XGU", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "CVT-12012": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O7DP", "drug_id_DB": "", "metabolic_annotation_str": "SCD(Acyl-CoA desaturase (SCD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SCD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6319"]}, "N-Pyridoxyl-Glycine-5-Monophosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02824", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase); SHMT1(Serine hydroxymethyltransferase, cytosolic); SHMT1(Serine hydroxymethyltransferase, cytosolic); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ODC1", "SHMT1", "SHMT1"], "metabolic_genes_id": ["4953", "6470", "6470"]}, "4-[6-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J2WW", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3,4-Dihydroxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S8UP", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-(4-Cyanobenzyl)-5-(4-fluorophenyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P1UO", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "4-methyl-2H-benzofuro[3,2-g]chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00JUD", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "4,5-Bis(4-chlorophenyl)isothiazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01VRB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "4'-(Benzensulfonamide)-4-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BR1V", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Hydoxyamidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04WCW", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID30273516-Compound-1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0G4YI", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "PMID29757691-Compound-2a-i": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0WD0M", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Psoralen": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D00VUI", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "2-Fluoro-4-[5-(3-hydroxyphenyl)-3-thienyl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3AN", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Pyridine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0BK2I", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3alpha-Hydroxyurs-12-en-28-oic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MTU", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "[3H]glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03BVK", "drug_id_DB": "", "metabolic_annotation_str": "SLC38A3(Solute carrier family 38 member 3 (SLC38A3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC38A3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["10991"]}, "NCI-159878": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R0AX", "drug_id_DB": "", "metabolic_annotation_str": "LIPE(Hormone sensitive lipase (LIPE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3991"]}, "Guanosine-5'-Triphosphate(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EQ4T", "drug_id_DB": "", "metabolic_annotation_str": "GCH1(GTP cyclohydrolase-I (GCH1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCH1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2643"]}, "CATECHIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V7AA", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "PTGS1", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "5742", "765", "768", "23632"]}, "3-(1,2-dihydroacenaphthylen-3-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7YL", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Disulfide compound 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RC5J", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "NSC-621351": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A5TD", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "N-(3,3-Diphenyl-propyl)-isonicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01DZF", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "4,5-dichloro-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6CZ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "3,3'-Pyridine-2,5-diyldiphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07VXQ", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "2-(2,3,4-trimethoxyphenyl)-1H-indene": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02CCB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "13-(N-Isopropylheptanamido)tridec-8(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AKP", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Trodusquemine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PTPN1(Tyrosine-protein phosphatase non-receptor type 1); ", "drug_id_TTD": "", "drug_id_DB": "DB06333", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "AS-1522489-00": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I5ZO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "1-adamantan-1-yl-3-(4-hydroxybutyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F5XQ", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "4-(2-fluoro-6-(3-fluorophenoxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D03DQQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-(4-hydroxybenzylideneamino)ethanesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09SFY", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "7-phenethoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QUG", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "768", "23632"]}, "3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D02DTR", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "(+/-)-threo-N-(3-Methylpyridine)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8MA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Sodium phenylarsonate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GQ9A", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "SKI-2852": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B6HE", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "2-Benzyl-6-methoxy-5-oxazol-5-yl-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04LRN", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "Meta-Nitro-Tyrosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K1AW", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "8-Imidazol-1-ylmethyl-5-nitro-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8SM", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Romidepsin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HDAC4(Histone deacetylase 4); HDAC1(Histone deacetylase 1); HDAC2(Histone deacetylase 2); HDAC6(Histone deacetylase 6); ", "drug_id_TTD": "", "drug_id_DB": "DB06176", "metabolic_annotation_str": "ABCC1(Multidrug resistance-associated protein 1); ABCC1(Multidrug resistance-associated protein 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC1", "ABCC1"], "metabolic_genes_id": ["4363", "4363"]}, "Methyl 14-(3-n-butylureido)tetradec-8(Z)-enoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03IVU", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "N-(2,4-dihydroxybenzyl)-3,5-dihydroxybenzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02PWZ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "1-Adamantan-1-yl-3-(2-hydroxy-phenyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AZT", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T2TW", "drug_id_DB": "DB07139", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "RP-73163": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D06KFR", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "2-(3-hydroxyphenyl)quinolin-6-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KG1D", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "NE58018": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z8EU", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "1-(4-aminophenylsulfonyl)-3-(2-mercaptoethyl)urea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XCL", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203"]}, "2-(cyclohexylthiomethyl)-5-hydroxy-4H-pyran-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QFU", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3,4-Dichlorobenzenemethanethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z0BB", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "CI-986": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0L8RG", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "N-omega-allyl-L-arginine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DD9E", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "N-benzyl-N-(phenylsulfonyl)benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08EDV", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "5-(6-Methoxynaphthalen-2-yl)pyridin-3-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02JUJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "N1-[4-(Phenylmethoxy)phenyl]-D-aspartamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1UV", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "2-phenyl-9H-indeno[2,1-d]pyrimidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q9NC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "2,6-dihydroxy-1,7-dimethoxyxanthone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7LD", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Isochroman-4-ketone derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0OE6G", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "(1-hydroxy-1-phosphono-heptyl)-phosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05YIK", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Protexia": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D06FGJ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["590"]}, "7,8-dihydroxy-4-phenyl-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06LED", "drug_id_DB": "DB08049", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "PAZ-320": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0H9WY", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8972", "8972"]}, "Isosorbide-2-benzylcarbamate-5-triflate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08BKE", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "NSC-613604": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4CX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-n-dodecyl-7-methoxytacrine hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03JRX", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Prostaglandin G2": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02IPX", "drug_id_DB": "DB03866", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Docosapentaenoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y8XJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "2-Phenyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S0PB", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "1-(4-Cyanobenzyl)-5-(2-fluorophenyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NV7W", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "1-[(3-Methoxybenzyl)amino]ethaniminium chloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01KAH", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "Mirvetuximab soravtansine": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0RP2W", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["2348"]}, "Threo-ritalinol methyl ether hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q9NW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Acivicin": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02JUT", "drug_id_DB": "", "metabolic_annotation_str": "CTPS1(CTP synthase (CTPS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTPS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1503"]}, "ON-09300": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D02KQE", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "KD-7040": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0MJ2H", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "1-(4-ethoxyphenyl)propan-2-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X0PA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "2-Deoxy-2fluoro-Glucose": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4EB", "drug_id_DB": "", "metabolic_annotation_str": "LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LCT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3938"]}, "Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08VGM", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "Tolmetin(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09BHB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "INCB01158": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0XI3E", "drug_id_DB": "", "metabolic_annotation_str": "ARG1(Arginase (ARG) ,MOA:Inhibitor); ARG2(Arginase (ARG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ARG1", "ARG2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["383", "384"]}, "Dipyridamole(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "RCAN1(Calcipressin-1); ", "drug_id_TTD": "", "drug_id_DB": "DB00975", "metabolic_annotation_str": "PDE5A(cGMP-specific 3',5'-cyclic phosphodiesterase); ADA(Adenosine deaminase); PDE4A(cAMP-specific 3',5'-cyclic phosphodiesterase 4A); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PDE5A", "ADA", "PDE4A"], "metabolic_genes_id": ["8654", "100", "5141"]}, "Pyrrolo[1,2-c]pyrazole derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0R0QY", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2-(N-Cyclopentylamino)-3'-bromopropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0CJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "CHLORANIL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D0BI", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43", "1066", "1066"]}, "Alpha-monofluoromethyl-3,4-dehydroornithine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TLJ", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "PMID26666989-Compound-Figure11Ala down": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0TE4S", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "1-adamantan-1-yl-3-(3-hexyloxypropyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VW6Y", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "HELENAQUINONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FVV", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "Isosorbide-di-phenylcarbamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06LRC", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Alpha-Phosphoribosylpyrophosphoric Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08NFH", "drug_id_DB": "", "metabolic_annotation_str": "UMPS(Orotidine 5'-monophosphate decarboxylase (UMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7372"]}, "ISIS 31963": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D9PL", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "D-Phenylalanine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CRH(Corticoliberin); ", "drug_id_TTD": "", "drug_id_DB": "DB02556", "metabolic_annotation_str": "KYAT1(Kynurenine--oxoglutarate transaminase 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["KYAT1"], "metabolic_genes_id": ["883"]}, "CLEMATOMANDSHURICA SAPONIN B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z7BK", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "CLEMATOMANDSHURICA SAPONIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07HKJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "(S)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TC4I", "drug_id_DB": "", "metabolic_annotation_str": "SPHK2(Sphingosine kinase 2 (SPHK2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["56848"]}, "4-Chloro-N-(3-morpholinopropyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06IAE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "NS 2359": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07QXU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Imipramine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06ZUK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "IPI-549": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0I3LO", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "N-(2-Propyloxy-4-nitrophenyl)methanesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3IK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Carprofen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00821", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "Adenosine monophosphate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06ACW", "drug_id_DB": "", "metabolic_annotation_str": "ADCY1(Adenylate cyclase type 1 (ADCY1) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["ADCY1"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["107"]}, "Imidazo triazine derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08CEK", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo triazine derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05UNO", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "PMID27977313-Compound-48": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01PYM", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Imidazo triazine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00ONN", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo triazine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ET2A", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Imidazo triazine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KZ5Q", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "PMID27977313-Compound-42": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L2LF", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-43": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V1XY", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-46": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01BXV", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-47": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KM8V", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-44": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K2GG", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-45": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0D1LI", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Torbafylline": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0F7TV", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Modulator); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Modulator", "Modulator"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "2-Bromo-N-(3-morpholinopropyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01JMW", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "N-2-phenylethyl-1H-pyrrole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SN3L", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "DEHYDROLEUCODIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U9QB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "BIBX-79": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0S1XO", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Modulator); LSS(Lanosterol synthase (LSS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["4047", "4047"]}, "Isojaspic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F9FG", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "246", "239"]}, "1-adamantan-1-yl-3-[4-(4-fluorophenoxy)butyl]urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4VS", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Alpha-monofluoromethyl-3,4-dehydroornithine ethyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H2OA", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S5LS", "drug_id_DB": "DB03844", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Desipramine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01UTL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "Phthalazinone derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00XFM", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Aza-C-nucleosides": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BP5T", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "Diethylcarbamazine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00711", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); PTGS1(Prostaglandin G/H synthase 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1"], "metabolic_genes_id": ["240", "240", "5742"]}, "3-[7-(benzylmethylamino)-heptyloxy]xanthen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GXM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "ISIS 2177": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00DYQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["240", "240"]}, "1,2-bis(2,3-difluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M2ZD", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "(+/-)-2-(4-methoxyphenyl)-7-methylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O0MY", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "LY309887": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0IZ1A", "drug_id_DB": "", "metabolic_annotation_str": "GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2618", "2618"]}, "Carbimazole": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D02CKX", "drug_id_DB": "DB00389", "metabolic_annotation_str": "TPO(Thyroid peroxidase (TPO) ,MOA:Inhibitor); TPO(Thyroid peroxidase (TPO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPO", "TPO"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7173", "7173"]}, "2-(4-tert-butylbenzylideneamino)ethanesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ORD", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "N-(2-nonyloxy-4-nitrophenyl)methanesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04DZZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Squalestatin 1": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "AKT1(RAC-alpha serine/threonine-protein kinase (AKT1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0O1AV", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2222"]}, "2-(4-aminophenylsulfonamido)acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01UNC", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "1-(4-Fluorobenzyl)-5-phenyl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06NFC", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "3,3'-(1,2,4-thiadiazole-3,5-diyl)diphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4XA", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "1-methyl-3-(phenylcarbamoyloxy)pyridinium bromide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OJ9P", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N-Methyl-N-phenyl-2-oxo-2H-chromene-3-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W1WE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Droxicam": {"drug_status_TTD": ["Withdrawn from market", "Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D0R6AB", "drug_id_DB": "DB09215", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "WX-037": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08RBS", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D01ABR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Dimethyl-pent-4-enyl-ammonium bromide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7ZN", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "(+/-)-2-(4-fluorophenyl)chroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZH0T", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Risedronate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0PA5S", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Felbinac(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y7EM", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "N-Hydroxy-N-methyl-3-phenanthren-9-yl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O6OJ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1,10-bis(pyridinium)-decane dibromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6WU", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "N5-(1-iminobutyl)-L-ornithine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GX7G", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "Morniflumate(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D00BDC", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "(R)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D01JYY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "KW-4490": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03ZVD", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "13-(3-n-Pentylthioureido)tridec-8(Z)-enoic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C8HN", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "D-tartaric acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "DDX6(Probable ATP-dependent RNA helicase DDX6); TREM1(Triggering receptor expressed on myeloid cells 1); HIF1AN(Hypoxia-inducible factor 1-alpha inhibitor); ", "drug_id_TTD": "", "drug_id_DB": "DB01694", "metabolic_annotation_str": "ATP6V1C1(V-type proton ATPase subunit C 1); B3GAT1(Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ATP6V1C1", "B3GAT1"], "metabolic_genes_id": ["528", "27087"]}, "QCP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H6DA", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6523"]}, "Gamma-acetylenic GABA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09IHN", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "8R-hydroxylobelane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z0LP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Methyl 4-(4-hydroxybenzylideneamino)benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07AUN", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "(E)-octadecan-9-ynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A6FX", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Aminoguanidine": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "CCR2(C-C chemokine receptor type 2 (CCR2) ,MOA:Antagonist); ", "drug_id_TTD": "D0V0NL", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "Luvox": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0M5JI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "Carbamate derivative 17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08SMT", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Carbamate derivative 16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05DBG", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Carbamate derivative 15": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08EMW", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Benzydamine": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06FJO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Carbamate derivative 13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0C5SQ", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Carbamate derivative 12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0NK4T", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Carbamate derivative 11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Q4OB", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "2-Hexyloxy-5-imidazol-1-yl-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D00AEX", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "5'-deoxy-5'-ureidoadenosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02YYQ", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "LX3305": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0FS6S", "drug_id_DB": "", "metabolic_annotation_str": "SGPL1(Sphingosine-1-phosphate lyase 1 (SGPL1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SGPL1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8879"]}, "RS-25344": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P2HX", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4C(Phosphodiesterase 4C (PDE4C) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4C", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5143", "5144"]}, "Mazindol(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0H8QL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6530"]}, "JX-929": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0H2YY", "drug_id_DB": "", "metabolic_annotation_str": "AICDA(Cytosine deaminase (AICDA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AICDA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["57379"]}, "1-(3-(4-fluorophenyl)propyl)-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D0DR", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588"]}, "PMID29338548-Compound-16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K6CM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "Tolazamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00839", "metabolic_annotation_str": "ABCC8(ATP-binding cassette sub-family C member 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC8"], "metabolic_genes_id": ["6833"]}, "4,9-Dihydro-3H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G8BT", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "THEASINENSIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T0XY", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "2-(10-Imidazol-1-yl-decyl)-isoindole-1,3-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01JWT", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "D-257A": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TJY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "(biphenyl-3-ylamino)methylenediphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09USO", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "D-257C": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VUT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "4-Methoxybenzaldehyde": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09SWE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PIK-93": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S5YV", "drug_id_DB": "", "metabolic_annotation_str": "PI4KB(Phosphatidylinositol-4-kinase beta (PI4KB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PI4KB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5298"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SJ1U", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0A8UJ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G7XW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03NCL", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N7BW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09MHU", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03PZZ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0JR0P", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K5JG", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "WY-50295-tromethamine": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0A7JH", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "G418": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03LMM", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "4-(3,5-Dimethoxyphenethyl)benzenamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WK9Q", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Octyl sulfamate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05TLB", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "1-(1-(4-thiophen-3-yl-phenyl)propyl)-1Himidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B9XL", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "CPI-006": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0S5RE", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["4907"]}, "1-Benzo[b]thiophen-2-yl-cyclohexylamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02BXG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "PMID29324067-Compound-40": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07UZL", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(2-Ethoxy-ethyl)-trimethyl-ammonium iodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TRN", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "[1,1':2',1'']-terphenyl-4,3'',5''-triol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "ABL1(Tyrosine-protein kinase ABL1 (ABL) ,MOA:Inhibitor); ", "drug_id_TTD": "D03PLP", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5243"]}, "4-(4-Fluorophenoxy)-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08JCC", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "6-isobutyl-4-methylpyridin-2-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00EVC", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "NSC-172033": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4BT", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "NBTGR": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09FHE", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2030"]}, "TY-11345": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0GY4V", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "4'-(4-Aminobenzensulfonamide)-4-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09YGD", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Piragliatin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QGH", "drug_id_DB": "", "metabolic_annotation_str": "GCK(Glucokinase (GCK) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GCK"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2645"]}, "4-aryl quinol derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01WCU", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "4-aryl quinol derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0VA1R", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "4-aryl quinol derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04ONQ", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID26815044-Compound-116": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0W8RV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-117": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EH4P", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "4-aryl quinol derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00TXZ", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "4-aryl quinol derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07PKU", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "CPP-115": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0EJ7U", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "1,2-Dihydroxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02YPE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Disulfiram(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0X5SD", "drug_id_DB": "", "metabolic_annotation_str": "ALDH3A2(Fatty aldehyde dehydrogenase (ALDH3A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH3A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["224"]}, "vesamicol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I1QF", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A3(Vesicular acetylcholine transporter (SLC18A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6572"]}, "Lauric Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "TLR4(Toll-like receptor 4 (TLR4) ,MOA:Inhibitor); LTF(Lactotransferrin (LTF) ,MOA:Inhibitor); HNF4A(Hepatocyte nuclear factor 4-alpha (HNF4A) ,MOA:Inhibitor); LY96(Lymphocyte antigen 96 (LY96) ,MOA:Inhibitor); ", "drug_id_TTD": "D0N0UC", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5320"]}, "1-(biphenyl-3-ylmethyl)-1H-1,2,4-triazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I5PY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "MK-2637": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0Y3AZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "AGN-2979": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09OWK", "drug_id_DB": "", "metabolic_annotation_str": "TPH1(Tryptophan 5-hydroxylase 1 (TPH1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TPH1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7166"]}, "FUKUGETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08NIT", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PELARGONIDIN CHLORIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O3DI", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "Vericigiuat": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08YVP", "drug_id_DB": "", "metabolic_annotation_str": "GUCY1B1(Guanylate cyclase soluble beta-1 (GUCY1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2983"]}, "diphosphoric acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N0JL", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "FADROZOLE": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0ZX1P", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0OP", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "SYL-040003": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R3DQ", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["762"]}, "1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L3IS", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "CRYPTADINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XRG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Beta-methoxyamphetamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R7ZC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Antagonist); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Antagonist); SLC6A3(Dopamine transporter (DAT) ,MOA:Antagonist); SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB", "SLC6A4", "SLC6A3", "SLC6A3", "SLC18A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Antagonist", "Inhibitor", "Antagonist", "Antagonist", "Antagonist"], "metabolic_genes_id": ["4128", "4129", "6532", "6531", "6531", "6571"]}, "Isothiazolone derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09ZAJ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "1-[(Z)-4-(triphenylmethoxy)-2-butenyl]thymine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I6UV", "drug_id_DB": "", "metabolic_annotation_str": "TK2(Thymidine kinase 2 (Mt-TK2) ,MOA:Inhibitor); TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK2", "TK1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7084", "7083"]}, "N-desalkylquetiapine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TH6L", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "4ALPHA-(HYDROXYMETHYL)-4ALPHA-DEMETHYLTERRITREM B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C0NS", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "UNBS-1450": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D04TSO", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["476"]}, "Lu-AA34893": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0A8QM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "Piretanide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09NNS", "drug_id_DB": "DB02925", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "WS-070117": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OH9B", "drug_id_DB": "", "metabolic_annotation_str": "LPL(Lipoprotein lipase (LPL) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LPL"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4023"]}, "Lumefantrine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06MQM", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["476"]}, "1-(Benzhydrylamino)ethaniminium bromide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q7NZ", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "6-Acetyl-7-ethoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01CXM", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "PMID9871507C14": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00OPO", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "3-(4-hydroxyphenyl)-6-methyl-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01HQV", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "ROSMARINIC ACID": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MCL1(Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1) ,MOA:Inhibitor); ", "drug_id_TTD": "D05PTT", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "YM443": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00WVW", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["43"]}, "L-serine-O-phosphate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PDPK1(Phosphoinositide dependent protein kinase-1 (PDPK1) ,MOA:Inhibitor); RHO(Rhodopsin (RHO) ,MOA:Inhibitor); PRKCQ(Protein kinase C theta (PRKCQ) ,MOA:Inhibitor); ", "drug_id_TTD": "D07PZQ", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "UK-371800": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D09OCK", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "S-(4-Ethylbenzyl)isothiourea hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05AFW", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4-Hydroxy-pentanoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07QSV", "drug_id_DB": "", "metabolic_annotation_str": "SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC52A2", "SLC52A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["79581", "79581"]}, "Fluticasone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "NR3C1(Glucocorticoid receptor); PGR(Progesterone receptor); NR3C2(Mineralocorticoid receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB13867", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PLA2G4A"], "metabolic_genes_id": ["5321"]}, "RIP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A1RG", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "1-(4-chlorophenethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3BL", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "4-Hydroxy-3-methyl-butyric acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00FPB", "drug_id_DB": "", "metabolic_annotation_str": "SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC52A2", "SLC52A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["79581", "79581"]}, "PMID26666989-Compound-Figure9left01": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0JO2A", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9left02": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0VJ0N", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "BAY 11-42524": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0M0YB", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "CLR-3001": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "DRD2(Dopamine D2 receptor (D2R) ,MOA:Modulator); ", "drug_id_TTD": "D04VHK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Mercaptopurine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09UZO", "drug_id_DB": "", "metabolic_annotation_str": "PPAT(Amidophosphoribosyltransferase (PPAT) ,MOA:Breaker); ", "drug_status_DB": "", "metabolic_genes_name": ["PPAT"], "metabolic_mechanism_of_action": ["Breaker"], "metabolic_genes_id": ["5471"]}, "US20160326143, 3": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0L5VH", "drug_id_DB": "", "metabolic_annotation_str": "LTC4S(Leukotriene C4 synthase (LTC4S) ,MOA:Inhibitor); LTC4S(Leukotriene C4 synthase (LTC4S) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTC4S", "LTC4S"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4056", "4056"]}, "LORNEIC ACID A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YZ0L", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "Sri-9662(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03060", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["DHFR"], "metabolic_genes_id": ["1719"]}, "METHYLHONOKIOL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01OFH", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "PMID25399762-Compound-Table 7-Vanillyl alcohol": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ME4N", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "5'-methylthio-immucillin-H": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SO9G", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "PMID25399762-Compound-Table 6-9": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D0IO2A", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Daporinad": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0H9SX", "drug_id_DB": "DB12731", "metabolic_annotation_str": "NAMPT(Nicotinamide phosphoribosyltransferase (NAMPT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NAMPT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10135"]}, "N-(4-Sulfamoyl-phenyl)-propionamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8LR", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "8-acetyl-7-ethoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06WZG", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "4-Methanesulfonylamino-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00NUK", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "4-Imidazol-1-yl-2-phenyl-chroman-7-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J3PK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-Cyclobutyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08NNF", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "EPALRESTATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4LM", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Acetic Acid Salicyloyl-Amino-Ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09XYZ", "drug_id_DB": "DB03667", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "AL-59640": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04BMR", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Modulator); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Modulator", "Modulator"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "2-methyl-3-(pyridin-4-yl)-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2ST", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "ER-34122": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0SZ3B", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "T83193": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0B5YS", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ALDH5A1(Succinate-semialdehyde dehydrogenase (ALDH5A1) ,MOA:Inhibitor); ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB", "ALDH5A1", "ABAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4129", "7915", "18"]}, "LAWSARITOL": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6RT", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "N-(3-Methanesulfonyl-4-methoxy-benzoyl)-guanidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07DUW", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1", "SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6548", "6550", "6550"]}, "5-iodo,5'-deoxytubercidin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03SHX", "drug_id_DB": "", "metabolic_annotation_str": "ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["132"]}, "Desethyl isoquine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0IM5E", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q1FX", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "N6-CYCLOPENTYLADENOSINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADORA3(Adenosine A3 receptor (ADORA3) ,MOA:Inhibitor); ADORA2A(Adenosine A2a receptor (ADORA2A) ,MOA:Inhibitor); ADORA2B(Adenosine A2b receptor (ADORA2B) ,MOA:Inhibitor); ADORA1(Adenosine A1 receptor (ADORA1) ,MOA:Inhibitor); ", "drug_id_TTD": "D03RFA", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2030"]}, "Low dose ITI-007": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Antagonist); ", "drug_id_TTD": "D03XWL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["6532"]}, "5-Bromomethyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ZYA", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "4-(2-oxo-2H-chromene-3-carboxamido)benzoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E8IE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Brofaromine": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0IZ1D", "drug_id_DB": "DB13876", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4128"]}, "NSC-368280": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02QSH", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-(5-Phenyl-furan-2-carbonyl)-guanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZSK", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "N-Hydroxy-N-methyl-2-naphthalen-2-yl-propionamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07PCS", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "5-Methyl-4-propyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ISP", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "2-valproylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07LYW", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "SCH-57726": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KD6S", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "N-(3-Chloro-phenyl)-2-cyclohexyl-acetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08IBD", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "(R)(+)-7-fluoro-2-p-tolylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02WOQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "6-fluorotryptophan": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U9QD", "drug_id_DB": "", "metabolic_annotation_str": "TPH1(Tryptophan 5-hydroxylase 1 (TPH1) ,MOA:Inhibitor); TPH2(L-Tryptophan hydroxylase 2 (TPH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPH1", "TPH2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7166", "121278"]}, "(E)-5-octadecen-7,9-diynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C8HK", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "7,8-dihydrobiopterin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3XT", "drug_id_DB": "", "metabolic_annotation_str": "TH(Tyrosine 3-monooxygenase (TH) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TH", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7054", "4843"]}, "NSC-645808": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "NQO2(Quinone reductase 2 (NQO2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0E0DQ", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "Kodaistatin A": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GG6X", "drug_id_DB": "", "metabolic_annotation_str": "SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC37A4", "SLC37A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2542", "2542"]}, "DIDODECANOYLPHLOROGLUCINOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J2EE", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5320"]}, "2-methyl-9H-indeno[2,1-d]pyrimidin-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FH5A", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "N-(phenylamino)-benzoate derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05GKS", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor. Antagonist. Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor; Antagonist; Blocker"], "metabolic_genes_id": ["8644"]}, "R-85355": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0S5DY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "L-746530": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06DCK", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID29130358-Compound-Figure11(3)": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "MMP2(Matrix metalloproteinase-2 (MMP-2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Y1LO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "N-ALLYLNORGALANTHAMINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D3TB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ETG", "drug_id_DB": "DB08480", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "ISOLICOFLAVONOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E5FV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "2-benzyl-N1-hydroxy-N3-(4-phenylbutyl)malonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YO0R", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Atorvastatin lactole derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09ZXW", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "CI-1018": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00DBE", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Biricodar(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02VJY", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5243"]}, "2-cyclohexylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HN0R", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Vortioxetine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HTR1A(5-hydroxytryptamine receptor 1A); HTR1B(5-hydroxytryptamine receptor 1B); HTR7(5-hydroxytryptamine receptor 7); HTR3A(5-hydroxytryptamine receptor 3A); ", "drug_id_TTD": "", "drug_id_DB": "DB09068", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "2alpha-Hydroxyolean-12-en-28-oic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X5YM", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Migalastat": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0MU9L", "drug_id_DB": "DB05018", "metabolic_annotation_str": "GLA(Alpha-galactosidase A (GLA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GLA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2717"]}, "N-[3,3-Bis-(4-fluorophenyl)-propyl]-benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I0YE", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Fostamatinib(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "BMPR1B(Bone morphogenetic protein receptor type-1B); PLK4(Serine/threonine-protein kinase PLK4); FAAH(Fatty-acid amide hydrolase 1); CIT(Citron Rho-interacting kinase); RIOK3(Serine/threonine-protein kinase RIO3); CHEK1(Serine/threonine-protein kinase Chk1); IKBKB(Inhibitor of nuclear factor kappa-B kinase subunit beta); CASK(Peripheral plasma membrane protein CASK); GAK(Cyclin-G-associated kinase); DCLK1(Serine/threonine-protein kinase DCLK1); MUSK(Muscle, skeletal receptor tyrosine-protein kinase); MAPK13(Mitogen-activated protein kinase 13); PDPK1(3-phosphoinositide-dependent protein kinase 1); MAP3K13(Mitogen-activated protein kinase kinase kinase 13); DAPK3(Death-associated protein kinase 3); RIPK2(Receptor-interacting serine/threonine-protein kinase 2); PRKAB2(5'-AMP-activated protein kinase subunit beta-2); NUAK1(NUAK family SNF1-like kinase 1); JAK2(Tyrosine-protein kinase JAK2); ROCK2(Rho-associated protein kinase 2); ULK1(Serine/threonine-protein kinase ULK1); ERN1(Serine/threonine-protein kinase/endoribonuclease IRE1); STK16(Serine/threonine-protein kinase 16); PAK3(Serine/threonine-protein kinase PAK 3); STK17B(Serine/threonine-protein kinase 17B); STK10(Serine/threonine-protein kinase 10); MAP3K6(Mitogen-activated protein kinase kinase kinase 6); OXSR1(Serine/threonine-protein kinase OSR1); MAP4K4(Mitogen-activated protein kinase kinase kinase kinase 4); LATS1(Serine/threonine-protein kinase LATS1); PAK4(Serine/threonine-protein kinase PAK 4); CHEK2(Serine/threonine-protein kinase Chk2); ABL1(Tyrosine-protein kinase ABL1); EGFR(Epidermal growth factor receptor); RAF1(RAF proto-oncogene serine/threonine-protein kinase); ERBB2(Receptor tyrosine-protein kinase erbB-2); NTRK1(High affinity nerve growth factor receptor); PRKCG(Protein kinase C gamma type); INSR(Insulin receptor); LCK(Tyrosine-protein kinase Lck); FYN(Tyrosine-protein kinase Fyn); CDK1(Cyclin-dependent kinase 1); FES(Tyrosine-protein kinase Fes/Fps); CSF1R(Macrophage colony-stimulating factor 1 receptor); CSN3(Kappa-casein); CTSL(Cathepsin L1); YES1(Tyrosine-protein kinase Yes); LYN(Tyrosine-protein kinase Lyn); RET(Proto-oncogene tyrosine-protein kinase receptor Ret); MET(Hepatocyte growth factor receptor); ROS1(Proto-oncogene tyrosine-protein kinase ROS); PDGFRB(Platelet-derived growth factor receptor beta); FGR(Tyrosine-protein kinase Fgr); SBK3(Uncharacterized serine/threonine-protein kinase SBK3); ADORA3(Adenosine receptor A3); KIT(Mast/stem cell growth factor receptor Kit); PIM1(Serine/threonine-protein kinase pim-1); FGFR1(Fibroblast growth factor receptor 1); CDK4(Cyclin-dependent kinase 4); SRC(Proto-oncogene tyrosine-protein kinase Src); INSRR(Insulin receptor-related protein); BRAF(Serine/threonine-protein kinase B-raf); PDGFRA(Platelet-derived growth factor receptor alpha); FER(Tyrosine-protein kinase Fer); PRKACA(cAMP-dependent protein kinase catalytic subunit alpha); PRKACA(cAMP-dependent protein kinase catalytic subunit alpha); FLT1(Vascular endothelial growth factor receptor 1); EIF2AK2(Interferon-induced, double-stranded RNA-activated protein kinase); CSNK2A2(Casein kinase II subunit alpha'); EPHA1(Ephrin type-A receptor 1); EPHA1(Ephrin type-A receptor 1); FGFR2(Fibroblast growth factor receptor 2); FGFR3(Fibroblast growth factor receptor 3); PRKACB(cAMP-dependent protein kinase catalytic subunit beta); JAK1(Tyrosine-protein kinase JAK1); CTSS(Cathepsin S); MARK3(MAP/microtubule affinity-regulating kinase 3); EPHA2(Ephrin type-A receptor 2); EPHA3(Ephrin type-A receptor 3); EPHA8(Ephrin type-A receptor 8); EPHB2(Ephrin type-B receptor 2); LTK(Leukocyte tyrosine kinase receptor); TYK2(Non-receptor tyrosine-protein kinase TYK2); WEE1(Wee1-like protein kinase); AXL(Tyrosine-protein kinase receptor UFO); MAPK4(Mitogen-activated protein kinase 4); TTK(Dual specificity protein kinase TTK); TIE1(Tyrosine-protein kinase receptor Tie-1); FLT4(Vascular endothelial growth factor receptor 3); KDR(Vascular endothelial growth factor receptor 2); MAP2K2(Dual specificity mitogen-activated protein kinase kinase 2); FLT3(Receptor-type tyrosine-protein kinase FLT3); ACVR1B(Activin receptor type-1B); TGFBR1(TGF-beta receptor type-1); TGFBR2(TGF-beta receptor type-2); CSK(Tyrosine-protein kinase CSK); PRKCI(Protein kinase C iota type); MTOR(Serine/threonine-protein kinase mTOR); MATK(Megakaryocyte-associated tyrosine-protein kinase); TEC(Tyrosine-protein kinase Tec); TXK(Tyrosine-protein kinase TXK); ABL2(Abelson tyrosine-protein kinase 2); FRK(Tyrosine-protein kinase FRK); ZAP70(Tyrosine-protein kinase ZAP-70); SYK(Tyrosine-protein kinase SYK); MAPK9(Mitogen-activated protein kinase 9); MAP2K3(Dual specificity mitogen-activated protein kinase kinase 3); CSNK1A1(Casein kinase I isoform alpha); CLK1(Dual specificity protein kinase CLK1); CLK2(Dual specificity protein kinase CLK2); CLK2(Dual specificity protein kinase CLK2); CLK3(Dual specificity protein kinase CLK3); GSK3A(Glycogen synthase kinase-3 alpha); GSK3B(Glycogen synthase kinase-3 beta); BLK(Tyrosine-protein kinase Blk); IRAK1(Interleukin-1 receptor-associated kinase 1); RPS6KA3(Ribosomal protein S6 kinase alpha-3); BMX(Cytoplasmic tyrosine-protein kinase BMX); NEK2(Serine/threonine-protein kinase Nek2); NEK3(Serine/threonine-protein kinase Nek3); NEK4(Serine/threonine-protein kinase Nek4); JAK3(Tyrosine-protein kinase JAK3); MAP2K6(Dual specificity mitogen-activated protein kinase kinase 6); PLK1(Serine/threonine-protein kinase PLK1); DAPK1(Death-associated protein kinase 1); LIMK1(LIM domain kinase 1); LIMK2(LIM domain kinase 2); MAPK10(Mitogen-activated protein kinase 10); PRKAG1(5'-AMP-activated protein kinase subunit gamma-1); PRKAA2(5'-AMP-activated protein kinase catalytic subunit alpha-2); EPHA5(Ephrin type-A receptor 5); EPHB4(Ephrin type-B receptor 4); EPHB1(Ephrin type-B receptor 1); EPHA4(Ephrin type-A receptor 4); SIK1(Serine/threonine-protein kinase SIK1); RIPK4(Receptor-interacting serine/threonine-protein kinase 4); CSNK2A1(Casein kinase II subunit alpha); MAP3K9(Mitogen-activated protein kinase kinase kinase 9); CDK16(Cyclin-dependent kinase 16); CDK17(Cyclin-dependent kinase 17); PRKCE(Protein kinase C epsilon type); TEK(Angiopoietin-1 receptor); MAP3K10(Mitogen-activated protein kinase kinase kinase 10); PRKCQ(Protein kinase C theta type); ACVR1(Activin receptor type-1); MST1R(Macrophage-stimulating protein receptor); PTK2(Focal adhesion kinase 1); PRKCD(Protein kinase C delta type); BTK(Tyrosine-protein kinase BTK); TYRO3(Tyrosine-protein kinase receptor TYRO3); TNK2(Activated CDC42 kinase 1); DDR1(Epithelial discoidin domain-containing receptor 1); DDR1(Epithelial discoidin domain-containing receptor 1); DDR1(Epithelial discoidin domain-containing receptor 1); DDR1(Epithelial discoidin domain-containing receptor 1); DDR1(Epithelial discoidin domain-containing receptor 1); DDR1(Epithelial discoidin domain-containing receptor 1); DDR1(Epithelial discoidin domain-containing receptor 1); ITK(Tyrosine-protein kinase ITK/TSK); MAP4K2(Mitogen-activated protein kinase kinase kinase kinase 2); MAP3K12(Mitogen-activated protein kinase kinase kinase 12); MERTK(Tyrosine-protein kinase Mer); PRKAA1(5'-AMP-activated protein kinase catalytic subunit alpha-1); PRKAA1(5'-AMP-activated protein kinase catalytic subunit alpha-1); PAK1(Serine/threonine-protein kinase PAK 1); MAP2K5(Dual specificity mitogen-activated protein kinase kinase 5); MAPK7(Mitogen-activated protein kinase 7); PAK2(Serine/threonine-protein kinase PAK 2); STK3(Serine/threonine-protein kinase 3); MAP3K1(Mitogen-activated protein kinase kinase kinase 1); PRKG2(cGMP-dependent protein kinase 2); TNK1(Non-receptor tyrosine-protein kinase TNK1); TNK1(Non-receptor tyrosine-protein kinase TNK1); PRPF4B(Serine/threonine-protein kinase PRP4 homolog); RIPK1(Receptor-interacting serine/threonine-protein kinase 1); CAMK2B(Calcium/calmodulin-dependent protein kinase type II subunit beta); CAMK2G(Calcium/calmodulin-dependent protein kinase type II subunit gamma); CAMK2D(Calcium/calmodulin-dependent protein kinase type II subunit delta); DYRK1A(Dual specificity tyrosine-phosphorylation-regulated kinase 1A); BMPR2(Bone morphogenetic protein receptor type-2); PTK6(Protein-tyrosine kinase 6); CAMK1(Calcium/calmodulin-dependent protein kinase type 1); IKBKE(Inhibitor of nuclear factor kappa-B kinase subunit epsilon); PTK2B(Protein-tyrosine kinase 2-beta); MELK(Maternal embryonic leucine zipper kinase); PRKD1(Serine/threonine-protein kinase D1); STK38(Serine/threonine-protein kinase 38); ERBB4(Receptor tyrosine-protein kinase erbB-4); EPHA7(Ephrin type-A receptor 7); RPS6KA1(Ribosomal protein S6 kinase alpha-1); RPS6KA1(Ribosomal protein S6 kinase alpha-1); TESK1(Dual specificity testis-specific protein kinase 1); MYLK(Myosin light chain kinase, smooth muscle); NTRK3(NT-3 growth factor receptor); PKN1(Serine/threonine-protein kinase N1); PKN2(Serine/threonine-protein kinase N2); MAPK14(Mitogen-activated protein kinase 14); MAP3K11(Mitogen-activated protein kinase kinase kinase 11); NTRK2(BDNF/NT-3 growth factors receptor); PHKG1(Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform); DDR2(Discoidin domain-containing receptor 2); AAK1(AP2-associated protein kinase 1); MYLK3(Myosin light chain kinase 3); SBK1(Serine/threonine-protein kinase SBK1); MAP3K19(Mitogen-activated protein kinase kinase kinase 19); LRRK2(Leucine-rich repeat serine/threonine-protein kinase 2); CDC42BPG(Serine/threonine-protein kinase MRCK gamma); NEK5(Serine/threonine-protein kinase Nek5); ULK3(Serine/threonine-protein kinase ULK3); MAP3K15(Mitogen-activated protein kinase kinase kinase 15); MARK2(Serine/threonine-protein kinase MARK2); TAOK1(Serine/threonine-protein kinase TAO1); CLASP1(CLIP-associating protein 1); TLK2(Serine/threonine-protein kinase tousled-like 2); PIM3(Serine/threonine-protein kinase pim-3); MYLK4(Myosin light chain kinase family member 4); CAMK1D(Calcium/calmodulin-dependent protein kinase type 1D); MAP4K3(Mitogen-activated protein kinase kinase kinase kinase 3); MAPKAPK5(MAP kinase-activated protein kinase 5); NIM1K(Serine/threonine-protein kinase NIM1); ULK2(Serine/threonine-protein kinase ULK2); MINK1(Misshapen-like kinase 1); DCLK2(Serine/threonine-protein kinase DCLK2); CAMKK1(Calcium/calmodulin-dependent protein kinase kinase 1); MYO3A(Myosin-IIIa); ANKK1(Ankyrin repeat and protein kinase domain-containing protein 1); NEK11(Serine/threonine-protein kinase Nek11); COQ8A(Atypical kinase COQ8A, mitochondrial); MAPK15(Mitogen-activated protein kinase 15); MAPK15(Mitogen-activated protein kinase 15); NEK9(Serine/threonine-protein kinase Nek9); STK35(Serine/threonine-protein kinase 35); STK32A(Serine/threonine-protein kinase 32A); CDKL2(Cyclin-dependent kinase-like 2); MAP4K1(Mitogen-activated protein kinase kinase kinase kinase 1); MAP4K1(Mitogen-activated protein kinase kinase kinase kinase 1); C8orf44-SGK3(Serine/threonine-protein kinase Sgk3); SGK3(Serine/threonine-protein kinase Sgk3); COQ8B(Atypical kinase COQ8B, mitochondrial); AURKB(Aurora kinase B); MARK4(MAP/microtubule affinity-regulating kinase 4); CAMK1G(Calcium/calmodulin-dependent protein kinase type 1G); NEK1(Serine/threonine-protein kinase Nek1); CDK15(Cyclin-dependent kinase 15); CAMKK2(Calcium/calmodulin-dependent protein kinase kinase 2); PKMYT1(Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase); MAP3K3(Mitogen-activated protein kinase kinase kinase 3); EIF2AK1(Eukaryotic translation initiation factor 2-alpha kinase 1); RIOK1(Serine/threonine-protein kinase RIO1); MKNK1(MAP kinase-interacting serine/threonine-protein kinase 1); RIOK2(Serine/threonine-protein kinase RIO2); TSSK1B(Testis-specific serine/threonine-protein kinase 1); STK33(Serine/threonine-protein kinase 33); DCLK3(Serine/threonine-protein kinase DCLK3); NUAK2(NUAK family SNF1-like kinase 2); SIK2(Serine/threonine-protein kinase SIK2); MYLK2(Myosin light chain kinase 2, skeletal/cardiac muscle); SLK(STE20-like serine/threonine-protein kinase); TAOK3(Serine/threonine-protein kinase TAO3); HIPK2(Homeodomain-interacting protein kinase 2); SRMS(Tyrosine-protein kinase Srms); HIPK3(Homeodomain-interacting protein kinase 3); PLK3(Serine/threonine-protein kinase PLK3); CLK4(Dual specificity protein kinase CLK4); MKNK2(MAP kinase-interacting serine/threonine-protein kinase 2); PAK6(Serine/threonine-protein kinase PAK 6); PAK6(Serine/threonine-protein kinase PAK 6); SNRK(SNF-related serine/threonine-protein kinase); STK36(Serine/threonine-protein kinase 36); BMP2K(BMP-2-inducible protein kinase); IRAK4(Interleukin-1 receptor-associated kinase 4); MAP3K20(Mitogen-activated protein kinase kinase kinase MLT); PLK2(Serine/threonine-protein kinase PLK2); MARK1(Serine/threonine-protein kinase MARK1); PAK5(Serine/threonine-protein kinase PAK 5); STK26(Serine/threonine-protein kinase 26); EIF2AK4(eIF-2-alpha kinase GCN2); STK17A(Serine/threonine-protein kinase 17A); STK39(STE20/SPS1-related proline-alanine-rich protein kinase); PRKAG3(5'-AMP-activated protein kinase subunit gamma-3); PRKAG2(5'-AMP-activated protein kinase subunit gamma-2); TBK1(Serine/threonine-protein kinase TBK1); DAPK2(Death-associated protein kinase 2); RPS6KA6(Ribosomal protein S6 kinase alpha-6); TNIK(TRAF2 and NCK-interacting protein kinase); TLK1(Serine/threonine-protein kinase tousled-like 1); TAOK2(Serine/threonine-protein kinase TAO2); ALK(ALK tyrosine kinase receptor); CILK1(Serine/threonine-protein kinase ICK); AURKC(Aurora kinase C); CAMK2A(Calcium/calmodulin-dependent protein kinase type II subunit alpha); STK38L(Serine/threonine-protein kinase 38-like); MAST1(Microtubule-associated serine/threonine-protein kinase 1); SIK3(Serine/threonine-protein kinase SIK3); MAP3K2(Mitogen-activated protein kinase kinase kinase 2); DYRK1B(Dual specificity tyrosine-phosphorylation-regulated kinase 1B); DYRK1B(Dual specificity tyrosine-phosphorylation-regulated kinase 1B); PRKAB1(5'-AMP-activated protein kinase subunit beta-1); MAP4K5(Mitogen-activated protein kinase kinase kinase kinase 5); IRAK3(Interleukin-1 receptor-associated kinase 3); STK24(Serine/threonine-protein kinase 24); MAP3K4(Mitogen-activated protein kinase kinase kinase 4); ", "drug_id_TTD": "", "drug_id_DB": "DB12010", "metabolic_annotation_str": "PIK3CD(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform); PIK3C2B(Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta); PIK3C2G(Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma); PDE5A(cGMP-specific 3',5'-cyclic phosphodiesterase); ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); UGT1A1(UDP-glucuronosyltransferase 1-1); PIK3CG(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform); PIP4K2B(Phosphatidylinositol 5-phosphate 4-kinase type-2 beta); PIP4K2B(Phosphatidylinositol 5-phosphate 4-kinase type-2 beta); TNNI3K(Serine/threonine-protein kinase TNNI3K); PIP4K2C(Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma); SLC29A1(Equilibrative nucleoside transporter 1); PI4KB(Phosphatidylinositol 4-kinase beta); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PIK3CD", "PIK3C2B", "PIK3C2G", "PDE5A", "ALOX5", "ALOX5", "UGT1A1", "PIK3CG", "PIP4K2B", "PIP4K2B", "TNNI3K", "PIP4K2C", "SLC29A1", "PI4KB"], "metabolic_genes_id": ["5293", "5287", "5288", "8654", "240", "240", "54658", "5294", "8396", "8396", "51086", "79837", "2030", "5298"]}, "AA-193": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05RZI", "drug_id_DB": "", "metabolic_annotation_str": "SLC2A9(Glucose transporter type 9 (GLUT9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC2A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["56606"]}, "PMID28870136-Compound-64": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LB7I", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-65": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0JF6W", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-67": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08ZDR", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "(+/-)-Daedalin A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S5OR", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "SGC0946": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S9SJ", "drug_id_DB": "", "metabolic_annotation_str": "DOT1L(Histone-lysine N-methyltransferase (HLNM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DOT1L"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["84444"]}, "PMID28870136-Compound-62": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Y2QO", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-63": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Y9TP", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-68": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04TGG", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "RP-64477": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07DBS", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "3-(5-Chloro-6-methoxy-naphthalen-2-yl)-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ZTZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "PSB-0963": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "P2RY2(P2Y purinoceptor 2 (P2RY2) ,MOA:Inhibitor); ", "drug_id_TTD": "D06GQY", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ENTPD1(Ectonucleoside triphosphate diphosphohydrolase 1 (CD39) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E", "ENTPD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4907", "953"]}, "4-Indan-(1E)-ylidenemethyl-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05YNW", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "PMID25514969-Compound-Figure2-2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XJ3S", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "Pravastatin derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KU2T", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID25514969-Compound-Figure2-4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0M4XO", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "2-(4-chlorobenzylidene)cyclopentylmethyl ether": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q9RA", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "Pantoprazole(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "DDAH1(N(G),N(G)-dimethylarginine dimethylaminohydrolase 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00213", "metabolic_annotation_str": "ATP4A(Potassium-transporting ATPase alpha chain 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ATP4A"], "metabolic_genes_id": ["495"]}, "4-Chloro-N-(2-morpholinoethyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S9JC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "4-Sulfamoyloxy-benzoic acid octyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03NUT", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "(S)-2-amino-6-hydroxy-N-(4-octylphenyl)hexanamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XSX", "drug_id_DB": "", "metabolic_annotation_str": "SPHK2(Sphingosine kinase 2 (SPHK2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["56848"]}, "Threo-3,4-dichlororitalinol hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q0MN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "8-(3-Methylbenzyloxy)caffeine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00OLX", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "IDD594": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FJ7G", "drug_id_DB": "DB08084", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "BMY-20844": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D08NXX", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "Cilomilast(TTD)": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02EMR", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "4,5-Dihydroxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S6XY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8RS", "drug_id_DB": "DB03286", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Glutathionylspermidine Disulfide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9NZ", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "Carboxyatractyloside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z0VL", "drug_id_DB": "DB02426", "metabolic_annotation_str": "SLC25A4(Adenine nucleotide translocator 1 (SLC25A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC25A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["291"]}, "benzylserine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VX9R", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A5(Alanine/serine/cysteine transporter 2 (SLC1A5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A5"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6510"]}, "1-(4-chlorophenyl)-2-(phenylsulfonyl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02KXX", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "AEOL-10150": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0G1EH", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "DuP-654": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06UVO", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "6-Chloropurine Riboside, 5'-Monophosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03948", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["IMPDH2"], "metabolic_genes_id": ["3615"]}, "Sulfonamide derivative 12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08RPE", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "Sulfonamide derivative 10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0HG2S", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "Sulfonamide derivative 11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02JOK", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "SPONGIADIOXIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NQ7I", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "LJP-1207": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V6DF", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8639"]}, "Amphetamine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ADRB2(Beta-2 adrenergic receptor); ADRA2A(Alpha-2A adrenergic receptor); ADRB3(Beta-3 adrenergic receptor); DRD2(D(2) dopamine receptor); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); ADRA1D(Alpha-1D adrenergic receptor); ADRA1A(Alpha-1A adrenergic receptor); ADRA1B(Alpha-1B adrenergic receptor); CARTPT(Cocaine- and amphetamine-regulated transcript protein); TAAR1(Trace amine-associated receptor 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00182", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); SLC6A2(Sodium-dependent noradrenaline transporter); MAOB(Amine oxidase [flavin-containing] B); MAOB(Amine oxidase [flavin-containing] B); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC18A2(Synaptic vesicular amine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MAOA", "SLC6A2", "MAOB", "MAOB", "SLC6A4", "SLC6A3", "SLC6A3", "SLC18A2"], "metabolic_genes_id": ["4128", "6530", "4129", "4129", "6532", "6531", "6531", "6571"]}, "Trimetrexate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01157", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["DHFR"], "metabolic_genes_id": ["1719"]}, "LUDARTIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06HJB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Thenoyltrifluoroacetone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04795", "metabolic_annotation_str": "CES1(Liver carboxylesterase 1); CES1(Liver carboxylesterase 1); SDHA(Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["CES1", "CES1", "SDHA"], "metabolic_genes_id": ["1066", "1066", "6389"]}, "Naphthalen-1-yl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I7BX", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "UNC0642": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BI4T", "drug_id_DB": "", "metabolic_annotation_str": "EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT1(Euchromatic histone-lysine N-methyltransferase 1 (EHMT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["10919", "10919", "10919", "10919", "10919", "10919", "10919", "79813"]}, "Sulfamic acid 7-sulfamoyloxy-heptyl ester": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05FNN", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Tromethamine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03ZFN", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "3-Beta-Hydroxy-5-Androsten-17-One": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9HX", "drug_id_DB": "", "metabolic_annotation_str": "HSD3B1(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); HSD3B2(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD3B1", "HSD17B1", "HSD3B2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3283", "3292", "3284"]}, "2-Cinnamamido-N1-hydroxy-N4-pentylsuccinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F2HJ", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Ampiroxicam": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D07OHO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "5-ketodihydromevinolin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I0IM", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "(R)(+)-7-fluoro-2-phenylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09PBW", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Nonanoic acid biphenyl-2-ylamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07LER", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "N-(1H-Indol-2-ylmethyl)-N-phenylamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01PES", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Icariside II": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06TLQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "1-(4-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NY4W", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Bis-sulfonamide derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RK3P", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Bis-sulfonamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I2HK", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Tert-Butyl 2-(2-oxohexadecanamido)acetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07TCK", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Sertraline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PGRMC1(Membrane-associated progesterone receptor component 1); SIGMAR1(Sigma non-opioid intracellular receptor 1); ", "drug_id_TTD": "", "drug_id_DB": "DB01104", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC29A4(Equilibrative nucleoside transporter 4); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3", "SLC29A4"], "metabolic_genes_id": ["6530", "6532", "6531", "6531", "222962"]}, "1-Acetoxylycorine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09REF", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "3-(3-Benzyl-6-methoxynaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q5ZZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "8S-hydroxylobelane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F8SA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "[1,4]Oxazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ODQ", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "1-(3-Cyano-phenyl)-1H-pyrazole-4-carboxylic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G8XL", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Tubocurarine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRNA7(Neuronal acetylcholine receptor subunit alpha-7); HTR3A(5-hydroxytryptamine receptor 3A); CHRNA2(Neuronal acetylcholine receptor subunit alpha-2); ", "drug_id_TTD": "", "drug_id_DB": "DB01199", "metabolic_annotation_str": "ACHE(Acetylcholinesterase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ACHE"], "metabolic_genes_id": ["43"]}, "(+/-)-2-Aminoindane-2-carboxylic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SC5V", "drug_id_DB": "", "metabolic_annotation_str": "SLC7A5(Large neutral amino acids transporter 1 (SLC7A5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC7A5"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8140"]}, "Hydroxycitric acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07WIB", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["279"]}, "TK-112690": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03LNM", "drug_id_DB": "", "metabolic_annotation_str": "UPP2(Uridine phosphorylase (UPP) ,MOA:Modulator); UPP1(Uridine phosphorylase (UPP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["UPP2", "UPP1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["151531", "7378"]}, "5-Aminomethyl-3-pyrrol-1-yl-oxazolidin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R7UO", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "2-(2-cyclohexylidenehydrazinyl)-4-p-tolylthiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I2GP", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(+/-)-threo-3',5'-Dimethylmethylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SWN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "N-(4,4-Diphenyl-butyl)-nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08USX", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "2-Amino-1-(4-methylthiophenyl)propane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SCH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "6530", "6532", "6531", "6531"]}, "AZD4831": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07SBP", "drug_id_DB": "", "metabolic_annotation_str": "MPO(Myeloperoxidase (MPO) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MPO"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4353"]}, "Piperidin-(2E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D0TO", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "4,5-Bis(4-methoxyphenyl)-1,2-selenazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D0JE", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "L-693612": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05EPY", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["759"]}, "13-(3-Pentyluredo)tridec-8(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U0WU", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "1,2-Di-p-tolyl-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UK5A", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1-(4-Cyanobenzyl)-5-methyl-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05FFY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "7-hydroxy-2-(3-hydroxyphenyl)chroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0EK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-(butylthio)-1,1,1-trifluoropropan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FO4J", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Fused heterocyclic compound 12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ND8U", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "Fused heterocyclic compound 11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04BAQ", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Fused heterocyclic compound 10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RK3S", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "BI-409306": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0W7UN", "drug_id_DB": "", "metabolic_annotation_str": "PDE9A(Phosphodiesterase 9 (PDE9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE9A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5152"]}, "Plasma derived human butyrylcholinesterase": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D04JMI", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["590"]}, "Chebulagic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J5OV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Galantamine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0R9VR", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "7,9-octadecadiynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C5LO", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "3-(5-((methylthio)methyl)furan-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1IE", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "PMID26666989-Compound-Figure9topright01": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0KK0E", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "ATN-224": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0T8MA", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6647"]}, "1,2-di(10H-phenothiazin-10-yl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A5FO", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "PF9601N": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0W7LO", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "GDC-0077": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0GW8X", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "Plitidepsin": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D07QJK", "drug_id_DB": "", "metabolic_annotation_str": "PPT1(Palmitoyl-protein thioesterase 1 (PPT1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PPT1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5538"]}, "4-nitrophenylsulfamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I8DW", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "(+/-)-threo-N-Allylmethylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I9ON", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Indirubin-5-sulfonate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CDK1(Cyclin-dependent kinase 1 (CDK1) ,MOA:Binder); CDK2(Cyclin-dependent kinase 2 (CDK2) ,MOA:Inhibitor); CDK5(Cyclin-dependent kinase 5 (CDK5) ,MOA:Inhibitor); ", "drug_id_TTD": "D0G2CT", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "XL-499": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D08TAB", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "3,6,9,12,15-Pentaoxaheptadecane(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02DWE", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); KYNU(Kynureninase (KYNU) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE", "KYNU"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["43", "8942"]}, "4-(4-Chlorophenyl)-5-p-tolyl-3H-1,2-dithiol-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G7RA", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Lunacalcipol": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00DYK", "drug_id_DB": "", "metabolic_annotation_str": "CYP24A1(Cytochrome P450 24 (CYP24A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP24A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1591"]}, "(2R,3S)-2-[(2-Iodophenoxy)phenylmethyl]morpholine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3DF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Tianeptine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06CVT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Bexagliflozin": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0OR3G", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6524"]}, "N-[3,3-Bis-(4-fluorophenyl)-propyl]-nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6IW", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "1-(2-(benzyloxy)phenyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0ZU5W", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "Cyclic peptide derivative 1": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); ", "drug_id_TTD": "D04OEV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "CORILAGIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03SPJ", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "9-N-Phenylmethylamino-Tacrine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RW1Y", "drug_id_DB": "DB03672", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Elosulfase alfa": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0J1UA", "drug_id_DB": "", "metabolic_annotation_str": "GALNS(N-acetylgalactosamine 6 sulfatase (GALNS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GALNS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2588"]}, "8(S)-amino-2(R)-methyl-7-oxononanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SZ9E", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "N1-(4-chlorobenzyl)-2-amino-N3-hydroxymalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NL7J", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "SL-25.1188": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0E3JL", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Calaspargase pegol": {"drug_status_TTD": ["Phase 3", "Approved"], "non_metabolic": "", "drug_id_TTD": "D01JJO", "drug_id_DB": "", "metabolic_annotation_str": "ASRGL1(Asparaginase (ASRGL1) ,MOA:Modulator); ASRGL1(Asparaginase (ASRGL1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ASRGL1", "ASRGL1"], "metabolic_mechanism_of_action": ["Modulator", "Inhibitor"], "metabolic_genes_id": ["80150", "80150"]}, "CC-1088": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U2DH", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "EZN-2279": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0V5KW", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["100"]}, "N-isopropyl estradiol-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B6SA", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "(+/-)-7-methyl-2-phenylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T1GP", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "ZAPRINAST": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D00YPW", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8654", "5144"]}, "CHS-828": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0Y1NC", "drug_id_DB": "", "metabolic_annotation_str": "NAMPT(Nicotinamide phosphoribosyltransferase (NAMPT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NAMPT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10135"]}, "Thiocarbamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3KP", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "PerioPatch": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U8IU", "drug_id_DB": "", "metabolic_annotation_str": "GUSB(Beta-glucuronidase (GUSB) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUSB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2990"]}, "4'-(4-Fluorobenzensulfonamide)-4-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7KE", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DY9U", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Ilepatril": {"drug_status_TTD": ["Discontinued in Phase 2/3", "Discontinued in Phase 2/3"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Modulator); ", "drug_id_TTD": "D0K6SM", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "Suramin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "F2(Prothrombin); RYR1(Ryanodine receptor 1); P2RY2(P2Y purinoceptor 2); SIRT5(NAD-dependent protein deacylase sirtuin-5, mitochondrial); ", "drug_id_TTD": "", "drug_id_DB": "DB04786", "metabolic_annotation_str": "PLA2G2A(Phospholipase A2, membrane associated); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PLA2G2A"], "metabolic_genes_id": ["5320"]}, "4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X9LJ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Resorcinol compound 34": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0T7BH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 32": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09QZB", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 33": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FL1E", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 30": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K1UO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 31": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K7LI", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID8496919C7": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T2DP", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Cholic Acid(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0OR2L", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); FECH(Ferrochelatase (FECH) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "FECH", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "2235", "1066", "1066"]}, "3-[5-(4-hydroxyphenyl)-2-thienyl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ZCG", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "1,2-NAPHTHOQUINONE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PTPN1(PTPN1 messenger RNA (PTPN1 mRNA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0W9VA", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "IDO1", "ACHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "3620", "43", "1066", "1066"]}, "(R)-2-((4-benzylphenoxy)methyl)piperidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C1XE", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "5-phenyl-1,3,4-thiadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N3DW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "2-(4-cyclohexylthiosemicarbazono)methyl-phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08BTV", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "BPH-628": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E9AL", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "BPH-629": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3GI", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Biphenyl derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0B7LR", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4-[5-(3-Hydroxyphenyl)-2-thienyl]benzene-1,2-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08OKP", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "NCX-6560": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0H0FX", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "[1,3]Oxazinan-(2E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4BM", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "2-(3'-Ethylsulfanyl-biphenyl-4-yl)-propionic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02GZX", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "MIN-117": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Antagonist); ", "drug_id_TTD": "D0Z4FE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Iclaprim": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D04LBC", "drug_id_DB": "DB06358", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1719"]}, "16-(thiophen-2-yl)methylene-estrone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A0CG", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Sulfamic acid 4-sulfamoyloxy-butyl ester": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04BKU", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Hydrohalisulfate 1": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A5BH", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "3-(butylsulfinyl)-1,1,1-trifluoropropan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9EB", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Etodolac(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "RXRA(Retinoic acid receptor RXR-alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB00749", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "DENBUFYLLINE": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D01XHG", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "(Z)-1,1,1,2,2,3,3-heptafluorohenicos-12-en-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2SE", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Benzimidazole derivative 16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KY1Y", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Benzimidazole derivative 17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0T1UU", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Benzimidazole derivative 14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I5DE", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "AK198": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K8NO", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Benzimidazole derivative 12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ZT9I", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Benzimidazole derivative 13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07YPE", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Benzimidazole derivative 11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N2DJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Naphthalen-1-yl(10H-phenothiazin-10-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7MN", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "CHYMOSTATIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L0QR", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "Celecoxib(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03RTS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "2-(1H-Imidazol-4-yl)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NI8W", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "1-aminohexylphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03JAL", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "L-Isofagomine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00MFZ", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2629", "2629"]}, "N5-[4-(3-methylphenoxy)phenyl]-L-glutamamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00FCJ", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "PMID15026062C41": {"drug_status_TTD": ["Clinical trial"], "non_metabolic": "", "drug_id_TTD": "D0A8UP", "drug_id_DB": "", "metabolic_annotation_str": "LIPE(Hormone sensitive lipase (LIPE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3991"]}, "PSX-4206": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00WKL", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8639"]}, "Benzofurans derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06RFO", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "SD-6010": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02MBN", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "(2,5-Diphenyl-furan-3-yl)-phenyl-methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W7BI", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "Tamoxifen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ESR1(Estrogen receptor); SHBG(Sex hormone-binding globulin); PRKCG(Protein kinase C gamma type); PRKCB(Protein kinase C beta type); AR(Androgen receptor); PRKCA(Protein kinase C alpha type); PRKCI(Protein kinase C iota type); MAPK8(Mitogen-activated protein kinase 8); ESRRG(Estrogen-related receptor gamma); PRKCE(Protein kinase C epsilon type); PRKCQ(Protein kinase C theta type); PRKCZ(Protein kinase C zeta type); PRKCD(Protein kinase C delta type); KCNH2(Potassium voltage-gated channel subfamily H member 2); ESR2(Estrogen receptor beta); ", "drug_id_TTD": "", "drug_id_DB": "DB00675", "metabolic_annotation_str": "EBP(3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["EBP"], "metabolic_genes_id": ["10682"]}, "Methoxyflurane(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GABRP(Gamma-aminobutyric acid receptor subunit pi); GABRD(Gamma-aminobutyric acid receptor subunit delta); GABRA1(Gamma-aminobutyric acid receptor subunit alpha-1); GABRA1(Gamma-aminobutyric acid receptor subunit alpha-1); GABRB1(Gamma-aminobutyric acid receptor subunit beta-1); GABRG2(Gamma-aminobutyric acid receptor subunit gamma-2); GLRA1(Glycine receptor subunit alpha-1); GABRB3(Gamma-aminobutyric acid receptor subunit beta-3); GABRA5(Gamma-aminobutyric acid receptor subunit alpha-5); GABRA3(Gamma-aminobutyric acid receptor subunit alpha-3); GRIA1(Glutamate receptor 1); GABRA2(Gamma-aminobutyric acid receptor subunit alpha-2); GABRB2(Gamma-aminobutyric acid receptor subunit beta-2); GABRA4(Gamma-aminobutyric acid receptor subunit alpha-4); GABRE(Gamma-aminobutyric acid receptor subunit epsilon); ATP2C1(Calcium-transporting ATPase type 2C member 1); KCNA1(Potassium voltage-gated channel subfamily A member 1); GABRA6(Gamma-aminobutyric acid receptor subunit alpha-6); GABRG1(Gamma-aminobutyric acid receptor subunit gamma-1); GABRG3(Gamma-aminobutyric acid receptor subunit gamma-3); ", "drug_id_TTD": "", "drug_id_DB": "DB01028", "metabolic_annotation_str": "MT-ND1(NADH-ubiquinone oxidoreductase chain 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MT-ND1"], "metabolic_genes_id": ["4535"]}, "2-Chlorobenzenemethanethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P3XW", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "LY-292223": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ECE1(Endothelin-converting enzyme 1 (ECE1) ,MOA:Inhibitor); PRKDC(DNA-dependent protein kinase catalytic (PRKDC) ,MOA:Inhibitor); ", "drug_id_TTD": "D07APP", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD", "ACE", "PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5293", "1636", "5291", "5294"]}, "N-hydroxysulfonamides": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EAQ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "16-(3-Ethylureido)hexadec-11(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AT6Z", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "PTX-007011": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D03CIN", "drug_id_DB": "", "metabolic_annotation_str": "COASY(Phosphopantetheine adenylyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COASY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["80347"]}, "1-Cyclohexyl-3-(1-propionylpiperidin-4-yl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01NFH", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Isopropyl dodecylfluorophosphonate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "CNR1(Cannabinoid receptor 1 (CB1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0HQ4M", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Fludarabine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0F2XQ", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "PACTIMIBE": {"drug_status_TTD": ["Phase 2/3", "Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D02GWF", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Sphingosine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03203", "metabolic_annotation_str": "GLTP(Glycolipid transfer protein); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["GLTP"], "metabolic_genes_id": ["51228"]}, "3-[5-(3,4-Difluorophenyl)-2-thienyl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02BEJ", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "3-(5-phenyl-2-thienyl)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G1DN", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "MESUAGENIN B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A6MF", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "MESUAGENIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03FHV", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03MYV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "5-Azidomethyl-3-pyrrol-1-yl-oxazolidin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07LCW", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Ethyl 4-(2-oxo-2H-chromene-3-carboxamido)benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05HJT", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Tetrahydro-pyrimidin-2-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08JSR", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "MK-591": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0M0QX", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Cyclopentyl-(3,4-dichloro-phenyl)-acetonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A0UC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "(+/-)-threo-3',4'-Dichlororitalinol methyl ether": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ZFN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Biphenyl-4-ylboronic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09OSN", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "6-nitroquipazine": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0S6PJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Uridine-5'-Diphosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03435", "metabolic_annotation_str": "B3GAT3(Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3); GYG1(Glycogenin-1); GLT6D1(Glycosyltransferase 6 domain-containing protein 1); B3GAT1(Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1); EXTL2(Exostosin-like 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["B3GAT3", "GYG1", "GLT6D1", "B3GAT1", "EXTL2"], "metabolic_genes_id": ["26229", "2992", "360203", "27087", "2135"]}, "Uracil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03419", "metabolic_annotation_str": "DPYD(Dihydropyrimidine dehydrogenase [NADP(+)]); UCKL1(Uridine-cytidine kinase-like 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["DPYD", "UCKL1"], "metabolic_genes_id": ["1806", "54963"]}, "1-Benzyl-5-phenyl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08YGW", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Icosapent(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "FFAR1(Free fatty acid receptor 1); PPARG(Peroxisome proliferator-activated receptor gamma); PPARD(Peroxisome proliferator-activated receptor delta); PPARA(Peroxisome proliferator-activated receptor alpha); TRPV1(Transient receptor potential cation channel subfamily V member 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00159", "metabolic_annotation_str": "ACSL4(Long-chain-fatty-acid--CoA ligase 4); PTGS1(Prostaglandin G/H synthase 1); SLC8A1(Sodium/calcium exchanger 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ACSL4", "PTGS1", "SLC8A1", "PTGS2"], "metabolic_genes_id": ["2182", "5742", "6546", "5743"]}, "1,10-phenanthroline-5,6-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JH7C", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "VX-661": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0Z5HR", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Regulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Regulator"], "metabolic_genes_id": ["1080"]}, "(1-Amino-3-methylsulfanyl-propyl)-phosphinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EG8X", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Acyl piperidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QZ8K", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4-(3'-furyl)-aniline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05CBG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "OBABERINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P1HA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "PMID18754614C10": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M1QJ", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "NSC-131736": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06AZC", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "PMID18754614C19": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A7FI", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID18754614C18": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PMR", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Tert-Butyl 5-(2-oxohexadecanamido)pentanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05BTF", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Octanoic acid biphenyl-2-ylamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A7YE", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "TACRINE(8)-4-AMINOQUINOLINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01MVX", "drug_id_DB": "DB04616", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N-(2-oxazolemethyl)milnacipran": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S9IO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7YL", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "PMID25399762-Compound-Figure3-Aspeverin": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08HOV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Biphenyl 1,2-diamine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0T5WX", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3620"]}, "NSC-645827": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4RW", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "1-Deoxy-1-Thio-Heptaethylene Glycol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04OUJ", "drug_id_DB": "DB02404", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-(4-tosylpiperazin-1-yl)nicotinonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03PVF", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "LY-221068": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D01QAR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "NR3C2(Mineralocorticoid receptor  (MR) ,MOA:Inhibitor); ", "drug_id_TTD": "D03TNT", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "1-(But-2-enylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EN7L", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Metamizole": {"drug_status_TTD": ["Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D06JRD", "drug_id_DB": "DB04817", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "S-(4-Fluorobenzyl)isothiourea hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02IVJ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D0BO", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "RG-7166": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D04VUY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "PMID17560788C29f": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8XW", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "TENIDAP": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02RQT", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "DNA vaccine, Memorial Sloan-Kettering Cancer Center": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D02CLU", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["7299"]}, "1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X8LG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02BXS", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "AGS-16C3F": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0XT5Q", "drug_id_DB": "", "metabolic_annotation_str": "ENPP3(Phosphodiesterase I beta (ENPP3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5169"]}, "Di(2,6-diisopropylphenol)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A0RT", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "3-(3-Phenyl-ureido)-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ZMH", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "Perhexiline(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00SBN", "drug_id_DB": "", "metabolic_annotation_str": "CPT1B(Carnitine O-palmitoyltransferase I (CPT1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CPT1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1375"]}, "(S)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W9JK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "Dioxothiomolybdenum(VI) ion": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02CWE", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Papaverine(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0NJ3V", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8654", "5144"]}, "2-Methyl-1,2-di-pyridin-3-yl-propyliodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04MEE", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Ketotifen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HRH1(Histamine H1 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00920", "metabolic_annotation_str": "PGD(6-phosphogluconate dehydrogenase, decarboxylating); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PGD"], "metabolic_genes_id": ["5226"]}, "DIHYDROCUBEBIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D00TOF", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "4-nitrophenyl phosphate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T0YI", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "MHL cyclohexylthiosemicarbazone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G1XC", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "6,7-dihydroxy-8-nitro-1-tetralone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M3PG", "drug_id_DB": "", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "(+/-)-threo-N-(2-Methylpyridine)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B9LI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "N-isobutylnorlitebamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9OW", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N-Hydroxy-3-naphthalen-2-yl-propionamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H7UQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Captopril(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "MMP2(72 kDa type IV collagenase); MMP9(Matrix metalloproteinase-9); BDKRB1(B1 bradykinin receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01197", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase); ACE(Angiotensin-converting enzyme); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["LTA4H", "ACE"], "metabolic_genes_id": ["4048", "1636"]}, "GNE Lipoplex": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0KX8B", "drug_id_DB": "", "metabolic_annotation_str": "GNE(N-acetylmannosamine kinase (GNE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GNE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10020"]}, "Gemcitabine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00441", "metabolic_annotation_str": "TYMS(Thymidylate synthase); RRM1(Ribonucleoside-diphosphate reductase large subunit); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["TYMS", "RRM1"], "metabolic_genes_id": ["7298", "6240"]}, "ISORHAMNETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07YDN", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "Carbamide derivative 3": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D02CTG", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "AL5424": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D6UL", "drug_id_DB": "DB01964", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "PMID28870136-Compound-48": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0DF2M", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-49": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03XTA", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-42": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0C2UP", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-43": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0C7ON", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-40": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AF4A", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-41": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QL7B", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-46": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01ADE", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "6-methoxy-1,9-dimethyl-9H-pyrido[3,4-b]indole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZI7F", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Ladostigil": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0C3UC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "ACHE", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "43", "4129"]}, "MINAMESTANE": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0FS9K", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "PMID16242323C16": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00MJG", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "(+)-(5S,8S,10S)-20-methoxypuupehenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K0QU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "6-(piperidin-4-ylmethoxy)-2-naphthonitrile": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01AOI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Flobufen": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0X8VV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Mycophenolate mofetil(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "PTGER2(Prostaglandin E2 receptor EP2 (PTGER2) ,MOA:Modulator); ", "drug_id_TTD": "D04FBR", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "(+/-)-threo-N-Ethylritalinol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AA9K", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "5-thia-8,11,14,17-eicosatetraenoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06JCT", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Simvastatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0H0ND", "drug_id_DB": "DB00641", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "3-((1H-imidazol-1-yl)methyl)-9H-xanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04WJN", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-(1H-Indol-2-ylmethyl)-N-methyl-N-phenylamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KDZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Chlorphrifos oxon": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "CNR1(Cannabinoid receptor 1 (CB1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0W6PT", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Azetidine-benzoxazin-3(4H)-one derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S9MR", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Azetidine-benzoxazin-3(4H)-one derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0VS7X", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Azetidine-benzoxazin-3(4H)-one derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J0UC", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "WAY-123641": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0MF3C", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "Testolactone": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0C7JF", "drug_id_DB": "DB00894", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Duroquinone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01WPJ", "drug_id_DB": "DB01927", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "N-(4'-Isonicotinoylbiphenyl-3-yl)acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E0ZS", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "Dutasteride(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01126", "metabolic_annotation_str": "SRD5A1(3-oxo-5-alpha-steroid 4-dehydrogenase 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SRD5A1"], "metabolic_genes_id": ["6715"]}, "4-Methylimidazole(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "MB(Myoglobin); ", "drug_id_TTD": "", "drug_id_DB": "DB03385", "metabolic_annotation_str": "CA2(Carbonic anhydrase 2); CA5A(Carbonic anhydrase 5A, mitochondrial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["CA2", "CA5A"], "metabolic_genes_id": ["760", "763"]}, "N-methoxyethyl estrone-16-methyl carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q9CI", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "1-(1-Naphthyl)-2-aminopropane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BE0S", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "(+/-)-2-(4'-Ethoxyphenyl)thiomorpholin-5-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D5KD", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "NSC-324572": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4JD", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "4,4-Diphenyl-N-(pyridin-3-yl)-butyramide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BI0Z", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Carbamide derivative 13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UI9T", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Alpha-7-Deoxyhomonojirimycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZC7V", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2548"]}, "3-(6-methoxynaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1PQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "Salicyclic acid": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D07HBX", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "PTGS1", "CA6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "5742", "765"]}, "Methyclothiazide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00232", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA4(Carbonic anhydrase 4); SLC12A1(Solute carrier family 12 member 1); ", "drug_status_DB": ".", "metabolic_genes_name": ["CA1", "CA2", "CA4", "SLC12A1"], "metabolic_genes_id": ["759", "760", "762", "6557"]}, "Uridine-Diphosphate-N-Acetylgalactosamine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02196", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase); UAP1(UDP-N-acetylhexosamine pyrophosphorylase); EXTL2(Exostosin-like 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["GALE", "UAP1", "EXTL2"], "metabolic_genes_id": ["2582", "6675", "2135"]}, "Anagrelide": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0D1HW", "drug_id_DB": "DB00261", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "6-amino-N-(2,4-dichlorobenzyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B3GP", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "PREMETREXED": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "PDF(Polypeptide deformylase (PDF) ,MOA:Inhibitor); ", "drug_id_TTD": "D0UZ9U", "drug_id_DB": "", "metabolic_annotation_str": "SLC46A1(Proton-coupled folate transporter (SLC46A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC46A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["113235"]}, "7-methoxy-2-oxo-2H-chromene-4-carboxylic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RB0D", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "768", "23632"]}, "CG-100649": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0W2CX", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "5743"]}, "4-methylstyrylboronic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X0RE", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["759"]}, "(1R)-MENTHYL HEXYL PHOSPHONATE GROUP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G6WQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "6-(hydroxymethyl)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L5TZ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "762", "765", "768", "23632"]}, "SEP-228432": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08SHE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Benzyl-(2-pyridin-3-yl-quinazolin-4-yl)-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01TOR", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A", "PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5138", "5141", "5142"]}, "1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CQD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "ASTRAGALIN": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08BFU", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE", "AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1636", "231"]}, "Licofelone(TTD)": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0N1SU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01PLP", "drug_id_DB": "", "metabolic_annotation_str": "LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHB(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHC(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LDHA", "LDHA", "LDHB", "LDHC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3939", "3939", "3945", "3948"]}, "2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MV0T", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "JNJ-10311795": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "CTSG(Cathepsin G (CTSG) ,MOA:Inhibitor); ", "drug_id_TTD": "D01YIO", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "1-Adamantan-1-yl-3-(3-methoxy-phenyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8EQ", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "[125I]7-azido-8-iodoketanserine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03TJJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6571"]}, "2-Pyridin-4-ylmethyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z5XD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Mesalazine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0C4YC", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "D-4418": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0K1OA", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "3,3',3''-Thiene-2,3,5-triyltriphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z1MJ", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Lauryl Dimethylamine-N-Oxide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "RHO(Rhodopsin (RHO) ,MOA:Inhibitor); ", "drug_id_TTD": "D0C7PY", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "NSC-661755": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0F4JL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "1,1,1,3-Tetrafluoro-heptadecan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CVD", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Monoaryl-1,2-diamine derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0E4BN", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3620"]}, "Monoaryl-1,2-diamine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03ZMX", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3620"]}, "Monoaryl-1,2-diamine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0GV6B", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Monoaryl-1,2-diamine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03NHO", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "2-morpholino-7-(2-phenylethynyl)-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04BXL", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "1,1,1-Trifluoro-4-(4-hexyloxy-phenyl)-butan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SIJ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "PF-4447943": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0A9IY", "drug_id_DB": "", "metabolic_annotation_str": "PDE9A(Phosphodiesterase 9 (PDE9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE9A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5152"]}, "SK&F 107649": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07LMV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "OLEANOLIC_ACID": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "PTPN1(PTPN1 messenger RNA (PTPN1 mRNA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0SJ2Q", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "4-Ethyl-5-methyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6QY", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "4-(4-(4-Nitrophenyl)thiazol-2-ylamino)phenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J3EJ", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203"]}, "10-Formyl-5,8,10-Trideazafolic Acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00UUG", "drug_id_DB": "", "metabolic_annotation_str": "GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2618", "2618"]}, "NSC-316158": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AN7U", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "CACOSPONGIONOLIDE B": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B9VV", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "5320"]}, "N-Hydroxy-N-methyl-3-naphthalen-1-yl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8UV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1-(3,4-dichlorophenyl)-3-hydroxyurea": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09UQM", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA4", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "762", "768"]}, "BMS-187745": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0W1MX", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Methyl estradiol-16-beta-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S2BW", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "GMX1777": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0V7YA", "drug_id_DB": "DB05217", "metabolic_annotation_str": "NAMPT(Nicotinamide phosphoribosyltransferase (NAMPT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NAMPT"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["10135"]}, "Multiform PI3K inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O6JE", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "NKY80": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03UXO", "drug_id_DB": "", "metabolic_annotation_str": "ADCY5(Adenylate cyclase type 5 (AC5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADCY5"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["111"]}, "4-Indan-(1Z)-ylidenemethyl-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02CSU", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "Fidarestat(TTD)": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D00EWR", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "(11H-Dibenzo[b,e][1,4]dioxepin-2-yl)-acetic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N0YS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "[1,5]Thiazocan-(4E)-ylideneamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BLJ", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "YM-511": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Y2OG", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "FPYVAE peptide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01WQF", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "1-adamantan-1-yl-3-((R)-1-phenyl-ethyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07HSQ", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "CR-4174": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KX7A", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Benzimidazole derivative 15": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0HH5B", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Tesofensine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB06156", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "FORMESTANE": {"drug_status_TTD": ["Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D0B6PZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Acetic acid 5-butyl-2-phenyl-thiazol-4-yl ester": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G3VE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "N-(2-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3CO", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PP121": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ABL1(ABL messenger RNA (ABL mRNA) ,MOA:Inhibitor); EGFR(Epidermal growth factor receptor (EGFR) ,MOA:Inhibitor); SRC(Proto-oncogene c-Src (SRC) ,MOA:Inhibitor); PDGFRA(Platelet-derived growth factor receptor alpha (PDGFRA) ,MOA:Inhibitor); KDR(Vascular endothelial growth factor receptor 2 (KDR) ,MOA:Inhibitor); MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); PRKDC(DNA-dependent protein kinase catalytic (PRKDC) ,MOA:Inhibitor); ", "drug_id_TTD": "D03EHM", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5291", "5294"]}, "Polythiazide": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06TNG", "drug_id_DB": "DB01324", "metabolic_annotation_str": "SLC12A3(Solute carrier family 12 member 3 (SLC12A3) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A3"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6559"]}, "Lacosamide(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "SCN11A(Voltage-gated sodium channel alpha Nav1.9 (SCN11A) ,MOA:Inhibitor); ", "drug_id_TTD": "D05OFX", "drug_id_DB": "", "metabolic_annotation_str": "DPYSL2(Dihydropyrimidinase related protein 2 (DPYSL2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DPYSL2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1808"]}, "1,1,1-Trifluoro-5-(4-octylphenoxy)pentan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F7IW", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "4-(4-Chlorophenyl)-5-p-tolylisothiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OW4W", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "PMID29757691-Compound-8d": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0B9TI", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "L-735021": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00CEN", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Bexlosteride": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0Z9UB", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "1-(1-Biphenyl-4-yl-2-methyl-propyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LXA", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "5-Iodouracil": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08EZR", "drug_id_DB": "DB03554", "metabolic_annotation_str": "DPYD(Dihydrothymine dehydrogenase (DPYD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DPYD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1806"]}, "N'-(phenylsulfonyl)benzofuran-2-carbohydrazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AW6C", "drug_id_DB": "", "metabolic_annotation_str": "BCAT2(Branched-chain-amino-acid transaminase 2 (BCAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCAT2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["587"]}, "JD-0100": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GQS", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Kushenol N": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03VSQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "(E)-4-(2-(furan-2-yl)vinyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FYN", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Dansylamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7NH", "drug_id_DB": "DB02866", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "2-(2-chlorophenylamino)-5-methylthiazol-4(5H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J6IE", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "L-Tyrosine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01CRB", "drug_id_DB": "", "metabolic_annotation_str": "TH(Tyrosine 3-monooxygenase (TH) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["TH"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["7054"]}, "OCID-2987": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S6MA", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Galanthamine derivative": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ST5U", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "BMS-753493": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0N2GC", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2348"]}, "Gamma-Homolinolenic acid": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0O1TC", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "TAS-203": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1HX", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Uridine Diphosphate Galactose": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K7WW", "drug_id_DB": "", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GALE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2582"]}, "Resorcinol compound 18": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0TL2C", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 19": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X7EQ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0E6LU", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0JC3U", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H0UC", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0PI1Z", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0P6ZB", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 15": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03MKE", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CH3F", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01EVP", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3hydroxy-1-methyl-1-phenylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0QS2N", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "N-propargyl-1H-pyrrole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H5MV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Gallium maltolate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB05420", "metabolic_annotation_str": "RRM1(Ribonucleoside-diphosphate reductase large subunit); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["RRM1"], "metabolic_genes_id": ["6240"]}, "3-(dimethylamino)phenyl phenylcarbamate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01OND", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Kaempferol-3-O-(2''-O-galloyl)-glucoside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HC9P", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Heteroaromatic ring derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FN8Y", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "Heteroaromatic ring derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0NG8Q", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "Heteroaromatic ring derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04TUG", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "Heteroaromatic ring derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J5GC", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "Methyl 2-(2-oxohexadecanamido)acetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07QSM", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "FYN(Fyn tyrosine protein kinase (FYN) ,MOA:Inhibitor); ", "drug_id_TTD": "D0OD8N", "drug_id_DB": "", "metabolic_annotation_str": "TKT(Transketolase (TK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TKT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7086"]}, "5-Indan-(1E)-ylidenemethyl-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03TRM", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "3-[5-Ethoxy-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3JZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "S-(4-Methoxybenzyl)isothiourea hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q9JG", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3-(2-Chloro-1,1-dimethyl-2-phenyl-ethyl)-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FRA", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "(E)-5-Styrylisatin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09XSB", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Heme": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HBA1(Hemoglobin (HB) ,MOA:Inhibitor); HBA2(Hemoglobin (HB) ,MOA:Inhibitor); ", "drug_id_TTD": "D0UU1I", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); CBS(Cystathionine beta-synthase (CBS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "HMOX1", "ALOX5", "ALOX5", "PTGS1", "NOS3", "NOS1", "NOS2", "PTGS2", "CBS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "3162", "240", "240", "5742", "4846", "4842", "4843", "5743", "875"]}, "2-Hydroxymethyl-Pyrrolidine-3,4-Diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06KVV", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "Bumetanide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0R7HO", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "3-[8-(benzylmethylamino)octyloxy]xanthen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B4DT", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "5-Naphthalen-2-yl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07NAH", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "N-adamantanemethyloxypentyl-1-deoxynojirimycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N9IX", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2548"]}, "Deutetrabenazine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0E7ZU", "drug_id_DB": "DB12161", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6571"]}, "(+/-)-threo-Benzylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06MFY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "4-(benzylideneamino)benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4IH", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Naftifine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00HPK", "drug_id_DB": "DB00735", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "Triazole propanedioic acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0R5DH", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "Rhopressa": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X2AT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6530"]}, "BIA 3-202": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0G4DE", "drug_id_DB": "", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "Methanesulfonyl fluoride": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0W3BA", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "DECIDIUM": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02VFM", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "NPRx-30": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FY2N", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["43"]}, "Schiff base compound 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0DW5P", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["4129"]}, "Schiff base compound 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D05RJG", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:.); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["4128", "4129"]}, "MRX-4": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03VYZ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "3-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ELJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "MRX-6": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07RKO", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "Tenoxicam(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0I6IB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "A1-10436": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01KKC", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "US10092575, Example 101": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03GTM", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "1-(3,5-bis(trifluoromethyl)benzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08OHU", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "2-(4-chlorophenyl)-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01FTB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "A1-10438": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0D5AI", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "N,N'-(1',3'-propylene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L0SD", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Cladribine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05GJW", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "3-(phenoxymethyl) benzylamine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0VY9O", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3-(phenoxymethyl) benzylamine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XO4I", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3-(phenoxymethyl) benzylamine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z1LJ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3-(phenoxymethyl) benzylamine derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Q1NF", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "N-Hydroxy-N-methyl-3-phenanthren-2-yl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C7GT", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "3-(phenoxymethyl) benzylamine derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CP6B", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "4-(2-Imidazol-1-yl-ethoxy)-benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y1YZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Benzamide derivative 16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AH1A", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Benzamide derivative 14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YO3X", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Benzamide derivative 15": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FX6I", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "D-1367": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0E8MW", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "N2-{4-[(3-chlorobenzyl)oxy]benzyl}glycinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7EJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Farletuzumab": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06XVN", "drug_id_DB": "DB05595", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2348"]}, "2-Methyl-2,4-Pentanediol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HSP90AA1(Heat shock protein 90 alpha (HSP90A) ,MOA:Inhibitor); CALM1(Calmodulin (CALM) ,MOA:Inhibitor); CALM2(Calmodulin (CALM) ,MOA:Inhibitor); CALM3(Calmodulin (CALM) ,MOA:Inhibitor); PTPN1(PTPN1 messenger RNA (PTPN1 mRNA) ,MOA:Inhibitor); PGF(Placenta growth factor (PlGF) ,MOA:Inhibitor); DLG4(Presynaptic density protein 95 (DLG4) ,MOA:Inhibitor); ", "drug_id_TTD": "D06GOK", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); CTPS1(CTP synthase (CTPS1) ,MOA:Inhibitor); NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); COASY(Phosphopantetheine adenylyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "CTPS1", "NOS3", "AKR1C3", "COASY"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "1503", "4846", "8644", "80347"]}, "5,6-Cyclic-Tetrahydropteridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P6IL", "drug_id_DB": "DB03332", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "GSK2636771": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0G3MN", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5291"]}, "GSK1018921": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0WY2L", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6536"]}, "1-butoxy-4-phenoxybenzene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07TVA", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "(4S,5R)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UP8X", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "1-(4-ethylpiperazin-1-yl)-2-phenylethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E3ST", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Didox": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04FXS", "drug_id_DB": "", "metabolic_annotation_str": "RRM1(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2B(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM1", "RRM2", "RRM2B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6240", "6241", "50484"]}, "Methazolamide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0C2II", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["759"]}, "1,4-Dithiothreitol(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "PPIB(Rotamase B (PPIB) ,MOA:Inhibitor); ", "drug_id_TTD": "D01GMJ", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2-(N-Pyrrolidinyl)-3'-fluoropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06LCK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "CATECHOL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07QJJ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "762"]}, "Dapagliflozin Propanediol; Saxagliptin Hydrochloride": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "DPP4(Dipeptidyl peptidase 4 (DPP-4) ,MOA:Modulator); ", "drug_id_TTD": "D0Y6QC", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "2-(4-methoxyphenyl)-4H-chromene-4-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P7SY", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Imidazole benzamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0F8KE", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Glibenclamide": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05LYX", "drug_id_DB": "", "metabolic_annotation_str": "ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC8"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6833"]}, "2,3-dihydro-1H-indene-5-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LC0F", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "23632"]}, "(S)-EF-1520": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WT5D", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); SLC6A12(Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1", "SLC6A12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6529", "6539"]}, "(E)-4-Methyl-6-(prop-1-enyl)pyridin-2-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8OA", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "1,2-dihydro-3-(2,3,4-trimethoxyphenyl)naphthalene": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OX0B", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "2-morpholino-N-phenethylpyrimidin-4-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K8AU", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1-(4-methoxyphenyl)-2-(phenylsulfonyl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4PP", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "ALX 1393": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E1OC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A5(Glycine transporter-2 (SLC6A5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A5"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9152"]}, "Ivosidenib": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07DCG", "drug_id_DB": "DB14568", "metabolic_annotation_str": "IDH1(Oxalosuccinate decarboxylase (IDH1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDH1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3417"]}, "Ro48-8071": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0X3GG", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "N-Cyclohexyl-N'-(4-Iodophenyl)Urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G8HM", "drug_id_DB": "DB02029", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "L-655240": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0I9JH", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "(+/-)-threo-Ritalinol methyl ether": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3DV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-Aminothiazoline(TTD)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ILO", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "CU-906": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ", "drug_id_TTD": "D0JD4S", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "4'-Phosphopantetheine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HSI", "drug_id_DB": "", "metabolic_annotation_str": "COASY(Phosphopantetheine adenylyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COASY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["80347"]}, "Chlorothiazide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00880", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); SLC12A3(Solute carrier family 12 member 3); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA1", "CA2", "SLC12A3"], "metabolic_genes_id": ["759", "760", "6559"]}, "[3H]folinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R4PS", "drug_id_DB": "", "metabolic_annotation_str": "SLC46A1(Proton-coupled folate transporter (SLC46A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC46A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["113235"]}, "UTIBAPRIL": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03DRW", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "N-Phenyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D8IH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "[3H]GBR12935": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "AGTR1(Angiotensin II receptor type-1 (AGTR1) ,MOA:Antagonist); ", "drug_id_TTD": "D07OOI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "1-(3-bromophenyl)-2-(tert-butylamino)propan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C0GL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "PMID1992149C9": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ITS", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Opicapone": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D01SGK", "drug_id_DB": "DB11632", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "1-adamantan-1-yl-3-(1-benzyl-piperidin-4-yl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3PF", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "3-[3-Methyl-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02BWQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "K-604": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03PYD", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "3,4-dibenzyloxy-2'-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1UP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "rawsonol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y6DJ", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3156"]}, "HR325": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0SX4K", "drug_id_DB": "", "metabolic_annotation_str": "DHODH(Dihydroorotate dehydrogenase (DHODH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHODH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1723"]}, "Vardenafil(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0C9SY", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["8654"]}, "3-[4-Methyl-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AH1B", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "J-104118": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06VOJ", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "DL-benzylsuccinic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "CPB2(Carboxypeptidase B2 (CPB2) ,MOA:Inhibitor); ", "drug_id_TTD": "D06LNX", "drug_id_DB": "", "metabolic_annotation_str": "CPA1(Carboxypeptidase A1 (CPA1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CPA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1357"]}, "2-(4-fluorophenyl)-7-methoxy-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G6MA", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "1,1,1-trifluoroheptadecan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R3AA", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "BRL-36378": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BNP", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "ALO-1567": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07DIX", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "AD-337": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D02ZCE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "3-(6-Amino-purin-9-yl)-non-5-yn-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0TP", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Benzisoselenazolone difluorocytidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KV5Z", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Tapentadol hydrochloride": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "OPRM1(Opioid receptor mu (MOP) ,MOA:Modulator); ", "drug_id_TTD": "D0K4MH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6530"]}, "4'-bromo-3-(imidazolylmethyl)flavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZHX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1-Bromo-4-imidazol-1-ylmethyl-xanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07PHV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "YM-75440": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M0HE", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "URSOLIC ACID": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PTPN1(PTPN1 messenger RNA (PTPN1 mRNA) ,MOA:Inhibitor); ", "drug_id_TTD": "D07LUJ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "PYGM", "HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "5837", "3290"]}, "BPH-830": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03DCE", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "M-40401": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0U0PV", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "ISIS 31982": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C1NA", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "1-benzylpiperidine hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01BPR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Rockout": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L0MJ", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "[1,4]Oxazepan-(3E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I3ZP", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "1-(1-phenylethylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06MNV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "2-Propyl-beta-carboline-2-ium iodide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02AFZ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Deprenyl": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y8AN", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Nepicastat oral": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0N5YD", "drug_id_DB": "", "metabolic_annotation_str": "DBH(Dopamine beta hydroxylase (DBH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DBH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1621"]}, "9-Ethyl-2-methyl-beta-carboline-2-ium iodide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8NK", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "5-Hydroxymethyl-3-pyrrol-1-yl-oxazolidin-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08QVY", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07SAF", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "FP-1102": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I1TM", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8639"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0HO0I", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07RUH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Trans-2-fluoro-2-(4-fluorophenyl)cyclopropanamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08PHY", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Guanine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02377", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase); GCH1(GTP cyclohydrolase 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PNP", "GCH1"], "metabolic_genes_id": ["4860", "2643"]}, "Indatraline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08NZE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Cyclosal-d4TMP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03OGO", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "bromocresol green": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KO9R", "drug_id_DB": "", "metabolic_annotation_str": "SLCO2A1(Prostaglandin transporter (SLC21A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLCO2A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6578"]}, "4,5-Dimethoxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08BNV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "N1-[4-(Phenylmethoxy)phenyl]-D-glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04DRM", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Pyruvic acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "SLC16A4(Monocarboxylate transporter 5); SLC16A5(Monocarboxylate transporter 6); SLC16A6(Monocarboxylate transporter 7); ", "drug_id_TTD": "", "drug_id_DB": "DB00119", "metabolic_annotation_str": "SLC16A3(Monocarboxylate transporter 4); SLC16A7(Monocarboxylate transporter 2); SLC16A8(Monocarboxylate transporter 3); PDHB(Pyruvate dehydrogenase E1 component subunit beta, mitochondrial); PC(Pyruvate carboxylase, mitochondrial); PKM(Pyruvate kinase PKM); PKLR(Pyruvate kinase PKLR); PKLR(Pyruvate kinase PKLR); SLC16A2(Monocarboxylate transporter 8); SLC16A1(Monocarboxylate transporter 1); SLC16A1(Monocarboxylate transporter 1); ABAT(4-aminobutyrate aminotransferase, mitochondrial); AGXT2(Alanine--glyoxylate aminotransferase 2, mitochondrial); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC16A3", "SLC16A7", "SLC16A8", "PDHB", "PC", "PKM", "PKLR", "PKLR", "SLC16A2", "SLC16A1", "SLC16A1", "ABAT", "AGXT2"], "metabolic_genes_id": ["9123", "9194", "23539", "5162", "5091", "5315", "5313", "5313", "6567", "6566", "6566", "18", "64902"]}, "(S)-tert-Butyl 4-(2-oxohexadecanamido)pentanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1YU", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "AAD-2004": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D00MBY", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Desipramine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ADRB2(Beta-2 adrenergic receptor); CHRM2(Muscarinic acetylcholine receptor M2); CHRM4(Muscarinic acetylcholine receptor M4); HTR1A(5-hydroxytryptamine receptor 1A); CHRM5(Muscarinic acetylcholine receptor M5); ADRA2A(Alpha-2A adrenergic receptor); CHRM1(Muscarinic acetylcholine receptor M1); DRD2(D(2) dopamine receptor); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); CHRM3(Muscarinic acetylcholine receptor M3); ADRA1D(Alpha-1D adrenergic receptor); HTR2A(5-hydroxytryptamine receptor 2A); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); ADRA1B(Alpha-1B adrenergic receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01151", "metabolic_annotation_str": "SMPD1(Sphingomyelin phosphodiesterase); SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SMPD1", "SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6609", "6530", "6532"]}, "4,8-Dimethyl-7-(2'-oxocyclohexyloxy)coumarin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01LUB", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "3,3'-thiene-2,5-diyldiphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TA0J", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Anti-Fas mabs": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07WAF", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["2194"]}, "Tranilast(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB07615", "metabolic_annotation_str": "HPGDS(Hematopoietic prostaglandin D synthase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["HPGDS"], "metabolic_genes_id": ["27306"]}, "N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06JVR", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "5'-Deoxy-5'-(N,N-dimethylamino)adenosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03OLX", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "D-Eritadenine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G3CQ", "drug_id_DB": "DB03769", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "Methyl-pentyl-prop-2-ynyl-amine oxalic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N6JE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Hesperetin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "SHBG(Sex hormone-binding globulin); MTTP(Microsomal triglyceride transfer protein large subunit); ", "drug_id_TTD": "", "drug_id_DB": "DB01094", "metabolic_annotation_str": "SOAT2(Sterol O-acyltransferase 2); SOAT1(Sterol O-acyltransferase 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["SOAT2", "SOAT1"], "metabolic_genes_id": ["8435", "6646"]}, "2-p-tolyl-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01DEU", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "DIDEAZAFOLATE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z9QC", "drug_id_DB": "", "metabolic_annotation_str": "GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2618", "2618"]}, "PMID8709131C2a (+)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L1ND", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "11-beta-HSD1 inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02WRO", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Iodoacetamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03GXQ", "drug_id_DB": "", "metabolic_annotation_str": "CKM(Creatine kinase (CK) ,MOA:Inhibitor); CKB(Creatine kinase (CK) ,MOA:Inhibitor); CKMT1B(Creatine kinase (CK) ,MOA:Inhibitor); CKMT1A(Creatine kinase (CK) ,MOA:Inhibitor); CKMT2(Creatine kinase (CK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CKM", "CKB", "CKMT1B", "CKMT1A", "CKMT2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1158", "1152", "1159", "548596", "1160"]}, "N-hydroxysulfamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CXX", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "Dexlansoprazole": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D06YYD", "drug_id_DB": "DB05351", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Inhibitor); ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "495", "496", "496"]}, "Thiazolidine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J6DS", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Thiazolidine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0IB3Z", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Thiazolidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0HH4L", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "4-Hydroxy-3-(1-naphthylmethyl)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CYJ", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "4(Z)-(5'-Deoxyadenosin-5'-ylidene)butanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1VT", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "US9453017, 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X0NV", "drug_id_DB": "", "metabolic_annotation_str": "PLD1(Phospholipase D1 (PLD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5337"]}, "US9453017, 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08SLU", "drug_id_DB": "", "metabolic_annotation_str": "PLD1(Phospholipase D1 (PLD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5337"]}, "PMID26666989-Compound-Figure12left": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0S5CP", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "4-(2-(phenoxymethyl)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0PR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "GW-796406": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Modulator); ", "drug_id_TTD": "D0C1AY", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "1-[(7-Fluoronaphth-2-yl)methyl]-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P3ND", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "SC-106": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D3KY", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "Pyrido[1,2,4]triazolo[4,3-a]pyrazine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z4IA", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "2-N-Methylamino-1-(4-methylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SD4O", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Vapaliximab": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D05YHW", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["8639"]}, "2-(tert-butylamino)-1-p-tolylpropan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BYB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "16-(pyridin-4-yl)methyl-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FPP", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "NP-0336": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W2SX", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "3-(pyridin-4-yl)-1H-indol-6-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4EM", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "R-phenserine": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0O5GK", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "SPD-473": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0LU6N", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Guanosine-5'-Diphosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HRAS(GTPase HRas); HRAS(GTPase HRas); RAP2A(Ras-related protein Rap-2a); RALA(Ras-related protein Ral-A); GNAT1(Guanine nucleotide-binding protein G(t) subunit alpha-1); EEF2(Elongation factor 2); GSPT1(Eukaryotic peptide chain release factor GTP-binding subunit ERF3A); ARF4(ADP-ribosylation factor 4); RAB5A(Ras-related protein Rab-5A); TGM2(Protein-glutamine gamma-glutamyltransferase 2); ARL3(ADP-ribosylation factor-like protein 3); ARL1(ADP-ribosylation factor-like protein 1); EIF2S3(Eukaryotic translation initiation factor 2 subunit 3); RAB7A(Ras-related protein Rab-7a); RAB9A(Ras-related protein Rab-9A); CDC42(Cell division control protein 42 homolog); RHOA(Transforming protein RhoA); ARF6(ADP-ribosylation factor 6); RAB11A(Ras-related protein Rab-11A); RAN(GTP-binding nuclear protein Ran); RAC1(Ras-related C3 botulinum toxin substrate 1); GNAI1(Guanine nucleotide-binding protein G(i) subunit alpha-1); EEF1A1(Elongation factor 1-alpha 1); ARF1(ADP-ribosylation factor 1); TGM3(Protein-glutamine gamma-glutamyltransferase E); RHEB(GTP-binding protein Rheb); IRGC(Interferon-inducible GTPase 5); EFL1(Elongation factor Tu GTP-binding domain-containing protein 1); RAB8B(Ras-related protein Rab-8B); ARL5B(ADP-ribosylation factor-like protein 5B); ARL5A(ADP-ribosylation factor-like protein 5A); SAR1B(GTP-binding protein SAR1b); ", "drug_id_TTD": "", "drug_id_DB": "DB04315", "metabolic_annotation_str": "GMDS(GDP-mannose 4,6 dehydratase); NME1(Nucleoside diphosphate kinase A); NME2(Nucleoside diphosphate kinase B); ADSS1(Adenylosuccinate synthetase isozyme 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["GMDS", "NME1", "NME2", "ADSS1"], "metabolic_genes_id": ["2762", "4830", "4831", "122622"]}, "Dexibuprofen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PLAT(Tissue-type plasminogen activator); THBD(Thrombomodulin); GP1BA(Platelet glycoprotein Ib alpha chain); BCL2(Apoptosis regulator Bcl-2); S100A7(Protein S100-A7); PPARG(Peroxisome proliferator-activated receptor gamma); PPARA(Peroxisome proliferator-activated receptor alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB09213", "metabolic_annotation_str": "CFTR(Cystic fibrosis transmembrane conductance regulator); PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); SLC15A1(Solute carrier family 15 member 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CFTR", "PTGS1", "PTGS2", "SLC15A1"], "metabolic_genes_id": ["1080", "5742", "5743", "6564"]}, "1-((9H-Fluoren-2-yl)methyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MM7G", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "7-Acetonyloxy-3,4-cyclopentene-8-methylcoumarin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00OQL", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Rilapladib(TTD)": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05GZD", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Modulator); TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B", "TK1", "PLA2G7"], "metabolic_mechanism_of_action": ["Modulator", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5319", "7083", "7941"]}, "PMID18155906C16f": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O7AS", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Benzamide derivative 18": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02DXA", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "4-(3-Phenylethynyl-benzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0FF0Z", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "GDC-0032": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0UP1Z", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Modulator); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CA", "PIK3CG"], "metabolic_mechanism_of_action": ["Modulator", "Inhibitor"], "metabolic_genes_id": ["5290", "5294"]}, "Genz-682452": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04SFN", "drug_id_DB": "", "metabolic_annotation_str": "UGCG(Ceramide glucosyltransferase (UGCG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["UGCG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7357"]}, "Uridine-Diphosphate-N-Acetylgalactosamine(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06UGK", "drug_id_DB": "", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GALE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2582"]}, "Isosorbide-2-(butylcarbamate)-5-mononitrate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01MAC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "2-Phenyl-cyclopropylamine hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LMT", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "7-(trifluoromethyl)-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E5ZP", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "N-propylnorlitebamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B2JV", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N1-(4-fluorobenzyl)-2-benzyl-N3-hydroxymalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K9XV", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "1,2-bis(2,3,4-trifluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P1IK", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CHRNB2(Neuronal acetylcholine receptor beta-2 (CHRNB2) ,MOA:Inhibitor); CHRNB4(Neuronal acetylcholine receptor beta-4 (CHRNB4) ,MOA:Inhibitor); CHRNA4(Neuronal acetylcholine receptor alpha-4 (CHRNA4) ,MOA:Inhibitor); ", "drug_id_TTD": "D00QCP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "2-methoxy-3,4-methylenedioxybenzophenone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H5II", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "SB 203580": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "IL1R1(Interleukin 1 receptor type 1 (IL1R1) ,MOA:Antagonist); MAPK14(Stress-activated protein kinase 2a (p38 alpha) ,MOA:Inhibitor); ", "drug_id_TTD": "D0F8DL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "N1-[4-(Phenylmethoxy)phenyl]-L-glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HA1K", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "2-(4-benzoylpiperazin-1-yl)thiazole-5-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1QW", "drug_id_DB": "", "metabolic_annotation_str": "SCD(Acyl-CoA desaturase (SCD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SCD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6319"]}, "1-(4-(3-morpholinopropoxy)phenyl)-3-phenylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01OZF", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Malonate sodium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03MXZ", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "Benzene sulfonamide derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LM5V", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Benzene sulfonamide derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0VI4S", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "PMID27537201-Compound-Figure17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S3BE", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Tezacaftor and ivacaftor": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0E1HC", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["1080"]}, "PMID27537201-Compound-Figure11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YX0O", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "IPRONIAZIDE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08CNS", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "3-Biphenyl-4-yl-N-hydroxy-N-methyl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TLZ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID29324067-Compound-25": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AH9P", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "N-(2,4-dihydroxybenzyl)-3,4,5-trihydroxybenzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07FKO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "5-Methyl-N-phenylbenzo[d]oxazol-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4MV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID25399762-Compound-Figure3-Fluevirosine A": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KW7O", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Tarnylcypromine derivative 2": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "KDM1A(Lysine-specific histone demethylase 1 (LSD) ,MOA:Inhibitor); KDM1B(Lysine-specific histone demethylase 1B (KDM1B) ,MOA:Inhibitor); ", "drug_id_TTD": "D04OHC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "MB07803": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0KU4M", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Modulator); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8789", "2203"]}, "(S)-2-amino-1-(4-ethylthiophenyl)-propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ZZA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "(+/-)-threo-4'-Ethylmethylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1KJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "N5-[4-(4-(3-Furyl)phenoxy)phenyl]-L-glutamamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B9UW", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "BENZIL": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7FX", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "PMID26666989-Compound-Figure12bottomright": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D08KMR", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "(R)-2-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G8UA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Benzyl-methyl-[1-(1H-pyrrol-2-yl)-vinyl]-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0JM", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "ROBINETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07NAY", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "CS-526": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0R7GH", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "PMID2231594C3k": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZJG", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID29130358-Compound-LonimacranthoideVI": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0JE1M", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "(E)-5-(3-Fluorostyryl)isatin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X8HH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "SC-45662": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U5EU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "N-(3-Methanesulfonyl-4-methyl-benzoyl)-guanidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03AGV", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1", "SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6548", "6550", "6550"]}, "LY2928057": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0IN8Z", "drug_id_DB": "", "metabolic_annotation_str": "SLC40A1(Solute carrier family 40 member 1 (SLC40A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC40A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["30061"]}, "N-Phenyl-1-methyl-1H-indole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05OXR", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "(S)-2-amino-1-(4-methylthiophenyl)-propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q2QA", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Aspirin": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0GY5Z", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3156", "5742", "5743"]}, "Parecoxib(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "LTF(Lactotransferrin); ", "drug_id_TTD": "", "drug_id_DB": "DB08439", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PTGS2"], "metabolic_genes_id": ["5743"]}, "(5-Imino-[1,4]thiazepan-3-yl)-methanol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XOR", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "Poly-substituted azoles statin lactone derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AP6V", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Poly-substituted azoles statin lactone derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RW8J", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "4-(1H-indol-3-yl)-N,N-dimethylcyclohex-3-enamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07DMN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "JATRORRHIZINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0NM", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "4-(2-(4-fluorophenoxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D04NKQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "ES-936": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GE8S", "drug_id_DB": "DB02400", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "CORDOIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0US0J", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Ketoprofen topical": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0XI1P", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "3,4,5-Trimethoxy-3'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NB8V", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "PMID27109571-Compound-19": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0RZ9C", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "Quinazoline alkaloid derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D01SQO", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "HQK-1004": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05RRA", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7083"]}, "Coprexa": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06WPM", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6647"]}, "(S)-Piperidine-3-carboxylic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03IWW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6529"]}, "Ribose-1-Phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04LUI", "drug_id_DB": "DB03101", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "IGN523": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0OQ5R", "drug_id_DB": "", "metabolic_annotation_str": "SLC3A2(Lymphocyte activation antigen 4F2 (SLC3A2) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC3A2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6520"]}, "BTT-1023": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06GUG", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["8639"]}, "1-adamantan-1-yl-3-(1-ethyl-piperidin-4-yl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XS3W", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Non-PEGylated butyrylcholinesterase": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M2EH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["590"]}, "3-[5-(4-Fluorophenyl)-2-thienyl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UR6C", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Cis-2-(para-fluorophenyl)cyclopropylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UL6Y", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Amfetamine transdermal": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0T3AP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "B7673": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01RCZ", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "4-[4-(benzyloxy)piperidino]butyl benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L1EI", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N4-Butyl-2-cinnamamido-N1-hydroxysuccinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J0WJ", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "ANONAINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "DRD2(Dopamine D2 receptor (D2R) ,MOA:Inhibitor); ", "drug_id_TTD": "D0HO7I", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "5,5'-methylenebis(1,3,4-oxadiazole-2(3H)-thione)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H5WY", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(2R,3S)-3-(6-Amino-purin-9-yl)-nonan-2-ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ADORA3(Adenosine A3 receptor (ADORA3) ,MOA:Inhibitor); ADORA2A(Adenosine A2a receptor (ADORA2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0I6XA", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Brasofensine(TTD)": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05BXO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "1-(1-Benzo[b]thiophen-2-yl-cyclopentyl)-azepane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y3DR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "1-(4-nitrobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S0EP", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "CDDO": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05SCE", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "AZD-4407": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0P3CF", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Benserazide": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0X8ED", "drug_id_DB": "DB12783", "metabolic_annotation_str": "DDC(Aromatic-L-amino-acid decarboxylase (DDC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DDC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1644"]}, "PNU-22394": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QRS", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-methyl-N-ethyl estradiol-16-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G7PB", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "HydrocoDex": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "SIGMAR1(Opioid receptor sigma 1 (OPRS1) ,MOA:Modulator); ", "drug_id_TTD": "D0Q7OA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "Dibutyl 2,2,2-trifluoro-1-phenylethyl phosphate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02VYI", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "GRASPA": {"drug_status_TTD": ["Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D09JKS", "drug_id_DB": "", "metabolic_annotation_str": "ASRGL1(Asparaginase (ASRGL1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ASRGL1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["80150"]}, "Pargyline(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0R0UJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Indazole derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06HOA", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["3620"]}, "N-[4-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y4CC", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "6-Phenylmethanesulfonyl-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03YBR", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "2-acetamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00FGB", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Lactam derivative 2": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0U0MZ", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "PMID27537201-Compound-Figure13b": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03HKN", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Moexipril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00HDU", "drug_id_DB": "DB00691", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "PMID22861813C8a": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I9PF", "drug_id_DB": "", "metabolic_annotation_str": "CTSA(Cathepsin A (CTSA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTSA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5476"]}, "9-(3-n-Pentylureido)non-4-ynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ATA", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Lactam derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0F6VD", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "GW274150": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05QJT", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4843"]}, "2-(N-Pyrrolidinyl)-3'-bromopropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U3SB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "TGX-221": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06DNH", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5291", "5294"]}, "4-[2-(4-Benzylphenoxy)ethyl]pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VN8V", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Pyrimethamine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00205", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["DHFR"], "metabolic_genes_id": ["1719"]}, "8-Azaguanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01OHV", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "RQ-00000004": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D05BCU", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "PMID29053063-Compound-4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UW6S", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "PMID29053063-Compound-5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07YWE", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Celecoxib(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CDH11(Cadherin-11); PDPK1(3-phosphoinositide-dependent protein kinase 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00482", "metabolic_annotation_str": "CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA2", "CA3", "PTGS2"], "metabolic_genes_id": ["760", "761", "5743"]}, "CGP-28014": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0P5TR", "drug_id_DB": "", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1312"]}, "Benzothiopyranoindole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y5AZ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "PMID29053063-Compound-14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V7PO", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "PMID29053063-Compound-15": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0TL1G", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); DAGLA(Diacylglycerol lipase alpha (DAGLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL", "DAGLA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["11343", "747"]}, "PMID29053063-Compound-17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G9NQ", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "DB-200": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0SG0N", "drug_id_DB": "", "metabolic_annotation_str": "CPT1B(Carnitine O-palmitoyltransferase I (CPT1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CPT1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1375"]}, "Clofarabine(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0R5RR", "drug_id_DB": "", "metabolic_annotation_str": "RRM1(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2B(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM1", "RRM2", "RRM2B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6240", "6241", "50484"]}, "CBF-BS2": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05JCG", "drug_id_DB": "", "metabolic_annotation_str": "G6PD(Glucose-6-phosphate dehydrogenase (G6PD) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["G6PD"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2539"]}, "1-(2-iodoethyl)-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05PNO", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "9-Hydroxypropyladenine, R-Isomer": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X1HX", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "N-(pyridin-4-ylmethyl) estradiol-16-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02DYZ", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Trichlormethiazide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y2IZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "Diethyl 2,2,2-trifluoro-1-phenylethyl phosphate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01GSO", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "PMID18754614C17": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U9GN", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "P-7170": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0R8ID", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K7HT", "drug_id_DB": "", "metabolic_annotation_str": "ADCY2(Adenylate cyclase type 2 (ADCY2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADCY2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["108"]}, "4-Hydrazino-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UM1I", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "(+)-3,3'-bisdemethyltanegool": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01PBO", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "246"]}, "HP-290": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09PTA", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "SC-236(TTD)": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D03NZV", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Deoxynojirimycin": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "GANAB(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0S5LT", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); GAA(Alpha-glucosidase (GLA) ,MOA:Inhibitor); GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); GANC(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM", "GAA", "GAA", "GANC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972", "2548", "2548", "2595"]}, "Octane-1,8-diyl disulfamate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D4OV", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "Naloxone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TLR4(Toll-like receptor 4); ESR1(Estrogen receptor); CREB1(Cyclic AMP-responsive element-binding protein 1); OPRM1(Mu-type opioid receptor); OPRD1(Delta-type opioid receptor); OPRK1(Kappa-type opioid receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01183", "metabolic_annotation_str": "CES1(Liver carboxylesterase 1); CES1(Liver carboxylesterase 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_genes_id": ["1066", "1066"]}, "(2R,3S,4S,5R)-2-hexylpiperidine-3,4,5-triol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R4JZ", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2629", "2629"]}, "BAY-44-3428": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0W7DD", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "6-(4-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XD1Q", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Poly-substituted miazine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CW2F", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2-N-Ethylamino-1-(4-ethylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04RUF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "8-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03GAQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "Nesiritide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05GRY", "drug_id_DB": "", "metabolic_annotation_str": "NPR1(Atrial natriuretic peptide receptor A (NPR1) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["NPR1"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["4881"]}, "NTE-122": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D03JRJ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "2-(4-methoxyphenyl)-N-(thiazol-2-yl)acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05WGA", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Saviprazole": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0FN1P", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "MLN0264": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U7VU", "drug_id_DB": "", "metabolic_annotation_str": "GUCY2C(Guanylyl cyclase C (GUCY2C) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY2C"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2984"]}, "2-N-Methoxyamino-1-(4-methylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VX1V", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "SCUTELLAREIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00LMG", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "MDL-18962": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M2IB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "H-PGDS inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N6JF", "drug_id_DB": "", "metabolic_annotation_str": "HPGDS(Glutathione-dependent PGD synthase (HPGDS) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["HPGDS"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["27306"]}, "3-chlorotyrosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6LZ", "drug_id_DB": "", "metabolic_annotation_str": "TH(Tyrosine 3-monooxygenase (TH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7054"]}, "R-KETOPROFEN": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "CXCL8(Interleukin-8 (IL8) ,MOA:Inhibitor); CXCR1(C-X-C chemokine receptor type 1 (CXCR1) ,MOA:Inhibitor); CXCR2(C-X-C chemokine receptor type 2 (CXCR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0ZL4F", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "GypensapogeninA": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03YOU", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "GypensapogeninB": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0R2YC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Methylphenidate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HTR1A(5-hydroxytryptamine receptor 1A); ", "drug_id_TTD": "", "drug_id_DB": "DB00422", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "Mercaptopurine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01033", "metabolic_annotation_str": "HPRT1(Hypoxanthine-guanine phosphoribosyltransferase); IMPDH2(Inosine-5'-monophosphate dehydrogenase 2); PPAT(Amidophosphoribosyltransferase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["HPRT1", "IMPDH2", "PPAT"], "metabolic_genes_id": ["3251", "3615", "5471"]}, "2-(4-hydroxylphenyl)-3-(3,5-dihydroxylphenyl) propenoic acid (NNU-hdpa)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WW1K", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "(10H-phenothiazin-10-yl)(phenyl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L3EE", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N-Methyl-N-Propargyl-1(R)-Aminoindan": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2AF", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "AG-120": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0R3OP", "drug_id_DB": "", "metabolic_annotation_str": "IDH1(Oxalosuccinate decarboxylase (IDH1) ,MOA:Inhibitor); IDH1(Mutated oxalosuccinate decarboxylase (mIDH1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDH1", "IDH1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3417", "3417"]}, "2,5-Anhydroglucitol-1,6-Biphosphate(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C2YL", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203"]}, "E-2011": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0G9AP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4128"]}, "PMID9003518C3": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K3TQ", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "Jaspic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JRW", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "6-bromo-3-(pyridin-4-yl)-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05SKE", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "EMD-53998": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0Y6HV", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "Formycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NH1Y", "drug_id_DB": "DB02281", "metabolic_annotation_str": "MTAP(S-methyl-5'-thioadenosine phosphorylase (MTAP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MTAP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4507"]}, "1,1,1,2,2-Pentafluoro-8-phenyl-octan-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U2QY", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "4-ethynyl benzene sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LJ5P", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Clorgyline": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09QDP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "L-beta-BA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HET", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A1(Excitatory amino acid transporter 3 (SLC1A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6505"]}, "THIOCITRULLINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E0QG", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "Fluorouracil(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "TERT(TERT messenger RNA (TERT mRNA) ,MOA:.); ", "drug_id_TTD": "D05LEO", "drug_id_DB": "", "metabolic_annotation_str": "TYMS(Thymidylate synthase messenger RNA (TYMS mRNA) ,MOA:.); DPYD(Dihydrothymine dehydrogenase (DPYD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMS", "DPYD"], "metabolic_mechanism_of_action": [".", "Inhibitor"], "metabolic_genes_id": ["7298", "1806"]}, "BNV-222": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R3OQ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["231"]}, "VN/107-1": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EDD", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "Uracil(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0DG", "drug_id_DB": "", "metabolic_annotation_str": "DPYD(Dihydrothymine dehydrogenase (DPYD) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DPYD"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1806"]}, "Thymine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4KL", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "Brinzolamide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01MUR", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["762"]}, "(R)-Rolipram(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04149", "metabolic_annotation_str": "PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); PDE4D(cAMP-specific 3',5'-cyclic phosphodiesterase 4D); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PDE4B", "PDE4D"], "metabolic_genes_id": ["5142", "5144"]}, "2,4-Diamino-butyric acid(GABA)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09TTI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); SLC6A11(GABA transporter-3 (SLC6A11) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1", "SLC6A11"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6529", "6538"]}, "Zomepirac(TTD)": {"drug_status_TTD": ["Withdrawn from market", "Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D0SU1G", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "US9434727, 120": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K0IZ", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "Beta-naphthylacetic acids derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G8VB", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor. Antagonist. Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor; Antagonist; Blocker"], "metabolic_genes_id": ["8644"]}, "Incadronate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0N4PZ", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "JBP-1": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PRSS1(Cationic trypsinogen (PRSS1) ,MOA:Modulator); PRSS1(Cationic trypsinogen (PRSS1) ,MOA:Modulator); GANAB(Alpha-glucosidase (GLA) ,MOA:Modulator); ", "drug_id_TTD": "D0JR9V", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Alpha-glucosidase (GLA) ,MOA:Modulator); GANC(Alpha-glucosidase (GLA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA", "GANC"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2548", "2595"]}, "3-((2-Pyrrolidine-1-yl)-ethyl)uracil": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7PF", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "N-Benzyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ZLS", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1-(3,4-difluorobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4XX", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "PMID25514969-Compound-11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LW9K", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "T0156": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LZ5R", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "PMID25514969-Compound-13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RY9R", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "PMID25514969-Compound-12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SQ4B", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "(S)-2-Amino-2-phenyl-ethanethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06VON", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Fluoro loxoprofen": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UH3D", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "(S)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06VYU", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "N-(4-methylthiazol-2-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01IMJ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Guanosine": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0H1OL", "drug_id_DB": "DB02857", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "1,2,4-triazole [4,3-a]quinoxaline derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J6KS", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "1,2,4-triazole [4,3-a]quinoxaline derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RI3W", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "1,2,4-triazole [4,3-a]quinoxaline derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09BDD", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Tranilast(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "HRH1(Histamine H1 receptor (H1R) ,MOA:Antagonist); ", "drug_id_TTD": "D0E6OC", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "8-methoxy-2-oxo-2H-chromene-3-carboxylic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06DYP", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "768", "23632"]}, "Uridine-5'-Diphosphate-Mannose": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z9JO", "drug_id_DB": "", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase (GALE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GALE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2582"]}, "CGS-19281A": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D1PE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "CYLINDOL A": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K3AO", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "2-((3-iodophenyl)(o-tolyloxy)methyl)morpholine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q9UZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "3-methoxy-N-(1,3,4-thiadiazol-2-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02GJI", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID17975902C5e": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ONZ", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "2-(3'-Vinyl-biphenyl-4-yl)-propionic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YI3V", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "(4-Methyl-2-oxo-2H-quinolin-1-yl)-acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IF8Z", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "GW-660511": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Modulator); ", "drug_id_TTD": "D0F9BX", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "8-(3-Methoxybenzyloxy)caffeine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B6MV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "SEH inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07NIT", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "ISIS 191759": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D0OO", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["8694", "8694"]}, "4-(Aminomethyl)-7-(benzyloxy)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T1FJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "3-(2,2-Diphenyl-vinyl)-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02XTS", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "IMAZODAN": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D09UMA", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A", "PDE5A", "PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5138", "8654", "5139"]}, "Apricoxib": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0S7IZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Indoline derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0J3OD", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "CZC-19091": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00LZO", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "Tert-butyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S8AS", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "[3H]TBZOH": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZYP", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6571"]}, "4-(3-methoxy-benzylideneamino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FEF", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Sodium phenylaminomethanesulfonate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07UCQ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "768"]}, "DFU": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01MFK", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Fomepizole(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01213", "metabolic_annotation_str": "ADH1C(Alcohol dehydrogenase 1C); CAT(Catalase); ADH1A(Alcohol dehydrogenase 1A); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ADH1C", "CAT", "ADH1A"], "metabolic_genes_id": ["126", "847", "124"]}, "Cartazolate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V1CL", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "1-(9-phenyl-9H-fluoren-9-yl)-1H-1,2,4-triazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GL0L", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3R14S-OCHRATOXIN A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KN6Q", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A8(Solute carrier family 22 member 8 (SLC22A8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A8"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9376"]}, "8-acetyl-7-butoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08JNO", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04HQK", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "4-(2-fluoro-6-(4-fluorophenoxy)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D01MBF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "ML272": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CI4A", "drug_id_DB": "", "metabolic_annotation_str": "PLD1(Phospholipase D1 (PLD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5337"]}, "4-(6-Methoxynaphthalen-2-yl)isoquinoline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CWR", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1584"]}, "2-Hex-5-enyl-5-non-8-enyl-pyrrolidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C6QF", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Polynoma-1": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "MAGEA3(Melanoma-associated antigen 3 (MAGEA3) ,MOA:.); MLANA(MART-1 melanoma antigen (MLANA) ,MOA:.); ", "drug_id_TTD": "D00DSV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["7299"]}, "Trans-2-fluoro-2-phenylcyclopropylamin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HBX", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "SAFINAMIDE MESYLATE": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0XM1A", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Citalopram derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "HRH1(Histamine H1 receptor (H1R) ,MOA:Inhibitor); ", "drug_id_TTD": "D0R6LF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "E-6700": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0K9UK", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "TBXAS1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["240", "240", "6916"]}, "TDI-0107": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W7DP", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6647"]}, "HALOXYSTEROL A": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G5SM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "HALOXYSTEROL B": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X3FF", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "BH4": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F9XO", "drug_id_DB": "", "metabolic_annotation_str": "PAH(Phenylalanine hydroxylase (PAH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PAH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5053"]}, "PMID27977313-Compound-Figure6C": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0NU8U", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "BW-A137C": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M6UM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "D-166A": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V3LR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0K3EW", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "MANGOSTIN": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PRC", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "Sterculic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GQC", "drug_id_DB": "", "metabolic_annotation_str": "SCD(Acyl-CoA desaturase (SCD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SCD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6319"]}, "PSEUDOCOCAINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K9OK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "TENOSAL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3KZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Potassium Chloride": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0E9JM", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6557"]}, "COCLAURINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KJH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "DIHYDROKAEMPFEROL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R4FM", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "GANSTIGMINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4OW", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-((4-aminophenyl)diazenyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H4CF", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "768"]}, "Befloxatone": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D05WEP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "PMID18754614C8": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09TKC", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "3-(5-methoxy-1H-inden-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D8YE", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Meloxicam(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00814", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "PMID18754614C7": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04AAT", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID18754614C4": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7IQ", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "4-(2-Hydroxy-ethyl)-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04VLI", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "765", "768", "23632"]}, "Hexane-1,6-Diol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "NR3C1(Glucocorticoid receptor (NR3C1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0O0ZU", "drug_id_DB": "DB02210", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "Cibacron blue": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GJP", "drug_id_DB": "", "metabolic_annotation_str": "HPGDS(Glutathione-dependent PGD synthase (HPGDS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HPGDS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["27306"]}, "Leucovorin Calcium": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0B6TW", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1719"]}, "Rhucin": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "SERPING1(C1 esterase inhibitor (SERPING1) ,MOA:Modulator); ", "drug_id_TTD": "D0Z7ZM", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "Sulfamic acid 3-sulfamoyloxy-phenyl ester": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07IHP", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Azole derivative 6": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0QT3C", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "Azole derivative 7": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D01DHT", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "Cis-2,6-dimethyl-1-methyl sulfonyl piperidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09JZY", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "4-AMINOPHENOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MTM", "drug_id_DB": "", "metabolic_annotation_str": "CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA14"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["23632"]}, "4-(3-cyclohexylureido)butanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TS7G", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Flurbiprofen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00712", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "Pancrecarb": {"drug_status_TTD": ["NDA filed", "NDA filed"], "non_metabolic": "", "drug_id_TTD": "D0A5DJ", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Modulator); PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A", "PNLIP"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["279", "5406"]}, "(3-fluoro-4-(4-phenoxybenzoyl)phenyl)acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BHS", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "1-phenyl-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01HRG", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "PMID27109571-Compound-30": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D01TJW", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-31": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D00RDL", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "Rutin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01698", "metabolic_annotation_str": "CBR1(Carbonyl reductase [NADPH] 1); AKR1C3(Aldo-keto reductase family 1 member C3); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CBR1", "AKR1C3"], "metabolic_genes_id": ["873", "8644"]}, "Zarnestra": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "FNTA(Farnesyl protein transferase (Ftase) ,MOA:Modulator); FNTB(Farnesyl protein transferase (Ftase) ,MOA:Modulator); FNTB(Farnesyl protein transferase (Ftase) ,MOA:Modulator); ", "drug_id_TTD": "D07NPS", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "PF-05212372": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08YFD", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "1-(1-phenyl-1H-tetrazol-5-ylthio)propan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R4DK", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Radafaxine": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0A5RD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "CT-10": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B6DV", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "7,9-tetradecadiynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09EBV", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Cyclohexyl-(3,4-dichloro-phenyl)-acetonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4HU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "5-[5-Bromo-indan-(1Z)-ylidenemethyl]-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02XHH", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "Piperidine-1-carboxylic acid adamantan-2-ylamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J3DW", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Lpc-Ether(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SS5D", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "4-Oxosebacic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VG6L", "drug_id_DB": "DB02260", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["210"]}, "5,6-dinitroacenaphthoquinone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WX6R", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43", "1066", "1066"]}, "2-[4-(2-Morpholin-4-ylethoxy)phenoxy]benzooxazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09PGC", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "3-hydroxydesaminokynurenine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4AX", "drug_id_DB": "", "metabolic_annotation_str": "KYNU(Kynureninase (KYNU) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KYNU"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8942"]}, "Isobutyl-(4-methyl-benzyl)-piperidin-4-yl-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09DWM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "5-(trifluoromethoxy)-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZR2T", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "11,12-dihydro-dibenzo[a,e]cyclooctene-5,6-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05XRY", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "5-benzyl-6-chloropyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09TBA", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "Resveratrol Potassium3-Sulfate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CW3A", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "2,6-Difluorobenzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05DFJ", "drug_id_DB": "DB03270", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "4-Sulfamoyloxy-benzoic acid heptyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YDQ", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "GRASSYSTATIN A": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PLG(Plasminogen (PLG) ,MOA:Inhibitor); CTSD(Cathepsin D (CTSD) ,MOA:Inhibitor); PRSS1(Cationic trypsinogen (PRSS1) ,MOA:Inhibitor); PRSS1(Cationic trypsinogen (PRSS1) ,MOA:Inhibitor); CASP4(Caspase-11 (CASP11) ,MOA:Inhibitor); CELA1(Pancreatic elastase 1 (CELA1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Y5IQ", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F0ZX", "drug_id_DB": "", "metabolic_annotation_str": "HNMT(Histamine N-methyltransferase (HNMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HNMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3176"]}, "(RS/SR)-2-[1-(4-chlorophenyl)propyl]piperidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R8TH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "US9434727, 40": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05AIC", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "HYDROSULFIDE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T6ZX", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Isocarboxazid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01247", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); MAOB(Amine oxidase [flavin-containing] B); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_genes_id": ["4128", "4129"]}, "2-Methyl-1,2-di-pyridin-3-yl-propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G3RD", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Uridine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y7DP", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "Milnacipran(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GRIN2D(Glutamate receptor ionotropic, NMDA 2D); GRIN3B(Glutamate receptor ionotropic, NMDA 3B); GRIN1(Glutamate receptor ionotropic, NMDA 1); GRIN2A(Glutamate receptor ionotropic, NMDA 2A); GRIN2B(Glutamate receptor ionotropic, NMDA 2B); GRIN2C(Glutamate receptor ionotropic, NMDA 2C); GRIN3A(Glutamate receptor ionotropic, NMDA 3A); ", "drug_id_TTD": "", "drug_id_DB": "DB04896", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_genes_id": ["6530", "6532"]}, "3-[4-Chloro-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05MQE", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "Spirapril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05MFG", "drug_id_DB": "DB01348", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Venlafaxine(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0P1UX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "Resorcinol compound 20": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05NHA", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "1,2-bis(2,5-difluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05EMT", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "FK-3311": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Z9YW", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "2-(N-tert-Butylamino)propiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00WMS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "DEXMETHYLPHENIDATE HYDROCHLORIDE": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D02QCD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EXD", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "1-(3-phenoxypropyl)-4-(piperidin-1-yl)piperidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00OUF", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "1-(4-Phenoxyphenyl)piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V0MH", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Idrapril": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08DWH", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "N-(4-Ethylphenyl)benzo[d]oxazol-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05GZI", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Chloroprocaine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "SCN10A(Sodium channel protein type 10 subunit alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB01161", "metabolic_annotation_str": "SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6531", "6531"]}, "NAFAZATROM": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0H2RB", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1,2-bis(2-fluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05VUC", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "N-Cyclohexyl-4-phenyl-butyramide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6GX", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Caffeine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ADORA3(Adenosine receptor A3); RYR1(Ryanodine receptor 1); ADORA2A(Adenosine receptor A2a); ADORA2B(Adenosine receptor A2b); ADORA1(Adenosine receptor A1); PRKDC(DNA-dependent protein kinase catalytic subunit); ATM(Serine-protein kinase ATM); ITPR2(Inositol 1,4,5-trisphosphate receptor type 2); ITPR3(Inositol 1,4,5-trisphosphate receptor type 3); ITPR1(Inositol 1,4,5-trisphosphate receptor type 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00201", "metabolic_annotation_str": "PIK3CD(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform); PDE2A(cGMP-dependent 3',5'-cyclic phosphodiesterase); PDE8A(High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A); PDE5A(cGMP-specific 3',5'-cyclic phosphodiesterase); PDE5A(cGMP-specific 3',5'-cyclic phosphodiesterase); PDE9A(High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A); PDE8B(High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B); PDE6A(Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha); PDE4A(cAMP-specific 3',5'-cyclic phosphodiesterase 4A); PDE6B(Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta); PIK3CA(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform); PIK3CB(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform); PDE6C(Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'); PDE1A(Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A); PDE1B(Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B); PDE1B(Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B); PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); PDE4C(cAMP-specific 3',5'-cyclic phosphodiesterase 4C); PDE4D(cAMP-specific 3',5'-cyclic phosphodiesterase 4D); PDE4D(cAMP-specific 3',5'-cyclic phosphodiesterase 4D); PDE3B(cGMP-inhibited 3',5'-cyclic phosphodiesterase B); PDE3B(cGMP-inhibited 3',5'-cyclic phosphodiesterase B); PDE7A(High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A); PDE1C(Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C); PDE3A(cGMP-inhibited 3',5'-cyclic phosphodiesterase A); PDE11A(Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A); PDE7B(cAMP-specific 3',5'-cyclic phosphodiesterase 7B); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PIK3CD", "PDE2A", "PDE8A", "PDE5A", "PDE5A", "PDE9A", "PDE8B", "PDE6A", "PDE4A", "PDE6B", "PIK3CA", "PIK3CB", "PDE6C", "PDE1A", "PDE1B", "PDE1B", "PDE4B", "PDE4B", "PDE4C", "PDE4D", "PDE4D", "PDE3B", "PDE3B", "PDE7A", "PDE1C", "PDE3A", "PDE11A", "PDE7B"], "metabolic_genes_id": ["5293", "5138", "5151", "8654", "8654", "5152", "8622", "5145", "5141", "5158", "5290", "5291", "5146", "5136", "5153", "5153", "5142", "5142", "5143", "5144", "5144", "5140", "5140", "5150", "5137", "5139", "50940", "27115"]}, "PHENSERINE TARTRATE": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0SR4T", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Homorisedronate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L8QX", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}alaninamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G5YA", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "RG7232": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01WMW", "drug_id_DB": "", "metabolic_annotation_str": "ABCA1(ATP-binding cassette transporter A1 (ABCA1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCA1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["19"]}, "INM-176": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D05UXU", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "5-hydroxy-1-tosyl-1H-pyrrol-2(5H)-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06SME", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "CL-301": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07NWZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6557"]}, "Methyl-(5-pyridin-3-yl-thiophen-2-yl)-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D01ARE", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "CGP-40215A": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0S6VX", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["262"]}, "RQ-00317076": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02HLL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Succinic acid": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06VNK", "drug_id_DB": "DB00139", "metabolic_annotation_str": "ALDH5A1(Succinate-semialdehyde dehydrogenase (ALDH5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7915"]}, "3-phenyl-9H-indeno[1,2-e][1,2,4]triazin-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08IDJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "RB-105": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Modulator); ", "drug_id_TTD": "D09GXF", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "Patuletin 3-O-beta-D-robinobioside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08DRD", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "AWD-12-281": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0F4TV", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "1,1,1-Trifluoro-8-phenyl-octan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1CK", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "TRIENTINE": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09VAZ", "drug_id_DB": "", "metabolic_annotation_str": "CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA14"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["23632"]}, "N6-[4-(4-methylphenoxy)phenyl]-L-homoglutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B0DP", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Daxalipram(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01647", "metabolic_annotation_str": "PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PDE4B"], "metabolic_genes_id": ["5142"]}, "N5-[4-(Phenylmethoxy)phenyl]-L-glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TNQ", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Zoniporide hydrochloride": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0C8PI", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "4-Sulfamoyloxy-benzoic acid propyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ACT", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "1-(4-Aminobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HL9S", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "ISIS 150452": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A3RM", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(SOD1 messenger RNA (SOD1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6647"]}, "ISIS 150453": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4SF", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(SOD1 messenger RNA (SOD1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6647"]}, "ISIS 150450": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07AGD", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(SOD1 messenger RNA (SOD1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6647"]}, "ISIS 150451": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MGX", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(SOD1 messenger RNA (SOD1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6647"]}, "ISIS 150454": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05RSX", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(SOD1 messenger RNA (SOD1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6647"]}, "S-4048": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A9CK", "drug_id_DB": "", "metabolic_annotation_str": "SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC37A4", "SLC37A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2542", "2542"]}, "N4-[4-(Phenylmethoxy)phenyl]-L-aspartamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZLZ", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Letrozole": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0C1WH", "drug_id_DB": "DB01006", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-o-Tolyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0UV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "4-amino-N-[4-(benzyloxy)phenyl]butanamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09MDO", "drug_id_DB": "DB07104", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "(S)-2-amino-1-(4-propylthiophenyl)-propane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SSS", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "6-amino-5-chlorouracil hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VW6H", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "K-828-AB": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0YC4F", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "(S)-Rolipram(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03606", "metabolic_annotation_str": "PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); PDE4D(cAMP-specific 3',5'-cyclic phosphodiesterase 4D); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PDE4B", "PDE4D"], "metabolic_genes_id": ["5142", "5144"]}, "Eflucimibe": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0W0ED", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Imino sugars": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9YU", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8972", "8972"]}, "N-benzyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6GG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-Naphthalen-2-ylmethyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6SA", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "CI-966": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08ESA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6529"]}, "Tetrabenazine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09PJX", "drug_id_DB": "DB04844", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6571"]}, "Turosteride": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0S3XE", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "79644"]}, "Beta-naphthylboronic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C8ZY", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "N-Benzyl-4-Sulfamoyl-Benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07RZN", "drug_id_DB": "DB01748", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Vitamin B3": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0N0ES", "drug_id_DB": "", "metabolic_annotation_str": "DGAT2(Diacylglycerol O-acyltransferase 2 (DGAT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["84649"]}, "4-(2-pyrrolidin-1-yl-pentanoyl)benzonitrile": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D3QE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "[3H]GSK931145": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8LR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6536"]}, "(R)-5-diphosphomevalonate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ERD", "drug_id_DB": "", "metabolic_annotation_str": "PMVK(Phosphomevalonate kinase (PMVK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PMVK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10654"]}, "Masoprocol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "SHBG(Sex hormone-binding globulin); ", "drug_id_TTD": "", "drug_id_DB": "DB00179", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_genes_id": ["240", "240"]}, "METIAPRIL": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02JUM", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Pentane-1,5-diamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02QGI", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "CRx-401": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0BZ1Q", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "PMID26666989-Compound-Figure12bottommiddle01": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0H0XX", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure12bottommiddle02": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0Y4KB", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "Fosfosal": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0N3UL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "3-Fluoro-4'-(pyridin-4-ylmethyl)biphenyl-4-ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q0BK", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "1-(4-aminosulfonylphenyl)-2-(4-pyridyl)acetylene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q8TK", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Ivacaftor": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0W7WC", "drug_id_DB": "DB08820", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1080"]}, "FS-205-397": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0E2CZ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "4-hexyl resorcinol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07EGB", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "[(125)I] RB129": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8IF", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); HSD11B2(Corticosteroid 11-beta-dehydrogenase 2 (HSD11B2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP", "HSD11B1", "HSD11B2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["290", "3290", "3291"]}, "S,S-(2-Hydroxyethyl)Thiocysteine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "SNX3(Sorting nexin-3); PIM1(Serine/threonine-protein kinase pim-1); PRKACA(cAMP-dependent protein kinase catalytic subunit alpha); PRKACA(cAMP-dependent protein kinase catalytic subunit alpha); SERPINB5(Serpin B5); CYTH2(Cytohesin-2); ", "drug_id_TTD": "", "drug_id_DB": "DB04530", "metabolic_annotation_str": "TYMS(Thymidylate synthase); ARG1(Arginase-1); PDE1B(Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B); PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["TYMS", "ARG1", "PDE1B", "PDE4B"], "metabolic_genes_id": ["7298", "383", "5153", "5142"]}, "INFRACTOPICRIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XN8A", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "L-791943": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V1IM", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "Indole and benzimidazole derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02AAR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["246"]}, "4,5-Dimethyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03JXX", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07EMX", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Chlorogenic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HCQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC37A4", "SLC37A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2542", "2542"]}, "Maleic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E7UH", "drug_id_DB": "DB04299", "metabolic_annotation_str": "GOT1(Cytoplasmic aspartate aminotransferase (GOT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GOT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2805"]}, "Dronedarone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CACNB4(Voltage-dependent L-type calcium channel subunit beta-4); CACNA1F(Voltage-dependent L-type calcium channel subunit alpha-1F); KCNK2(Potassium channel subfamily K member 2); ADRA2A(Alpha-2A adrenergic receptor); THRA(Thyroid hormone receptor alpha); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); ADRA1D(Alpha-1D adrenergic receptor); ADRA1A(Alpha-1A adrenergic receptor); ADRA1B(Alpha-1B adrenergic receptor); KCNJ4(Inward rectifier potassium channel 4); KCNJ3(G protein-activated inward rectifier potassium channel 1); KCNQ1(Potassium voltage-gated channel subfamily KQT member 1); KCNQ1(Potassium voltage-gated channel subfamily KQT member 1); CACNB3(Voltage-dependent L-type calcium channel subunit beta-3); KCNJ2(Inward rectifier potassium channel 2); CACNA1D(Voltage-dependent L-type calcium channel subunit alpha-1D); CACNB1(Voltage-dependent L-type calcium channel subunit beta-1); CACNB2(Voltage-dependent L-type calcium channel subunit beta-2); KCNH2(Potassium voltage-gated channel subfamily H member 2); CACNA1S(Voltage-dependent L-type calcium channel subunit alpha-1S); KCNJ12(ATP-sensitive inward rectifier potassium channel 12); SCN5A(Sodium channel protein type 5 subunit alpha); KCND3(Potassium voltage-gated channel subfamily D member 3); KCNJ14(ATP-sensitive inward rectifier potassium channel 14); ", "drug_id_TTD": "", "drug_id_DB": "DB04855", "metabolic_annotation_str": "SLC8A1(Sodium/calcium exchanger 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC8A1"], "metabolic_genes_id": ["6546"]}, "8-Bromo-6-methyl-3-phenylcoumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K1FE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Phenylbutazone(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07VHR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "(E)-8-(3-chlorostyryl)-caffeine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADORA3(Adenosine A3 receptor (ADORA3) ,MOA:Antagonist); ADORA2B(Adenosine A2b receptor (ADORA2B) ,MOA:Antagonist); ADORA1(Adenosine A1 receptor (ADORA1) ,MOA:Antagonist); ", "drug_id_TTD": "D0TU7I", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Diflunisal(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00861", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "PMID16242323C22c": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01UWZ", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "PMID16242323C22d": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IY3E", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "PMID28870136-Compound-44": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CH7Z", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "PMID28870136-Compound-45": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01OIQ", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "6-bromo-5-methyl-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N9ZR", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "METHOXYUNDECYLPHOSPHINIC ACID(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB08222", "metabolic_annotation_str": "CLPS(Colipase); PNLIP(Pancreatic triacylglycerol lipase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["CLPS", "PNLIP"], "metabolic_genes_id": ["1208", "5406"]}, "SF1126(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR); PRKDC(DNA-dependent protein kinase catalytic subunit); ", "drug_id_TTD": "", "drug_id_DB": "DB05210", "metabolic_annotation_str": "PIK3R2(Phosphatidylinositol 3-kinase regulatory subunit beta); PIK3R1(Phosphatidylinositol 3-kinase regulatory subunit alpha); PIK3R3(Phosphatidylinositol 3-kinase regulatory subunit gamma); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PIK3R2", "PIK3R1", "PIK3R3"], "metabolic_genes_id": ["5296", "5295", "8503"]}, "5-hydroxy-pentanoate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05SGJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC52A2", "SLC52A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["79581", "79581"]}, "NSC-354279": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00SRM", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "KURARINOL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W4ZU", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A", "PDE4A", "PDE4B", "PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8654", "5141", "5142", "5139"]}, "GS-9820": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03IJO", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "6-methyl-2-oxo-2H-chromene-3-carboxylic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G3BI", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "768", "23632"]}, "bromo-deaza-SAH": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L0DC", "drug_id_DB": "", "metabolic_annotation_str": "DOT1L(Histone-lysine N-methyltransferase (HLNM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DOT1L"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["84444"]}, "Ethyl Dihydrogen Phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MNG", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N'-(2-phenylallyl)hydrazine hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02PSR", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Pimagedine HCl": {"drug_status_TTD": ["Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D0J3BY", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "[131I]-Metuximab injection": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0E5BW", "drug_id_DB": "", "metabolic_annotation_str": "BSG(Basigin (BSG) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["BSG"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["682"]}, "1,2-bis(2,6-difluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04CDV", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Fidarestat(Stereoisomer)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KCB", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "11beta-hydroxysteroid dehydrogenase-1 (HSD1) inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CG0G", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Oxyphenbutazone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03585", "metabolic_annotation_str": "PLA2G2E(Group IIE secretory phospholipase A2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PLA2G2E"], "metabolic_genes_id": ["30814"]}, "3-(4-sulfamoylphenyl)propanoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09CSP", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "N-Hydroxy-N-methyl-benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2QP", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "RBx10558": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02GSA", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID29338548-Compound-34": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0GX8J", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-36": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0E2VI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-37": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WT3F", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-30": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H5WE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-31": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07GSH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-33": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0T1BE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "3-[3-(benzylmethylamino)propoxy]xanthen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L9YJ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "PMID29338548-Compound-38": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03PQS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-39": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06OSE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PALMATINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02SGJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "E-101": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0XD5A", "drug_id_DB": "", "metabolic_annotation_str": "MPO(Myeloperoxidase (MPO) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MPO"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4353"]}, "N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05WQN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Methyl piperate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EX4L", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Piridronic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05XLD", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "2-(3-benzoyl-1H-pyrrol-1-yl)acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03LRQ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Aminoglutethimide": {"drug_status_TTD": ["Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0M6DO", "drug_id_DB": "DB00357", "metabolic_annotation_str": "CYP11A1(Cholesterol desmolase (CYP11A1) ,MOA:Inhibitor); CYP11A1(Cholesterol desmolase (CYP11A1) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11A1", "CYP11A1", "CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1583", "1583", "1588"]}, "Dazoxiben": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D04EEU", "drug_id_DB": "DB03052", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "RVT-103+RVT-104": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0S1KR", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Sodium valproate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R5HK", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "AZD-3241": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08TRG", "drug_id_DB": "", "metabolic_annotation_str": "MPO(Myeloperoxidase (MPO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MPO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4353"]}, "[Fe(CN)6]4-": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ENA", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "3-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06AKB", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "5,6-Dichloro-N-(3-morpholinopropyl)nicotinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZA4J", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "2-acetamido-2,3-dihydro-1H-indene-5-sulfonic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09TES", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "23632"]}, "Phenyl-phosphonic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00CIW", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "762"]}, "GSK-264220A": {"drug_status_TTD": ["Clinical trial"], "non_metabolic": "", "drug_id_TTD": "D02NHW", "drug_id_DB": "", "metabolic_annotation_str": "LIPG(Endothelial lipase (LIPG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9388"]}, "Triazole derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09AXR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "Ketoprofen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CXCR1(C-X-C chemokine receptor type 1); ", "drug_id_TTD": "", "drug_id_DB": "DB01009", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "(+/-)-threo-3',4'-Dichloromethylphenidate amide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BJN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "R-fadrozole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JE1I", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "(10H-phenothiazin-10-yl)(m-tolyl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05VLV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "8-hydroxyguanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07FSW", "drug_id_DB": "", "metabolic_annotation_str": "GCH1(GTP cyclohydrolase-I (GCH1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCH1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2643"]}, "[2-(Imidazol-1-yl)ethyl]-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02QWB", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Flanvotumab": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D05WQT", "drug_id_DB": "", "metabolic_annotation_str": "TYRP1(Melanoma antigen gp75 (TYRP1) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["TYRP1"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["7306"]}, "ML-3375": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "MAPK12(MAP kinase p38 (MAPK12) ,MOA:Inhibitor); MAPK11(Stress-activated protein kinase 2b (p38 beta) ,MOA:Inhibitor); MAPK14(Stress-activated protein kinase 2a (p38 alpha) ,MOA:Inhibitor); ", "drug_id_TTD": "D09HBZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Glycine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "GRIN3B(Glutamate receptor ionotropic, NMDA 3B); GLRA3(Glycine receptor subunit alpha-3); GLRA1(Glycine receptor subunit alpha-1); GLRA2(Glycine receptor subunit alpha-2); GARS1(Glycine--tRNA ligase); GLRB(Glycine receptor subunit beta); GRIN2A(Glutamate receptor ionotropic, NMDA 2A); GPR18(N-arachidonyl glycine receptor); GNMT(Glycine N-methyltransferase); GRIN2C(Glutamate receptor ionotropic, NMDA 2C); GLYATL2(Glycine N-acyltransferase-like protein 2); GLYATL1(Glycine N-acyltransferase-like protein 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00145", "metabolic_annotation_str": "GCAT(2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial); ALAS1(5-aminolevulinate synthase, nonspecific, mitochondrial); AGXT(Serine--pyruvate aminotransferase); ALAS2(5-aminolevulinate synthase, erythroid-specific, mitochondrial); SHMT1(Serine hydroxymethyltransferase, cytosolic); SHMT1(Serine hydroxymethyltransferase, cytosolic); SHMT2(Serine hydroxymethyltransferase, mitochondrial); GSS(Glutathione synthetase); GATM(Glycine amidinotransferase, mitochondrial); BAAT(Bile acid-CoA:amino acid N-acyltransferase); BAAT(Bile acid-CoA:amino acid N-acyltransferase); GNMT(Glycine N-methyltransferase); GLYAT(Glycine N-acyltransferase); AGXT2(Alanine--glyoxylate aminotransferase 2, mitochondrial); PIPOX(Peroxisomal sarcosine oxidase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["GCAT", "ALAS1", "AGXT", "ALAS2", "SHMT1", "SHMT1", "SHMT2", "GSS", "GATM", "BAAT", "BAAT", "GNMT", "GLYAT", "AGXT2", "PIPOX"], "metabolic_genes_id": ["23464", "211", "189", "212", "6470", "6470", "6472", "2937", "2628", "570", "570", "27232", "10249", "64902", "51268"]}, "Tetra-hydro-isoquinoline derivative 4": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0R6RT", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "MAOA", "ACHE", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "4128", "43", "4129"]}, "6-(3-(pyridin-4-yl)phenyl)naphthalen-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LC7Z", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "6-Deoxy-Alpha-D-Glucose": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "GANAB(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0E0VN", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); GAA(Alpha-glucosidase (GLA) ,MOA:Inhibitor); GANC(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A", "GAA", "GANC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["279", "2548", "2595"]}, "3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BD0K", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "768"]}, "ETHOXYCOUMARIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05VSK", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "768", "23632"]}, "TAK-935": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06EHX", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-hydroxylase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "Enalaprilat": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0N5HJ", "drug_id_DB": "DB09477", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Dextroamphetamine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ADRA2A(Alpha-2A adrenergic receptor); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); ADRA1D(Alpha-1D adrenergic receptor); ADRA1A(Alpha-1A adrenergic receptor); ADRA1B(Alpha-1B adrenergic receptor); ADRA1B(Alpha-1B adrenergic receptor); TAAR1(Trace amine-associated receptor 1); ", "drug_id_TTD": "", "drug_id_DB": "DB01576", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC18A2(Synaptic vesicular amine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3", "SLC18A2"], "metabolic_genes_id": ["6530", "6531", "6531", "6571"]}, "OxycoDex": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "SIGMAR1(Opioid receptor sigma 1 (OPRS1) ,MOA:Modulator); ", "drug_id_TTD": "D02JNX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "6-(Biphenyl-2-sulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07XXK", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "4-(Spiro[chromene-2,4'-piperidine]-4-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); OPRM1(Opioid receptor mu (MOP) ,MOA:Inhibitor); OPRD1(Opioid receptor delta (OPRD1) ,MOA:Inhibitor); OPRK1(Opioid receptor kappa (OPRK1) ,MOA:Inhibitor); KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0L9YP", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "(R/S)-2-((4-phenoxyphenoxy)methyl)piperidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00TNN", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "6-chloro-5-pentylpyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E7SH", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "SCH-48375": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W0PH", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "2-fluoromevalonate 5-diphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4YV", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "5-Imidazol-1-yl-5,6,7,8-tetrahydro-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K2SE", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "16beta-cyano-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EK5U", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Cylopentenyl cytosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GK2Q", "drug_id_DB": "", "metabolic_annotation_str": "CTPS1(CTP synthase (CTPS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTPS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1503"]}, "Cyclopentenylcytosine": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0VW0I", "drug_id_DB": "", "metabolic_annotation_str": "CTPS1(CTP synthase (CTPS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTPS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1503"]}, "P-Anisic Acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02795", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2); PLA2G2E(Group IIE secretory phospholipase A2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PLA2G1B", "PLA2G2E"], "metabolic_genes_id": ["5319", "30814"]}, "Rivastigmine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00989", "metabolic_annotation_str": "BCHE(Cholinesterase); ACHE(Acetylcholinesterase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_genes_id": ["590", "43"]}, "5-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AZ0Y", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(R)-PFI-2": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J6OV", "drug_id_DB": "", "metabolic_annotation_str": "SETD7(Histone-lysine N-methyltransferase SETD7 (SETD7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SETD7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["80854"]}, "2-(benzyloxyamino)-N-hydroxy-3-methylpentanamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07VXX", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "1,2-bis(3,4,5-trifluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CN8Z", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Equilin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R6DT", "drug_id_DB": "DB02187", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "3-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T8BU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "NCX-701": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03CFJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "5-Ethyl-4-methyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XJ1C", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "AS-604850": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03DRM", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "2-Hydroxyiminours-12-en-28-oic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G9FQ", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Sodium pyruvate": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D02ECG", "drug_id_DB": "", "metabolic_annotation_str": "CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["762"]}, "Teriflunomide(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D07QFP", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); DHODH(Dihydroorotate dehydrogenase (DHODH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR", "DHODH"], "metabolic_mechanism_of_action": ["Inhibitor", "Modulator"], "metabolic_genes_id": ["3156", "1723"]}, "4-Sulfamoyloxy-benzoic acid hexyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D1CV", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "4-(2-phenoxyphenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D00KRQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "6-fluoromevalonate pyrophosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I0QH", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "Echothiophate Iodide": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0U8AT", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["43"]}, "Sodium N-methylphenylaminomethanesulfonate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M9IQ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "768"]}, "Ezetimibe-glucuronide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09XJH", "drug_id_DB": "", "metabolic_annotation_str": "NPC1L1(Niemann-Pick C1-like protein 1 (NPC1L1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NPC1L1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["29881"]}, "PYRIPYROPENE A": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2NK", "drug_id_DB": "", "metabolic_annotation_str": "SOAT2(SOAT2 messenger RNA (SOAT2 mRNA) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SOAT2", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8435", "1066", "1066"]}, "PRX-102": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D07URD", "drug_id_DB": "", "metabolic_annotation_str": "GLA(Alpha-galactosidase A (GLA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GLA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2717"]}, "PRX-105": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0JA7V", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "VAR-10300": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02AQM", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "N-hydroxy-N-[1-(4-isobutylphenyl)ethyl]urea": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K7XQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "240", "240"]}, "PMID8246233C5ab": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00TBG", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2'-hydroxy-3,4,5-trimethoxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q4CT", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "5,5-diethyl-2-(phenethylamino)oxazol-4(5H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W9WG", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D6OR", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "PMID8709131C23": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XN1T", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "(R)-Mesopram": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06KPK", "drug_id_DB": "", "metabolic_annotation_str": "PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5142"]}, "CGS-23885": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U2YL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "2-(N,N-Diethylamino)-3'-chloropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R5AD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "Dutasteride + tamsulosin": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "ADRA1A(Adrenergic receptor alpha-1A (ADRA1A) ,MOA:Antagonist); ", "drug_id_TTD": "D09JFY", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "79644"]}, "4,5,6,7-tetrafluoro-3-methyl-1H-indazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C3CS", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "3,5-dibromo-2-(2,4-dibromophenoxy)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L6RV", "drug_id_DB": "", "metabolic_annotation_str": "GMPS(Glutamine amidotransferase (GMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8833"]}, "6-bromo-5-phenylpyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I7IF", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "LC-350189": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0I5JM", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PMID27109571-Compound-18": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D05WXM", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "TRL-382": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01HXN", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "QCPac": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q2YH", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6523"]}, "VELNACRINE": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0L8QQ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID27109571-Compound-12": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D09VOD", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-13": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0ND3H", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MO1P", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "PMID27109571-Compound-11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05UGS", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "PMID27109571-Compound-16": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D01CDK", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-17": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D07PLJ", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-14": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D01GOO", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "PMID27109571-Compound-15": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D08SNH", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "Sorbinil": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D02CGC", "drug_id_DB": "DB02712", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "4-(2,5-Diphenyl-furan-3-yl)-morpholine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J4AT", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "1-methyl-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U3JD", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "(Amino-phenyl-methyl)-phosphinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04MKQ", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "13-(3-n-Pentylureido)tridec-8(E)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07UIO", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Isosorbide-2-benzylcarbamate-5-pentanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JCW", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Cyclothiazide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "FXYD2(Sodium/potassium-transporting ATPase subunit gamma); SFRP4(Secreted frizzled-related protein 4); ", "drug_id_TTD": "", "drug_id_DB": "DB00606", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); CA4(Carbonic anhydrase 4); CA6(Carbonic anhydrase 6); CA5A(Carbonic anhydrase 5A, mitochondrial); CA7(Carbonic anhydrase 7); CA9(Carbonic anhydrase 9); CA13(Carbonic anhydrase 13); CA14(Carbonic anhydrase 14); CA5B(Carbonic anhydrase 5B, mitochondrial); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA1", "CA1", "CA2", "CA2", "CA3", "CA4", "CA6", "CA5A", "CA7", "CA9", "CA13", "CA14", "CA5B"], "metabolic_genes_id": ["759", "759", "760", "760", "761", "762", "765", "763", "766", "768", "377677", "23632", "11238"]}, "KH064": {"drug_status_TTD": ["Clinical trial"], "non_metabolic": "", "drug_id_TTD": "D0LB0X", "drug_id_DB": "DB04287", "metabolic_annotation_str": "PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5320"]}, "3-[5-Ethoxy-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N9PY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "1-hydroxy-3-(4-(trifluoromethyl)phenyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08EJQ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Lumiracoxib(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D04YMH", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "4-(4-Decyloxy-phenyl)-1,1,1-trifluoro-butan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U2GX", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "TAMARIXETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PZE", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "RJM-0035-K002": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OZ3S", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Methotrexate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00563", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase); TYMS(Thymidylate synthase); ATIC(Bifunctional purine biosynthesis protein PURH); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["DHFR", "TYMS", "ATIC"], "metabolic_genes_id": ["1719", "7298", "471"]}, "4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3PV", "drug_id_DB": "", "metabolic_annotation_str": "LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHB(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHC(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LDHA", "LDHA", "LDHB", "LDHC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3939", "3939", "3945", "3948"]}, "SKF89976A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08YGM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6529"]}, "Ethyl estrone-16-methylcarboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01AVM", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "N-Hydroxy-N-methyl-3-naphthalen-2-yl-propionamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06KQD", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Cyclopentyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TBI", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "COCAINE.HCL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NW3Z", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "3-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7RB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "SK&F-95601": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D03CCH", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "HQL-79": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PI1C", "drug_id_DB": "", "metabolic_annotation_str": "HPGDS(Glutathione-dependent PGD synthase (HPGDS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HPGDS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["27306"]}, "SDZ-87-469": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D06MUZ", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6713"]}, "SB-381320": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WW7A", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7941"]}, "Buthionine sulfoximine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6VR", "drug_id_DB": "", "metabolic_annotation_str": "GCLM(Glutamate--cysteine ligase modifier (GCLM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCLM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2730"]}, "(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholin-5-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3ZS", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AF7J", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "2-(o-toluidino)-5-ethylthiazol-4(5H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03JWH", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "PMID25399762-Compound-Table1-C10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00VSX", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0B2YJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C12": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05UNM", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01JDK", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID25399762-Compound-Table1-C18": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02FRR", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "1,2,4-Triazole-Carboxamidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03RGI", "drug_id_DB": "DB02048", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "7-bromo-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LL3D", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "N-[2-(Indol-3-yl)ethyl]-S-benzyl-dithiocarbamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06MUL", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PHENYLTHIOUREA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02CFH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "6-Amino-benzothiazole-2-sulfonic acid amide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O1QT", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Sulfanilamide derivative": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09NCW", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "NORBOLDINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GXL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "L-NG-nitroarginine methyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q0MM", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "FAS1": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D04RSI", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "2-tert-Butyldimethylsilyloxylycorine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E2GV", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "US9434727, 63": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YU9U", "drug_id_DB": "", "metabolic_annotation_str": "RBP4(Plasma retinol-binding protein (RBP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RBP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5950"]}, "GERANIIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C6QS", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "Carinatumins B (2)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07FFB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "(8R,8'R,9'S)-5-methoxyclusin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4AC", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Pyrazolo[3,4-c]pyridine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06ZAE", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "2-hydroxygarveatin E": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N6QU", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID27967267-Compound-7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0T0CB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID27967267-Compound-3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04TGJ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1-(3,4-Dichloro-phenyl)-3-methylamino-indan-5-ol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZAT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "(R)-Mevalonate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03GRA", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "1,1,1-trifluoro-3-(hexylsulfinyl)propan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F7NU", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Icosapent(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0G2MW", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Binder); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Binder", "Binder"], "metabolic_genes_id": ["5742", "5743"]}, "Imidazopyridine derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0C3ZN", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Imidazopyridine derivative 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UJ5D", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Imidazopyridine derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0BR7G", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "POP-1": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PRSS1(Cationic trypsinogen (PRSS1) ,MOA:Modulator); PRSS1(Cationic trypsinogen (PRSS1) ,MOA:Modulator); GANAB(Alpha-glucosidase (GLA) ,MOA:Modulator); ", "drug_id_TTD": "D08SMN", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Alpha-glucosidase (GLA) ,MOA:Modulator); GANC(Alpha-glucosidase (GLA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA", "GANC"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2548", "2595"]}, "Ibuprofen(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "THBD(Thrombomodulin); GP1BA(Platelet glycoprotein Ib alpha chain); BCL2(Apoptosis regulator Bcl-2); S100A7(Protein S100-A7); PPARG(Peroxisome proliferator-activated receptor gamma); PPARA(Peroxisome proliferator-activated receptor alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB01050", "metabolic_annotation_str": "CFTR(Cystic fibrosis transmembrane conductance regulator); PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CFTR", "PTGS1", "PTGS2"], "metabolic_genes_id": ["1080", "5742", "5743"]}, "SKF-96067": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02THB", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "(-)-3,3'-bisdemethylpinoresinol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N7XM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "246"]}, "Threo-N-ethylritalinol hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06OIU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Edoxudine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y4MD", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "Aom-0890": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V3BI", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "Amocarzine": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0SH2X", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "KF-A6": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "HRH1(Histamine H1 receptor (H1R) ,MOA:Inhibitor); ", "drug_id_TTD": "D08RCH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "KF-A5": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08MEN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "E-0722": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0B0GC", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["231"]}, "(+/-)-threo-N-(3-Phenylpropyl)ritalinol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08XGL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-aminopyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07PYV", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "(+/-)-threo-N-Benzylmethylphenidate amide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A0LZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "CP-461": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0M7OU", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Trans-2-fluoro-2-p-tolylcyclopropanamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F2DC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Forodesine": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D02ZUO", "drug_id_DB": "DB06185", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "[3-(Biphenyl-4-yloxy)-propyl]-dimethyl-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R1EO", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "Di-substituted piperidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0BS8I", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Di-substituted piperidine derivative 2": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0K3EB", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Di-substituted piperidine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00GSF", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1-(3-chloropyridin-2-yl)-4-tosylpiperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DS7W", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "6-Nitro-4-phenyl-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X8DW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "RXP-407": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FMN", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "(+/-)-2-Methyl-1-(1-phenylethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z3ZZ", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "Pyrimidinone derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03RAU", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "1-(3-benzyl-6,7-dichloroquinoxalin-2-yl)hydrazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WI3V", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "3,3'-(1,2,4,5-tetrazine-3,6-diyl)diphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R3HP", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "3,7-Bis(2-hydroxyethyl)icaritin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09WUP", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "L-NIO": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ELA", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "L-NIL": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0Y7VJ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04PSK", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "Divalproex sodium": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03LGY", "drug_id_DB": "", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "DIGITOXIGENIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ZNS", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["476"]}, "1-(1-p-tolylethylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08OFD", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "7,8,4'-trihydroxyisoflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09FDZ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Propylthiouracil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00550", "metabolic_annotation_str": "TPO(Thyroid peroxidase); TPO(Thyroid peroxidase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["TPO", "TPO"], "metabolic_genes_id": ["7173", "7173"]}, "Furan-3-yl(4-(methylsulfonyl)phenyl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q4LI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Sibutramine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01105", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "GALANGIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ADORA3(Adenosine A3 receptor (ADORA3) ,MOA:Inhibitor); ADORA2A(Adenosine A2a receptor (ADORA2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Y7HG", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "TEI-6522": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0OK8M", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "1-(10H-phenothiazin-10-yl)-2-phenylpropan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H3WJ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "4-Sulfamoyloxy-benzoic acid butyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P6IO", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "3-methyl-2(1H)-thioxo-4(3H)-quinazolinone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P0XO", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Remogliflozin etabonate": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "SLC5A4(Sodium/glucose cotransporter 2 (SLC5A4) ,MOA:Blocker); ", "drug_id_TTD": "D0V4MB", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6524"]}, "Equilenin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WDY", "drug_id_DB": "", "metabolic_annotation_str": "HSD3B1(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); HSD3B2(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD3B1", "HSD3B2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3283", "3284"]}, "Phenylalanine hydroxylase": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00IDR", "drug_id_DB": "", "metabolic_annotation_str": "PAH(Phenylalanine hydroxylase (PAH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PAH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5053"]}, "3,4-Dimethyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G4ZL", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "3-(2-N-Piperidyl-acetamino)-rutaecarpine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E0ZV", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID28447479-Compound-11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S8EH", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "PMID28447479-Compound-10": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WX7F", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "CA9-ADC": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D01BUS", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["768"]}, "PMID28447479-Compound-14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02FWT", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "Etarotene": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); RPP21(Ribonuclease P protein (RPP) ,MOA:Modulator); ", "drug_id_TTD": "D0FQ6O", "drug_id_DB": "", "metabolic_annotation_str": "RPP14(Ribonuclease P protein (RPP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["RPP14"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["11102"]}, "2-(naphthalen-2-yl)-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZPU", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "FERULIC ACID": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented", "Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D03SLR", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "MAOB", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "4129", "768", "23632"]}, "GLENVASTATIN": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U5NU", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "R zileuton": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0C5HV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Fluoro-Phosphite Ion": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05DGE", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Maprotiline": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03KQF", "drug_id_DB": "DB00934", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "4-Bromo-6-nitro-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02JOZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "EVT-301": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0P1WB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "ISIS 140153": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A9LB", "drug_id_DB": "", "metabolic_annotation_str": "SOAT2(SOAT2 messenger RNA (SOAT2 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SOAT2"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["8435"]}, "6-(4-Chloro-benzenesulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02AAH", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Sulfamic acid chroman-2-ylmethyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04MAM", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Monobenzone": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0H6TP", "drug_id_DB": "DB00600", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID25399762-Compound-Table 7-Vanillic acid": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UA3V", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "6-(4-Nitro-benzylsulfanyl)-9-phenethyl-9H-purine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V8DJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2030"]}, "N2-{4-[(4-nitrobenzyl)oxy]benzyl}glycinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08BUB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(R)-DULOXETINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05UMA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Nitroflurbiprofen": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04TNI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Icopezil maleate": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0B2BQ", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Isocitric Acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01727", "metabolic_annotation_str": "IDH1(Isocitrate dehydrogenase [NADP] cytoplasmic); IDH2(Isocitrate dehydrogenase [NADP], mitochondrial); ACO2(Aconitate hydratase, mitochondrial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["IDH1", "IDH2", "ACO2"], "metabolic_genes_id": ["3417", "3418", "50"]}, "2-Methyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8CM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "9-O-[5-(Phenylol-1-yloxy)pentyl]berberine bromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09XSI", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "N1,2-dibenzyl-N3-hydroxymalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z2JN", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "6-chloro-5-hexylpyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0CO5S", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "EMATE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R7QY", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "STS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "412"]}, "PMID26666989-Compound-Figure9bottomright": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D06PSM", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "Prasterone(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "AR(Androgen receptor (AR) ,MOA:Antagonist); ", "drug_id_TTD": "D0K0EK", "drug_id_DB": "", "metabolic_annotation_str": "G6PD(Glucose-6-phosphate dehydrogenase (G6PD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["G6PD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2539"]}, "10-EPI-8-DEOXY-CUMAMBRIN B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C3XU", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "(+/-)-threo-3',4'-Dichlororitalinol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07SUN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Desoxypeganine": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0T5AW", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Modulator); ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "ACHE"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["4128", "43"]}, "PIPERINE": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0H7PW", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "[4-(3-Adamantan-1-yl-ureido)-phenyl]-acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06OFY", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "(+/-)-2-(4'-Methoxyphenyl)thiomorpholin-5-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ID3Y", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "sergliflozin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X1TN", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "PMID29338548-Compound-18": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08GXR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-19": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Y9FA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-13": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H2KL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "2,2-Dimethoxy-1,2-diphenyl-ethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AOG", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "PMID29338548-Compound-17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02TZT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I7AJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "PMID29338548-Compound-15": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EV6V", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "Fluorouracil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00544", "metabolic_annotation_str": "TYMS(Thymidylate synthase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["TYMS"], "metabolic_genes_id": ["7298"]}, "(S)-N2-[4-(benzyloxy)benzyl]serinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U4JD", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "digeranyl bisphosphonate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DC3N", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "N-allylnorlitebamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H7OP", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "16-isobutylidene-estrone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01OCZ", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "N-benzyl-2-thiomorpholinopyrimidin-4-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E4BT", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "2-Methyl-1,2-di-pyridin-3-yl-1-methoxypropane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9JF", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "VLTS-582": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LE6M", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "Tolcapone": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y7PG", "drug_id_DB": "DB00323", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "Galantamine analog 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0W9ZU", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Bupropion(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0X4ZR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "4-((3',4'-Difluorobiphenyl-4-yl)methyl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09VQZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "6-Methoxy-5-oxazol-5-yl-2-phenyl-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A0UW", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "AMINOBENZTROPINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "CHRM1(Muscarinic acetylcholine receptor M1 (CHRM1) ,MOA:Inhibitor); ", "drug_id_TTD": "D03WGD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "ND7001": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0I2VT", "drug_id_DB": "DB05142", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5138"]}, "N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U7GL", "drug_id_DB": "DB02069", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Adenosine-5'-Diphosphate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PDXK(Pyridoxal kinase (PDXK) ,MOA:Inhibitor); HSP90AA1(Heat shock protein 90 alpha (HSP90A) ,MOA:Inhibitor); KIT(Tyrosine-protein kinase Kit (KIT) ,MOA:Inhibitor); HSPA8(Lipopolysaccharide-associated protein 1 (HSPA8) ,MOA:Inhibitor); GSK3B(Glycogen synthase kinase-3 beta (GSK-3B) ,MOA:Inhibitor); KIF11(Kinesin-like protein KIF11 (KIF11) ,MOA:Inhibitor); ", "drug_id_TTD": "D04QOU", "drug_id_DB": "", "metabolic_annotation_str": "PDXK(Pyridoxal kinase (PDXK) ,MOA:Inhibitor); HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); GCLM(Glutamate--cysteine ligase modifier (GCLM) ,MOA:Inhibitor); COASY(Phosphopantetheine adenylyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDXK", "HMGCR", "TK1", "GCLM", "COASY"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8566", "3156", "7083", "2730", "80347"]}, "Naproxcinod": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0U5OU", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Methyl 6-(3-cyclohexylureido)hexanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7FK", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "APIGENIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "AR(Androgen receptor messenger RNA (AR mRNA) ,MOA:Inhibitor); CSNK2A1(Casein kinase II alpha (CSNK2A1) ,MOA:Inhibitor); CDK6(Cyclin-dependent kinase 6 (CDK6) ,MOA:Inhibitor); ", "drug_id_TTD": "D00RIX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "HSD17B1", "AKR1B1", "CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "3292", "231", "1545"]}, "Nitecapone": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08LVF", "drug_id_DB": "", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1312"]}, "BW B218C": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PU1J", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "PMID29053063-Compound-11c": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "ABHD6(Monoacylglycerol lipase ABHD6 (ABHD6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0TU6D", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Propidium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08UET", "drug_id_DB": "DB02166", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "NOStentin": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0KM3P", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4843"]}, "Enprofylline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ADORA3(Adenosine receptor A3); ADORA2A(Adenosine receptor A2a); ADORA2B(Adenosine receptor A2b); ADORA1(Adenosine receptor A1); ", "drug_id_TTD": "", "drug_id_DB": "DB00824", "metabolic_annotation_str": "PDE4A(cAMP-specific 3',5'-cyclic phosphodiesterase 4A); PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PDE4A", "PDE4B"], "metabolic_genes_id": ["5141", "5142"]}, "PMID29053063-Compound-11d": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "ABHD6(Monoacylglycerol lipase ABHD6 (ABHD6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0GT0I", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "NSC-224124": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MGN", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "N,N'-(1',4'-butylene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06RTA", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Tellurium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A1QJ", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "6-methoxy-1,2-dimethyl-9H-beta-carbolin-2-ium": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00MFR", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "FR-123826": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0R5TT", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Dilazep": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GUM", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2030"]}, "6-amino-5-bromouracil": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X5RA", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "Carbenoxolone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4VR", "drug_id_DB": "DB02329", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "99mTc-fanolesomab": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07WLI", "drug_id_DB": "", "metabolic_annotation_str": "FUT4(Fucosyltransferase IV (CD15) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["FUT4"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["2526"]}, "Dephospho Coenzyme A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SK8U", "drug_id_DB": "", "metabolic_annotation_str": "COASY(Phosphopantetheine adenylyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COASY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["80347"]}, "3-bromo-7-nitro-1H-indazole": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X5QJ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "MK-386": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0C1SI", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "Aceclofenac": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0T8VY", "drug_id_DB": "DB06736", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "7-Hydroxy-4-phenylcoumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OC4B", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "3-[3-Phenyl-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0CT", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "LYSICAMINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01RUH", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-(N-Morpholino)-Ethanesulfonic Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PDF(Polypeptide deformylase (PDF) ,MOA:Inhibitor); ", "drug_id_TTD": "D07KZA", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); CMA1(Chymase (CYM) ,MOA:Inhibitor); HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE", "CMA1", "HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43", "1215", "3290"]}, "6-Bromo-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02NMY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "(RS/SR)-2-[1-(4-chlorophenyl)ethyl]piperidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y1MJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "4-Iodo-6-nitro-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02GSL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "5-methyl-cyclosal-d4TMP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P7TN", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Trimidox": {"drug_status_TTD": ["Preclinical", "Preclinical", "Preclinical", "Preclinical"], "non_metabolic": "F10(Coagulation factor Xa (F10) ,MOA:Inhibitor); ", "drug_id_TTD": "D0X1ZV", "drug_id_DB": "", "metabolic_annotation_str": "RRM1(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2B(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM1", "RRM2", "RRM2B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6240", "6241", "50484"]}, "Topiroxostat": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0WK0P", "drug_id_DB": "DB01685", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "N5-(4-Phenoxyphenyl)-L-glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09OWF", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "PMID29757691-Compound-7": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0W9OC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "PMID29757691-Compound-4": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0AA7U", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "ACHE", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "43", "4129"]}, "Phentermine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0U0RZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "TZI-41078": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0B6VN", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Diflorasone(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0G7KJ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "Bendroflumethiazide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KCNMA1(Calcium-activated potassium channel subunit alpha-1); ", "drug_id_TTD": "", "drug_id_DB": "DB00436", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA4(Carbonic anhydrase 4); SLC12A3(Solute carrier family 12 member 3); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA1", "CA2", "CA4", "SLC12A3"], "metabolic_genes_id": ["759", "760", "762", "6559"]}, "3-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08UXT", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Alpha-monofluoromethyl-3,4-dehydroornithine methyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08CKE", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "F-11105": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0O2EB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "4-hydroxy-6-nitro-3-phenylquinolin-2(1H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0QP7C", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "HONOKIOL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04DQJ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "Escitalopram(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D08RBC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Myricetin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T3PW", "drug_id_DB": "DB02375", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "XEN-2174": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U2XU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "2-hydroxyoleic acid": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D02DWK", "drug_id_DB": "", "metabolic_annotation_str": "SGMS1(Sphingomyelin synthase (SMS) ,MOA:Modulator); SGMS2(Sphingomyelin synthase (SMS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SGMS1", "SGMS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["259230", "166929"]}, "S-9977": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0F3FB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N-Methylmesoporphyrin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X5ZA", "drug_id_DB": "", "metabolic_annotation_str": "FECH(Ferrochelatase (FECH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FECH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2235"]}, "4-Fluoro-1,1':4',1''-terphenyl-3,3''-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BF3Y", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Carbamate derivative 2": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "FAAH(Fatty-acid amide hydrolase 1 (FAAH1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0S8TB", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "2,4-dichloro-5-sulfamoylbenzoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S6CO", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Carbamate derivative 9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L6XG", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "ISOFORMONENTIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08MTZ", "drug_id_DB": "", "metabolic_annotation_str": "ALDH2(Mitochondrial aldehyde dehydrogenase (ALDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["217"]}, "1-(3-(3-morpholinopropoxy)phenyl)-3-phenylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02UJV", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "GW-637185X": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EI8V", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "ZINC584606052": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04VJX", "drug_id_DB": "", "metabolic_annotation_str": "PDE4C(Phosphodiesterase 4C (PDE4C) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4C"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5143"]}, "PX-12(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB05448", "metabolic_annotation_str": "TXNRD1(Thioredoxin reductase 1, cytoplasmic); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["TXNRD1"], "metabolic_genes_id": ["7296"]}, "Asasantin": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0F3IP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "2,6-di-t-butylphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06MZK", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D03KXT", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "Alrestatin": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03PIB", "drug_id_DB": "DB02020", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Naphthalen-2-yl(10H-phenothiazin-10-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M6IJ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "PMID18324760C28": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P0MP", "drug_id_DB": "", "metabolic_annotation_str": "ACE2(Angiotensin-converting enzyme 2 (ACE2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["59272"]}, "[2-(Pyrazol-1-yl)ethyl]-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02CYZ", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "(S)-2-Amino-5-(N-methyl-guanidino)-pentanoic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8EU", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "N-Hydroxy-2-naphthalen-2-yl-acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KB6Q", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "HOMOAROMOLINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02QWO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "1-(1-Propionylpiperidin-4-yl)-3-m-tolylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1SE", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "N-3-(4-bromophenyl)propyl imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ZQK", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "2-(4-Butoxy-phenoxy)-N-hydroxy-acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X8BS", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "264W94": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02JIN", "drug_id_DB": "", "metabolic_annotation_str": "SLC10A2(Ileal sodium/bile acid cotransporter (SLC10A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC10A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6555"]}, "N-Methyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0GZ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Tyloxapol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB06439", "metabolic_annotation_str": "LPL(Lipoprotein lipase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["LPL"], "metabolic_genes_id": ["4023"]}, "Brocresine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06KMO", "drug_id_DB": "", "metabolic_annotation_str": "HDC(Histidine decarboxylase (HDC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HDC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3067"]}, "BIBB-515": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0I2YV", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Modulator); LSS(Lanosterol synthase (LSS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["4047", "4047"]}, "Lanosterol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P4PQ", "drug_id_DB": "DB03696", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "NS-2389": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0M9LB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "PMID24556381C10l": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ELANE(Neutrophil elastase (NE) ,MOA:Inhibitor); ELANE(Neutrophil elastase (NE) ,MOA:Inhibitor); ", "drug_id_TTD": "D06GTS", "drug_id_DB": "", "metabolic_annotation_str": "CEL(Bile-salt-activated lipase (CEL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CEL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1056"]}, "PMID24556381C10f": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ELANE(Neutrophil elastase (NE) ,MOA:Inhibitor); ELANE(Neutrophil elastase (NE) ,MOA:Inhibitor); ", "drug_id_TTD": "D0T9WZ", "drug_id_DB": "", "metabolic_annotation_str": "CEL(Bile-salt-activated lipase (CEL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CEL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1056"]}, "PMID27841045-Compound-155": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S0EM", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PMID27841045-Compound-157": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LX9F", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PMID27841045-Compound-156": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J0JH", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "3-(4-cyclohexylthiosemicarbazono)methyl-phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06IMK", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03XKJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-[5-(2-Ethyl-phenyl)-furan-2-carbonyl]-guanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ZIP", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "CUDC-907": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0E6UZ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "1-fluoro-5-phenyl-3-aza-bicyclo[3.1.0]hexane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E2XW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Dexniguldipine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB14068", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ABCB1"], "metabolic_genes_id": ["5243"]}, "TILIROSIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IB3K", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Firocoxib": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SNR", "drug_id_DB": "DB09217", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "PMID25399762-Compound-Table1-C25": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J3JY", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Diethylcarbamazine(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D06RCB", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "3-(6-Ethoxy-naphthalen-2-yl)-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R0TE", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "8-acetyl-7-methoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F7KC", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "JTT-811": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08VMO", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "1-(4-fluorophenyl)-2-pyrrolidin-1-yl-pentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L6RY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "Azide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09JHA", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "4-Hydroxy-5-methoxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01QDG", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Sulfamic acid 4-sulfamoyloxymethyl-benzyl ester": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N5KX", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "768"]}, "(-)-Phenserine": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D07CIN", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "(R)-Indan-1-yl-methyl-prop-2-ynyl-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7FP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Pelubiprofen": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0X4JN", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Sulpiride(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "DRD2(D(2) dopamine receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00391", "metabolic_annotation_str": "CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA2", "CA3"], "metabolic_genes_id": ["760", "761"]}, "PMID2231594C3j": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MU7C", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Elapegademase": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01VEJ", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["100"]}, "Dideazaacyclotetrahydrofolic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R7LQ", "drug_id_DB": "", "metabolic_annotation_str": "GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2618", "2618"]}, "PMID2231594C3q": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UQ6A", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID2231594C3u": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02EQL", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Galantamine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHRNA7(Neuronal acetylcholine receptor subunit alpha-7); ", "drug_id_TTD": "", "drug_id_DB": "DB00674", "metabolic_annotation_str": "BCHE(Cholinesterase); ACHE(Acetylcholinesterase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_genes_id": ["590", "43"]}, "Hydroxyacetic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01HNP", "drug_id_DB": "", "metabolic_annotation_str": "G6PD(Glucose-6-phosphate dehydrogenase (G6PD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["G6PD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2539"]}, "4-[4-(benzyloxy)piperidino]butyl-3-fluorobenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06KQH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "9-octadecynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09QIA", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "WAY-256805": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KS0I", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "Atamestane-plus- Toremifene": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0B4ES", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1588"]}, "KA2237": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0J8MA", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "2-(biphenyl-4-yl)vinylboronic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FD8G", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["759"]}, "(3-methyl-4-(4-phenoxybenzoyl)phenyl)acetic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05XPT", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "PMID27537201-Compound-Figure13c": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EF9J", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "(3-bromophenyl)(10H-phenothiazin-10-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J8LQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "PMID29757691-Compound-10": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0X9CR", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "6-hydroxy-2-methyl-9H-beta-carbolin-2-ium": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02LWX", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "PF-04971729": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Q3VE", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "A-80040": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IY5Y", "drug_id_DB": "", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "TS antisense + raltitrexed": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V5YQ", "drug_id_DB": "", "metabolic_annotation_str": "TYMS(Thymidylate synthase messenger RNA (TYMS mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMS"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["7298"]}, "4-Butoxy-N-hydroxy-N-methyl-benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02RBU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "CHF-3381": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04RCT", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "S-(2-boronoethyl)-L-cysteine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A8ZM", "drug_id_DB": "", "metabolic_annotation_str": "ARG2(Kidney-type arginase (ARG2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ARG2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["384"]}, "4-(4-hydroxy-benzylideneamino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03VUQ", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "5743"]}, "S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08DOY", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "Para-chloroamphetamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CMJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "1-(phenylsulfonyl)butan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06RKS", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "4-(3-nitro-benzylideneamino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JT8Y", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "MF-152": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O3TT", "drug_id_DB": "", "metabolic_annotation_str": "SCD(Acyl-CoA desaturase (SCD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SCD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6319"]}, "KURARINONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01PNM", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "3-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09YXV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "4-methoxy-N-(thiazol-2-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00OWZ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "N-Acetylalanine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09MYF", "drug_id_DB": "DB02518", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Broussoflavonol F": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3LG", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "AMINOTHIAZOLINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y2AO", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "2'-Deoxyuridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00CVB", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D05YUI", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["100"]}, "2-Thiomethyl-3-Phenylpropanoic Acid(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MMP8(Matrix metalloproteinase-8 (MMP-8) ,MOA:Inhibitor); ", "drug_id_TTD": "D0W3UL", "drug_id_DB": "", "metabolic_annotation_str": "CPA1(Carboxypeptidase A1 (CPA1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CPA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1357"]}, "TD-9855": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02JKY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6530", "6532"]}, "PMID24099220C5i": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z3NE", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID1656041C74": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R8YV", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Imidazo isoindole derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WR7B", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Y-40613": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08QZD", "drug_id_DB": "", "metabolic_annotation_str": "CMA1(Chymase (CYM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CMA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1215"]}, "Digitoxin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01396", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase subunit alpha-1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ATP1A1"], "metabolic_genes_id": ["476"]}, "NLG8189": {"drug_status_TTD": ["Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D0B5HS", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Metoprine": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "PDF(Polypeptide deformylase (PDF) ,MOA:Inhibitor); ", "drug_id_TTD": "D02AIM", "drug_id_DB": "DB04655", "metabolic_annotation_str": "HNMT(Histamine N-methyltransferase (HNMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HNMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3176"]}, "RWJ-387273": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H6ZC", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8654"]}, "3-Methyl-[1,4]thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WEI", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "1-(3-Chloro-phenyl)-3-cyclohexyl-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B0ES", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "PMID1656041C4ff": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00TIO", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Ouabain(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0AR3J", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["476"]}, "Sulfamic acid 3-(3-hydroxy-benzoyl)-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06DVJ", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "T-588": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03NZM", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A3(Vesicular acetylcholine transporter (SLC18A3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6572"]}, "1,8-Dihydroxy-2-propionyl-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ENR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-Methylamino-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07AGM", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760"]}, "3-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01JVG", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "2-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T5OW", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203"]}, "1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q8IQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "(S)-2-Amino-4-phenyl-butane-1-thiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DS7F", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "(R)-N-isopropyl-N-(pyrrolidin-3-yl)-2-naphthamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NM1F", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "2-(2-cycloheptylidenehydrazinyl)-4-phenylthiazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q1IP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "SALACINOL": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2", "Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D07TSW", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM", "GAA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972", "2548"]}, "tryptanthrin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I9AT", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29053063-Compound-7b": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03HHN", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "PMID29053063-Compound-7c": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0TT7U", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "PMID29053063-Compound-7a": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03LKM", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "PMID29053063-Compound-7f": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00VBP", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "PMID29053063-Compound-7d": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0D2YG", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "PMID29053063-Compound-7e": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0TW7K", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "4-hydroxybenzaldehyde": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D00BRD", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB", "ABAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4129", "18"]}, "BENZENEMETHANETHIOL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GYX", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Cetilistat(TTD)": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D04NRB", "drug_id_DB": "", "metabolic_annotation_str": "LIPF(Gastric triacylglycerol lipase (LIPF) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPF"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8513"]}, "2-(4-Fluoro-indole-1-sulfonyl)-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I1RP", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "GP-683": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0JI1J", "drug_id_DB": "", "metabolic_annotation_str": "ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["132"]}, "Her2- and PSA-targeted TGX-D1": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1CF", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "2-(1H-Indol-3-ylmethyl)-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R1ER", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "5-hydroxy-2-(propylthiomethyl)-4H-pyran-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X9DP", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "[Cu(CN)2]-": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L2GD", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "762"]}, "Acenanthrene-9,10-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6PO", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Triazole gold complexe 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0NX8E", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Triazole gold complexe 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01IPU", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Triazole gold complexe 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00LBC", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "2,3-dihydroxypropanal": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09PNQ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "CMI-206": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "PTAFR(Platelet-activating factor receptor (PTAFR) ,MOA:Modulator); ", "drug_id_TTD": "D0V4GT", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "IP10 C8": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "DPP4(Dipeptidyl peptidase 4 (DPP-4) ,MOA:Modulator); ", "drug_id_TTD": "D0E3HY", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["290"]}, "5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00TWK", "drug_id_DB": "DB08466", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Cilostazol": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03VPC", "drug_id_DB": "DB01166", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "BICARBONATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09JAR", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "PF-4957325-00": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TE9G", "drug_id_DB": "", "metabolic_annotation_str": "PDE8A(Phosphodiesterase 8 (PDE8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE8A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5151"]}, "PMID20299227C20": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RN8T", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "QSPac": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6SV", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6523"]}, "L-652,343": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00OWE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "3-(6-Amino-purin-9-yl)-6-phenyl-hexan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00FIT", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "(R)-EF-1520": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I7AL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); SLC6A12(Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1", "SLC6A12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6529", "6539"]}, "(+/-)-7-fluoro-2-phenylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IK2S", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID19191557C19": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ATQ", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID19191557C14": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00YIS", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "P-Coumaric Acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AU0M", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "Omapatrilat": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Modulator); ", "drug_id_TTD": "D05UQD", "drug_id_DB": "DB00886", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "2-Thiophen-2-ylmethyl-1,2-dihydro-indazol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X9RM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-Amino-3-iodo-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01STY", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "Fluorinated donepezil derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XS3N", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Fluorinated donepezil derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AH3R", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "(RS/SR)-2-[1-(4-chlorophenyl)butyl]piperidine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IR0R", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Disulfiram(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00822", "metabolic_annotation_str": "ALDH2(Aldehyde dehydrogenase, mitochondrial); DBH(Dopamine beta-hydroxylase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALDH2", "DBH"], "metabolic_genes_id": ["217", "1621"]}, "Clodronate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00HNB", "drug_id_DB": "", "metabolic_annotation_str": "SLC25A4(Adenine nucleotide translocator 1 (SLC25A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC25A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["291"]}, "ANS-6637": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D09PSY", "drug_id_DB": "", "metabolic_annotation_str": "ALDH2(Mitochondrial aldehyde dehydrogenase (ALDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["217"]}, "5-Pyridin-3-yl-thiophene-2-carbaldehyde oxime": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C7JC", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Acetazolamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00819", "metabolic_annotation_str": "CA12(Carbonic anhydrase 12); CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); CA4(Carbonic anhydrase 4); AQP1(Aquaporin-1); CA7(Carbonic anhydrase 7); CA14(Carbonic anhydrase 14); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA3", "CA4", "AQP1", "CA7", "CA14"], "metabolic_genes_id": ["771", "759", "760", "761", "762", "358", "766", "23632"]}, "PMID16242323C26a": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04SPQ", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "PMID16242323C26b": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RG1F", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "PMID16242323C26c": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KS1Z", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "N-(1H-Indol-2-ylmethyl)-N-(4-phenylbutyl)amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08PEW", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "SEP-227900": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0XW4W", "drug_id_DB": "", "metabolic_annotation_str": "DAO(D-amino acid oxidase (DAO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DAO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1610"]}, "Piperidine-1-carboxylic acid adamantan-2-yl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A5JU", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "US10065972, Example 281": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D08ETC", "drug_id_DB": "", "metabolic_annotation_str": "AADAT(Kynurenine oxoglutarate transaminase II (AADAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AADAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["51166"]}, "Mefenamic acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00784", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "Fidarestat(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02021", "metabolic_annotation_str": "AKR1B10(Aldo-keto reductase family 1 member B10); AKR1B1(Aldose reductase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["AKR1B10", "AKR1B1"], "metabolic_genes_id": ["57016", "231"]}, "4-(2-(diethylamino)ethylamino)-1-naphthol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06OUR", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "5-Amino-[1,3,4]thiadiazole-2-thiol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X1MY", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "N-omega-propargyl-L-arginine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L4RU", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A3JR", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Benzyl-(2-imidazol-1-yl-quinazolin-4-yl)-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09AUL", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142"]}, "(+/-)-threo-N-(2-Methylfuran)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L2JS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Procaine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KCNN4(Intermediate conductance calcium-activated potassium channel protein 4); DNMT1(DNA (cytosine-5)-methyltransferase 1); HTR3A(5-hydroxytryptamine receptor 3A); KCNMA1(Calcium-activated potassium channel subunit alpha-1); CHRNA2(Neuronal acetylcholine receptor subunit alpha-2); KCNMB1(Calcium-activated potassium channel subunit beta-1); KCNMB4(Calcium-activated potassium channel subunit beta-4); GRIN3A(Glutamate receptor ionotropic, NMDA 3A); KCNN1(Small conductance calcium-activated potassium channel protein 1); KCNN2(Small conductance calcium-activated potassium channel protein 2); KCNMB3(Calcium-activated potassium channel subunit beta-3); KCNN3(Small conductance calcium-activated potassium channel protein 3); SCN10A(Sodium channel protein type 10 subunit alpha); KCNMB2(Calcium-activated potassium channel subunit beta-2); DNMT3A(DNA (cytosine-5)-methyltransferase 3A); ", "drug_id_TTD": "", "drug_id_DB": "DB00721", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); MAOB(Amine oxidase [flavin-containing] B); PLA2G4A(Cytosolic phospholipase A2); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ASPG(60 kDa lysophospholipase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MAOA", "MAOB", "PLA2G4A", "SLC6A3", "SLC6A3", "ASPG"], "metabolic_genes_id": ["4128", "4129", "5321", "6531", "6531", "374569"]}, "CP-126998": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G2WI", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["43"]}, "(S)-2-Amino-4-methyl-pentane-1-thiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q0EY", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Butyl-methyl-prop-2-ynyl-amine hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07KCC", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "CPC-250": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0WI9W", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "(R)(+)-7-methyl-2-phenylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B3QN", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "DuP-129": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0K8KJ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1-benzyl-2,3-dimethyl-1H-indole-7-carboxylic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YW9C", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "4-(Methylhydrazino)-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q5VB", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "(+/-)-threo-N-(2-Chlorobenzyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R9ZS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "7-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MB3S", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Daxalipram(TTD)": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0I0GM", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00WVG", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "1-Adamantan-1-yl-3-(4-hydroxy-phenyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q8NE", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "N5-[4-(2-methylphenoxy)phenyl]-L-glutamamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07KBF", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "1-phenyl-3-aza-bicyclo[3.1.0]hexane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09ZIU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "(1-Amino-3-phenyl-propyl)-phosphinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KIV", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "1-Imidazol-1-ylmethyl-4-nitro-xanthen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CTI", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588"]}, "1-Methyl-2-(4-phenylsulfanyl-phenyl)-ethylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09YHS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "5-Chloro-N-phenylbenzo[d]oxazol-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08HFK", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Cilomilast(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03849", "metabolic_annotation_str": "PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); PDE4D(cAMP-specific 3',5'-cyclic phosphodiesterase 4D); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PDE4B", "PDE4D"], "metabolic_genes_id": ["5142", "5144"]}, "BAICALEIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); TNF(Tumor necrosis factor (TNF) ,MOA:Inhibitor); SELL(L-selectin (SELL) ,MOA:Inhibitor); PREP(Prolyl endopeptidase (PREP) ,MOA:Inhibitor); ", "drug_id_TTD": "D00YEV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "XDH", "GLO1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "7498", "2739"]}, "2-Amino-5-(N-nitro-guanidino)-pentanoic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03FJM", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "PF-03772304": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ", "drug_id_TTD": "D05RSS", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "Perifosine(TTD)": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0R1VU", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "Glipizide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PPARG(Peroxisome proliferator-activated receptor gamma); ", "drug_id_TTD": "", "drug_id_DB": "DB01067", "metabolic_annotation_str": "ABCC8(ATP-binding cassette sub-family C member 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC8"], "metabolic_genes_id": ["6833"]}, "PMID27172114-Compound-30": {"drug_status_TTD": ["Patented", "Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D04MIQ", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); TDO2(Tryptophan 2,3-dioxygenase (TDO) ,MOA:Inhibitor); IDO2(Indoleamine 2,3-dioxygenase 2 (IDO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1", "TDO2", "TDO2", "IDO2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3620", "6999", "6999", "169355"]}, "Indomethacin analog 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0E2TY", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor. Antagonist. Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor; Antagonist; Blocker"], "metabolic_genes_id": ["8644"]}, "N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T2VH", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "762"]}, "Silymarin": {"drug_status_TTD": ["Phase 4", "Phase 4"], "non_metabolic": "", "drug_id_TTD": "D0AZ8C", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "AMG-126737": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07IZR", "drug_id_DB": "", "metabolic_annotation_str": "TPSAB1(Tryptase alpha/beta-1 (Tryptase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TPSAB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7177"]}, "S-P-Nitrobenzyloxycarbonylglutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X7OS", "drug_id_DB": "DB03130", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "24-ethylcholest-6-ene-3,5-diol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V3LC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "5-deoxy-5-phosphono-D-arabinonate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04LDP", "drug_id_DB": "", "metabolic_annotation_str": "PGD(Phosphogluconate dehydrogenase (PGD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PGD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5226"]}, "2-pentafluorophenylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J3SP", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "2-Cyclopentylaminomethyl-pyrrolidine-3,4-diol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T0EJ", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "(+/-)-threo-Ritalinol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6TF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "ROLIPRAM": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0T5PO", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A", "PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8654", "5141", "5142", "5144"]}, "4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01REI", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "Alpha-substituted pirinixic acid and pirinixic acid ester derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0OE9W", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "Melatonin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ESR1(Estrogen receptor); CALM1(Calmodulin); NQO2(Ribosyldihydronicotinamide dehydrogenase [quinone]); CALR(Calreticulin); MTNR1A(Melatonin receptor type 1A); MTNR1B(Melatonin receptor type 1B); RORB(Nuclear receptor ROR-beta); ", "drug_id_TTD": "", "drug_id_DB": "DB01065", "metabolic_annotation_str": "MPO(Myeloperoxidase); EPX(Eosinophil peroxidase); ASMT(Acetylserotonin O-methyltransferase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["MPO", "EPX", "ASMT"], "metabolic_genes_id": ["4353", "8288", "438"]}, "GLYCYRRHIZIN": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0T8QB", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Methoxsalen": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D08SKH", "drug_id_DB": "", "metabolic_annotation_str": "CYP2A6(Cytochrome P450 2A6 (CYP2A6) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2A6"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["1548"]}, "N-Cyclohexyl-N'-(Propyl)Phenyl Urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MHZ", "drug_id_DB": "DB04213", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "NSC-356781": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S8MJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "6-(Naphthalene-1-sulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P1ZM", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Cyclohexyl-ethyl-substituted diaza and triaza-tricyclic compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CE7G", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["3620"]}, "VAS-203": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0N2JI", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "INCB24360": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0G7MV", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(2R,5R)-delta-methyl-alpha-acetylenic putrescine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02XYV", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "Cyclizine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HRH1(Histamine H1 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01176", "metabolic_annotation_str": "SULT1E1(Estrogen sulfotransferase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["SULT1E1"], "metabolic_genes_id": ["6783"]}, "4-phenyl-1,2,3,6-tetrahydropyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07AAZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "6-hydroxydopa quinone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M9YH", "drug_id_DB": "DB04334", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8639"]}, "Rigosertib": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "PLK1(Polo-like kinase 1 (PLK1) ,MOA:Modulator); ", "drug_id_TTD": "D0KF9Q", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "NITRAQUAZONE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V5BX", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142"]}, "Hexahydro quinoline derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0DA8D", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID19502059C25d": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N7RK", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PERSICARIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E5IM", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "NM-702": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06LFV", "drug_id_DB": "DB05505", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "IDD552": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JEY", "drug_id_DB": "DB02834", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "N-(5-Amino-6-oxo-heptyl)-acetamidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V5HI", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "PI-3065": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SSI", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5291", "5294"]}, "S-(2,4-Dichlorobenzyl)isothiourea hydrobromide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09JOM", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4-methyl-7-(2-oxocyclopentyloxy)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A1RE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "2-phenyl-N-(1,3,4-thiadiazol-2-yl)acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05DAE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-((4-hydroxyphenyl)diazenyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04HRS", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "768"]}, "Adamantan-1-yl-pyrrolidin-1-yl-methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VC2M", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Lead acetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4VW", "drug_id_DB": "", "metabolic_annotation_str": "FECH(Ferrochelatase (FECH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FECH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2235"]}, "Exemestane": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0D2VS", "drug_id_DB": "DB00990", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Resorcinol compound 8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D06WGO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K5KG", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "Resorcinol compound 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0NR2A", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 7": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02JVX", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0EQ3V", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KU5J", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07RJD", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ZJ4M", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Resorcinol compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0G5CV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "2-ethylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AOA", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Ro-46-5934": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0TK0W", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "US10065972, Example 560": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03DSN", "drug_id_DB": "", "metabolic_annotation_str": "AADAT(Kynurenine oxoglutarate transaminase II (AADAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AADAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["51166"]}, "(R)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F2SM", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "6-fluoro-5-phenylpyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E9PL", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "(R)-1-((S)-morpholin-2-yl)-1,2-diphenylethanol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D1KK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "2-hydroxy-3-isopropyl-2,4,6-cycloheptatrien-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A6ZK", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Huperzine A": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06XWB", "drug_id_DB": "DB04864", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Fluoxetine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0TR5X", "drug_id_DB": "DB00472", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "SKLB-010": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09OWC", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4843"]}, "N-(4-methylthiazol-2-yl)-2-phenylacetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06IVU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Carbidopa": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0P7JZ", "drug_id_DB": "DB00190", "metabolic_annotation_str": "DDC(Aromatic-L-amino-acid decarboxylase (DDC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DDC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1644"]}, "2beta,3alpha-dihydroxyolean-12-en-28-oic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N2SM", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "3-[5-(benzylmethylamino)pentyloxy]xanthen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H3BC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); PRKDC(DNA-dependent protein kinase catalytic (PRKDC) ,MOA:Inhibitor); ", "drug_id_TTD": "D0W1ST", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD", "PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5293", "5291", "5294"]}, "3-(furan-3-yl)-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08OSM", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "6-Hydroxyuridine-5'-Phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P0EP", "drug_id_DB": "", "metabolic_annotation_str": "UMPS(Orotidine 5'-monophosphate decarboxylase (UMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7372"]}, "PUUPEHENONE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BXV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "246", "239"]}, "SYM2081": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S8AN", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A3(Excitatory amino acid transporter 1 (SLC1A3) ,MOA:Modulator); SLC1A2(Excitatory amino acid transporter 2 (SLC1A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A3", "SLC1A2"], "metabolic_mechanism_of_action": ["Modulator", "Inhibitor"], "metabolic_genes_id": ["6507", "6506"]}, "PMID29473428-Compound-80": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z5PM", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Styrylboronic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F7QZ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["759"]}, "N-(3-Phenylpropyl)-1H-indole-2-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07LCU", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "B-5354a": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D02YQJ", "drug_id_DB": "", "metabolic_annotation_str": "SPHK1(Sphingosine kinase 1 (SPHK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8877"]}, "Esomeprazole magnesium + Aspirin": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0B2ZZ", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["495"]}, "1-Cyclohexyl-3-(4-methoxy-phenyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09FEC", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "TAK-438": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02CPP", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "4-(2-(benzyloxy)-3-fluorophenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D05LJC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Tranylcypromine": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0H0HJ", "drug_id_DB": "DB00752", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Carbodine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B3MG", "drug_id_DB": "", "metabolic_annotation_str": "CTPS1(CTP synthase (CTPS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTPS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1503"]}, "7-hydroxy-8-propionyl-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EH0S", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "Oxaprozin": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0M9DC", "drug_id_DB": "DB00991", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "8-(3-Bromobenzyloxy)caffeine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07NBB", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "1-pentenyl-4-(aminosulfonyl)benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06OVA", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Piroxicam(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D00IBN", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5742"]}, "Probucol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01599", "metabolic_annotation_str": "ABCA1(ATP-binding cassette sub-family A member 1); CES1(Liver carboxylesterase 1); CES1(Liver carboxylesterase 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCA1", "CES1", "CES1"], "metabolic_genes_id": ["19", "1066", "1066"]}, "AZD-4017": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0R8IU", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "WY-28342": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0H0IA", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "BN82451": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0I8QS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Diamine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L0CV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Diamine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QU3G", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "RG-4929": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09DIB", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "3-hydroxy-N,N,N-trimethylbenzenaminium iodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03PQH", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID27537201-Compound-Figure15b": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SH0L", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PMID27537201-Compound-Figure15a": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00YVL", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "TROPOLONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7GL", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "S33005": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08MUX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "Pyrazolo[3,4-d]pyrimidine derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V6LW", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "(RS)-5-diphosphomevalonate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A5IX", "drug_id_DB": "", "metabolic_annotation_str": "MVK(Mevalonate kinase (MVK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4598"]}, "Pyrazolo[3,4-d]pyrimidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07YWQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Pyrazolo[3,4-d]pyrimidine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01IRA", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Pyrazolo[3,4-d]pyrimidine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07OOA", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Methotrexate(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0SV8E", "drug_id_DB": "", "metabolic_annotation_str": "SLC19A1(Solute carrier family 19 member 1 (SLC19A1) ,MOA:Modulator); SLC46A1(Proton-coupled folate transporter (SLC46A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC19A1", "SLC46A1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6573", "113235"]}, "3-(imidazolylmethyl)-4'-methoxyflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00BVP", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "(11H-Dibenzo[b,e][1,4]dioxepin-7-yl)-acetic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X5RR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Biopterin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03886", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase); SPR(Sepiapterin reductase); PTS(6-pyruvoyl tetrahydrobiopterin synthase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["DHFR", "SPR", "PTS"], "metabolic_genes_id": ["1719", "6697", "5805"]}, "1-methyl-1H-indole-3-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00FPG", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "(4-methoxyphenyl)(4-phenylazepan-1-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01CAC", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "VDA-1102 topical ointment": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "VDAC1(Voltage-dependent anion-selective channel 1 (VDAC1) ,MOA:Modulator); ", "drug_id_TTD": "D06QBX", "drug_id_DB": "", "metabolic_annotation_str": "HK2(Hexokinase-2 (HK2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HK2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3099"]}, "R-68151": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "F10(Coagulation factor Xa (F10) ,MOA:Inhibitor); ", "drug_id_TTD": "D0G5GJ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Isosorbide-2-benzyl carbamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W4WB", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Phenylthioacetate derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0JM7W", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "Choline alfoscerate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04660", "metabolic_annotation_str": "GM2A(Ganglioside GM2 activator); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["GM2A"], "metabolic_genes_id": ["2760"]}, "P2B-001": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "DRD2(Dopamine D2 receptor (D2R) ,MOA:Inhibitor); ", "drug_id_TTD": "D01NKW", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "3-(4-Benzoylpiperazine-1-carbonyl)coumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V7EA", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Pyrimidine benzenesulfonamide derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0OM6D", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Pyrimidine benzenesulfonamide derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0R5HG", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Pyrimidine benzenesulfonamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0T8AS", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "6-(4-Methylpyridin-3-yl)-2-naphthonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3CX", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "US8933095, 14": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SZ7H", "drug_id_DB": "", "metabolic_annotation_str": "AADAT(Kynurenine oxoglutarate transaminase II (AADAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AADAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["51166"]}, "Benzene sulfonamide derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N9WZ", "drug_id_DB": "", "metabolic_annotation_str": "KMO(Kynurenine 3-hydroxylase (KMO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KMO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8564"]}, "Fructose-6-Phosphate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H3IJ", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203"]}, "4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiol-3-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4LI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "4-Hydroxy-Aconitate Ion": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02UII", "drug_id_DB": "DB03964", "metabolic_annotation_str": "ACO2(Citrate hydro-lyase (ACO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACO2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["50"]}, "CHRYSOERIOL": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01FGM", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH", "CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["7498", "1545"]}, "US8933095, 16": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D09JPJ", "drug_id_DB": "", "metabolic_annotation_str": "AADAT(Kynurenine oxoglutarate transaminase II (AADAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AADAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["51166"]}, "NN-414": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D02ZPN", "drug_id_DB": "", "metabolic_annotation_str": "ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC8"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6833"]}, "N-(2-Methyl-1H-indol-5-yl)benzamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ILX", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PMID27977313-Compound-Figure4b": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0NM0B", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "(4-(thiophen-2-yl)phenyl)methanamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I4OV", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "(+/-)-threo-N-(3-Methylfuran)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09FTL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "TS-033": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D08WGZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "2-butylamido-5-sulfonamidoindane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SF3B", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "CAP-232": {"drug_status_TTD": ["Phase 2a"], "non_metabolic": "", "drug_id_TTD": "D09EFC", "drug_id_DB": "", "metabolic_annotation_str": "PKM(Pyruvate kinase M2 (PKM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PKM"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5315"]}, "Al7089a": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04XMZ", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "N-(3-phenylpropyl)-1H-pyrrole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y4JQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "2-(2-Amino-ethyl)-7-imino-azepane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IR4Y", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "N-n-octyl-7-methoxytacrine hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q3EV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "SULFATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03LWY", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["759"]}, "US8933095, 18": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RR5C", "drug_id_DB": "", "metabolic_annotation_str": "AADAT(Kynurenine oxoglutarate transaminase II (AADAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AADAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["51166"]}, "4-[1-(4'-Methoxybiphenyl-4-yl)propyl]pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T1CH", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "LIRIMILAST": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0F5IY", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "3-(3'-furyl)-aniline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GE9U", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "LY2365109": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1CN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "IP10.C8-1": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "DPP4(Dipeptidyl peptidase 4 (DPP-4) ,MOA:Inhibitor); ", "drug_id_TTD": "D05VCA", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Perhexiline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KCNH2(Potassium voltage-gated channel subfamily H member 2); ", "drug_id_TTD": "", "drug_id_DB": "DB01074", "metabolic_annotation_str": "CPT2(Carnitine O-palmitoyltransferase 2, mitochondrial); CPT1A(Carnitine O-palmitoyltransferase 1, liver isoform); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CPT2", "CPT1A"], "metabolic_genes_id": ["1376", "1374"]}, "7-methoxy-2-p-tolyl-4H-chromene-4-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07HFF", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "CNX-010": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I5ND", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "4-(2-Phenylacetamido)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O0UE", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "6-(Naphthalene-2-sulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08JEI", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "CHOLINE IODIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q2DE", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "29-methylidene-2,3-oxidosqualene": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C4PT", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "Bis(14)-Huperzine B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04KWA", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N5-[4-(4-methylphenoxy)phenyl]-L-glutamamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G8SW", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "NSC-88915": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "RHO(Rhodopsin (RHO) ,MOA:Inhibitor); ", "drug_id_TTD": "D09KUE", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "6-Pyridin-3-yl-1,2,3,4-tetrahydronaphthalen-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ZQM", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "[1,4]Thiazepan-(3E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TYS", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "COUMARIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ZMQ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "4'-(5-Chloro-2-thienyl)biphenyl-3-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q6AD", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "AC-8632": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P7HI", "drug_id_DB": "", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "Alpha-Methylisocitric Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01EVI", "drug_id_DB": "DB04072", "metabolic_annotation_str": "ACO2(Citrate hydro-lyase (ACO2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACO2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["50"]}, "Trans-(R(S))-2-Hydroxy-1-phenylethyl nitrate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03MJM", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "Idelalisib": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0J5VR", "drug_id_DB": "DB09054", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "S-(N-propyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03OXL", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "AVE-0657": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01ICY", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6550", "6550"]}, "Methyl 4-(3-cyclohexylureido)butanoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05NZH", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "3-(2-Diethylamino-acetamino)-rutaecarpine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07VIO", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "EC20": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D00BHL", "drug_id_DB": "", "metabolic_annotation_str": "FOLR1(Folate receptor alpha (FOLR1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FOLR1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2348"]}, "(+/-)-nantenine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); DRD2(Dopamine D2 receptor (D2R) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA2C(Adrenergic receptor alpha-2C (ADRA2C) ,MOA:Inhibitor); DRD1(Dopamine D1 receptor (D1R) ,MOA:Inhibitor); DRD4(Dopamine D4 receptor (D4R) ,MOA:Inhibitor); DRD4(Dopamine D4 receptor (D4R) ,MOA:Inhibitor); DRD5(Dopamine D5 receptor (D5R) ,MOA:Inhibitor); HRH2(Histamine H2 receptor (H2R) ,MOA:Inhibitor); ADRA1D(Adrenergic receptor alpha-1D (ADRA1D) ,MOA:Inhibitor); HTR1D(5-HT 1D receptor (HTR1D) ,MOA:Inhibitor); HTR1B(5-HT 1B receptor (HTR1B) ,MOA:Inhibitor); HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); HTR7(5-HT 7 receptor (HTR7) ,MOA:Inhibitor); ADRA1A(Adrenergic receptor alpha-1A (ADRA1A) ,MOA:Inhibitor); ADRA1B(Adrenergic receptor alpha-1B (ADRA1B) ,MOA:Inhibitor); OPRM1(Opioid receptor mu (MOP) ,MOA:Inhibitor); HTR2B(5-HT 2B receptor (HTR2B) ,MOA:Inhibitor); HTR5A(5-HT 5A receptor (HTR5A) ,MOA:Inhibitor); HTR6(5-HT 6 receptor (HTR6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0L5MW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "4-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0AL2D", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "BPH-608": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N4AH", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "2-(tert-Butylamino)-3'-fluoropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J5EF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "N-isopropylnorlitebamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ZHK", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "6-hydroxy-7,9-octadecadiynoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01YQX", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "DIETHOXYFLOURESCEIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FZC", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "SAR-650984": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0NS1X", "drug_id_DB": "", "metabolic_annotation_str": "CD38(Cyclic ADP-ribose hydrolase 1 (CD38) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["CD38"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["952"]}, "PMID19191557C32": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KMC", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "PMID19191557C35": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E1BR", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "AMXT-1501": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01OHD", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "[3H]nisoxetine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H3CQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "4-Imidazol-1-ylmethylthioxanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I2UE", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "4-chloro-7-methyl-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1TQ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "(R)-3-Prop-2-ynylamino-indan-5-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BAO", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(S)-2-Amino-propane-1-thiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R9AA", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "1,5-bis(4-hydroxyphenyl)penta-1,4-dien-3-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0J6RQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "3'-(5-Chloro-2-thienyl)biphenyl-3-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CED", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Primary alcohol metabolite of celecoxib": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4VL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Azetidinyl-piperazine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0OK3K", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "5-Ethyl-3,4-diphenyl-isoxazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06WML", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "5-aminoquinolin-8-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3ON", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "MORACHALCONE A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8JC", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "(6-Ethoxy-2-naphthyl)-2-aminopropane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L5EW", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Acitretin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "RARA(Retinoic acid receptor alpha); RARG(Retinoic acid receptor gamma); RXRA(Retinoic acid receptor RXR-alpha); RXRB(Retinoic acid receptor RXR-beta); RXRB(Retinoic acid receptor RXR-beta); RXRB(Retinoic acid receptor RXR-beta); RXRB(Retinoic acid receptor RXR-beta); RXRB(Retinoic acid receptor RXR-beta); RXRB(Retinoic acid receptor RXR-beta); RXRG(Retinoic acid receptor RXR-gamma); ", "drug_id_TTD": "", "drug_id_DB": "DB00459", "metabolic_annotation_str": "RBP1(Retinol-binding protein 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["RBP1"], "metabolic_genes_id": ["5947"]}, "16-(pyridin-2-yl)methylene-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02XZO", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Quinoline-8-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F7SO", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "768"]}, "Acarbose(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0AD5C", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8972", "8972"]}, "4-(2-Phenylacetamidomethyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06XNT", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "1-(4-fluorobenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QPR", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "Riociguat(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D04UKC", "drug_id_DB": "", "metabolic_annotation_str": "GUCY2D(Soluble guanylyl cyclase (GUCY2D) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY2D"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3000"]}, "NSC-2113": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07DGS", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "1-Deaza-Adenosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03PLV", "drug_id_DB": "DB04218", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "1-Ethylidenethiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M4XH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Petrosaspongiolide M": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05DUX", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "PMID7473541C11": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LT7Y", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Imidazotriazinone derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0L0MI", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "3-isopr-sal-cyclosal-d4TMP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E4GM", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Petrosaspongiolide P": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02COQ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "2,3-dimethoxy-2'-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LB6L", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Nortriptyline(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D04WFD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TGC", "drug_id_DB": "DB04754", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "1,2,4-triazole [1,5-a]pyrimidin-7-yl derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0H4LG", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "1,2,4-triazole [1,5-a]pyrimidin-7-yl derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0HC5P", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "1,2,4-triazole [1,5-a]pyrimidin-7-yl derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0T8MJ", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "3-(1,1-Dimethyl-2-phenyl-ethyl)-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V9JS", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "3-(1,3 dodecadiynyl)-6-oxiranebutanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08SKU", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PDE4 inhibitors, Scottich Biomedical": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G1YQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "N1-(3,3-diphenylpropyl)-N3-hydroxymalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00SLJ", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Methyl Mercury Ion": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "CDC25B(M-phase inducer phosphatase 2 (MPIP2) ,MOA:Inhibitor); ", "drug_id_TTD": "D09CZV", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "PF-877423": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03QYZ", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "E-5324": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01IDE", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "N*1*-(5-Methyl-2-nitro-phenyl)-butane-1,4-diamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IX0N", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "Folic Acid": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0Z0DW", "drug_id_DB": "", "metabolic_annotation_str": "SLC19A1(Solute carrier family 19 member 1 (SLC19A1) ,MOA:Modulator); SLC46A1(Proton-coupled folate transporter (SLC46A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC19A1", "SLC46A1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6573", "113235"]}, "4-fluoroselegiline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07KIB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "NSC-654077": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B4IN", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "Phenanthrene-9,10-dione": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q2YJ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "1066", "1066"]}, "1-(2-(2-bromophenyl)-1-phenylethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ZDY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "PMID26815044-Compound-32": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D04HEW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Allyl 4-(aminosulfonyl)benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05NAR", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "PRINOMIDE TROMETHAMINE": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0V7HI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Isosorbide-di-(benzylcarbamate)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01AJQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "PMID26815044-Compound-31": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01NJW", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "ISIS 1831": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EK3T", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["240", "240"]}, "16-(pyridin-4-yl)methylene-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ERB", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "PMID7966163C3f": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07KJI", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "CH-4051": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02OTK", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1719"]}, "M-0011": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "MAN2C1(Alpha-mannosidase (MANA) ,MOA:Modulator); MAN2B2(Alpha-mannosidase (MANA) ,MOA:Modulator); ", "drug_id_TTD": "D06SVC", "drug_id_DB": "", "metabolic_annotation_str": "MAN2B1(Alpha-mannosidase (MANA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAN2B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4125"]}, "MK-0873": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0M7CB", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Y-700": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0E4FM", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "1-(10H-phenothiazin-10-yl)-3-phenylpropan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P3VH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "N-(thiazol-2-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z7QZ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-(2-AMINOETHYL)BENZENESULFONAMIDE(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB08782", "metabolic_annotation_str": "CA2(Carbonic anhydrase 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["CA2"], "metabolic_genes_id": ["760"]}, "5-Ethyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03YZT", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "1-(3,4-dichlorophenyl)-2-(phenylsulfonyl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D3PY", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "SCR-44001": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ", "drug_id_TTD": "D05SXC", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "L-5-iodo-2'-deoxyuridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HO0W", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "2-N-Propargylamino-1-(4-methylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05FMK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "CFG920": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D05RVA", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "NSC-94891": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P5ZV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "PMID29166791-Compound-AMPCP": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0KS3G", "drug_id_DB": "", "metabolic_annotation_str": "NT5E(Ecto-5'-nucleotidase (CD73) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NT5E"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4907"]}, "ME-401": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08WLY", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "N1-hydroxy-2-isobutyl-N3-phenethylmalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GB8I", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "BUTEIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EW3L", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Isosorbide-2-benzylcarbamate-5-tosylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VI6N", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Tetra-hydro-oxazolopyridine derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "GRM5(Metabotropic glutamate receptor 5 (mGluR5) ,MOA:Modulator); ", "drug_id_TTD": "D0GQ2Z", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "Tetra-hydro-oxazolopyridine derivative 2": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "GRM5(Metabotropic glutamate receptor 5 (mGluR5) ,MOA:Modulator); ", "drug_id_TTD": "D0DL1O", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "4-Imidazol-1-ylmethyl-1-nitro-xanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01LOU", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Netarsudil(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ROCK2(Rho-associated protein kinase 2); ROCK1(Rho-associated protein kinase 1); ", "drug_id_TTD": "", "drug_id_DB": "DB13931", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A2"], "metabolic_genes_id": ["6530"]}, "2,5-Anhydroglucitol-1,6-Biphosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02778", "metabolic_annotation_str": "FBP1(Fructose-1,6-bisphosphatase 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["FBP1"], "metabolic_genes_id": ["2203"]}, "Isoflurophate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TF(Serotransferrin); ", "drug_id_TTD": "", "drug_id_DB": "DB00677", "metabolic_annotation_str": "BCHE(Cholinesterase); ACHE(Acetylcholinesterase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_genes_id": ["590", "43"]}, "NSC-125034": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S7AY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["239"]}, "1-[(n-but-1-ylamino)ethyl]-1,1-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06UVF", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "Nitroglycerin(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D07YDE", "drug_id_DB": "", "metabolic_annotation_str": "GUCY1A1(Soluble guanylate cyclase (GCS) ,MOA:Modulator); GUCY1B1(Soluble guanylate cyclase (GCS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY1A1", "GUCY1B1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2982", "2983"]}, "FSA2": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0R2SW", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "Biphenyl-3-carboxylic acid hydroxyamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QBX", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Carzenide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09PWX", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "765", "768", "23632"]}, "Ketorolac": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0D9JW", "drug_id_DB": "DB00465", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Sophoraflavanone G": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VE0Q", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "Silicon-modified indomethacin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y4ZI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Angiotensin IV": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L3PY", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "2-Methoxyphenol": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I7TW", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0J4CB", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "3-Isobutyl-[1,4]thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08CMQ", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "Putrescine": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00FMV", "drug_id_DB": "DB01917", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1", "AMD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4953", "262"]}, "Acetoacetyl-Coenzyme A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CGD", "drug_id_DB": "", "metabolic_annotation_str": "HMGCS2(Hydroxymethylglutaryl-CoA synthase 2 (HMGCS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3158"]}, "US10092575, Example 141": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0WS3T", "drug_id_DB": "", "metabolic_annotation_str": "PDE1B(Phosphodiesterase 1B (PDE1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5153"]}, "Coenzyme A(TTD)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3NA", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); CRAT(Carnitine acyltransferase (CRAT) ,MOA:Inhibitor); COASY(Phosphopantetheine adenylyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR", "CRAT", "COASY"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3156", "1384", "80347"]}, "1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4UA", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "BU-4601A": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0C9RZ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Ceronapril": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05NRI", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "2-Phenylheme": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02AVZ", "drug_id_DB": "DB03906", "metabolic_annotation_str": "HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMOX1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3162"]}, "4-Sulfamoyloxy-benzoic acid cyclohexyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P9ZV", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "8-aminoguanosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FI2L", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "Physostigmine": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09JVV", "drug_id_DB": "DB00981", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "DIMETHYLSPINGOSINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M9DT", "drug_id_DB": "", "metabolic_annotation_str": "SPHK2(Sphingosine kinase 2 (SPHK2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SPHK2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["56848"]}, "Biphenyl-2-ylmethyl-(S)-pyrrolidin-3-yl-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06WIV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "6-chloro-5-(2-thienyl)pyrimidine-2,4(1H,3H)-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C0HN", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "[3H]hemicholinium-3": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05AFI", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A7(High affinity choline transporter 1 (CHT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A7"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["60482"]}, "4,5-Bis(4-methoxyphenyl)isothiazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F0JU", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "(4-sulfamoylphenylethylthioureido)fluorescein": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BM2T", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "2-(4-benzylphenoxy)ethanamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W2OP", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "5-(4-Methoxyphenyl)-4-p-tolyl-1,2-selenazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07RTV", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "2-ethylestradiol 3,17-O,O-bis-sulfamate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8VZ", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "PhyllanthoidA": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07MEE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "3-Hydroxyhippuric acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05JZS", "drug_id_DB": "", "metabolic_annotation_str": "KYNU(Kynureninase (KYNU) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["KYNU"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8942"]}, "UE-2343": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0OE5S", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Farnesol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M0CF", "drug_id_DB": "DB02509", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "IDH305": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0RZ9V", "drug_id_DB": "", "metabolic_annotation_str": "IDH1(Oxalosuccinate decarboxylase (IDH1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDH1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3417"]}, "1,4-Naphthoquinone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DQ6Z", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "N-benzylacetimidamide hydrobromide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05PZA", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "3-(4-Trifluoromethylphenyl)-2-nortropene": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05VTT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "N-Phenyl-1H-indole-2-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K9UN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "GSK931145": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07PKH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "3-(piperidin-4-yl)-2-(o-tolyloxy)pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D00FMX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "NORSTEPHALAGINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "DRD1(Dopamine D1 receptor (D1R) ,MOA:Inhibitor); ", "drug_id_TTD": "D09CVV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-(N-Pyrrolidinyl)-3'-nitropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VY9K", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "1-(pyridin-2-yl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA1D(Adrenergic receptor alpha-1D (ADRA1D) ,MOA:Inhibitor); ADRA1A(Adrenergic receptor alpha-1A (ADRA1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D07JMN", "drug_id_DB": "", "metabolic_annotation_str": "PLD1(Phospholipase D1 (PLD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5337"]}, "4-Benzythiopyridine-3-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06IOI", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "3-acetyl-11-keto-ursolic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J5RQ", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "4-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J2RI", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "Morpholino(1'H-phenothiazin-1'-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09HZE", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "DEMETHYLDEBROMOFLUSTRAMINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZWS", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "SMP-797": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02EZF", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "LY294002": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D09SFV", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "3-(2-Amino-ethyl)-5-imino-[1,4]oxazepane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07MFH", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "8-prenylapigenin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X7SR", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "SINITRODIL": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D7XW", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8654"]}, "CLR-1401": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D07MEX", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "3-(dodecylsulfonyl)-1,1,1-trifluoropropan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02SDT", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "CLR-1404": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03KHN", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "Zaragozic Acid D": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05URH", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Zaragozic Acid C": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04GSN", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Inositol 1,3,4,5-Tetrakisphosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PDPK1(3-phosphoinositide-dependent protein kinase 1); CYTH3(Cytohesin-3); AKT1(RAC-alpha serine/threonine-protein kinase); BTK(Tyrosine-protein kinase BTK); CYTH2(Cytohesin-2); PLEKHA4(Pleckstrin homology domain-containing family A member 4); DAPP1(Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide); ", "drug_id_TTD": "", "drug_id_DB": "DB01863", "metabolic_annotation_str": "ITPKA(Inositol-trisphosphate 3-kinase A); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ITPKA"], "metabolic_genes_id": ["3706"]}, "(+/-)-2-(4'-Propoxyphenyl)thiomorpholine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FXH", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "1-Adamantan-1-yl-3-phenyl-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6SS", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Ethyl 3-(pyridin-4-yl)-1H-indole-6-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZG3O", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-4-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SM4F", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "Oglemilast": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0L8KJ", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "(R)-Rolipram(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01RUN", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142"]}, "Sibutramine(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D08KVZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6530", "6532"]}, "3-phenyl-cyclosal-d4TMP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X7CW", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1-(4-Butoxy-phenyl)-1H-imidazole": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D07VHB", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "PMID7650673C4q": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4FC", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "6-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01TDC", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "7-Methoxy-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P5OF", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "5-Nitroindazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VB2W", "drug_id_DB": "DB04534", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4843"]}, "N*1*-(6-Nitro-quinolin-2-yl)-ethane-1,2-diamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N7IH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "4,4'-dihydroxyoctafluoroazobenzene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VR9L", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "N-(propargyl),N-(pyrrol-2-ylmethyl)amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G4BG", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Etamicastat": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0H5HZ", "drug_id_DB": "", "metabolic_annotation_str": "DBH(Dopamine beta hydroxylase (DBH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DBH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1621"]}, "SCOPOLETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QOR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "Huprine Y": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A0FK", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N-phenyl-1H-pyrrole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0KU2D", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Metformin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PRKAB1(5'-AMP-activated protein kinase subunit beta-1); ", "drug_id_TTD": "", "drug_id_DB": "DB00331", "metabolic_annotation_str": "GPD1(Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic); ETFDH(Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["GPD1", "ETFDH"], "metabolic_genes_id": ["2819", "2110"]}, "1,1,1,2,2,3,3-heptafluoro-8-phenyloctan-4-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UV2N", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "METHOXYUNDECYLPHOSPHINIC ACID(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04HWJ", "drug_id_DB": "", "metabolic_annotation_str": "PNLIP(Pancreatic triacylglycerol lipase (PNLIP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNLIP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5406"]}, "3,4-dihydroxybenzaldehyde-O-ethyloxime": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1MF", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Coenzyme Q10 analog": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0MM6A", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1728"]}, "4-Imidazol-1-ylmethyl-3-nitroxanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K5JU", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "UCB-35440": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "HRH1(Histamine H1 receptor (H1R) ,MOA:Modulator); ", "drug_id_TTD": "D04JIM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "NSC-126445": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X2NH", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "N2-[4-(benzyloxy)benzyl]glycinamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T6XC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Resorcinol compound 9": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RC7R", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "1-(2-(naphthalen-1-yl)-1-phenylethyl)piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J8DC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "N-(Propylamide-benzophenone)-1-deoxynojirimycin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q7SF", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2629", "2629"]}, "1-(4-methoxyphenylsulfonyl)-4-phenylazepan-4-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03KRW", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "4-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03MKT", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "5-Methyl-oxazolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05LPK", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "2-(8-Imidazol-1-yl-octyl)-isoindole-1,3-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KVN", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "Benzo[1,3]dioxol-5-ylmethyl-quinazolin-4-yl-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O3QI", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "HT-0712": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07OCV", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Eldacimibe": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0YB4D", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "6-(2-Bromo-benzenesulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9KV", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Heptulose-2-Phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9CW", "drug_id_DB": "DB04195", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Anthracen-10-yl(10H-phenothiazin-10-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00AHD", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "3-(phenoxymethyl) benzylamine derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MA7A", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "BPH-715": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X1FT", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "(+/-)-7-methoxy-2-p-tolylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02KXU", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Ethoxzolamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00311", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); CA4(Carbonic anhydrase 4); CA7(Carbonic anhydrase 7); ", "drug_status_DB": ".", "metabolic_genes_name": ["CA1", "CA2", "CA3", "CA4", "CA7"], "metabolic_genes_id": ["759", "760", "761", "762", "766"]}, "PMID15686906C29": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q6WP", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Alpha-methylcubebin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GOQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Isosorbide-2-benzylcarbamate-5-cyclopentanoate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01QRR", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Thymidine-5'-Phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZH0I", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "BIS(18)-HUPERZINE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EPB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Hydrazinoacetic acid": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0BB4J", "drug_id_DB": "", "metabolic_annotation_str": "CTH(Cystathionine gamma-lyase (CTH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1491"]}, "PMID17709461C4g": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z5BQ", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "NSC-369087": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y4TE", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "2-Cinnamamido-N1-hydroxy-N4-octylsuccinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z4NU", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "2-(1H-Imidazol-1-yl)-1-(4-nitrophenyl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08UQH", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "5-chloro-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03TPH", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "3,4-Dihydroxybenzaldehyde": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03VOJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "5-methylenearisteromycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2MS", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "3-(5,6,7,8-Tetrahydronaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VL3R", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA2C(Adrenergic receptor alpha-2C (ADRA2C) ,MOA:Inhibitor); HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D05GDP", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "GHRP-2": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D08VRX", "drug_id_DB": "", "metabolic_annotation_str": "PGD(Phosphogluconate dehydrogenase (PGD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PGD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5226"]}, "Maltose(TTD)": {"drug_status_TTD": ["Phase 1/2", "Phase 1/2", "Phase 1/2", "Phase 1/2", "Phase 1/2"], "non_metabolic": "GANAB(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_id_TTD": "D04RYY", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); GAA(Alpha-glucosidase (GLA) ,MOA:Inhibitor); GANC(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM", "GAA", "GANC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972", "2548", "2595"]}, "(+/-)-2-(4-fluorophenyl)-7-methylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04DCW", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Ethoxzolamide(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D07INV", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Modulator); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Modulator", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "1-Phenyl-2-pyridin-3-yl-propan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y2AK", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "3-Mercuri-4-Aminobenzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A2PD", "drug_id_DB": "DB04203", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "PMID26815044-Compound-49": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02SGL", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-48": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0M4EQ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PMID26815044-Compound-47": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X0RV", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Tolbutamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KCNJ1(ATP-sensitive inward rectifier potassium channel 1); ", "drug_id_TTD": "", "drug_id_DB": "DB01124", "metabolic_annotation_str": "ABCC8(ATP-binding cassette sub-family C member 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC8"], "metabolic_genes_id": ["6833"]}, "3'-(1,2,3-Triazol-1-yl)-3'-deoxy-beta-D-thymidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O7GD", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "5-Methyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D9LT", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "6-(3-Chloro-benzenesulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R7IJ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Alpha-D-Glucose-6-Phosphate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01AWD", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM", "AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5837", "231"]}, "NV-52": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D07YEK", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "1,2-bis(2,6-difluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01VCS", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "N-(2-benzyl),N-(1-methylpyrrol-2-ylmethyl)amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C9RO", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "SL125": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I0NP", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "CD-581": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0F5NB", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "6-acetyl-7-methoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05VUA", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "fasidotrilat": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MME(Neutral endopeptidase (MME) ,MOA:Inhibitor); ", "drug_id_TTD": "D04DHD", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "(6-Propoxy-2-naphthyl)-2-aminopropane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IP7L", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Benzamide derivative 19": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D04EFQ", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "Ponalrestat": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "SLC5A4(Sodium/glucose cotransporter 2 (SLC5A4) ,MOA:Blocker); ", "drug_id_TTD": "D0U9TM", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "(E)-3-(4-(4-phenoxybenzoyl)phenyl)acrylic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q4GH", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "4-(2-((dimethylamino)methyl)phenoxy)benzonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04IZU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4WB", "drug_id_DB": "DB07711", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "(5-phenylfuran-2-yl)methanamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0YQ8U", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "P-6915": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ", "drug_id_TTD": "D0QE9F", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "TVB-2640": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0K9BV", "drug_id_DB": "", "metabolic_annotation_str": "FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FASN"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2194"]}, "Avasimibe": {"drug_status_TTD": ["Discontinued in Phase 3", "Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0O1KX", "drug_id_DB": "DB06442", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Huprine-Tacrine Heterodimer": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09JCF", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "1,2-indanedione": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XGP", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "1066", "1066"]}, "INK-1117": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0S6MV", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Inhibitor); PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CA", "PIK3CB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5290", "5291"]}, "SCH-351591": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D01FXD", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "PF-4989216": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00JIV", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "7-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07TUX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "2-(4-Methyl-indole-1-sulfonyl)-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03DUX", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "2-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IF2H", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K0SA", "drug_id_DB": "DB08082", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "S-(3,4-Dichlorobenzyl)isothiourea hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P1CO", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "1-(4-Aminophenyl)-2-(1H-imidazol-1-yl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XS6T", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Betais-sulfonylamino derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07WOT", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "BW-858C": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R2MQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Amineptine(TTD)": {"drug_status_TTD": ["Withdrawn from market", "Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D08QUV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-[7-(Benzyloxy)-2-oxo-2H-chromen-4-yl]acetamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S3QN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "RWJ-67657": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D06OZJ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "3,6,9,12,15-Pentaoxaheptadecane(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02343", "metabolic_annotation_str": "ACHE(Acetylcholinesterase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ACHE"], "metabolic_genes_id": ["43"]}, "SOPHOFLAVESCENOL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00QCL", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A", "PDE4A", "PDE4B", "PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8654", "5141", "5142", "5139"]}, "Xylopyranose": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YC4O", "drug_id_DB": "", "metabolic_annotation_str": "LCT(Lactase-phlorizin hydrolase (LCT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LCT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3938"]}, "1-furan-2-yl-3-pyridin-2-yl-propenone (FPP-3)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B0XK", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "MLN1117": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0Y2NS", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5290"]}, "Pyridoxamine-5'-Phosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02142", "metabolic_annotation_str": "BCAT2(Branched-chain-amino-acid aminotransferase, mitochondrial); KYAT1(Kynurenine--oxoglutarate transaminase 1); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["BCAT2", "KYAT1"], "metabolic_genes_id": ["587", "883"]}, "2-[1,4]Diazepan-1-yl-6-nitro-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0VD4L", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "2-(Aminomethyl)-5-(2'-naphthyl)tetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09QZM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "ISA-2011B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GG9W", "drug_id_DB": "", "metabolic_annotation_str": "PIP5K1A(PtdIns(4)P-5-kinase 1 alpha (PIP5K1A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIP5K1A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8394"]}, "4-Imidazol-1-ylmethyl-2-nitroxanthen-9-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HC9U", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Mycophenolic bis(sulfonamide)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4UE", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); PPAT(Amidophosphoribosyltransferase (PPAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2", "PPAT"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3615", "5471"]}, "Allopurinol": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D04KYY", "drug_id_DB": "DB00437", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PF-06840003": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0J1HB", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K3CE", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-Chloro-4-hydrazino-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01UDU", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "LM-4108": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0QV6M", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Secondary and tertiary (hetero)arylamide derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01OGR", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Secondary and tertiary (hetero)arylamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0J7HR", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Napitane mesilate": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06KOL", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6530"]}, "Undecyl-Phosphinic Acid Butyl Ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BWD", "drug_id_DB": "DB02457", "metabolic_annotation_str": "LIPF(Gastric triacylglycerol lipase (LIPF) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPF"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8513"]}, "7-Hydroxy-6-nitro-2-phenyl-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L7MI", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "1,5-Dihydroxy-10H-anthracen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0KF", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "3-O-METHYLQUERCETIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L9EF", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "S-(N-phenyl-N-hydroxycarbamoyl)glutathione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z9WS", "drug_id_DB": "", "metabolic_annotation_str": "GLO1(Lactoylglutathione lyase (GLO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2739"]}, "4-Methyl-5-propyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05APC", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "INV-311": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01ZZG", "drug_id_DB": "", "metabolic_annotation_str": "MPO(Myeloperoxidase (MPO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MPO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4353"]}, "(8R,8'R)-4-hydroxycubebinone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B2ZB", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "[N-[2-[(3'-N'-PROPYL-3''ALPHA-(BIS(4-FLUORORPHENYL)METHOXY)TROPANE-2''BETA-CARBOXYLIC ACID METHYL ESTER)(2-MERCAPTOETHYL)AMINO]ACETYL]-2-AMINOETHANETHIOLATO]RHENIUM(V) OXIDE (DIASTEREOMERIC MIX)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WVJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "CPC-212": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0X1XK", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N-(furan-2-ylmethyl)estradiol-16-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K6MM", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "YH-4808": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03RVC", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ATP4B(Gastric H(+)/K(+) ATPase (Proton pump) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A", "ATP4B", "ATP4B"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["495", "496", "496"]}, "Beta-1-C-Butyl-1-deoxygalactonojirimycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07RRH", "drug_id_DB": "", "metabolic_annotation_str": "GLA(Alpha-galactosidase A (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2717"]}, "ODQ": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R3FS", "drug_id_DB": "", "metabolic_annotation_str": "GUCY2D(Soluble guanylyl cyclase (GUCY2D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY2D"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3000"]}, "3-(6-Amino-purin-9-yl)-8-phenyl-octan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XFT", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "NSC-292213": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JWS", "drug_id_DB": "", "metabolic_annotation_str": "ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX12", "ATIC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["239", "471"]}, "GUAIACOL": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02JUW", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "(Z)-2'-des-methyl sulindac sulfide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D6UC", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "3-(6-Amino-purin-9-yl)-4-p-tolyl-butan-2-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2OM", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Cocaine(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D04XPW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Methyl 2-(naphthalen-2-yl)benzoate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R1AE", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "DS-7309": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03MDW", "drug_id_DB": "", "metabolic_annotation_str": "GCK(Glucokinase (GCK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2645"]}, "N-9xxx": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4SI", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2936"]}, "1,9-bis(pyridinium)-nonane dibromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L5QJ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4WI", "drug_id_DB": "DB03781", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "2,4-dimethoxy-2'-hydroxychalcone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C6WN", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "N-[2-(4'-Nitrophenyl)ethyl]-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M0FE", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Haloperidol(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HTR1A(5-hydroxytryptamine receptor 1A); ADRA2A(Alpha-2A adrenergic receptor); DRD2(D(2) dopamine receptor); ADRA2B(Alpha-2B adrenergic receptor); ADRA2C(Alpha-2C adrenergic receptor); CHRM3(Muscarinic acetylcholine receptor M3); DRD1(D(1A) dopamine receptor); HTR2A(5-hydroxytryptamine receptor 2A); HTR7(5-hydroxytryptamine receptor 7); ADRA1A(Alpha-1A adrenergic receptor); HRH1(Histamine H1 receptor); HTR6(5-hydroxytryptamine receptor 6); GRIN2B(Glutamate receptor ionotropic, NMDA 2B); MCHR1(Melanin-concentrating hormone receptor 1); SIGMAR1(Sigma non-opioid intracellular receptor 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00502", "metabolic_annotation_str": "SLC18A2(Synaptic vesicular amine transporter); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["SLC18A2"], "metabolic_genes_id": ["6571"]}, "(R)(+)-7-methyl-2-p-tolylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P1YC", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "4-[4-(benzyloxy)piperidino]butyl-3-chlorobenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S3WF", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "2-Amino-indan-5-sulfonic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C4QB", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "23632"]}, "AL6528": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09LMH", "drug_id_DB": "DB04371", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Rolafagrel": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0V7GC", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "Hexane-1,6-diamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09JPC", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "762", "765", "768", "23632"]}, "Hemicholinium-3": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0JB1D", "drug_id_DB": "", "metabolic_annotation_str": "CHKA(Choline kinase (CHKA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CHKA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1119"]}, "Ethacrynic acid": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06TNL", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "6-(Benzothiazole-2-sulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02WZA", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "2-N-Ethylamino-1-(4-methylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SA1G", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Resveratrol Potassium4,-Sulfate": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JZY", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "NOS2", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "4843", "5743"]}, "3-(2-Nitro-ethyl)-[1,4]oxazepan-(5Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LB9U", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "(S)(+)-7-fluoro-2-p-tolylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00PJT", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Mallotinic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05UWZ", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "Oleanonic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "PTPN1(PTPN1 messenger RNA (PTPN1 mRNA) ,MOA:Inhibitor); ", "drug_id_TTD": "D02KKU", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Thalidomide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); TNF(Tumor necrosis factor); ORM2(Alpha-1-acid glycoprotein 2); NFKB1(Nuclear factor NF-kappa-B p105 subunit); FGFR2(Fibroblast growth factor receptor 2); CRBN(Protein cereblon); ", "drug_id_TTD": "", "drug_id_DB": "DB01041", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS2"], "metabolic_genes_id": ["5743"]}, "Aminophylline": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03TYI", "drug_id_DB": "DB01223", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "Lumacaftor": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0X0CB", "drug_id_DB": "DB09280", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Regulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Regulator"], "metabolic_genes_id": ["1080"]}, "6-Methoxy-4,9-dihydro-3H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C7PD", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "N-Benzylmethylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1WF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "3-(decylsulfinyl)-1,1,1-trifluoropropan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VKB", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "(S)-2-Amino-4-methylsulfanyl-butane-1-thiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GI9S", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Menadione(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03GET", "drug_id_DB": "", "metabolic_annotation_str": "AOX1(Aldehyde oxidase (AOX1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AOX1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["316"]}, "4-amino-N-(4-chlorophenyl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02DYG", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "6-(4-Bromo-benzenesulfonyl)-2H-pyridazin-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y7PW", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "NA-808": {"drug_status_TTD": ["Preclinical", "Preclinical", "Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0Q7JJ", "drug_id_DB": "", "metabolic_annotation_str": "SPTLC1(Serine palmitoyltransferase (SPTC) ,MOA:Modulator); SPTLC2(Serine palmitoyltransferase (SPTC) ,MOA:Modulator); SPTLC3(Serine palmitoyltransferase (SPTC) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SPTLC1", "SPTLC2", "SPTLC3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["10558", "9517", "55304"]}, "Cis-2-phenylcyclopropylamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X8RN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Chloroprocaine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07NAJ", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium pump subunit alpha-1 (ATP1A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["476"]}, "PMID25399762-Compound-Table1-C8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0GY4F", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(Z)-3-[2-(9H-fluoren-2-yloxy)ethylidene]-quinuclidine hydrochloride 31": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ABI", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "4-methyl-6-propylpyridin-2-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TMX", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "PIK-75": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "PRKDC(DNA-dependent protein kinase catalytic (PRKDC) ,MOA:Inhibitor); ", "drug_id_TTD": "D00HSJ", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Inhibitor); PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB", "PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5291", "5294"]}, "Beta-1-C-butenyl-1-deoxygalactonojirimycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RU5N", "drug_id_DB": "", "metabolic_annotation_str": "GLA(Alpha-galactosidase A (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2717"]}, "LY3381916": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0C4PB", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3-(naphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FAB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "MIF(Macrophage migration inhibitory factor (MIF) ,MOA:Inhibitor); MIF(Macrophage migration inhibitory factor (MIF) ,MOA:Inhibitor); ", "drug_id_TTD": "D0A6HS", "drug_id_DB": "DB08765", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Gavilimomab": {"drug_status_TTD": ["Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D03RDQ", "drug_id_DB": "", "metabolic_annotation_str": "BSG(Basigin (BSG) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["BSG"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["682"]}, "3,9-dihydroxy-2,10-diprenylpterocap-6a-ene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H1JX", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "ANG-3407": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M1YW", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "1,5-Dideoxy-1,5-imino-D-xylitol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R8TR", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2629", "2629"]}, "6-Azido-8-(3-iodo-phenyl)-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04XRV", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "POLYGALATENOSIDE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V9SV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "4-Methyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7NS", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "1-(4-aminosulfonylphenyl)-2-(2-pyridyl)acetylene": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V9AU", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "MOR-202": {"drug_status_TTD": ["Phase 1/2"], "non_metabolic": "", "drug_id_TTD": "D0O4IN", "drug_id_DB": "", "metabolic_annotation_str": "CD38(Cyclic ADP-ribose hydrolase 1 (CD38) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["CD38"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["952"]}, "4-(Hydroxymercury)Benzoic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07QHM", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "4-(benzylideneamino)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S2II", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "5743"]}, "2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05BMD", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "SB-202235": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z0ZM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Phlorizin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06WAL", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6523"]}, "Spiroglumide": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "CCKBR(Gastrin/cholecystokinin type B receptor (CCKBR) ,MOA:Antagonist); ", "drug_id_TTD": "D04KHY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "6s-5,6,7,8-Tetrahydrobiopterin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03EBE", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "Ibandronate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00710", "metabolic_annotation_str": "GGPS1(Geranylgeranyl pyrophosphate synthase); FDPS(Farnesyl pyrophosphate synthase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["GGPS1", "FDPS"], "metabolic_genes_id": ["9453", "2224"]}, "1-Methyl-5-(4-phenylazo-phenyl)-piperidin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09KZA", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "4-Ethoxy-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04VSP", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "ASP-4901": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0BT7R", "drug_id_DB": "", "metabolic_annotation_str": "PDE9A(Phosphodiesterase 9 (PDE9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE9A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5152"]}, "4-methoxynaphthalen-1-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z4JG", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "BMN-701": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D05JEG", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2548"]}, "Lesinurad(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0C3SW", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["116085"]}, "Adamantan-1-yl-(4-ethyl-piperazin-1-yl)-methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09KDS", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "N-benzyl-N-isobutylpiperidin-4-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D8YY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "6-phenyl-3-(pyridin-4-yl)-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02YMQ", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "Dasotraline": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0W6KM", "drug_id_DB": "DB12305", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Exiguamine A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MC4U", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "KF-66490": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E5VP", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7WE", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "3-(3-methoxyphenyl)-6-methyl-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O1GE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "1-(9H-fluoren-9-yl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07TIJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1-hydroxy-3-(4-nitrophenyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VQZ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "PITAVASTATIN CALCIUM": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0G1WL", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "PX-867": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0T5IN", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5294"]}, "PX-866": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0AW5T", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "1-(4-(methylsulfonyl)phenyl)-3-p-tolylurea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7BP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "2-ethyl-3-(4-hydroxy) benzoyl benzofuran derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03PZX", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "EUSYNSTYELAMIDE B": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06BCG", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "Aromatic hydrazine carboxyimidoamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07DFC", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Aromatic hydrazine carboxyimidoamide derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UT0X", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Aromatic hydrazine carboxyimidoamide derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0P0PT", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Aromatic hydrazine carboxyimidoamide derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05XAH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Aromatic hydrazine carboxyimidoamide derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03BRP", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Aromatic hydrazine carboxyimidoamide derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02EGY", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Atorvastatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01QIN", "drug_id_DB": "DB01076", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Saliphenylhalamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K1UF", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["495"]}, "7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C9WW", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Isofagomine tartrate": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04BQV", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2629", "2629"]}, "3-Hydroxy-7-(3-hydroxyphenyl)-1-naphthonitrile": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D1KA", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "VAGANINE D": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N4QQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "RS-1636": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4GD", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "K-103-IP": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0R4OI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "4-(3-fluoro-2-phenoxyphenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D09IIH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "PMID27841045-Compound-133": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0AU8E", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PMID27841045-Compound-132": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0B5QZ", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PMID27841045-Compound-131": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0GQ0V", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "Stannsoporfin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04912", "metabolic_annotation_str": "HMOX1(Heme oxygenase 1); HMOX2(Heme oxygenase 2); HMOX2(Heme oxygenase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["HMOX1", "HMOX2", "HMOX2"], "metabolic_genes_id": ["3162", "3163", "3163"]}, "PMID27841045-Compound-137": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07TTT", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PMID27841045-Compound-136": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QY4O", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "PMID27841045-Compound-135": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0YX0S", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "2-(tert-butylamino)-1-(3-chlorophenyl)butan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R8EV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "1-deoxygalactonojirimycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A0UR", "drug_id_DB": "", "metabolic_annotation_str": "GLA(Alpha-galactosidase A (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2717"]}, "T-226293": {"drug_status_TTD": ["Preclinical", "Preclinical"], "non_metabolic": "MCHR1(Melanin-concentrating hormone receptor 1 (MCHR1) ,MOA:Antagonist); ", "drug_id_TTD": "D0K6NS", "drug_id_DB": "", "metabolic_annotation_str": "DHCR24(Delta(24)-sterol reductase (DHCR24) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DHCR24"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1718"]}, "BC11-38": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03QTH", "drug_id_DB": "", "metabolic_annotation_str": "PDE11A(Phosphodiesterase 11A (PDE11A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE11A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["50940"]}, "CBT-1": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D06XVF", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5243"]}, "biochanin A": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S9YX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); FASN(Fatty acid synthase (FASN) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "FASN"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "2194"]}, "Enzastaurin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CHEK1(Serine/threonine-protein kinase Chk1); CHEK2(Serine/threonine-protein kinase Chk2); PRKCB(Protein kinase C beta type); AKT1(RAC-alpha serine/threonine-protein kinase); AURKB(Aurora kinase B); CDK15(Cyclin-dependent kinase 15); ", "drug_id_TTD": "", "drug_id_DB": "DB06486", "metabolic_annotation_str": "PIK3R1(Phosphatidylinositol 3-kinase regulatory subunit alpha); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PIK3R1"], "metabolic_genes_id": ["5295"]}, "BL-1021": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0FM7Z", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6530", "6532"]}, "Trimethoprim": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0AO5H", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1719"]}, "4,5,6,7-tetrafluoro-3-perfluorophenyl-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8TM", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "3alpha-(bis-chloro-phenylmethoxy)tropane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CHRM1(Muscarinic acetylcholine receptor M1 (CHRM1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0F0BS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Diamine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01QYA", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(S)(+)-7-methyl-2-phenylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N4DR", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "N1-(4-chlorobenzyl)-2-benzyl-N3-hydroxymalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01LFP", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "Superoxide dismutase": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05RTV", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "Venglustat": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07WEN", "drug_id_DB": "", "metabolic_annotation_str": "UGCG(Ceramide glucosyltransferase (UGCG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UGCG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7357"]}, "2-methoxyphenyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05DIN", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "ATR-101": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0MB2Z", "drug_id_DB": "", "metabolic_annotation_str": "SOAT2(Sterol O-acyltransferase (SOAT) ,MOA:Modulator); SOAT1(Sterol O-acyltransferase (SOAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOAT2", "SOAT1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8435", "6646"]}, "KC-11425": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "PTAFR(Platelet-activating factor receptor (PTAFR) ,MOA:Antagonist); ", "drug_id_TTD": "D01LXG", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Antagonist); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Antagonist", "Antagonist"], "metabolic_genes_id": ["240", "240"]}, "3-Ethyl-[1,4]thiazepan-(5E)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09NRX", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "ACACETIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NS1S", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "XDH", "CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "7498", "1545"]}, "ORG 34517/34850": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "NR3C1(Glucocorticoid receptor (NR3C1) ,MOA:Antagonist); ", "drug_id_TTD": "D0E2WF", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "3-(2-N-Pyrrolyl-acetamino)-rutaecarpine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LT0T", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "4-Hydroxy-4-phenyl-but-2-enoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CQQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC52A2", "SLC52A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["79581", "79581"]}, "Biphenyl derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0OZ8W", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "N-n-nonyl-7-methoxytacrine hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H2UG", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Meclofenamic acid(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D08IFL", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "AMG 151": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D07JHK", "drug_id_DB": "", "metabolic_annotation_str": "GCK(Glucokinase (GCK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2645"]}, "PYROVALERONE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ICX", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Bip-tyr-ala-pro-lys-thr(obzl)-gly": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U6PD", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "5-Chloro-N-(4-ethylphenyl)benzo[d]oxazol-2-amine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U9UL", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-fluorobenzaldehyde O-benzoyloxime": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6UV", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase (PLA2G7) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G7"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7941"]}, "Wortmannin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PLK1(Serine/threonine-protein kinase PLK1); ", "drug_id_TTD": "", "drug_id_DB": "DB08059", "metabolic_annotation_str": "PIK3R1(Phosphatidylinositol 3-kinase regulatory subunit alpha); PIK3CA(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform); PIK3CG(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PIK3R1", "PIK3CA", "PIK3CG"], "metabolic_genes_id": ["5295", "5290", "5294"]}, "1-(benzofuran-2-yl)-3-aza-bicyclo[3.1.0]hexane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03BUG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Imidazole derivative 11": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0IA4F", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "diphosphoglycolyl proline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SPH", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "BW-1370U87": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0E8UJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "16-(4-dimethylamino-benzylidene)-estradiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HR7O", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "INDOPROFEN": {"drug_status_TTD": ["Withdrawn from market", "Withdrawn from market", "Withdrawn from market", "Withdrawn from market", "Withdrawn from market"], "non_metabolic": "CXCR1(C-X-C chemokine receptor type 1 (CXCR1) ,MOA:Inhibitor); CXCR2(C-X-C chemokine receptor type 2 (CXCR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Q5PL", "drug_id_DB": "", "metabolic_annotation_str": "FABP1(Fatty acid-binding protein 1 (FABP1) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP1", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2168", "5742", "5743"]}, "4-AMBA": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S3VV", "drug_id_DB": "", "metabolic_annotation_str": "SLC15A1(Solute carrier family 15 member 1 (SLC15A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC15A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6564"]}, "Trans-3-(o-tolyloxy)-2,3-dihydro-1H-inden-1-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8BJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "TRISMETHOXYRESVERATROL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "ABL1(Tyrosine-protein kinase ABL1 (ABL) ,MOA:Inhibitor); ", "drug_id_TTD": "D0O9NE", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1", "CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5243", "1545"]}, "(S)-N2-{4-[(4-nitrobenzyl)oxy]benzyl}serinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GCE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "PRONTOCIL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SV6C", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "PMID29473428-Compound-60": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K4KM", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "BMS-816336": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08VSQ", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "Boswellia acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RM0U", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "3-[5-(4-hydroxyphenyl)-1,3-oxazol-2-yl]phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0EL1Y", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "N,N'-(1',5'-pentylene)-bis-(-)-nor-MEP": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A8OX", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "AL7099A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XX9C", "drug_id_DB": "DB03221", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "GT-16-239": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0YQ9G", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["3156"]}, "Fluvoxamine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03HFG", "drug_id_DB": "DB00176", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "LITOXETINE": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D07AHC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "SNAP-5114": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H7WK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A11(Gamma-aminobutyric acid transporter 4 (SLC6A11) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A11"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6538"]}, "Eniluracil(TTD)": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09QOR", "drug_id_DB": "", "metabolic_annotation_str": "DPYD(Dihydrothymine dehydrogenase (DPYD) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DPYD"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1806"]}, "Iobenguane I-123": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02JIS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "3,3'-(1,3-Thiazol-2,4-diyl)diphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T6WL", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "2-Morpholin-4-yl-8-phenylethynyl-chromen-4-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W3RR", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A", "PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5138", "5139"]}, "4-(2-AMINOETHYL)BENZENESULFONAMIDE(TTD)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04NSN", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "768", "23632"]}, "4-Isopropyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KOE", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D00PYW", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "(RS)-tacrine(10)-hupyridone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09FAU", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "S-Oxy Cysteine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "PREP(Prolyl endopeptidase (PREP) ,MOA:Inhibitor); ", "drug_id_TTD": "D02XCE", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6647"]}, "Petrosamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M9JF", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "PMID18800762C47": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TK4X", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "1,4-dideoxy-1,4-imino-D-arabinito": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GS0O", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "S-34324": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA2C(Adrenergic receptor alpha-2C (ADRA2C) ,MOA:Inhibitor); ", "drug_id_TTD": "D0FU5E", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "3-(4-Amino-phenyl)-pyrrolidine-2,5-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H1LK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Terpyridineplatinum(II) complexe 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0E0EF", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Terpyridineplatinum(II) complexe 4": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D05SHW", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR", "TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2936", "7296"]}, "Terpyridineplatinum(II) complexe 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K8NP", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Terpyridineplatinum(II) complexe 3": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D03BPZ", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR", "TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2936", "7296"]}, "Terpyridineplatinum(II) complexe 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RE1D", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "Licofelone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB04725", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); PTGS2(Prostaglandin G/H synthase 2); PLA2G2E(Group IIE secretory phospholipase A2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS2", "PLA2G2E"], "metabolic_genes_id": ["240", "240", "5743", "30814"]}, "Sulfamoylamide derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0F3VN", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Edrophonium(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01010", "metabolic_annotation_str": "BCHE(Cholinesterase); ACHE(Acetylcholinesterase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_genes_id": ["590", "43"]}, "4-[2-(3,5-Dimethoxy-phenyl)-vinyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9IK", "drug_id_DB": "", "metabolic_annotation_str": "CYP1B1(Cytochrome P450 1B1 (CYP1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1545"]}, "2-BFi": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA2C(Adrenergic receptor alpha-2C (ADRA2C) ,MOA:Inhibitor); ", "drug_id_TTD": "D0LI3J", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Valbenazine Tosylate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0JJ7S", "drug_id_DB": "", "metabolic_annotation_str": "SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC18A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6571"]}, "EGT-0001474": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08OUL", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "PF-3463275": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0O0BM", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6536"]}, "Polycyclic compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0U9LS", "drug_id_DB": "", "metabolic_annotation_str": "PTGES(Prostaglandin E synthase (PTGES) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGES"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9536"]}, "(2-bromophenyl)difluoromethanesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JIN", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "(+/-)-2-Amino-1,2,3,4-tetrahydro-2-naphthoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01BCL", "drug_id_DB": "", "metabolic_annotation_str": "SLC7A5(Large neutral amino acids transporter 1 (SLC7A5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC7A5"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8140"]}, "1-phenyl-3-(phenylsulfonyl)propan-1-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04KAZ", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "GSK-1362885": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0AL0S", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Myophosphorylase (PYGM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5837"]}, "Empagliflozin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06ALD", "drug_id_DB": "DB09038", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "NXN-188": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "HTR1D(5-HT 1D receptor (HTR1D) ,MOA:Modulator); HTR1B(5-HT 1B receptor (HTR1B) ,MOA:Modulator); ", "drug_id_TTD": "D0O2XJ", "drug_id_DB": "DB06096", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "N-butylresorcinol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M2EN", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "EM-1424": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZR1V", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "5-hydroxy-L-tryptophan": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BNS", "drug_id_DB": "", "metabolic_annotation_str": "SLC36A2(Solute carrier family 36 member 2 (SLC36A2) ,MOA:Inhibitor); SLC36A1(Solute carrier family 36 member 1 (SLC36A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC36A2", "SLC36A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["153201", "206358"]}, "6-Imidazol-1-yl-3,4-dihydro-1H-quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04KDB", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "4-(N-Methyl-hydrazino)-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M7VN", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760"]}, "KF24345": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08GKT", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2030"]}, "4-ISOPROPYLPHENSERINE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O2OH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06HFV", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "4,6-dichloro-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04EXR", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "ISIS 191761": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I4JB", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["8694", "8694"]}, "ABBV-2222": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01DGZ", "drug_id_DB": "", "metabolic_annotation_str": "CFTR(cAMP-dependent chloride channel (CFTR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CFTR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1080"]}, "Trans-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07WFU", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Chlorpheniramine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HRH1(Histamine H1 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01114", "metabolic_annotation_str": "SLC6A2(Sodium-dependent noradrenaline transporter); SLC6A4(Sodium-dependent serotonin transporter); SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "1-(1-Benzo[b]thiophen-2-yl-cycloheptyl)-azepane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E8FG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "PMID2153213C13b": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06BIF", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "N-(naphthalen-2-yl)benzo[d]isoxazol-3-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z0XL", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "PMID2153213C13g": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09TKN", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "(-)-clusin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09VMS", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "TEFLUDAZINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01OGZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Tolbutamide(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D06OIV", "drug_id_DB": "", "metabolic_annotation_str": "ABCC9(ATP-binding cassette transporter C9 (ABCC9) ,MOA:Blocker); ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC9", "ABCC8"], "metabolic_mechanism_of_action": ["Blocker", "Blocker"], "metabolic_genes_id": ["10060", "6833"]}, "Midismase": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09IUR", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6647"]}, "PMID8246233C35": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NJ5U", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "4-[(3'-Hydroxybiphenyl-4-yl)methyl]pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I1YH", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588", "1584"]}, "LCQ908": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0F1CE", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Modulator); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8694", "8694"]}, "Elaidoylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "HTR7(5-HT 7 receptor (HTR7) ,MOA:Modulator (allosteric modulator)); ", "drug_id_TTD": "D03AHJ", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5320"]}, "4-(3,4,5-Trimethoxyphenethyl)aniline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04HVL", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "6-Nitro-2-piperazin-1-yl-4-vinyl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4FO", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "MMDA(TTD)": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I4ME", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Antagonist); SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Antagonist); SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC18A2(Synaptic vesicle amine transporter (SLC18A2) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "SLC6A2", "MAOB", "SLC6A4", "SLC6A3", "SLC6A3", "SLC18A2"], "metabolic_mechanism_of_action": ["Antagonist", "Modulator", "Antagonist", "Modulator", "Modulator", "Modulator", "Antagonist"], "metabolic_genes_id": ["4128", "6530", "4129", "6532", "6531", "6531", "6571"]}, "Meclofenamic acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "KCNQ3(Potassium voltage-gated channel subfamily KQT member 3); KCNQ2(Potassium voltage-gated channel subfamily KQT member 2); KCNQ2(Potassium voltage-gated channel subfamily KQT member 2); ", "drug_id_TTD": "", "drug_id_DB": "DB00939", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "5-fluoro-6-[(2-aminoimidazol-1-yl)methyl]uracil": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01DAQ", "drug_id_DB": "", "metabolic_annotation_str": "TYMP(Thymidine phosphorylase (TYMP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYMP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1890"]}, "1-(1-(pyrazin-2-yl)ethylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HS3M", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "4-Hydroxy-piperidine-3-carboxylic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ER1G", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A1(GABA transporter GAT-1 (SLC6A1) ,MOA:Inhibitor); SLC6A11(GABA transporter-3 (SLC6A11) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A1", "SLC6A11"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6529", "6538"]}, "Polyestradiol Phosphate": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D03DXN", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6715", "79644"]}, "(-)-hydroxycitrate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IC1N", "drug_id_DB": "", "metabolic_annotation_str": "ACLY(ATP-citrate synthase (ACLY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACLY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["47"]}, "PBI-05204": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0A4YK", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1A3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1A2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1", "ATP1B1", "ATP1A3", "ATP1B2", "ATP1A2", "ATP1B3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["476", "481", "478", "482", "477", "483"]}, "[14C]histidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "SLC15A3(Solute carrier family 15 member 3 (SLC15A3) ,MOA:Modulator); SLC15A4(Solute carrier family 15 member 4 (SLC15A4) ,MOA:Modulator); ", "drug_id_TTD": "D0XT2X", "drug_id_DB": "", "metabolic_annotation_str": "SLC38A5(Solute carrier family 38 member 5 (SLC38A5) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC38A5"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["92745"]}, "Acetyl CoA carboxylase inhibitors": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01PNV", "drug_id_DB": "", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "BMN-103": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V3WN", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8972", "8972"]}, "Isoxyl": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0I8CA", "drug_id_DB": "", "metabolic_annotation_str": "SCD(Acyl-CoA desaturase (SCD) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["SCD"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["6319"]}, "Dimethylnordihydroguarierate acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I6ZS", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "Digitoxin(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved", "Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0M3QP", "drug_id_DB": "", "metabolic_annotation_str": "ATP1A1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B1(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1A3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1A2(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ATP1B3(Sodium/potassium-transporting ATPase (SPT ATPase) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP1A1", "ATP1B1", "ATP1A3", "ATP1B2", "ATP1A2", "ATP1B3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["476", "481", "478", "482", "477", "483"]}, "1614235 + 2330672": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0D2WX", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Modulator); SLC10A2(Ileal sodium/bile acid cotransporter (SLC10A2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC10A2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6523", "6555"]}, "AVE-2268": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0B6QZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(Sodium/glucose cotransporter 2 (SGLT2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6524"]}, "Ibuprofen(TTD)": {"drug_status_TTD": ["Approved", "Approved", "Approved", "Approved"], "non_metabolic": "CXCL8(Interleukin-8 (IL8) ,MOA:Inhibitor); CXCR1(C-X-C chemokine receptor type 1 (CXCR1) ,MOA:Inhibitor); CXCR2(C-X-C chemokine receptor type 2 (CXCR2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0R1QE", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Lactol derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CM4R", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Alpha-acarviosinyl-(1-->7)-3-alpha-D-glucopyranosylpropen": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A5MA", "drug_id_DB": "", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["279"]}, "5-cyclohexyl-1,3,4-oxadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q6UT", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "9-(3-aminopropoxy)-7H-furo[3,2-g]chromen-7-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U9VX", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "7-Fluoro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GTN", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "4-(Isopropylamino)-1-naphthol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S1FF", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Vestronidase alfa": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0OY4K", "drug_id_DB": "", "metabolic_annotation_str": "GUSB(Beta-glucuronidase (GUSB) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUSB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2990"]}, "Phenacetin": {"drug_status_TTD": ["Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D0O2IE", "drug_id_DB": "DB03783", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Anamorelin": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "GANAB(Alpha-glucosidase (GLA) ,MOA:Modulator); ", "drug_id_TTD": "D03WAU", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Alpha-glucosidase (GLA) ,MOA:Modulator); GANC(Alpha-glucosidase (GLA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA", "GANC"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["2548", "2595"]}, "1,2-bis(4-fluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DW9J", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "RWJ-416457": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0I9LO", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Verdoheme": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06UNX", "drug_id_DB": "DB04803", "metabolic_annotation_str": "HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMOX1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3162"]}, "TRACIZOLINE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "ADRA2A(Adrenergic receptor alpha-2A (ADRA2A) ,MOA:Inhibitor); ADRA2B(Adrenergic receptor alpha-2B (ADRA2B) ,MOA:Inhibitor); ADRA2C(Adrenergic receptor alpha-2C (ADRA2C) ,MOA:Inhibitor); ", "drug_id_TTD": "D09BIV", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "SC-58125": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D07TZM", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "2-(2-methoxyphenoxy)-3-(piperidin-4-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0KT2M", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "(+/-)-threo-N-(3-Chlorobenzyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01EOU", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Benazepril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0U3EC", "drug_id_DB": "DB00542", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "BPH-676": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4NK", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "5-Pyridin-3-yl-2,3-dihydro-1H-inden-1-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G9WP", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "Azole benzene derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0VY5N", "drug_id_DB": "", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "CMI-977": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04TCU", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Clofarabine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "POLA1(DNA polymerase alpha catalytic subunit); ", "drug_id_TTD": "", "drug_id_DB": "DB00631", "metabolic_annotation_str": "RRM1(Ribonucleoside-diphosphate reductase large subunit); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["RRM1"], "metabolic_genes_id": ["6240"]}, "T863": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D02NRD", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "Beta-L-fucose": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08QQR", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0B0LC", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "RWJ-63556": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D08JKK", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["240", "240", "5743"]}, "4-[4-(benzyloxy)piperidino]butyl-4-nitrobenzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y2TE", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "D-7193": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0L7OY", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "ARACHIDONYL TRIFLUOROMETHYLKETONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J8TY", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "Levamisole(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0CF2Q", "drug_id_DB": "", "metabolic_annotation_str": "ALPL(Alkaline phosphatase tissue-nonspecific (ALPL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALPL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["249"]}, "4-(2-fluoro-6-phenoxyphenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR1A(5-HT 1A receptor (HTR1A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0E6PQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "1,2-Diacetoxylycorine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02TKC", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "Huperaine A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07DFF", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "(South)-Methanocarba-Thymidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07OOW", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "Eltenac": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0JF6O", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Methyl 2-(Diallylamino)-1H-indole-3-carboxylate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SS4S", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "3-(phenoxymethyl)-5H-indeno[1,2-c]pyridazin-5-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I6GH", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "S-Ethylisothiourea(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02234", "metabolic_annotation_str": "NOS3(Nitric oxide synthase, endothelial); NOS2(Nitric oxide synthase, inducible); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["NOS3", "NOS2"], "metabolic_genes_id": ["4846", "4843"]}, "WIN-35066-2": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G5RH", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "4-(5-(4-Hydroxyphenyl)isothiazol-4-yl)phenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00VHS", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Dipyridamole(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0F9GE", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8654"]}, "RESORCINOL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02DBP", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA2", "PTGS1", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "760", "5742", "23632"]}, "GW-406381": {"drug_status_TTD": ["Discontinued in Phase 3"], "non_metabolic": "", "drug_id_TTD": "D00RSK", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "1-(but-2-ylamino)ethyl 1,I-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ZMS", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "LIDOFLAZINE": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0L7VL", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A1(Solute carrier family 29 member 1 (SLC29A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2030"]}, "4-Amino-3-bromo-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P6AM", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "(+/-)-threo-N-(3-Phenylpropyl)methylphenidate": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YD9W", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Eptastigmine": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D01LYX", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "N-Methylnaloxonium": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06ZPI", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Plecanatide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB13170", "metabolic_annotation_str": "GUCY1A2(Guanylate cyclase soluble subunit alpha-2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["GUCY1A2"], "metabolic_genes_id": ["2977"]}, "TA-7906": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02POH", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "Purin-6-one derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0K3QR", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "4,6-Dideoxyglucose": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "GANAB(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_id_TTD": "D0IT1M", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Alpha-glucosidase (GLA) ,MOA:Inhibitor); GANC(Alpha-glucosidase (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA", "GANC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2548", "2595"]}, "Radiosensitizer gene therapy": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0X4NF", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "3-chlorophenyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZZU", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Pravastatin": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D02RQU", "drug_id_DB": "DB00175", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Ularitide": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0L5WD", "drug_id_DB": "DB05034", "metabolic_annotation_str": "NPR1(Atrial natriuretic peptide receptor A (NPR1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["NPR1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4881"]}, "AP-2238": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S2DW", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "HYRTIOSULAWESINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YD6H", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "A-76202M": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0H9SF", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8972", "8972"]}, "3,4-bis(3,4-dimethoxyphenyl)furan-2(5H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JKK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Benzimidazole derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0MT3J", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Threo-1-aza-5-phenyl[4.4.0]decane hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TE5Q", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Benzimidazole derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00JQA", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0HR8H", "drug_id_DB": "", "metabolic_annotation_str": "DPYD(Dihydrothymine dehydrogenase (DPYD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DPYD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1806"]}, "2-(2,3-bis(2-chlorobenzyloxy)phenyl)acetic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08KLL", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0FY1W", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7083"]}, "Monoamine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02TIY", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Ethyl 2beta-hydroxyolean-12-en-28-oate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08VUO", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Monoamine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03KNZ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Monoamine derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X5VH", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Monoamine derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SD9L", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Montelukast(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "CYSLTR1(Cysteinyl leukotriene receptor 1); ", "drug_id_TTD": "", "drug_id_DB": "DB00471", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_genes_id": ["240", "240"]}, "Halisulfate 1": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M9VY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "4-Bromo-1-imidazol-1-ylmethyl-xanthen-9-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07IQG", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588"]}, "(R/S)-2-((4-benzylphenoxy)methyl)piperidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZJS", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "1-adamantan-1-yl-3-(2-hydroxyethyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J0YB", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "4-chloro-1H-indazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07GEN", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "Pegvaliase": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0T8HZ", "drug_id_DB": "", "metabolic_annotation_str": "PAH(Phenylalanine hydroxylase (PAH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PAH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5053"]}, "2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0M0KX", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565", "3292"]}, "Diclofenac": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0TG1H", "drug_id_DB": "DB00586", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "1-Benzo[b]thiophen-2-yl-cycloheptylamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U3PC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "ETC-1002": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0D9NY", "drug_id_DB": "", "metabolic_annotation_str": "ACLY(ATP-citrate synthase (ACLY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACLY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["47"]}, "3-sal-cyclosal-d4TMP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0ED", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "ALD-401": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D8SN", "drug_id_DB": "", "metabolic_annotation_str": "ALDH2(Mitochondrial aldehyde dehydrogenase (ALDH2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["217"]}, "N-(naphthylamino)-benzoate derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0M6LX", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor. Antagonist. Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor; Antagonist; Blocker"], "metabolic_genes_id": ["8644"]}, "Acerogenin C": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M8VV", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6524"]}, "Acerogenin A": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GXT", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6523"]}, "PF-05175157": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D03KHO", "drug_id_DB": "", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "PDE4 inhibitors, GlaxoSmithKline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QUD", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142", "5144"]}, "O-DESMETHYL TRAMADOL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "OPRM1(Opioid receptor mu (MOP) ,MOA:Inhibitor); OPRD1(Opioid receptor delta (OPRD1) ,MOA:Inhibitor); OPRK1(Opioid receptor kappa (OPRK1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0D5QV", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "TZI-41127": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SQY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "1,2,6-tri-O-galloyl-beta-D-glucose": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07WLU", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "5'-(N-ethyl-N-isopropyl)amiloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V5NZ", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "Haloxysterol C": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E0LL", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Haloxysterol D": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09MCN", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "US20160326143, 28": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0CT4T", "drug_id_DB": "", "metabolic_annotation_str": "LTC4S(Leukotriene C4 synthase (LTC4S) ,MOA:Inhibitor); LTC4S(Leukotriene C4 synthase (LTC4S) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTC4S", "LTC4S"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4056", "4056"]}, "PIRITREXIM": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D09AYQ", "drug_id_DB": "", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase (DHFR) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["DHFR"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1719"]}, "NW-1772": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OW5Y", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Pyrido[2,3-d]pyrimidine-2,4-diamine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0OC1S", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "13-(N-Methyl-n-heptnamido)tridec-8(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01CGC", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "SPR-210": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0E6LC", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "EM-1745": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W5CR", "drug_id_DB": "DB02323", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Intravenous glibenclamide": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "TRPM4(Long transient receptor potential channel 4 (TRPM4) ,MOA:Inhibitor); ", "drug_id_TTD": "D0E2DO", "drug_id_DB": "", "metabolic_annotation_str": "ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC8"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6833"]}, "PMID7932551C9": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K1MB", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Etomoxir": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D00UEQ", "drug_id_DB": "", "metabolic_annotation_str": "CPT1B(Carnitine O-palmitoyltransferase I (CPT1B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CPT1B"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1375"]}, "5-fluoro-6-azido-UMP": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08OFS", "drug_id_DB": "", "metabolic_annotation_str": "UMPS(Orotidine 5'-monophosphate decarboxylase (UMPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["UMPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7372"]}, "1-Butyl-3-methyl-3,7-dihydro-purine-2,6-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00JBC", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4D(Phosphodiesterase 4D (PDE4D) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4D"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5144"]}, "Mitotane(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ESR1(Estrogen receptor); PGR(Progesterone receptor); FDX1(Adrenodoxin, mitochondrial); AR(Androgen receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00648", "metabolic_annotation_str": "CYP11B1(Cytochrome P450 11B1, mitochondrial); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CYP11B1"], "metabolic_genes_id": ["1584"]}, "2-(2-Methylpropanoyl)-1,3,5-benzenetriol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R1UO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "2-(3-hydroxyphenyl)-7-methoxychroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B8PE", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Guanosine-5'-Monophosphate(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HINT1(Histidine triad nucleotide-binding protein 1); DLG4(Disks large homolog 4); TGM3(Protein-glutamine gamma-glutamyltransferase E); ", "drug_id_TTD": "", "drug_id_DB": "DB01972", "metabolic_annotation_str": "PDE5A(cGMP-specific 3',5'-cyclic phosphodiesterase); ATIC(Bifunctional purine biosynthesis protein PURH); GMPR(GMP reductase 1); GUK1(Guanylate kinase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PDE5A", "ATIC", "GMPR", "GUK1"], "metabolic_genes_id": ["8654", "471", "2766", "2987"]}, "XGP-110": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N8TM", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "EHNA": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ZHQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A", "ADA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5138", "100"]}, "7-Ethoxy-1,3-dihydro-imidazo[4,5-b]quinolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DX3V", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "N-((1H-indol-2-yl)methyl)-2-phenylethanamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y0LQ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "(Hydroxyethyloxy)Tri(Ethyloxy)Octane(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "RHO(Rhodopsin); ", "drug_id_TTD": "", "drug_id_DB": "DB04233", "metabolic_annotation_str": "CLPS(Colipase); PNLIP(Pancreatic triacylglycerol lipase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["CLPS", "PNLIP"], "metabolic_genes_id": ["1208", "5406"]}, "PF-4181366": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06NIT", "drug_id_DB": "", "metabolic_annotation_str": "PDE9A(Phosphodiesterase 9 (PDE9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE9A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5152"]}, "2'-Nitro-biphenyl-4-carboxylic acid hydroxyamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0PD7X", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "6-(aminomethyl)-2H-chromen-2-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N1AW", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "768", "23632"]}, "2-morpholino-7-phenyl-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MJ1L", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "GS-9901": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0U5PT", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "6-methoxy-2,9-dimethyl-9H-beta-carbolin-2-ium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DV9Z", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "SC-57666": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D02OHR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "PMID27414413-Compound-Figure6right": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07FCV", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "PMID2296027C29": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZQ3B", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "1-(4-(benzyloxy)phenyl)-3-hydroxyurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D7ES", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Nonsteroidal anti-inflammatory drugs (NSAIDs)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07XEB", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "A-79175": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0L1IH", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Thiocoumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03MJJ", "drug_id_DB": "DB02462", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "E-5110": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0Y2MP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "ZT-1": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D05REB", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-Indan-(1Z)-ylidenemethyl-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07PYC", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "(2S)-5,7,2',4'-tetrahydroxyflavanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09XKH", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06JYY", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1584"]}, "5-(6-hydroxy-2-naphthyl)pyridin-3-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M3RQ", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "ICI-199441": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); OPRM1(Opioid receptor mu (MOP) ,MOA:Inhibitor); OPRD1(Opioid receptor delta (OPRD1) ,MOA:Inhibitor); OPRK1(Opioid receptor kappa (OPRK1) ,MOA:Inhibitor); UTS2R(Urotensin II receptor (UTS2R) ,MOA:Inhibitor); ", "drug_id_TTD": "D03SAV", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565"]}, "3-methoxy-4-hydroxylonchocarpin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N4YR", "drug_id_DB": "", "metabolic_annotation_str": "ODC1(Ornithine decarboxylase (ODC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ODC1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4953"]}, "2-(2-(2,6-dimethylphenylamino)phenyl)acetic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U0YE", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "6-Iodo-2-piperazin-1-yl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HOP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "PMID2296027C25": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J9DY", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Methyl 4-(4-tert-butylbenzylideneamino)benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05DIH", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "2-N-Methylamino-1-(4-methylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2WN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "1,5-Dihydro-imidazo[2,1-b]quinazolin-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TE6A", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "(24S)-ethylcholesta-7,9(11),22(E)-triene-3b-ol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01GWN", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Isosorbide-di-(4-nitrophenyl carbamate)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05EPI", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PCE", "drug_id_DB": "DB01922", "metabolic_annotation_str": "AMY2A(Pancreatic alpha-amylase (AMY2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMY2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["279"]}, "PG-1014491": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06QJG", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "ITdU": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01VKE", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "N-[(4-bromo-1-benzothien-3-yl)methyl]sulfamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LM8L", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "6-Nitro-benzothiazole-2-sulfonic acid amide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JYF", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Malathion(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0K3LW", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3-benzyloxyphenyloxoacetic acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0CK1D", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "3-Hydroxy-3-Methyl-Glutaric Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IJ7H", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H1BY", "drug_id_DB": "DB04392", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0J3SN", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "PMID23428964CI3": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H5BG", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "PMID29473428-Compound-47": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N6UO", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-43": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07JFY", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-41": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0V3KH", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Antagonist); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Antagonist"], "metabolic_genes_id": ["3620"]}, "7-propoxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OT5L", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "765", "768", "23632"]}, "1,1,1-trifluoro-3-(hexylsulfonyl)propan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04JVA", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "2-(o-toluidino)-5-isopropylthiazol-4(5H)-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TF9R", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "GB-12819": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D0C4XQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565", "6531", "6531"]}, "Darbufelone": {"drug_status_TTD": ["Phase 2/3", "Phase 2/3", "Phase 2/3"], "non_metabolic": "", "drug_id_TTD": "D0AL8T", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["240", "240", "5743"]}, "Piperidine derivative 1": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "HRH1(Histamine H1 receptor (H1R) ,MOA:.); HRH3(Histamine H3 receptor (H3R) ,MOA:.); ", "drug_id_TTD": "D0VX6P", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6532"]}, "3,4-Benzo-7-acetonyloxy-8-methoxycoumarin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0TL3S", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "9-Hydroxypropyladenine, S-Isomer": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R0EI", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "4-(ethylamino)naphthalen-1-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02XRG", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(S)-Norfluoxetine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AWN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "p-nitrophenyl glutamyl anilide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00IWH", "drug_id_DB": "", "metabolic_annotation_str": "SLC1A5(Alanine/serine/cysteine transporter 2 (SLC1A5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC1A5"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6510"]}, "PF-3052334": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0MF7U", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "2-amino-4,6-dimethylpyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W9UV", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "1-(3-(4-chlorophenyl)propyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GIK", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "(-)-cubebin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NC3P", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "API-023": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0Z9NY", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["495"]}, "2-isooleanolic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08ZIA", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "N5-[4-(1H-pyrrol-1-yl)phenyl]-L-glutamamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WZB", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "N1-(naphthalen-1-yl)ethane-1,2-diamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X5HL", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA4", "CA6", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "762", "765", "768", "23632"]}, "5-(pyridin-4-yl)-1,3,4-oxadiazole-2(3H)-thione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04QYN", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "N-cetylgallate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01VEP", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}, "3,5-Diamino-4'-amino-trans-stilbene": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03FBI", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FK0A", "drug_id_DB": "DB02911", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "Bendroflumethiazide(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D02PAH", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A3(Solute carrier family 12 member 3 (SLC12A3) ,MOA:Blocker); SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A3", "SLC12A1"], "metabolic_mechanism_of_action": ["Blocker", "Blocker"], "metabolic_genes_id": ["6559", "6557"]}, "AZD7687": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0EY0A", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "4-ANDROSTENE-3-17-DIONE": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M8RO", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "HSD17B1", "AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "3292", "8644"]}, "Cetilistat(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB06586", "metabolic_annotation_str": "PNLIP(Pancreatic triacylglycerol lipase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PNLIP"], "metabolic_genes_id": ["5406"]}, "Milnacipran(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09VGC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "Dihydroxyfumaric acid derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LA2R", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "5'-deoxy-4'-hydroxy-5'-methylthio-DADMe-ImmH": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7LB", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "4-amino-1,2,5-oxadiazole-3-carboximidamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YU9L", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Thioureido sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I0RT", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760"]}, "1-(10H-phenothiazin-10-yl)-2-phenylethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J1IX", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Diphenylpyraline(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "HRH1(Histamine H1 receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB01146", "metabolic_annotation_str": "SLC6A3(Sodium-dependent dopamine transporter); SLC6A3(Sodium-dependent dopamine transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_genes_id": ["6531", "6531"]}, "Dual PI3K/mTOR inhibitors": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Inhibitor); ", "drug_id_TTD": "D0I5QK", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "ELLAGIC ACID": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "HSPA1A(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); HSPA1A(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); HSPA1A(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); HSPA1A(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); HSPA1A(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); HSPA1B(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); HSPA1B(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); HSPA1B(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); HSPA1B(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); HSPA1B(Heat shock protein 70 (HSP70) ,MOA:Inhibitor); SYK(Tyrosine-protein kinase SYK (SYK) ,MOA:Inhibitor); GSK3B(Glycogen synthase kinase-3 beta (GSK-3B) ,MOA:Inhibitor); CSNK2A1(Casein kinase II alpha (CSNK2A1) ,MOA:Inhibitor); SMAD3(Mothers against decapentaplegic homolog 3 (SMAD3) ,MOA:Inhibitor); ", "drug_id_TTD": "D0A1CM", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA6(Carbonic anhydrase VI (CA-VI) ,MOA:Inhibitor); SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA4", "CA6", "SQLE", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "762", "765", "6713", "768", "23632"]}, "2-N-Propargylamino-1-(4-methylthiophenyl)butane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05YHP", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "N,Ndimethyl milnacipran": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0BM0M", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "Monoisopropylphosphorylserine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8RP", "drug_id_DB": "DB01805", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Hexanoic acid 2,5-diphenyl-thiazol-4-yl ester": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T8TS", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Bicifadine": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D03QIE", "drug_id_DB": "DB04889", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6530", "6532"]}, "PMID8709131C4": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N4BQ", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "2-Aminomethyl-5-(p-bromophenyl)tetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03HQF", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "PMID26666989-Compound-Figure11topright": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D06TPL", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "1-phenyl-1-(piperidin-2-yl)propan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08JCK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "(-)-dihydroclusin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06MLU", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "(4e)-4-Aminohex-4-Enoic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05TEW", "drug_id_DB": "DB01699", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "Gabapentin enacarbil(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05KBU", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A6(Sodium-dependent multivitamin transporter (SLC5A6) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A6"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8884"]}, "4-Ethyl-pyrrolidin-(2Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02EOF", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842", "4843"]}, "1-(4-Methoxybenzyl)-5-phenyl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T8JU", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Ethinamate(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0CK3G", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "ZOPOLRESTAT": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06EDT", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["231"]}, "Quercetin(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "EIF3F(Eukaryotic translation initiation factor 3 subunit F); STK17B(Serine/threonine-protein kinase 17B); ESR1(Estrogen receptor); SHBG(Sex hormone-binding globulin); HSP90AA1(Heat shock protein HSP 90-alpha); PIM1(Serine/threonine-protein kinase pim-1); NQO2(Ribosyldihydronicotinamide dehydrogenase [quinone]); CEBPB(CCAAT/enhancer-binding protein beta); UBA1(Ubiquitin-like modifier-activating enzyme 1); AHR(Aryl hydrocarbon receptor); HSPA2(Heat shock-related 70 kDa protein 2); ACTB(Actin, cytoplasmic 1); CSNK2B(Casein kinase II subunit beta); CSNK2B(Casein kinase II subunit beta); CSNK2B(Casein kinase II subunit beta); CSNK2B(Casein kinase II subunit beta); CSNK2B(Casein kinase II subunit beta); CSNK2B(Casein kinase II subunit beta); CSNK2B(Casein kinase II subunit beta); CSNK2A1(Casein kinase II subunit alpha); SF3B3(Splicing factor 3B subunit 3); UGT3A1(UDP-glucuronosyltransferase 3A1); ESR2(Estrogen receptor beta); RUVBL2(RuvB-like 2); ", "drug_id_TTD": "", "drug_id_DB": "DB04216", "metabolic_annotation_str": "ATP5F1B(ATP synthase subunit beta, mitochondrial); CBR1(Carbonyl reductase [NADPH] 1); ATP5F1A(ATP synthase subunit alpha, mitochondrial); ATP5F1C(ATP synthase subunit gamma, mitochondrial); PIK3CG(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform); CYP1B1(Cytochrome P450 1B1); HIBCH(3-hydroxyisobutyryl-CoA hydrolase, mitochondrial); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ATP5F1B", "CBR1", "ATP5F1A", "ATP5F1C", "PIK3CG", "CYP1B1", "HIBCH"], "metabolic_genes_id": ["506", "873", "498", "509", "5294", "1545", "26275"]}, "Candoxatril(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "MME(Neprilysin); ", "drug_id_TTD": "", "drug_id_DB": "DB00616", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ACE"], "metabolic_genes_id": ["1636"]}, "Gemcitabine prodrug": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0H2JD", "drug_id_DB": "", "metabolic_annotation_str": "RRM2(Ribonucleoside-diphosphate reductase M2 (RRM2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6241"]}, "N-(4-Ethoxybutyl)-2-oxohexadecanamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01GZV", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "2-Hydrazinocarbonyl-benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06KTD", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["760", "768"]}, "1-adamantan-1-yl-3-(1-propyl-piperidin-4-yl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IC8U", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "BMN-168": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05TXS", "drug_id_DB": "", "metabolic_annotation_str": "PAH(Phenylalanine hydroxylase (PAH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PAH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5053"]}, "4S-4,5-Diamino-N-(4-phenoxyphenyl)pentanamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M2CY", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "BW A360C": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03QNE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "CX-9051": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XC1F", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "GS-6637": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D00IXN", "drug_id_DB": "", "metabolic_annotation_str": "ALDH2(Mitochondrial aldehyde dehydrogenase (ALDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["217"]}, "4-(2-Hydroxyethoxy)-1-naphthol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XOT", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "TPO gene plasmid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M9ZL", "drug_id_DB": "", "metabolic_annotation_str": "TPO(Thyroid peroxidase (TPO) ,MOA:Modulator); TPO(Thyroid peroxidase (TPO) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["TPO", "TPO"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["7173", "7173"]}, "1-(1-Biphenyl-4-yl-pentyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q1LG", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "N-(2-aminoethyl)-2-oxo-2H-chromene-3-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02KGZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "amg-1": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01HST", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4'-cyano-3-(imidazolylmethyl)-7-methoxyflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05PXK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "Mitiglinide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "PPARG(Peroxisome proliferator-activated receptor gamma); ", "drug_id_TTD": "", "drug_id_DB": "DB01252", "metabolic_annotation_str": "ABCC8(ATP-binding cassette sub-family C member 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ABCC8"], "metabolic_genes_id": ["6833"]}, "Ethyl 4-(2-oxohexadecanamido)benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q1LD", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "4-phenyliminomethyl-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09DMR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "1,2-bis(2,5-difluorophenyl)-2-hydroxyethanone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00PLH", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "2-(4-phenoxyphenoxy)ethanamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02AYI", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); PLA2G2A(Group IIA phospholipase A2 (GIIA sPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H", "PLA2G2A"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4048", "5320"]}, "1-Ethyl-5-(imidazol-1-yl-phenyl-methyl)-1H-indole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06FHE", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1588"]}, "1-(2-(2-ethoxyphenyl)-1-phenylethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z6YA", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "N-(4-Bromo-3-methanesulfonyl-benzoyl)-guanidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05CQR", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); SLC9A3(Sodium/hydrogen exchanger 3 (SLC9A3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1", "SLC9A3", "SLC9A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6548", "6550", "6550"]}, "Isorhamnetin 3-O-rhamnoside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7VA", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "10-CF3C(OH)2-DDACTHF": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XU7N", "drug_id_DB": "", "metabolic_annotation_str": "GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2618", "2618"]}, "(10r)-10-Formyl-5,8,10-Trideazafolic Acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E0CV", "drug_id_DB": "", "metabolic_annotation_str": "GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2618", "2618"]}, "2-(6-Imidazol-1-yl-hexyl)-isoindole-1,3-dione": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01NZS", "drug_id_DB": "", "metabolic_annotation_str": "TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6916"]}, "Teglicar": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01FCK", "drug_id_DB": "", "metabolic_annotation_str": "CRAT(Carnitine acyltransferase (CRAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CRAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1384"]}, "PMID18295483C2": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06MYN", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R4KQ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "NITRATE": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00RJT", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Methyclothiazide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03GVC", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6557"]}, "1-(2-amino-benzothiazol-6-yl)-2-ethyl-isothiourea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X2XQ", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4842"]}, "CLP-1001": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0D1ZS", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A2(Na-K-Cl cotransporter (NKCC) ,MOA:Modulator); SLC12A1(Na-K-Cl cotransporter (NKCC) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A2", "SLC12A1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6558", "6557"]}, "AP-Cav": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01FMS", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4846"]}, "2pyrrolidin-1-yl-1-phenylpentan-1-one": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B4FN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "Pyrido/pyrrolo-fused pyrimidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D02BGU", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "5-oxo-1-tosyl-2,5-dihydro-1Hpyrrol-2-yl acetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D1HC", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["759"]}, "DZNep": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X3MK", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "1-methyl-1H-indole-3-carbaldehyde": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D1KZ", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "1-(2'-chlorophenyl)penta-1,4-dien-3-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I8HK", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2936"]}, "Cystamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WI3W", "drug_id_DB": "", "metabolic_annotation_str": "GCLM(Glutamate--cysteine ligase modifier (GCLM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GCLM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2730"]}, "CR-3294": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0I8ZM", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "NO-antihypertensives": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0N7QP", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Ring-fused compound 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D07IZC", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["116085"]}, "Benzyl-(2-phenyl-quinazolin-4-yl)-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7GF", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "SLC6A3", "SLC6A3", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "6531", "6531", "5142"]}, "1-Octyl-3-(1-propionylpiperidin-4-yl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ARH", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "N-[4-(trifluoromethyl)phenyl]sulfamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K5NQ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "BRL-61063": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "ADORA1(Adenosine A1 receptor (ADORA1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0K2BQ", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "1-(4-Cyanobenzyl)-5-formyl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07EJK", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Mesalazine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "IKBKB(Inhibitor of nuclear factor kappa-B kinase subunit beta); CHUK(Inhibitor of nuclear factor kappa-B kinase subunit alpha); PPARG(Peroxisome proliferator-activated receptor gamma); ", "drug_id_TTD": "", "drug_id_DB": "DB00244", "metabolic_annotation_str": "MPO(Myeloperoxidase); ALOX5(Arachidonate 5-lipoxygenase); ALOX5(Arachidonate 5-lipoxygenase); PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MPO", "ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_genes_id": ["4353", "240", "240", "5742", "5743"]}, "Methylphenidate(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D02PPN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Blocker); SLC6A3(Dopamine transporter (DAT) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Blocker", "Blocker"], "metabolic_genes_id": ["6531", "6531"]}, "N-(5-chlorobenzo[d]oxazol-2-yl)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X6YR", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203"]}, "2-Amino-N-[4-(phenylmethoxy)phenyl]-acetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06RWH", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "2-(N-Cyclopentylamino)-3'-methoxypropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZE4C", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "Pyrido[1,2,4]triazolo[4,3-a]pyrazine derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0SV1I", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Pyrido[1,2,4]triazolo[4,3-a]pyrazine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0D0QT", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "US8592431, 181": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0TI5Y", "drug_id_DB": "", "metabolic_annotation_str": "SLC33A1(Acetyl-CoA transporter (SLC33A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC33A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9197"]}, "US8592431, 185": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Z5GO", "drug_id_DB": "", "metabolic_annotation_str": "SLC33A1(Acetyl-CoA transporter (SLC33A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC33A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9197"]}, "Multi-epitope tyrosinase/gp100 vaccine": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "PMEL(Melanocytes lineage-specific antigen GP100 (PMEL) ,MOA:.); ", "drug_id_TTD": "D0N7FD", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["7299"]}, "3-(4H-Imidazol-4-yl)benzenethiol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G3RO", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "4-(2-Pyridin-4-ylacetamido)benzenesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GVA", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "N-Hydroxy-N-methyl-2,3,3-triphenyl-acrylamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06GRW", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "Tenoxicam(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00469", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "AR9281": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0KL3U", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "8-(3-Nitro-phenyl)-6-pyridin-4-ylmethyl-quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4HG", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5141"]}, "(+/-)-7-methoxy-2-(4-methoxyphenyl)chroman-4-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00HVZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "4129"]}, "PMID25399762-Compound-Table 5-8": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03EHC", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Ibudilast(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB05266", "metabolic_annotation_str": "PDE4A(cAMP-specific 3',5'-cyclic phosphodiesterase 4A); PDE4B(cAMP-specific 3',5'-cyclic phosphodiesterase 4B); PDE4C(cAMP-specific 3',5'-cyclic phosphodiesterase 4C); PDE4D(cAMP-specific 3',5'-cyclic phosphodiesterase 4D); PDE3A(cGMP-inhibited 3',5'-cyclic phosphodiesterase A); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PDE4A", "PDE4B", "PDE4C", "PDE4D", "PDE3A"], "metabolic_genes_id": ["5141", "5142", "5143", "5144", "5139"]}, "PARAOXON": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CNR1(Cannabinoid receptor 1 (CB1) ,MOA:Inhibitor); ", "drug_id_TTD": "D08XQI", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "43"]}, "Tamarixetin 3-glucoside-7-sulfate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U8GZ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Chlormerodrin(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D06EMT", "drug_id_DB": "", "metabolic_annotation_str": "ALDH5A1(Succinate-semialdehyde dehydrogenase (ALDH5A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALDH5A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["7915"]}, "Tariquidar": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D04RLX", "drug_id_DB": "DB06240", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5243"]}, "N,N-Dimethyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B6IQ", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Rh-alphaglucosidase": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0M1CZ", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["8972", "8972"]}, "Glisoxepide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01289", "metabolic_annotation_str": "KCNJ8(ATP-sensitive inward rectifier potassium channel 8); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["KCNJ8"], "metabolic_genes_id": ["3764"]}, "PMID17888661C18": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KPR", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "PMID17888661C19": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03LRN", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08HPU", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "AR-C102222": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05VAB", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "2-oxo-2H-chromene-3-carboxylic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H3NS", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA4(Carbonic anhydrase IV (CA-IV) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA4", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "762", "768", "23632"]}, "(-)-Phenethylcymserine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U9AU", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "3-(3-methylthiophen-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06TRS", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "5-(4'-benzoylbiphenyl-4-yl)-2-furoic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1XN", "drug_id_DB": "", "metabolic_annotation_str": "CKM(Creatine kinase (CK) ,MOA:Inhibitor); CKB(Creatine kinase (CK) ,MOA:Inhibitor); CKMT1B(Creatine kinase (CK) ,MOA:Inhibitor); CKMT1A(Creatine kinase (CK) ,MOA:Inhibitor); CKMT2(Creatine kinase (CK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CKM", "CKB", "CKMT1B", "CKMT1A", "CKMT2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1158", "1152", "1159", "548596", "1160"]}, "CP-640186": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07WIC", "drug_id_DB": "", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "NSC-30171": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HXC", "drug_id_DB": "", "metabolic_annotation_str": "ATIC(Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ATIC"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["471"]}, "PMID9003518C4": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05VRO", "drug_id_DB": "", "metabolic_annotation_str": "LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); LSS(Lanosterol synthase (LSS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LSS", "LSS"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4047", "4047"]}, "Isopropyl 10H-phenothiazine-10-carboxylate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KTT", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "AMG 319": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03FOP", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CD(PI3-kinase delta (PIK3CD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5293"]}, "3-Phenyl-2-nortropene": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08IFQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "3-(4-hexylthiosemicarbazono)methyl-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y9SI", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "Neplanocin A": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0R2QS", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "Iso-OMPA": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09QDC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "Isosorbide-2-(benzylcarbamate)-5-benzoate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0LL8H", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1-(2-phenoxybenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08TKB", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "JASPAQUINOL": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07EAJ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "246"]}, "Methazolamide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00703", "metabolic_annotation_str": "CA1(Carbonic anhydrase 1); CA2(Carbonic anhydrase 2); CA3(Carbonic anhydrase 3); CA4(Carbonic anhydrase 4); CA7(Carbonic anhydrase 7); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CA1", "CA2", "CA3", "CA4", "CA7"], "metabolic_genes_id": ["759", "760", "761", "762", "766"]}, "2'-Monophosphoadenosine 5'-Diphosphoribose": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PDF(Polypeptide deformylase (PDF) ,MOA:Inhibitor); ", "drug_id_TTD": "D0J2FY", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); G6PD(Glucose-6-phosphate dehydrogenase (G6PD) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR", "G6PD", "HSD17B1", "AKR1B1", "HSD11B1", "NOS1", "AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3156", "2539", "3292", "231", "3290", "4842", "8644"]}, "(S,S)-(-)-bis(12)-hupyridone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09DJX", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "1-[4-(Benzothiazol-2-yloxy)benzyl]piperidin-4-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09BWE", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Girentuximab": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0I8MT", "drug_id_DB": "DB05304", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["768"]}, "Clobetasol": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0FL5V", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "Esreboxetine": {"drug_status_TTD": ["Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01NJT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6530"]}, "Benzomate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W6GB", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "3-Imidazol-1-ylmethyl-2-isopropyl-1H-indole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01CGR", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "Octahydro-isoindol-(1Z)-ylideneamine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D07INO", "drug_id_DB": "", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4842", "4843"]}, "(S)-2-Amino-6-[(E)-ethylimino]-hexanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W5UJ", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "PMID8426367C18": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05YUT", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "NSC-65069": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O8YZ", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "OXYBENZONE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02CWR", "drug_id_DB": "", "metabolic_annotation_str": "LIPE(Hormone sensitive lipase (LIPE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3991"]}, "4-Methoxy-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00IKQ", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "(S)-Rolipram(TTD)": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02FZD", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142"]}, "6-Pyridin-3-yl-naphthalen-2-ol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02ALK", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "Linetastine": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "PRKCB(Protein kinase C beta (PRKCB) ,MOA:Inhibitor); ", "drug_id_TTD": "D0E8UV", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "2-(N-tert-Butylamino)-3',4'-dichloropropiophenone": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GDI", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzothiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08UIO", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Melanoma vaccine": {"drug_status_TTD": ["Phase 3", "Phase 3", "Phase 3"], "non_metabolic": "PMEL(Melanocytes lineage-specific antigen GP100 (PMEL) ,MOA:.); MLANA(MART-1 melanoma antigen (MLANA) ,MOA:.); ", "drug_id_TTD": "D0U9MJ", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["7299"]}, "CIMICOXIB": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0U8OD", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5743"]}, "(+/-)-2-p-tolylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R3LP", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "3-(3,4-Dimethylbenzyl)-4-hydroxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06BHJ", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "AL7182": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B8CU", "drug_id_DB": "DB02602", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "Trans,trans-1,3-bis-(4-hydroxycyclohexyl)urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R1YP", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "PMID30273516-Compound-13": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D01RUI", "drug_id_DB": "", "metabolic_annotation_str": "GLS(Glutaminase (GLS) ,MOA:Inhibitor); GLS2(Glutaminase (GLS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLS", "GLS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2744", "27165"]}, "Abietic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0UQ6U", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "N-unsubstituted carbamate esters": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09FAF", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "Tiaprofenic acid(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0S7VO", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "BM-162115": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P0DA", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "CGS-26529": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D02QGM", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "4-Hydroxy-pent-2-enoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00ENC", "drug_id_DB": "", "metabolic_annotation_str": "SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); SLC52A2(Gamma-hydroxybutyrate receptor (SLC52A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC52A2", "SLC52A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["79581", "79581"]}, "Oleic acid anilide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7YM", "drug_id_DB": "", "metabolic_annotation_str": "SOAT2(SOAT2 messenger RNA (SOAT2 mRNA) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SOAT2", "CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8435", "1066", "1066"]}, "13-n-Heptanamidotridec-8(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00CHD", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "N-(indolylcarbonyl)-piperidine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Q8RC", "drug_id_DB": "", "metabolic_annotation_str": "AKR1C3(Dihydrodiol dehydrogenase type I (AKR1C3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1C3"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8644"]}, "2,4'-Dimethoxy-5,3'-di-(2-propenyl)-biphenyl": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01JYF", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); ALOX5(LOX-5 messenger RNA (ALOX5 mRNA) ,MOA:Inhibitor); PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5", "PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240", "5742", "5743"]}, "PMID16242323C18a": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00EYY", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "PMID16242323C18b": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M8SY", "drug_id_DB": "", "metabolic_annotation_str": "ACAT1(Acetoacetyl-CoA thiolase (ACAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACAT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["38"]}, "Tri-substituted benzene derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0OW2D", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["246"]}, "(-)-cubebinin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HSP", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "F(4-Fluoro)VAE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X1VL", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Plecanatide(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07FEC", "drug_id_DB": "", "metabolic_annotation_str": "GUCY2C(Guanylyl cyclase C (GUCY2C) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GUCY2C"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2984"]}, "Polidocanol - BioForm Medical/Chemische Fabrik Kreussler & Co": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0LW9U", "drug_id_DB": "", "metabolic_annotation_str": "CPS1(Carbamoyl-phosphate synthetase I (CPS1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CPS1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1373"]}, "AZD6482": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0D0QA", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3-kinase beta (PIK3CB) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5291"]}, "Lumiracoxib(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01283", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_genes_id": ["5742", "5743"]}, "YM-17E": {"drug_status_TTD": ["Discontinued in Phase 1", "Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0IZ7T", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); CES1(Liver carboxylesterase (CES1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["1066", "1066"]}, "Tipelukast": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0Q7UG", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Pentanoic acid (4-sulfamoyl-phenyl)-amide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q0XO", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "Epalrestat": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D03KOZ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05ETN", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "Sri-9439(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB03351", "metabolic_annotation_str": "DHFR(Dihydrofolate reductase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["DHFR"], "metabolic_genes_id": ["1719"]}, "PMID26666989-Compound-Figure12topmiddile": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D09YQO", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "2,3,4,5-Tetrabromo-6-(2,4-dibromo-phenoxy)-phenol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4CI", "drug_id_DB": "", "metabolic_annotation_str": "ALOX15(Arachidonate 15-lipoxygenase (15-LOX) ,MOA:Inhibitor); ALOX12(Arachidonate 12-lipoxygenase (12-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX15", "ALOX12"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["246", "239"]}, "PIBTU": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00PEC", "drug_id_DB": "", "metabolic_annotation_str": "NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4843"]}, "7-O-b-D-Glucopyranosyl-a-homonojirimycin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JCA", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2548"]}, "MCT-125": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02GWJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6530"]}, "4-butylphenylboronic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05NFU", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760"]}, "6-(Dihydroxy-Isobutyl)-Thymine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08AOD", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "s-allylglycine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09OTM", "drug_id_DB": "", "metabolic_annotation_str": "GAD2(Glutamate decarboxylase 2 (GAD2) ,MOA:Inhibitor); GAD1(Glutamic acid decarboxylase 1 (GAD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GAD2", "GAD1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2572", "2571"]}, "1-(2-Phenoxy-ethyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R8NE", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "US8741907-compound-3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X5XB", "drug_id_DB": "", "metabolic_annotation_str": "PDE3B(Phosphodiesterase 3B (PDE3B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5140"]}, "3,3'-Thiene-2,4-diyldiphenol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08OQX", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "3-(4-o-Tolylpiperazine-1-carbonyl)coumarin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08WRG", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "N-(4-Phenylbutyl)-1H-indole-2-carboxamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08HNJ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Imidazo[1,5-a]pyridine derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0RH9K", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Imidazo[1,5-a]pyridine derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ZV6F", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3-Hydroxy-2-butanone": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00NDF", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Ramipril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D01STB", "drug_id_DB": "DB00178", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "PMID29473428-Compound-21": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0P1HR", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-22": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03TZE", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "PMID29473428-Compound-29": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0JR2C", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "Alpha-D-Glucose-1-Phosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S5WE", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "1-[7-(triphenylmethoxy)heptyl]thymine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8AD", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "1,2-bis(3-fluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y6RZ", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "Galsulfase(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05UHF", "drug_id_DB": "", "metabolic_annotation_str": "ARSB(N-acetylgalactosamine-4-sulfatase (G4S) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ARSB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["411"]}, "Amodiaquine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D04NQI", "drug_id_DB": "DB00613", "metabolic_annotation_str": "HNMT(Histamine N-methyltransferase (HNMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HNMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3176"]}, "2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzooxazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03GON", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "DEOXYCYTIDINE": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0RX7Z", "drug_id_DB": "", "metabolic_annotation_str": "TK1(Thymidine kinase 1 (TK1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TK1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7083"]}, "2-cyclopropyl-4-substituted-phenoxy-quinoline derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LJ0M", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "Acetic acid 2-hept-2-ynylsulfanyl-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02VLR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "[(2-aminooxyethyl)methylamino]-5'-deoxyadenosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0P5YR", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "4-nitrophenyl-difluoromethanesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I5YQ", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "MANOALIDE": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D00XQO", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5319"]}, "PMID27977313-Compound-39": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0Q6PR", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "2-(4-(methylsulfonyl)phenyl)-3-phenylquinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V2QP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Indeloxazine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D07TGY", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "(+/-)-threo-Methylphenidate amide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D03NUN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "PMID27977313-Compound-32": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D05HHG", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-31": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D01XRW", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-30": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0S3QX", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "TgBSSL": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D2RR", "drug_id_DB": "", "metabolic_annotation_str": "CEL(Bile-salt-activated lipase (CEL) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CEL"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1056"]}, "SC-75416": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D02DYU", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Tetrahydrouridine": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0I5OR", "drug_id_DB": "", "metabolic_annotation_str": "CDA(Cytidine deaminase (CDA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CDA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["978"]}, "phloretin": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "CLCN3(Chloride channel protein 3 (CLC-3) ,MOA:Blocker (channel blocker)); ", "drug_id_TTD": "D0HD2G", "drug_id_DB": "", "metabolic_annotation_str": "AQP9(Aquaporin-9 (AQP9) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AQP9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["366"]}, "1-(4-Chlorobenzyl)-5-phenyl-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W8IZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "12-(3-Adamantan-1-yl-ureido)-dodeca noic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S0SH", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "LY3023414": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "MTOR(Serine/threonine-protein kinase mTOR (mTOR) ,MOA:Modulator); ", "drug_id_TTD": "D0H1WC", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CA(PI3-kinase alpha (PIK3CA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5290"]}, "2-(2-cyclohexylidenehydrazinyl)-4-phenylthiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E4HB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "isoferulic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04EWW", "drug_id_DB": "", "metabolic_annotation_str": "PMVK(Phosphomevalonate kinase (PMVK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PMVK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10654"]}, "JZL184": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0MZ", "drug_id_DB": "", "metabolic_annotation_str": "MGLL(Monoglyceride lipase (MAGL) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGLL"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["11343"]}, "Epostane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09SWM", "drug_id_DB": "", "metabolic_annotation_str": "HSD3B1(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); HSD3B2(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD3B1", "HSD3B2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3283", "3284"]}, "2-Hydroxyiminoolean-12-en-28-oic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J3YD", "drug_id_DB": "", "metabolic_annotation_str": "PYGM(Glycogen phosphorylase muscle form (GP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGM"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5837"]}, "Ethylisothiourea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I7VD", "drug_id_DB": "", "metabolic_annotation_str": "NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); NOS2(Nitric-oxide synthase inducible (NOS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS3", "NOS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4846", "4843"]}, "QLT-091382": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08FSR", "drug_id_DB": "", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4OP", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "2-(6-Methoxy-indole-1-sulfonyl)-benzoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05GVL", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2167"]}, "GP-3269": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D01GVC", "drug_id_DB": "", "metabolic_annotation_str": "ADK(Adenosine kinase (ADK) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADK"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["132"]}, "Flavanone": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0B4VE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB", "HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4129", "3290"]}, "1-(2-mercaptoethyl)-3-(m-tolylsulfonyl)urea": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H6WG", "drug_id_DB": "", "metabolic_annotation_str": "FBP2(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); FBP1(Fructose-1,6-bisphosphatase (FBP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FBP2", "FBP1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8789", "2203"]}, "1-(3-Methylbutylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F1XE", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "3-(6-Methoxy-3-methylnaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S8FV", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "2-N-Hydroxyamino-1-(4-methylthiophenyl)propane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03ETK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "Sulfamic acid 4-(2-methoxy-benzoyl)-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0B1JM", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "2,3-dichloro-1,4-naphthoquinone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I2RW", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "VAR-10200": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V4KL", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["4129"]}, "1-(Butan-2-ylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08UML", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Entacapone+levodopa+carbidopa": {"drug_status_TTD": ["Phase 3"], "non_metabolic": "", "drug_id_TTD": "D0R2NE", "drug_id_DB": "", "metabolic_annotation_str": "COMT(Catechol-O-methyl-transferase (COMT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["COMT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1312"]}, "ISIS 191729": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T7SU", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); DGAT1(DGAT1 messenger RNA (DGAT1 mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["8694", "8694"]}, "Acetyl CoA carboxylase inhibitors, Bayer": {"drug_status_TTD": ["Terminated"], "non_metabolic": "", "drug_id_TTD": "D0Q6GR", "drug_id_DB": "", "metabolic_annotation_str": "ACACB(Acetyl-CoA carboxylase 2 (ACACB) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACACB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["32"]}, "Seco-exiguamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DR7W", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "(4-bromophenyl)difluoromethanesulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0IU3X", "drug_id_DB": "", "metabolic_annotation_str": "CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["759", "760", "768"]}, "1,4-Di(berberine-9-O-yl)ethane dibromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00FPI", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "HT-1067": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0O5QL", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Benzbromarone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB12319", "metabolic_annotation_str": "CYP2C9(Cytochrome P450 2C9); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["CYP2C9"], "metabolic_genes_id": ["1559"]}, "Ethacrynate Sodium": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0W5UV", "drug_id_DB": "", "metabolic_annotation_str": "SLC12A1(Solute carrier family 12 member 1 (SLC12A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC12A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6557"]}, "Asfotase alfa(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05XSJ", "drug_id_DB": "", "metabolic_annotation_str": "ALPL(Alkaline phosphatase tissue-nonspecific (ALPL) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALPL"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["249"]}, "ETHIOFENCARB": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02XQX", "drug_id_DB": "", "metabolic_annotation_str": "LIPE(Hormone sensitive lipase (LIPE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LIPE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3991"]}, "ELACRIDAR": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D09FGX", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5243"]}, "moexiprilat": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R6KV", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1636"]}, "Phenanthrene-3-carboxylic acid hydroxyamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ZGR", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "6-hydroxy-2,9-dimethyl-9H-beta-carbolin-2-ium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ER5C", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "3'-(1-Benzothien-2-yl)biphenyl-3-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00PUR", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "1-(1-Benzo[b]thiophen-2-yl-cyclohexyl)-azepane": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00KIK", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "(S,S)-(-)-bis(10)-hupyridone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y3LO", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Fludarabine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "POLA1(DNA polymerase alpha catalytic subunit); ", "drug_id_TTD": "", "drug_id_DB": "DB01073", "metabolic_annotation_str": "RRM1(Ribonucleoside-diphosphate reductase large subunit); DCK(Deoxycytidine kinase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["RRM1", "DCK"], "metabolic_genes_id": ["6240", "1633"]}, "BENZYLIMIDAZOLE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X0IH", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "4,4'-(ethane-1,2-diyl)dibenzene-1,3-diol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07DAP", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "9-Deazainosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I8JJ", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "2-Cyclohexyl-N-phenyl-acetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08YJF", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "13-(5-n-Pentylfuran-2-yl)tridec-8(Z)-enoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07HWV", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "LIQUIRTIGENIN": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K4PY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "XDH"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "7498"]}, "P'-geranyl 3,5,7-trihydroxy-3-methylheptanate 7-diphosphate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01JCH", "drug_id_DB": "", "metabolic_annotation_str": "MVD(Diphosphomevalonate decarboxylase (MVD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MVD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4597"]}, "5-(4-Chlorophenyl)-4-p-tolylisothiazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03TLR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "1-(4-nitro-2-phenoxybenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V3MV", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "4-Amino Hexanoic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L5IN", "drug_id_DB": "DB04235", "metabolic_annotation_str": "ABAT(GABA transaminase (ABAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABAT"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["18"]}, "ISIS 147919": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D9QN", "drug_id_DB": "", "metabolic_annotation_str": "SCD(Acyl-CoA desaturase (SCD) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["SCD"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["6319"]}, "1-(3-Chloro-phenyl)-3-(4-hydroxy-decyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06RJQ", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "1-Adamantan-1-yl-3-decyl-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0XG0G", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Pyridine-carboximide derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0OT8R", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "Pyridine-carboximide derivative 2": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D05REP", "drug_id_DB": "", "metabolic_annotation_str": "DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); DGAT1(Diacylglycerol acyltransferase 1 (DGAT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DGAT1", "DGAT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8694", "8694"]}, "N,N-Diisopropyl-1'H-phenothiazine-1'-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XHC", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "1-(2-(6-fluoronaphthalen-2-yl)ethyl)piperazine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0S9AY", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532"]}, "Cilazapril": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D04GKO", "drug_id_DB": "DB01340", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "Aminolevulinic acid hci": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y7ZD", "drug_id_DB": "", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["210"]}, "N-Tridecanoic Acid(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB02448", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2); PLA2G2A(Phospholipase A2, membrane associated); PLA2G2E(Group IIE secretory phospholipase A2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PLA2G1B", "PLA2G2A", "PLA2G2E"], "metabolic_genes_id": ["5319", "5320", "30814"]}, "4-(3-Benzoyl-1H-pyrrol-1-yl)butanoic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G4CJ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "3-Indan-(1E)-ylidenemethyl-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01SUE", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "Dexfenfluramine": {"drug_status_TTD": ["Withdrawn from market"], "non_metabolic": "", "drug_id_TTD": "D0F9SG", "drug_id_DB": "DB01191", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "N1,2-dibenzyl-N3-hydroxy-N1-phenethylmalonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02EFK", "drug_id_DB": "", "metabolic_annotation_str": "ANPEP(Aminopeptidase N (ANPEP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ANPEP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["290"]}, "REV-5901": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D0O8ZE", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "XR-9544": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0A4TF", "drug_id_DB": "", "metabolic_annotation_str": "ABCB1(Multidrug resistance protein 1 (ABCB1) ,MOA:Inhibitor); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ABCC1(Multidrug resistance-associated protein 1 (ABCC1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCB1", "ABCC1", "ABCC1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5243", "4363", "4363"]}, "Isosorbide-2-(cyclohexylcarbamate)-5-mononitrate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05QFR", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Omeprazole(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "AHR(Aryl hydrocarbon receptor); ", "drug_id_TTD": "", "drug_id_DB": "DB00338", "metabolic_annotation_str": "ATP4A(Potassium-transporting ATPase alpha chain 1); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["ATP4A"], "metabolic_genes_id": ["495"]}, "4-Thiocyanato-benzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05PRS", "drug_id_DB": "", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "N-Cyclohexyl-2-(4-methoxy-phenyl)-acetamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S3KS", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "(+/-)-7-fluoro-2-(4-methoxyphenyl)chroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03XQB", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "Naphthalene-2,6-disulfonic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M6CB", "drug_id_DB": "", "metabolic_annotation_str": "LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHA(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHB(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); LDHC(L-lactate dehydrogenase (LDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LDHA", "LDHA", "LDHB", "LDHC"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3939", "3939", "3945", "3948"]}, "SB-435495": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D09NBM", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G1B(Phospholipase A2 (PLA2G1B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G1B"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5319"]}, "6-methoxy-2-oxo-2H-chromene-3-carboxylic acid": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00XJA", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "Safinamide": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0TV6I", "drug_id_DB": "DB06654", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "5-(2-(1H-imidazol-1-yl)ethyl)quinoline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X8UK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "BIM23A760": {"drug_status_TTD": ["Phase 2", "Phase 2", "Phase 2"], "non_metabolic": "DRD2(Dopamine D2 receptor (D2R) ,MOA:Modulator); ", "drug_id_TTD": "D04FNQ", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "(2R,3S,4S,5R)-2-propylpiperidine-3,4,5-triol": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YQR", "drug_id_DB": "", "metabolic_annotation_str": "GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); GBA(Glucosylceramidase (GBA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GBA", "GBA"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2629", "2629"]}, "PMID27967267-Compound-27": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0I6UA", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["43"]}, "COH29": {"drug_status_TTD": ["Phase 1", "Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0NS6Z", "drug_id_DB": "", "metabolic_annotation_str": "RRM1(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); RRM2B(Ribonucleotide reductase (RIR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["RRM1", "RRM2", "RRM2B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6240", "6241", "50484"]}, "PMID27967267-Compound-28": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0ZX8C", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["43"]}, "Pamidronate": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0BF8G", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "1-(1-(4-bromophenyl)ethylidene)thiosemicarbazide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E7TO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "METHYLTHIOADENOSINE": {"drug_status_TTD": ["Terminated", "Terminated", "Terminated", "Terminated", "Terminated"], "non_metabolic": "ADORA3(Adenosine A3 receptor (ADORA3) ,MOA:Inhibitor); ADORA2A(Adenosine A2a receptor (ADORA2A) ,MOA:Inhibitor); ADORA2B(Adenosine A2b receptor (ADORA2B) ,MOA:Inhibitor); ADORA1(Adenosine A1 receptor (ADORA1) ,MOA:Inhibitor); ", "drug_id_TTD": "D0E4WF", "drug_id_DB": "", "metabolic_annotation_str": "MTAP(S-methyl-5'-thioadenosine phosphorylase (MTAP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MTAP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4507"]}, "FR-146687": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D01CJY", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Steroid 5-alpha-reductase 1 (SRD5A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6715"]}, "Lycorine dimer salt derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03VUN", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "HepaStem": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D05XZQ", "drug_id_DB": "", "metabolic_annotation_str": "PAH(Phenylalanine hydroxylase (PAH) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PAH"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["5053"]}, "Isosorbide-2-(propylcarbamate)-5-mononitrate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0WH4J", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "decynium 22": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "NQO2(Quinone reductase 2 (NQO2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0I5YK", "drug_id_DB": "", "metabolic_annotation_str": "SLC29A4(Solute carrier family 29 member 4 (SLC29A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC29A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["222962"]}, "Sch-40120": {"drug_status_TTD": ["Terminated", "Terminated"], "non_metabolic": "", "drug_id_TTD": "D06MPF", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "Bis(2,4-dinitrophenyl)sulfane": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09GTJ", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "4-(Benzylamino)-1-naphthol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00UIK", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3-Chloro-N-(2-methyl-1H-indol-5-yl)benzamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D6QI", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "Benzamidine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "ATOX1(Copper transport protein ATOX1); KLK1(Kallikrein-1); PRSS1(Trypsin-1); PRSS1(Trypsin-1); PRSS2(Trypsin-2); PRSS2(Trypsin-2); PRSS3(Trypsin-3); CSNK2A1(Casein kinase II subunit alpha); KLK6(Kallikrein-6); ST14(Suppressor of tumorigenicity 14 protein); ", "drug_id_TTD": "", "drug_id_DB": "DB03127", "metabolic_annotation_str": "ECI1(Enoyl-CoA delta isomerase 1, mitochondrial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["ECI1"], "metabolic_genes_id": ["1632"]}, "1-(1-phenyl-2-(pyridin-2-yl)ethyl)piperazine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y6GQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "(2-Butyryloxy-ethyl)-trimethyl-ammonium iodide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SE8T", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "TAK-831": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D03RXS", "drug_id_DB": "", "metabolic_annotation_str": "DAO(D-amino acid oxidase (DAO) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DAO"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1610"]}, "L-Phenylalanine": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0R1CR", "drug_id_DB": "", "metabolic_annotation_str": "TH(Tyrosine 3-monooxygenase (TH) ,MOA:Binder); ", "drug_status_DB": "", "metabolic_genes_name": ["TH"], "metabolic_mechanism_of_action": ["Binder"], "metabolic_genes_id": ["7054"]}, "N5-[4-(3-Phenylpropoxy)phenyl]-L-glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01YJJ", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "Patuletin 3-O-beta-D-galactoside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z3FX", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Uridine-Diphosphate-N-Acetylglucosamine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "MGAT1(Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase); ", "drug_id_TTD": "", "drug_id_DB": "DB03397", "metabolic_annotation_str": "GALE(UDP-glucose 4-epimerase); UAP1(UDP-N-acetylhexosamine pyrophosphorylase); EXTL2(Exostosin-like 2); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["GALE", "UAP1", "EXTL2"], "metabolic_genes_id": ["2582", "6675", "2135"]}, "6-Carboxymethyluracil": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O0AI", "drug_id_DB": "DB03048", "metabolic_annotation_str": "DPYD(Dihydrothymine dehydrogenase (DPYD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["DPYD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1806"]}, "PMID25815140C48": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05TGQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC28A2(Solute carrier family 28 member 2 (SLC28A2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC28A2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9153"]}, "(-)-cubebininolide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KIF", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1576"]}, "E5700": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07JLS", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "N-Formylmethionine(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "SERPINC1(Antithrombin-III); HLA-B(HLA class I histocompatibility antigen, B-27 alpha chain); HLA-B(HLA class I histocompatibility antigen, B-27 alpha chain); HLA-B(HLA class I histocompatibility antigen, B-27 alpha chain); HLA-B(HLA class I histocompatibility antigen, B-27 alpha chain); HLA-B(HLA class I histocompatibility antigen, B-27 alpha chain); HLA-B(HLA class I histocompatibility antigen, B-27 alpha chain); S100B(Protein S100-B); RNASE1(Ribonuclease pancreatic); UBC(Polyubiquitin-C); S100G(Protein S100-G); RABGGTB(Geranylgeranyl transferase type-2 subunit beta); B2M(Beta-2-microglobulin); B2M(Beta-2-microglobulin); CLPP(ATP-dependent Clp protease proteolytic subunit, mitochondrial); RABGGTA(Geranylgeranyl transferase type-2 subunit alpha); RABGGTA(Geranylgeranyl transferase type-2 subunit alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB04464", "metabolic_annotation_str": "MT-CO1(Cytochrome c oxidase subunit 1); MT-CO2(Cytochrome c oxidase subunit 2); MT-CO3(Cytochrome c oxidase subunit 3); MT-ND1(NADH-ubiquinone oxidoreductase chain 1); COX6C(Cytochrome c oxidase subunit 6C); COX8A(Cytochrome c oxidase subunit 8A, mitochondrial); COX5B(Cytochrome c oxidase subunit 5B, mitochondrial); COX4I1(Cytochrome c oxidase subunit 4 isoform 1, mitochondrial); COX6B1(Cytochrome c oxidase subunit 6B1); COX7C(Cytochrome c oxidase subunit 7C, mitochondrial); COX5A(Cytochrome c oxidase subunit 5A, mitochondrial); COX7A1(Cytochrome c oxidase subunit 7A1, mitochondrial); COX7B(Cytochrome c oxidase subunit 7B, mitochondrial); COX6A2(Cytochrome c oxidase subunit 6A2, mitochondrial); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["MT-CO1", "MT-CO2", "MT-CO3", "MT-ND1", "COX6C", "COX8A", "COX5B", "COX4I1", "COX6B1", "COX7C", "COX5A", "COX7A1", "COX7B", "COX6A2"], "metabolic_genes_id": ["4512", "4513", "4514", "4535", "1345", "1351", "1329", "1327", "1340", "1350", "9377", "1346", "1349", "1339"]}, "UNC0638": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0GK7A", "drug_id_DB": "", "metabolic_annotation_str": "EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT2(Histone-lysine N-methyltransferase EHMT2 (EHMT2) ,MOA:Inhibitor); EHMT1(Euchromatic histone-lysine N-methyltransferase 1 (EHMT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT2", "EHMT1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["10919", "10919", "10919", "10919", "10919", "10919", "10919", "79813"]}, "1-Adamantan-1-yl-3-(2-methoxy-phenyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09DPC", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "Mercuribenzoic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CGS", "drug_id_DB": "DB03975", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "3-Sulfinoalanine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E8JM", "drug_id_DB": "", "metabolic_annotation_str": "GSR(Glutathione reductase (GR) ,MOA:Inhibitor); HMGCS2(Hydroxymethylglutaryl-CoA synthase 2 (HMGCS2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GSR", "HMGCS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2936", "3158"]}, "N-isopropyl estradiol-16-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08CXO", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "Geranyl Diphosphate(TTD)": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02YHA", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "1-(4-Nitro-2-phenylsulfanylbenzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F4WQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "N-[2-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01RDB", "drug_id_DB": "", "metabolic_annotation_str": "SLC9A1(Sodium/hydrogen exchanger 1 (SLC9A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC9A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6548"]}, "Bip-tyr-thr-pro-ala-thr(obzl)-gly": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z8DJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6531", "6531"]}, "2-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04VNR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "GLUTARATE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04XDS", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A8(Solute carrier family 22 member 8 (SLC22A8) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A8"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["9376"]}, "[6,3''']biflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07VJT", "drug_id_DB": "", "metabolic_annotation_str": "PLA2G4A(Cytosolic phospholipase A2 (GIVA cPLA2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PLA2G4A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5321"]}, "RC-8800": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D09WTQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP46A1(Cholesterol 24-monooxygenase (CYP46A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP46A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["10858"]}, "PELITREXOL": {"drug_status_TTD": ["Phase 2", "Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0J9IH", "drug_id_DB": "", "metabolic_annotation_str": "GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); GART(Glycinamide ribonucleotide formyltransferase (GART) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GART", "GART"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2618", "2618"]}, "OLPADRONIC ACID SODIUM SALT": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0OJ5M", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2224"]}, "6-hydroxy-1,2,9-trimethyl-9H-beta-carbolin-2-ium": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G5TL", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "4-(4'-Fluoro-biphenyl-4-ylmethyl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00DSE", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1586", "1584"]}, "ISIS 32028": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06IZU", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "ISIS 32021": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05YJU", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "ISIS 32020": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H7CG", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CB(PI3K p110 beta messenger RNA (PIK3CB mRNA) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CB"], "metabolic_mechanism_of_action": ["."], "metabolic_genes_id": ["5291"]}, "4-(Cyanomethylthio)pyridine-3-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01OTW", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "1-(3-phenylpropyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D09TTR", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "KOJIC ACID": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0F3CO", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "5alpha-Androstan-3,17-Dione": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T5MO", "drug_id_DB": "", "metabolic_annotation_str": "HSD3B1(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); HSD3B2(Hydroxysteroid dehydrogenase 3-beta (HSD3B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD3B1", "HSD17B1", "HSD3B2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3283", "3292", "3284"]}, "HS-173": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R2UG", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "8-prenylquercetin": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0W2BI", "drug_id_DB": "", "metabolic_annotation_str": "PDE5A(Phosphodiesterase 5A (PDE5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE5A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["8654"]}, "2-(Carbazole-9-sulfonyl)-benzoic acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C1DG", "drug_id_DB": "", "metabolic_annotation_str": "FABP4(Fatty acid-binding protein 4 (FABP4) ,MOA:Inhibitor); FABP5(Fatty acid-binding protein 5 (FABP5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FABP4", "FABP5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2167", "2171"]}, "CS-891B": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D06AVN", "drug_id_DB": "", "metabolic_annotation_str": "SRD5A1(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); SRD5A3(Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SRD5A1", "SRD5A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6715", "79644"]}, "Organon-2": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0O5ZT", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6536"]}, "Organon-3": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0I6JG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6536"]}, "3-(3,4-dihydronaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I5NW", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "4-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07ZCD", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "PONKORANOL": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05GYF", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "ML-3163": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); MAPK12(MAP kinase p38 (MAPK12) ,MOA:Inhibitor); MAPK11(Stress-activated protein kinase 2b (p38 beta) ,MOA:Inhibitor); MAPK14(Stress-activated protein kinase 2a (p38 alpha) ,MOA:Inhibitor); ", "drug_id_TTD": "D08DSJ", "drug_id_DB": "", "metabolic_annotation_str": "CYP3A4(Albendazole monooxygenase (CYP3A4) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP3A4", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1576", "1565", "1565", "1565", "1565", "1565"]}, "2-Bromoacetyl Group": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05DOM", "drug_id_DB": "DB02198", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Kojic acid-phenylalanine amide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0ZK2F", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0RK7J", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768"]}, "Purine Riboside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0R7RB", "drug_id_DB": "", "metabolic_annotation_str": "ADA(Adenosine deaminase (ADA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ADA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["100"]}, "Isosorbide-2-benzylcarbamate-5-acetate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06BDB", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "Phenazone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D03IRR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Dextromethorphan Polistirex": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "SIGMAR1(Opioid receptor sigma 1 (OPRS1) ,MOA:Modulator); ", "drug_id_TTD": "D00KFB", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "9-O-[2-(Phenylol-1-yloxy)ethyl]berberine bromide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01DHW", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "(S)(+)-7-fluoro-2-phenylchroman-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I5CZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "1-Adamantan-1-yl-3-(4-hydroxy-decyl)-urea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9ZN", "drug_id_DB": "", "metabolic_annotation_str": "EPHX2(Soluble epoxide hydrolase (EPHX2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["EPHX2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2053"]}, "3-Fluoren-9-ylidenemethyl-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D00GCK", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "GZ402666": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D0Q1UB", "drug_id_DB": "", "metabolic_annotation_str": "GAA(Lysosomal alpha-glucosidase (GAA) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["GAA"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["2548"]}, "Lornoxicam": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0UL2L", "drug_id_DB": "DB06725", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "Hexahydro naphthalene derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0M9ZW", "drug_id_DB": "", "metabolic_annotation_str": "HMGCR(HMG-CoA reductase (HMGCR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMGCR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3156"]}, "SRI-224": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D02JWY", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "SC-560": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M5MI", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "Deserpidine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D09HDR", "drug_id_DB": "", "metabolic_annotation_str": "ACE(Angiotensin-converting enzyme (ACE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1636"]}, "N-(pyridin-3-ylmethyl)aniline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G0JC", "drug_id_DB": "DB06851", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "ARH-1029": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E2MI", "drug_id_DB": "", "metabolic_annotation_str": "ATP4A(Gastric H(+)/K(+) ATPase alpha (ATP4A) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ATP4A"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["495"]}, "RDEA3170": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0P3ZN", "drug_id_DB": "", "metabolic_annotation_str": "SLC22A12(Urate anion exchanger 1 (URAT1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC22A12"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["116085"]}, "PMID27967267-Compound-neostenine": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03WGA", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "JES-9501": {"drug_status_TTD": ["Phase 1"], "non_metabolic": "", "drug_id_TTD": "D09MEV", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["590"]}, "Tetraethylene Glycol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0D9PI", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Phenylbutazone(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB00812", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1); PTGS2(Prostaglandin G/H synthase 2); PTGIS(Prostacyclin synthase); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["PTGS1", "PTGS2", "PTGIS"], "metabolic_genes_id": ["5742", "5743", "5740"]}, "3,4'-(Ethane-1,2-diyl)dibenzenamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D08KLN", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "8-methyl-2-morpholino-7-phenyl-4H-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07BFF", "drug_id_DB": "", "metabolic_annotation_str": "PDE3A(Phosphodiesterase 3A (PDE3A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE3A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5139"]}, "NSC-106547": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05GWI", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "8-Acetyl-7-hydroxy-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K1FG", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "Alstiphyllanine D": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L8OJ", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "Alstiphyllanine E": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D05AZW", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "Alstiphyllanine F": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D01DIQ", "drug_id_DB": "", "metabolic_annotation_str": "SLC5A1(Sodium/glucose cotransporter 1 (SGLT1) ,MOA:Inhibitor); SLC5A2(SLC5A2 messenger RNA (SLC5A2 mRNA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC5A1", "SLC5A2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6523", "6524"]}, "ETH615": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0H7GH", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["240", "240"]}, "(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FR3X", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "NSC-93405": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K8EE", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "1-(3,5-dimethylphenyl)-2-(phenylsulfonyl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Q2MI", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "N5-[4-(Phenylmethoxy)phenyl]-D-glutamine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0U1EV", "drug_id_DB": "", "metabolic_annotation_str": "LTA4H(Leukotriene A-4 hydrolase (LTA4H) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["LTA4H"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4048"]}, "4-Methylthiopyridine-3-sulfonamide": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J7GU", "drug_id_DB": "", "metabolic_annotation_str": "CA12(Carbonic anhydrase XII (CA-XII) ,MOA:Inhibitor); CA1(Carbonic anhydrase I (CA-I) ,MOA:Inhibitor); CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); CA14(Carbonic anhydrase XIV (CA-XIV) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA12", "CA1", "CA2", "CA9", "CA14"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["771", "759", "760", "768", "23632"]}, "[2-(6-Chloro-purin-9-yl)ethyl]-bisphosphonic acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0MY0R", "drug_id_DB": "", "metabolic_annotation_str": "FDPS(Geranyltranstransferase (FDPS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDPS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2224"]}, "N-benzyl-2-morpholinopyrimidin-4-amine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z4OS", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "CALYSTEGINE B2": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S4DV", "drug_id_DB": "", "metabolic_annotation_str": "GLA(Alpha-galactosidase A (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2717"]}, "3-MeSO2-DDE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X4LQ", "drug_id_DB": "", "metabolic_annotation_str": "CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1584"]}, "DEOXYGALACTONOJIRIMYCIN": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D07CAW", "drug_id_DB": "", "metabolic_annotation_str": "GLA(Alpha-galactosidase A (GLA) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["GLA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2717"]}, "6-(3-Hydroxyphenyl)-1-phenyl-2-naphthol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V2QH", "drug_id_DB": "", "metabolic_annotation_str": "HSD17B1(Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD17B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3292"]}, "10R-hydroxylobelane": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09WVS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Citalopram": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0Y5DO", "drug_id_DB": "DB00215", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["6532"]}, "2-Aminomethyl-5-(p-t-butylphenyl)tetrahydrofuran": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02YSN", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "5-Fluorolevulinic Acid": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0NV2V", "drug_id_DB": "", "metabolic_annotation_str": "ALAD(Delta-aminolevulinic acid dehydratase (ALAD) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ALAD"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["210"]}, "Nabumetone(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D05CKR", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Azetidine derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0IY1Z", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "3-[4-Methyl-indan-(1E)-ylidenemethyl]-pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04CLL", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "ARQ 761": {"drug_status_TTD": ["Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0DR0P", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "CZC 24832": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06PWI", "drug_id_DB": "", "metabolic_annotation_str": "PIK3CG(PI3-kinase gamma (PIK3CG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PIK3CG"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5294"]}, "5'-Methylthio-ImmH": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0E6BI", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "SSR-103800": {"drug_status_TTD": ["Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0Y9KR", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A9(Glycine transporter GlyT-1 (SLC6A9) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A9"], "metabolic_mechanism_of_action": ["Blocker"], "metabolic_genes_id": ["6536"]}, "4'-(p-toluenesulfonamide)-3,4-dihydroxy chalcone": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O6OI", "drug_id_DB": "", "metabolic_annotation_str": "MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); MGAM(Intestinal maltase-glucoamylase (MGAM) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MGAM", "MGAM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["8972", "8972"]}, "WIN-35065": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02LQG", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6532", "6531", "6531"]}, "Hexadecanal(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "RHO(Rhodopsin); ", "drug_id_TTD": "", "drug_id_DB": "DB03381", "metabolic_annotation_str": "DBI(Acyl-CoA-binding protein); ", "drug_status_DB": "Experimental", "metabolic_genes_name": ["DBI"], "metabolic_genes_id": ["1622"]}, "1-(4-methyl-benzyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N5GZ", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "S 3025": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S5RY", "drug_id_DB": "", "metabolic_annotation_str": "SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); SLC37A4(Glucose-6-phosphate translocase (SLC37A4) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC37A4", "SLC37A4"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["2542", "2542"]}, "5-Methyl-3,4-diphenyl-isoxazole": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D04YPP", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "Hydroxydimethylarsine Oxide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06YEV", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); NOS3(Nitric-oxide synthase endothelial (NOS3) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1", "NOS3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["231", "4846"]}, "1-butyryl-1H-indole-2,3-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0M5NR", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "PMID25399762-Compound-Figure1-Eryngiolide A": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0N1CG", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "PMID26666989-Compound-Figure9middle06": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0TY4L", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9middle07": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0AJ3H", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9middle04": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D02KWZ", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9middle05": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D07POD", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9middle02": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0N1IA", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9middle03": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D00PEV", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "PMID26666989-Compound-Figure9middle01": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0YE8Q", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "1,1,1-trifluorododecan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I7FF", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "PMID26666989-Compound-Figure9middle08": {"drug_status_TTD": ["Patented", "Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D09PAZ", "drug_id_DB": "", "metabolic_annotation_str": "PYGL(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGB(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); PYGM(Glycogen phosphorylase (PYG) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PYGL", "PYGB", "PYGM"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5836", "5834", "5837"]}, "Tacrine-coumarin hybrid derivative 1": {"drug_status_TTD": ["Patented", "Patented"], "non_metabolic": "", "drug_id_TTD": "D0T9JB", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:.); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:.); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": [".", "."], "metabolic_genes_id": ["4128", "4129"]}, "3-(3-cyano-1H-indol-6-yl)-1-methyl-1-phenylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0G3BY", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "1-hydroxy-3-phenylurea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T4WL", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Hydralazine(TTD)": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0K1XK", "drug_id_DB": "", "metabolic_annotation_str": "AOC3(Membrane copper amine oxidase (AOC3) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["AOC3"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["8639"]}, "1-(1-Biphenyl-4-yl-butyl)-1H-imidazole": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0SU0Y", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "7-methoxy-8-propionyl-2H-chromen-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0T9BB", "drug_id_DB": "", "metabolic_annotation_str": "CA9(Carbonic anhydrase IX (CA-IX) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA9"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["768"]}, "ERITADENINE": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X7PP", "drug_id_DB": "", "metabolic_annotation_str": "AHCY(Adenosylhomocysteinase (AHCY) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AHCY"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["191"]}, "Sulfamic acid 3-(4-methoxy-benzoyl)-phenyl ester": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KKB", "drug_id_DB": "", "metabolic_annotation_str": "STS(Steryl-sulfatase (STS) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["STS"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["412"]}, "1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0K1NM", "drug_id_DB": "DB07342", "metabolic_annotation_str": "HMOX1(Heme oxygenase 1 (HMOX1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HMOX1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3162"]}, "4-(2-((3-fluorophenoxy)methyl)phenyl)piperidine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0H2TS", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "CI-1044": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0DL6J", "drug_id_DB": "", "metabolic_annotation_str": "PDE4A(Phosphodiesterase 4A (PDE4A) ,MOA:Inhibitor); PDE4B(Phosphodiesterase 4B (PDE4B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE4A", "PDE4B"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5141", "5142"]}, "3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); ", "drug_id_TTD": "D02GFK", "drug_id_DB": "", "metabolic_annotation_str": "CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP2D6(Debrisoquine 4-hydroxylase (CYP2D6) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP2D6", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1565", "1565", "1565", "1565", "1565", "1584"]}, "(S)-N2-[4-(benzyloxy)benzyl]alaninamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05OTR", "drug_id_DB": "", "metabolic_annotation_str": "MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOB"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4129"]}, "(S)-FLURBIPROFEN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "PSEN1(Gamma-secretase (GS) ,MOA:Inhibitor); PSEN1(Presenilin 1 (PSEN1) ,MOA:Inhibitor); PSEN2(Presenilin 2 (PSEN2) ,MOA:Inhibitor); APH1B(Gamma-secretase (GS) ,MOA:Inhibitor); NCSTN(Gamma-secretase (GS) ,MOA:Inhibitor); APH1A(Gamma-secretase (GS) ,MOA:Inhibitor); PSENEN(Gamma-secretase (GS) ,MOA:Inhibitor); ", "drug_id_TTD": "D0G2IC", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["5742", "5743"]}, "7-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02UVG", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "3-(4-methyl-3,4-dihydronaphthalen-2-yl)pyridine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0X1QS", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); CYP11B1(Steroid 11-beta-hydroxylase (CYP11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "CYP11B1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "1584"]}, "Moclobemide(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB01171", "metabolic_annotation_str": "MAOA(Amine oxidase [flavin-containing] A); MAOA(Amine oxidase [flavin-containing] A); MAOB(Amine oxidase [flavin-containing] B); MAOB(Amine oxidase [flavin-containing] B); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["MAOA", "MAOA", "MAOB", "MAOB"], "metabolic_genes_id": ["4128", "4128", "4129", "4129"]}, "Riluzole(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "SCN5A(Sodium channel protein type 5 subunit alpha); ", "drug_id_TTD": "", "drug_id_DB": "DB00740", "metabolic_annotation_str": "SLC7A11(Cystine/glutamate transporter); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["SLC7A11"], "metabolic_genes_id": ["23657"]}, "8-Methoxy-4,9-dihydro-3H-beta-carboline": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "HTR2A(5-HT 2A receptor (HTR2A) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Y1GL", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); MAOB(Monoamine oxidase type B (MAO-B) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA", "MAOB"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["4128", "4129"]}, "1-(4-Chloro-phenyl)-2-p-tolyl-ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L1ST", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1-phenyl-4-(1-phenyl-1H-tetrazol-5-yl)butan-2-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06CPL", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3290"]}, "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 6": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0FV3G", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01RGM", "drug_id_DB": "DB02991", "metabolic_annotation_str": "NOS1(Nitric-oxide synthase brain (NOS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NOS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4842"]}, "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 4": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0QE7X", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 5": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0X2UO", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 2": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0XJ4J", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 3": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LI6Z", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0UR7K", "drug_id_DB": "", "metabolic_annotation_str": "PDE2A(Phosphodiesterase 2A (PDE2A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PDE2A"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5138"]}, "Apigenin-7-O-beta-D-glucuronide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01LWJ", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "Org-33201": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Y1EX", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Modulator"], "metabolic_genes_id": ["1588"]}, "4-formylphenyl-O-beta-D-ribopyranoside": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0FS3L", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "DUP 697": {"drug_status_TTD": ["Discontinued in Phase 1"], "non_metabolic": "", "drug_id_TTD": "D08GRY", "drug_id_DB": "", "metabolic_annotation_str": "PTGS2(Prostaglandin G/H synthase 2 (COX-2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5743"]}, "Felbinac prodrug": {"drug_status_TTD": ["Preclinical", "Preclinical"], "non_metabolic": "", "drug_id_TTD": "D0T2ZQ", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase (COX) ,MOA:Modulator); PTGS2(Prostaglandin G/H synthase (COX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1", "PTGS2"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["5742", "5743"]}, "7-Oxo-7H-dibenzo[de,g]quinoline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0I3UA", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "(R,S)-N-(R-phenylethyl)-1H-pyrrole-2-carboxamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04UYZ", "drug_id_DB": "", "metabolic_annotation_str": "MAOA(Monoamine oxidase type A (MAO-A) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["MAOA"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4128"]}, "Febuxostat": {"drug_status_TTD": ["Approved"], "non_metabolic": "", "drug_id_TTD": "D0A5SE", "drug_id_DB": "DB04854", "metabolic_annotation_str": "XDH(Xanthine dehydrogenase/oxidase (XDH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["XDH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7498"]}, "3-methoxy-4-(oxazol-5-yl)aniline": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0L0ZP", "drug_id_DB": "", "metabolic_annotation_str": "IMPDH2(Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IMPDH2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3615"]}, "EUK-189": {"drug_status_TTD": ["Phase 1", "Phase 1"], "non_metabolic": "", "drug_id_TTD": "D06VAQ", "drug_id_DB": "", "metabolic_annotation_str": "SOD1(Superoxide dismutase Cu-Zn (SOD Cu-Zn) ,MOA:Modulator); CAT(Catalase (CAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SOD1", "CAT"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["6647", "847"]}, "N-n-heptyl-7-methoxytacrine hydrochloride": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0C0XU", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "FPL-62064": {"drug_status_TTD": ["Phase 3", "Phase 3"], "non_metabolic": "", "drug_id_TTD": "D02YEY", "drug_id_DB": "", "metabolic_annotation_str": "ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ALOX5(Arachidonate 5-lipoxygenase (5-LOX) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["ALOX5", "ALOX5"], "metabolic_mechanism_of_action": ["Modulator", "Modulator"], "metabolic_genes_id": ["240", "240"]}, "PMID7629799C6": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06AJN", "drug_id_DB": "", "metabolic_annotation_str": "FDFT1(Squalene synthetase (FDFT1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["FDFT1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["2222"]}, "Octahydro-pyrrolo[3,4-c]-pyrrole derivative 1": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0E3ED", "drug_id_DB": "", "metabolic_annotation_str": "ENPP2(Extracellular lysophospholipase D (E-NPP2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ENPP2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5168"]}, "N-(piperidin-4-yl)-N-propyl-2-naphthamide": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "KCNH2(Voltage-gated potassium channel Kv11.1 (KCNH2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0A7GW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A4"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6532"]}, "4-amino-N-p-tolylbenzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04ORY", "drug_id_DB": "", "metabolic_annotation_str": "PTGS1(Prostaglandin G/H synthase 1 (COX-1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PTGS1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["5742"]}, "propargylglycine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D06HNS", "drug_id_DB": "", "metabolic_annotation_str": "CTH(Cystathionine gamma-lyase (CTH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CTH"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1491"]}, "Methyl Phosphinic Acid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J4QH", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE", "ACHE"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["590", "43"]}, "S-2-(o-toluidino)-2-oxoethyl carbamothioate": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9BS", "drug_id_DB": "", "metabolic_annotation_str": "TYR(Tyrosinase (TYR) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TYR"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7299"]}, "Glimepiride(TTD)": {"drug_status_TTD": ["Approved", "Approved"], "non_metabolic": "", "drug_id_TTD": "D0B2GI", "drug_id_DB": "", "metabolic_annotation_str": "ABCC9(ATP-binding cassette transporter C9 (ABCC9) ,MOA:Blocker); ABCC8(ATP-binding cassette transporter C8 (ABCC8) ,MOA:Blocker); ", "drug_status_DB": "", "metabolic_genes_name": ["ABCC9", "ABCC8"], "metabolic_mechanism_of_action": ["Blocker", "Blocker"], "metabolic_genes_id": ["10060", "6833"]}, "PMID27977313-Compound-17": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D03CQQ", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PF-18298": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D06EMC", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Inhibitor); SLC6A4(Serotonin transporter (SERT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); SLC6A3(Dopamine transporter (DAT) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A4", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor", "Inhibitor", "Inhibitor"], "metabolic_genes_id": ["6530", "6532", "6531", "6531"]}, "PMID27977313-Compound-19": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D0LB6Q", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "PMID27977313-Compound-18": {"drug_status_TTD": ["Patented"], "non_metabolic": "", "drug_id_TTD": "D00CLK", "drug_id_DB": "", "metabolic_annotation_str": "TXNRD1(Cytoplasmic thioredoxin reductase (TXNRD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["TXNRD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["7296"]}, "4-(2,2-Diphenyl-vinyl)-pyridine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0Z4GR", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "1,1,1-trifluoro-3-(octylsulfonyl)propan-2-one": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D00IAK", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "1,2-bis(2,4-difluorophenyl)ethane-1,2-dione": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D02HQS", "drug_id_DB": "", "metabolic_annotation_str": "CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); CES1(Liver carboxylesterase (CES1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CES1", "CES1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1066", "1066"]}, "5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D0V2QF", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ST3GAL5(Lactosylceramide alpha-2,3-sialyltransferase (ST3GAL5) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1", "ST3GAL5"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["262", "8869"]}, "3-fluoro-4'-(1-(pyridin-4-yl)propyl)biphenyl-4-ol": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0J4VA", "drug_id_DB": "", "metabolic_annotation_str": "CYP17A1(Steroid 17-alpha-monooxygenase (S17AH) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP17A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1586"]}, "5'-Deoxy-5'-(N,N-dimethylamino)-8-methyladenosine": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YM6B", "drug_id_DB": "", "metabolic_annotation_str": "AMD1(S-adenosylmethionine decarboxylase proenzyme (AMD1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AMD1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["262"]}, "8-aza-DADMe-ImmH": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0N2AA", "drug_id_DB": "", "metabolic_annotation_str": "PNP(Purine nucleoside phosphorylase (PNP) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["PNP"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["4860"]}, "3,5-Difluorobenzenesulfonamide": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0S6GK", "drug_id_DB": "DB02087", "metabolic_annotation_str": "CA2(Carbonic anhydrase II (CA-II) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CA2"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["760"]}, "(4-bromophenyl)(10H-phenothiazin-10-yl)methanone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D01XKY", "drug_id_DB": "", "metabolic_annotation_str": "BCHE(Cholinesterase (BCHE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["BCHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["590"]}, "S-(4-Chlorobenzyl)isothiourea hydrochloride": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0O9QG", "drug_id_DB": "", "metabolic_annotation_str": "IDO1(Indoleamine 2,3-dioxygenase 1 (IDO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["IDO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["3620"]}, "6-Imidazol-1-yl-isoquinoline": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D08PKR", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); TBXAS1(Thromboxane-A synthase (TBXAS1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1", "TBXAS1"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["1588", "6916"]}, "3-(imidazolylmethyl)-7-methoxy-4'-nitroflavone": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D04VRY", "drug_id_DB": "", "metabolic_annotation_str": "CYP19A1(Aromatase (CYP19A1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["CYP19A1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1588"]}, "(5-Bromo-pentyl)-trimethyl-ammonium": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D05KZH", "drug_id_DB": "", "metabolic_annotation_str": "ACHE(Acetylcholinesterase (AChE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["ACHE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["43"]}, "Rilapladib(Drug Bank)": {"drug_status_TTD": [], "non_metabolic": "", "drug_id_TTD": "", "drug_id_DB": "DB05119", "metabolic_annotation_str": "PLA2G7(Platelet-activating factor acetylhydrolase); ", "drug_status_DB": "Investigational", "metabolic_genes_name": ["PLA2G7"], "metabolic_genes_id": ["7941"]}, "Manifaxine": {"drug_status_TTD": ["Discontinued in Phase 2", "Discontinued in Phase 2", "Discontinued in Phase 2"], "non_metabolic": "", "drug_id_TTD": "D0O6QW", "drug_id_DB": "", "metabolic_annotation_str": "SLC6A2(Norepinephrine transporter (NET) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); SLC6A3(Dopamine transporter (DAT) ,MOA:Modulator); ", "drug_status_DB": "", "metabolic_genes_name": ["SLC6A2", "SLC6A3", "SLC6A3"], "metabolic_mechanism_of_action": ["Modulator", "Modulator", "Modulator"], "metabolic_genes_id": ["6530", "6531", "6531"]}, "NSC-99528": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "NQO2(Quinone reductase 2 (NQO2) ,MOA:Inhibitor); ", "drug_id_TTD": "D0M0WT", "drug_id_DB": "", "metabolic_annotation_str": "NQO1(Quinone reductase 1 (NQO1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["NQO1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["1728"]}, "2-(3,4-Dihydroxy-phenyl)-7-hydroxy-chromen-4-one": {"drug_status_TTD": ["Investigative"], "non_metabolic": "", "drug_id_TTD": "D0YJ3Q", "drug_id_DB": "", "metabolic_annotation_str": "AKR1B1(Aldose reductase (AKR1B1) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["AKR1B1"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["231"]}, "11-keto-beta-boswellicacid": {"drug_status_TTD": ["Investigative", "Investigative"], "non_metabolic": "", "drug_id_TTD": "D09VYW", "drug_id_DB": "", "metabolic_annotation_str": "HSD11B1(Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) ,MOA:Inhibitor); HSD11B2(Corticosteroid 11-beta-dehydrogenase 2 (HSD11B2) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["HSD11B1", "HSD11B2"], "metabolic_mechanism_of_action": ["Inhibitor", "Inhibitor"], "metabolic_genes_id": ["3290", "3291"]}, "PEDUNCULAGIN": {"drug_status_TTD": ["Investigative", "Investigative", "Investigative"], "non_metabolic": "F2(Coagulation factor IIa (F2) ,MOA:Inhibitor); F10(Coagulation factor Xa (F10) ,MOA:Inhibitor); ", "drug_id_TTD": "D0Z2TG", "drug_id_DB": "", "metabolic_annotation_str": "SQLE(Squalene monooxygenase (SQLE) ,MOA:Inhibitor); ", "drug_status_DB": "", "metabolic_genes_name": ["SQLE"], "metabolic_mechanism_of_action": ["Inhibitor"], "metabolic_genes_id": ["6713"]}}, "targets_drug_dict": {"['2571', '2572']": ["s-allylglycine"], "['5290', '5294']": ["GDC-0032"], "['3176']": ["Diphenhydramine(TTD)", "(L-)-S-adenosyl-L-homocysteine", "4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE", "Metoprine", "Amodiaquine"], "['27115', '50940', '5136', '5137', '5138', '5139', '5140', '5140', '5141', '5142', '5142', '5143', '5144', '5144', '5145', '5146', '5150', '5151', '5152', '5153', '5153', '5158', '5290', '5291', '5293', '8622', '8654', '8654']": ["Caffeine(Drug Bank)"], "['6715', '6718']": ["Finasteride(Drug Bank)"], "['4047', '4047']": ["Tetradecane", "PMID22533316C4", "PMID22533316C3", "PMID22533316C1", "ZD-9720", "BIBX-79", "Ro48-8071", "PMID9003518C3", "[3-(Biphenyl-4-yloxy)-propyl]-dimethyl-amine", "BIBB-515", "Lanosterol", "29-methylidene-2,3-oxidosqualene", "PMID9003518C4"], "['1806', '7298']": ["Fluorouracil(TTD)"], "['4128', '4129', '6531', '6531', '6532', '6571']": ["Beta-methoxyamphetamine"], "['1585', '1586', '6715', '79644']": ["Spironolactone(Drug Bank)"], "['8833']": ["2,3,4-tribromo-6-(2,4-dibromophenoxy)phenol", "Decoyinine", "3,4,5-tribromo-2-(2', 4'-dibromo-phenoxy)phenol", "3,5-dibromo-2-(2,4-dibromophenoxy)phenol"], "['43', '590']": ["3-[6-(benzylmethylamino)hexyloxy]xanthen-9-one", "CHF-2819", "BENZOQUINONE", "LIPOCRINE", "Isosorbide-2-benzylcarbamate-5-cyclopropanoate", "N,N'-(1',8'-octylene)-bis-(-)-nor-MEP", "Tacrine heterodimer derivative 1", "6-methoxy-2-methyl-9H-beta-carbolin-2-ium", "9-O-[2-(Phenylol-1-yloxy)hexyl]berberine bromide", "Isosorbide-di-(ethylcarbamate)", "N,N'-(1',12'-dodecydene)-bis-(-)-nor-MEP", "1,2-Di(berberine-9-O-yl)ethane dibromide", "Decyle nelycorine dibromo salt derivative 1", "(-)-Tolserine", "Isosorbide-2-(methylcarbamate)-5-mononitrate", "9-O-[3-(2-Pyridinoxyl)butyl]-berberine bromide", "9-O-[3-(4-Nitro-phenoxyl)butyl]-berberine bromide", "N,N'-(1',9'-nonylene)-bis-(-)-nor-MEP", "9-O-[3-(4-Bromo-phenoxyl)butyl]-berberine bromide", "CAPROCTAMINE", "3-(2-Diethylamino-propionamino)-rutaecarpine", "3-(2-N-Piperidyl-propionamino)-rutaecarpine", "Bis-7-tacrine", "Egonol compound 1", "N,N'-(1',6-hexylene)-bis-(-)-nor-MEP", "1,3-Di(berberine-9-O-yl)ethane dibromide", "TOLSERINE", "Pyridostigmine(Drug Bank)", "9-O-[3-(Phenylamino)propyl]-berberine bromide", "9-O-[3-(Phenylol-1-yloxy)propyl]berberine bromide", "Isosorbide-2-(methylcarbamate)-5-benzoate", "N-n-pentyl-7-methoxytacrine hydrochloride", "PMID29757691-Compound-2a", "MEMOQUIN", "3-[4-(benzylmethylamino)butoxy]xanthen-9-one", "N,N'-(1',11'-undecydene)-bis-(-)-nor-MEP", "6-chlorotacrine hydrochloride", "9-O-[4-(Phenylol-1-yloxy)butyl]berberine bromide", "3-(2-N-Pyrrolyl-propionamino)-rutaecarpine", "XANTHOSTIGMINE", "Huprine X", "PMID29757691-Compound-8c", "PMID29757691-Compound-8b", "PMID29757691-Compound-8a", "(+/-)-huprineY hydrochloride", "6-hydroxy-1,2-dimethyl-9H-beta-carbolin-2-ium", "N-n-hexyl-7-methoxytacrine hydrochloride", "1,11-bis(pyridinium)-undecane dibromide", "N,N'-(1',7'-heptylene)-bis-(-)-nor-MEP", "24-ethyl-cholest-7-ene-3,5,6-triol", "N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine", "N,N'-(1',10'-decylene)-bis-(-)-nor-MEP", "PMID29757691-Compound-2a-i", "Isochroman-4-ketone derivative 1", "3-[7-(benzylmethylamino)-heptyloxy]xanthen-9-one", "1,10-bis(pyridinium)-decane dibromide", "LAWSARITOL", "6-methoxy-1,9-dimethyl-9H-pyrido[3,4-b]indole", "2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine", "PMID29757691-Compound-8d", "3-(dimethylamino)phenyl phenylcarbamate", "3-[8-(benzylmethylamino)octyloxy]xanthen-9-one", "2-Propyl-beta-carboline-2-ium iodide", "9-Ethyl-2-methyl-beta-carboline-2-ium iodide", "Quinazoline alkaloid derivative 1", "Indoline derivative 1", "HALOXYSTEROL A", "HALOXYSTEROL B", "3-[3-(benzylmethylamino)propoxy]xanthen-9-one", "Rivastigmine(Drug Bank)", "Di-substituted piperidine derivative 2", "9-O-[5-(Phenylol-1-yloxy)pentyl]berberine bromide", "N-benzyl-2-thiomorpholinopyrimidin-4-amine", "6-methoxy-1,2-dimethyl-9H-beta-carbolin-2-ium", "PMID29757691-Compound-7", "N-Methyl-1'H-phenothiazine-1'-carboxamide", "(-)-Phenserine", "Galantamine(Drug Bank)", "PMID29757691-Compound-10", "6-hydroxy-2-methyl-9H-beta-carbolin-2-ium", "24-ethylcholest-6-ene-3,5-diol", "3-[5-(benzylmethylamino)pentyloxy]xanthen-9-one", "N-n-octyl-7-methoxytacrine hydrochloride", "3-(2-Diethylamino-acetamino)-rutaecarpine", "Isosorbide-di-(benzylcarbamate)", "Isoflurophate(Drug Bank)", "Isosorbide-2-benzylcarbamate-5-cyclopentanoate", "Huprine-Tacrine Heterodimer", "1,9-bis(pyridinium)-nonane dibromide", "3-(2-N-Pyrrolyl-acetamino)-rutaecarpine", "N-n-nonyl-7-methoxytacrine hydrochloride", "N,N'-(1',5'-pentylene)-bis-(-)-nor-MEP", "(RS)-tacrine(10)-hupyridone", "Edrophonium(Drug Bank)", "4-ISOPROPYLPHENSERINE", "Eptastigmine", "Haloxysterol C", "Haloxysterol D", "(24S)-ethylcholesta-7,9(11),22(E)-triene-3b-ol", "Iso-OMPA", "1,4-Di(berberine-9-O-yl)ethane dibromide", "6-hydroxy-1,2,9-trimethyl-9H-beta-carbolin-2-ium", "9-O-[2-(Phenylol-1-yloxy)ethyl]berberine bromide", "7-Oxo-7H-dibenzo[de,g]quinoline", "N-n-heptyl-7-methoxytacrine hydrochloride", "Methyl Phosphinic Acid"], "['6576']": ["1,2,3-benzenetricarboxylic acid"], "['6531', '6531', '6534']": ["PMID25037917C58"], "['1588', '2194']": ["biochanin A"], "['3764']": ["Thiamylal(Drug Bank)", "Glisoxepide(Drug Bank)"], "['1152', '1158', '1159', '1160', '548596']": ["Iodoacetamide", "5-(4'-benzoylbiphenyl-4-yl)-2-furoic acid"], "['23632', '759', '760', '768', '771']": ["4-(2-Propynylthio)pyridine-3-sulfonamide", "4,4'-thiodipyridine-3-sulfonamide", "4-(Allylamino)-3-pyridinesulfonamide", "Prop-2-ynyl 4-sulfamoylbenzoate", "4-(Quinolinoxy)-3-pyridinesulfonamide", "2-oxo-2H-thiochromene-3-carboxylic acid", "4-(Carbamolymethylthio)pyridine-3-sulfonamide", "N-propynyl amidebenzenesulphonide", "4-Hydrazino-3-pyridinesulfonamide", "4-(Methylhydrazino)-3-pyridinesulfonamide", "4-Benzythiopyridine-3-sulfonamide", "4-Ethoxy-3-pyridinesulfonamide", "4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide", "4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide", "6-methoxy-2-oxo-2H-chromene-3-carboxylic acid", "4-(Cyanomethylthio)pyridine-3-sulfonamide", "4-Methylthiopyridine-3-sulfonamide"], "['1588', '231', '3292']": ["NSC-94258"], "['1565', '1565', '1565', '1565', '1565', '1584']": ["3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine"], "['6571']": ["Alseroxylon", "SOM3355", "Reserpine(TTD)", "Propylhexedrine(Drug Bank)", "[11C]DTBZ", "Alkavervir", "Deserpidine(Drug Bank)", "Lobeline(TTD)", "NBI-98854", "[125I]7-azido-8-iodoketanserine", "Deutetrabenazine", "[3H]TBZOH", "Tetrabenazine", "Haloperidol(Drug Bank)", "Valbenazine Tosylate"], "['3067']": ["Lixivaptan", "ALPHA-FMH", "AMA", "Brocresine"], "['27115', '50940', '5136', '5137', '5138', '5139', '5140', '5141', '5142', '5143', '5144', '5145', '5146', '5150', '5151', '5152', '5153', '5158', '8622', '8654']": ["Trapidil(Drug Bank)"], "['759', '760', '761', '762', '766']": ["Ethoxzolamide(Drug Bank)", "Methazolamide(Drug Bank)"], "['1545', '231', '240', '240', '246', '2739', '3292']": ["KAEMPFEROL"], "['5290', '5291', '5293', '5294']": ["Buparlisib", "CH-5132799"], "['7372']": ["5-fluoro-6-iodo-UMP", "5-fluoro-6-amino-UMP", "5-Fluoro-6-ethyluridine-5'-O-monophosphate", "Pyrazofurin", "Alpha-Phosphoribosylpyrophosphoric Acid", "6-Hydroxyuridine-5'-Phosphate", "5-fluoro-6-azido-UMP"], "['6240', '7298']": ["Gemcitabine(Drug Bank)"], "['18', '23539', '5091', '5162', '5313', '5313', '5315', '64902', '6566', '6566', '6567', '9123', '9194']": ["Pyruvic acid(Drug Bank)"], "['1545', '5243']": ["TRISMETHOXYRESVERATROL"], "['2222']": ["N-hydroxyglycine derivative", "SQ-34919", "SQ-32709", "3-[1'-{4'-(Benzyloxy)-phenyl}]-quinuclidine-2-ene", "L-731128", "BPH-652", "3-[7'-(Methoxy)-napht-2'-yl]-quinuclidine-2-ene", "A-87049", "ZARAGOZIC ACID B", "J-104123", "PMID7629799C2d", "PMID7629799C2e", "2-[4-(2-Thienyl)phenyl]-4-methylmorpholin-2-ol", "L-731120", "Zaragozic Acid D2", "PMID18754614C9", "PMID8709131C15", "PMID8709131C17", "PMID20299227C12", "ER-119884", "PMID7473541C19", "PMID19191557C8", "PMID19191557C3", "PMID8576905C4", "PMID7473541C20", "PMID7473541C21", "PMID7966163C6d", "PMID7966163C6g", "PMID7966163C6c", "Zwitterionic sulfobetaine derivative", "PMID12238936C3a", "PMID12238936C3f", "PMID7966163C4e", "PMID19191557C21", "Lapaquistat acetate", "CP-294838", "PMID9216829C5m", "PMID9216829C5j", "PMID22464687C15a", "PMID19456099C13", "PMID19456099C15", "RPR-101821", "Squalestatin 1", "PMID9871507C14", "PMID8496919C7", "PMID18754614C10", "PMID18754614C19", "PMID18754614C18", "BMS-187745", "L-735021", "J-104118", "YM-75440", "BPH-830", "PMID8709131C2a (+)", "PMID18754614C17", "PMID18754614C8", "PMID18754614C7", "PMID18754614C4", "PMID8709131C23", "PMID20299227C20", "PMID19191557C19", "PMID19191557C14", "PMID19191557C32", "PMID19191557C35", "PMID7473541C11", "PMID7966163C3f", "1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one", "Zaragozic Acid D", "Zaragozic Acid C", "PMID7650673C4q", "PMID17709461C4g", "(Z)-3-[2-(9H-fluoren-2-yloxy)ethylidene]-quinuclidine hydrochloride 31", "PMID8709131C4", "1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole", "E5700", "PMID7629799C6"], "['210', '2739', '3283', '3284', '760']": ["2-Sulfhydryl-Ethanol"], "['9152']": ["ALX 1393"], "['3162']": ["12-Phenylheme", "Stannsoporfin(TTD)", "Tin protoporphyrin", "Biliverdine Ix Alpha", "2-Phenylheme", "Verdoheme", "1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone"], "['4953', '5837']": ["N'-Pyridoxyl-Lysine-5'-Monophosphate"], "['5950']": ["US9434727, 93", "US8586571, 6", "US8586571, 12", "US8586571, 36", "US9434727, 153", "US8853215, 3", "A1-10436", "A1-10438", "US9434727, 120", "US9434727, 40", "US9434727, 63"], "['4128', '4129', '6530', '6531', '6531', '6532']": ["Phentermine(Drug Bank)"], "['23430', '7177']": ["BMS-262084"], "['1719', '5742', '5743']": ["Aminosalicylic Acid"], "['4846']": ["Se-Ethyl-Isoselenourea", "4-Methyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine", "Tilarginine acetate", "4-Ethyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine", "L-Homoarginine", "7-Nitroindazole-2-Carboxamidine", "N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane", "4-Methyl-3,6-dihydro-1H-pyridin-(2Z)-ylideneamine", "L-NAME", "2-Aminothiazoline(Drug Bank)", "S-Isopropyl-Isothiourea", "S-(Dimethylarsenic)Cysteine", "Cacodylate Ion", "L-2-Amino-4-(Guanidinooxy)Butyric Acid", "N-(Chlorophenyl)-N'-Hydroxyguanidine", "MTR105", "Autologous cell based gene therapy", "L-NMMA", "5,6-Cyclic-Tetrahydropteridine", "1,2,4-Triazole-Carboxamidine", "L-NG-nitroarginine methyl ester", "VAS-203", "6s-5,6,7,8-Tetrahydrobiopterin", "2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine", "AP-Cav"], "['239', '240', '240', '246']": ["PUUPEHEDIONE", "Isojaspic acid", "PUUPEHENONE"], "['18', '4129', '7915']": ["T83193"], "['6530', '6532']": ["Duloxetine(TTD)", "(R)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile", "(S)-NORDULOXETINE", "1-(2-(3-methoxyphenyl)-1-phenylethyl)piperazine", "Amineptine(Drug Bank)", "N,N-dimethyl(2-phenoxyphenyl)methanamine", "((3R,4R)-4-(o-tolyloxy)chroman-3-yl)methanamine", "Amitifadine(Drug Bank)", "Amfepramone", "1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX)", "1-(1-phenyl-2-o-tolylethyl)piperazine", "Paroxetine(Drug Bank)", "2-(2-fluorophenoxy)-3-(piperidin-4-yl)pyridine", "Atomoxetine(Drug Bank)", "4-((naphthalen-2-yloxy)methyl)piperidine", "Levomilnacipran", "1-(2-((3-fluorophenoxy)methyl)phenyl)piperazine", "(S)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile", "norzotepine", "Nortriptyline(Drug Bank)", "Protriptyline(Drug Bank)", "1-(2-(2-fluorobenzyloxy)phenyl)piperazine", "1-(1,2-diphenylethyl)piperazine", "1-(2-(3-fluorophenoxy)phenyl)piperazine", "R-sibutramine metabolite", "1-(2-(2-ethylphenyl)-1-phenylethyl)piperazine", "Amitriptyline", "Clomipramine(Drug Bank)", "MDL-28618", "2-(Aminomethyl)-5-(1'-naphthethyl)tetrahydrofuran", "3-(1H-indol-1-yl)-N-methyl-3-phenylpropan-1-amine", "1-(2-(3-chlorophenyl)-1-phenylethyl)piperazine", "3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile", "Doxepin(Drug Bank)", "Vortioxetine(Drug Bank)", "1-(2-(benzyloxy)phenyl)piperazine", "2-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile", "N-(2-oxazolemethyl)milnacipran", "(S)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide", "Isobutyl-(4-methyl-benzyl)-piperidin-4-yl-amine", "Milnacipran(Drug Bank)", "Venlafaxine(TTD)", "KF-A5", "Bupropion(TTD)", "TD-9855", "(R)-N-isopropyl-N-(pyrrolidin-3-yl)-2-naphthamide", "S33005", "1-(2-(2-bromophenyl)-1-phenylethyl)piperazine", "3-(piperidin-4-yl)-2-(o-tolyloxy)pyridine", "Sibutramine(TTD)", "N-benzyl-N-isobutylpiperidin-4-amine", "BL-1021", "S-34324", "Bicifadine", "1-(2-(2-ethoxyphenyl)-1-phenylethyl)piperazine", "1-(2-(6-fluoronaphthalen-2-yl)ethyl)piperazine"], "['4128', '4129', '4353', '6530', '6531', '6531', '6532', '6571']": ["Nomifensine(Drug Bank)"], "['1800']": ["Cilastatin"], "['5169']": ["AGS-16M8F", "AGS-16C3F"], "['240', '240', '240', '240', '5742', '5743']": ["TEBUFELONE"], "['1576', '240', '240', '3162', '4842', '4843', '4846', '5742', '5743', '875']": ["Heme"], "['5168']": ["Complex heterocyclic compound 1", "Tetra-hydro-carboline derivative 1", "Tetra-hydro-carboline derivative 2", "PMID28447479-Compound-20", "PMID28447479-Compound-21", "PMID28447479-Compound-22", "PMID28447479-Compound-23", "PMID28447479-Compound-24", "Pyrazole derivative 87", "Pyridine and pyrimidine derivative 1", "Piperazine derivative 8", "Dihydropyrido pyrimidine derivative 1", "PMID28447479-Compound-4", "Imidazopyrimidinone derivative 1", "Heteroaromatic ring derivative 4", "Heteroaromatic ring derivative 2", "Heteroaromatic ring derivative 3", "Heteroaromatic ring derivative 1", "Pyrazolo[3,4-c]pyridine derivative 1", "Pyrimidinone derivative 5", "PMID28447479-Compound-11", "PMID28447479-Compound-10", "PMID28447479-Compound-14", "Pyrido/pyrrolo-fused pyrimidine derivative 1", "Octahydro-pyrrolo[3,4-c]-pyrrole derivative 1"], "['1312', '1543', '1545', '1588']": ["2-Methoxyestradiol(Drug Bank)"], "['5742', '759', '760', '762', '765', '771']": ["Salicyclic acid"], "['1080']": ["CFTR inhibitors", "iOWH032", "GlyH-101", "ABBV-3067", "CFTRinh-172", "Crofelemer", "ABBV-2451", "ABBV-2737", "VX-661", "Tezacaftor and ivacaftor", "Ivacaftor", "Lumacaftor", "ABBV-2222"], "['124']": ["Fomepizole(TTD)"], "['290', '29881', '6646']": ["Ezetimibe(Drug Bank)"], "['498', '506', '509']": ["Piceatannol(Drug Bank)"], "['6546']": ["Dronedarone(Drug Bank)"], "['10558', '55304', '9517']": ["NA-808"], "['6647']": ["TDI-0079", "APN-201", "ISIS 150463", "ISIS 150464", "EC-SOD, PPL Therapeutics", "Tempol", "Pegorgotein", "BIIB067", "ISIS-SOD1", "Methoxyestradiol", "PC-SOD", "ISIS-SOD1Rx", "EUK-207", "TDI-0060", "AEOL-10150", "ATN-224", "M-40401", "Coprexa", "TDI-0107", "ISIS 150452", "ISIS 150453", "ISIS 150450", "ISIS 150451", "ISIS 150454", "VLTS-582", "Superoxide dismutase", "S-Oxy Cysteine", "Midismase"], "['4907']": ["PMID28870136-Compound-39", "PMID28870136-Compound-38", "PMID28870136-Compound-37", "PMID28870136-Compound-36", "Acid blue 25", "Pentoxifylline(Drug Bank)", "PSB-0952", "PMID28870136-Compound-59", "PMID28870136-Compound-58", "PMID28870136-Compound-55", "PMID28870136-Compound-54", "PMID28870136-Compound-57", "PMID28870136-Compound-56", "PMID28870136-Compound-51", "PMID28870136-Compound-50", "PMID28870136-Compound-53", "PMID28870136-Compound-52", "Oleclumab", "alphabeta-methyleneADP", "PMID28870136-Compound-61", "PMID28870136-Compound-47", "PMID28870136-Compound-60", "PMID28870136-Compound-69", "RB 2", "CPI-006", "PMID28870136-Compound-64", "PMID28870136-Compound-65", "PMID28870136-Compound-67", "PMID28870136-Compound-62", "PMID28870136-Compound-63", "PMID28870136-Compound-68", "PMID28870136-Compound-48", "PMID28870136-Compound-49", "PMID28870136-Compound-42", "PMID28870136-Compound-43", "PMID28870136-Compound-40", "PMID28870136-Compound-41", "PMID28870136-Compound-46", "PMID28870136-Compound-44", "PMID28870136-Compound-45", "PMID29166791-Compound-AMPCP"], "['5319', '5320']": ["CACOSPONGIONOLIDE", "N-Tridecanoic Acid(TTD)", "Cacospongionolide E", "BOLINAQUINONE", "CACOSPONGIONOLIDE B"], "['23657']": ["Riluzole(Drug Bank)"], "['23632', '759', '762', '765', '768', '771']": ["HERNIARIN", "Hexane-1,6-diamine"], "['6559']": ["Indapamide(Drug Bank)", "Metolazone", "Hydrochlorothiazide(Drug Bank)", "Polythiazide"], "['108']": ["A1-adenosine receptor", "Forskolin", "2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE(TTD)"], "['6530', '6531', '6531', '6571']": ["Dextroamphetamine(Drug Bank)"], "['1621']": ["Nepicastat oral", "Etamicastat"], "['7306']": ["Flanvotumab"], "['8972', '8972']": ["2-Aminomethyl-pyrrolidine-3,4-diol", "Celgosivir", "KOTALANOL", "SC-49483", "Alpha-glucosidase", "De-O-sulfonated kotalanol", "GSC-1", "Miglitol(TTD)", "3-(4-(4-hydroxyphenyl)phthalazin-1-ylamino)phenol", "Voglibose", "2,5-Dideoxy-2,5-imino-D-mannitol", "PAZ-320", "Imino sugars", "2-Cyclopentylaminomethyl-pyrrolidine-3,4-diol", "Acarbose(TTD)", "1,4-dideoxy-1,4-imino-D-arabinito", "BMN-103", "A-76202M", "Rh-alphaglucosidase", "PONKORANOL", "4'-(p-toluenesulfonamide)-3,4-dihydroxy chalcone"], "['23632', '759', '760', '762', '768', '771']": ["PHENOL", "6-methyl-2-oxo-2H-chromene-3-carboxylic acid", "4-(2-AMINOETHYL)BENZENESULFONAMIDE(TTD)"], "['4128', '4128', '4129', '4129']": ["Moclobemide(Drug Bank)"], "['2167', '2171']": ["BMS-480404", "5-Carbazol-9-yl-pentanoic acid", "4-Carbazol-9-yl-butyric acid", "Hexadecanoic acid", "PMID27109571-Compound-27", "PMID27109571-Compound-26", "PMID27109571-Compound-25", "PMID27109571-Compound-23", "PMID27109571-Compound-22", "PMID27109571-Compound-21", "PMID27109571-Compound-20", "PMID27109571-Compound-29", "PMID27109571-Compound-28", "PMID27109571-Compound-24", "PMID27109571-Compound-19", "PMID27109571-Compound-30", "PMID27109571-Compound-31", "PMID27109571-Compound-18", "PMID27109571-Compound-12", "PMID27109571-Compound-13", "PMID27109571-Compound-16", "PMID27109571-Compound-17", "PMID27109571-Compound-14", "PMID27109571-Compound-15", "2-(2,3-bis(2-chlorobenzyloxy)phenyl)acetic acid", "2-(Carbazole-9-sulfonyl)-benzoic acid"], "['6565']": ["Lys[Z(NO2)]-Lys[Z(NO2)]"], "['291', '292', '293', '523']": ["Etidronic acid(Drug Bank)"], "['1636', '18', '4048', '4842', '4846', '5319', '6647', '760', '8644']": ["Acetate Ion"], "['4128', '4129', '43']": ["Ladostigil", "PMID29757691-Compound-4"], "['1719', '471', '7298']": ["Methotrexate(Drug Bank)"], "['4129', '5294']": ["5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE(TTD)"], "['6531', '6531', '6532']": ["1-(thiophen-2-yl)-3-aza-bicyclo[3.1.0]hexane", "1-(naphthalen-2-yl)-3-aza-bicyclo[3.1.0]hexane", "3-(4-Chlorophenyl)-2-nortropene", "3-(4-Fluorophenyl)-2-nortropene", "3-(3,4-dichlorophenyl)-2-nortropene", "10S-hydroxylobelane", "10R-hydroxylobel-7-ene", "(2R,3S)-2-[(3-Iodophenoxy)phenylmethyl]morpholine", "(2R,3S)-2-[(4-Iodophenoxy)phenylmethyl]morpholine", "3-alpha-Phenylmethoxy-3-beta-phenyl-nortropane", "8S-hydroxylobel-9-ene", "6-(3-aza-bicyclo[3.1.0]hexan-1-yl)quinoline", "Erythro-3,4-dichloromethylphenidate hydrochloride", "8R-hydroxylobel-9-ene", "(2R,3R)-iodoreboxetine", "10S-hydroxylobel-7-ene", "(2S,3S)-iodoreboxetine", "(cis)-1,6-diphenyl-3-aza-bicyclo[3.1.0]hexane", "R-226161", "1-Biphenyl-4-yl-3-aza-bicyclo[3.1.0]hexane", "8R-hydroxylobelane", "Threo-3,4-dichlororitalinol hydrochloride", "8S-hydroxylobelane", "(2R,3S)-2-[(2-Iodophenoxy)phenylmethyl]morpholine", "MIN-117", "1-benzylpiperidine hydrochloride", "COCAINE.HCL", "1-phenyl-3-aza-bicyclo[3.1.0]hexane", "3-(4-Trifluoromethylphenyl)-2-nortropene", "1-(benzofuran-2-yl)-3-aza-bicyclo[3.1.0]hexane", "Threo-1-aza-5-phenyl[4.4.0]decane hydrochloride", "3-Phenyl-2-nortropene", "10R-hydroxylobelane", "WIN-35065"], "['240', '240', '246']": ["(-)-pinoresinol", "(+)-3,3'-bisdemethyltanegool", "(-)-3,3'-bisdemethylpinoresinol", "JASPAQUINOL"], "['10919', '10919', '10919', '10919', '10919', '10919', '10919', '79813']": ["BIX-01294", "A-366", "UNC0642", "UNC0638"], "['1066', '1066', '126', '1327', '1329', '1339', '1340', '1345', '1346', '1349', '1350', '1351', '2172', '2235', '4512', '4513', '4514', '5319', '9377']": ["Cholic Acid(Drug Bank)"], "['240', '240', '5742']": ["Hyperforin", "4'-Methoxy-5,3'-dipropyl-biphenyl-2ol", "Diethylcarbamazine(Drug Bank)"], "['6555']": ["S-8921", "A-3309", "AZD-7806", "GSK2330672", "264W94"], "['1374', '1376']": ["Perhexiline(Drug Bank)"], "['5226', '8833']": ["Pyrophosphate 2-"], "['5152']": ["PF-04447943", "E2027", "BI-409306", "PF-4447943", "ASP-4901", "PF-4181366"], "['1066', '1066', '43', '590']": ["Tacrine(Drug Bank)", "3,4,5,6-Tetrachloro-[1,2]benzoquinone", "NSC-23180", "CHLORANIL", "5,6-dinitroacenaphthoquinone"], "['10599', '28234']": ["[3H]estradiol-17beta-glucuronide"], "['5153']": ["IC-041", "US10034861, Example 165", "US10034861, Example 164", "AC1MOZOL", "US9073936, 2", "US10092575, Example 158", "US9073936, 3", "US9073936, 1", "US10034861, Example 1", "AC1LDDOQ", "US10092575, Example 101", "B7673", "US10092575, Example 141"], "['759', '760', '765', '768']": ["4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide", "4-amino-6-chlorobenzene-1,3-disulfonamide", "4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide"], "['3615', '5471']": ["6-Chloropurine Riboside, 5'-Monophosphate(TTD)", "Mycophenolic hydroxamic acid", "Tiazofurin adenine dinucleotide", "Mycophenolic bis(sulfonamide)"], "['4843', '5742', '5743']": ["Resveratrol Potassium4,-Sulfate"], "['5151']": ["PF-04957325", "US8846654, 251", "US8846654, 294", "AC1M1SP5", "US9493447, 1001", "BC11-28", "US8846654, 11", "PF-4957325-00"], "['2548', '2548', '2595', '8972', '8972']": ["Deoxynojirimycin"], "['2030']": ["[3H]nitrobenzylmercaptopurine ribonucleoside", "9-Benzyl-6-(4-nitro-benzylsulfanyl)-9H-purine", "Nitrobenzylthioinosine", "S6-nitrobenzyl mercaptopurine riboside", "NBTGR", "N6-CYCLOPENTYLADENOSINE", "6-(4-Nitro-benzylsulfanyl)-9-phenethyl-9H-purine", "Dilazep", "KF24345", "LIDOFLAZINE"], "['50940', '8654']": ["Tadalafil(Drug Bank)"], "['38']": ["PMID16242323C15b", "PMID16242323C15a", "(Z)-2,6-diisopropyl-N-phenyloctadec-9-enamide", "Benoxaprofen", "ATR-01", "PMID25470667-Compound-K-604", "Nonanoic acid biphenyl-2-ylamide", "Octanoic acid biphenyl-2-ylamide", "PMID16242323C16", "PMID16242323C22c", "PMID16242323C22d", "PMID16242323C26a", "PMID16242323C26b", "PMID16242323C26c", "PMID16242323C18a", "PMID16242323C18b"], "['23632', '760', '762', '765', '768', '771']": ["6-(hydroxymethyl)-2H-chromen-2-one"], "['5033']": ["Lufironil", "SAFIRONIL"], "['3991']": ["PMI-008", "BIFENOX", "2-(3-methoxybenzylthio)-2-phenylacetic acid", "NCI-58425", "BENZYL BENZOATE", "NCI-159878", "PMID15026062C41", "OXYBENZONE", "ETHIOFENCARB"], "['2805']": ["Maleic Acid"], "['43', '5743']": ["THIOCTIC ACID"], "['27115']": ["BRL50481"], "['23632', '5742', '759', '760', '762', '765', '768', '771']": ["CATECHIN"], "['92745']": ["[3H]histidine", "[14C]histidine"], "['6240']": ["LOR-2501", "Hydroxyurea(Drug Bank)", "Gallium maltolate(Drug Bank)", "Clofarabine(Drug Bank)"], "['5320']": ["DYSIDINE", "LUFFARIELLOLIDE", "OCHNAFLAVONE", "1,4-Butanediol(TTD)", "Lauric Acid", "DIDODECANOYLPHLOROGLUCINOL", "Suramin(Drug Bank)", "KH064", "Elaidoylamide"], "['5743', '7498']": ["WOGONIN"], "['27087', '528']": ["D-tartaric acid(Drug Bank)"], "['4507']": ["5'-Deoxy-5'-(Methylthio)-Tubercidin", "Formycin", "METHYLTHIOADENOSINE"], "['6647', '847']": ["EUK-189"], "['2168', '5742', '5743']": ["INDOPROFEN"], "['471']": ["NSC-37173", "NSC-45592", "NSC-37031", "NSC-26699", "NSC-47729", "FAICAR", "NSC-58046", "NSC-324572", "NSC-88915", "NSC-126445", "NSC-30171"], "['4128']": ["(6-Butoxy-2-naphthyl)-2-aminopropane", "ESUPRONE", "Cis-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine", "DECYL(DIMETHYL)PHOSPHINE OXIDE", "1-(4-butoxyphenyl)propan-2-amine", "HARMINE", "CS-722", "1-(3-(4-chlorobenzyl)quinoxalin-2-yl)hydrazine", "KadcoccitoneA", "PMID25399762-Compound-Figure1-Neonectrolide A", "N-Benzyl-(6-methoxy-2-naphthyl)-2-aminopropane", "2-(3-benzylquinoxalin-2-ylamino)ethanol", "CX157", "Moclobemide(TTD)", "PMID25399762-Compound-Figure3-Lycojaponicumin A", "Isocarboxazid(TTD)", "N-(4-phenylbutyl)-1H-pyrrole-2-carboxamide", "PMID25399762-Compound-Figure1-Chukrasone A", "PMID25399762-Compound-Figure1-Chukrasone B", "6,11-dihydro-5H-benzo[a]carbazole", "5-Methoxymethyl-3-pyrrol-1-yl-oxazolidin-2-one", "1-(4-propoxyphenyl)propan-2-amine", "AphanamgrandiolA", "N-Benzyl-(6-butoxy-2-naphthyl)-2-aminopropane", "Bifemelane", "FA-70", "6-Chloro-N-(2-morpholinoethyl)nicotinamide", "IncarviatoneA", "6-Fluoro-N-(2-morpholinoethyl)nicotinamide", "N-benzyl,N-methyl-1H-pyrrole-2-carboxamide", "6-Hydroxy-N-(2-morpholinoethyl)nicotinamide", "6-Chloro-N-(3-morpholinopropyl)nicotinamide", "3-aminoacetamido-4'-methylfuro[3,2-g]coumarin", "PMID25399762-Compound-Figure1-Aphanamixoid A", "PMID25399762-Compound-Figure2-Artoxanthochromane", "N-(1-Methyl-1H-indol-2-ylmethyl)-N-phenylamine", "N-((1H-indol-2-yl)methyl)(phenyl)methanamine", "3-benzyl-N-(2-morpholinoethyl)quinoxalin-2-amine", "7-acetonyloxy-3-acetylamino-8-methoxycoumarin", "N-methyl-N-(prop-2-ynyl)-1H-pyrrole-2-carboxamide", "NSC-656158", "MyriberineA", "3,4-Benzo-7-acetonyloxy-8-methylcoumarin", "(6-methylthio-2-naphthyl)isopropylamine", "1-(3-benzylquinoxalin-2-yl)hydrazine", "2-(4-methoxyphenyl)-4,5-dihydro-1H-imidazole", "N-benzyl-1H-pyrrole-2-carboxamide", "2-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-imidazole", "5,6-Dichloro-N-(2-morpholinoethyl)nicotinamide", "1-(2-Naphthyl)-2-aminopropane", "PMID25399762-Compound-Figure1-Sarcaboside A", "PMID25399762-Compound-Figure1-Sarcaboside B", "HouttuynoidA", "PMID25399762-Compound-Table 5-O-methyl-M30", "2-phenyl-5H-indeno[1,2-d]pyrimidine", "PMID25399762-Compound-Figure2-Spirooliganone B", "RS-8359", "PMID25399762-Compound-Figure3-Lycojaponicumin C", "PMID25399762-Compound-Figure3-Lycojaponicumin B", "4-methyl-2H-benzofuro[3,2-g]chromen-2-one", "1-(4-ethoxyphenyl)propan-2-amine", "4-Chloro-N-(3-morpholinopropyl)nicotinamide", "N-2-phenylethyl-1H-pyrrole-2-carboxamide", "Brofaromine", "4-Chloro-N-(2-morpholinoethyl)nicotinamide", "5-Azidomethyl-3-pyrrol-1-yl-oxazolidin-2-one", "Ethyl 4-(2-oxo-2H-chromene-3-carboxamido)benzoate", "PMID25399762-Compound-Figure3-Aspeverin", "1-(1-Naphthyl)-2-aminopropane", "N-propargyl-1H-pyrrole-2-carboxamide", "PMID29324067-Compound-25", "PMID25399762-Compound-Figure3-Fluevirosine A", "(S)-2-amino-1-(4-ethylthiophenyl)-propane", "N-Phenyl-1-methyl-1H-indole-2-carboxamide", "(S)-2-amino-1-(4-methylthiophenyl)-propane", "GypensapogeninA", "GypensapogeninB", "E-2011", "Clorgyline", "Befloxatone", "N'-(2-phenylallyl)hydrazine hydrochloride", "5,6-Dichloro-N-(3-morpholinopropyl)nicotinamide", "1-(3-benzyl-6,7-dichloroquinoxalin-2-yl)hydrazine", "3-methyl-2(1H)-thioxo-4(3H)-quinazolinone", "N-(1H-Indol-2-ylmethyl)-N-(4-phenylbutyl)amine", "N-(3-phenylpropyl)-1H-pyrrole-2-carboxamide", "PhyllanthoidA", "N-phenyl-1H-pyrrole-2-carboxamide", "N-(2-benzyl),N-(1-methylpyrrol-2-ylmethyl)amine", "Secondary and tertiary (hetero)arylamide derivative 2", "BW-1370U87", "Trans-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine", "9-(3-aminopropoxy)-7H-furo[3,2-g]chromen-7-one", "N-((1H-indol-2-yl)methyl)-2-phenylethanamine", "PMID25399762-Compound-Table 5-8", "PMID25399762-Compound-Figure1-Eryngiolide A", "(R,S)-N-(R-phenylethyl)-1H-pyrrole-2-carboxamide"], "['2730', '4537']": ["N-Formylmethionine(TTD)"], "['4129']": ["(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide", "[(1e)-4-Phenylbut-1-Enyl]Benzene", "7-fluoro-2-(4-fluorophenyl)-4H-chromene-4-thione", "Phenelzine(TTD)", "4-oxo-4H-chromene-3-carboxylic acid", "7-fluoro-2-p-tolyl-4H-chromen-4-one", "N-cyclohexyl-2-oxo-2H-chromene-3-carboxamide", "Selegiline Hydrochloride", "Lazabemide analog 1", "Isopropyl-methyl-prop-2-ynyl-amine hydrochloride", "Selegiline(TTD)", "Coumaricacid", "2-p-tolyl-4H-chromen-4-one", "(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide", "7-methoxy-2-p-tolyl-4H-chromen-4-one", "Budipine", "L-136662", "(+/-)-7-fluoro-2-(4-fluorophenyl)chroman-4-one", "Coumarin/resveratrol hybrid derivative 1", "Coumarin/resveratrol hybrid derivative 2", "Cis-2-fluoro-2-phenylcyclopropanamine", "PMID25399762-Compound-Table1-C2", "PMID25399762-Compound-Table1-C3", "PMID25399762-Compound-Table1-C1", "PMID25399762-Compound-Table1-C6", "PMID25399762-Compound-Table1-C7", "PMID25399762-Compound-Table1-C4", "PMID25399762-Compound-Table1-C5", "PMID25399762-Compound-Table1-C9", "Lazabemide", "(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}serinamide", "(S)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one", "SKL-PD", "PMID29324067-Compound-38", "Methyl-(1,2,3,4-tetrahydro-naphthalen-1-yl)-amine", "Neu-120", "Piperonal", "NSC-50187", "(E)-6-Styrylisatin", "Milacemide", "7-methyl-2-p-tolyl-4H-chromene-4-thione", "Heteroaryl-cyclopropylamine derivative 3", "4-Hydroxy-2,5-dimethyl-3(2H)-furanone", "N-(2-phenylcyclopropyl) amino acid derivative 1", "7-fluoro-2-p-tolyl-4H-chromene-4-thione", "MOFEGILINE", "Heptyl-methyl-prop-2-ynyl-amine hydrochloride", "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "(+/-)-2-(4-fluorophenyl)-7-methoxychroman-4-one", "(S)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one", "PMID25399762-Compound-Table1-C24", "PMID25399762-Compound-Table1-C21", "PMID25399762-Compound-Table1-C20", "PMID25399762-Compound-Table1-C23", "PMID25399762-Compound-Table1-C22", "PMID25399762-Compound-Table 6-12", "PMID25399762-Compound-Table 6-13", "PMID25399762-Compound-Table 6-10", "PMID25399762-Compound-Table 6-11", "PMID25399762-Compound-Table 6-14", "PMID25399762-Compound-Table 6-15", "(+/-)-7-methyl-2-p-tolylchroman-4-one", "Benzylcinnamate", "2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole", "1,2,3,4-Tetrahydro-naphthalen-1-ylamine", "4-Hydroxybenzylalcohol", "RG1577", "7-fluoro-2-(4-methoxyphenyl)-4H-chromen-4-one", "(S)(+)-7-methyl-2-p-tolylchroman-4-one", "Cis-2-Fluoro-2-(4-methoxyphenyl)cyclopropylamine", "(R)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one", "(+/-)-7-fluoro-2-p-tolylchroman-4-one", "N-Propargyl-1(S)-Aminoindan", "(R)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}alaninamide", "Cis-2-(4-chlorophenyl)-2-fluorocyclopropanamine", "3-(4-methoxyphenyl)-6-methyl-2H-chromen-2-one", "1,4-diphenyl-(1E,3E)-1,3-butadiene", "Rasagiline", "2-p-tolyl-4H-chromene-4-thione", "(S)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}serinamide", "8-Bromo-6-methyl-3-(4'-methoxyphenyl)coumarin", "N-benzyl-2-oxo-2H-chromene-3-carboxamide", "PMID25399762-Compound-Table1-C14", "PMID25399762-Compound-Table1-C15", "PMID25399762-Compound-Table1-C17", "PMID25399762-Compound-Table 7-Veratraldehyde", "PMID25399762-Compound-Table1-C19", "2-Hydrazino-3-methyl-4(3H)-quinazolinone", "2-(2,4-dichlorophenyl)-4,5-dihydro-1H-imidazole", "LU-53439", "CHALCONE", "3-(2-Bromophenyl)-6-methylcoumarin", "Ethylvanillin", "EUGENOL", "EVT302", "(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide", "N-isobutyl-2-oxo-2H-chromene-3-carboxamide", "Sulphadoxine", "4-Hydroxybenzoicacid", "1H-Indole-2,3-dione", "2-Bromo-N-(3-morpholinopropyl)nicotinamide", "(+/-)-2-(4-methoxyphenyl)-7-methylchroman-4-one", "N-Methyl-N-phenyl-2-oxo-2H-chromene-3-carboxamide", "(+/-)-2-(4-fluorophenyl)chroman-4-one", "4-Methoxybenzaldehyde", "PMID29324067-Compound-40", "3-(4-hydroxyphenyl)-6-methyl-2H-chromen-2-one", "PMID25399762-Compound-Table 7-Vanillyl alcohol", "PMID25399762-Compound-Table 6-9", "(R)(+)-7-fluoro-2-p-tolylchroman-4-one", "2-methyl-9H-indeno[2,1-d]pyrimidin-9-one", "4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN", "(R)(+)-7-fluoro-2-phenylchroman-4-one", "5-Aminomethyl-3-pyrrol-1-yl-oxazolidin-2-one", "2-(2-cyclohexylidenehydrazinyl)-4-p-tolylthiazole", "PF9601N", "SL-25.1188", "(+/-)-7-methyl-2-phenylchroman-4-one", "Lauryl Dimethylamine-N-Oxide", "JD-0100", "Schiff base compound 2", "2-(4-chlorophenyl)-4,5-dihydro-1H-imidazole", "N2-{4-[(3-chlorobenzyl)oxy]benzyl}glycinamide", "2-(4-methoxyphenyl)-4H-chromene-4-thione", "2-(4-fluorophenyl)-7-methoxy-4H-chromen-4-one", "Deprenyl", "Methyl-pentyl-prop-2-ynyl-amine oxalic acid", "2-p-tolyl-4,5-dihydro-1H-imidazole", "2-Phenyl-cyclopropylamine hydrochloride", "Benzyl-methyl-[1-(1H-pyrrol-2-yl)-vinyl]-amine", "CORDOIN", "Cis-2-(para-fluorophenyl)cyclopropylamine", "Pargyline(TTD)", "N-Methyl-N-Propargyl-1(R)-Aminoindan", "SAFINAMIDE MESYLATE", "(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}alaninamide", "3-phenyl-9H-indeno[1,2-e][1,2,4]triazin-9-one", "8-Bromo-6-methyl-3-phenylcoumarin", "(E)-8-(3-chlorostyryl)-caffeine", "Methyl piperate", "VAR-10300", "(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholin-5-one", "PMID25399762-Compound-Table1-C16", "PMID25399762-Compound-Table1-C10", "PMID25399762-Compound-Table1-C11", "PMID25399762-Compound-Table1-C12", "PMID25399762-Compound-Table1-C13", "PMID25399762-Compound-Table1-C18", "EVT-301", "PMID25399762-Compound-Table 7-Vanillic acid", "N2-{4-[(4-nitrobenzyl)oxy]benzyl}glycinamide", "(S)-N2-[4-(benzyloxy)benzyl]serinamide", "PMID25399762-Compound-Table1-C25", "(+/-)-7-fluoro-2-phenylchroman-4-one", "Butyl-methyl-prop-2-ynyl-amine hydrochloride", "(R)(+)-7-methyl-2-phenylchroman-4-one", "4-phenyl-1,2,3,6-tetrahydropyridine", "(R)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one", "P2B-001", "N-(2-Methyl-1H-indol-5-yl)benzamide", "7-methoxy-2-p-tolyl-4H-chromene-4-thione", "(R)-3-Prop-2-ynylamino-indan-5-ol", "4-fluoroselegiline", "Tetra-hydro-oxazolopyridine derivative 1", "Tetra-hydro-oxazolopyridine derivative 2", "2-Methoxyphenol", "Farnesol", "(+/-)-7-methoxy-2-p-tolylchroman-4-one", "3,4-Dihydroxybenzaldehyde", "(+/-)-2-(4-fluorophenyl)-7-methylchroman-4-one", "N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE", "Secondary and tertiary (hetero)arylamide derivative 1", "(R)(+)-7-methyl-2-p-tolylchroman-4-one", "(S)(+)-7-fluoro-2-p-tolylchroman-4-one", "PMID25399762-Compound-Table1-C8", "3-(3-methoxyphenyl)-6-methyl-2H-chromen-2-one", "RS-1636", "(S)(+)-7-methyl-2-phenylchroman-4-one", "(S)-N2-{4-[(4-nitrobenzyl)oxy]benzyl}serinamide", "RWJ-416457", "3-(phenoxymethyl)-5H-indeno[1,2-c]pyridazin-5-one", "NW-1772", "N-(2-aminoethyl)-2-oxo-2H-chromene-3-carboxamide", "(+/-)-2-p-tolylchroman-4-one", "3-Hydroxy-2-butanone", "Indeloxazine", "2-(2-cyclohexylidenehydrazinyl)-4-phenylthiazole", "VAR-10200", "HT-1067", "(+/-)-7-fluoro-2-(4-methoxyphenyl)chroman-4-one", "Safinamide", "(S)(+)-7-fluoro-2-phenylchroman-4-one", "(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide", "NSC-93405", "(S)-N2-[4-(benzyloxy)benzyl]alaninamide"], "['5321']": ["[3,4''']biflavone", "AR-C70484XX", "Ethyl 2-(2-oxohexadecanamido)acetate", "1,1,1,3-Tetrafluoro-6-phenylhexan-2-one", "(S)-Ethyl 6-(2-oxohexadecanamido)decanoate", "[6,4''']biflavone", "1,1,1-Trifluoro-6-(4-hexyloxy-phenyl)-hexan-2-one", "Methyl 2-(2-oxo-8-phenyloctanamido)acetate", "ECOPLADIB", "6-(4-Decyloxy-phenyl)-1,1,1-trifluoro-hexan-2-one", "Tert-Butyl 3-(2-oxo-8-phenyloctanamido)propanoate", "AX-048", "WAY-196025", "Allyl 4-(2-oxohexadecanamido)butanoate", "Darapladib(Drug Bank)", "1,1,1,3-Tetrafluoro-7-phenylheptan-2-one", "ZPL521", "Methyl arachidonyl fluorophosphonate", "(S)-Methyl 4-(2-oxohexadecanamido)octanoate", "1,1,1,2,2,4-hexafluoro-7-phenylheptan-3-one", "1,1,1-Trifluoro-6-(naphthalen-2-yl)hexan-2-one", "1,1,1,2,2,3,3,5-octafluoro-8-phenyloctan-4-one", "[4',4''']-biflavone", "4-(2-oxohexadecanamido)butanoic acid", "Tert-Butyl 3-(2-oxohexadecanamido)propanoate", "EFIPLADIB", "AX-006", "1-Imidazol-1-yl-3-(4-octylphenoxy)propan-2-one", "1,1,1-Trifluoro-7-phenylheptan-2-one", "1,1,1,2,2-Pentafluoro-9-phenyl-nonan-3-one", "Fluticasone(Drug Bank)", "Tert-Butyl 2-(2-oxohexadecanamido)acetate", "(Z)-1,1,1,2,2,3,3-heptafluorohenicos-12-en-4-one", "Tert-Butyl 5-(2-oxohexadecanamido)pentanoate", "1,1,1,3-Tetrafluoro-heptadecan-2-one", "1,1,1-Trifluoro-4-(4-hexyloxy-phenyl)-butan-2-one", "1,1,1-Trifluoro-5-(4-octylphenoxy)pentan-2-one", "Methyl 2-(2-oxohexadecanamido)acetate", "1,1,1-trifluoroheptadecan-2-one", "(S)-tert-Butyl 4-(2-oxohexadecanamido)pentanoate", "1,1,1,2,2-Pentafluoro-8-phenyl-octan-3-one", "1,1,1-Trifluoro-8-phenyl-octan-2-one", "4-(4-Decyloxy-phenyl)-1,1,1-trifluoro-butan-2-one", "1,1,1,2,2,3,3-heptafluoro-8-phenyloctan-4-ol", "ARACHIDONYL TRIFLUOROMETHYLKETONE", "N-(4-Ethoxybutyl)-2-oxohexadecanamide", "Ethyl 4-(2-oxohexadecanamido)benzoate", "[6,3''']biflavone"], "['60482']": ["[3H]hemicholinium-3"], "['4537']": ["6-Thiophen-2-yl-imidazo[2,1-b]thiazole", "6-Thiophen-3-yl-imidazo[2,1-b]thiazole", "NADH(TTD)"], "['3099']": ["VDA-1102 topical ointment"], "['5743', '760']": ["4-(4-hydroxy-benzylideneamino)-benzenesulfonamide", "4-(benzylideneamino)benzenesulfonamide"], "['5742']": ["Acetic acid 2-hept-3-ynylsulfanyl-phenyl ester", "4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiole-3-thione", "2-(1,1'-Biphenyl-4-Yl)Propanoic Acid", "Acetic acid 2-pentylsulfanyl-phenyl ester", "Acetic acid 2-hexylsulfanyl-phenyl ester", "Bromfenac(TTD)", "Acetic acid 2-heptylselanyl-phenyl ester", "N-(3-phenoxypyridin-4-yl)methanesulfonamide", "(-)-3-O-acetylspectaline", "2-(2-methoxyphenyl)-1H-indene", "SRT501", "Balsalazide(TTD)", "2-(3'-Ethyl-biphenyl-4-yl)-propionic acid", "Protoporphyrin Ix Containing Co", "4-amino-N-(2-chlorophenyl)benzenesulfonamide", "5-(4-Chlorophenyl)-4-(4-methoxyphenyl)isothiazole", "DEMETHOXYCURCUMIN", "N-(3-phenoxy-4-pyridinyl)propanesulfonamide", "(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid", "Suprofen(TTD)", "IODOINDOMETHACIN", "5-(2-1H-indenyl)-1,3-benzodioxole", "Acetic acid 2-heptylsulfanyl-phenyl ester", "2-[4-(1H-Indol-5-yl)-phenyl]-propionic acid", "4-(4-Chlorophenyl)-5-(4-methoxyphenyl)isothiazole", "Acetic acid 2-hex-2-ynylsulfanyl-phenyl ester", "5-(4-Methoxyphenyl)-4-p-tolylisothiazole", "P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid", "EPICATECHIN", "Salsalate(TTD)", "2'-epi-guianin", "O-Acetylserine", "2-(3'-Allyl-biphenyl-4-yl)-propionic acid", "IODOSUPROFEN", "FR122047", "Arachidonic Acid", "5-(4-Chlorophenyl)-4-p-tolyl-3H-1,2-dithiol-3-one", "Acetic Acid Salicyloyl-Amino-Ester", "4-(4-Chlorophenyl)-5-p-tolyl-3H-1,2-dithiol-3-one", "2-(3'-Ethylsulfanyl-biphenyl-4-yl)-propionic acid", "Metamizole", "Mesalazine(TTD)", "4-(4-Chlorophenyl)-5-p-tolylisothiazole", "Gamma-Homolinolenic acid", "2-(3'-Vinyl-biphenyl-4-yl)-propionic acid", "1-(4-aminosulfonylphenyl)-2-(4-pyridyl)acetylene", "TRL-382", "Piroxicam(TTD)", "Phenacetin", "4-(5-(4-Hydroxyphenyl)isothiazol-4-yl)phenol", "2-(2-Methylpropanoyl)-1,3,5-benzenetriol", "Acetic acid 2-hept-2-ynylsulfanyl-phenyl ester", "5-(4-Chlorophenyl)-4-p-tolylisothiazole", "2-Bromoacetyl Group", "Phenazone", "SC-560", "4-amino-N-p-tolylbenzenesulfonamide"], "['1719', '7298']": ["Pralatrexate(Drug Bank)"], "['2548', '2595', '2645', '279', '5742', '5837']": ["Beta-D-Glucose(TTD)"], "['2760', '5319']": ["Lpc-Ether(Drug Bank)"], "['2348']": ["MK-8109", "Pyrimethamine(TTD)", "EC-145", "EC0489", "Talotrexin", "IMGN-853", "FolateImmune", "Mirvetuximab soravtansine", "BMS-753493", "Farletuzumab", "EC20"], "['4842', '4843']": ["4-Ethyl-oxazolidin-(2Z)-ylideneamine", "4-[(2-Methyl-1H-imidazol-1-yl)methyl]pyridine", "7-Butyl-azepan-(2Z)-ylideneamine", "Azonan-(2Z)-ylideneamine", "(4S,5S)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine", "(4S,5R)-4,5-Dimethyl-oxazolidin-(2Z)-ylideneamine", "N-Omega-Propyl-L-Arginine", "AR-C133057XX", "3-Butyl-[1,4]thiazepan-(5E)-ylideneamine", "4-Butyl-thiazolidin-(2E)-ylideneamine", "3-Propyl-[1,4]thiazepan-(5E)-ylideneamine", "(R)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine", "4-Methyl-oxazolidin-(2Z)-ylideneamine", "Azocan-(2Z)-ylideneamine", "((E)-7-But-2-enyl)-azepan-(2Z)-ylideneamine", "5-Ethyl-4-propyl-pyrrolidin-(2Z)-ylideneamine", "3,4-Dihydro-1H-quinolin-(2E)-ylideneamine", "5-Bromomethyl-oxazolidin-(2Z)-ylideneamine", "[1,4]Oxazepan-(5E)-ylideneamine", "(4S,5R)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine", "4,5,6,7-tetrafluoro-3-methyl-1H-indazole", "2-(2-Amino-ethyl)-7-imino-azepane", "5-Ethyl-oxazolidin-(2Z)-ylideneamine", "3-Isobutyl-[1,4]thiazepan-(5E)-ylideneamine", "4-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine", "3-(2-Amino-ethyl)-5-imino-[1,4]oxazepane", "5-Methyl-oxazolidin-(2Z)-ylideneamine", "4-Methyl-5-propyl-pyrrolidin-(2Z)-ylideneamine", "3-(2-Nitro-ethyl)-[1,4]oxazepan-(5Z)-ylideneamine", "4-Isopropyl-pyrrolidin-(2Z)-ylideneamine", "AR-C102222", "Octahydro-isoindol-(1Z)-ylideneamine"], "['3939', '3939', '3945']": ["Stiripentol(Drug Bank)"], "['8435']": ["ISIS 140157", "ISIS 140158", "ISIS 140148", "ISIS 140161", "ISIS 140153"], "['5837']": ["4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid", "1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose", "2alpha-Hydroxyurs-12-en-28-oic acid", "Beta-D-Glucopyranose Spirohydantoin", "2-isoursolic acid", "PSN357", "JTT-651", "Acurea", "C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide", "Benzyl 2-hydroxyiminoolean-12-en-28-oate", "BETULIN", "1-N-Acetyl-Beta-D-Glucosamine", "N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea", "2-Deoxy-Glucose-6-Phosphate", "Flavopiridol", "N-Acetyl-N'-Beta-D-Glucopyranosyl Urea", "1-D-glucopyranosyl uracil", "ASIATIC ACID", "N-Butyl 2beta-hydroxyolean-12-en-28-oate", "23-hydroxybetulinic acid", "2beta,3alpha-dihydroxyurs-12-en-28-oic acid", "1-D-glucopyranosyl cytosine", "2-Oxoolean-12-en-28-oic acid", "Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide", "3alpha-Hydroxyurs-12-en-28-oic Acid", "L-serine-O-phosphate", "2alpha-Hydroxyolean-12-en-28-oic acid", "C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide", "Indirubin-5-sulfonate", "OLEANOLIC_ACID", "2-Hydroxyiminours-12-en-28-oic acid", "Fluoro-Phosphite Ion", "2beta,3alpha-dihydroxyolean-12-en-28-oic acid", "Heptulose-2-Phosphate", "Oleanonic acid", "GSK-1362885", "Ethyl 2beta-hydroxyolean-12-en-28-oate", "2-isooleanolic acid", "Alpha-D-Glucose-1-Phosphate", "2-Hydroxyiminoolean-12-en-28-oic acid"], "['10060', '6833']": ["Repaglinide(TTD)", "Tolbutamide(TTD)", "Glimepiride(TTD)"], "['3938', '5837']": ["Nojirimycine Tetrazole"], "['5743']": ["2,4'-Dimethoxy-5,3'-dipropyl-biphenyl", "Meloxicam(TTD)", "L-748780", "L-768277", "Lenalidomide(Drug Bank)", "4-amino-N-(4-iodophenyl)benzenesulfonamide", "(E)-3-(4-(methylsulfonyl)styryl)thiophene", "Valdecoxib(TTD)", "E-6087", "Etoricoxib", "RPR 200765A", "L-745337", "Ketoprofen(TTD)", "Flurbiprofen(TTD)", "PMI-001", "Indomethacin(TTD)", "Diflunisal(TTD)", "4-(4-methoxy-benzylideneamino)-benzenesulfonamide", "Nimesulide(TTD)", "Microxine", "Flosulide", "5-methoxy-2-(4-(methylsulfonyl)phenyl)-1H-indole", "NEOLIGNAN 9-NOR-7,8-DEHYDRO-ISOLICARIN B", "(E)-4-(2-(thiophen-3-yl)vinyl)benzenesulfonamide", "4-(4-methyl-benzylideneamino)-benzenesulfonamide", "2-(4-(methylsulfonyl)phenyl)pyridine", "1-(4-(methylsulfonyl)phenyl)-1H-indole", "Niflumic Acid", "NMI-150", "SB 239063", "NSC-27236", "Oxindole 94", "4-(3-hydroxy-benzylideneamino)-benzenesulfonamide", "3-benzyloxy-4-methoxy-2'-hydroxychalcone", "COX-2 inhibitors", "2'-Hydroxychalcone", "NS398", "4-(4-methyl-phenyliminomethyl)-benzenesulfonamide", "Nectamazin C", "4-((4-methoxyphenyl)diazenyl)benzenesulfonamide", "GSK-644784", "L-761000", "Mefenamic acid(TTD)", "PAC-10649", "1-(4-(methylsulfonyl)phenyl)-1H-pyrrole", "8alpha,19-dihydroxylabd-13 E-en-15-oic acid", "(E)-2-(4-(methylsulfonyl)styryl)thiophene", "Rofecoxib", "4-fluoro-N-(4-(methylsulfonyl)phenyl)aniline", "4-(4-fluoro-phenyliminomethyl)-benzenesulfonamide", "ketoprofen patch", "Carprofen(TTD)", "Tilmacoxib", "alpha-linolenic acid", "GR-253035", "Topical etoricoxib", "3-Bromo-2'-hydroxy-4-methoxychalcone", "4-benzyloxy-2'-hydroxychalcone", "6,7'-oxybis(2-phenyl-4H-chromen-4-one)", "3,4-dihydroxyxanthone", "Etodolac(TTD)", "OCOPHYLLALS A", "OCOPHYLLALS B", "S-33516", "1-(2-hydroxyphenyl)-3-p-tolylprop-2-en-1-one", "SC-558", "1,3-bis(nitrooxy)propan-2-yl 2-acetoxybenzoate", "Bimetopyrole", "NSAIDs", "S-2474", "(E)-2-(4-(methylsulfonyl)styryl)furan", "(E)-4-(2-(thiophen-2-yl)vinyl)benzenesulfonamide", "4-(4-fluoro-benzylideneamino)-benzenesulfonamide", "4-(4-nitro-benzylideneamino)-benzenesulfonamide", "2,6-dihydroxy-1,7-dimethoxyxanthone", "Prostaglandin G2", "ON-09300", "Tolmetin(TTD)", "CLEMATOMANDSHURICA SAPONIN B", "CLEMATOMANDSHURICA SAPONIN A", "Celecoxib(TTD)", "5-thia-8,11,14,17-eicosatetraenoic acid", "CR-4174", "(E)-4-(2-(furan-2-yl)vinyl)benzenesulfonamide", "Tenoxicam(TTD)", "3,4-dibenzyloxy-2'-hydroxychalcone", "SB 203580", "PMID29130358-Compound-LonimacranthoideVI", "Parecoxib(Drug Bank)", "SC-236(TTD)", "Fluoro loxoprofen", "Apricoxib", "4-(3-methoxy-benzylideneamino)-benzenesulfonamide", "DFU", "TENOSAL", "FK-3311", "RQ-00317076", "Phenylbutazone(TTD)", "2'-hydroxy-3,4,5-trimethoxychalcone", "Lumiracoxib(TTD)", "Furan-3-yl(4-(methylsulfonyl)phenyl)methanone", "FR-123826", "GW-637185X", "Firocoxib", "4-(3-nitro-benzylideneamino)-benzenesulfonamide", "2,3-dimethoxy-2'-hydroxychalcone", "PRINOMIDE TROMETHAMINE", "Silicon-modified indomethacin", "RWJ-67657", "LM-4108", "2,4-dimethoxy-2'-hydroxychalcone", "Thalidomide(Drug Bank)", "Ibuprofen(TTD)", "SC-58125", "GW-406381", "XGP-110", "SC-57666", "CX-9051", "4-phenyliminomethyl-benzenesulfonamide", "CIMICOXIB", "Tiaprofenic acid(TTD)", "2-(4-(methylsulfonyl)phenyl)-3-phenylquinoline", "SC-75416", "Nabumetone(TTD)", "DUP 697"], "['5295', '5296', '8503']": ["SF1126(Drug Bank)"], "['495', '495', '496', '496']": ["Dexlansoprazole"], "['6570', '6571']": ["Reserpine(Drug Bank)"], "['1591']": ["Lunacalcipol"], "['9468']": ["CT-2584", "Sphingosine(TTD)"], "['3417', '3418', '3419', '3420', '3421']": ["AG-881", "AG-221", "ENASIDENIB MESYLATE"], "['11343']": ["ABX-1431", "Carbamide derivative 26", "Carbamide derivative 24", "Carbamide derivative 25", "Pyrazole derivative 80", "Pyrazole derivative 83", "Pyrazole derivative 82", "Pyrazole derivative 85", "Pyrazole derivative 84", "Piperazine carbamic compound 4", "Piperazine carbamic compound 5", "Piperazine carbamic compound 1", "Piperazine carbamic compound 2", "Piperazine carbamic compound 3", "Pyrazole derivative 81", "Azetidinyl-piperidine derivative 2", "Azetidinyl-piperidine derivative 3", "Azetidinyl-piperidine derivative 1", "Carbamate derivative 14", "Carbamate derivative 10", "Azetidinyl-piperazine derivative 1", "Azetidinyl-piperazine derivative 3", "Carbamate derivative 17", "Carbamate derivative 16", "Carbamate derivative 15", "Carbamate derivative 13", "Carbamate derivative 12", "Carbamate derivative 11", "Azetidine-benzoxazin-3(4H)-one derivative 2", "Azetidine-benzoxazin-3(4H)-one derivative 3", "Azetidine-benzoxazin-3(4H)-one derivative 1", "PMID29053063-Compound-4", "PMID29053063-Compound-5", "PMID29053063-Compound-14", "PMID29053063-Compound-17", "PMID29053063-Compound-11c", "PMID29053063-Compound-11d", "Carbamate derivative 9", "PMID29053063-Compound-7b", "PMID29053063-Compound-7c", "PMID29053063-Compound-7a", "PMID29053063-Compound-7f", "PMID29053063-Compound-7d", "PMID29053063-Compound-7e", "Azetidinyl-piperazine derivative 2", "JZL184"], "['7357']": ["N-butylgalactonojirimycin", "Miglustat", "Eliglustat tartrate", "GZ402671", "Genz-682452", "Venglustat"], "['23632', '762', '765', '768', '771']": ["Ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate", "N1-(naphthalen-1-yl)ethane-1,2-diamine"], "['240', '240', '240', '240']": ["BW A4C", "N-hydroxy-N-[1-(4-isobutylphenyl)ethyl]urea"], "['5471']": ["Azathioprine(TTD)", "Dasatinib(Drug Bank)", "Mercaptopurine(TTD)"], "['1066', '1066', '6389']": ["Thenoyltrifluoroacetone(Drug Bank)"], "['873']": ["N6022"], "['1588', '4129']": ["(+/-)-7-methoxy-2-phenylchroman-4-one", "(+/-)-7-methoxy-2-(4-methoxyphenyl)chroman-4-one"], "['262']": ["Guanylhydrazone", "5'-Deoxy-5'-dimethylsulfonioadenosine chloride", "MGBG", "Hydroxyalanine", "Tromethamine(TTD)", "5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine", "5'-Deoxy-5'-(N,N-dimethylamino)adenosine", "CGP-40215A", "ORG 34517/34850", "[(2-aminooxyethyl)methylamino]-5'-deoxyadenosine", "5'-Deoxy-5'-(N,N-dimethylamino)-8-methyladenosine"], "['5337']": ["1-(pyridin-4-yl)piperazine", "US9127005, P0L", "US9127005, P2B", "US9127005, P2C", "HALOPEMIDE", "US9453017, 2", "US9453017, 1", "ML272", "1-(pyridin-2-yl)piperazine"], "['5138', '5139', '5141', '5142', '5144', '8654']": ["isobutylmethylxanthine"], "['240', '240', '5742', '5743']": ["2-Benzyl-1,2-dihydro-indazol-3-one", "PHENIDONE", "5,3'-Dipropyl-biphenyl-2,4'-diol", "2-(3-Phenyl-propyl)-1,2-dihydro-indazol-3-one", "Balsalazide(Drug Bank)", "SKF-105809", "2-Phenethyl-1,2-dihydro-indazol-3-one", "2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one", "2-Phenyl-1,2-dihydro-indazol-3-one", "METHYLHONOKIOL", "2-Naphthalen-2-ylmethyl-1,2-dihydro-indazol-3-one", "2-Methyl-1,2-dihydro-indazol-3-one", "HONOKIOL", "WY-28342", "Meclofenamic acid(Drug Bank)", "2,4'-Dimethoxy-5,3'-di-(2-propenyl)-biphenyl"], "['23632']": ["4-AMINOPHENOL", "TRIENTINE"], "['210']": ["5-hydroxyvaleric acid", "Laevulinic Acid", "Porphobilinogen", "4,7-Dioxosebacic Acid", "Delta-Amino Valeric Acid(TTD)", "3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid", "4-Oxosebacic Acid", "Aminolevulinic acid hci", "5-Fluorolevulinic Acid"], "['8394']": ["ISA-2011B"], "['1384', '1431', '1622', '3156', '39']": ["Coenzyme A(Drug Bank)"], "['4125']": ["M-0011"], "['412']": ["3-{3-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate", "Sulfamic acid 3-benzoyl-phenyl ester", "2-Amino-3-Oxo-4-Sulfo-Butyric Acid", "Sulfamic acid 3-(3-methoxy-benzoyl)-phenyl ester", "Estradiol 17-O-sulfamate", "4-(4-cyclohexylthiosemicarbazono)methyl-phenol", "2-Adamantan-2-ylidenemethyl-benzooxazol-6-ol", "PGL-2001", "4-Sulfamoyloxy-benzoic acid cycloheptyl ester", "4-Sulfamoyloxy-benzoic acid pentyl ester", "4-Sulfamoyloxy-benzoic acid cyclopentyl ester", "Sulfamic acid 4-(3-methoxy-benzoyl)-phenyl ester", "STX 64", "4-Sulfamoyloxy-benzoic acid cyclooctyl ester", "Estradiol 3,17-O,O-bis-sulfamate", "PGL-2", "Sulfamic acid 3-(4-hydroxy-benzoyl)-phenyl ester", "3-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate", "4-Sulfamoyloxy-benzoic acid nonyl ester", "Sulfamic acid 2-nonyl-4-oxo-4H-chromen-6-yl ester", "Nortropinyl-arylsulfonylurea 3", "Sulfamic acid 4-benzoyl-phenyl ester", "Sulfamic acid 4-(2-hydroxy-benzoyl)-phenyl ester", "2-methylsulfanylestradiol 3,17-O,O-bis-sulfamate", "2',4'-dicyanobiphenyl-4-yl sulfamate", "4-Sulfamoyloxy-benzoic acid octyl ester", "2-(4-cyclohexylthiosemicarbazono)methyl-phenol", "MHL cyclohexylthiosemicarbazone", "Tranilast(TTD)", "4-Sulfamoyloxy-benzoic acid heptyl ester", "4-Sulfamoyloxy-benzoic acid propyl ester", "4-Sulfamoyloxy-benzoic acid hexyl ester", "4-Sulfamoyloxy-benzoic acid butyl ester", "3-(4-cyclohexylthiosemicarbazono)methyl-phenol", "Sulfamic acid 3-(3-hydroxy-benzoyl)-phenyl ester", "4-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate", "4-Sulfamoyloxy-benzoic acid cyclohexyl ester", "2-ethylestradiol 3,17-O,O-bis-sulfamate", "3-(4-hexylthiosemicarbazono)methyl-benzoic acid", "Benzomate", "Sulfamic acid 4-(2-methoxy-benzoyl)-phenyl ester", "Sulfamic acid 3-(4-methoxy-benzoyl)-phenyl ester"], "['1066', '1066', '2235', '5319']": ["Cholic Acid(TTD)"], "['3156']": ["CP-83101", "PMID1656041C4rr", "SQ-33600", "PMID2153213C2d", "PMID2153213C2f", "PMID2153213C2c", "Bervastatin", "PMID8246237C18t", "Brutieridin", "BPL-001", "HMG-CoA reductase inhibitor", "Fluvastatin", "Statin", "Dalvastatin", "GFPDGG", "NCX-1067", "PMID1875346C18", "Lovastatin", "PMID2909732C7", "PMID8246234C3h", "PMID1895299C4p", "PMID1992149C13", "BMY-22089", "PMID1656041C11jj", "PMID1895299C6v", "Premarin/Pravachol", "SR12813", "DFGYVAE", "PMID1895299C1", "GFPEGG", "PMID1656041C11nn", "(Z)-5-octadecen-7,9-diynoic acid", "GFPTGG", "Mevastatin", "PMID1527791C29", "o-hydroxyatorvastatin", "PMID1992138C8b", "PMID18412317C13b", "Hexahydro naphthalene derivative 1", "Hexahydro naphthalene derivative 3", "PMID2296036C2t", "PMID1656041C11dd", "BMY-21950", "Quinoline derivative 17", "Quinoline derivative 16", "(Z)-7-octedecan-9-ynoic acid", "XZK-monascus", "Pitavastatin derivative 1", "GLPTGG", "LAROPIPRANT", "PMID1656041C11ff", "Quinoline derivative 1", "PMID2296036C2g", "Cerivastatin", "Lactol derivative 1", "PMID15686906C17", "PMID8246233C28", "TOCOTRIENOL", "PMID18072721C50", "Sterol derivative 3", "Sterol derivative 2", "Sterol derivative 1", "Rosuvastatin", "CRILVASTATIN", "MT-001", "PMID2296036C4d", "PMID2296036C4i", "PMID2153213C1a", "PMID2153213C1e", "PMID2153213C1f", "GLPDGG peptide", "PMID17574412C33", "PMID17574411C41", "PMID17574411C42", "Crestor/TriLipix", "(E)-octadecan-9-ynoic acid", "(E)-5-octadecen-7,9-diynoic acid", "Atorvastatin lactole derivative 1", "Pravastatin derivative 1", "5-ketodihydromevinolin", "7,9-octadecadiynoic acid", "NCX-6560", "PMID17560788C29f", "Simvastatin", "FPYVAE peptide", "1,4-Dithiothreitol(TTD)", "PMID1992149C9", "rawsonol", "PMID18155906C16f", "PMID27537201-Compound-Figure17", "PMID27537201-Compound-Figure11", "PMID2231594C3k", "Poly-substituted azoles statin lactone derivative 2", "Poly-substituted azoles statin lactone derivative 1", "PMID27537201-Compound-Figure13b", "Poly-substituted miazine derivative 1", "7,9-tetradecadiynoic acid", "RBx10558", "PMID8246233C5ab", "(R)-Mevalonate", "GLENVASTATIN", "PMID2231594C3j", "PMID2231594C3q", "PMID2231594C3u", "9-octadecynoic acid", "PMID27537201-Compound-Figure13c", "PMID1656041C74", "PMID1656041C4ff", "PMID19502059C25d", "PMID27537201-Compound-Figure15b", "PMID27537201-Compound-Figure15a", "6-hydroxy-7,9-octadecadiynoic acid", "3-(1,3 dodecadiynyl)-6-oxiranebutanoic acid", "PMID15686906C29", "PITAVASTATIN CALCIUM", "Atorvastatin", "GT-16-239", "PMID2153213C13b", "PMID2153213C13g", "PMID8246233C35", "Lactol derivative 2", "Pravastatin", "PMID7932551C9", "PMID2296027C29", "PMID2296027C25", "3-Hydroxy-3-Methyl-Glutaric Acid", "PF-3052334", "PMID8426367C18", "F(4-Fluoro)VAE", "2-cyclopropyl-4-substituted-phenoxy-quinoline derivative 1", "Hexahydro naphthalene derivative 2"], "['374569', '4128', '4129', '5321', '6531', '6531']": ["Procaine(Drug Bank)"], "['5138', '5139']": ["2-Morpholin-4-yl-8-phenylethynyl-chromen-4-one"], "['11238', '23632', '377677', '759', '759', '760', '760', '761', '762', '763', '765', '766', '768']": ["Cyclothiazide(Drug Bank)"], "['51458', '6005']": ["[14C]methylamine"], "['6531', '6531']": ["(+/-)-threo-N-(4-Phenylbutyl)ritalinol", "Fluoratec", "Bip-tyr-thr-pro-lys-thr(obzl)-gly", "Ioflupane i-123", "Bip-tyr-thr-ala-pro-phe", "(+/-)-threo-N-Propargylmethylphenidate", "(+/-)-threo-3-Fluororitalinol", "ISOTETRANDRINE", "(+/-)-threo-N-(4-Phenylbutyl)methylphenidate", "(RS/SR)-2-[1-(4-chlorophenyl)pentyl]piperidine", "(+/-)-threo-N-(5-Phenylpentyl)methylphenidate", "(+/-)-threo-N-(2-Methylthiopene)methylphenidate", "(+/-)-threo-N-Benzyl-3'-chloromethylphenidate", "Altropane", "DIMETHYLGRISABINE", "(+/-)-threo-N-(2-Phenylethyl)methylphenidate", "Bip-tyr-thr-pro-thr(obzl)-gly", "(+/-)-threo-N-Benzyl-3',4'-dichlororitalinol", "Modafinil", "(+/-)-threo-N-(4-Nitrobenzyl)methylphenidate", "(1-Phenyl-ethyl)-(2-phenyl-quinazolin-4-yl)-amine", "(+/-)-threo-N-(4-Methylpyridine)methylphenidate", "2-(N-tert-Butylamino)-4'-chloropropiophenone", "(+/-)-threo-N-Methyl-30-methylmethylphenidate", "ANTIOQUINE", "(+/-)-threo-N-(2-Phenylethyl)ritalinol", "ISOPILINE", "(+/-)-threo-N-(3-Methylthiopene)methylphenidate", "(RS/SR)-2-[1-(3,4-dichlorophenyl)butyl]piperidine", "Seridopidine", "1-Benzo[b]thiophen-2-yl-cyclopentylamine", "Threo-ritalinol hydrochloride", "SECOCULARIDINE", "(+/-)-threo-N-(4-Chlorobenzyl)methylphenidate", "(+/-)-threo-N-(4-Methoxybenzyl)methylphenidate", "RTI-336", "O-methyldauricine", "Bip-tyr-thr-pro-lys-thr", "Vanoxerine", "NAV5001", "2-phenylpiperidine hydrochloride", "O-2442", "2-(N-Isopropylamino)-3'-chloropropiophenone", "(RS/SR)-2-[1-(4-chlorophenyl)hexyl]piperidine", "(+/-)-threo-3',5'-Dichloromethylphenidate", "Bip-tyr(3bzl)-thr-pro-lys-thr", "1-(4-aminophenyl)-2-pyrrolidin-1-yl-pentan-1-one", "2-(tert-Butylamino)-3',5'-difluoropropiophenone", "4-[(diphenylmethyl)amino]-2-phenylquinazoline", "ANOLOBINE", "(+/-)-threo-N-(6-Phenylhexyl)methylphenidate", "(+/-)-threo-N-(3-Methylpyridine)methylphenidate", "Threo-ritalinol methyl ether hydrochloride", "1-Benzo[b]thiophen-2-yl-cyclohexylamine", "(+/-)-threo-3',5'-Dimethylmethylphenidate", "(+/-)-threo-N-Allylmethylphenidate", "(+/-)-threo-3',4'-Dichlororitalinol methyl ether", "OBABERINE", "(+/-)-threo-N-(2-Methylpyridine)methylphenidate", "(+/-)-threo-N-Ethylritalinol", "1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine", "(+/-)-threo-Benzylphenidate", "(+/-)-threo-Ritalinol methyl ether", "[3H]GBR12935", "Indatraline", "(+/-)-threo-4'-Ethylmethylphenidate", "Amfetamine transdermal", "ANONAINE", "1-(1-Benzo[b]thiophen-2-yl-cyclopentyl)-azepane", "PSEUDOCOCAINE", "COCLAURINE", "(RS/SR)-2-[1-(4-chlorophenyl)propyl]piperidine", "DEXMETHYLPHENIDATE HYDROCHLORIDE", "Chloroprocaine(Drug Bank)", "4-(2-pyrrolidin-1-yl-pentanoyl)benzonitrile", "(+/-)-threo-3',4'-Dichloromethylphenidate amide", "NORBOLDINE", "Threo-N-ethylritalinol hydrochloride", "(+/-)-threo-N-(3-Phenylpropyl)ritalinol", "(+/-)-threo-N-Benzylmethylphenidate amide", "(+/-)-threo-3',4'-Dichlororitalinol", "AMINOBENZTROPINE", "(RS/SR)-2-[1-(4-chlorophenyl)ethyl]piperidine", "HOMOAROMOLINE", "(RS/SR)-2-[1-(4-chlorophenyl)butyl]piperidine", "(+/-)-threo-N-(2-Methylfuran)methylphenidate", "(+/-)-threo-N-(2-Chlorobenzyl)methylphenidate", "(+/-)-threo-Ritalinol", "(+/-)-threo-N-(3-Methylfuran)methylphenidate", "2-(tert-Butylamino)-3'-fluoropropiophenone", "NORSTEPHALAGINE", "Amineptine(TTD)", "[N-[2-[(3'-N'-PROPYL-3''ALPHA-(BIS(4-FLUORORPHENYL)METHOXY)TROPANE-2''BETA-CARBOXYLIC ACID METHYL ESTER)(2-MERCAPTOETHYL)AMINO]ACETYL]-2-AMINOETHANETHIOLATO]RHENIUM(V) OXIDE (DIASTEREOMERIC MIX)", "Methyl 2-(naphthalen-2-yl)benzoate", "N-Benzylmethylphenidate", "Bip-tyr-ala-pro-lys-thr(obzl)-gly", "1-(1-Benzo[b]thiophen-2-yl-cycloheptyl)-azepane", "(+/-)-threo-N-(3-Chlorobenzyl)methylphenidate", "(+/-)-threo-N-(3-Phenylpropyl)methylphenidate", "1-Benzo[b]thiophen-2-yl-cycloheptylamine", "Diphenylpyraline(Drug Bank)", "N,Ndimethyl milnacipran", "1-phenyl-1-(piperidin-2-yl)propan-2-one", "Methylphenidate(TTD)", "(+/-)-threo-Methylphenidate amide", "1-(1-Benzo[b]thiophen-2-yl-cyclohexyl)-azepane", "Bip-tyr-thr-pro-ala-thr(obzl)-gly"], "['231']": ["Ranirestat", "WF-2421", "ARI-809", "QUERCITRIN", "Zenarestat", "Isorhamnetin 3,7-disulfate", "O7-Nitrooxyethyl chrysin", "2-Benzhydryl-7-hydroxy-chromen-4-one", "PALBINONE", "6-(4-Methoxy-benzenesulfonyl)-2H-pyridazin-3-one", "M-16209", "6-(Benzofuran-2-sulfonyl)-2H-pyridazin-3-one", "LIDORESTAT", "6-(1H-Indole-2-sulfonyl)-2H-pyridazin-3-one", "AD-5467", "Quercetin 3-O-neohesperidoside", "TINGENONE", "2-Benzyl-7-hydroxy-chromen-4-one", "Apigenin-7-O-beta-D-glucuronide methyl ester", "Inhibitor Idd 384", "3-(3-Benzoyl-1H-pyrrol-1-yl)propanoic acid", "O5-Acetyl-O7-nitrooxyethyl chrysin", "6-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one", "TRIPTOCALLINE A", "6-methoxykaempferol 3-O-beta-D-robinobioside", "MINALRESTAT", "CTL-102-GDEPT", "FR-62765", "IMIRESTAT", "QR-333", "2-(3,4-Dihydroxy-benzyl)-7-hydroxy-chromen-4-one", "3,5-dichlorosalicylic acid", "(8-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid", "TINGENIN B", "4-(3-Methoxy-phenyl)-isoxazolidine-3,5-dione", "daidzein", "2-(Phenylsulfonamido)acetic Acid", "6-(2-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one", "(6-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid", "6-(2-Chloro-benzenesulfonyl)-2H-pyridazin-3-one", "ADMVA", "6-Benzenesulfonyl-2H-pyridazin-3-one", "7-Hydroxy-2-(4-methoxy-benzyl)-chromen-4-one", "(6-Methoxy-2-oxo-2H-quinolin-1-yl)-acetic acid", "MANGIFERIN", "6,7-Dihydroxy-2-phenyl-chromen-4-one", "6-(Toluene-4-sulfonyl)-2H-pyridazin-3-one", "7-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one", "T2c-003", "Sulindac(TTD)", "SSR-125047", "3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid", "2-(4-aminophenylsulfonamido)acetic acid", "EPALRESTATE", "IDD594", "AK198", "Fidarestat(TTD)", "ALO-1567", "6-Phenylmethanesulfonyl-2H-pyridazin-3-one", "6-(4-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one", "BNV-222", "(4-Methyl-2-oxo-2H-quinolin-1-yl)-acetic acid", "Patuletin 3-O-beta-D-robinobioside", "Fidarestat(Stereoisomer)", "2-(3-benzoyl-1H-pyrrol-1-yl)acetic acid", "6-(Biphenyl-2-sulfonyl)-2H-pyridazin-3-one", "Sorbinil", "E-0722", "6-(4-Chloro-benzenesulfonyl)-2H-pyridazin-3-one", "7-Hydroxy-4-phenylcoumarin", "Alrestatin", "JTT-811", "N-Acetylalanine", "2,3-dihydroxypropanal", "6-(Naphthalene-1-sulfonyl)-2H-pyridazin-3-one", "IDD552", "6-(Naphthalene-2-sulfonyl)-2H-pyridazin-3-one", "6-(2-Bromo-benzenesulfonyl)-2H-pyridazin-3-one", "6-(3-Chloro-benzenesulfonyl)-2H-pyridazin-3-one", "Ponalrestat", "7-Hydroxy-6-nitro-2-phenyl-chromen-4-one", "6-(Benzothiazole-2-sulfonyl)-2H-pyridazin-3-one", "6-(4-Bromo-benzenesulfonyl)-2H-pyridazin-3-one", "SPR-210", "ZOPOLRESTAT", "Isorhamnetin 3-O-rhamnoside", "Tamarixetin 3-glucoside-7-sulfate", "Epalrestat", "4-(3-Benzoyl-1H-pyrrol-1-yl)butanoic acid", "Patuletin 3-O-beta-D-galactoside", "Apigenin-7-O-beta-D-glucuronide", "2-(3,4-Dihydroxy-phenyl)-7-hydroxy-chromen-4-one"], "['3706']": ["Inositol 1,3,4,5-Tetrakisphosphate(Drug Bank)"], "['1545', '1588', '2739', '3292']": ["NARINGENIN"], "['2203', '4048', '8789']": ["4-(2-amino-1,3-thiazol-4-yl)phenol(TTD)"], "['113235']": ["[3H]N5-methylfolate", "PREMETREXED", "[3H]folinic acid"], "['3939', '3939', '3945', '3948']": ["4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid", "3-Hydroxyisoxazole-4-Carboxylic Acid", "3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID", "4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid", "Naphthalene-2,6-disulfonic acid"], "['8879']": ["LX-2932", "PMID24809814C31", "LX2931", "LX3305"], "['4047', '4047', '412', '4843', '5320', '5406', '5742', '5743', '8513']": ["B-Octylglucoside"], "['30814', '5320']": ["1,4-Butanediol(Drug Bank)"], "['5139']": ["Enoximone", "BEMORADAN", "7-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one", "TETRAHYDROBENXIMIDAZOLE", "CI-930", "VESNARINONE", "7-Iodo-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one", "8-methyl-2-morpholino-7-phenoxy-4H-chromen-4-one", "LAS-31180", "BENZOYLENUREA", "8-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one", "7-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one", "6-(2-Imidazol-1-yl-vinyl)-1H-quinolin-2-one", "5-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one", "1,3-Dihydro-naphtho[2,3-d]imidazol-2-one", "1,3,9,9a-Tetrahydro-imidazo[4,5-b]quinolin-2-one", "1,3-Dihydro-imidazo[4,5-b]quinolin-2-one", "BMY-20844", "Anagrelide", "2-morpholino-7-(2-phenylethynyl)-4H-chromen-4-one", "8-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one", "EMD-53998", "Cilostazol", "Aminophylline", "6-Imidazol-1-yl-3,4-dihydro-1H-quinolin-2-one", "7-Fluoro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one", "7-Ethoxy-1,3-dihydro-imidazo[4,5-b]quinolin-2-one", "2-morpholino-7-phenyl-4H-chromen-4-one", "1,5-Dihydro-imidazo[2,1-b]quinazolin-2-one", "8-methyl-2-morpholino-7-phenyl-4H-chromen-4-one"], "['24']": ["StarGen"], "['240', '240', '279']": ["Acanthus ilicifolius Linn"], "['108', '111']": ["2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE(Drug Bank)"], "['759', '760', '762', '768']": ["SULFAMIDE", "SULFAMATE"], "['9536']": ["PMID28627961-Compound-31", "PMID28627961-Compound-30", "PMID28627961-Compound-33", "PMID28627961-Compound-32", "Piperidine carboxamide derivative 1", "Carboxylic acid derivative 1", "PMID28627961-Compound-22", "Pyrimidine derivative 2", "Methyl-piperidine compound 1", "PMID28627961-Compound-44", "PMID28627961-Compound-41", "Phthalazinone derivative 1", "Benzimidazole derivative 16", "Benzimidazole derivative 17", "Benzimidazole derivative 14", "Benzimidazole derivative 12", "Benzimidazole derivative 13", "Benzimidazole derivative 11", "Benzimidazole derivative 15", "Benzamide derivative 16", "Benzamide derivative 14", "Benzamide derivative 15", "Imidazole benzamide derivative 1", "L-655240", "AAD-2004", "Benzamide derivative 18", "Imidazopyridine derivative 6", "Imidazopyridine derivative 7", "Imidazopyridine derivative 5", "Alpha-substituted pirinixic acid and pirinixic acid ester derivative 1", "Betais-sulfonylamino derivative 1", "Boswellia acid derivative 1", "Polycyclic compound 1"], "['2053']": ["N-(naphthalen-1-yl)benzo[d]isoxazol-3-amine", "N-Cyclohexyl-2-phenyl-acetamide", "1-Cycloheptyl-3-(1-propionylpiperidin-4-yl)urea", "13-n-Heptanamidotridec-5-ynoic acid", "3-(3-Adamantan-1-yl-ureido)-benzoic acid", "1,3-DIPHENYLUREA", "N-(3-Phenyl-propyl)-nicotinamide", "1-adamantan-1-yl-3-(4-pentyloxybutyl)urea", "1-(1-Propionylpiperidin-4-yl)-3-o-tolylurea", "12-(3-n-Hexylureido)dodec-8(Z)-enoic acid", "N-(3,3-diphenyl-propyl)-nicotinamide", "1-adamantan-1-yl-3-(3-hydroxypropyl)urea", "1-Adamantan-1-yl-3-(4-methoxy-phenyl)-urea", "GSK2256294", "13-(3-n-Pentylureido)tridec-5(Z)-enoic acid", "N,N'-dicyclohexyl-urea", "1-adamantan-1-yl-3-(2-heptyloxyethyl)urea", "Ebselen(Drug Bank)", "4-(3-Adamantan-1-yl-ureido)-benzoic acid", "1-adamantan-1-yl-3-(5-butoxypentyl)urea", "12-(3-n-Pentylureidooxy)dodec-8(Z)-enoic acid", "1-adamantan-1-yl-3-(5-hydroxypentyl)urea", "N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide", "2-Cyclohexyl-N-phenethyl-acetamide", "N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE", "1-Adamantan-1-yl-3-(3-hydroxy-phenyl)-urea", "13-(3-n-Pentylureido)tridec-8-ynoic acid", "9-(3-n-Pentylureido)non-4(Z)-enoic acid", "2-Adamantan-1-yl-N-decyl-acetamide", "1-adamantan-1-yl-3-(1-butyl-piperidin-4-yl)-urea", "1-adamantan-1-yl-3-piperidin-4-yl-urea", "6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID", "N-Cyclohexyl-N'-Decylurea", "Cis-1-adamantan-1-yl-3-(4-hydroxycyclohexyl)urea", "Dodecanoic acid adamantan-1-ylamide", "N-(biphenyl-3-yl)benzo[d]isoxazol-3-amine", "1-adamantan-1-yl-3-(6-propyloxyhexyl)urea", "1-(1-Adamantyl)-3-(1-propionylpiperidin-4-yl)urea", "14-(n-Hexylamino)-14-oxotetradec-8(Z)-enoic acid", "1-adamantan-1-yl-3-piperidin-4-ylmethyl-urea", "6-amino-N-(3,3-diphenylpropyl)nicotinamide", "1-adamantan-1-yl-3-(4-pentyloxycylclohexyl)urea", "Cis-1-adamantan-1-yl-3-(4-methoxycyclohexyl)urea", "1-Cyclohexyl-3-phenyl-urea", "N-adamantyl-N'-cyclohexylurea", "13-(n-Pentylcarbamoyloxy)tridec-8(Z)-enoic acid", "1-Phenyl-3-(1-propionylpiperidin-4-yl)urea", "1-Cyclohexyl-3-phenethyl-urea", "2-Cyclohexyl-N-(4-methoxy-phenyl)-acetamide", "EXRD-4605", "N-(biphenyl-4-yl)benzo[d]isoxazol-3-amine", "1-(1-Propionylpiperidin-4-yl)-3-p-tolylurea", "N-benzyl-6-(3,3,3-trifluoropropoxy)nicotinamide", "1-adamantan-1-yl-3-(6-hydroxyhexyl)urea", "N-(3,3-Diphenyl-propyl)-isonicotinamide", "13-(N-Isopropylheptanamido)tridec-8(Z)-enoic acid", "1-adamantan-1-yl-3-(4-hydroxybutyl)urea", "Methyl 14-(3-n-butylureido)tetradec-8(Z)-enoate", "1-Adamantan-1-yl-3-(2-hydroxy-phenyl)-urea", "1-adamantan-1-yl-3-(3-hexyloxypropyl)urea", "1-adamantan-1-yl-3-[4-(4-fluorophenoxy)butyl]urea", "13-(3-n-Pentylthioureido)tridec-8(Z)-enoic Acid", "N-(3-Chloro-phenyl)-2-cyclohexyl-acetamide", "N-[3,3-Bis-(4-fluorophenyl)-propyl]-benzamide", "N-(4,4-Diphenyl-butyl)-nicotinamide", "13-(3-Pentyluredo)tridec-8(Z)-enoic acid", "N-[3,3-Bis-(4-fluorophenyl)-propyl]-nicotinamide", "16-(3-Ethylureido)hexadec-11(Z)-enoic acid", "1-Cyclohexyl-3-(1-propionylpiperidin-4-yl)urea", "4,4-Diphenyl-N-(pyridin-3-yl)-butyramide", "6-amino-N-(2,4-dichlorobenzyl)nicotinamide", "1-Adamantan-1-yl-3-(3-methoxy-phenyl)-urea", "1-adamantan-1-yl-3-((R)-1-phenyl-ethyl)-urea", "N-Cyclohexyl-N'-(4-Iodophenyl)Urea", "1-adamantan-1-yl-3-(1-benzyl-piperidin-4-yl)-urea", "1-(4-(3-morpholinopropoxy)phenyl)-3-phenylurea", "1-adamantan-1-yl-3-(1-ethyl-piperidin-4-yl)-urea", "9-(3-n-Pentylureido)non-4-ynoic acid", "SEH inhibitors", "4-(3-cyclohexylureido)butanoic acid", "N-Cyclohexyl-4-phenyl-butyramide", "13-(3-n-Pentylureido)tridec-8(E)-enoic acid", "[4-(3-Adamantan-1-yl-ureido)-phenyl]-acetic acid", "Methyl 6-(3-cyclohexylureido)hexanoate", "1-(3-(3-morpholinopropoxy)phenyl)-3-phenylurea", "1-(1-Propionylpiperidin-4-yl)-3-m-tolylurea", "1-(3-Chloro-phenyl)-3-cyclohexyl-urea", "1-Adamantan-1-yl-3-(4-hydroxy-phenyl)-urea", "N-Cyclohexyl-N'-(Propyl)Phenyl Urea", "1-Cyclohexyl-3-(4-methoxy-phenyl)-urea", "Methyl 4-(3-cyclohexylureido)butanoate", "1-Adamantan-1-yl-3-phenyl-urea", "N-(naphthalen-2-yl)benzo[d]isoxazol-3-amine", "1-adamantan-1-yl-3-(2-hydroxyethyl)urea", "13-(N-Methyl-n-heptnamido)tridec-8(Z)-enoic acid", "1-adamantan-1-yl-3-(1-propyl-piperidin-4-yl)-urea", "1-Octyl-3-(1-propionylpiperidin-4-yl)urea", "AR9281", "Trans,trans-1,3-bis-(4-hydroxycyclohexyl)urea", "13-n-Heptanamidotridec-8(Z)-enoic acid", "12-(3-Adamantan-1-yl-ureido)-dodeca noic acid", "2-Cyclohexyl-N-phenyl-acetamide", "13-(5-n-Pentylfuran-2-yl)tridec-8(Z)-enoic acid", "1-(3-Chloro-phenyl)-3-(4-hydroxy-decyl)-urea", "1-Adamantan-1-yl-3-decyl-urea", "N-Cyclohexyl-2-(4-methoxy-phenyl)-acetamide", "1-Adamantan-1-yl-3-(2-methoxy-phenyl)-urea", "1-Adamantan-1-yl-3-(4-hydroxy-decyl)-urea"], "['1584', '1586', '1588']": ["4'-(Pyridin-4-ylmethyl)biphenyl-3-amine", "4-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine", "3-(1-ethyl-3,4-dihydronaphthalen-2-yl)-pyridine", "4-((1H-imidazol-1-yl)methyl)benzonitrile", "3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine", "4-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine", "4-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine", "4-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine", "3-(6-methoxynaphthalen-2-yl)pyridine", "4-Indan-(1Z)-ylidenemethyl-pyridine", "4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine", "3-Fluoro-4'-(pyridin-4-ylmethyl)biphenyl-4-ol", "3-(6-Ethoxy-naphthalen-2-yl)-pyridine", "4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diol", "3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine", "4-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine", "5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine", "4-[(3'-Hydroxybiphenyl-4-yl)methyl]pyridine"], "['6523', '6524']": ["LIK-066", "10-methoxy-N(1)-methylburnamine-17-O-veratrate", "O-spiroketal glucoside", "Burnamine-17-O-3',4',5'-trimethoxybenzoate", "ACEROGENIN B", "LX-4211", "Kushenol N", "sergliflozin", "KURARINONE", "Sophoraflavanone G", "Alstiphyllanine D", "Alstiphyllanine E", "Alstiphyllanine F"], "['2766', '2987', '471', '8654']": ["Guanosine-5'-Monophosphate(Drug Bank)"], "['4128', '43', '6532']": ["Minaprine(Drug Bank)"], "['5291', '5294']": ["PQR309", "3-(4-morpholinothieno[3,2-d]pyrimidin-2-yl)phenol", "AZD8186", "KU-0060648", "PP121", "TGX-221", "PI-3065", "PIK-75"], "['32']": ["Soraphen A", "Axokine", "A-80040", "AC-8632", "2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid", "Acetyl CoA carboxylase inhibitors", "PF-05175157", "CP-640186", "QLT-091382", "Acetyl CoA carboxylase inhibitors, Bayer"], "['56606']": ["AA-193"], "['760', '768']": ["2-(benzyloxyamino)-N-hydroxyhexanamide", "MMI270", "2-(N''-Acetyl-hydrazino)-benzenesulfonamide", "2-Sulfamoyl-benzoic acid methyl ester", "1,4-phenylene disulfamate", "Sulfamic acid 4-sulfamoyloxymethyl-benzyl ester", "Quinoline-8-sulfonamide", "2-Hydrazinocarbonyl-benzenesulfonamide"], "['1854']": ["TAS-114"], "['5406']": ["Dalbavancin", "Orlistat(TTD)", "Daio-Orengedokuto (DOT)", "AZM-131", "MS-1819", "B-Nonylglucoside", "(Hydroxyethyloxy)Tri(Ethyloxy)Octane(TTD)", "METHOXYUNDECYLPHOSPHINIC ACID(TTD)", "Cetilistat(Drug Bank)"], "['1723', '3156']": ["Teriflunomide(TTD)"], "['4597']": ["P'-geranyl 3,5,8-trihydroxy-3-methyloctanate 8-diphosphate", "P'-geranyl 2-fluoromevalonate 5-diphosphate", "P'-geranyl 3,5,9-trihydroxy-3-methylnonanate 9-diphosphate", "2,2-difluoromevalonate 5-diphosphate", "6-fluoromevalonate 5-diphosphate", "analog 3 (Vlattas et al., 1996)", "2-fluoromevalonate 5-diphosphate", "6-fluoromevalonate pyrophosphate", "diphosphoglycolyl proline", "PMID17888661C18", "PMID17888661C19", "P'-geranyl 3,5,7-trihydroxy-3-methylheptanate 7-diphosphate"], "['217']": ["prunetin", "Daidzin", "CVT-10216", "crotylaldehyde", "ISOFORMONENTIN", "ANS-6637", "ALD-401", "GS-6637"], "['59272']": ["ORE-1001(TTD)", "GSK2586881", "MLN4760", "Hydroxychloroquine(Drug Bank)", "PMID18324760C28"], "['5148', '5149', '8654']": ["Vardenafil(Drug Bank)"], "['240', '240', '6916']": ["E-6700"], "['2539']": ["EPIANDROSTERONE", "Metazamide", "CBF-BS2", "Prasterone(TTD)", "Hydroxyacetic Acid"], "['6646', '8435']": ["Hesperetin(Drug Bank)", "ATR-101"], "['4860', '50484', '6240', '6241']": ["Cladribine(Drug Bank)"], "['5742', '5743']": ["N-(3-phenylamino-4-pyridinyl)methanesulfonamide", "RP-66364", "4,5-Bis(4-chlorophenyl)-1,2-selenazole", "diclofenac sodium patch", "Naproxen", "Nepafenac", "N-(1H-indazol-5-yl)acetamide", "Tiaprofenic acid(Drug Bank)", "Piroxicam(Drug Bank)", "Loxoprofen gel", "(11H-Dibenzo[b,e][1,4]dioxepin-8-yl)-acetic acid", "NCX-4016", "5-(4-Chlorophenyl)-4-p-tolyl-1,2-selenazole", "N-(3-(phenylthio)pyridin-4-yl)methanesulfonamide", "S-14080", "ThermoProfen", "N-(3-phenoxy-4-pyridinyl)ethanesulfonamide", "3 beta-O-acetyloleanolic acid", "Suprofen(Drug Bank)", "1-(4-(methylsulfonyl)phenyl)-3-phenylurea", "Florifenine", "3-(4-Methanesulfonyl-phenyl)-1-phenyl-propynone", "Amtolmetin guacil", "2-(N-(2-fluorophenyl)pyrrol-2-yl) acetic acid", "SC-58451", "Fenoprofen", "2-(N-(2-Ffuorophenyl)pyrrol-3-yl) acetic acid", "KC-764", "PSD-508", "Pirazolac", "(R)-2-(4-Isobutyl-phenyl)-N-phenyl-propionamide", "ATLIPROFEN METHYL ESTER", "IMRECOXIB", "Eicosapentaenoic acid/docosa-hexaenoic acid", "NCX 1022", "Salsalate(Drug Bank)", "4-(4-Chlorophenyl)-5-p-tolyl-1,2-selenazole", "Tolmetin(Drug Bank)", "Bermoprofen", "5-Phenyl-pentanoic acid benzyl-hydroxy-amide", "Nabumetone(Drug Bank)", "Dexibuprofen(TTD)", "FENBUFEN", "Bromfenac(Drug Bank)", "Prifelone", "Meclofenamate Sodium", "2-(p-Methylsulfonylbenzoyl)furan", "Oxametacin", "NMI-1182", "4-aminosalicylate sodium (oral controlled release, ulcerative colitis), AGI Therapeutics", "4,5-Bis(4-chlorophenyl)isothiazole", "2-(2,3,4-trimethoxyphenyl)-1H-indene", "Carprofen(Drug Bank)", "Droxicam", "Felbinac(TTD)", "Morniflumate(TTD)", "Benzydamine", "Ampiroxicam", "4,5-Bis(4-methoxyphenyl)-1,2-selenazole", "Etodolac(Drug Bank)", "(11H-Dibenzo[b,e][1,4]dioxepin-2-yl)-acetic acid", "D-1367", "1,2-dihydro-3-(2,3,4-trimethoxyphenyl)naphthalene", "Ketoprofen topical", "R-KETOPROFEN", "Zomepirac(TTD)", "Meloxicam(Drug Bank)", "Flurbiprofen(Drug Bank)", "Resveratrol Potassium3-Sulfate", "CRx-401", "Fosfosal", "FS-205-397", "Diflunisal(Drug Bank)", "Ketoprofen(Drug Bank)", "NCX-701", "Icosapent(TTD)", "Nitroflurbiprofen", "Naproxcinod", "Aceclofenac", "TZI-41078", "F-11105", "Carbamate derivative 2", "Asasantin", "Pelubiprofen", "Mefenamic acid(Drug Bank)", "Oxaprozin", "BN82451", "(11H-Dibenzo[b,e][1,4]dioxepin-7-yl)-acetic acid", "4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiol-3-one", "Primary alcohol metabolite of celecoxib", "5-Ethyl-3,4-diphenyl-isoxazole", "Ketorolac", "4,5-Bis(4-methoxyphenyl)isothiazole", "5-(4-Methoxyphenyl)-4-p-tolyl-1,2-selenazole", "(Z)-2'-des-methyl sulindac sulfide", "4-amino-N-(4-chlorophenyl)benzenesulfonamide", "1-(4-aminosulfonylphenyl)-2-(2-pyridyl)acetylene", "1-(4-(methylsulfonyl)phenyl)-3-p-tolylurea", "K-103-IP", "Meclofenamic acid(TTD)", "D-7193", "Eltenac", "Diclofenac", "E-5110", "2-(2-(2,6-dimethylphenylamino)phenyl)acetic acid", "Tenoxicam(Drug Bank)", "Lumiracoxib(Drug Bank)", "Lornoxicam", "5-Methyl-3,4-diphenyl-isoxazole", "(S)-FLURBIPROFEN", "Felbinac prodrug"], "['10060']": ["BMS-191095", "BTS-67582", "CCX915(TTD)", "KRN-2391"], "['2643', '4860']": ["Guanine(Drug Bank)"], "['5243']": ["4,3'',5''-trimethoxy-[1,1':2',1'']-terphenyl", "Fentanyl(Drug Bank)", "ONT-093", "Miltefosine(Drug Bank)", "W-198", "6-(3,5-dimethoxy-phenyl)-naphthalen-2-ol", "EDP-322", "[1,1':2',1'']-terphenyl-4,3'',5''-triol", "Biricodar(TTD)", "Dexniguldipine(Drug Bank)", "CBT-1", "Tariquidar", "ELACRIDAR"], "['3290']": ["2-(adamantan-1-ylamino)-5,5-diethyl-oxazol-4-one", "Adamantan-2-yl-piperidin-1-yl-methanone", "11-keto-ursolic acid", "2-(phenylsulfonyl)-1-p-tolylethanone", "Adamantan-1-yl-piperidin-1-yl-methanone", "BMS-770767", "JTT-654", "3-benzyl-1-cyclohexylpyrrolidin-2-one", "3-epicorosolic acid methyl ester", "1-(2-adamantyl)-3-benzylpyrrolidin-2-one", "PF-915275", "5-isopropyl-2-(phenylamino)thiazol-4(5H)-one", "AZD8329", "1-(4-tert-butylphenylsulfonyl)azepan-4-ol", "Tormentic acid methyl ester", "1-(3-nitropyridin-2-yl)-4-tosylpiperazine", "A-849531", "1-(4-nitrophenyl)-2-(phenylsulfonyl)ethanone", "1-(3-methoxyphenyl)-2-(phenylsulfonyl)ethanone", "BVT.2733", "1-(4-fluorophenyl)-3-(phenylsulfonyl)propan-1-one", "1-(4-ethylphenylsulfonyl)-4-phenylazepan-4-ol", "Corosolic acid", "INCB13739", "1-(3-methylpyridin-2-yl)-4-tosylpiperazine", "BVT-3498", "2-(phenylsulfonyl)-1-(thiophen-3-yl)ethanone", "2-(benzylamino)-5,5-diethyloxazol-4(5H)-one", "1-(4-fluorophenyl)-2-(phenylsulfonyl)ethanone", "LY-2523199", "MERCK-544", "EQ-1280", "HPP-851", "1-(4-tert-butylphenylsulfonyl)-4-methoxyazepane", "Adamantan-1-yl-piperazin-1-yl-methanone", "FIG 1", "1-phenyl-2-(1-phenyl-1H-tetrazol-5-yloxy)ethanone", "2-(cyclooctylamino)-5,5-diethyloxazol-4(5H)-one", "1-(4-chlorophenylsulfonyl)-4-phenylazepan-4-ol", "AMG-221", "BI-135585", "1,1-diphenyl-3-(phenylsulfonyl)propan-2-one", "SKI-2852", "N-benzyl-N-(phenylsulfonyl)benzamide", "1-(4-chlorophenyl)-2-(phenylsulfonyl)ethanone", "2-(4-tosylpiperazin-1-yl)nicotinonitrile", "(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE", "2-(2-chlorophenylamino)-5-methylthiazol-4(5H)-one", "1-(4-ethylpiperazin-1-yl)-2-phenylethanone", "1-(4-methoxyphenyl)-2-(phenylsulfonyl)ethanone", "11-beta-HSD1 inhibitors", "1-(1-phenyl-1H-tetrazol-5-ylthio)propan-2-one", "Piperidine-1-carboxylic acid adamantan-2-ylamide", "11beta-hydroxysteroid dehydrogenase-1 (HSD1) inhibitors", "5,5-diethyl-2-(phenethylamino)oxazol-4(5H)-one", "2-(o-toluidino)-5-ethylthiazol-4(5H)-one", "1-(3-chloropyridin-2-yl)-4-tosylpiperazine", "Carbenoxolone", "1-(phenylsulfonyl)butan-2-one", "Piperidine-1-carboxylic acid adamantan-2-yl ester", "GLYCYRRHIZIN", "Adamantan-1-yl-pyrrolidin-1-yl-methanone", "AZD-4017", "RG-4929", "(4-methoxyphenyl)(4-phenylazepan-1-yl)methanone", "CNX-010", "PF-877423", "1-(3,4-dichlorophenyl)-2-(phenylsulfonyl)ethanone", "UE-2343", "3-acetyl-11-keto-ursolic acid", "1-(4-methoxyphenylsulfonyl)-4-phenylazepan-4-ol", "Adamantan-1-yl-(4-ethyl-piperazin-1-yl)-methanone", "BMS-816336", "1-phenyl-3-(phenylsulfonyl)propan-1-one", "2-(o-toluidino)-5-isopropylthiazol-4(5H)-one", "Abietic acid", "1-(3,5-dimethylphenyl)-2-(phenylsulfonyl)ethanone", "1-phenyl-4-(1-phenyl-1H-tetrazol-5-yl)butan-2-one"], "['2168']": ["1-anilinonaphthalene-8-sulfonic acid", "FENOFIBRIC ACID"], "['23632', '768', '771']": ["7-phenethoxy-2H-chromen-2-one", "ETHOXYCOUMARIN"], "['6517', '6517']": ["DS-1150b"], "['9153']": ["PMID25815140C48"], "['1737']": ["Radicicol(Drug Bank)"], "['4144']": ["AG-270"], "['768']": ["8-acetyl-7-propoxy-2H-chromen-2-one", "PMID30074415-Compound-12", "Sulfonamide-thiadiazole derivative 1", "Sulfonamide-thiadiazole derivative 2", "2-(benzyloxyamino)-N-hydroxyacetamide", "90Y-cG250", "7-ethoxy-8-propionyl-2H-chromen-2-one", "6-Acetyl-7-hydroxy-2H-chromen-2-one", "7-hydroxycoumarin", "7-hydroxy-6-propionyl-2H-chromen-2-one", "8-Propionyl-7-propoxy-2H-chromen-2-one", "8-acetyl-7-(benzyloxy)-2H-chromen-2-one", "PMID30074415-Compound-GS3", "INDISULAM", "BAY 79-4620", "6-acetyl-7-propoxy-2H-chromen-2-one", "6-Acetyl-7-ethoxy-2H-chromen-2-one", "8-acetyl-7-ethoxy-2H-chromen-2-one", "Sulfonamide derivative 12", "8-acetyl-7-butoxy-2H-chromen-2-one", "2-(benzyloxyamino)-N-hydroxy-3-methylpentanamide", "CA9-ADC", "8-acetyl-7-methoxy-2H-chromen-2-one", "BICARBONATE", "7-hydroxy-8-propionyl-2H-chromen-2-one", "(4-sulfamoylphenylethylthioureido)fluorescein", "6-acetyl-7-methoxy-2H-chromen-2-one", "Girentuximab", "8-Acetyl-7-hydroxy-2H-chromen-2-one", "7-methoxy-8-propionyl-2H-chromen-2-one"], "['57379']": ["JX-929"], "['1066', '1066', '3620', '43', '590']": ["1,2-NAPHTHOQUINONE"], "['80854']": ["(R)-PFI-2"], "['6319']": ["Aramchol", "MK-8245", "CVT-12012", "2-(4-benzoylpiperazin-1-yl)thiazole-5-carboxamide", "Sterculic acid", "MF-152", "Isoxyl", "ISIS 147919"], "['231', '5837']": ["Alpha-D-Glucose-6-Phosphate"], "['3291']": ["RG-7234", "Ganoderic acid A"], "['5138', '5141', '5142']": ["Benzyl-(2-pyridin-4-yl-quinazolin-4-yl)-amine", "Benzyl-(2-pyridin-3-yl-quinazolin-4-yl)-amine"], "['270', '271', '272']": ["Coformycin"], "['200576']": ["Apilimod dimesylate", "LAM-002"], "['6559', '759', '760', '762']": ["Bendroflumethiazide(Drug Bank)"], "['2984']": ["ISIS-GCCRrx", "MLN0264", "Plecanatide(TTD)"], "['224']": ["NSC-527035", "S-methyl 4-methyl-4-morpholinopent-2-ynethioate", "Aloe-emodin", "NPS 1776", "Disulfiram(TTD)"], "['4953', '6470', '6470']": ["N-Pyridoxyl-Glycine-5-Monophosphate(Drug Bank)"], "['4843', '7054']": ["7,8-dihydrobiopterin"], "['116085']": ["Benzene sulfonamide derivative 16", "Cycloalkyl acid derivative 2", "Cycloalkyl acid derivative 1", "Benzoic acid derivative 1", "Tihoacetate derivative 1", "RDEA-684", "Tetrazole acetic acid derivative 1", "Succinamide derivative 1", "PMID27414413-Compound-Figure8right", "URC102", "Sulfonamide derivative 10", "Sulfonamide derivative 11", "Fused heterocyclic compound 12", "Benzofurans derivative 1", "Triazole propanedioic acid derivative 1", "Phenylthioacetate derivative 1", "Lesinurad(TTD)", "2-ethyl-3-(4-hydroxy) benzoyl benzofuran derivative 1", "PMID27414413-Compound-Figure6right", "3-benzyloxyphenyloxoacetic acid derivative 1", "Ring-fused compound 1", "RDEA3170"], "['122622', '2746', '5207', '54963']": ["Guanosine-5'-Triphosphate(Drug Bank)"], "['146802', '358', '55244']": ["[14C]TEA"], "['240', '240', '4353', '5742', '5743']": ["Mesalazine(Drug Bank)"], "['3931']": ["MEDI6012"], "['6557', '759']": ["Chlorthalidone(Drug Bank)"], "['23632', '765', '768', '771']": ["N1-(2-aminoethyl)ethane-1,2-diamine", "7-butoxy-2H-chromen-2-one", "7-propoxy-2H-chromen-2-one"], "['222962', '6530', '6531', '6531', '6532']": ["Sertraline(Drug Bank)"], "['276', '277', '278', '279', '280']": ["5-Hydroxymethyl-Chonduritol(Drug Bank)"], "['4535']": ["Methoxyflurane(Drug Bank)"], "['239', '246']": ["(+)-(5S,8S,10S)-20-methoxy-9,15-ene-puupehenol", "Polybrominated diphenyl ether derivative", "(+)-(5S,8S,9R,10S)-20-methoxypuupehenone", "3,4,6-Tribromo-2-(2,4-dibromo-phenoxy)-phenol", "CHLOROPUUPEHENONE", "DYSIDENIN", "NSC-172033", "(+)-(5S,8S,10S)-20-methoxypuupehenol", "NSC-661755", "Jaspic acid", "MANGOSTIN", "Dimethylnordihydroguarierate acid", "2,3,4,5-Tetrabromo-6-(2,4-dibromo-phenoxy)-phenol"], "['30814']": ["Oxyphenbutazone(Drug Bank)"], "['19']": ["Probucol(TTD)", "RG7232"], "['1080', '5742', '5743', '6564']": ["Dexibuprofen(Drug Bank)"], "['6506', '6511']": ["threo-3-methylglutamate"], "['2936']": ["2,4,6 trinitrobenzene sulfonate 1,3-bis (2-chlorethyl)-1-nitrosourea", "Oxidized glutathione", "3,6-Dihydroxy-Xanthene-9-Propionic Acid", "4-nitrobenzo[c][1,2,5]thiadiazole", "Trans-(1S(R),2S(R))-2-Hydroxycyclooctyl nitrate", "N-6060", "N-6547", "3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol", "Meta-Nitro-Tyrosine", "Glutathionylspermidine Disulfide", "Trans-(R(S))-2-Hydroxy-1-phenylethyl nitrate", "N-9xxx", "1-(2'-chlorophenyl)penta-1,4-dien-3-one"], "['132']": ["ABT-702", "6-Benzylthioinosine", "A-134974", "5'-iodotubercidin", "Iodotubercidin", "MB-03966", "5-iodo,5'-deoxytubercidin", "GP-683", "GP-3269"], "['290', '3290', '3291']": ["[(125)I] RB129"], "['18']": ["Vigabatrin", "3-chloro-1-(4-hydroxyphenyl)propan-1-one", "4-hydroxybenzylamine", "Pyruvic acid(TTD)", "4-hydroxy-3-nitrobenzaldehyde", "Pyridoxal Phosphate", "CPP -15", "L-Alanine", "Gamma-acetylenic GABA", "CPP-115", "K-828-AB", "Sodium valproate", "Divalproex sodium", "(4e)-4-Aminohex-4-Enoic Acid", "4-Amino Hexanoic Acid"], "['2629', '2629']": ["Taliglucerase alfa", "N-(Propylamide-acetophenone)-1-deoxynojirimycin", "(2R,3S,4S,5R)-2-nonylpiperidine-3,4,5-triol", "Velaglucerase alfa", "L-Isofagomine", "(2R,3S,4S,5R)-2-hexylpiperidine-3,4,5-triol", "N-(Propylamide-benzophenone)-1-deoxynojirimycin", "1,5-Dideoxy-1,5-imino-D-xylitol", "Isofagomine tartrate", "(2R,3S,4S,5R)-2-propylpiperidine-3,4,5-triol"], "['1215', '3290', '43', '590']": ["2-(N-Morpholino)-Ethanesulfonic Acid"], "['1178']": ["Para-Mercury-Benzenesulfonic Acid(Drug Bank)"], "['8566']": ["L-betagamma-meATP"], "['4363', '4363', '9429']": ["Biricodar(Drug Bank)"], "['4056', '4056', '5319']": ["Azelastine(Drug Bank)"], "['43']": ["SM-10888", "PMID27967267-Compound-43", "6-Methyl-4-(4-phenylpiperazin-1-yl)coumarin", "10-Hydroxy-infractopicrin", "BIS(9)-HUPERZINE B", "(3-Bromo-propyl)-trimethyl-ammonium", "6-Methyl-4-(4-o-tolylpiperazin-1-yl)coumarin", "OBIDOXIME", "Alkylene Linked Bis-Galanthamine derivative", "(3R)-9-amino-3-methyl-1,2,3,4-tetrahydroacridine", "PMID27967267-Compound-42", "N-benzylnorlitebamine", "3-[(1s)-1-(Dimethylamino)Ethyl]Phenol", "Rivastigmine(TTD)", "CI-1002", "BZYX", "PMID27967267-Compound-neotuberostemonine", "Trimethyl-(4-oxo-pentyl)-ammonium iodide", "(4-Iodo-butyl)-trimethyl-ammonium iodide", "(-)-huperzine B", "BIS(8)-HUPERZINE B", "Mesuagenin D", "TRIMEDOXIME", "1-(3-Bromomethyl-phenyl)-2,2,2-trifluoro-ethanone", "N-(14-methylallyl)norgalanthamine", "N-butylnorlitebamine", "Pseudocolumbamine trifluoroacetate", "ABS-301", "TERRITREM B", "Pyridostigmine(TTD)", "Hexyl-trimethyl-ammonium", "5-Hex-5-enyl-2-nonyl-3,4-dihydro-2H-pyrrole", "Ambenonium", "KW-5092", "(R)-tacrine(10)-hupyridone", "Isoflurophate(TTD)", "4-[4-(benzhydryloxy)piperidino]butyl benzoate", "F-3796", "Donepezil(TTD)", "3-(2,5-Dioxo-pyrrolidin-1-yl)-benzoic acid", "CORONARIDINE", "2-Hex-5-enyl-5-nonyl-pyrrolidine", "9-Ethyl-beta-carboline", "Demecarium bromide", "9-hydrazino-1,2,3,4-tetrahydroacridine", "GENESERINE", "ZIFROSILONE", "(4-Bromo-butyl)-trimethyl-ammonium", "PMID27967267-Compound-stenine", "SPH-1285", "2-Hex-5-enyl-5-non-8-enyl-3,4-dihydro-2H-pyrrole", "TASPINE", "Allyl-trimethyl-ammonium", "Tacrine-dihydropyridine hybrid derivative 1", "(S)-tacrine(10)-hupyridone", "FR-152558", "Zanapezil", "Trimethyl-(3-nitro-phenyl)-ammonium iodide", "3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM", "Pseudopalmatine trifluoroacetate", "(2-Chloro-ethyl)-trimethyl-ammonium chloride", "MF268", "Ranitidine(Drug Bank)", "9-amino-7H-dibenzo[de,h]quinolin-7-one", "CLEBOPRIDE", "GTP-004", "BIS(12)-HUPERZINE B", "5-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine", "Tacrine(TTD)", "1-benzene sulfonyl-cis-2,6-dimethyl piperidine", "NP-7557", "8-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine", "(3-Hydroxy-2-methyl-phenyl)-trimethyl-ammonium", "7-methoxytacrine", "Tacrine-phenothiazine hybrid derivative 1", "BIS(16)-HUPERZINE B", "CHLORPYRIFOS", "Tacrine-caffeic acid hybrid derivative 1", "Tacrine-caffeic acid hybrid derivative 2", "3-(4-Phenylpiperazin-1-carbonyl)coumarin", "Tacrine-indole hybrid derivative 1", "Tacrine-indole hybrid derivative 3", "Tacrine-indole hybrid derivative 2", "T-82", "N-n-propyl-7-methoxytacrine hydrochloride", "(2-Mercapto-ethyl)-trimethyl-ammonium iodide", "But-3-enyl-trimethyl-ammonium bromide", "Caracemide", "PMID27967267-Compound-12", "PMID27967267-Compound-13", "PMID27967267-Compound-14", "PMID27967267-Compound-15", "Neostigmine", "AP-2243", "9-Amino-1,2,3,4-tetrahydro-acridine-1,7-diol", "MF-8615", "6-Methyl-4-(4-benzoylpiperazin-1-yl)coumarin", "PMID27967267-Compound-39", "PMID27967267-Compound-36", "6,8-Dichloro-1,2,3,4-tetrahydro-acridin-9-ylamine", "TURBINATINE", "1,3-Bis-(3-imidazolidin-2-yl-phenyl)-urea", "VOACANGINE", "TAK-802", "Decamethonium(Drug Bank)", "4-formylphenyl-O-beta-Dglucopyranoside", "BW284C51", "BIS(20)-HUPERZINE B", "3-(3-Carboxy-propionylamino)-benzoic acid", "N-isopropylnorlitebamineN-methoiodide", "Pralidoxime Chloride", "Ethyl octylfluorophosphonate", "Edrophonium(TTD)", "NP-61", "ETHYLPHENSERINE", "3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1H-indazole", "N-n-dodecyl-7-methoxytacrine hydrochloride", "Isosorbide-di-phenylcarbamate", "Dimethyl-pent-4-enyl-ammonium bromide", "(2-Ethoxy-ethyl)-trimethyl-ammonium iodide", "1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE", "CRYPTADINE B", "4ALPHA-(HYDROXYMETHYL)-4ALPHA-DEMETHYLTERRITREM B", "YM443", "N-ALLYLNORGALANTHAMINE", "Tubocurarine(Drug Bank)", "Galantamine(TTD)", "Isopropyl dodecylfluorophosphonate", "MESUAGENIN B", "MESUAGENIN A", "TACRINE(8)-4-AMINOQUINOLINE", "1-Deoxy-1-Thio-Heptaethylene Glycol", "N-isobutylnorlitebamine", "Chlorphrifos oxon", "Galanthamine derivative", "Methanesulfonyl fluoride", "DECIDIUM", "NPRx-30", "2-morpholino-N-phenethylpyrimidin-4-amine", "R-phenserine", "N-propylnorlitebamine", "HP-290", "2-Hex-5-enyl-5-non-8-enyl-pyrrolidine", "GANSTIGMINE", "Cis-2,6-dimethyl-1-methyl sulfonyl piperidine", "PHENSERINE TARTRATE", "INM-176", "N-benzyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine", "INFRACTOPICRIN", "(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE", "Echothiophate Iodide", "PRX-105", "VELNACRINE", "Carinatumins B (2)", "PMID27967267-Compound-7", "PMID27967267-Compound-3", "Amocarzine", "3-(2-N-Piperidyl-acetamino)-rutaecarpine", "Icopezil maleate", "N-allylnorlitebamine", "Galantamine analog 1", "Propidium", "LYSICAMINE", "S-9977", "Fluorinated donepezil derivative 1", "Fluorinated donepezil derivative 2", "CP-126998", "CPC-250", "7-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine", "Ro-46-5934", "Huperzine A", "3-hydroxy-N,N,N-trimethylbenzenaminium iodide", "3-(4-Benzoylpiperazine-1-carbonyl)coumarin", "CHOLINE IODIDE", "Bis(14)-Huperzine B", "N-isopropylnorlitebamine", "Isosorbide-2-benzylcarbamate-5-tosylate", "Physostigmine", "Huprine Y", "BIS(18)-HUPERZINE B", "3,6,9,12,15-Pentaoxaheptadecane(Drug Bank)", "CPC-212", "Petrosamine", "Beta-L-fucose", "Huperaine A", "AP-2238", "6-methoxy-2,9-dimethyl-9H-beta-carbolin-2-ium", "ZT-1", "Isosorbide-di-(4-nitrophenyl carbamate)", "Malathion(TTD)", "Monoisopropylphosphorylserine", "(S,S)-(-)-bis(12)-hupyridone", "3-(4-o-Tolylpiperazine-1-carbonyl)coumarin", "6-hydroxy-2,9-dimethyl-9H-beta-carbolin-2-ium", "(S,S)-(-)-bis(10)-hupyridone", "PMID27967267-Compound-27", "PMID27967267-Compound-28", "Lycorine dimer salt derivative 1", "(2-Butyryloxy-ethyl)-trimethyl-ammonium iodide", "PMID27967267-Compound-neostenine", "Tetraethylene Glycol", "N-benzyl-2-morpholinopyrimidin-4-amine", "4-formylphenyl-O-beta-D-ribopyranoside", "(5-Bromo-pentyl)-trimethyl-ammonium"], "['760', '763']": ["4-Methylimidazole(Drug Bank)"], "['291']": ["Cardiolipin", "Di-Stearoyl-3-Sn-Phosphatidylcholine", "bongkrek acid", "Carboxyatractyloside", "Clodronate"], "['3290', '4129']": ["Flavanone"], "['7166']": ["KAR5585", "AGN-2979"], "['43', '759', '760']": ["PARAOXON"], "['760', '762', '768']": ["1-(3,4-dichlorophenyl)-3-hydroxyurea"], "['1200']": ["Cerliponase Alfa"], "['5291', '5293', '5294']": ["Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate"], "['1644']": ["3-hydroxybenzylhydrazine", "Patrome", "AV-201", "Benserazide", "Carbidopa"], "['759', '760', '768']": ["4-Hydrazinocarbonyl-benzenesulfonamide", "Aminobenzolamide derivative", "2-nonylamido-5-sulfonamidoindane", "1-pentafluorophenylamido-5-sulfonamidoindane", "4-azidobenzenesulfonamide", "N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide", "Sulfamic acid 12-sulfamoyloxy-dodecyl ester", "Sulfamic acid 16-sulfamoyloxy-hexadecyl ester", "PHENYLSULFAMATE", "1-acetamido-5-sulfonamidoindane", "1-valproylamido-5-sulfonamidoindane", "2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide", "4-methylphenyl-difluoromethanesulfonamide", "PHENYLMETHANESULFONAMIDE", "2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide", "PHENYLDIFLUOROMETHANESULFONAMIDE", "3-bromophenyl-difluoromethanesulfonamide", "3-Fluoro-4-hydrazino-benzenesulfonamide", "2-propylamido-5-sulfonamidoindane", "1-cyclohexylamido-5-sulfonamidoindane", "N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide", "Sulfamic acid 6-sulfamoyloxy-hexyl ester", "2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide", "2-valproylamido-5-sulfonamidoindane", "2-cyclohexylamido-5-sulfonamidoindane", "Sulfamic acid 7-sulfamoyloxy-heptyl ester", "3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide", "4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide", "Sulfamic acid 4-sulfamoyloxy-butyl ester", "2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide", "2-acetamido-5-sulfonamidoindane", "4-ethynyl benzene sulfonamide", "Sulfamic acid 3-sulfamoyloxy-phenyl ester", "HYDROSULFIDE", "Azide", "5-Amino-[1,3,4]thiadiazole-2-thiol", "2-pentafluorophenylamido-5-sulfonamidoindane", "2-ethylamido-5-sulfonamidoindane", "2-butylamido-5-sulfonamidoindane", "NSC-654077", "3-Chloro-4-hydrazino-benzenesulfonamide", "2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide", "(2-bromophenyl)difluoromethanesulfonamide", "4-nitrophenyl-difluoromethanesulfonamide", "(4-bromophenyl)difluoromethanesulfonamide"], "['2542', '2542']": ["S 1743", "Mumbaistatin", "Kodaistatin C", "S 0957", "Kodaistatin A", "S-4048", "Chlorogenic acid", "S 3025"], "['210', '2628']": ["Delta-Amino Valeric Acid(Drug Bank)"], "['978']": ["Tetrahydrouridine"], "['760', '762']": ["Phenyl-phosphonic acid"], "['23632', '759', '760', '762', '765', '768', '771']": ["Syringic Acid", "4-Hydrazino-benzenesulfonamide", "Decane-1,10-diyl disulfamate", "CL-5343", "2,4-Disulfamyltrifluoromethylaniline", "BENZOLAMIDE", "Decyl sulfamate", "4-Amino-3-fluoro-benzenesulfonamide", "GALLICACID", "4-Amino-3-chloro-benzenesulfonamide", "PARABEN", "Octyl sulfamate", "Octane-1,8-diyl disulfamate", "Pentane-1,5-diamine", "P-Coumaric Acid", "4-Amino-3-iodo-benzenesulfonamide", "COUMARIN", "4-Amino-3-bromo-benzenesulfonamide", "6-(aminomethyl)-2H-chromen-2-one"], "['4524']": ["677T", "EX5"], "['80150', '80150']": ["Calaspargase pegol"], "['5834', '5836', '5837']": ["PMID26666989-Compound-Figure11Ala up", "PMID26666989-Compound-Figure9toprightR02", "PMID26666989-Compound-Figure9middle11", "PMID26666989-Compound-Figure9middle10", "PMID26666989-Compound-Figure9middle13", "PMID26666989-Compound-Figure9middle12", "PMID26666989-Compound-Figure11Ala down", "PMID26666989-Compound-Figure9left01", "PMID26666989-Compound-Figure9left02", "PMID26666989-Compound-Figure9topright01", "PMID26666989-Compound-Figure12left", "PMID26666989-Compound-Figure12bottomright", "PMID26666989-Compound-Figure12bottommiddle01", "PMID26666989-Compound-Figure12bottommiddle02", "PMID26666989-Compound-Figure9bottomright", "PMID26666989-Compound-Figure11topright", "PMID26666989-Compound-Figure12topmiddile", "PMID26666989-Compound-Figure9middle06", "PMID26666989-Compound-Figure9middle07", "PMID26666989-Compound-Figure9middle04", "PMID26666989-Compound-Figure9middle05", "PMID26666989-Compound-Figure9middle02", "PMID26666989-Compound-Figure9middle03", "PMID26666989-Compound-Figure9middle01", "PMID26666989-Compound-Figure9middle08"], "['2805', '875']": ["aminooxyacetic acid"], "['169355', '3620', '6999', '6999']": ["2,3-diamino-benzo[b]thiophene derivative 5", "2,3-diamino-benzo[b]thiophene derivative 4", "2,3-diamino-benzo[b]thiophene derivative 7", "2,3-diamino-benzo[b]thiophene derivative 6", "2,3-diamino-benzo[b]thiophene derivative 1", "2,3-diamino-benzo[b]thiophene derivative 2", "2,3-diamino-benzo[b]thiophene derivative 8", "PMID27172114-Compound-30"], "['4907', '953']": ["PSB-0963"], "['5244']": ["LANIQUIDAR", "Dofequidar fumarate", "Dexniguldipine(TTD)"], "['4017']": ["GS-6624"], "['5498']": ["Aminolevulinic Acid Hydrochloride"], "['251']": ["Levamisole(Drug Bank)"], "['762']": ["Sodium sulfamate", "Aminocarbonyl dihydrogen phosphate", "2-Propyl-pentanoic acid 4-sulfamoyl-benzyl ester", "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS", "2-Propyl-pentanoic acid 4-sulfamoyl-benzylamide", "Trisodium phosphate", "SODIUM CITRATE", "Phenylarsonic acid", "Sodium phenylarsonate", "SYL-040003", "Malonate sodium", "Brinzolamide(TTD)", "N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-benzamide", "[Fe(CN)6]4-", "Sodium pyruvate"], "['221955', '747']": ["RHC80267"], "['759', '760', '762']": ["N-1,3,4-thiadiazol-2-ylsulfamide", "Sodium trithiocarbonate", "N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide", "Trecadrine", "Phenyl Boronic acid", "N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide", "N-hydroxysulfonamides", "N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide", "N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide", "N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide"], "['5141', '5142', '5143', '5144']": ["Dyphylline(Drug Bank)", "Piclamilast(Drug Bank)", "RS-25344"], "['23632', '6713', '759', '760', '762', '765', '768', '771']": ["ELLAGIC ACID"], "['2548']": ["Alpha-Homonojirimycin", "(R)-2,6-Bis-hydroxymethyl-piperidine-3,4,5-triol", "(-)-uniflorine A", "VALIOLAMINE", "2,5-imino-2,5,6-trideoxy-D-manno-heptitol", "UNIFLORINE B", "Alpha-7-Deoxyhomonojirimycin", "N-adamantanemethyloxypentyl-1-deoxynojirimycin", "BMN-701", "7-O-b-D-Glucopyranosyl-a-homonojirimycin", "GZ402666"], "['6557', '759', '760', '762']": ["Methyclothiazide(Drug Bank)"], "['2752']": ["NLX-P101"], "['8140']": ["BCH", "(+/-)-2-Aminoindane-2-carboxylic acid", "(+/-)-2-Amino-1,2,3,4-tetrahydro-2-naphthoic acid"], "['2203']": ["Managlinat dialanetil(Drug Bank)", "2,5-Anhydroglucitol-1,6-Biphosphate(Drug Bank)"], "['759']": ["CYANATE", "[Au(CN)2]-", "Cynooxide anion", "BENZENESULFONAMIDE", "Acetazolamide(TTD)", "L-693612", "4-methylstyrylboronic acid", "Methazolamide(TTD)", "2-(biphenyl-4-yl)vinylboronic acid", "Styrylboronic acid", "SULFATE", "5-oxo-1-tosyl-2,5-dihydro-1Hpyrrol-2-yl acetate"], "['10901', '10901', '112724', '112724', '112724', '112724', '112724', '112724', '112724', '112724', '112724', '112724', '145226', '216', '220', '50700', '51109', '5730', '57665', '5959', '8854', '9227', '9249']": ["Vitamin A(Drug Bank)"], "['50484', '6240', '6241']": ["Amidox", "G-207 virus construct", "Didox", "Clofarabine(TTD)", "Trimidox", "COH29"], "['216', '217']": ["Calcium carbimide(TTD)"], "['2717', '3938', '43', '590']": ["Fucose"], "['7299']": ["1-(4-Methylpent-3-en-2-ylidene)thiosemicarbazide", "4-adamantyl resorcinol", "1-(3-Phenylallylidene)thiosemicarbazide", "5-{8(Z),-pentadecenyl}resorcinol", "1-(Propan-2-ylidene)thiosemicarbazide", "Kazinol F", "Kazinol C", "5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol", "HINOKITIOL", "5-(pyridin-4-yl)-1,3,4-thiadiazole-2(3H)-thione", "3-(2,4-dihydroxyphenyl)propionic acid", "PMID26815044-Compound-127", "PMID26815044-Compound-126", "PMID26815044-Compound-125", "PMID26815044-Compound-124", "PMID26815044-Compound-123", "PMID26815044-Compound-122", "PMID26815044-Compound-121", "Thiazole derivative 1", "5-benzyl-1,3,4-oxadiazole-2(3H)-thione", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 10", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 11", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 13", "2-(ethylthiomethyl)-5-hydroxy-4H-pyran-4-one", "Resorcinol compound 29", "Resorcinol compound 28", "Resorcinol compound 25", "Resorcinol compound 24", "Resorcinol compound 27", "Resorcinol compound 26", "Resorcinol compound 21", "Resorcinol compound 23", "Resorcinol compound 22", "4',4-Dihydroxychalcone", "PMID26815044-Compound-93", "5-benzhydryl-1,3,4-thiadiazole-2(3H)-thione", "4-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol", "Multi-epitope peptide melanoma vaccine", "5-(3-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione", "5-phenyl-1,3,4-oxadiazole-2(3H)-thione", "N-(2,4-dihydroxybenzyl)-3,4-dihydroxybenzamide", "1-Propylidenethiosemicarbazide", "5-benzhydryl-1,3,4-oxadiazole-2(3H)-thione", "2,4,3',5'-tetrahydroxybibenzyl", "ETHISTERONE", "4'-(4-Nitrobenzensulfonamide)-4-hydroxychalcone", "4'-Amino-4-hydroxychalcone", "5-{8(Z),11(Z),14-pentadecatrienyl}resorcinol", "SODIUM ZINC DIHYDROLIPOYLHISTIDINATE", "Nicotinyl hydroxamic acid derivative 1", "OXYRESVERATROL", "7-(3,5-dihydroxyphenyl)naphthalene-1,3-diol", "MKC-1106-MT", "P-coumaric acid derivative 3", "DAEDALIN A", "1'-(4-Methyl-benzyl)-[1,4']bipiperidinyl", "P-coumaric acid derivative 4", "1-(1,4-diacetylphenyl)dithiosemicarbazide", "Benzoic acid linked peptide analog 5", "Benzoic acid linked peptide analog 4", "Benzoic acid linked peptide analog 6", "Benzoic acid linked peptide analog 1", "Benzoic acid linked peptide analog 3", "Benzoic acid linked peptide analog 2", "Crocusatin-K", "4'-(p-Toluenesulfonamide)-4-hydroxychalcone", "1-(4-bromophenyl)-3-hydroxyurea", "PMID26815044-Compound-30", "7,3',4'-trihydroxyisoflavone", "2,2',4,4'-tetrahydroxychalcone", "1-Cyclopentylidenethiosemicarbazide", "2-(hexylthiomethyl)-5-hydroxy-4H-pyran-4-one", "2-(butylthiomethyl)-5-hydroxy-4H-pyran-4-one", "1-(1-(thiophen-2-yl)ethylidene)thiosemicarbazide", "PMID26815044-Compound-50", "PMID26815044-Compound-51", "PMID26815044-Compound-52", "2,2',4,4',6'-pentahydroxychalcone", "3-hydroxyphenethyl 3,4,5-trihydroxybenzoate", "PMID26815044-Compound-64", "1-Cyclohexylidenethiosemicarbazide", "Benzothiazoline derivative 1", "PMID26815044-Compound-114", "PMID26815044-Compound-115", "P-coumaric acid derivative 2", "P-coumaric acid derivative 1", "P-coumaric acid derivative 6", "PMID26815044-Compound-118", "P-coumaric acid derivative 5", "1-(1-(4-fluorophenyl)ethylidene)thiosemicarbazide", "2,2',4,4'-tetrahydroxy-6'-methoxychalcone", "2,2'-bi(1,3,4-thiadiazole)-5,5'(4H,4'H)-dithione", "5,5'-methylenebis(1,3,4-thiadiazole-2(3H)-thione)", "2-(heptylthiomethyl)-5-hydroxy-4H-pyran-4-one", "ASKENDOSIDE B", "4-hydroxyphenethyl 3,4,5-trihydroxybenzoate", "Thiazoline derivative 2", "Thiazoline derivative 1", "Hydroquinone", "5-{8(Z),11(Z)-pentadecadienyl}resorcinol", "KAZINOL S", "2-hydroxy-5-isopropyl-2,4,6-cycloheptatrien-1-one", "Monoamine derivative 2", "2-hydroxyphenethyl 3,4,5-trihydroxybenzoate", "5-hydroxy-2-(pentylthiomethyl)-4H-pyran-4-one", "PMID26815044-Compound-H", "PMID26815044-Compound-I", "1-(2,5-Dimethyl-1H-pyrrol-1-yl)thiourea", "5-(4-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione", "Benzothiazole analog 4", "Benzothiazole analog 5", "Benzothiazole analog 2", "Benzothiazole analog 3", "Benzothiazole analog 1", "1-(3-Oxocyclohexylidene)thiosemicarbazide", "1-(1-(pyridin-3-yl)ethylidene)thiosemicarbazide", "Broussonin C", "Polyhydroxy benzamide derivative 3", "Polyhydroxy benzamide derivative 2", "Polyhydroxy benzamide derivative 1", "Polyhydroxy benzamide derivative 5", "Polyhydroxy benzamide derivative 4", "Cyclohexyl carbamate derivative 1", "Cyclohexyl carbamate derivative 2", "Cyclohexyl carbamate derivative 3", "Cyclohexyl carbamate derivative 4", "Cyclohexyl carbamate derivative 5", "Cyclohexyl carbamate derivative 6", "Cyclohexyl carbamate derivative 7", "Cyclohexyl carbamate derivative 8", "4'-(Benzensulfonamide)-4-hydroxychalcone", "N-(2,4-dihydroxybenzyl)-3,5-dihydroxybenzamide", "2-(cyclohexylthiomethyl)-5-hydroxy-4H-pyran-4-one", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 8", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 9", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 2", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 3", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 1", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 6", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 7", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 4", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 5", "4'-(4-Aminobenzensulfonamide)-4-hydroxychalcone", "PMID26815044-Compound-116", "PMID26815044-Compound-117", "ROSMARINIC ACID", "PMID29130358-Compound-Figure11(3)", "(+/-)-Daedalin A", "4'-(4-Fluorobenzensulfonamide)-4-hydroxychalcone", "Resorcinol compound 34", "Resorcinol compound 32", "Resorcinol compound 33", "Resorcinol compound 30", "Resorcinol compound 31", "5-phenyl-1,3,4-thiadiazole-2(3H)-thione", "1-(But-2-enylidene)thiosemicarbazide", "DNA vaccine, Memorial Sloan-Kettering Cancer Center", "Resorcinol compound 18", "Resorcinol compound 19", "Resorcinol compound 10", "Resorcinol compound 11", "Resorcinol compound 12", "Resorcinol compound 13", "Resorcinol compound 14", "Resorcinol compound 15", "Resorcinol compound 16", "Resorcinol compound 17", "3hydroxy-1-methyl-1-phenylurea", "3-(phenoxymethyl) benzylamine derivative 2", "3-(phenoxymethyl) benzylamine derivative 3", "3-(phenoxymethyl) benzylamine derivative 1", "3-(phenoxymethyl) benzylamine derivative 6", "3-(phenoxymethyl) benzylamine derivative 5", "1-(1-phenylethylidene)thiosemicarbazide", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 12", "Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 14", "Thiazolidine derivative 2", "Thiazolidine derivative 3", "Thiazolidine derivative 1", "N-(2,4-dihydroxybenzyl)-3,4,5-trihydroxybenzamide", "5,5'-methylenebis(1,3,4-oxadiazole-2(3H)-thione)", "Polynoma-1", "Resorcinol compound 20", "1-(3-phenoxypropyl)-4-(piperidin-1-yl)piperidine", "4-hexyl resorcinol", "5-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol", "1-hydroxy-3-(4-(trifluoromethyl)phenyl)urea", "PHENYLTHIOUREA", "1-(1-p-tolylethylidene)thiosemicarbazide", "7,8,4'-trihydroxyisoflavone", "Monobenzone", "5-hydroxy-2-(propylthiomethyl)-4H-pyran-4-one", "Resorcinol compound 8", "Resorcinol compound 6", "Resorcinol compound 7", "Resorcinol compound 4", "Resorcinol compound 5", "Resorcinol compound 2", "Resorcinol compound 3", "Resorcinol compound 1", "2-hydroxy-3-isopropyl-2,4,6-cycloheptatrien-1-one", "Diamine derivative 2", "Diamine derivative 3", "TROPOLONE", "1-Ethylidenethiosemicarbazide", "PMID26815044-Compound-32", "PMID26815044-Compound-31", "3,4-dihydroxybenzaldehyde-O-ethyloxime", "Resorcinol compound 9", "3-(phenoxymethyl) benzylamine derivative 4", "PMID26815044-Compound-49", "PMID26815044-Compound-48", "PMID26815044-Compound-47", "1-hydroxy-3-(4-nitrophenyl)urea", "Aromatic hydrazine carboxyimidoamide derivative 1", "Aromatic hydrazine carboxyimidoamide derivative 2", "Aromatic hydrazine carboxyimidoamide derivative 3", "Aromatic hydrazine carboxyimidoamide derivative 4", "Aromatic hydrazine carboxyimidoamide derivative 5", "Aromatic hydrazine carboxyimidoamide derivative 6", "Diamine derivative 1", "N-butylresorcinol", "1-(1-(pyrazin-2-yl)ethylidene)thiosemicarbazide", "5-cyclohexyl-1,3,4-oxadiazole-2(3H)-thione", "Benzimidazole derivative 4", "Benzimidazole derivative 3", "Monoamine derivative 1", "Monoamine derivative 3", "Monoamine derivative 4", "Monoamine derivative 5", "1-(4-(benzyloxy)phenyl)-3-hydroxyurea", "5-(pyridin-4-yl)-1,3,4-oxadiazole-2(3H)-thione", "Dihydroxyfumaric acid derivative 1", "Multi-epitope tyrosinase/gp100 vaccine", "Melanoma vaccine", "1-(3-Methylbutylidene)thiosemicarbazide", "1-(Butan-2-ylidene)thiosemicarbazide", "4,4'-(ethane-1,2-diyl)dibenzene-1,3-diol", "1-(1-(4-bromophenyl)ethylidene)thiosemicarbazide", "KOJIC ACID", "Kojic acid-phenylalanine amide", "SRI-224", "1-hydroxy-3-phenylurea", "S-2-(o-toluidino)-2-oxoethyl carbamothioate"], "['8644']": ["ASP-9521", "Indomethacin analog 1", "Isoquinolone derivative 1", "EM1396", "M-Phenoxybenzoic Acid For Cis-Isomer", "3-Phenylcyclopentanecarboxylic acid", "Nitrogen/sulfur-substituted estrene derivative 1", "2-(4-Chlorobenzylidene)cyclopentanone", "Indomethacin analog 2", "N-(benzimidazolylcarbonyl)-piperidine derivative 1", "2-[(2,2-diphenylacetyl)amino]benzoic acid", "N-(pyridinepyrroylylcarbonyl)-piperidine derivative 1", "Rutin(TTD)", "3-Bromo-5-phenylsalicylc acid", "2,2-Dibenzylcyclopentanol", "N-(benzimidazole/indole) benzoic acid derivative 2", "N-(benzimidazole/indole) benzoic acid derivative 1", "2-(4-chlorobenzylidene)cyclopentyl ethyl ether", "N-(phenylamino)-benzoate derivative 1", "2-(4-chlorobenzylidene)cyclopentylmethyl ether", "Beta-naphthylacetic acids derivative 1", "Indomethacin analog 3", "EM-1424", "N-(naphthylamino)-benzoate derivative 1", "N-(indolylcarbonyl)-piperidine derivative 1"], "['1645']": ["2-HYDROXY-3,5-DIIODOBENZOIC ACID(Drug Bank)"], "['5743', '759', '760']": ["CG-100649"], "['476', '477', '478', '481', '482', '483']": ["Cordil", "Digoxin(TTD)", "Rostafuroxin", "Istaroxime(TTD)", "Sanguinarine", "PBI-05204", "Digitoxin(TTD)"], "['6520']": ["IGN523"], "['8639']": ["VAP-1", "Vapill", "ASP8232", "Clonidine(TTD)", "PXS-4159", "RTU-1096", "LJP-1207", "PSX-4206", "FP-1102", "Vapaliximab", "BTT-1023", "6-hydroxydopa quinone", "Hydralazine(TTD)"], "['6548', '6550', '6550']": ["HOE-694", "N-(4-Cyano-3-methanesulfonyl-benzoyl)-guanidine", "N-(5-Methanesulfonyl-2-methyl-benzoyl)-guanidine", "ENIPORIDE", "CARIPORIDE", "N-(4-Chloro-3-methanesulfonyl-benzoyl)-guanidine", "N-(3-Methanesulfonyl-4-methoxy-benzoyl)-guanidine", "N-(3-Methanesulfonyl-4-methyl-benzoyl)-guanidine", "N-(4-Bromo-3-methanesulfonyl-benzoyl)-guanidine"], "['1312']": ["Entacapone", "5,6-dihydroxy-7-nitro-2,3-dihydroinden-1-one", "BIA", "3,5-Dinitrocatechol", "1-(3,4-dihydroxy-5-nitrophenyl)-2-phenoxyethanone", "(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE", "1-(3,4-dihydroxy-2-nitrophenyl)-2-phenylethanone", "PGX-200097", "7,8-dihydroxy-4-phenyl-2H-chromen-2-one", "6,7-dihydroxy-8-nitro-1-tetralone", "BIA 3-202", "Opicapone", "CGP-28014", "Tolcapone", "Nitecapone", "Entacapone+levodopa+carbidopa"], "['2235']": ["N-Methylmesoporphyrin Containing Copper", "N-Methylmesoporphyrin", "Lead acetate"], "['7086']": ["1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane"], "['6715', '79644']": ["Azelaic Acid", "ONO-3805", "IZONSTERIDE", "GI-197111", "MK-0963", "Epristeride", "FK-143", "Finasteride(TTD)", "Dutasteride(TTD)", "MK-434", "Turosteride", "Dutasteride + tamsulosin", "Polyestradiol Phosphate", "CS-891B"], "['1548']": ["Methoxsalen"], "['3615', '5837']": ["Inosinic Acid(TTD)"], "['4128', '4129', '43', '590']": ["Tetra-hydro-isoquinoline derivative 3", "Tetra-hydro-isoquinoline derivative 2", "Tetra-hydro-isoquinoline derivative 1", "Tetra-hydro-isoquinoline derivative 4"], "['1636', '4048']": ["Captopril(Drug Bank)"], "['1080', '57468', '6557', '6558', '6560']": ["Bumetanide(Drug Bank)"], "['5138', '5139', '8654']": ["IMAZODAN"], "['29881']": ["Ezetimibe(TTD)", "Ezetimibe-glucuronide"], "['28234', '53919', '6579']": ["[3H]BSP"], "['2548', '2595', '8972', '8972']": ["Double Oxidized Cysteine", "Miglitol(Drug Bank)", "Maltose(TTD)"], "['4843', '4846']": ["6-Nitroindazole", "N,N-dimethylarginine", "5-Nitroindazole", "S-Ethylisothiourea(Drug Bank)", "Ethylisothiourea"], "['1565', '1565', '1565', '1565', '1565', '1576']": ["1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)", "2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine", "2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole", "1H-1,2,3-benzotriazol-1-amine", "(5-pyridin-3-yl-furan-2-yl)methanethiol", "3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine", "DIHYDROCUBEBIN", "6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)", "Methyl-(5-pyridin-3-yl-thiophen-2-yl)-amine", "4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine", "1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)", "1-(4-Butoxy-phenyl)-1H-imidazole", "4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine", "2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine", "ML-3163"], "['6506', '6507']": ["SYM2081"], "['55089']": ["[14C]glycine"], "['5141', '5142', '5144']": ["ASP-3258", "TJN-598", "ZL-N-91", "Revamilast", "OX-914", "D-22888", "L-869298", "GSK-356278", "V-11294A", "GW-3600", "UCB-101333-3", "CDP840", "CHF-5480", "YM-976", "AVE-8112", "CD-160130", "Ronomilast", "CH-3697", "AN-2898", "GPD-1116", "NIK-616", "TOFIMILAST", "Piclamilast(TTD)", "LAS-37779", "MEM-1414", "SOTB07", "L-454560", "Torbafylline", "KW-4490", "AL-59640", "CI-1018", "CC-1088", "DENBUFYLLINE", "D-4418", "OCID-2987", "TAS-203", "AWD-12-281", "Daxalipram(TTD)", "LIRIMILAST", "PDE4 inhibitors, Scottich Biomedical", "MK-0873", "Oglemilast", "HT-0712", "SCH-351591", "KF-66490", "TA-7906", "PDE4 inhibitors, GlaxoSmithKline"], "['7915']": ["Succinic acid", "Chlormerodrin(TTD)"], "['23657', '240', '240', '38', '5319', '5742', '5743', '6916']": ["Sulfasalazine(Drug Bank)"], "['23632', '771']": ["2-amino-2,3-dihydro-1H-indene-5-sulfonamide", "2-acetamido-2,3-dihydro-1H-indene-5-sulfonic acid"], "['1644', '2643', '7054']": ["ProSavin"], "['64781']": ["NVP 231"], "['10654']": ["3-hydroxy-3-methyl-6-phosphohexanoic acid", "cinnamic acid", "(R)-5-diphosphomevalonate", "isoferulic acid"], "['249']": ["Levamisole(TTD)", "Asfotase alfa(TTD)"], "['80150']": ["GRASPA"], "['7941']": ["(E)-(thiophen-2-ylmethylidene)amino benzoate", "GSK2647544", "3,4-difluorobenzaldehyde O-benzoyloxime", "RPAF-AH", "Bicyclic pyrimidine derivative 2", "GSK568859", "Benzaldehyde O-benzoyloxime", "Goxalapladib", "SB-381320", "4-fluorobenzaldehyde O-benzoyloxime", "Rilapladib(Drug Bank)"], "['495', '496', '496']": ["Omeprazole(TTD)", "Esomeprazole(TTD)", "SKF-97574", "AZD-0865", "YH-1238", "S-tenatoprazole", "Pantoprazole(TTD)", "SORAPRAZAN", "LEMINOPRAZOLE", "AR-H047108", "PUMAPRAZOLE", "TY-11345", "CS-526", "RQ-00000004", "Saviprazole", "SK&F-95601", "SKF-96067", "TAK-438", "YH-4808"], "['4128', '4129', '6530', '6531', '6531', '6532', '6570', '6571']": ["MMDA(Drug Bank)"], "['1491']": ["AKOS003197197", "5-Hydrazino-1H-tetrazole", "Hydrazinoacetic acid", "propargylglycine"], "['11238', '23632', '377677', '6559', '759', '759', '760', '760', '761', '762', '762', '763', '765', '766', '768', '768', '771']": ["Benzthiazide(Drug Bank)"], "['1545']": ["KAEMPFERIDE", "3-[2-(3,5-Dimethoxy-phenyl)-vinyl]-furan", "2-[2-(3,5-Dimethoxy-phenyl)-vinyl]-thiophene", "DIOSMETIN", "ISOSAKUTANETIN", "ERIODICTYOL", "HOMOERIODICTYOL", "PINOCEMBRIN", "Genistein(Drug Bank)", "N-(2,4-Dimethoxy-phenyl)-3,5-dimethoxy-benzamide", "ISORHAMNETIN", "TAMARIXETIN", "GALANGIN", "4-[2-(3,5-Dimethoxy-phenyl)-vinyl]-pyridine"], "['84444']": ["EPZ-004777", "EPZ-5676", "SGC0946", "bromo-deaza-SAH"], "['4363', '4363', '5243']": ["XR-9504", "XR-9456", "XR-9577", "XR-9544"], "['3612']": ["L-Myo-Inositol-1-Phosphate(Drug Bank)"], "['6536']": ["AMG 747", "JNJ-17305600", "[3H](R)-NPTS", "ORG-25935", "[3H]SB-733993", "[35S]ACPPB", "[3H]NFPS", "PMID29338548-Compound-41", "PMID29338548-Compound-40", "PMID29338548-Compound-45", "PMID29338548-Compound-44", "PMID29338548-Compound-47", "PMID29338548-Compound-46", "PMID29338548-Compound-49", "PMID29338548-Compound-48", "PMID29338548-Compound-27", "PMID29338548-Compound-26", "PMID29338548-Compound-25", "PMID29338548-Compound-24", "PMID29338548-Compound-23", "PMID29338548-Compound-22", "PMID29338548-Compound-21", "PMID29338548-Compound-20", "PMID29338548-Compound-29", "PMID29338548-Compound-28", "Organon", "RO-4840700", "SSR-504734", "Glycine type-1 transporter inhibitors", "Org-24461", "ALX-5407", "[3H]N-methyl-SSR504734", "DCCCyB", "GlyT1 PET radiotracers", "R1678", "AS-1522489-00", "PMID29338548-Compound-16", "MK-2637", "GSK1018921", "[3H]GSK931145", "PMID29338548-Compound-34", "PMID29338548-Compound-36", "PMID29338548-Compound-37", "PMID29338548-Compound-30", "PMID29338548-Compound-31", "PMID29338548-Compound-33", "PMID29338548-Compound-38", "PMID29338548-Compound-39", "PMID29338548-Compound-18", "PMID29338548-Compound-19", "PMID29338548-Compound-13", "PMID29338548-Compound-17", "PMID29338548-Compound-14", "PMID29338548-Compound-15", "LY2365109", "GSK931145", "PF-3463275", "Organon-2", "Organon-3", "SSR-103800"], "['50']": ["Tricarballylic Acid", "Aconitate Ion", "Isocitric Acid(TTD)", "4-Hydroxy-Aconitate Ion", "Alpha-Methylisocitric Acid"], "['953']": ["PSB-6426"], "['3417']": ["BAY1436032", "Ivosidenib", "IDH305"], "['4353']": ["AZD5904", "4-aminobenzoic acid hydrazide", "AZD4831", "E-101", "AZD-3241", "INV-311"], "['3162', '3163', '3163']": ["Stannsoporfin(Drug Bank)"], "['10249', '189', '211', '212', '23464', '2628', '27232', '2937', '51268', '570', '570', '6470', '6470', '6472', '64902']": ["Glycine(Drug Bank)"], "['5294']": ["GSK2126458", "SF1126(TTD)", "GDC-0084", "GSK1059615", "VS-5584", "GDC-0980/RG7422", "Enzastaurin(TTD)", "Staurosporine(Drug Bank)", "5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE(Drug Bank)", "BAG956", "Adyvia", "LOR-220", "PA-799", "XL147", "PKI-402", "AEZS-126", "TG100-115(TTD)", "SAR245409", "BGT226", "VE-822", "GDC0941", "PF-05212384", "PI-103", "BEZ235", "HM-5016699", "CLR457", "DS-7423", "ZSTK474", "PF-04691502", "IPI-549", "WX-037", "GDC-0077", "Multiform PI3K inhibitors", "CU-906", "P-7170", "CZC-19091", "AS-604850", "Myricetin", "CUDC-907", "KA2237", "Her2- and PSA-targeted TGX-D1", "PF-03772304", "Perifosine(TTD)", "Rigosertib", "SCR-44001", "LY294002", "CLR-1401", "CLR-1404", "P-6915", "PF-4989216", "PX-867", "PX-866", "Dual PI3K/mTOR inhibitors", "HS-173", "CZC 24832"], "['5141', '5144']": ["1-Methyl-3-propyl-3,7-dihydro-purine-2,6-dione", "1-Butyl-3-methyl-3,7-dihydro-purine-2,6-dione"], "['2944', '59272']": ["Chloroquine(Drug Bank)"], "['1503']": ["Cyclopentylcytosine", "Acivicin", "Cylopentenyl cytosine", "Cyclopentenylcytosine", "Carbodine"], "['100', '5141', '8654']": ["Dipyridamole(Drug Bank)"], "['3158']": ["Acetoacetyl-Coenzyme A"], "['5295']": ["Enzastaurin(Drug Bank)"], "['6572']": ["aminobenzovesamicol", "[3H]vesamicol", "[123I]iodobenzovesamicol", "vesamicol", "T-588"], "['8513']": ["Cetilistat(TTD)", "Undecyl-Phosphinic Acid Butyl Ester"], "['6916']": ["EV-077", "ONO-1581", "4-Methyl-pyridine", "Ridogrel(Drug Bank)", "PYRIDINE", "Imitrodast", "G-619", "MILACAINIDE TARTRATE", "FK-070", "CV-6504.HCL", "Satigrel", "CGS-13080", "2-(10-Imidazol-1-yl-decyl)-isoindole-1,3-dione", "Dazoxiben", "5-Imidazol-1-yl-5,6,7,8-tetrahydro-quinoline", "NM-702", "2-(8-Imidazol-1-yl-octyl)-isoindole-1,3-dione", "NV-52", "Rolafagrel", "2-(6-Imidazol-1-yl-hexyl)-isoindole-1,3-dione"], "['4048']": ["(R)-N-benzyl-4-(pyrrolidin-2-ylmethoxy)aniline", "2-(4-Piperidin-1-ylmethylphenoxy)benzothiazole", "4-(4-butoxyphenoxy)phenol", "N1-[4-(Phenylmethoxy)phenyl]-L-aspartamine", "N5-[4-(N-Phenylamino)phenyl]-L-glutamine", "N5-[4-(Phenylmethoxy)phenyl]-L-glutamamide", "3-(Benzyloxy)Pyridin-2-Amine", "1-[4-(4-Iodophenoxy)phenyl]piperazine", "1-(pentyloxy)-4-phenoxybenzene", "4-(2-amino-1,3-thiazol-4-yl)phenol(Drug Bank)", "Acebilustat", "4-(4-(pentyloxy)phenoxy)phenol", "2-(7-(benzyloxy)-1H-indol-3-yl)ethanamine", "N5-[(4-Phenoxy)-3-pyridyl]-L-glutamamide", "DG051", "(R)-2-((4-phenoxyphenoxy)methyl)piperidine", "N5-[4-Benzylphenyl]-L-glutamamide", "2-[4-(2-Piperidin-1-ylethyl)phenoxy]benzothiazole", "Bestatin", "N5-[4-(2-Oxo-3-phenylpropoxy)phenyl]-L-glutamine", "5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole", "(S)-2-((4-phenoxyphenoxy)methyl)piperidine", "JNJ-10392980", "N5-[4-(2-phenylethoxy)phenyl]-L-glutamine", "N-methyl-1-(2-thiophen-2-ylphenyl)methanamine", "(R/S)-2-((4-benzylphenoxy)methyl)piperazine", "(R)-2-(4-Benzylphenoxymethyl)pyrrolidine", "(4-fluorophenyl)(pyridin-4-yl)methanone", "4-(4-propoxyphenoxy)phenol", "SA-6541", "1-(2,2'-bithiophen-5-yl)methanamine", "N1-[4-(Phenylmethoxy)phenyl]-D-aspartamine", "8(S)-amino-2(R)-methyl-7-oxononanoic acid", "(R)-2-((4-benzylphenoxy)methyl)piperidine", "N5-[4-(3-methylphenoxy)phenyl]-L-glutamamide", "1-butoxy-4-phenoxybenzene", "N1-[4-(Phenylmethoxy)phenyl]-D-glutamine", "N1-[4-(Phenylmethoxy)phenyl]-L-glutamine", "N5-[4-(4-(3-Furyl)phenoxy)phenyl]-L-glutamamide", "4-[2-(4-Benzylphenoxy)ethyl]pyridine", "2-[4-(2-Morpholin-4-ylethoxy)phenoxy]benzooxazole", "1-(4-Phenoxyphenyl)piperazine", "N6-[4-(4-methylphenoxy)phenyl]-L-homoglutamine", "N5-[4-(Phenylmethoxy)phenyl]-L-glutamine", "N4-[4-(Phenylmethoxy)phenyl]-L-aspartamine", "4-amino-N-[4-(benzyloxy)phenyl]butanamide", "(R/S)-2-((4-phenoxyphenoxy)methyl)piperidine", "N5-(4-Phenoxyphenyl)-L-glutamine", "5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol", "N5-[4-(2-methylphenoxy)phenyl]-L-glutamamide", "(4-(thiophen-2-yl)phenyl)methanamine", "N5-[4-(4-methylphenoxy)phenyl]-L-glutamamide", "2-(4-benzylphenoxy)ethanamine", "(R/S)-2-((4-benzylphenoxy)methyl)piperidine", "N5-[4-(1H-pyrrol-1-yl)phenyl]-L-glutamamide", "4S-4,5-Diamino-N-(4-phenoxyphenyl)pentanamide", "2-Amino-N-[4-(phenylmethoxy)phenyl]-acetamide", "1-[4-(Benzothiazol-2-yloxy)benzyl]piperidin-4-ol", "2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzothiazole", "2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzooxazole", "N5-[4-(3-Phenylpropoxy)phenyl]-L-glutamine", "N-(pyridin-3-ylmethyl)aniline", "N5-[4-(Phenylmethoxy)phenyl]-D-glutamine"], "['5293']": ["IC87114", "RP6530", "IC980033", "INCB40093", "INCB50465", "Pyrrolo[2,3-d]pyrimidine derivative 28", "XL-499", "GS-9820", "Idelalisib", "ME-401", "GS-9901", "AMG 319"], "['6579']": ["naringin"], "['121278', '7054', '7166']": ["alpha-propyldopacetamide"], "['6578']": ["PMID26099857-Compound-WO2011037610Formula(I)", "bromsulphthalein", "bromocresol green"], "['2194']": ["3,7,3',4'-TETRAHYDROXYFLAVONE", "PA-824", "C75", "GALLOCATECHIN GALLATE", "GSK2194069", "Cerulenin", "4-hydroxy-8-nitro-3-phenylquinolin-2(1H)-one", "MT-061 lead", "(-)-CATECHINGALLATE", "MG-28", "FAS-031", "2-Hexadecynoic acid", "Anti-Fas mabs", "FAS1", "4-hydroxy-6-nitro-3-phenylquinolin-2(1H)-one", "FSA2", "TVB-2640"], "['5226']": ["4-phospho-D-erythronate", "6-Phosphogluconic Acid", "(2R)-2-Methyl-4,5-dideoxy", "Ketotifen(Drug Bank)", "5-deoxy-5-phosphono-D-arabinonate", "GHRP-2"], "['10007', '2645', '276', '277', '278', '279', '280', '3098', '360203', '5742', '5837']": ["Beta-D-Glucose(Drug Bank)"], "['1584', '1588']": ["3-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine", "3-[4-Fluoro-indan-(1E)-ylidenemethyl]-pyridine", "3-(5-Bromo-6-methoxy-naphthalen-2-yl)-pyridine", "3-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine", "3-[4-Chloro-indan-(1E)-ylidenemethyl]-pyridine", "3-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine", "3-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine", "3-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine", "1-(3-Methoxy-naphthalen-2-yl)-1H-imidazole", "1-Naphthalen-2-yl-1H-imidazole", "5-[5-Bromo-indan-(1E)-ylidenemethyl]-1H-imidazole", "3-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine", "3-[7-Methoxy-indan-(1E)-ylidenemethyl]-pyridine", "5-Pyridin-3-yl-1,3-dihydro-2H-indol-2-one", "5-Indan-(1Z)-ylidenemethyl-1H-imidazole", "FADROZOLE", "3-(5-Chloro-6-methoxy-naphthalen-2-yl)-pyridine", "1-(4-Cyanobenzyl)-5-methyl-1H-imidazole", "5-Indan-(1E)-ylidenemethyl-1H-imidazole", "3-[5-Ethoxy-indan-(1Z)-ylidenemethyl]-pyridine", "3-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine", "5-[5-Bromo-indan-(1Z)-ylidenemethyl]-1H-imidazole", "3-[4-Chloro-indan-(1Z)-ylidenemethyl]-pyridine", "3-[5-Ethoxy-indan-(1E)-ylidenemethyl]-pyridine", "3-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine", "3-(naphthalen-2-yl)pyridine", "5-Pyridin-3-yl-2,3-dihydro-1H-inden-1-one", "3-Indan-(1Z)-ylidenemethyl-pyridine", "3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine", "3-Indan-(1E)-ylidenemethyl-pyridine", "3-(3,4-dihydronaphthalen-2-yl)pyridine", "3-[4-Methyl-indan-(1E)-ylidenemethyl]-pyridine", "3-(4-methyl-3,4-dihydronaphthalen-2-yl)pyridine"], "['2495']": ["Ferritarg P"], "['3290', '3291']": ["3-acetyl-11-keto-beta-boswellic acid", "11-keto-beta-boswellicacid"], "['587', '883']": ["Pyridoxamine-5'-Phosphate(Drug Bank)"], "['10587', '6241', '7296']": ["Motexafin gadolinium(Drug Bank)"], "['476', '6557', '759', '760', '762', '766', '768', '771']": ["Hydroflumethiazide(Drug Bank)"], "['5209']": ["PFK-158"], "['2110', '2819']": ["Metformin(Drug Bank)"], "['8644', '873']": ["Rutin(Drug Bank)"], "['1719', '5805', '6697']": ["Biopterin(Drug Bank)"], "['2618', '2618']": ["Glycinamide Ribonucleotide", "AG2034", "10-trifluoroacetyl-DDACTHF", "DDATHF", "LY309887", "10-Formyl-5,8,10-Trideazafolic Acid", "DIDEAZAFOLATE", "Dideazaacyclotetrahydrofolic acid", "10-CF3C(OH)2-DDACTHF", "(10r)-10-Formyl-5,8,10-Trideazafolic Acid", "PELITREXOL"], "['10057', '873']": ["Curcumin(Drug Bank)"], "['79581', '79581']": ["4-Hydroxy-3-methyl-but-2-enoic acid", "4-hydroxy-but-2-enoate", "4-Hydroxy-4-phenyl-butyric acid", "4-Cyclohexyl-4-hydroxy-but-2-enoic acid", "4-Hydroxy-pentanoic acid", "4-Hydroxy-3-methyl-butyric acid", "5-hydroxy-pentanoate", "4-Hydroxy-4-phenyl-but-2-enoic acid", "4-Hydroxy-pent-2-enoic acid"], "['3620', '6999', '6999']": ["2,3-diamino-benzo[b]thiophene derivative 3", "Indazole derivative 3", "PMID29473428-Compound-76"], "['10135']": ["Daporinad", "CHS-828", "GMX1777"], "['6530']": ["1-(2-(2-chlorophenoxy)pyridin-3-yl)piperazine", "Protriptyline(TTD)", "AMIFLAMINE", "Reboxetine", "Atomoxetine(TTD)", "Phendimetrazine(Drug Bank)", "PTI-601", "{2-[3-(Phenylsulfonyl)-1H-indol-4-yl]ethyl}amine", "Metaiodobenzylguanidine I-131", "Amoxapine(TTD)", "SPN-812", "Desvenalfaxine succinate", "Roclatan", "Trimipramine(TTD)", "Hypericum", "BLI-1005", "Imipramine(TTD)", "Desipramine(TTD)", "Mazindol(TTD)", "N-desalkylquetiapine", "4-(3'-furyl)-aniline", "Rhopressa", "Tapentadol hydrochloride", "Maprotiline", "Phentermine(TTD)", "XEN-2174", "WAY-256805", "(R)-1-((S)-morpholin-2-yl)-1,2-diphenylethanol", "3-(3'-furyl)-aniline", "[3H]nisoxetine", "Netarsudil(Drug Bank)", "Napitane mesilate", "POLYGALATENOSIDE B", "Iobenguane I-123", "Milnacipran(TTD)", "Esreboxetine", "MCT-125"], "['240', '240', '2739', '7498']": ["BAICALEIN"], "['4882']": ["Chimeric natriuretic peptide"], "['6510']": ["benzylserine", "p-nitrophenyl glutamyl anilide"], "['122622', '2762', '4830', '4831']": ["Guanosine-5'-Diphosphate(Drug Bank)"], "['239', '471']": ["NSC-292213"], "['290']": ["2-Cinnamamido-N4-hexyl-N1-hydroxysuccinamide", "(1-Amino-3-methyl-butyl)-phosphinic acid", "Icatibant(Drug Bank)", "(S)-2-Amino-3-phenyl-propane-1-thiol", "1-aminopentylphosphonic acid monophenyl ester", "(1-Amino-2-phenyl-ethyl)-phosphinic acid", "KELATORPHAN", "2-amino-N1-benzyl-N3-hydroxymalonamide", "(1-Amino-ethyl)-phosphinic acid", "1-aminobutylphosphonic acid", "2-benzyl-N1-hydroxy-N3-(3-phenylpropyl)malonamide", "N-Hydroxy-2-(naphthalen-2-ylsulfanyl)-acetamide", "N1-(3-phenoxybenzyl)-N3-hydroxymalonamide", "N1-benzyl-N3-hydroxy-2-isobutylmalonamide", "2-benzyl-N1-hydroxy-N3-phenethylmalonamide", "N-biphenyl-3-ylmethyl-N'-hydroxy-malonamide", "1-aminohexylphosphonic acid monophenyl ester", "2-benzyl-N1-hydroxy-N3-(4-phenylbutyl)malonamide", "2-Cinnamamido-N1-hydroxy-N4-pentylsuccinamide", "N1-(4-chlorobenzyl)-2-amino-N3-hydroxymalonamide", "1-aminohexylphosphonic acid", "(1-Amino-3-methylsulfanyl-propyl)-phosphinic acid", "N1-(4-fluorobenzyl)-2-benzyl-N3-hydroxymalonamide", "N4-Butyl-2-cinnamamido-N1-hydroxysuccinamide", "(S)-2-Amino-2-phenyl-ethanethiol", "(Amino-phenyl-methyl)-phosphinic acid", "N1,2-dibenzyl-N3-hydroxymalonamide", "(S)-2-Amino-4-phenyl-butane-1-thiol", "IP10 C8", "(S)-2-Amino-4-methyl-pentane-1-thiol", "(1-Amino-3-phenyl-propyl)-phosphinic acid", "IP10.C8-1", "(S)-2-Amino-propane-1-thiol", "N1-(3,3-diphenylpropyl)-N3-hydroxymalonamide", "N1-hydroxy-2-isobutyl-N3-phenethylmalonamide", "Angiotensin IV", "2-Cinnamamido-N1-hydroxy-N4-octylsuccinamide", "(S)-2-Amino-4-methylsulfanyl-butane-1-thiol", "N1-(4-chlorobenzyl)-2-benzyl-N3-hydroxymalonamide", "PMID23428964CI3", "N1,2-dibenzyl-N3-hydroxy-N1-phenethylmalonamide"], "['6529']": ["Metadoxine", "(R)-nipecotic acid", "Tiagabine", "(S)-Piperidine-3-carboxylic acid", "CI-966", "SKF89976A"], "['3000']": ["NS 2028", "FK-409", "BAY 1021189", "Riociguat(TTD)", "ODQ"], "['1576', '23632', '4843', '5742', '5743', '7498', '759', '760', '762', '765', '768', '771']": ["Curcumin(TTD)"], "['6532']": ["6,6-dimethyl-1-phenyl-3-aza-bicyclo[3.1.0]hexane", "2-Amino-1-(4-methylthiophenyl)butane", "3-(3-aminocyclopentyl)-1H-indole-5-carbonitrile", "4-Allyl-6-nitro-2-piperazin-1-yl-quinoline", "3-(1H-indol-3-yl)-N,N-dimethylpropan-1-amine", "4-Benzyl-6-nitro-2-piperazin-1-yl-quinoline", "ZIMELIDINE", "2-N-Cyclopropylamino-1-(4-methylthiophenyl)butane", "4-Furan-2-yl-6-nitro-2-piperazin-1-yl-quinoline", "1-(1,3-diphenylpropyl)piperazine", "2-N-Hydroxyamino-1-(4-ethylthiophenyl)butane", "2-N-Ethylamino-1-(4-methylthiophenyl)butane", "Verapamil(Drug Bank)", "3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzamide", "2-N-Allylamino-1-(4-methylthiophenyl)propan", "Chlorphentermine Hydrochloride", "OPC-14523(Drug Bank)", "Vortioxetine(TTD)", "YM-992", "1-(4-Benzylsulfanyl-phenyl)-propylamine", "JNJ-28583867", "DA-8031", "A-80426", "AVP-786", "MOXIFETIN HYDROGEN MALEATE", "2-N-Hydroxyamino-1-(4-methylthiophenyl)butane", "ITI-007", "Irindalone", "2-N-Hydroxyamino-1-(4-ethylthiophenyl)propane", "2-N,N-Dimethylamino-1-(4-methylthiophenyl)propane", "Sertraline(TTD)", "2-Amino-1-(4-ethylthiophenyl)butane", "Seroxat", "Paroxetine(TTD)", "2-Amino-1-(4-ethylthiophenyl)propane", "QUIPAZINE", "BGC-20-1259", "N-cyclobutyl-N-(piperidin-4-yl)-2-naphthamide", "2-N-(n-Propyl)amino-1-(4-methylthiophenyl)butane", "CX-1001", "1-(2-(naphthalen-2-yl)-1-phenylethyl)piperazine", "2-(3-Methyl-piperazin-1-yl)-6-nitro-quinoline", "1-Methyl-4-p-tolyl-piperidine-4-carbonitrile", "Desvenlafaxine(TTD)", "Trazodone", "6,8-Dinitro-2-piperazin-1-yl-quinoline", "4-Chloro-6-nitro-2-piperazin-1-yl-quinoline", "1-(1-phenyl-2-(pyridin-4-yl)ethyl)piperazine", "2-N-(Isopropyl)amino-1-(4-methylthiophenyl)butane", "1-(2-(naphthalen-2-yl)ethyl)piperazine", "6-Chloro-2-piperazin-1-yl-quinoline", "PMID29334795-Compound-61", "2-N-Ethylamino-1-(4-ethylthiophenyl)propane", "2-N-Methylamino-1-(4-ethylthiophenyl)propane", "3-Bromo-6-nitro-2-piperazin-1-yl-quinoline", "Clomipramine(TTD)", "Vilazodone", "Luvox", "Lu-AA34893", "CLR-3001", "Low dose ITI-007", "Tianeptine(TTD)", "Cyclopentyl-(3,4-dichloro-phenyl)-acetonitrile", "6-nitroquipazine", "SEP-228432", "AD-337", "2-N-Methylamino-1-(4-methylthiophenyl)propane", "Brasofensine(TTD)", "HydrocoDex", "2-N-Ethylamino-1-(4-ethylthiophenyl)butane", "2-N-Methoxyamino-1-(4-methylthiophenyl)propane", "Citalopram derivative 1", "Cyclohexyl-(3,4-dichloro-phenyl)-acetonitrile", "OxycoDex", "KF-A6", "6-Nitro-4-phenyl-2-piperazin-1-yl-quinoline", "4-Bromo-6-nitro-2-piperazin-1-yl-quinoline", "6-Bromo-2-piperazin-1-yl-quinoline", "4-Iodo-6-nitro-2-piperazin-1-yl-quinoline", "Escitalopram(TTD)", "1-fluoro-5-phenyl-3-aza-bicyclo[3.1.0]hexane", "1-Methyl-2-(4-phenylsulfanyl-phenyl)-ethylamine", "Fluoxetine", "(+/-)-nantenine", "Nortriptyline(TTD)", "2-N-Propargylamino-1-(4-methylthiophenyl)propane", "N*1*-(6-Nitro-quinolin-2-yl)-ethane-1,2-diamine", "1-(2-(naphthalen-1-yl)-1-phenylethyl)piperazine", "4-(2-((dimethylamino)methyl)phenoxy)benzonitrile", "2-[1,4]Diazepan-1-yl-6-nitro-quinoline", "2-N-Ethylamino-1-(4-methylthiophenyl)propane", "Fluvoxamine", "LITOXETINE", "TEFLUDAZINE", "6-Nitro-2-piperazin-1-yl-4-vinyl-quinoline", "O-DESMETHYL TRAMADOL", "6-Iodo-2-piperazin-1-yl-quinoline", "2-N-Methylamino-1-(4-methylthiophenyl)butane", "Piperidine derivative 1", "2-N-Propargylamino-1-(4-methylthiophenyl)butane", "2-N-Hydroxyamino-1-(4-methylthiophenyl)propane", "Dexfenfluramine", "1-(1-phenyl-2-(pyridin-2-yl)ethyl)piperazine", "2-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole", "Dextromethorphan Polistirex", "Citalopram", "N-(piperidin-4-yl)-N-propyl-2-naphthamide"], "['8654']": ["TPN-729", "PF-489791", "EXISULIND", "Trequinsin", "SK&F-96321", "7-(2-Hydroxyethyl)-3-O-rhamnosylicariin", "UK-369003", "Avanafil", "SKF-96231", "EMR-62203", "CKD-533", "Udenafil", "SOPHORAFLAVANONE B", "DASANTAFIL", "FR-229934", "ICARIIN", "Tadalafil(TTD)", "Guanosine-5'-Monophosphate(TTD)", "E-4021", "SLX-2101", "Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine", "UK-371800", "LORNEIC ACID A", "SCH-57726", "Icariside II", "Vardenafil(TTD)", "T0156", "Cartazolate", "Rhucin", "Aom-0890", "3,7-Bis(2-hydroxyethyl)icaritin", "RWJ-387273", "8-prenylapigenin", "SINITRODIL", "Benzo[1,3]dioxol-5-ylmethyl-quinazolin-4-yl-amine", "Dipyridamole(TTD)", "BRL-61063", "8-prenylquercetin"], "['1728', '1806', '2936', '4128', '4129', '4842', '7296', '7498']": ["Flavin-Adenine Dinucleotide"], "['1588', '23632', '412', '759', '760', '762', '765', '768', '771']": ["COUMATE"], "['23632', '762', '765', '768']": ["SPERMINE"], "['23632', '4129', '759', '760', '762', '765', '768', '771']": ["FERULIC ACID"], "['246', '7941']": ["Indolizine derivative 1"], "['5742', '5743', '8644']": ["Flufenamic Acid"], "['11102']": ["Etarotene"], "['5742', '5743', '6530', '6532']": ["Acetaminophen(TTD)"], "['5290', '5297']": ["BYL719"], "['5290', '5294', '5295']": ["Wortmannin(Drug Bank)"], "['384', '4953']": ["Difluoromethylornithine"], "['6652']": ["CP-470,711"], "['1584', '1586']": ["4-(4-(thiophen-3-yl)benzyl)pyridine", "6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione", "4-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine", "5-[4-(Pyridin-4-ylmethyl)phenyl]-1H-indole", "1-(4-Bromobenzyl)-1H-imidazole", "3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine", "4'-(Pyridin-4-ylmethyl)biphenyl-4-amine", "4-(4-(thiophen-2-yl)benzyl)pyridine", "6-(pyridin-3-yl)-2-naphthonitrile", "6-[4-(Pyridin-4-ylmethyl)phenyl]naphthalen-2-ol", "7-(1-(1H-imidazol-1-yl)ethyl)-9H-fluoren-2-ol", "4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diamine", "N-(4'-Isonicotinoylbiphenyl-3-yl)acetamide", "4-((3',4'-Difluorobiphenyl-4-yl)methyl)pyridine", "1-(4-fluorobenzyl)-1H-imidazole", "6-Pyridin-3-yl-naphthalen-2-ol", "4-(4'-Fluoro-biphenyl-4-ylmethyl)pyridine"], "['5141']": ["NIS-62949", "6-Imidazol-1-ylmethyl-8-phenyl-quinoline", "2,5-Bis-(3-cyclopentyloxy-4-methoxy-phenyl)-furan", "Enprofylline(TTD)", "2,5-Bis-(3,4-dimethoxy-phenyl)-furan", "GSK256066", "Dyphylline(TTD)", "8-(3-Azido-phenyl)-6-iodo-quinoline", "8-(3-Azido-phenyl)-6-pyridin-4-ylmethyl-quinoline", "Cilomilast(TTD)", "(2,5-Diphenyl-furan-3-yl)-phenyl-methanone", "L-791943", "4-(2,5-Diphenyl-furan-3-yl)-morpholine", "6-Azido-8-(3-iodo-phenyl)-quinoline", "8-(3-Nitro-phenyl)-6-pyridin-4-ylmethyl-quinoline"], "['5319', '7083', '7941']": ["Rilapladib(TTD)"], "['6557']": ["Calyculin-A", "Chlorthalidone(TTD)", "Furosemide(TTD)", "Hydroflumethiazide(TTD)", "Torasemide(TTD)", "Aldosterone(TTD)", "Piretanide", "Bumetanide(TTD)", "Trichlormethiazide(TTD)", "Potassium Chloride", "CL-301", "Ethacrynic acid", "Methyclothiazide(TTD)", "Ethacrynate Sodium"], "['5140']": ["US9388139, 12", "US8741907-compound-3"], "['5743', '760', '761']": ["Valdecoxib(Drug Bank)", "Celecoxib(Drug Bank)"], "['1503', '4846', '5319', '80347', '8644']": ["2-Methyl-2,4-Pentanediol"], "['2730']": ["BSO", "Buthionine sulfoximine", "Cystamine"], "['4023']": ["AMT-011", "Ibrolipim", "WS-070117", "Tyloxapol(Drug Bank)"], "['5142']": ["Filaminast", "3-(2-Bromophenyl)-2-thioxo-(1H )-quinazolin-4-one", "8-Bromo-Adenosine-5'-Monophosphate", "Papaverine(Drug Bank)", "Daxalipram(Drug Bank)", "(R)-Mesopram"], "['1066', '1066', '7941']": ["(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE"], "['759', '760', '761', '762', '763']": ["Brinzolamide(Drug Bank)"], "['2739']": ["S-(N-4bromophenyl-N-hydroxycarbamoyl)glutathione", "S-(N-ethyl-N-hydroxycarbamoyl)glutathione", "S-(N-4chlorophenyl-N-hydroxycarbamoyl)glutathione", "S-(N-heptyl-N-hydroxycarbamoyl)glutathione", "S-(N-hexyl-N-hydroxycarbamoyl)glutathione", "S-(N-methyl-N-hydroxycarbamoyl)glutathione", "S-(N-pentyl-N-hydroxycarbamoyl)glutathione", "S-p-bromobenzyl glutatione", "S-(N-butyl-N-hydroxycarbamoyl)glutathione", "S-Benzyl-Glutathione", "CYANIDIN", "PELARGONIDIN CHLORIDE", "S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione", "S-P-Nitrobenzyloxycarbonylglutathione", "S-(N-propyl-N-hydroxycarbamoyl)glutathione", "S-(N-phenyl-N-hydroxycarbamoyl)glutathione"], "['262', '4953']": ["Putrescine"], "['11254', '153201']": ["NOX-200"], "['1636', '231']": ["CONTIGOSIDE B", "ASTRAGALIN"], "['6530', '6531', '6531']": ["(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol", "2-(N-tert-Butylamino)-3'-chloropentanophenone", "Bupropion(Drug Bank)", "2-(N-tert-Butylamino)-3'-chloroheptanophenone", "2-(N-Cyclopentylamino)-3'-chloropropiophenone", "Bupropion+naltrexone", "2-(N-tert-Butylamino)-3'-chlorooctanophenone", "Phenmetrazine", "1-(2,3-Dihydro-1H-indol-5-ylmethyl)-propylamine", "2-(N-Cyclopentylamino)-3'-fluoropropiophenone", "Cis-3-phenoxy-2,3-dihydro-1H-inden-1-amine", "2-(N-Pyrrolidinyl)-3'-methylpropiophenone", "2-((2-iodophenoxy)(phenyl)methyl)morpholine", "2-(N-Pyrrolidinyl)-3'-methoxypropiophenone", "2-(2,3-Dihydro-1H-indol-5-yl)-1-methyl-ethylamine", "2-(N-tert-Butylamino)-3'-chlorohexanophenone", "2-(tert-butylamino)-1-m-tolylpropan-1-one", "2-(N-Cyclopentylamino)-3'-methylpropiophenone", "Trodusquemine(Drug Bank)", "2-(N-Cyclopentylamino)-3'-bromopropiophenone", "2-(N-Pyrrolidinyl)-3'-fluoropropiophenone", "1-(3-bromophenyl)-2-(tert-butylamino)propan-1-one", "2-(tert-butylamino)-1-p-tolylpropan-1-one", "(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol", "2-(N-Pyrrolidinyl)-3'-bromopropiophenone", "Methylphenidate(Drug Bank)", "2-((3-iodophenyl)(o-tolyloxy)methyl)morpholine", "Radafaxine", "2-(N-tert-Butylamino)propiophenone", "2-(N,N-Diethylamino)-3'-chloropropiophenone", "1-(4-fluorophenyl)-2-pyrrolidin-1-yl-pentan-1-one", "1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one", "2-(N-Pyrrolidinyl)-3'-nitropropiophenone", "Spiroglumide", "2pyrrolidin-1-yl-1-phenylpentan-1-one", "Manifaxine"], "['6476']": ["Scopolamine(Drug Bank)"], "['6554', '6555']": ["LUM001"], "['1545', '1588', '231', '3292']": ["APIGENIN"], "['1636', '2629', '2629', '43']": ["2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose"], "['6505']": ["NBI-59159", "L-beta-BA"], "['4843']": ["4-(1H-IMIDAZOL-1-YL)PHENOL", "HP-228", "MPL-S", "1-(6-Amino-4-methylpyridin-2-yl)propan-2-ol", "(S)-N-(1-phenylethyl)acetimidamide hydrobromide", "(4S,5S)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine", "4-Methyl-6-(2-methylprop-1-enyl)pyridin-2-amine", "3-Butyl-[1,4]oxazepan-(5Z)-ylideneamine", "(4S,5R)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine", "LT-1951", "L-Thiocitrulline", "4r-Fluoro-N6-Ethanimidoyl-L-Lysine", "KD-7332", "Oxazolidin-(2Z)-ylideneamine", "BYK-191023", "ONO-1714", "BXT-51072", "6-(4-Fluorobutyl)-4-methylpyridin-2-amine", "S-Ethylisothiourea(TTD)", "KD-7040", "Aminoguanidine", "5-Methyl-4-propyl-pyrrolidin-(2Z)-ylideneamine", "SD-6010", "[1,5]Thiazocan-(4E)-ylideneamine", "(E)-4-Methyl-6-(prop-1-enyl)pyridin-2-amine", "CDDO", "GW274150", "Pimagedine HCl", "NOStentin", "AMINOTHIAZOLINE", "SKLB-010", "N-benzylacetimidamide hydrobromide", "6-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine", "4,5,6,7-tetrafluoro-3-perfluorophenyl-1H-indazole", "Thiocoumarin", "CR-3294", "(S)-2-Amino-6-[(E)-ethylimino]-hexanoic acid", "PIBTU"], "['9955']": ["O2-Sulfo-Glucuronic Acid(Drug Bank)", "N,O6-Disulfo-Glucosamine(Drug Bank)"], "['2548', '279', '6476', '8972', '8972']": ["Acarbose(Drug Bank)"], "['1080', '5742', '5743']": ["Ibuprofen(Drug Bank)"], "['4842']": ["N5-(1-iminopent-3-enyl)-L-ornithine", "7-chloro-1H-indazole", "Hexahydro-cyclopenta[b]pyrrol-(2Z)-ylideneamine", "Eusynstyelamide C", "5-iodo-1H-indazole", "5-N-Allyl-Arginine", "N5-(1-Imino-3-Butenyl)-L-Ornithine", "Hexahydro-pyrrolizin-(3E)-ylideneamine", "N-Isopropyl-N'-Hydroxyguanidine", "1-Benzyl-2-methyl-1H-imidazole", "N-Butyl-N'-Hydroxyguanidine", "4-bromo-1H-indazole", "5-bromo-1H-indazole", "6-bromo-1H-indazole", "4-iodo-1H-indazole", "NXN-462", "6-chloro-1H-indazole", "5-chloro-1H-indazole", "1-[(3-Methoxybenzyl)amino]ethaniminium chloride", "1-(Benzhydrylamino)ethaniminium bromide", "Tetrahydro-pyrimidin-2-ylideneamine", "7-bromo-1H-indazole", "2-aminopyridine", "(+/-)-2-Methyl-1-(1-phenylethyl)-1H-imidazole", "N*1*-(5-Methyl-2-nitro-phenyl)-butane-1,4-diamine", "7-Methoxy-1H-indazole", "EUSYNSTYELAMIDE B", "NXN-188", "4-chloro-1H-indazole", "2-amino-4,6-dimethylpyridine", "S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea"], "['1066', '1066', '19']": ["Probucol(Drug Bank)"], "['383', '5142', '5153', '7298']": ["S,S-(2-Hydroxyethyl)Thiocysteine(Drug Bank)"], "['5290', '5293', '5294']": ["BAY 80-6946"], "['7364']": ["Autoantibody LKM-3", "ISOLONGIFOLOL"], "['1588', '6916']": ["6-Imidazol-1-yl-isoquinoline"], "['2739', '5320', '5742', '5743', '8644']": ["Indomethacin(Drug Bank)"], "['1584']": ["1-(3-Chlorobenzyl)-1H-imidazole", "3-(6-Bromo-naphthalen-2-yl)-pyridine", "1-(4-Bromobenzyl)-5-phenyl-1H-imidazole", "3-[1-(4-Cyanobenzyl)-1H-imidazol-5-yl]-1-propanol", "(4-((1H-imidazol-1-yl)methyl)phenyl)methanol", "3-Imidazol-1-ylmethyl-1H-indole", "Metyrapone", "5-Naphthalen-2-yl-oxazole", "3-(6-Methoxynaphthalen-2-yl)-5-phenylpyridine", "1-(6-Methoxy-naphthalen-2-yl)-1H-imidazole", "1-(3-Bromobenzyl)-1H-imidazole", "(3-((1H-imidazol-1-yl)methyl)phenyl)methanol", "1-(4-Cyanobenzyl)-5-phenyl-1H-imidazole", "1-(4-Cyanobenzyl)-5-hydroxymethyl-1H-imidazole", "3-[(Z)-2-phenylvinyl]pyridine", "3-(4-ethyl-3,4-dihydronaphthalen-2-yl)pyridine", "1-(3-Fluorobenzyl)-1H-imidazole", "Methyl 3-(1-Benzyl-1H-imidazol-5-yl)-propanoate", "3-(1H-inden-2-yl)pyridine", "2-Methyl-1,2-di-pyridin-3-yl-propan-1-one oxime", "3-(1,2-dihydroacenaphthylen-5-yl)pyridine", "1-(4-Cyanobenzyl)-5-(4-pyridyl)-1H-imidazole", "1-(4-Cyanobenzyl)-5-(4-methylphenyl)-1H-imidazole", "1-(3,4-dihydronaphthalen-2-yl)-1H-imidazole", "2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-one", "2-Methyl-1,2-di-pyridin-3-yl-propylchloride", "METYRAPOL", "4-(6-Methoxy-3-methylnaphthalen-2-yl)isoquinoline", "1-(4-Cyanobenzyl)-5-bromo-1H-imidazole", "3-(6-Methoxynaphthalen-2-yl)-4-methylpyridine", "1-(4-Cyanobenzyl)-5-(2-methylphenyl)-1H-imidazole", "3-Phenanthren-9-yl-pyridine", "3-[1-(4-Bromobenzyl)-1H-imidazol-5-yl]-1-propanol", "1-(4-Cyanobenzyl)-5-(3-methylphenyl)-1H-imidazole", "1-(4-Cyanobenzyl)-5-(3-fluorophenyl)-1H-imidazole", "3-(2,3-Dihydro-1,4-benzodioxin-6-yl)pyridine", "1-Ethyl-3-imidazol-1-ylmethyl-1H-indole", "6-Isoquinolin-4-yl-3,4-dihydroquinolin-2(1H)-one", "4-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine", "3-Ethoxy-5-(6-methoxynaphthalen-2-yl)pyridine", "7-Pyridin-3-yl-2H-1,4-benzothiazin-3(4H)-one", "3-((1H-imidazol-1-yl)methyl)aniline", "3-Imidazol-1-yl-quinoline", "3-(1-Benzyl-1H-imidazol-5-yl)-1-propanol", "3-(3-Benzylnaphthalen-2-yl)pyridine", "1-(4-Cyanobenzyl)-5-(4-fluorophenyl)-1H-imidazole", "3-(1,2-dihydroacenaphthylen-3-yl)pyridine", "5-(6-Methoxynaphthalen-2-yl)pyridin-3-ol", "1-(4-Cyanobenzyl)-5-(2-fluorophenyl)-1H-imidazole", "1-(4-Fluorobenzyl)-5-phenyl-1H-imidazole", "3-(3-Benzyl-6-methoxynaphthalen-2-yl)pyridine", "1-Benzyl-5-phenyl-1H-imidazole", "2-Methyl-1,2-di-pyridin-3-yl-propyliodide", "3-(2-Chloro-1,1-dimethyl-2-phenyl-ethyl)-pyridine", "5-Naphthalen-2-yl-1H-imidazole", "4-(2-Imidazol-1-yl-ethoxy)-benzamide", "2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-ol", "3-(5-methoxy-1H-inden-2-yl)pyridine", "2-Methyl-1,2-di-pyridin-3-yl-propane", "1-(4-Aminobenzyl)-1H-imidazole", "R-fadrozole", "2-Methyl-1,2-di-pyridin-3-yl-1-methoxypropane", "6-(4-Methylpyridin-3-yl)-2-naphthonitrile", "6-Pyridin-3-yl-1,2,3,4-tetrahydronaphthalen-2-ol", "3-(1,1-Dimethyl-2-phenyl-ethyl)-pyridine", "3-(5,6,7,8-Tetrahydronaphthalen-2-yl)pyridine", "1-Phenyl-2-pyridin-3-yl-propan-1-one", "SL125", "Mitotane(Drug Bank)", "1-(4-Methoxybenzyl)-5-phenyl-1H-imidazole", "1-(4-Cyanobenzyl)-5-formyl-1H-imidazole", "3-Imidazol-1-ylmethyl-2-isopropyl-1H-indole", "1-(2-Phenoxy-ethyl)-1H-imidazole", "1-(4-Chlorobenzyl)-5-phenyl-1H-imidazole", "3-(6-Methoxy-3-methylnaphthalen-2-yl)pyridine", "BENZYLIMIDAZOLE", "3-MeSO2-DDE"], "['6530', '6532', '6609']": ["Desipramine(Drug Bank)"], "['30814', '5319', '5320']": ["N-Tridecanoic Acid(Drug Bank)"], "['43', '4842', '590']": ["Donepezil(Drug Bank)"], "['6648']": ["Imisopasem manganese"], "['111']": ["NKY80"], "['952']": ["HuMax-CD38b", "Daratumumab", "SAR-650984", "MOR-202"], "['240', '240', '5743']": ["Morniflumate(Drug Bank)", "RWJ-63556", "Darbufelone"], "['124', '126', '847']": ["Fomepizole(Drug Bank)"], "['1586']": ["1-(1-Biphenyl-4-yl-3-methyl-butyl)-1H-imidazole", "4'-(1-(pyridin-4-yl)propyl)biphenyl-3-ol", "1-(1-Biphenyl-4-yl-propyl)-1H-imidazole", "Seviteronel", "1-(4-iodobenzyl)-1H-imidazole", "1-(3,4-dichlorobenzyl)-1H-imidazole", "1-(1-(4-thiophen-3-ylphenyl)ethyl)-1H-imidazole", "4'-(2-methyl-1-(pyridin-4-yl)propyl)biphenyl-3-ol", "1-(4-chlorobenzyl)-1H-imidazole", "Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,4-diol", "Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,5-diol", "ABIRATERONE", "1-(1-(Biphenyl-4-yl)allyl)-1H-imidazole", "2,3,4,5-Tetrafluoro-6-pentafluorophenylazo-phenol", "1-(3,5-dichlorobenzyl)-1H-imidazole", "1-(1-Biphenyl-4-yl-ethyl)-1H-imidazole", "4-[4-(6-methoxynaphthalen-2-yl)benzyl]pyridine", "1-(4-bromophenethyl)-1H-imidazole", "2-(1-Imidazol-1-yl-ethyl)-9H-carbazole", "ISOCONAZOLE", "TAK-700", "1-((9H-Fluoren-2-yl)ethyl)-1H-imidazole", "4'-(Pyridin-4-ylmethyl)biphenyl-4-carboxamide", "Abiraterone acetate", "1-(Bis-biphenyl-4-yl-methyl)-1H-imidazole", "1-(3,5-difluorobenzyl)-1H-imidazole", "4-((1H-imidazol-1-yl)methyl)phenol", "1-(1-(4'-Ethylbiphenyl-4-yl)propyl)-1H-imidazole", "1-(1-Biphenyl-4-yl-2-phenyl-ethyl)-1H-imidazole", "1-(3,5-dibromobenzyl)-1H-imidazole", "1-(1-(4-thiophen-3-yl-phenyl)propyl)-1Himidazole", "1-(4-chlorophenethyl)-1H-imidazole", "Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3-ol", "1-(1-Biphenyl-4-yl-2-methyl-propyl)-1H-imidazole", "1-(3,5-bis(trifluoromethyl)benzyl)-1H-imidazole", "1-((9H-Fluoren-2-yl)methyl)-1H-imidazole", "1-(4-nitrobenzyl)-1H-imidazole", "VN/107-1", "1-(3,4-difluorobenzyl)-1H-imidazole", "3-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine", "6-(3-(pyridin-4-yl)phenyl)naphthalen-2-ol", "N-3-(4-bromophenyl)propyl imidazole", "4-[1-(4'-Methoxybiphenyl-4-yl)propyl]pyridine", "CFG920", "Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-4-ol", "ANG-3407", "1-(3-(4-chlorophenyl)propyl)-1H-imidazole", "1-(1-Biphenyl-4-yl-pentyl)-1H-imidazole", "1-(3-phenylpropyl)-1H-imidazole", "1-(4-methyl-benzyl)-1H-imidazole", "1-(1-Biphenyl-4-yl-butyl)-1H-imidazole", "3-fluoro-4'-(1-(pyridin-4-yl)propyl)biphenyl-4-ol"], "['1585']": ["LCI699"], "['6529', '6539']": ["LU32-176B", "(R/S) EF-1500", "(S)-EF-1520", "(R)-EF-1520"], "['240', '240', '3620']": ["Avastin+/-Tarceva"], "['55867', '9356', '9376']": ["Probenecid(Drug Bank)"], "['6713']": ["Procyanidin B-2 3,3'-di-O-gallate", "Green tea", "Sanguiin H-6", "FR-194738", "Trisnorsqualene cyclopropylamine", "FUROSIN", "Chebulinic acid", "Mallotusinic acid", "Tolnaftate", "EUGENIIN", "Allylamines", "1(beta)-O-galloylpedunculagin", "OCTYL_GALLATE", "Trisnorsqualene difluoromethylidene", "Trisnorsqualene alcohol", "ETHYLGALLATE", "NB-598", "N-dodecylgallate", "THEASINENSIN A", "CORILAGIN", "Thiocarbamate", "Naftifine", "SDZ-87-469", "GERANIIN", "Tellurium", "Mallotinic acid", "1,2,6-tri-O-galloyl-beta-D-glucose", "N-cetylgallate", "PEDUNCULAGIN"], "['3283', '3284']": ["4-MA", "Trilostane(Drug Bank)", "17 beta-N,N-diethylcarbamoyl-4-aza-5 alpha-androstan-3-one (4MA)", "Equilenin", "Epostane"], "['206358']": ["indole-3-propionic acid"], "['1622']": ["Hexadecanal(Drug Bank)"], "['9197']": ["[14C]acetylCoA", "US8592431, 457", "US8592431, 181", "US8592431, 185"], "['9376']": ["HEPTANOATE", "AMINOHIPPURIC ACID", "Buproprion+zonisamide", "FLUORESCEIN", "ADIPATE", "Probenecid(TTD)", "3R14S-OCHRATOXIN A", "GLUTARATE"], "['7498']": ["3,5-bis(2-methylpyridin-4-yl)-1H-1,2,4-triazole", "3,4'-(1H-1,2,4-triazole-3,5-diyl)dipyridine", "3,5-di(pyridin-4-yl)-1H-1,2,4-triazole", "Azaindole derivative 7", "Aom-0763", "PMID27841045-Compound-143", "PMID27841045-Compound-144", "PMID27841045-Compound-145", "PMID27841045-Compound-130", "Oxypurinol", "Azole benzene derivative 3", "Azole benzene derivative 2", "Azole benzene derivative 4", "2-chloro-6(methylamino)purine", "Azaindole derivative 3", "Azaindole derivative 6", "Azaindole derivative 4", "Azaindole derivative 5", "PMID27841045-Compound-129", "PMID27841045-Compound-134", "AMENTOFLAVONE", "NC-2500", "BOF-4272", "Fused heterocyclic compound 7", "Fused heterocyclic compound 6", "Fused heterocyclic compound 5", "Fused heterocyclic compound 4", "Fused heterocyclic compound 3", "Fused heterocyclic compound 2", "Fused heterocyclic compound 1", "Fused heterocyclic compound 9", "Fused heterocyclic compound 8", "FUKUGETIN", "1-(3-Cyano-phenyl)-1H-pyrazole-4-carboxylic acid", "Fused heterocyclic compound 11", "Fused heterocyclic compound 10", "Dioxothiomolybdenum(VI) ion", "ROBINETIN", "SCUTELLAREIN", "DIHYDROKAEMPFEROL", "LC-350189", "Topiroxostat", "PMID27841045-Compound-155", "PMID27841045-Compound-157", "PMID27841045-Compound-156", "PERSICARIN", "Y-700", "Allopurinol", "3-O-METHYLQUERCETIN", "PMID27841045-Compound-133", "PMID27841045-Compound-132", "PMID27841045-Compound-131", "PMID27841045-Compound-137", "PMID27841045-Compound-136", "PMID27841045-Compound-135", "Azole benzene derivative 1", "Febuxostat"], "['23632', '760', '765', '768', '771']": ["2-Amino-benzenesulfonamide", "4-(2-Hydroxy-ethyl)-benzenesulfonamide"], "['23632', '5742', '760', '771']": ["RESORCINOL"], "['240', '240', '30814', '5743']": ["Licofelone(Drug Bank)"], "['2717']": ["(+)-5-deoxyadeenophorine", "Migalastat", "PRX-102", "Beta-1-C-Butyl-1-deoxygalactonojirimycin", "Beta-1-C-butenyl-1-deoxygalactonojirimycin", "1-deoxygalactonojirimycin", "CALYSTEGINE B2", "DEOXYGALACTONOJIRIMYCIN"], "['5290', '5291']": ["INK-1117"], "['231', '57016']": ["Fidarestat(Drug Bank)"], "['5298']": ["PIK-93"], "['4128', '43']": ["Desoxypeganine"], "['23632', '760', '762', '768', '771']": ["3-Amino-benzenesulfonamide"], "['2135', '2582', '6675']": ["Uridine-Diphosphate-N-Acetylgalactosamine(Drug Bank)", "Uridine-Diphosphate-N-Acetylglucosamine(Drug Bank)"], "['4513']": ["Talmapimod(Drug Bank)"], "['5409']": ["LY134046"], "['2760']": ["BIW-8962", "Choline alfoscerate(Drug Bank)"], "['1808']": ["Lacosamide(TTD)"], "['2730', '3156', '7083', '80347', '8566']": ["Adenosine-5'-Diphosphate"], "['1621', '217']": ["Disulfiram(Drug Bank)"], "['43', '6530']": ["Suronacrine maleate"], "['231', '4846']": ["Hydroxydimethylarsine Oxide"], "['27115', '5136', '5137', '5152', '5153', '8654']": ["SCH51866"], "['113235', '6573']": ["Methotrexate(TTD)", "Folic Acid"], "['6715']": ["5-(4-Chloro-phenyl)-1-methyl-piperidine-2-thione", "Levonorgestrel(Drug Bank)", "4-(4-phenoxybenzoyl)benzoic acid", "1-Methyl-5-phenyl-piperidin-2-one", "5-(4-Chloro-phenyl)-1-methyl-piperidin-2-one", "1,2,5,6-tetrahydro pyrido[1,2-a]quinolin-3-one", "4-[4-benzyloxy)benzoyl]benzoic acid", "4-[4-(benzhydryloxy)benzoyl]benzoic acid", "3,4,5,6-Tetrahydrobenzo[c]quinolizin-3-(4aH)-one", "4-Methyl-5,6-dihydro-pyrido[1,2-a]quinolin-3-one", "LY-266111", "AS-601811", "{4-[4-(4-bromophenoxy)benzoyl]phenyl}acetic acid", "Dutasteride(Drug Bank)", "Bexlosteride", "(3-fluoro-4-(4-phenoxybenzoyl)phenyl)acetic acid", "MK-386", "(3-methyl-4-(4-phenoxybenzoyl)phenyl)acetic acid", "4,4'-dihydroxyoctafluoroazobenzene", "(E)-3-(4-(4-phenoxybenzoyl)phenyl)acrylic acid", "1-Methyl-5-(4-phenylazo-phenyl)-piperidin-2-one", "FR-146687"], "['6564']": ["4-AMBA"], "['279', '5406']": ["Liprotamase", "Pancrecarb"], "['1373']": ["Polidocanol - BioForm Medical/Chemische Fabrik Kreussler & Co"], "['222962']": ["decynium 22"], "['366']": ["phloretin"], "['1056', '6555']": ["Taurocholic Acid"], "['4353', '438', '8288']": ["Melatonin(Drug Bank)"], "['1636']": ["SCH-54470", "BMS-182657", "Imidapril hci", "Hydrochlorothiazide(TTD)", "Enalapril", "Rescinnamine", "Alacepril", "M-100240", "Zabiciprilat", "Captopril(TTD)", "[Cyclopentyl-(2-nitro-benzoyl)-amino]-acetic acid", "DU-1777", "Trandolapril", "Gallopamil", "Quinapril", "lisinopril-tryptophan", "Delapril", "Perindopril", "SQ-26332", "Lisinopril", "CGS-30440", "Fosinopril", "N-Carboxymethyl-N-cyclopentyl-phthalamic acid", "Temocapril hydrochloride", "RIP", "Ilepatril", "Kaempferol-3-O-(2''-O-galloyl)-glucoside", "UTIBAPRIL", "BRL-36378", "GW-796406", "Moexipril", "GW-660511", "Spirapril", "Idrapril", "RB-105", "METIAPRIL", "Enalaprilat", "RJM-0035-K002", "RXP-407", "Omapatrilat", "BUTEIN", "Ceronapril", "fasidotrilat", "Benazepril", "Candoxatril(Drug Bank)", "NO-antihypertensives", "Ramipril", "moexiprilat", "Cilazapril", "Deserpidine(TTD)"], "['116085', '2194']": ["MORIN"], "['3620']": ["5-(isopropylamino)quinolin-8-ol", "Monofluorine derivative 1", "Benzimidazole and imadazopyridine carboximidamide compound 1", "Benzimidazole and imadazopyridine carboximidamide compound 2", "5-phenyl-1H-1,2,3-triazole", "Sulfonamide derivative 6", "Sulfonamide derivative 7", "Sulfonamide derivative 8", "S-(2-Chlorobenzyl)isothiourea hydrochloride", "Imidazoleisoindoles derivative 1", "Imidazoleisoindoles derivative 2", "GARVEATIN A", "L-Tryptophan", "S-(4-Methylbenzyl)isothiourea hydrochloride", "4-phenylthiazole-2-thiol", "Garveatin C", "Garveatin E", "NLG802", "ANNULIN A", "Sulfamic acid ester derivative 1", "BMS-986205", "Amide derivative 2", "1H-indole-4,7-dione", "S-Benzyl-brassinin", "KHK2455", "S-(4-Nitrobenzyl)isothiourea hydrochloride", "2-HYDROXYGARVIN A", "Hydroxy amidine derivative 2", "Pyridino tricyclic compound 1", "S-(4-Bromobenzyl)isothiourea hydrobromide", "1-methyl-L-tryptophan", "BLV-0801", "4-Chlorobenzenemethanethiol", "4-Fluorobenzenemethanethiol", "Five-membered heteroaromatic compound 1", "Five-membered heteroaromatic compound 3", "Five-membered heteroaromatic compound 2", "Indazole derivative 4", "Thieno[2,3-c]pyridine derivative 1", "Aryl sulphoxide imine derivative 1", "4-(Cyclohexylamino)-1-naphthol", "4-(methylamino)naphthalen-1-ol", "2-(1H-Imidazol-4-yl)benzene-1,3-diol", "4-Phenylimidazole", "PMID29473428-Compound-48", "EXIGUAMINE B", "3-(1H-Imidazol-4-yl)benzenethiol", "Aryl 1,2-diamine derivative 1", "Biphenyl derivative 2", "Epacadostat", "4-(propylamino)naphthalen-1-ol", "2-methoxy-1,4-naphthoquinone", "ANNULIN B", "ANNULIN C", "4-(tert-butylamino)naphthalen-1-ol", "2,3-dihydrobenzo[d]thiazole-2-thiol", "2,4-Dichlorobenzenemethanethiol", "S-(3-Chlorobenzyl)isothiourea hydrochloride", "4-aminonaphthalen-1-ol", "PMID29473428-Compound-4", "PMID29473428-Compound-6", "4-(1H-1,2,3-triazol-5-yl)pyridine", "4-Methoxybenzenemethanethiol", "PMID29473428-Compound-72", "PMID29473428-Compound-71", "PMID29473428-Compound-70", "2,2-dimethyl-2H-benzo[g]chromene-5,10-dione", "Cyclic hydroxamate derivative 1", "PMID29473428-Compound-50", "PMID29473428-Compound-53", "PMID29473428-Compound-52", "PMID29473428-Compound-54", "PMID29473428-Compound-59", "PMID29473428-Compound-58", "S-(4-Cyanobenzyl)isothiourea hydrobromide", "PMID29473428-Compound-34", "PMID29473428-Compound-33", "PMID29473428-Compound-39", "PMID29473428-Compound-15", "PMID29473428-Compound-14", "PMID29473428-Compound-17", "PMID29473428-Compound-16", "PMID29473428-Compound-11", "PMID29473428-Compound-10", "4-Methylbenzenemethanethiol", "4-(Pent-3-ylamino)-1-naphthol", "Hydroxy amidine derivative 1", "Naphthalene-1,4-diol", "Hydoxyamidine derivative 1", "Pyridine derivative 1", "3,4-Dichlorobenzenemethanethiol", "Pyrrolo[1,2-c]pyrazole derivative 1", "S-(4-Ethylbenzyl)isothiourea hydrochloride", "Biphenyl derivative 3", "2-(1H-Imidazol-4-yl)phenol", "2-Chlorobenzenemethanethiol", "Acyl piperidine derivative 1", "Biphenyl 1,2-diamine derivative 1", "S-(4-Fluorobenzyl)isothiourea hydrochloride", "Carbamide derivative 13", "Monoaryl-1,2-diamine derivative 4", "Monoaryl-1,2-diamine derivative 3", "Monoaryl-1,2-diamine derivative 2", "Monoaryl-1,2-diamine derivative 1", "S-(4-Methoxybenzyl)isothiourea hydrochloride", "Indazole derivative 2", "N-[2-(Indol-3-yl)ethyl]-S-benzyl-dithiocarbamate", "2-hydroxygarveatin E", "PMID24099220C5i", "Imidazo isoindole derivative 1", "NLG8189", "tryptanthrin", "BENZENEMETHANETHIOL", "4-(2-(diethylamino)ethylamino)-1-naphthol", "Cyclohexyl-ethyl-substituted diaza and triaza-tricyclic compound 1", "INCB24360", "Hexahydro quinoline derivative 1", "S-(2,4-Dichlorobenzyl)isothiourea hydrobromide", "PMID29473428-Compound-80", "5-aminoquinolin-8-ol", "1,4-Naphthoquinone", "S-(3,4-Dichlorobenzyl)isothiourea hydrochloride", "PF-06840003", "LY3381916", "4-methoxynaphthalen-1-amine", "Exiguamine A", "Biphenyl derivative 1", "PMID29473428-Compound-60", "Sulfamoylamide derivative 1", "4-(Isopropylamino)-1-naphthol", "PMID29473428-Compound-47", "PMID29473428-Compound-43", "PMID29473428-Compound-41", "4-(ethylamino)naphthalen-1-ol", "4-amino-1,2,5-oxadiazole-3-carboximidamide", "4-(2-Hydroxyethoxy)-1-naphthol", "amg-1", "3-(4H-Imidazol-4-yl)benzenethiol", "Imidazo[1,5-a]pyridine derivative 2", "Imidazo[1,5-a]pyridine derivative 1", "PMID29473428-Compound-21", "PMID29473428-Compound-22", "PMID29473428-Compound-29", "2,3-dichloro-1,4-naphthoquinone", "Seco-exiguamine", "4-(Benzylamino)-1-naphthol", "Azetidine derivative 5", "S-(4-Chlorobenzyl)isothiourea hydrochloride"], "['5338']": ["VU0364739"], "['412', '760']": ["STX-140", "EMATE"], "['18', '6529', '6538']": ["NIPECOTIC ACID"], "['6557', '6559']": ["Bendroflumethiazide(TTD)"], "['3764', '6833']": ["Gliquidone(Drug Bank)"], "['6557', '6558']": ["Torasemide(Drug Bank)", "CLP-1001"], "['10682']": ["SR-31747", "Tamoxifen(Drug Bank)"], "['1208', '5406']": ["METHOXYUNDECYLPHOSPHINIC ACID(Drug Bank)", "(Hydroxyethyloxy)Tri(Ethyloxy)Octane(Drug Bank)"], "['4942']": ["Canaline"], "['10919', '10919', '10919', '10919', '10919', '10919', '10919']": ["BRD9539", "UNC0321"], "['3157']": ["(S)-3-hydroxy-3-methylglutaryl-CoA", "L-659,699"], "['2548', '2595', '279']": ["6-Deoxy-Alpha-D-Glucose"], "['1066', '1066', '8435']": ["PYRIPYROPENE A", "Oleic acid anilide"], "['3251', '3615', '5471']": ["Mercaptopurine(Drug Bank)"], "['1806', '54963']": ["Uracil(Drug Bank)"], "['51166']": ["US10065972, Example 396", "US8933095, 1", "US10065972, Example 281", "US10065972, Example 560", "US8933095, 14", "US8933095, 16", "US8933095, 18"], "['3615']": ["1-methoxy-3-(3-(pyridin-4-yl)-1H-indol-6-yl)urea", "Selenazole-4-Carboxyamide-Adenine Dinucleotide", "3-(thiophen-3-yl)-1H-indol-6-amine", "1-(3-cyano-1-methyl-1H-indol-6-yl)-3-phenylurea", "3-(pyridin-4-yl)-1H-indol-7-amine", "C2-MAD", "C4-MAD", "6-bromo-1-methyl-3-(pyridin-4-yl)-1H-indole", "Urea and carbamate bioisostere derivative 1", "3-(furan-3-yl)-1-methyl-1H-indole", "N-benzyl-9-oxo-9,10-dihydroacridine-3-carboxamide", "1-methyl-1H-indole-3-carbonitrile", "2-methyl-3-(pyridin-4-yl)-1H-indol-6-amine", "2-Benzyl-6-methoxy-5-oxazol-5-yl-1H-indole", "2-methyl-3-(pyridin-4-yl)-1H-indole", "6-Chloropurine Riboside, 5'-Monophosphate(Drug Bank)", "Mycophenolate mofetil(TTD)", "Rockout", "3-(pyridin-4-yl)-1H-indol-6-amine", "6-bromo-3-(pyridin-4-yl)-1H-indole", "6-Methoxy-5-oxazol-5-yl-2-phenyl-1H-indole", "3-(furan-3-yl)-1H-indole", "1-methyl-1H-indole-3-carboxamide", "Ethyl 3-(pyridin-4-yl)-1H-indole-6-carboxylate", "6-phenyl-3-(pyridin-4-yl)-1H-indole", "1-methyl-1H-indole-3-carbaldehyde", "3-(3-cyano-1H-indol-6-yl)-1-methyl-1-phenylurea", "3-methoxy-4-(oxazol-5-yl)aniline"], "['1066', '1066', '6530', '6531', '6531', '6532']": ["Cocaine(Drug Bank)"], "['1565', '1565', '1565', '1565', '1565']": ["Bis-(5-pyridin-3-yl-thiophen-2-ylmethyl)-amine", "GNF-PF-2094", "GBR-12289", "GBR 12530", "Go-Y022", "BS 7581", "GNF-PF-4292", "Prodipine", "(2-hydroxy-3-phenoxypropyl)(propan-2-yl)amine", "BMS-694153", "ISOQUINE", "SB-210313", "4-(3-Pent-1-ynyl-benzyl)-1H-imidazole", "Kaempferol-3-O-methyl ether", "BS 9106", "GNF-PF-5411", "4-methylaminomethyl-7-methoxycoumarin", "(5-(pyridin-3-yl)furan-2-yl)methanamine", "BS 7840", "2-Hexyloxy-5-imidazol-1-yl-pyridine", "Desethyl isoquine", "4-(3-Phenylethynyl-benzyl)-1H-imidazole", "4-(Spiro[chromene-2,4'-piperidine]-4-yl)benzamide", "1,5-bis(4-hydroxyphenyl)penta-1,4-dien-3-one", "(5-phenylfuran-2-yl)methanamine", "ICI-199441"], "['84649']": ["PF-06427878", "PMID25470667-Compound-roselipins", "ARI-3037MO", "Vitamin B3"], "['5053']": ["ALTU-236", "Sapropterin hydrochloride", "alpha-methylphenylalanine", "BH4", "Phenylalanine hydroxylase", "Pegvaliase", "BMN-168", "HepaStem"], "['4967']": ["CPI-613"], "['10157', '1036', '10797', '10873', '1109', '11112', '124', '126', '126328', '127', '128', '131', '1579', '1586', '160287', '1645', '1646', '1717', '1719', '1727', '1737', '1738', '1962', '216', '217', '218', '220', '221', '222', '224', '231', '23530', '2597', '26227', '26330', '2746', '2747', '2747', '275', '2819', '2936', '29920', '3028', '3030', '3033', '3156', '3162', '3163', '3163', '3248', '3283', '3284', '3290', '3291', '3292', '3293', '3294', '3295', '3419', '3420', '3421', '35', '3615', '374291', '3939', '3939', '3945', '3948', '4190', '4191', '4199', '4200', '4329', '4535', '4536', '4537', '4538', '4539', '4540', '4541', '4694', '4695', '4696', '4696', '4697', '4698', '4700', '4700', '4700', '4700', '4700', '4701', '4702', '4704', '4705', '4706', '4707', '4708', '4709', '4710', '4711', '4712', '4713', '4714', '4715', '4716', '4717', '4718', '4719', '4719', '4720', '4722', '4722', '4723', '4724', '4725', '4726', '4728', '4729', '4731', '4967', '501', '50814', '51079', '51478', '5160', '5161', '5162', '55967', '5831', '5860', '5959', '622', '622', '6307', '644', '645', '6652', '7264', '7264', '7299', '7358', '7915', '7923', '7923', '7923', '7923', '7923', '7923', '8644', '8659', '8854', '92483', '9563']": ["NADH(Drug Bank)"], "['191', '2643', '3162', '4846', '5320']": ["2-Propanol, Isopropanol"], "['5139', '5141', '5142', '8654']": ["KURARINOL", "SOPHOFLAVESCENOL"], "['2597']": ["Omigapil", "Saframycin A"], "['6530', '6531', '6531', '6532']": ["Venlafaxine(Drug Bank)", "DOV 21947", "1-(3-chlorophenyl)-2-(piperidin-1-yl)propan-1-one", "2-Aminomethyl-5-(p-methoxyphenyl)tetrahydrofuran", "WIN-35065-2", "7-(piperidin-4-ylmethoxy)-2-naphthonitrile", "2-(2-chlorophenoxy)-3-(piperidin-4-yl)pyridine", "(S)-3-(naphthalen-2-ylmethoxy)pyrrolidine", "D-254C", "2-(Aminomethyl)-5-phenethyltetrahydrofuran", "RTI-219", "1-(3-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one", "1-(4-bromophenyl)-2-(tert-butylamino)propan-1-one", "2-(N-Cyclopropylamino)-3-chloropropiophenone", "Desvenlafaxine(Drug Bank)", "1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine", "PF-526014", "D-211B", "D-211A", "2-(2'-Aminoethyl)-5-benzyltetrahydrofuran", "2-Aminomethyl-5-(phenyl)tetrahydrofuran", "Amoxapine(Drug Bank)", "1-(2-(phenoxymethyl)phenyl)piperazine", "1-(2-phenoxyphenyl)piperazine", "(R)-3-(naphthalen-2-ylmethoxy)pyrrolidine", "1S,2R-milnacipran", "4-(2-(2-fluorobenzyloxy)phenyl)piperidine", "Duloxetine(Drug Bank)", "[3H]WIN35428", "[3-(3,4-Dichloro-phenyl)-indan-1-yl]-methyl-amine", "4-(2-(3-chlorophenoxy)phenyl)piperidine", "DIFLUOROBENZTROPINE", "4-(2-(4-fluorophenoxy)-4-methylphenyl)piperidine", "Escitalopram(Drug Bank)", "1-(3,4-dichlorophenyl)-3-aza-bicyclo[3.1.0]hexane", "1-(3,4-Dichloro-phenyl)-3-diethylamino-indan-5-ol", "NISOXETINE", "8-Methyl-3-p-tolyl-8-aza-bicyclo[3.2.1]octane", "1-(2-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one", "4-(2-fluoro-6-(2-fluorophenoxy)phenyl)piperidine", "(+/-)-3-((naphthalen-2-yloxy)methyl)pyrrolidine", "4-(2-(benzyloxy)phenyl)piperidine", "2-(tert-Butylamino)-3',4'-dichloropentanophenone", "Amitifadine(TTD)", "4-(2-(benzyloxy)-6-fluorophenyl)piperidine", "1-(2-(2-chlorophenyl)-1-phenylethyl)piperazine", "3-p-Tolyl-8-aza-bicyclo[3.2.1]octane", "2-(Aminomethyl)-5-(1'-naphthyl)tetrahydrofuran", "DOV-216303", "4-(2-(2-fluoro-5-methylphenoxy)phenyl)piperidine", "2-(tert-Butylamino)-3',4'-dichlorobutyrophenone", "1-(2-(4-fluorophenoxy)phenyl)piperazine", "METHYLENEDIOXYAMPHETAMINE", "2-Aminomethyl-5-(p-chlorophenyl)tetrahydrofuran", "Loxapine(Drug Bank)", "GSK-1360707", "1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX)", "Trimipramine(Drug Bank)", "4-(2-(3-fluorophenoxy)phenyl)piperidine", "1-(4-nitrophenyl)-2-pyrrolidin-1-yl-pentan-1-one", "Imipramine(Drug Bank)", "(R)-Norfluoxetine", "R-NORDULOXETINE", "PF-3409409", "2-phenoxy-3-(piperidin-4-yl)pyridine", "1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX)", "4-(2-(4-fluorobenzyloxy)phenyl)piperidine", "1-(1,4-diphenylbutan-2-yl)piperazine", "4-(2-(3-fluorophenoxy)-4-methylphenyl)piperidine", "1-(3-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one", "1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one", "4-(2-fluoro-6-(3-fluorophenoxy)phenyl)piperidine", "NS 2359", "1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine", "(R)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide", "D-257A", "D-257C", "1-(4-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one", "RG-7166", "1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one", "6-(piperidin-4-ylmethoxy)-2-naphthonitrile", "Tesofensine(Drug Bank)", "4-(2-(phenoxymethyl)phenyl)piperidine", "SPD-473", "(R)-2-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol", "4-(1H-indol-3-yl)-N,N-dimethylcyclohex-3-enamine", "4-(2-(4-fluorophenoxy)phenyl)piperidine", "4-(2-fluoro-6-(4-fluorophenoxy)phenyl)piperidine", "D-166A", "3-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol", "4-(2-phenoxyphenyl)piperidine", "1-(3,4-Dichloro-phenyl)-3-methylamino-indan-5-ol", "Sibutramine(Drug Bank)", "(R)-DULOXETINE", "NS-2389", "Para-chloroamphetamine", "4-(2-(benzyloxy)-3-fluorophenyl)piperidine", "Biphenyl-2-ylmethyl-(S)-pyrrolidin-3-yl-amine", "2-(Aminomethyl)-5-(2'-naphthyl)tetrahydrofuran", "Cocaine(TTD)", "Dasotraline", "4-(3-fluoro-2-phenoxyphenyl)piperidine", "2-(tert-butylamino)-1-(3-chlorophenyl)butan-1-one", "3alpha-(bis-chloro-phenylmethoxy)tropane", "PYROVALERONE", "Trans-3-(o-tolyloxy)-2,3-dihydro-1H-inden-1-amine", "Chlorpheniramine(Drug Bank)", "2-(2-methoxyphenoxy)-3-(piperidin-4-yl)pyridine", "4-(2-fluoro-6-phenoxyphenyl)piperidine", "WIN-35066-2", "(S)-Norfluoxetine", "2-Aminomethyl-5-(p-bromophenyl)tetrahydrofuran", "2-(N-Cyclopentylamino)-3'-methoxypropiophenone", "2-(N-tert-Butylamino)-3',4'-dichloropropiophenone", "2-Aminomethyl-5-(p-t-butylphenyl)tetrahydrofuran", "4-(2-((3-fluorophenoxy)methyl)phenyl)piperidine", "PF-18298"], "['23632', '759', '760', '771']": ["2,3-dihydro-1H-indene-5-sulfonamide", "2-Amino-indan-5-sulfonic acid"], "['1588', '7498']": ["LIQUIRTIGENIN"], "['6550', '6550']": ["AZD1722", "AZD1772//RDX5791", "RDX-5791", "AVE-0657"], "['8942']": ["3-methoxydesaminokynurenine", "3-hydroxydesaminokynurenine", "3-Hydroxyhippuric acid"], "['4842', '4846']": ["Nitroarginine", "1-(2-amino-benzothiazol-5-yl)-2-ethyl-isothiourea", "5-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine", "S-Ethyl-N-Phenyl-Isothiourea", "1-(2-amino-benzothiazol-6-yl)-2-ethyl-isothiourea"], "['6548']": ["BIIB-513", "N-(5-m-Tolyl-furan-2-carbonyl)-guanidine", "Homoserine Lactone", "N-(5-o-Tolyl-furan-2-carbonyl)-guanidine", "N-[5-(2-Nitro-phenyl)-furan-2-carbonyl]-guanidine", "N-(5-Phenyl-furan-2-carbonyl)-guanidine", "N-[4-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine", "Zoniporide hydrochloride", "N-[5-(2-Ethyl-phenyl)-furan-2-carbonyl]-guanidine", "5'-(N-ethyl-N-isopropyl)amiloride", "N-[2-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine"], "['3988']": ["SBC-102"], "['2936', '3158']": ["3-Sulfinoalanine"], "['10020']": ["GNE Lipoplex"], "['5293', '5294']": ["IPI-145", "TG100-115(Drug Bank)", "TGR-1202", "Wortmannin(TTD)"], "['682']": ["[131I]-Metuximab injection", "Gavilimomab"], "['18', '3939', '3939', '3945', '3948']": ["OXAMATE"], "['5141', '5142', '5144', '8654']": ["ROLIPRAM"], "['759', '760', '761', '762']": ["Dorzolamide(Drug Bank)", "Topiramate(Drug Bank)"], "['51228']": ["Sphingosine(Drug Bank)"], "['1586', '1588']": ["1-Imidazol-1-ylmethylxanthen-9-one", "3-[4-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine", "1-(3-(4-fluorophenyl)propyl)-1H-imidazole", "1-Imidazol-1-ylmethyl-4-nitro-xanthen-9-one", "4-Bromo-1-imidazol-1-ylmethyl-xanthen-9-one", "1-Ethyl-5-(imidazol-1-yl-phenyl-methyl)-1H-indole"], "['30814', '5319']": ["P-Anisic Acid(Drug Bank)"], "['30814', '5743']": ["Nimesulide(Drug Bank)"], "['5315']": ["CAP-232"], "['3290', '5319', '5837']": ["URSOLIC ACID"], "['116085', '1244', '4363', '4363']": ["Sulfinpyrazone(Drug Bank)"], "['2167', '2168']": ["OLEIC ACID"], "['56848']": ["(R)-2-amino-3-(4-octylphenylamino)propan-1-ol", "(R)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide", "ROMe", "ABC294640", "(S)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide", "(S)-2-amino-6-hydroxy-N-(4-octylphenyl)hexanamide", "DIMETHYLSPINGOSINE"], "['100']": ["GSK2696273", "3-(6-Amino-purin-9-yl)-4-butoxy-butan-2-ol", "FR230513", "Pentostatin", "3-(6-Amino-purin-9-yl)-5-m-tolyl-pentan-2-ol", "FR117016", "3-(6-Amino-purin-9-yl)-7-phenyl-heptan-2-ol", "FR236913", "3-(6-Amino-purin-9-yl)-non-5-en-2-ol", "6-Hydroxy-1,6-Dihydro Purine Nucleoside", "FR221647", "3-(6-Amino-purin-9-yl)-4-phenethyloxy-butan-2-ol", "FR239087", "FR233623", "6-Hydroxy-7,8-Dihydro Purine Nucleoside", "3-(6-Amino-purin-9-yl)-6-o-tolyl-hexan-2-ol", "EZN-2279", "Fludarabine(TTD)", "Cladribine(TTD)", "3-(6-Amino-purin-9-yl)-non-5-yn-2-ol", "Elapegademase", "Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy", "3-(6-Amino-purin-9-yl)-6-phenyl-hexan-2-ol", "1-Deaza-Adenosine", "(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol", "3-(6-Amino-purin-9-yl)-8-phenyl-octan-2-ol", "3-(6-Amino-purin-9-yl)-4-p-tolyl-butan-2-ol", "Purine Riboside"], "['3939', '3939']": ["Nicotinamide(Drug Bank)"], "['2983']": ["RIG-200", "Vericigiuat"], "['6609', '759']": ["Amlodipine(Drug Bank)"], "['1375']": ["SDZ-CPI-975", "Perhexiline(TTD)", "DB-200", "Etomoxir"], "['107']": ["Adenosine monophosphate"], "['6528']": ["Ad5CMV-NIS"], "['1588']": ["NSC-122427", "(2S)-abyssinone II", "4'-cyano-3-(imidazolylmethyl)flavone", "4-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine", "MR-20814", "7-((1H-imidazol-1-yl)methyl)-4H-chromen-4-one", "3-Methoxyl-4'-amino-trans-stilbene", "N-(2-benzyloxy-4-nitrophenyl)methanesulfonamide", "3-(imidazolylmethyl)-4'-nitroflavone", "2-Phenyl-3-pyridin-4-ylmethylene-chroman-4-one", "5-[5-Methoxy-indan-(1Z)-ylidenemethyl]-thiazole", "2,3,5-Trimethoxy-4'-amino-trans-stilbene", "3-(4-Amino-phenyl)-3-heptyl-piperidine-2,6-dione", "11BETA,13-DIHYDRO-10-EPI-8-DEOXYCUMAM-BRIN B", "5-[5-Methoxy-indan-(1E)-ylidenemethyl]-thiazole", "1-(2-(benzo[b]thiophen-4-yl)ethyl)-1H-imidazole", "(2S)-euchrenone a7", "NSC-666292", "2,3,4-Trimethoxy-4'-amino-trans-stilbene", "ANDROSTENEDONE", "3-(imidazolylmethyl)flavone", "4-Fluoren-9-ylidenemethyl-pyridine", "N-(2-hexyloxy-4-nitrophenyl)methanesulfonamide", "4-Imidazol-1-ylmethyl-1-nitrothioxanthen-9-one", "3-(4-Amino-phenyl)-1-methyl-pyrrolidine-2,5-dione", "LIAROZOLE", "Isogemichalcone C", "NSC-12999", "4-Imidazol-1-ylmethylxanthen-9-one", "4'-bromo-3-(imidazolylmethyl)-7-methoxyflavone", "4-(3,4-Dimethoxyphenethyl)aniline", "flavone", "NSC-356483", "MONODICTYOCHROMONE B", "Gamma-mangostin", "3,4-Dimethoxy-4'-amino-trans-stilbene", "2,4-Dimethoxy-3'-amino-trans-stilbene", "3-(4-Amino-phenyl)-3-hexyl-piperidine-2,6-dione", "NKS-01", "GARCINONE D", "2-Imidazol-1-ylmethylxanthen-9-one", "3,5-Dimethoxy-4'-amino-trans-stilbene", "4-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one", "NSC-93358", "1-(7-Methoxy-2-phenyl-chroman-4-yl)-1H-imidazole", "Benzyl-biphenyl-4-ylmethyl-imidazol-1-yl-amine", "Dextromethorphan+quinidine", "MR-20492", "MR-20496", "MR-20494", "1-(9-Phenyl-9H-fluoren-9-yl)1H-imidazole", "3-[3-Methyl-indan-(1E)-ylidenemethyl]-pyridine", "5-((1H-imidazol-1-yl)methyl)-7,8-dihydroquinoline", "6-((1H-imidazol-1-yl)methyl)-2H-chromene-2-thione", "NSC-683634", "2,5-Dimethoxy-4'-amino-trans-stilbene", "4-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine", "3-Amino-4'-amino-trans-stilbene", "MR-16089", "2-Phenyl-4-[1,2,4]triazol-1-yl-chroman-7-ol", "3-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine", "7-[1,2,4]Triazol-4-ylmethyl-chromen-4-one", "7-hydroxy-2-phenylchroman-4-one", "VOROZOLE", "3-(4-Amino-phenyl)-3-propyl-piperidine-2,6-dione", "ALBANOL A", "NSC-368272", "1-(1-Benzyl-2-biphenyl-4-yl-ethyl)-1H-imidazole", "3-(4-Amino-phenyl)-3-methyl-pyrrolidine-2,5-dione", "Rogletimide", "FINROZOLE", "3,5-Diacetoxy-4'-amino-trans-stilbene", "2,3-Dimethoxy-4'-amino-trans-stilbene", "7-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one", "NSC-289311", "NSC-625409", "3-(4-Amino-phenyl)-3-ethyl-pyrrolidine-2,5-dione", "4-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine", "2,4-Dimethoxy-4'-amino-trans-stilbene", "CGS-18320B", "Anastrozole", "9-Hydroxy-7,8-benzoflavone", "7,4'-Dihydroxyflavone", "BGS-649", "7-((1H-imidazol-1-yl)methyl)isoquinoline", "4-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one", "Aminoglutethemide", "5-Bromo-8-imidazol-1-ylmethyl-chromen-4-one", "4-(1-Imidazol-1-yl-vinyl)-benzonitrile", "3-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine", "ALPHA-NAPHTHOFLAVONE", "3-Nitro-4'-nitro-trans-stilbene", "2-Imidazol-1-yl-7-methoxy-3-phenyl-chromen-4-one", "NSC-75308", "2-(4-hydroxyphenyl)-7-methoxychroman-4-one", "5-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyrimidine", "3,5-Dihydroxyl-4'-amino-trans-stilbene", "GOSSYPETIN", "3,4,5-Trimethoxy-4'-amino-trans-stilbene", "2-phenyl-2,3-dihydrobenzo[h]chromen-4-one", "4-[6-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine", "8-Imidazol-1-ylmethyl-5-nitro-chromen-4-one", "NSC-613604", "Docosapentaenoic acid", "N-(2-Propyloxy-4-nitrophenyl)methanesulfonamide", "DEHYDROLEUCODIN", "N-(2-nonyloxy-4-nitrophenyl)methanesulfonamide", "4-(3,5-Dimethoxyphenethyl)benzenamine", "1-(biphenyl-3-ylmethyl)-1H-1,2,4-triazole", "4-Imidazol-1-yl-2-phenyl-chroman-7-ol", "NSC-368280", "ISOLICOFLAVONOL", "4-Indan-(1E)-ylidenemethyl-pyridine", "LUDARTIN", "7-hydroxy-2-(3-hydroxyphenyl)chroman-4-one", "NSC-131736", "MINAMESTANE", "3-((1H-imidazol-1-yl)methyl)-9H-xanthen-9-one", "Testolactone", "YM-511", "FORMESTANE", "3-[3-Methyl-indan-(1Z)-ylidenemethyl]-pyridine", "3-[4-Methyl-indan-(1Z)-ylidenemethyl]-pyridine", "4'-bromo-3-(imidazolylmethyl)flavone", "1-Bromo-4-imidazol-1-ylmethyl-xanthen-9-one", "1-[(7-Fluoronaphth-2-yl)methyl]-1H-imidazole", "3,4,5-Trimethoxy-3'-amino-trans-stilbene", "MDL-18962", "3-(2,2-Diphenyl-vinyl)-pyridine", "1-(9-phenyl-9H-fluoren-9-yl)-1H-1,2,4-triazole", "Letrozole", "3-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine", "10-EPI-8-DEOXY-CUMAMBRIN B", "3-[3-Phenyl-indan-(1E)-ylidenemethyl]-pyridine", "Atamestane-plus- Toremifene", "Broussoflavonol F", "NSC-356781", "Exemestane", "3-(imidazolylmethyl)-4'-methoxyflavone", "4-Imidazol-1-ylmethylthioxanthen-9-one", "MORACHALCONE A", "NSC-94891", "4-Imidazol-1-ylmethyl-1-nitro-xanthen-9-one", "4-Imidazol-1-ylmethyl-3-nitroxanthen-9-one", "NSC-369087", "2-(1H-Imidazol-1-yl)-1-(4-nitrophenyl)ethanone", "7-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one", "1-(4-Aminophenyl)-2-(1H-imidazol-1-yl)ethanone", "4-Imidazol-1-ylmethyl-2-nitroxanthen-9-one", "4-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine", "N-[2-(4'-Nitrophenyl)ethyl]-imidazole", "1-(9H-fluoren-9-yl)-1H-imidazole", "3-(4-Amino-phenyl)-pyrrolidine-2,5-dione", "4-(3,4,5-Trimethoxyphenethyl)aniline", "3,4-bis(3,4-dimethoxyphenyl)furan-2(5H)-one", "2-(3-hydroxyphenyl)-7-methoxychroman-4-one", "(2S)-5,7,2',4'-tetrahydroxyflavanone", "3,5-Diamino-4'-amino-trans-stilbene", "4'-cyano-3-(imidazolylmethyl)-7-methoxyflavone", "1-(2-phenoxybenzyl)-1H-imidazole", "1-(4-nitro-2-phenoxybenzyl)-1H-imidazole", "5-(2-(1H-imidazol-1-yl)ethyl)quinoline", "1-(4-Nitro-2-phenylsulfanylbenzyl)-1H-imidazole", "4-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine", "3-Fluoren-9-ylidenemethyl-pyridine", "3,4'-(Ethane-1,2-diyl)dibenzenamine", "Org-33201", "4-(2,2-Diphenyl-vinyl)-pyridine", "3-(imidazolylmethyl)-7-methoxy-4'-nitroflavone"], "['5138']": ["Oxindole derivative 1", "Triazolo-pyridine derivative 4", "Triazolo-pyridine derivative 6", "Triazolo-pyridine derivative 2", "Triazolo-pyridine derivative 3", "Benzodiazepine derivative 2", "Pyrido[3,2-e][1,2,4]triazolo[4,3-a]pyrazine derivative 2", "Triazolo-phthalazine derivative 1", "Cyclic Guanosine Monophosphate", "Triazolo-pyridine derivative 5", "BAY-60-7550", "PMID27321640-Compound-76", "PMID27321640-Compound-75", "PMID27321640-Compound-74", "PMID27321640-Compound-59", "PMID27321640-Compound-58", "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 4", "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 5", "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 6", "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 7", "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 1", "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 2", "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 3", "Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivative 8", "Pyrido[3,2-e][1,2,4]triazolo[4,3-a]pyrazine derivative 1", "Imidazo[5,1-c][1,2,4]benzotriazine derivative 4", "Imidazo[5,1-c][1,2,4]benzotriazine derivative 1", "Imidazo[5,1-c][1,2,4]benzotriazine derivative 2", "Imidazo[5,1-c][1,2,4]benzotriazine derivative 3", "Imidazo triazine derivative 5", "Imidazo triazine derivative 4", "Imidazo triazine derivative 1", "Imidazo triazine derivative 3", "Imidazo triazine derivative 2", "Pyrido[1,2,4]triazolo[4,3-a]pyrazine derivative 1", "(2R,3S)-3-(6-Amino-purin-9-yl)-nonan-2-ol", "1,2,4-triazole [4,3-a]quinoxaline derivative 3", "1,2,4-triazole [4,3-a]quinoxaline derivative 2", "1,2,4-triazole [4,3-a]quinoxaline derivative 1", "CP-461", "ND7001", "Pyrazolo[3,4-d]pyrimidine derivative 4", "Pyrazolo[3,4-d]pyrimidine derivative 1", "Pyrazolo[3,4-d]pyrimidine derivative 3", "Pyrazolo[3,4-d]pyrimidine derivative 2", "Imidazotriazinone derivative 1", "1,2,4-triazole [1,5-a]pyrimidin-7-yl derivative 1", "1,2,4-triazole [1,5-a]pyrimidin-7-yl derivative 3", "1,2,4-triazole [1,5-a]pyrimidin-7-yl derivative 2", "Purin-6-one derivative 1", "Pyrido[2,3-d]pyrimidine-2,4-diamine derivative 1", "Pyrido[1,2,4]triazolo[4,3-a]pyrazine derivative 3", "Pyrido[1,2,4]triazolo[4,3-a]pyrazine derivative 2", "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 6", "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 4", "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 5", "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 2", "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 3", "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 1"], "['5139', '5141', '5142', '5143', '5144']": ["Ibudilast(Drug Bank)"], "['26']": ["Diminazene"], "['1119']": ["TCD-717", "Bisquinolinium derivative", "Hemicholinium-3"], "['1384']": ["LXR-015-2", "Teglicar"], "['5243', '5244']": ["LY335979"], "['476']": ["Almitrine", "Istaroxime(Drug Bank)", "Aluminium", "Artemether", "Deslanoside", "Digoxin(Drug Bank)", "Acetyldigitoxin", "UNBS-1450", "Lumefantrine", "DIGITOXIGENIN", "Digitoxin(Drug Bank)", "Ouabain(TTD)", "Chloroprocaine(TTD)"], "['3283', '3284', '3292']": ["3-Beta-Hydroxy-5-Androsten-17-One", "5alpha-Androstan-3,17-Dione"], "['1544', '1551', '1559', '1565', '1565', '1565', '1565', '1565', '1571', '1576', '1577', '240', '240', '64816']": ["Diacerein(Drug Bank)"], "['8694', '8694']": ["PMID25470667-Compound-BAY744113", "amidepsines", "PMID25470667-Compound-AZD3988", "PF-04620110", "Hesperetin(TTD)", "Pyrazolo[1,5-a]pyrimidine derivative 28", "Pyrazolo[1,5-a]pyrimidine derivative 29", "Pyrazine carboxamide derivative 1", "P-7435", "Pyridine-amide derivative 1", "Lactam derivative 3", "Lactam derivative 4", "Lactam derivative 5", "ISIS 191756", "ISIS 191755", "PMID25470667-Compound-PF-04620110", "JTT-553", "ISIS 191731", "DS-7250", "Carbamide derivative 3", "Lactam derivative 2", "Lactam derivative 1", "ISIS 191759", "Azole derivative 6", "Azole derivative 7", "Benzamide derivative 19", "ISIS 191761", "LCQ908", "T863", "AZD7687", "ISIS 191729", "Pyridine-carboximide derivative 1", "Pyridine-carboximide derivative 2"], "['6557', '7915']": ["Chlormerodrin(Drug Bank)"], "['9962']": ["Vitamin C"], "['2548', '8972', '8972']": ["SALACINOL"], "['2182', '5742', '5743', '6546']": ["Icosapent(Drug Bank)"], "['3417', '3417']": ["AG-120"], "['3613']": ["L-Myo-Inositol-1-Phosphate(TTD)"], "['1545', '26275', '498', '506', '509', '5294', '873']": ["Quercetin(Drug Bank)"], "['8877']": ["PMID27539678-Compound-13", "PMID27539678-Compound-11", "PMID27539678-Compound-10", "PMID27539678-Compound-17", "PMID27539678-Compound-16", "PMID27539678-Compound-14", "PMID27539678-Compound-12", "SK1-I", "PMID27539678-Compound-7", "PMID27539678-Compound-6", "PMID27539678-Compound-9", "F-12509A", "VPC-94075", "Methylbenzenesulfonamide derivative 1", "Phenoxodiol", "PF-543", "GSK618334", "B-5354a"], "['30061']": ["Ferroportin mab", "LY2928057"], "['9429']": ["Sulfasalazine(TTD)"], "['5476']": ["SAR164653", "example 166  (WO2014154727)", "PMID22861813C8a"], "['6609']": ["Chlorpromazine(Drug Bank)"], "['5142', '5144']": ["(R)-Rolipram(Drug Bank)", "(S)-Rolipram(Drug Bank)", "Cilomilast(Drug Bank)"], "['132', '6715']": ["GP515"], "['10723', '10723', '57468', '6560', '9990']": ["DIOA"], "['2990']": ["PerioPatch", "Vestronidase alfa"], "['3145']": ["P-9808"], "['5141', '5142', '6531', '6531']": ["Benzyl-(2-phenyl-quinazolin-4-yl)-amine"], "['1718']": ["Diazacholesterol", "T-226293"], "['2588']": ["BMN-110", "Elosulfase alfa"], "['1719']": ["TNP-351", "MDAM (y-methylene-10-deazaaminopterin)", "1954U89", "Proguanil(Drug Bank)", "L-MDAM", "Methotrexate Sodium", "Sri-9662(Drug Bank)", "Trimetrexate(Drug Bank)", "Iclaprim", "Pyrimethamine(Drug Bank)", "Leucovorin Calcium", "CH-4051", "Trimethoprim", "PIRITREXIM", "Sri-9439(Drug Bank)"], "['27115', '5150']": ["PF-3557156"], "['3292']": ["3-(6-hydroxy-2-naphthyl)benzoic acid", "3-(2-naphthyl)phenol", "7-Hydroxy-3-(3-hydroxyphenyl)-1-naphthonitrile", "N-(1'-Phenyl-ethyl) estradiol-16-carboxamide", "1,1':4',1''-terphenyl-3,4''-diol", "16-beta-hydroxymethyl-estradiol", "4'-(6-Methoxypyridin-3-yl)biphenyl-3-ol", "16-(pyridin-3-yl)methyl-estradiol", "3-[4-(4-Hydroxyphenyl)-1,3-oxazol-2-yl]phenol", "2-Hydroxy-N,6-bis(3-hydroxyphenyl)-1-naphthamide", "7-(3-Hydroxy-phenyl)-naphthalen-2-ol", "3,4'-(thiophene-2,4-diyl)diphenol", "16-(4-dimethylamino-benzylidene)-estrone", "N-methyl-N-ethyl estrone-16-methyl carboxamide", "3-[5-(4-hydroxyphenyl)-1,3-thiazol-2-yl]phenol", "N-isopropyl estrone-16-methyl carboxamide", "N-N-diethyl estradiol-16-methyl carboxamide", "N,N-diethyl estrone-16-methyl carboxamide", "N-(furan-2-ylmethyl)-estrone-16-methyl carboxamide", "16-(pyridin-3-yl)methylene-estradiol", "2-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol", "6-(4-Hydroxy-phenyl)-naphthalen-1-ol", "4-Methyl-1,1':4',1''-terphenyl-3,4''-diol", "N-methyl estrone-16-methyl carboxamide", "3,3'-(3-Methylthiene-2,5-diyl]diphenol", "16-(pyridin-2-yl)methyl-estradiol", "6-oxo-estrone", "N-(pyridin-3-ylmethyl) estradiol-16-carboxamide", "3-[5-(4-Hydroxyphenyl)-2-thienyl]-5-methylphenol", "1-Bromo-6-(3-hydroxyphenyl)-2-naphthol", "16-isobutylidene-estradiol", "16-beta-ethoxymethyl-estrone", "N-ethyl estrone-16-methyl carboxamide", "3,3'-pyrazine-2,5-diyldiphenol", "3-(3-hydroxyphenyl)quinolin-7-ol", "16-(4-cyano-benzylidene)-estradiol", "N-ethyl estradiol-16-methyl carboxamide", "N-methyl estradiol-16-methyl carboxamide", "16-(2',2'-Dimethyl)-propylidene-estradiol", "3,3'-(3-Phenylthiene-2,5-diyl)diphenol", "6-oxo-16-formyl-estrone", "3-[4-(5-Chloro-2-thienyl)pyridin-2-yl]phenol", "N-(4'-methyl-piperazinyl) estradiol-16-carboxamide", "16-(2',2'-Dimethyl)-propylidene-estrone", "3-[6-(5-Chloro-2-thienyl)pyridin-2-yl]phenol", "3-[2-(5-Chloro-2-thienyl)pyridin-4-yl]phenol", "3,3'-(1,2,4-Thiadiazol-2,5-diyl)diphenol", "3-[3-(4-hydroxyphenyl)isoxazol-5-yl]phenol", "3-[5-(3-Fluorophenyl)-2-thienyl]phenol", "2-Fluoro-4-[5-(3-hydroxyphenyl)-3-thienyl]phenol", "3,3'-Pyridine-2,5-diyldiphenol", "2-(3-hydroxyphenyl)quinolin-6-ol", "3,3'-(1,2,4-thiadiazole-3,5-diyl)diphenol", "N-isopropyl estradiol-16-methyl carboxamide", "3-[5-(4-hydroxyphenyl)-2-thienyl]phenol", "4-[5-(3-Hydroxyphenyl)-2-thienyl]benzene-1,2-diol", "16-(thiophen-2-yl)methylene-estrone", "3-[5-(3,4-Difluorophenyl)-2-thienyl]phenol", "3-(5-phenyl-2-thienyl)phenol", "N-methoxyethyl estrone-16-methyl carboxamide", "3,3',3''-Thiene-2,3,5-triyltriphenol", "Methyl estradiol-16-beta-carboxylate", "3,3'-thiene-2,5-diyldiphenol", "16-(pyridin-4-yl)methyl-estradiol", "3-[5-(4-Fluorophenyl)-2-thienyl]phenol", "N-methyl-N-ethyl estradiol-16-carboxamide", "N-(pyridin-4-ylmethyl) estradiol-16-carboxamide", "16beta-cyano-estradiol", "Equilin", "Ethyl estrone-16-methylcarboxylate", "3,3'-(1,2,4,5-tetrazine-3,6-diyl)diphenol", "16-isobutylidene-estrone", "4-Fluoro-1,1':4',1''-terphenyl-3,3''-diol", "3-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol", "4'-(5-Chloro-2-thienyl)biphenyl-3-ol", "3'-(5-Chloro-2-thienyl)biphenyl-3-ol", "16-(pyridin-2-yl)methylene-estradiol", "16-(pyridin-4-yl)methylene-estradiol", "N-(furan-2-ylmethyl)estradiol-16-carboxamide", "3-Hydroxy-7-(3-hydroxyphenyl)-1-naphthonitrile", "16-(4-dimethylamino-benzylidene)-estradiol", "3-[5-(4-hydroxyphenyl)-1,3-oxazol-2-yl]phenol", "3,3'-(1,3-Thiazol-2,4-diyl)diphenol", "EM-1745", "5-(6-hydroxy-2-naphthyl)pyridin-3-ol", "3,3'-Thiene-2,4-diyldiphenol", "3'-(1-Benzothien-2-yl)biphenyl-3-ol", "N-isopropyl estradiol-16-carboxamide", "6-(3-Hydroxyphenyl)-1-phenyl-2-naphthol"], "['80347']": ["PTX-007011", "4'-Phosphopantetheine", "Dephospho Coenzyme A"], "['240', '240']": ["1-(4-methoxyphenyl)-3-(1,3,4-thiadiazol-2-yl)urea", "ABT-761", "BUDDLEDIN A", "PYROGALLOL", "2-(4-Phenyl-butyl)-1,2-dihydro-indazol-3-one", "N-Hydroxy-N-methyl-3-naphthalen-2-yl-acrylamide", "5-Methyl-2-p-tolyl-thiazol-4-ol", "ANTHRONE", "4-Pentadeca-1,3,6-trienylsulfanyl-butyric acid", "2-(4-Butoxy-phenoxy)-N-hydroxy-propionamide", "N-Hydroxy-4-naphthalen-2-yl-benzamide", "ICI-211965", "Zileuton", "N-(1,3,4-thiadiazol-2-yl)benzamide", "Epocarbazolin-A", "E-6080", "Phenanthrene-2-carboxylic acid hydroxyamide", "3,4,5-trimethoxy-N-(thiazol-2-yl)benzamide", "5S-HETE", "N-Phenylbenzo[d]oxazol-2-amine", "KC-11404", "2-Biphenyl-4-yl-N-hydroxy-N-methyl-acetamide", "1,8,9-Trimethoxy-9,10-dihydro-anthracene", "4-Bromo-N-hydroxy-benzamide", "Rilopirox", "ISIS 1827", "10-Benzoyl-1,8-dihydroxy-10H-anthracen-9-one", "Tepoxalin", "L-702-539", "1-(4-methoxyphenyl)-3-(5-methylthiazol-2-yl)urea", "1,2-Dihydro-indazol-3-one", "N-(5-methylthiazol-2-yl)benzamide", "CJ-13610", "L-689065", "Ibuproxam", "1,3,8-Trihydroxy-6-methyl-10H-anthracen-9-one", "2,4'-Diacetoxy-5,3'-di-(2-propenyl)-biphenyl", "TA-270", "ISAINDIGOTONE", "3-Biphenyl-3-yl-N-hydroxy-N-methyl-acrylamide", "N-(5-methylthiazol-2-yl)-2-phenylacetamide", "MK-886", "Anthracene-2-carboxylic acid hydroxyamide", "1,8-Dichloro-10H-anthracen-9-one", "1-Methyl-1,2-dihydro-indazol-3-one", "FPL-64170", "CV-6504", "E-3040", "SKF-104351", "4-(dimethylamino)-N-(thiazol-2-yl)benzamide", "SC-41661A", "BW755C", "BI-L-357", "ZM-230487", "4-(1H-indol-3-yl)-1-morpholinobutan-1-one", "2-(4-Methoxy-phenyl)-5-phenyl-thiazol-4-ol", "PD-169316", "BW B70C", "BF-389", "(N-(3-phenoxycinnamyl)-acetohydroxamic acid", "2-(4-Butoxy-phenoxy)-N-hydroxy-N-methyl-acetamide", "2-Thiazol-5-ylmethyl-1,2-dihydro-indazol-3-one", "Naphthalene-2-carboxylic acid hydroxyamide", "1-Benzyl-1,2-dihydro-indazol-3-one", "Acetic acid 2-phenyl-5-propyl-thiazol-4-yl ester", "MLN-977", "N-Hydroxy-N-methyl-3-phenanthren-3-yl-acrylamide", "2,4,5-Triarylimidazole analogue", "N-Hydroxy-4-isobutyl-benzamide", "2-phenyl-N-(thiazol-2-yl)acetamide", "ISIS 1820", "ISIS 1821", "ISIS 1822", "2-Pyridin-3-ylmethyl-1,2-dihydro-indazol-3-one", "10-Acetyl-1,8-dihydroxy-10H-anthracen-9-one", "CMI-392", "3-Benzoyl-N-hydroxy-benzamide", "N-Hydroxy-3-naphthalen-2-yl-N-phenyl-acrylamide", "CGS 8515", "PTC299", "N-Hydroxy-4-iodo-benzamide", "5-Methoxy-N-phenylbenzo[d]oxazol-2-amine", "Biphenyl-4-carboxylic acid hydroxyamide", "1-Hydroxy-10H-anthracen-9-one", "2-Naphthalen-1-ylmethyl-1,2-dihydro-indazol-3-one", "2-(benzyloxy)naphthalene", "N-(3-Bromophenyl)-5-methoxybenzo[d]oxazol-2-amine", "N-Hydroxy-3-naphthalen-2-yl-N-p-tolyl-acrylamide", "N-(4-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine", "MK-866", "1-Hydroxy-8-methoxy-10H-anthracen-9-one", "N-Hydroxy-3-naphthalen-2-yl-acrylamide", "OPC-21268", "N-Hydroxy-3-phenyl-acrylamide", "N-hydroxy-4-(naphthalen-1-yl)benzamide", "ZD-2138", "AA-861", "N-hydroxycarbamate derivative", "15-hydroxyeicosatetraenoic acid", "2-Pyridin-2-ylmethyl-1,2-dihydro-indazol-3-one", "A-78773", "PD-146176", "Methyl 2-(Benzylamino)-1H-indole-3-carboxylate", "1-(4-methoxyphenyl)-3-(4-methylthiazol-2-yl)urea", "A-80263", "ZD-7717", "PF-4191834", "3-methoxy-N-(4-methylthiazol-2-yl)benzamide", "3,4-Dihydroxycinnamic Acid(TTD)", "N-Hydroxy-2-methyl-3-naphthalen-2-yl-acrylamide", "FR-122788", "3,4-Dihydroxy-10H-anthracen-9-one", "CI-986", "ISIS 2177", "N-Hydroxy-N-methyl-3-phenanthren-9-yl-acrylamide", "WY-50295-tromethamine", "1,2-Dihydroxy-10H-anthracen-9-one", "ER-34122", "N-Hydroxy-N-methyl-2-naphthalen-2-yl-propionamide", "R-85355", "L-746530", "4,5-Dihydroxy-10H-anthracen-9-one", "DuP-654", "Chebulagic acid", "MK-591", "LY-221068", "TENIDAP", "N-Hydroxy-3-naphthalen-2-yl-propionamide", "Flobufen", "Licofelone(TTD)", "2-Pyridin-4-ylmethyl-1,2-dihydro-indazol-3-one", "SK&F 107649", "N-Hydroxy-N-methyl-3-naphthalen-1-yl-acrylamide", "Acetic acid 5-butyl-2-phenyl-thiazol-4-yl ester", "N-(2-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine", "N-Hydroxy-N-methyl-3-phenanthren-2-yl-acrylamide", "4,5-Dimethoxy-10H-anthracen-9-one", "3-Biphenyl-4-yl-N-hydroxy-N-methyl-acrylamide", "5-Methyl-N-phenylbenzo[d]oxazol-2-amine", "SC-45662", "AZD-4407", "2-(4-methoxyphenyl)-N-(thiazol-2-yl)acetamide", "2-(4-hydroxylphenyl)-3-(3,5-dihydroxylphenyl) propenoic acid (NNU-hdpa)", "N-(4-methylthiazol-2-yl)benzamide", "CYLINDOL A", "3-methoxy-N-(1,3,4-thiadiazol-2-yl)benzamide", "BW-A137C", "N-(4-Ethylphenyl)benzo[d]oxazol-2-amine", "NAFAZATROM", "Masoprocol(Drug Bank)", "N-Hydroxy-N-methyl-benzamide", "CGS-23885", "N-Hydroxy-N-methyl-3-naphthalen-2-yl-propionamide", "R zileuton", "BW B218C", "3-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acrylamide", "N-Hydroxy-2-naphthalen-2-yl-acetamide", "2-(4-Butoxy-phenoxy)-N-hydroxy-acetamide", "Diethylcarbamazine(TTD)", "4-Hydroxy-5-methoxy-10H-anthracen-9-one", "4-Butoxy-N-hydroxy-N-methyl-benzamide", "4-methoxy-N-(thiazol-2-yl)benzamide", "1,8-Dihydroxy-2-propionyl-10H-anthracen-9-one", "2-(1H-Indol-3-ylmethyl)-1,2-dihydro-indazol-3-one", "CMI-206", "L-652,343", "2-Thiophen-2-ylmethyl-1,2-dihydro-indazol-3-one", "5-Chloro-N-phenylbenzo[d]oxazol-2-amine", "Silymarin", "2-phenyl-N-(1,3,4-thiadiazol-2-yl)acetamide", "N-(4-methylthiazol-2-yl)-2-phenylacetamide", "R-68151", "ISIS 1831", "N-(thiazol-2-yl)benzamide", "Biphenyl-3-carboxylic acid hydroxyamide", "BU-4601A", "UCB-35440", "CD-581", "2-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acetamide", "BW-858C", "1-furan-2-yl-3-pyridin-2-yl-propenone (FPP-3)", "1,5-Dihydroxy-10H-anthracen-9-one", "SB-202235", "KC-11425", "5-Chloro-N-(4-ethylphenyl)benzo[d]oxazol-2-amine", "CMI-977", "Methyl 2-(Diallylamino)-1H-indole-3-carboxylate", "Montelukast(Drug Bank)", "TZI-41127", "2'-Nitro-biphenyl-4-carboxylic acid hydroxyamide", "A-79175", "Hexanoic acid 2,5-diphenyl-thiazol-4-yl ester", "BW A360C", "N-Hydroxy-N-methyl-2,3,3-triphenyl-acrylamide", "Linetastine", "CGS-26529", "Tipelukast", "Phenanthrene-3-carboxylic acid hydroxyamide", "REV-5901", "BIM23A760", "Sch-40120", "ETH615", "FPL-62064"], "['1723']": ["BREQUINAR", "LAS-186323", "BAY2402234", "FK778", "Teriflunomide(Drug Bank)", "Vidofludimus", "HR325"], "['1806', '316', '7498']": ["Eniluracil(Drug Bank)"], "['3938']": ["2,5-dideoxy-2,5-imino-dl-glycero-D-manno-heptitol", "Hyacinthacine B3", "Gluconolactone", "ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE", "D-Gluconhydroximo-1,5-Lactam", "2-Deoxy-2fluoro-Glucose", "Xylopyranose"], "['1545', '1588', '231']": ["CHRYSIN"], "['210', '5142']": ["S,S-(2-Hydroxyethyl)Thiocysteine(TTD)"], "['23632', '760', '762', '765', '771']": ["Sulfamylon"], "['6523', '6555']": ["1614235 + 2330672"], "['231', '57016', '5742', '5743']": ["Sulindac(Drug Bank)"], "['23632', '759', '768', '771']": ["7-methoxy-2-oxo-2H-chromene-4-carboxylic acid", "8-methoxy-2-oxo-2H-chromene-3-carboxylic acid"], "['4842', '4843', '4846']": ["N-Omega-Hydroxy-L-Arginine", "2-Methyl-[1,4]thiazepan-(5E)-ylideneamine", "3-Methyl-pyrrolidin-(2Z)-ylideneamine", "(S)-6-Amino-2-(2-imino-ethylamino)-hexanoic acid", "N5-(1-iminobut-3-enyl)-L-ornithine", "(5S,6S)-[Octahydro-quinolin-(2E)-ylidene]amine", "4-Methyl-piperidin-(2E)-ylideneamine", "L-Nw-nitroarginine", "7-Methyl-[1,4]thiazepan-(5E)-ylideneamine", "6-(3-Fluoropropyl)-4-methylpyridin-2-amine", "(5S,6R)-[Octahydro-quinolin-(2E)-ylidene]amine", "[1,3]Thiazinan-(2E)-ylideneamine", "Azepan-(2Z)-ylideneamine", "7-nitro-1H-indazole", "[1,4]Thiazepan-(5E)-ylideneamine", "6-(2-Fluoropropyl)-4-methylpyridin-2-amine", "(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin", "Pyrrolidin-(2Z)-ylideneamine", "2-amino-4-methylpyridine", "3-Bromo-1H-indazole-7-carbonitrile", "1400W", "N5-(1-iminopropyl)-L-ornithine", "7-(2-Nitro-ethyl)-azepan-(2Z)-ylideneamine", "Hexahydro-cyclopenta[c]pyrrol-(1Z)-ylideneamine", "N-omega-allyl-L-arginine", "N5-(1-iminobutyl)-L-ornithine", "6-isobutyl-4-methylpyridin-2-amine", "Piperidin-(2E)-ylideneamine", "[1,3]Oxazinan-(2E)-ylideneamine", "4-Ethyl-5-methyl-pyrrolidin-(2Z)-ylideneamine", "2-Aminothiazoline(TTD)", "[1,4]Oxazepan-(3E)-ylideneamine", "(5-Imino-[1,4]thiazepan-3-yl)-methanol", "THIOCITRULLINE", "(S)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine", "4,5-Dimethyl-pyrrolidin-(2Z)-ylideneamine", "5-Ethyl-4-methyl-pyrrolidin-(2Z)-ylideneamine", "L-NIO", "L-NIL", "3,4-Dimethyl-pyrrolidin-(2Z)-ylideneamine", "3-bromo-7-nitro-1H-indazole", "(S)-2-Amino-5-(N-methyl-guanidino)-pentanoic acid", "3-Methyl-[1,4]thiazepan-(5E)-ylideneamine", "N-omega-propargyl-L-arginine", "2-Amino-5-(N-nitro-guanidino)-pentanoic acid", "N-(5-Amino-6-oxo-heptyl)-acetamidine", "[1,4]Thiazepan-(3E)-ylideneamine", "5-Methyl-pyrrolidin-(2Z)-ylideneamine", "4-methyl-6-propylpyridin-2-amine", "4-Methyl-pyrrolidin-(2Z)-ylideneamine", "3-Ethyl-[1,4]thiazepan-(5E)-ylideneamine", "4-Ethyl-pyrrolidin-(2Z)-ylideneamine"], "['2936', '7296']": ["Golden phosphorous acetyletic compound 1", "Golden phosphorous acetyletic compound 2", "Acyl oxymethyl acrylamide ester derivative 1", "Terpyridineplatinum(II) complexe 4", "Terpyridineplatinum(II) complexe 3"], "['18', '2875', '4128', '4129', '84706', '8639']": ["Phenelzine(Drug Bank)"], "['1215']": ["ASB17061", "Benzylsulfinic Acid", "SUN-C8257", "Phenylalanylmethane", "Rac-2q", "NK3201", "BCEAB", "SUN13834", "KM-01221", "BAY 11-42524", "CHYMOSTATIN", "JNJ-10311795", "Y-40613"], "['1565', '1565', '1565', '1565', '1565', '1576', '3292']": ["4-[5-(3-Hydroxyphenyl)-2-thienyl)-2-methyl]phenol", "4-[5-(3-Hydroxyphenyl)-3-thienyl]-2-methylphenol", "2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol"], "['476', '6559', '759', '760', '762']": ["Trichlormethiazide(Drug Bank)"], "['3295']": ["3r-Hydroxydecanoyl-Coa"], "['6783']": ["Cyclizine(Drug Bank)"], "['121278', '5053', '7166']": ["fenclonine"], "['5139', '5141', '5142', '6523', '6524', '8654']": ["KURAIDIN"], "['239']": ["(-)-7-N-methyldibromophakellin", "NEODYSIDENIN", "NSC-125034"], "['246']": ["3,6,8-Tribromo-dibenzo[1,4]dioxin-1-ol", "PMID26560362-Compound-90", "IGERNELLIN", "Subersic acid", "(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID", "Imidazole derivative 10", "ISOSCOPOLETIN", "3,4-Dibromo-2-(5-bromo-2-hydroxy-phenoxy)-phenol", "Isothiazolone derivative 1", "SPONGIADIOXIN A", "Hydrohalisulfate 1", "Benzothiopyranoindole", "Indole and benzimidazole derivative 1", "Triazole derivative 3", "SCOPOLETIN", "Imidazole derivative 11", "Halisulfate 1", "Nonsteroidal anti-inflammatory drugs (NSAIDs)", "Tri-substituted benzene derivative 1"], "['4128', '4129', '4129', '6530', '6531', '6531', '6532', '6571']": ["Amphetamine(Drug Bank)"], "['5141', '5142']": ["Benzyl-(2-thiophen-2-yl-quinazolin-4-yl)-amine", "RS-14491", "8-(3-Nitro-phenyl)-6-phenyl-[1,7]naphthyridine", "Enprofylline(Drug Bank)", "Benzyl-(2-imidazol-1-yl-quinazolin-4-yl)-amine", "NITRAQUAZONE", "(R)-Rolipram(TTD)", "(S)-Rolipram(TTD)", "CI-1044"], "['760', '762', '771']": ["CATECHOL"], "['8884']": ["Gabapentin enacarbil(TTD)"], "['121278', '7166']": ["Telotristat ethyl", "6-fluorotryptophan"], "['1384', '3156', '80347']": ["Coenzyme A(TTD)"], "['1545', '240', '240', '7498']": ["ACACETIN"], "['11343', '747']": ["PMID29053063-Compound-15"], "['760', '761']": ["Sulpiride(Drug Bank)"], "['8564']": ["Cyclopropane 1-carboxylic acid derivative 9", "Cyclopropane 1-carboxylic acid derivative 1", "Cyclopropane 1-carboxylic acid derivative 3", "Benzene sulfonamide derivative 1", "Benzene sulfonamide derivative 3", "Benzene sulfonamide derivative 2", "Benzene sulfonamide derivative 7", "PMID27172114-Compound-49", "PMID27172114-Compound-47", "Cyclopropane 1-carboxylic acid derivative 8", "Cyclopropane 1-carboxylic acid derivative 2", "Cyclopropane 1-carboxylic acid derivative 4", "Cyclopropane 1-carboxylic acid derivative 5", "Cyclopropane 1-carboxylic acid derivative 6", "Cyclopropane 1-carboxylic acid derivative 7", "Aryl pyrimidine derivative 9", "Aryl pyrimidine derivative 8", "Aryl pyrimidine derivative 3", "Aryl pyrimidine derivative 2", "Aryl pyrimidine derivative 7", "Aryl pyrimidine derivative 6", "Aryl pyrimidine derivative 5", "Aryl pyrimidine derivative 4", "Isoxazoles and isoxazoline derivative 5", "Isoxazoles and isoxazoline derivative 4", "Isoxazoles and isoxazoline derivative 6", "Isoxazoles and isoxazoline derivative 1", "Isoxazoles and isoxazoline derivative 3", "Isoxazoles and isoxazoline derivative 2", "Cyclopropane 1-carboxylic acid derivative 10", "Benzene sulfonamide derivative 5", "Benzene sulfonamide derivative 4", "Pyrimidine benzenesulfonamide derivative 3", "Pyrimidine benzenesulfonamide derivative 2", "Pyrimidine benzenesulfonamide derivative 1", "Benzene sulfonamide derivative 6"], "['1357']": ["PMID18078750C1b", "SQ-14603", "DL-benzylsuccinic acid", "2-Thiomethyl-3-Phenylpropanoic Acid(TTD)"], "['5319']": ["LY178002", "P-Anisic Acid(TTD)", "WA-8242-A1", "ABYSSINONE V", "YM-26734", "Darapladib(TTD)", "EPC-K1", "Mepacrine", "4'-hydroxy-6,3',5'-triprenylisoflavonone", "BMY-30129", "SB-203347", "Miltefosine(TTD)", "methylglyoxal", "folipastatin", "LY256548", "Heptanoic Acid", "AGN-190383", "AllerB", "HELENAQUINONE", "WAY-123641", "MRX-4", "MRX-6", "SC-106", "Hexane-1,6-Diol", "PF-05212372", "Lpc-Ether(TTD)", "Diflorasone(TTD)", "Petrosaspongiolide M", "Petrosaspongiolide P", "3,9-dihydroxy-2,10-diprenylpterocap-6a-ene", "HYRTIOSULAWESINE", "Clobetasol", "BM-162115", "MANOALIDE", "SB-435495"], "['5144', '8654']": ["ZAPRINAST", "Papaverine(TTD)"], "['6241']": ["CO-101", "CALAA-01", "Gemcitabine(TTD)", "LY-2334737", "MDL 101,731", "Gallium maltolate(TTD)", "Hydroxyurea(TTD)", "Triapine", "NKP-46", "Gemcitabine prodrug"], "['2982', '2983']": ["Sodium nitroprusside", "Nitroglycerin(TTD)"], "['222']": ["Calcium carbimide(Drug Bank)"], "['1056']": ["CVT-1", "Bucelipase alfa", "PMID24556381C10l", "PMID24556381C10f", "TgBSSL"], "['526', '6241']": ["Gallium nitrate(Drug Bank)"], "['23632', '759', '760', '765', '768', '771']": ["4-(hydroxymethyl)benzenesulfonamide", "6-Hydroxy-benzothiazole-2-sulfonic acid amide", "Carzenide"], "['2582']": ["UDP-glucose", "Phenyl-Uridine-5'-Diphosphate", "Uridine-Diphosphate-N-Acetylglucosamine(TTD)", "PSAMMAPLIN A", "Tetramethylammonium Ion", "Uridine-5'-Diphosphate(TTD)", "Uridine Diphosphate Galactose", "Uridine-Diphosphate-N-Acetylgalactosamine(TTD)", "Uridine-5'-Diphosphate-Mannose"], "['2194', '5406', '8513']": ["Orlistat(Drug Bank)"], "['10858']": ["PMID25514969-Compound-9", "PMID25514969-Compound-8", "PMID25514969-Compound-10", "PMID25514969-Compound-Figure3", "PMID25514969-Compound-Figure2-3", "PMID25514969-Compound-Figure2-2", "PMID25514969-Compound-Figure2-4", "PMID25514969-Compound-11", "PMID25514969-Compound-13", "PMID25514969-Compound-12", "TAK-935", "RC-8800"], "['4881', '4882']": ["Nesiritide(Drug Bank)"], "['51079']": ["Flurpiridaz F 18"], "['1565', '1565', '1565', '1565', '1565', '6531', '6531']": ["GB-12819"], "['55627']": ["ND1251"], "['50940']": ["BC11-38"], "['5947']": ["Acitretin(Drug Bank)"], "['7083']": ["Penciclovir", "TK-DLI", "9-(4-Hydroxybutyl)-N2-Phenylguanine", "5-Bromothienyldeoxyuridine", "6-Hydroxypropylthymine", "Ad-OC-hsvTK/valacyclovir", "P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate", "5-propyl-2'-deoxyuridine", "FV-100", "Deoxythymidine", "Sitimagene ceradenovec", "2-phenylamino-9-(4-hydroxy-butyl)-6-oxopurine", "3-(2-propyn-1-yl)thymidine", "5-Bromovinyldeoxyuridine", "1-[2-(2-triphenylmethoxyethoxy)ethyl]thymine", "5-Iododeoxyuridine", "L-5-(bromovinyl)deoxyuridine", "BVDU-MP", "N2-(3-trifluoromethylphenyl)guanine", "5-Iodo-2'-Deoxyuridine-5'-Monophosphate", "2'-deoxythymidine triphosphate", "HQK-1004", "9-Hydroxypropyladenine, R-Isomer", "Edoxudine", "2'-Deoxyuridine", "L-5-iodo-2'-deoxyuridine", "Thymidine-5'-Phosphate", "3'-(1,2,3-Triazol-1-yl)-3'-deoxy-beta-D-thymidine", "(South)-Methanocarba-Thymidine", "Radiosensitizer gene therapy", "Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy", "ITdU", "9-Hydroxypropyladenine, S-Isomer", "6-(Dihydroxy-Isobutyl)-Thymine", "1-[7-(triphenylmethoxy)heptyl]thymine", "DEOXYCYTIDINE"], "['759', '760', '771']": ["Thioureido sulfonamide"], "['1890']": ["5-butyl-6-chloropyrimidine-2,4(1H,3H)-dione", "1-(cyclopropyl)methyl-5'-O-tritylinosine", "1-benzyl-5'-O-tritylinosine", "5-bromo-6-(cyclopropylamino)uracil hydrochloride", "5-bromo-6-hydrazinouracil hydrochloride", "1-allyl-5'-O-tritylinosine", "6-chloro-5-propylpyrimidine-2,4(1H,3H)-dione", "6-chloro-5-phenylpyrimidine-2,4(1H,3H)-dione", "5-chloro-6-hydrazinouracil hydrochloride", "6-chloro-5-heptylpyrimidine-2,4(1H,3H)-dione", "1-(cyclohexyl)methyl-5'-O-tritylinosine", "2'-aminoimidazolylmethyluracils", "1-propyl-5'-O-tritylinosine", "Thymine", "5-benzyl-6-chloropyrimidine-2,4(1H,3H)-dione", "Uridine(TTD)", "6-amino-5-chlorouracil hydrochloride", "6-chloro-5-pentylpyrimidine-2,4(1H,3H)-dione", "6-bromo-5-phenylpyrimidine-2,4(1H,3H)-dione", "6-chloro-5-hexylpyrimidine-2,4(1H,3H)-dione", "6-amino-5-bromouracil", "6-fluoro-5-phenylpyrimidine-2,4(1H,3H)-dione", "6-chloro-5-(2-thienyl)pyrimidine-2,4(1H,3H)-dione", "5-fluoro-6-[(2-aminoimidazol-1-yl)methyl]uracil"], "['4953']": ["APA", "3-(Aminooxy)propan-1-amine hydrochloride", "1-Amino-3-(aminoxy)-2-propanol Dihydrochloride", "4-hydroxylonchocarpin", "N-Pyridoxyl-Glycine-5-Monophosphate(TTD)", "DFMO", "LONCHOCARPUSONE", "ZAPOTIN", "Eflornithine", "Pyridoxine-5'-Phosphate", "Alpha-monofluoromethyl-3,4-dehydroornithine", "Alpha-monofluoromethyl-3,4-dehydroornithine ethyl ester", "G418", "Alpha-monofluoromethyl-3,4-dehydroornithine methyl ester", "(2R,5R)-delta-methyl-alpha-acetylenic putrescine", "AMXT-1501", "3-methoxy-4-hydroxylonchocarpin"], "['2224', '9453']": ["Geranyl Diphosphate(Drug Bank)", "ISOPENTENYL PYROPHOSPHATE(Drug Bank)", "Ibandronate(Drug Bank)"], "['4128', '4129', '6530', '6531', '6531', '6532', '6571']": ["MMDA(TTD)"], "['153201', '206358']": ["5-hydroxy-L-tryptophan"], "['6564', '6565']": ["[3H]GlySar", "[11C]GlySar", "Lys[Z(NO2)]-Pro", "[14C]GlySar"], "['47']": ["SB-201076", "(-)-hydroxycitrate", "ETC-1002"], "['523']": ["Cruentaren"], "['6529', '6538']": ["GSK683699", "2,4-Diamino-butyric acid(GABA)", "4-Hydroxy-piperidine-3-carboxylic acid"], "['2526']": ["99mTc-fanolesomab"], "['6505', '6506', '6507', '6511', '6512']": ["[3H]ETB-TBOA", "[3H]L-aspartic acid", "D-aspartic acid", "DL-TBOA"], "['316']": ["Isovanillin", "Menadione(TTD)"], "['2194', '6713']": ["Epigallocatechin gallate(TTD)"], "['3156', '5742', '5743']": ["Aspirin"], "['1586', '6715']": ["2,3,5,6-Tetrafluoro-4-pentafluorophenylazo-phenol"], "['3417', '3418', '50']": ["Isocitric Acid(Drug Bank)"], "['100', '5138']": ["EHNA"], "['280']": ["Maltose(Drug Bank)"], "['2167']": ["2-(3-Methyl-indole-1-sulfonyl)-benzoic acid", "PMID27109571-Compound-7", "PMID27109571-Compound-8", "PMID27109571-Compound-9", "3-Carbazol-9-yl-propionic acid", "2-(5-Bromo-indole-1-sulfonyl)-benzoic acid", "LINOLEIC ACID", "PMID27109571-Compound-10", "PMID27109571-Compound-11", "2-(4-Fluoro-indole-1-sulfonyl)-benzoic acid", "1-benzyl-2,3-dimethyl-1H-indole-7-carboxylic acid", "2-(4-Methyl-indole-1-sulfonyl)-benzoic acid", "2-(6-Methoxy-indole-1-sulfonyl)-benzoic acid"], "['6557', '760']": ["Furosemide(Drug Bank)"], "['10728', '5742', '5743']": ["Acetaminophen(Drug Bank)"], "['760', '765', '771']": ["4-CYANOPHENOL"], "['23632', '759', '762', '768', '771']": ["2-oxo-2H-chromene-3-carboxylic acid"], "['7298']": ["10-Propargyl-5,8-Dideazafolic Acid(Drug Bank)", "ICI-198583", "Plevitrexed (R)-isomer", "Fluorouracil(Drug Bank)", "TS antisense + raltitrexed"], "['495']": ["AG-SPT201", "OPC-22575", "CA-50040", "Rabeprazole", "CDRI-85/92", "PA-10040", "Esomeprazole(Drug Bank)", "Pantoprazole(Drug Bank)", "Esomeprazole magnesium + Aspirin", "Saliphenylhalamide", "API-023", "Omeprazole(Drug Bank)", "ARH-1029"], "['54407', '55089', '81539']": ["[3H]alanine"], "['27165', '2744']": ["PMID30273516-Compound-40", "PMID30273516-Compound-41", "PMID30273516-Compound-22a", "PMID30273516-Compound-22b", "CB-839", "PMID30273516-Compound-12", "PMID30273516-Compound-15", "PMID30273516-Compound-14", "PMID30273516-Compound-39", "PMID30273516-Compound-38", "PMID30273516-Compound-37", "PMID30273516-Compound-1", "PMID30273516-Compound-13"], "['1733', '7173', '7173']": ["Propylthiouracil(TTD)"], "['1576', '1584']": ["3-methoxy-5-(6-methoxynaphthalen-2-yl)pyridine", "6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one", "4-(6-Methoxynaphthalen-2-yl)isoquinoline", "3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine"], "['1588', '3292', '8644']": ["4-ANDROSTENE-3-17-DIONE"], "['1545', '7498']": ["CHRYSOERIOL"], "['4056', '4056']": ["US20160326143, 50", "US20160326143, 38", "US20160326143, 3", "US20160326143, 28"], "['262', '8869']": ["5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine"], "['10991']": ["[3H]glutamine"], "['1728']": ["NSC-339583", "NSC-339580", "Menadione(Drug Bank)", "3-Benzyl-4-hydroxy-6,7-dimethyl-2H-chromen-2-one", "4-Hydroxy-3-(2-naphthylmethyl)-2H-chromen-2-one", "NSC-275420", "3-Benzyl-4-hydroxy-2H-chromen-2-one", "2-Benzyl-1-hydroxy-3H-benzo[f]chromen-3-one", "Quinones", "4-amino-2H-chromen-2-one", "Ethyl Bis(4-hydroxy-2-oxo-2H-chromen-3-yl)acetate", "3-Benzyl-4-hydroxy-2H-benzo[h]chromen-2-one", "NSC-106080", "NSC-73410", "BioE-743", "NSC-621351", "NSC-645808", "NSC-645827", "Duroquinone", "NSC-316158", "4-Hydroxy-3-(1-naphthylmethyl)-2H-chromen-2-one", "ES-936", "NSC-354279", "NSC-224124", "NSC-2113", "Coenzyme Q10 analog", "Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]", "NSC-65069", "3-(3,4-Dimethylbenzyl)-4-hydroxy-2H-chromen-2-one", "NSC-106547", "ARQ 761", "NSC-99528"], "['2203', '8789']": ["3-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol", "Managlinat dialanetil(TTD)", "4,6-Dichloro-1H-indole-2-carboxylic acid", "1-(4-aminophenylsulfonyl)-3-(2-mercaptoethyl)urea", "4-(4-(4-Nitrophenyl)thiazol-2-ylamino)phenol", "MB07803", "2,5-Anhydroglucitol-1,6-Biphosphate(TTD)", "2-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol", "Fructose-6-Phosphate", "N-(5-chlorobenzo[d]oxazol-2-yl)benzenesulfonamide", "1-(2-mercaptoethyl)-3-(m-tolylsulfonyl)urea"], "['18', '4129']": ["4-hydroxybenzaldehyde"], "['6506']": ["WAY-213613"], "['151531', '7378']": ["TK-112690"], "['4598']": ["dolichol phosphate", "(RS)-5-diphosphomevalonate"], "['7083', '7084']": ["1-[5-(triphenylmethoxy)pentyl]thymine", "1-[6-(triphenylmethoxy)hexyl]thymine", "1-[(Z)-4-(triphenylmethoxy)-2-butenyl]thymine"], "['768', '771']": ["4-(4'-N-Methylphenyl)diazenylbenzenesulfonamide", "Sodium phenylaminomethanesulfonate", "Sodium N-methylphenylaminomethanesulfonate"], "['23632', '5742', '590']": ["Beta-D-Mannose"], "['5740', '5742', '5743']": ["Phenylbutazone(Drug Bank)"], "['166929', '259230']": ["2-hydroxyoleic acid"], "['6524']": ["Empagli ozin", "BI-44847", "FORMONONETIN", "YM-543", "ISIS-SGLT2", "MAACKIAIN", "Dapagliflozin", "SERGLIFLOZIN A", "ASP1941", "RO-4998452", "Canagliflozin", "Bexagliflozin", "Dapagliflozin Propanediol; Saxagliptin Hydrochloride", "Remogliflozin etabonate", "PF-04971729", "TS-033", "EGT-0001474", "Empagliflozin", "AVE-2268", "Acerogenin C"], "['26', '6548']": ["Amiloride(Drug Bank)"], "['760', '771']": ["4-Methylamino-benzenesulfonamide", "4-(N-Methyl-hydrazino)-benzenesulfonamide"], "['1576', '3292', '7299']": ["6-(3-Hydroxy-phenyl)-naphthalen-2-ol"], "['384']": ["N-hydroxy-nor-L-arginine", "S-(2-boronoethyl)-L-cysteine"], "['4128', '6530', '6531', '6531', '6532']": ["2-Amino-1-(4-methylthiophenyl)propane"], "['10560', '80704']": ["[3H]thiamine"], "['1636', '5291', '5293', '5294']": ["LY-292223"], "['6538']": ["Beta-Alanine", "SNAP-5114"], "['759', '760', '768', '771']": ["4-(4-Cyanophenoxy)-3-pyridinesulfonamide", "1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide", "4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide", "4-Benzenesulfonylamino-benzenesulfonamide", "N-(4-cyanophenyl)sulfamide", "4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide", "N-(pentafluorophenyl)sulfamide", "SACCHARIN", "N-(4-Sulfamoyl-phenyl)-benzamide", "N-(4-Sulfamoyl-phenyl)-butyramide", "1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide", "4-(4-Fluorophenoxy)-3-pyridinesulfonamide", "N-(4-Sulfamoyl-phenyl)-propionamide", "4-Methanesulfonylamino-benzenesulfonamide", "3-(3-Phenyl-ureido)-benzenesulfonamide", "N-hydroxysulfamide", "Sulfanilamide derivative", "4-Methoxy-3-pyridinesulfonamide", "Pentanoic acid (4-sulfamoyl-phenyl)-amide", "2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide"], "['759', '762']": ["Carbamoyl phosphate disodium", "[Cu(CN)2]-"], "['760']": ["2-methoxyestradiol-17-O-sulfamate", "N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide", "Di(2,6-di-t-butylphenol)", "3-hydroxy-2-methoxybenzaldehyde", "Sodium 2,3,5,6-tetrafluorobenzoate", "4-Flourobenzenesulfonamide", "Dorzolamide(TTD)", "2-methoxyestrrone-3-O-sulfamate", "4-(4-tert-butylbenzylideneamino)benzoic acid", "4-methyl-2-oxo-2H-chromen-7-yl sulfamate", "AL5927", "4-Nitro-benzenesulfonamide", "4-Methylimidazole(TTD)", "AL4623", "BUTYLATEDHYDROXYTOLUENE", "N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide", "Di(2,6-dimethylphenol)", "Chlorothiazide(TTD)", "4-Sulfonamide-[1-(4-Aminobutane)]Benzamide", "4-((benzylideneamino)methyl)benzenesulfonamide", "4-methoxyphenylsulfamide", "P-tolylboronic acid", "SODIUM PERFLUOROHEXANESULFONAMIDE", "Sulfamic acid benzo[1,3]dioxol-2-ylmethyl ester", "AL5300", "Benzthiazide(TTD)", "PHENYLSULFAMIDE", "6-hydroxybenzo[d][1,3]oxathiol-2-one", "2,6-di-tert-butyl-4-methoxyphenol", "N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE", "3-Nitro-benzenesulfonamide", "SULTHIAME", "(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate", "N-(1-benzofuran-3-ylmethyl)sulfamide", "2-(benzylideneamino)ethanesulfonamide", "4-(4-hydroxybenzylideneamino)benzoic acid", "Cyclothiazide(TTD)", "1,2,4-Triazole", "N-[(5-chloro-1-benzothien-3-yl)methyl]sulfamide", "2-(4-hydroxybenzylideneamino)ethanesulfonamide", "N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide", "2-(4-tert-butylbenzylideneamino)ethanesulfonamide", "Methyl 4-(4-hydroxybenzylideneamino)benzoate", "4-nitrophenylsulfamide", "Di(2,6-diisopropylphenol)", "AL5424", "Dansylamide", "4-(benzylideneamino)benzoic acid", "2,6-Difluorobenzenesulfonamide", "N-Benzyl-4-Sulfamoyl-Benzamide", "Sulfamic acid chroman-2-ylmethyl ester", "N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide", "2,6-di-t-butylphenol", "1-pentenyl-4-(aminosulfonyl)benzoate", "Al7089a", "Methyl Mercury Ion", "Allyl 4-(aminosulfonyl)benzoate", "4-(2-AMINOETHYL)BENZENESULFONAMIDE(Drug Bank)", "3-Mercuri-4-Aminobenzenesulfonamide", "GUAIACOL", "AL6528", "6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE", "4-(Hydroxymercury)Benzoic Acid", "PRONTOCIL", "AL7099A", "Methyl 4-(4-tert-butylbenzylideneamino)benzoate", "N-[(4-bromo-1-benzothien-3-yl)methyl]sulfamide", "6-Nitro-benzothiazole-2-sulfonic acid amide", "Ethinamate(TTD)", "AL7182", "4-Thiocyanato-benzenesulfonamide", "Mercuribenzoic Acid", "3,5-Difluorobenzenesulfonamide"], "['57468']": ["VU0240551", "CLP-635"], "['7054']": ["3-iodotyrosine", "Meta-Tyrosine", "Metyrosine", "L-Tyrosine", "3-chlorotyrosine", "L-Phenylalanine"], "['4128', '4129']": ["7-Methoxy-9H-beta-carboline", "2-Furan-2-yl-4,5-dihydro-1H-imidazole", "8-Benzyloxycaffeine", "2-Chloro-N-(3-morpholinopropyl)nicotinamide", "Tarnylcypromine derivative 3", "(+/-)-2-Phenylthiomorpholin-5-one", "(6-Benzyloxy-2-naphthyl)-2-aminopropane", "2-Phenethyl-4,5-dihydro-1H-imidazole", "(7-Benzyloxy-2-oxo-2H-chromen-4-yl)acetonitrile", "(6-Methoxy-2-naphthyl)-2-aminopropane", "8-[(3-Trifluoromethyl)benzyloxy]caffeine", "3,4-Dichloro-N-(2-methyl-1H-indol-5-yl)benzamide", "6-amino-9-methoxy-7H-furo[3,2-g]chromen-7-one", "TRYPTOLINE", "8-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline", "N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide", "6-Bromo-4,9-dihydro-3H-beta-carboline", "C-(1H-Indol-3-yl)-methylamine", "2-(5-phenyl-furan-2-yl)-4,5-dihydro-1H-imidazole", "N-(2-phenylethyl),N-(pyrrol-2-ylmethyl)amine", "N-Benzyl-1H-indole-2-carboxamide", "(+/-)-2-(4'-Ethoxyphenyl)thiomorpholine", "TRYPTAMINE", "Phenyl 4-(4,5-dihydro-1H-imidazol-2-yl)benzoate", "5-Bromo-4,9-dihydro-3H-beta-carboline", "N-methyl,N-(benzyl),N-(pyrrol-2-ylmethyl)amine", "Trans-2-(4-chlorophenyl)-2-fluorocyclopropanamine", "7-Bromo-4,9-dihydro-3H-beta-carboline", "Heteroaryl-cyclopropylamine derivative 1", "2-oxo-N-m-tolyl-2H-chromene-3-carboxamide", "1-(4-(benzyloxy)phenyl)propan-2-amine", "(+/-)-2-(4'-Propoxyphenyl)thiomorpholin-5-one", "3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin", "6-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline", "N-(2-phenylcyclopropyl) amino acid derivative 3", "8-Bromo-4,9-dihydro-3H-beta-carboline", "N-(2-Phenylethyl)-1H-indole-2-carboxamide", "7-Acetonyloxy-3,4-cyclohexene-8-methylcoumarin", "8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline", "N-Benzyl-N-(1H-indol-2-ylmethyl)-N-methylamine", "N-methyl,N-(propargyl),N-(pyrrol-2-ylmethyl)amine", "2-oxo-N-p-tolyl-2H-chromene-3-carboxamide", "(+/-)-2-(4'-Butoxyphenyl)thiomorpholine", "(S)-2-amino-1-(4-butylthiophenyl)-propane", "(+/-)-2-Phenylthiomorpholine", "N-(4-Ethylphenyl)-2-oxo-2H-chromene-3-carboxamide", "Selegiline(Drug Bank)", "N-(benzyl),N-(pyrrol-2-ylmethyl)amine", "AS602868", "2-Phenoxymethyl-4,5-dihydro-1H-imidazole", "2-(4,5-dihydro-1H-imidazol-2-yl)quinoline", "N-Methyl,N-phenyl-1H-indole-2-carboxamide", "5-Methoxy-4,9-dihydro-3H-beta-carboline", "9-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline", "8-(3-Chlorobenzyloxy)caffeine", "2-oxo-N-phenyl-2H-chromene-3-carboxamide", "2-Bromo-N-(2-morpholinoethyl)nicotinamide", "1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole", "Pargyline(Drug Bank)", "2-Chloro-N-(2-morpholinoethyl)nicotinamide", "(E)-5-(3-Chlorostyryl)isatin", "5-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline", "N-Benzyl,N-methyl-1H-indole-2-carboxamide", "(+/-)-2-(4'-Butoxyphenyl)thiomorpholin-5-one", "TOLOXATONE", "(+/-)-2-(4'-Methoxyphenyl)thiomorpholine", "5-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline", "8-(3-Fluorobenzyloxy)caffeine", "(R/R)BEFLOXATONE", "HYDRAZINECARBOXAMIDE", "Psoralen", "2-phenyl-9H-indeno[2,1-d]pyrimidine", "4,9-Dihydro-3H-beta-carboline", "4-(2-oxo-2H-chromene-3-carboxamido)benzoic acid", "8-(3-Methylbenzyloxy)caffeine", "N-(1H-Indol-2-ylmethyl)-N-phenylamine", "Cyclic peptide derivative 1", "N-(1H-Indol-2-ylmethyl)-N-methyl-N-phenylamine", "(+/-)-2-(4'-Ethoxyphenyl)thiomorpholin-5-one", "(E)-5-Styrylisatin", "Schiff base compound 1", "5-Hydroxymethyl-3-pyrrol-1-yl-oxazolidin-2-one", "Trans-2-fluoro-2-(4-fluorophenyl)cyclopropanamine", "4,8-Dimethyl-7-(2'-oxocyclohexyloxy)coumarin", "7-Acetonyloxy-3,4-cyclopentene-8-methylcoumarin", "IPRONIAZIDE", "Tarnylcypromine derivative 2", "(E)-5-(3-Fluorostyryl)isatin", "PNU-22394", "CGS-19281A", "8-(3-Methoxybenzyloxy)caffeine", "4-(Aminomethyl)-7-(benzyloxy)-2H-chromen-2-one", "Trans-2-fluoro-2-phenylcyclopropylamin", "Isocarboxazid(Drug Bank)", "(S)-2-amino-1-(4-propylthiophenyl)-propane", "N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide", "(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholine", "Trans-2-fluoro-2-p-tolylcyclopropanamine", "2-(naphthalen-2-yl)-4,5-dihydro-1H-imidazole", "PIPERINE", "(+/-)-2-(4'-Methoxyphenyl)thiomorpholin-5-one", "N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide", "(R)-Indan-1-yl-methyl-prop-2-ynyl-amine", "CHF-3381", "2-(2-cycloheptylidenehydrazinyl)-4-phenylthiazole", "2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole", "4-methyl-7-(2-oxocyclopentyloxy)-2H-chromen-2-one", "N-(3-Phenylpropyl)-1H-indole-2-carboxamide", "Tranylcypromine", "8-(3-Bromobenzyloxy)caffeine", "(6-Ethoxy-2-naphthyl)-2-aminopropane", "N-Phenyl-1H-indole-2-carboxamide", "(+/-)-2-(4'-Propoxyphenyl)thiomorpholine", "N-(propargyl),N-(pyrrol-2-ylmethyl)amine", "N2-[4-(benzyloxy)benzyl]glycinamide", "7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline", "(6-Propoxy-2-naphthyl)-2-aminopropane", "2-[7-(Benzyloxy)-2-oxo-2H-chromen-4-yl]acetamide", "6-Methoxy-4,9-dihydro-3H-beta-carboline", "Cis-2-phenylcyclopropylamine", "2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole", "7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin", "2-BFi", "TRACIZOLINE", "6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline", "3,4-Benzo-7-acetonyloxy-8-methoxycoumarin", "N-(4-Phenylbutyl)-1H-indole-2-carboxamide", "3-Chloro-N-(2-methyl-1H-indol-5-yl)benzamide", "Tacrine-coumarin hybrid derivative 1", "7-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline", "8-Methoxy-4,9-dihydro-3H-beta-carboline"], "['43', '8942']": ["3,6,9,12,15-Pentaoxaheptadecane(TTD)"], "['2977']": ["Riociguat(Drug Bank)", "Plecanatide(Drug Bank)"], "['759', '760']": ["N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE", "4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide", "4-(2-Phenylacetamidoethyl)benzenesulfonamide", "4-phenoxyphenylboronic acid", "Ethinamate(Drug Bank)", "ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE", "3-phenylprop-1-enylboronic acid", "4-bromophenylboronic acid", "IODIDE", "4-(2-Phenylacetamido)-3-bromobenzenesulfonamide", "4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide", "Phenethylboronic acid", "3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide", "2-Hydroxycinnamic acid", "Dichlorphenamide", "4-[2-(2-Thienyl)acetamido]benzenesulfonamide", "4-(2-Pyridin-2-ylacetamido)benzenesulfonamide", "Phenoxyarsonous acid", "4,6-Dinitro salicylic acid", "4-methoxyphenylboronic acid", "4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide", "4-isothiocyanatobenzenesulfonamide", "5-Chlorosalicylic Acid", "2-Acetylamino-indan-5-sulfonic acid hydrate", "Benzothiazole-2-sulfonic acid amide", "Biphenyl-4-ylboronic acid", "4-nitrophenyl phosphate", "5-hydroxy-1-tosyl-1H-pyrrol-2(5H)-one", "Beta-naphthylboronic acid", "3-(4-sulfamoylphenyl)propanoic acid", "6-Amino-benzothiazole-2-sulfonic acid amide", "2,4-dichloro-5-sulfamoylbenzoic acid", "4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide", "4-(2-Phenylacetamido)benzenesulfonamide", "4-(2-Phenylacetamidomethyl)benzenesulfonamide", "Ethoxzolamide(TTD)", "NITRATE", "N-[4-(trifluoromethyl)phenyl]sulfamide", "4-(2-Pyridin-4-ylacetamido)benzenesulfonamide", "N-unsubstituted carbamate esters", "4-butylphenylboronic acid"], "['6833']": ["Gliclazide", "NS-11757", "Chlorpropamide(Drug Bank)", "HBR-985", "Acetohexamide(TTD)", "Glimepiride(Drug Bank)", "Repaglinide(Drug Bank)", "Tolazamide(Drug Bank)", "Glibenclamide", "Glipizide(Drug Bank)", "NN-414", "Tolbutamide(Drug Bank)", "Intravenous glibenclamide", "Mitiglinide(Drug Bank)"], "['43', '6530', '6531', '6531', '6532']": ["4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one"], "['1576', '3292']": ["3,3-(1,3-Thiazole-2,5-diyl)diphenol", "1,1':4',1''-terphenyl-3,3''-diol", "3-[5-(4-Hydroxyphenyl)-3-thienyl]phenol"], "['6539']": ["NNC052090"], "['191', '217', '2548', '2582', '2595', '2936', '3156', '3292', '3295', '3615', '3939', '3939', '3945', '3948', '644', '6652', '8972', '8972']": ["Nicotinamide-Adenine-Dinucleotide"], "['7177']": ["Lactoferrin", "APC-2059", "Pentamidine(TTD)", "BABIM", "APC-366", "Actoferrin", "BAY-17-1998", "MOL 6131", "BAY-44-3428", "GRASSYSTATIN A", "AMG-126737"], "['216', '3156', '7167']": ["1,4-Dithiothreitol(Drug Bank)"], "['2224']": ["1-[(prop-1-ylamino)ethyl]-1,1-bisphosphonic acid", "NE58027", "NE10790", "1-[(tert-butylamino)ethyl]-1,1-bisphosphonicacid", "PMID12014956C12 ", "NE58043", "BPH-675", "NE58062", "NE-10575", "NERIDRONIC ACID", "1-[(n-oct-1-ylamino)ethyl]-1,1-bisphosphonic acid", "1-[(prop-2-ylamino)ethyl]-1,1-bisphosphonicacid", "Dimethylallyl Diphosphate(TTD)", "BPH-252", "Zoledronate", "1-[(n-hex-1-ylamino)ethyl]-1,1-bisphosphonic acid", "Bisphosphonates", "ISOPENTENYL PYROPHOSPHATE(TTD)", "Minodronate", "PMID18800762C11", "PMID18800762C14", "PMID18800762C16", "PMID18800762C19", "1-[(cyclohexylamino)ethyl]-1,1-bisphosphonicacid", "Alendronate", "(2E, 6E)-farnesylbisphosphonate", "Isopentyl Pyrophosphate", "Ibandronate(TTD)", "PMID18800762C51", "3-azageranylgeranyl diphosphate", "[2-(Purin-9-yl)ethyl]-bisphosphonic acid", "NE97220", "[2-(Imidazol-2-yl-thio)ethyl]-bisphosphonic acid", "[2-(Benzoimidazol-1-yl)ethyl]-bisphosphonic acid", "BPH-742", "NE21650", "NE11808", "PMID17963374C31", "GERANYLGERANYL DIPHOSPHATE", "NE58018", "(1-hydroxy-1-phosphono-heptyl)-phosphonic acid", "Risedronate", "(biphenyl-3-ylamino)methylenediphosphonic acid", "diphosphoric acid", "BPH-628", "BPH-629", "Incadronate", "PMID17975902C5e", "Zarnestra", "CT-10", "Homorisedronate", "Piridronic acid", "[2-(Imidazol-1-yl)ethyl]-bisphosphonic acid", "digeranyl bisphosphonate", "[2-(Pyrazol-1-yl)ethyl]-bisphosphonic acid", "BPH-608", "1-[(n-but-1-ylamino)ethyl]-1,1-bisphosphonic acid", "BPH-715", "PMID18800762C47", "BPH-676", "1-(but-2-ylamino)ethyl 1,I-bisphosphonic acid", "PG-1014491", "PMID18295483C2", "Pamidronate", "Geranyl Diphosphate(TTD)", "OLPADRONIC ACID SODIUM SALT", "[2-(6-Chloro-purin-9-yl)ethyl]-bisphosphonic acid"], "['3423']": ["Idursulfase(TTD)", "Recombinant human iduronate-2-sulfatase"], "['760', '765', '768', '771']": ["2-hydrazinylbenzenesulfonamide", "P-TOLUENESULFONAMIDE"], "['6534']": ["LP-403812"], "['240', '240', '7296']": ["5,8-Dihydroxy-1,4-naphthoquinone"], "['5033', '8639']": ["Hydralazine(Drug Bank)"], "['122622', '3615', '5837']": ["Inosinic Acid(Drug Bank)"], "['240', '240', '4860']": ["7-tert-butyl-2, 3-dihydro-3, 3-dimethyl substituted dihydrofuran 30 (DHDMBF30)"], "['6530', '6531', '6531', '6532', '6571']": ["Mazindol(Drug Bank)", "METHYLENEDIOXYMETHAMPHETAMINE"], "['4048', '5320']": ["2-(4-phenoxyphenoxy)ethanamine"], "['1633', '6240']": ["Fludarabine(Drug Bank)"], "['6448']": ["HGT-1410"], "['476', '477', '478']": ["Ouabain(Drug Bank)"], "['27306']": ["Praziquantel", "Protoporphyrin IX", "S-hexylglutathione", "Tranilast(Drug Bank)", "H-PGDS inhibitors", "Cibacron blue", "HQL-79"], "['279']": ["Pyroglutamic Acid", "Alpha-acarviosinyl-(1-->9)-3-alpha-D-glucopyranosylpropen", "5-Hydroxymethyl-Chonduritol(TTD)", "Acarbose Derived Hexasaccharide", "4,6-Dideoxy-4-Amino-Alpha-D-Glucose", "Hydroxycitric acid", "Alpha-acarviosinyl-(1-->7)-3-alpha-D-glucopyranosylpropen", "Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam"], "['1610']": ["SEP-227900", "TAK-831"], "['2135', '26229', '27087', '2992', '360203']": ["Uridine-5'-Diphosphate(Drug Bank)"], "['55244']": ["Metformin(TTD)"], "['84649', '8694', '8694']": ["PMID25470667-Compound-Figure4-1A"], "['1066', '1066', '590']": ["1,2-bis(2,3-fluorophenyl)ethane-1,2-dione", "1-(3,4-dichlorobenzyl)-1H-indole-2,3-dione", "ACENAPHTHOQUINONE", "Phenanthrene-9,10-dione", "1,2-indanedione"], "['55']": ["MVI-816"], "['2717', '3938']": ["2,5-dideoxy-2,5-imino-D-altritol"], "['1633']": ["LP-661438"], "['2645']": ["PF-04937319", "TAK-329", "GK1-399", "ADV-1002401", "BMS-820132", "LY-2599506", "Piragliatin", "DS-7309", "AMG 151"], "['2030', '240', '240', '51086', '5287', '5288', '5293', '5294', '5298', '54658', '79837', '8396', '8396', '8654']": ["Fostamatinib(Drug Bank)"], "['9388']": ["GSK-264220A"], "['191']": ["5'-S-ethyl-5'-thioadenosine", "5(E)-(5'-Deoxyadenosin-5'-ylidene)pentanoic acid", "ARISTEROMYCIN", "NORARISTEROMYCIN", "FLUORO-NEPLANOCIN A", "3'-Oxo-Adenosine", "5'-deoxy-5'-ureidoadenosine", "D-Eritadenine", "4(Z)-(5'-Deoxyadenosin-5'-ylidene)butanoic acid", "5-methylenearisteromycin", "DZNep", "Neplanocin A", "ERITADENINE"], "['5143']": ["US10077269, Example 6", "CS-W011402", "ZINC584606052"], "['1632']": ["Benzamidine(Drug Bank)"], "['1584', '5139']": ["6-Pyridin-3-yl-3,4-dihydro-1H-quinolin-2-one"], "['5291']": ["ISIS 32003", "ISIS 32002", "ISIS 32000", "ISIS 32005", "ISIS 32004", "ISIS 32008", "ISIS 32006", "ISIS 31996", "ISIS 32024", "BAY 1082439", "ISIS 32039", "ISIS 32035", "ISIS 32014", "ISIS 32015", "ISIS 32010", "ISIS 31963", "GSK2636771", "ISIS 31982", "AZD6482", "ISIS 32028", "ISIS 32021", "ISIS 32020"], "['210', '27306', '3162', '4842', '760']": ["Formic Acid"], "['2548', '2595']": ["Tendamistat", "JBP-1", "POP-1", "Anamorelin", "4,6-Dideoxyglucose"], "['231', '2539', '3156', '3290', '3292', '4842', '8644']": ["2'-Monophosphoadenosine 5'-Diphosphoribose"], "['6839']": ["chaetocin"], "['5742', '5743', '6916']": ["5-(2-Imidazol-1-yl-ethyl)-7,8-dihydro-quinoline"], "['4881']": ["Nitroprusside(Drug Bank)", "Nitroglycerin(Drug Bank)", "Nesiritide(TTD)", "Ularitide"], "['5144']": ["BPN14770"], "['1806']": ["RO-09-4889", "FL-386", "5-Iodouracil", "Uracil(TTD)", "Eniluracil(TTD)", "(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione", "6-Carboxymethyluracil"], "['383', '384']": ["BCT-100", "INCB01158"], "['883']": ["D-Phenylalanine(Drug Bank)"], "['6523']": ["GSK1614235", "QNEQCPQVSac", "T-1095", "QCP", "QCPac", "QSPac", "Phlorizin", "Acerogenin A"], "['1066', '1066', '2717', '3938', '4842', '5319', '5742', '590']": ["Alpha-D-Mannose"], "['411']": ["Galsulfase(TTD)"], "['10599', '28231', '28232', '53919', '6579']": ["[3H]estrone-3-sulphate"], "['5290']": ["BLY719", "PWT-33597", "MLN1117", "LY3023414"], "['2030', '3177']": ["Ethanol(Drug Bank)"], "['6697']": ["N-acetylserotonin(Drug Bank)"], "['6559', '759', '760']": ["Chlorothiazide(Drug Bank)"], "['189']": ["AMT-030"], "['4363', '4363']": ["Sulfinpyrazone(TTD)", "Pyrrolopyrimidine", "Romidepsin(Drug Bank)"], "['1576']": ["AVI-4557(TTD)", "(-)-yatein", "1-Acetoxy-2-tert-butyldimethylsilyl-oxylycorine", "Casopitant(Drug Bank)", "Alpha-Hydroxy-Midazolam", "Go-Y026", "3-(5-[1,3]dithiolan-2-yl-furan-2-yl)pyridine", "BERGAPTOL", "PMX-53", "(-)-thujaplicatintrimethyl ether", "GSK-8062", "MEDIORESINOL", "3-(pyridin-3-yl)prop-2-yn-1-amine", "ETHOXYCLUSIN", "ML-3403", "2-fluoro-5-(3-methylthiophen-2-yl)pyridine", "2,5-bis(4-hydroxybenzylidene)cyclopentanone", "HINOKININ", "BMS-536924", "5-(2-phenethylpiperazin-1-yl)-1H-indazole", "Geranylcoumarin", "1-Acetoxylycorine", "3-(5-((methylthio)methyl)furan-2-yl)pyridine", "JATRORRHIZINE", "PALMATINE", "ML-3375", "2-tert-Butyldimethylsilyloxylycorine", "(8R,8'R,9'S)-5-methoxyclusin", "TILIROSIDE", "5-Pyridin-3-yl-thiophene-2-carbaldehyde oxime", "DIETHOXYFLOURESCEIN", "Alpha-methylcubebin", "(8R,8'R)-4-hydroxycubebinone", "(-)-clusin", "1,2-Diacetoxylycorine", "(-)-cubebin", "(-)-dihydroclusin", "3-(3-methylthiophen-2-yl)pyridine", "(-)-cubebinin", "(-)-cubebininolide"], "['18', '7915']": ["1-(4-hydroxyphenyl)prop-2-en-1-one"], "['1066', '1066']": ["CL-277082", "1,2-Bis-(3-nitro-phenyl)-ethane-1,2-dione", "Thenoyltrifluoroacetone(TTD)", "1,1,1-trifluoro-3-(octylsulfinyl)propan-2-one", "1-dodecyl-1H-indole-2,3-dione", "5,7-dichloro-1H-indole-2,3-dione", "Dimethyl 2,2,2-trifluoro-1-phenylethyl phosphate", "1-(4-Chloro-phenyl)-2-phenyl-ethane-1,2-dione", "VULM-1457", "447C88", "CL-283796", "1-(2-bromoethyl)-1H-indole-2,3-dione", "3-(decylthio)-1,1,1-trifluoropropan-2-one", "KY-382", "PD-132301-2", "1,2-Bis-(4-methoxy-phenyl)-ethane-1,2-dione", "1,2-bis(2-fluorophenyl)ethane-1,2-dione", "1,2-bis(3,4-difluorophenyl)-2-hydroxyethanone", "1,2-bis(2,4-difluorophenyl)-2-hydroxyethanone", "YM-750", "3,5-Di-tert-butyl-[1,2]benzoquinone", "FR-145237", "1-(4-Nitro-phenyl)-2-phenyl-ethane-1,2-dione", "1,2-bis(2,3,5-trifluorophenyl)ethane-1,2-dione", "(E)-Octadec-9-enoic acid phenylamide", "1-Phenyl-propane-1,2-dione", "1-hexadecyl-1H-indole-2,3-dione", "1,2-bis(3,4,5-trifluorophenyl)-2-hydroxyethanone", "1-(3,4-Dimethyl-phenyl)-2-phenyl-ethane-1,2-dione", "O-Sialic Acid", "CEB-925", "1,2-dicyclohexylethane-1,2-dione", "3-(decylsulfonyl)-1,1,1-trifluoropropan-2-one", "RP-70676", "Lecimibide", "CI-976", "1-benzyl-1H-indole-2,3-dione", "1-Phenyl-2-p-tolyl-ethane-1,2-dione", "1-propionyl-1H-indole-2,3-dione", "Heptane-2,3-dione", "1,2-Bis-(4-bromo-phenyl)-ethane-1,2-dione", "4-(2-Oxo-2-phenyl-acetyl)-benzoic acid", "1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone", "6,7-dichloro-1H-indole-2,3-dione", "1,2-bis(3,5-difluorophenyl)-2-hydroxyethanone", "1,2-Bis-(2-chloro-phenyl)-ethane-1,2-dione", "Thieno[3,2-e][1]benzothiophene-4,5-dione", "4,7-dichloro-1H-indole-2,3-dione", "HL-004", "1,2-bis(3-fluorophenyl)-2-hydroxyethanon", "1,1,1-trifluoro-3-(hexylthio)propan-2-one", "CI-999", "2,2-dimethyl-3-methyleneheptadecane", "1,2-bis(3,4-difluorophenyl)ethane-1,2-dione", "BENZOIN", "FR-129169", "1,2-Bis-(3-methoxy-phenyl)-ethane-1,2-dione", "1,2-bis(2,3,5-trifluorophenyl)-2-hydroxyethanone", "GR148672X", "1-(4-Methoxy-phenyl)-2-phenyl-ethane-1,2-dione", "3-(dodecylsulfinyl)-1,1,1-trifluoropropan-2-one", "1,2-Di-naphthalen-2-yl-ethane-1,2-dione", "4-Piperidino-Piperidine", "1,2-Bis-(4-chloro-phenyl)-ethane-1,2-dione", "7-chloro-1H-indole-2,3-dione", "1-(4-chlorobenzyl)-1H-indole-2,3-dione", "4-chloro-1H-indole-2,3-dione", "1,2-bis(2,3,6-trifluorophenyl)ethane-1,2-dione", "1,2-bis(3,5-difluorophenyl)ethane-1,2-dione", "1,1,1-trifluoro-3-(octylthio)propan-2-one", "F-1394", "4,5-dichloro-1H-indole-2,3-dione", "RP-73163", "1,2-bis(2,3-difluorophenyl)-2-hydroxyethanone", "RP-64477", "1,2-Di-p-tolyl-ethane-1,2-dione", "3-(butylthio)-1,1,1-trifluoropropan-2-one", "3-(butylsulfinyl)-1,1,1-trifluoropropan-2-one", "PACTIMIBE", "1,10-phenanthroline-5,6-dione", "K-604", "7-(trifluoromethyl)-1H-indole-2,3-dione", "1,2-bis(2,3,4-trifluorophenyl)ethane-1,2-dione", "2-methoxy-3,4-methylenedioxybenzophenone", "BENZIL", "Dibutyl 2,2,2-trifluoro-1-phenylethyl phosphate", "1-(2-iodoethyl)-1H-indole-2,3-dione", "Diethyl 2,2,2-trifluoro-1-phenylethyl phosphate", "Naloxone(Drug Bank)", "NTE-122", "1-phenyl-1H-indole-2,3-dione", "5-(trifluoromethoxy)-1H-indole-2,3-dione", "11,12-dihydro-dibenzo[a,e]cyclooctene-5,6-dione", "1,2-bis(2,5-difluorophenyl)ethane-1,2-dione", "1,2-bis(2-fluorophenyl)-2-hydroxyethanone", "Eflucimibe", "6-bromo-5-methyl-1H-indole-2,3-dione", "1,2-bis(2,6-difluorophenyl)-2-hydroxyethanone", "SCH-48375", "1,2-bis(3,4,5-trifluorophenyl)ethane-1,2-dione", "1-methyl-1H-indole-2,3-dione", "1,1,1-trifluoro-3-(hexylsulfinyl)propan-2-one", "TEI-6522", "2,2-Dimethoxy-1,2-diphenyl-ethanone", "Acenanthrene-9,10-dione", "DuP-129", "4-chloro-7-methyl-1H-indole-2,3-dione", "E-5324", "SMP-797", "3-(dodecylsulfonyl)-1,1,1-trifluoropropan-2-one", "Eldacimibe", "5-chloro-1H-indole-2,3-dione", "1,2-bis(2,6-difluorophenyl)ethane-1,2-dione", "Avasimibe", "3-(decylsulfinyl)-1,1,1-trifluoropropan-2-one", "4,6-dichloro-1H-indole-2,3-dione", "1,2-bis(4-fluorophenyl)ethane-1,2-dione", "N-Methylnaloxonium", "1,1,1-trifluoro-3-(hexylsulfonyl)propan-2-one", "1,2-bis(2,5-difluorophenyl)-2-hydroxyethanone", "YM-17E", "1,2-bis(3-fluorophenyl)ethane-1,2-dione", "1-butyryl-1H-indole-2,3-dione", "1,1,1-trifluorododecan-2-one", "1-(4-Chloro-phenyl)-2-p-tolyl-ethane-1,2-dione", "1,1,1-trifluoro-3-(octylsulfonyl)propan-2-one", "1,2-bis(2,4-difluorophenyl)ethane-1,2-dione"], "['2224', '3422']": ["Dimethylallyl Diphosphate(Drug Bank)"], "['6507']": ["UCPH-101"], "['590']": ["Butanoic Acid", "2-biphenyl-4-yl-1-phenothiazin-10-yl-ethanone", "DODECANESULFONATE ION", "O-tolyl 10H-phenothiazine-10-carboxylate", "(1S)-MENTHYL HEXYL PHOSPHONATE GROUP", "N,N-Diethyl-1'H-phenothiazine-1'-carboxamide", "Isosorbide-2-benzylcarbamate-5-propionate", "N-Isopropyl-1'H-phenothiazine-1'-carboxamide", "N-Cyclopentyl-1'H-phenothiazine-1'-carboxamide", "9-[9-(beta-Carboline-9-yl)nonyl]-beta-carboline", "Butyl 10H-phenothiazine-10-carboxylate", "1-(10H-phenothiazin-10-yl)-4-phenylbutan-1-one", "N,N-Dipropyl-1'H-phenothiazine-1'-carboxamide", "Mivacurium(Drug Bank)", "1-(10H-phenothiazin-10-yl)-3-phenylbutan-1-one", "P-tolyl 10H-phenothiazine-10-carboxylate", "NOSTOCARBOLINE", "Phenyl 10H-phenothiazine-10-carboxylate", "(1'H-Phenothiazin-1'-yl)(piperidin-1-yl)methanone", "BChE inhibitors", "3-[10-(benzylmethylamino)decyloxy]xanthen-9-one", "4-[4-(benzyloxy)piperidino]butyl-4-chlorobenzoate", "9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE", "AS-1397", "3-[11-(benzylmethylamino)undecyloxy]xanthen-9-one", "MF-8623", "Isosorbide-2-benzylcarbamate-5-nicotinate", "Isosorbide-2-(benzylcarbamate)-5-mononitrate", "(10H-phenothiazin-10-yl)(p-tolyl)methanone", "Monoisopropyl Ester Phosphonic Acid Group", "Hexafluronium bromide", "2-Methyl-beta-carboline-2-ium iodide", "Butyrylthiocholine", "3-methoxyphenyl 10H-phenothiazine-10-carboxylate", "Recombinant human butyrylcholinesterase", "N-Cyclohexyl-1'H-phenothiazine-1'-carboxamide", "(-)-DEBROMOFLUSTRAMINE B", "N,N'-(1',2'-ethylene)-bis-(-)-nor-MEP", "3-[12-(benzylmethylamino)dodecyloxy]xanthen-9-one", "M-tolyl 10H-phenothiazine-10-carboxylate", "Isosorbide-2-(butylcarbamate)-5-benzoate", "Bis-cyclosal-d4TMP", "4-methoxyphenyl 10H-phenothiazine-10-carboxylate", "Isosorbide-2-benzylcarbamate-5-isonicotinate", "9-[5-(beta-Carboline-9-yl)pentyl]-beta-carboline", "4-[4-(benzyloxy)piperidino]butyl-4-fluorobenzoate", "(10H-phenothiazin-10-yl)(o-tolyl)methanone", "Malathion(Drug Bank)", "Isosorbide-2-(ethylcarbamate)-5-mononitrate", "N-tert-Butyl-1'H-phenothiazine-1'-carboxamide", "4-chlorophenyl 10H-phenothiazine-10-carboxylate", "Volanesorsen", "Methyl 10H-phenothiazine-10-carboxylate", "Isosorbide-2-benzylcarbamate-5-(o-toluate)", "3-[9-(benzylmethylamino)nonyloxy]xanthen-9-one", "N-(Adamant-1-yl)-1'H-phenothiazine-1'-carboxamide", "N-Neopentyl-1'H-phenothiazine-1'-carboxamide", "ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE", "Naphthalen-2-yl 10H-phenothiazine-10-carboxylate", "Diethylphosphono Group", "(4-nitrophenyl)(10H-phenothiazin-10-yl)methanone", "MEPTAZINOL", "Isosorbide-di-(propylcarbamate)", "N-p-Tolyl-1'H-phenothiazine-1'-carboxamide", "Isosorbide-di-(butylcarbamate)", "1-(10H-phenothiazin-10-yl)-2-phenylbutan-1-one", "Protexia", "Isosorbide-2-benzylcarbamate-5-triflate", "1-methyl-3-(phenylcarbamoyloxy)pyridinium bromide", "N-Cyclobutyl-1'H-phenothiazine-1'-carboxamide", "Naphthalen-1-yl 10H-phenothiazine-10-carboxylate", "Plasma derived human butyrylcholinesterase", "1,2-di(10H-phenothiazin-10-yl)ethane-1,2-dione", "9-N-Phenylmethylamino-Tacrine", "Naphthalen-1-yl(10H-phenothiazin-10-yl)methanone", "(1R)-MENTHYL HEXYL PHOSPHONATE GROUP", "N,N'-(1',3'-propylene)-bis-(-)-nor-MEP", "N-Phenyl-1'H-phenothiazine-1'-carboxamide", "Cyclosal-d4TMP", "NP-0336", "Isosorbide-2-(butylcarbamate)-5-mononitrate", "Non-PEGylated butyrylcholinesterase", "4-[4-(benzyloxy)piperidino]butyl benzoate", "(10H-phenothiazin-10-yl)(phenyl)methanone", "N-Benzyl-1'H-phenothiazine-1'-carboxamide", "Tert-butyl 10H-phenothiazine-10-carboxylate", "N-o-Tolyl-1'H-phenothiazine-1'-carboxamide", "Ethyl Dihydrogen Phosphate", "RVT-103+RVT-104", "(10H-phenothiazin-10-yl)(m-tolyl)methanone", "Isosorbide-2-benzylcarbamate-5-pentanoate", "Cyclopentyl 10H-phenothiazine-10-carboxylate", "Di-substituted piperidine derivative 1", "Di-substituted piperidine derivative 3", "1-(10H-phenothiazin-10-yl)-2-phenylpropan-1-one", "N,N'-(1',4'-butylene)-bis-(-)-nor-MEP", "5-methyl-cyclosal-d4TMP", "Naphthalen-2-yl(10H-phenothiazin-10-yl)methanone", "4-[4-(benzyloxy)piperidino]butyl-3-fluorobenzoate", "(3-bromophenyl)(10H-phenothiazin-10-yl)methanone", "Isosorbide-2-benzyl carbamate", "3-isopr-sal-cyclosal-d4TMP", "1-(10H-phenothiazin-10-yl)-3-phenylpropan-1-one", "Morpholino(1'H-phenothiazin-1'-yl)methanone", "DEMETHYLDEBROMOFLUSTRAMINE B", "3-phenyl-cyclosal-d4TMP", "Anthracen-10-yl(10H-phenothiazin-10-yl)methanone", "4-[4-(benzyloxy)piperidino]butyl-3-chlorobenzoate", "VAGANINE D", "2-methoxyphenyl 10H-phenothiazine-10-carboxylate", "4-[4-(benzyloxy)piperidino]butyl-4-nitrobenzoate", "3-chlorophenyl 10H-phenothiazine-10-carboxylate", "3-sal-cyclosal-d4TMP", "1-(10H-phenothiazin-10-yl)-2-phenylethanone", "N,N-Dimethyl-1'H-phenothiazine-1'-carboxamide", "(-)-Phenethylcymserine", "Isopropyl 10H-phenothiazine-10-carboxylate", "Isosorbide-2-(benzylcarbamate)-5-benzoate", "N,N-Diisopropyl-1'H-phenothiazine-1'-carboxamide", "Isosorbide-2-(cyclohexylcarbamate)-5-mononitrate", "Isosorbide-2-(propylcarbamate)-5-mononitrate", "Isosorbide-2-benzylcarbamate-5-acetate", "JES-9501", "(4-bromophenyl)(10H-phenothiazin-10-yl)methanone"], "['760', '762', '790']": ["N-(phosphonacetyl)-L-aspartate"], "['1583', '1583', '1588']": ["3-(4-Amino-phenyl)-3-butyl-piperidine-2,6-dione", "3-(4-Amino-phenyl)-3-pentyl-piperidine-2,6-dione", "Aminoglutethimide"], "['760', '768', '771']": ["ACETYLSULFANILAMIDE", "3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide", "2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide", "N-(4-Sulfamoyl-phenyl)-isobutyramide", "3-((4-aminophenyl)diazenyl)benzenesulfonamide", "3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide", "4-((4-hydroxyphenyl)diazenyl)benzenesulfonamide"], "['6713', '7498']": ["1,2,3,4,6-penta-O-galloyl-beta-D-glucose"], "['1327', '1329', '1339', '1340', '1345', '1346', '1349', '1350', '1351', '4512', '4513', '4514', '4535', '9377']": ["N-Formylmethionine(Drug Bank)"], "['3615', '5805']": ["Mycophenolate mofetil(Drug Bank)"], "['7173', '7173']": ["Methimazole", "Carbimazole", "Propylthiouracil(Drug Bank)", "TPO gene plasmid"], "['5538']": ["Plitidepsin"], "['587']": ["N-[O-Phosphono-Pyridoxyl]-Isoleucine", "Alpha-ketoisovalerate", "N'-(phenylsulfonyl)quinoline-6-carbohydrazide", "Pyridoxamine-5'-Phosphate(TTD)", "N'-(phenylsulfonyl)benzofuran-2-carbohydrazide"], "['116085', '55867']": ["Lesinurad(Drug Bank)"], "['23632', '358', '759', '760', '761', '762', '766', '771']": ["Acetazolamide(Drug Bank)"], "['4860']": ["9-Deazahypoxanthine", "DADMe-ImmG", "2,8-Diamino-9-benzyl-1,9-dihydro-purin-6-one", "9-(5,5-Difluoro-5-Phosphonopentyl)Guanine", "(+/-)-5'-deoxy-4'-fluoro-5'-methylthio-DADMe-ImmH", "5'-phenylthio-ImmH", "8-Iodo-Guanine", "GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE", "Hypoxanthine", "CI-972", "2'3'-Dideoxyinosine", "3-Deoxyguanosine", "MT-Immucillin-H", "BCX-3408", "Immucillin-G", "Peldesine", "8-amino-9-benzylguanine", "8-AMINOGUANINE", "9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE", "Aza-C-nucleosides", "5'-methylthio-immucillin-H", "2-Hydroxymethyl-Pyrrolidine-3,4-Diol", "Ribose-1-Phosphate", "8-Azaguanine", "3-((2-Pyrrolidine-1-yl)-ethyl)uracil", "Guanosine", "Forodesine", "GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE", "8-aminoguanosine", "5'-deoxy-4'-hydroxy-5'-methylthio-DADMe-ImmH", "9-Deazainosine", "5'-Methylthio-ImmH", "8-aza-DADMe-ImmH"], "['2643']": ["Guanine(TTD)", "Guanosine-5'-Triphosphate(TTD)", "8-hydroxyguanine"], "['10724']": ["MK 8719"], "['7296']": ["Fotemustine", "4,6-dinitrobenzo[c][1,2,5]thiadiazole", "Palmarumycin derivative 4", "Palmarumycin derivative 1", "Palmarumycin derivative 2", "Palmarumycin derivative 3", "Arsenic trioxide(Drug Bank)", "Disulfide compound 1", "PMID27977313-Compound-5", "PMID27977313-Compound-7", "PMID27977313-Compound-6", "PMID27977313-Compound-8", "3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide", "Spermidine", "Metal complex derivative 2", "Metal complex derivative 3", "Metal complex derivative 1", "Golden phosphorous acetyletic compound 3", "Acyl oxymethyl acrylamide ester derivative 2", "4-aryl quinol derivative 1", "Binuclear gold(I) compound 2", "Binuclear gold(I) compound 3", "Binuclear gold(I) compound 1", "PMID27977313-Compound-28", "PMID27977313-Compound-29", "PMID27977313-Compound-27", "Disulfide compound 2", "PMID27977313-Compound-48", "PMID27977313-Compound-42", "PMID27977313-Compound-43", "PMID27977313-Compound-46", "PMID27977313-Compound-47", "PMID27977313-Compound-44", "PMID27977313-Compound-45", "4-aryl quinol derivative 4", "4-aryl quinol derivative 5", "4-aryl quinol derivative 7", "4-aryl quinol derivative 2", "4-aryl quinol derivative 3", "Bis-sulfonamide derivative 2", "Bis-sulfonamide derivative 1", "Benzisoselenazolone difluorocytidine derivative 1", "PMID27977313-Compound-Figure6C", "PX-12(Drug Bank)", "Triazole gold complexe 3", "Triazole gold complexe 2", "Triazole gold complexe 1", "PMID27977313-Compound-Figure4b", "Terpyridineplatinum(II) complexe 5", "Terpyridineplatinum(II) complexe 1", "Terpyridineplatinum(II) complexe 2", "PMID27977313-Compound-39", "PMID27977313-Compound-32", "PMID27977313-Compound-31", "PMID27977313-Compound-30", "Bis(2,4-dinitrophenyl)sulfane", "PMID27977313-Compound-17", "PMID27977313-Compound-19", "PMID27977313-Compound-18"], "['1559']": ["Sulfaphenazole", "Benzbromarone(Drug Bank)"], "['23632', '762', '768', '771']": ["7-(benzyloxy)-2H-chromen-2-one"]}}